data_2ndo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ndo _Structure_validation_residue.Date_analyzed 2017-02-03 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.757 0.313 . . . . 1.37 110.78 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -128.62 136.56 50.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.959 -0.564 . . . . 2.29 109.833 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.63 132.71 49.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 1.83 110.563 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.22 -14.07 55.13 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.866 -0.683 . . . . 0.78 111.917 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.494 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 41.2 tptt -115.38 -74.85 0.6 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.455 -0.202 . . . . 2.32 110.455 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -78.41 -41.73 32.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 1.46 111.027 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -136.85 164.28 28.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.156 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.24 123.84 18.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.136 -0.484 . . . . 1.51 110.284 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.9 m -76.9 127.95 33.67 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.854 -0.425 . . . . 1.54 109.854 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.55 140.97 37.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.813 0.339 . . . . 1.36 110.851 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -25.26 45.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.054 0.454 . . . . 2.33 110.01 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -109.35 90.16 8.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.642 -0.708 . . . . 4.04 109.244 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.24 148.72 30.95 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.525 2.15 . . . . 1.06 112.62 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.1 t -93.88 113.91 29.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.61 -0.723 . . . . 1.3 109.871 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.36 129.16 35.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.087 -0.506 . . . . 1.48 110.481 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.75 34.53 34.45 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.922 -0.656 . . . . 0.8 112.127 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.05 149.12 35.4 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.46 -0.2 . . . . 1.2 110.46 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.5 169.55 11.02 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.888 2.392 . . . . 0.63 112.711 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -65.84 -61.67 1.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.046 -0.524 . . . . 1.79 111.065 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.31 105.12 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.101 0.477 . . . . 1.11 110.747 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.7 tp -107.9 124.28 49.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.147 -0.479 . . . . 1.16 110.707 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -126.35 140.59 52.39 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.164 -0.471 . . . . 1.61 110.024 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -113.15 147.67 36.92 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.081 -0.34 . . . . 0.61 110.081 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.38 174.23 12.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.276 0.56 . . . . 0.67 111.396 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.2 t -153.62 139.26 17.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.439 -0.8 . . . . 1.52 109.079 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.487 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 97.3 m-85 -72.5 -15.0 61.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.947 0.404 . . . . 0.71 110.607 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.414 ' CE1' ' HA2' ' A' ' 69' ' ' GLY . 79.3 m-85 -89.19 -0.53 57.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.549 . . . . 2.16 110.419 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.3 t -108.25 112.61 61.15 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.954 -0.566 . . . . 0.89 111.104 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.55 -23.85 70.41 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.372 2.048 . . . . 0.86 110.935 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -66.63 -28.71 68.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.459 -0.792 . . . . 2.46 109.932 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.46 -38.46 34.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.627 -0.509 . . . . 0.5 109.627 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -59.95 -38.15 81.6 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.259 0.552 . . . . 2.22 109.693 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.627 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 7.7 tt0 -66.7 -39.87 88.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.589 -0.732 . . . . 2.82 110.785 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -78.39 -26.4 46.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.556 -0.293 . . . . 1.05 111.333 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 3.6 tp10 -83.64 -55.02 4.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.529 0.566 . . . . 1.89 112.529 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.95 -48.54 6.47 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.929 0.714 . . . . 2.0 112.929 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 99.7 t -64.62 -54.61 28.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 121.75 -0.594 . . . . 1.18 111.608 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.9 mt -91.59 -31.39 15.91 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.536 0.569 . . . . 1.13 112.536 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 23.9 m-70 59.71 45.08 13.35 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.079 0.466 . . . . 1.19 110.017 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.8 -55.55 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.599 -0.728 . . . . 1.13 111.055 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 m -53.48 -47.76 69.52 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.502 0.501 . . . . 1.37 111.708 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.84 -43.97 97.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.513 -0.312 . . . . 1.73 111.226 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -65.24 -44.32 88.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.127 -0.488 . . . . 1.42 110.781 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.661 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 75.4 t -61.81 -47.1 94.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.984 -0.553 . . . . 1.14 110.638 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -53.57 -31.49 46.92 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.284 0.475 . . . . 1.96 112.284 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -89.67 -26.23 20.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.3 0.481 . . . . 2.52 112.3 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 55.2 mttt -84.79 -17.44 38.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.746 0.308 . . . . 1.93 111.568 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 86.4 mt -71.54 136.72 83.45 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.517 -0.311 . . . . 1.54 110.553 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.0 161.44 46.09 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.416 2.077 . . . . 0.97 111.968 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 128.87 38.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.944 0.402 . . . . 2.63 111.368 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.6 -17.06 23.59 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.824 -0.625 . . . . 0.82 112.093 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -98.4 122.01 49.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.642 0.258 . . . . 1.65 110.622 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -104.52 152.65 22.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.03 -0.359 . . . . 2.85 110.03 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.9 ttt -103.82 151.99 22.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.858 0.361 . . . . 1.76 110.318 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.79 124.74 22.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.013 -0.539 . . . . 1.15 110.066 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -114.43 119.4 36.76 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.548 -0.538 . . . . 1.3 109.548 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.449 ' CD2' ' HA ' ' A' ' 138' ' ' GLN . 8.0 m-30 -111.21 151.45 28.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.268 0.556 . . . . 1.05 111.873 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -102.25 130.26 48.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.383 -0.826 . . . . 0.78 109.855 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 m -86.78 159.42 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 111.475 0.176 . . . . 1.37 111.475 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.641 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 41.0 m-20 -107.62 -1.39 21.21 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.452 0.538 . . . . 1.08 112.452 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -96.35 10.68 37.29 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.681 -0.407 . . . . 0.87 111.543 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.86 102.06 4.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.839 0.352 . . . . 1.67 110.398 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.99 7.88 0.69 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.675 -0.693 . . . . 0.78 112.258 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.31 -116.64 8.18 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.941 -0.647 . . . . 0.81 112.408 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.48 -50.69 5.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.884 0.373 . . . . 2.47 111.0 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.52 -15.01 56.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.927 -0.579 . . . . 2.46 111.492 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.414 ' HA2' ' CE1' ' A' ' 29' ' ' PHE . . . -56.87 -31.97 61.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.087 -0.578 . . . . 0.72 112.548 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.641 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 85.2 mttt -74.91 -38.5 61.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.39 . . . . 3.18 110.794 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.34 -40.88 97.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 1.65 111.021 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.89 -26.66 65.22 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.876 -0.33 . . . . 1.65 111.229 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.2 m -66.88 -35.74 80.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.328 0.585 . . . . 1.19 109.492 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -73.48 -41.32 63.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 1.35 109.625 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.96 -41.54 99.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.542 -0.753 . . . . 1.31 110.76 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -61.01 -36.77 80.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.075 -0.511 . . . . 0.59 110.778 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.04 93.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 1.33 110.111 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.81 -41.54 90.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.028 -0.533 . . . . 1.48 109.923 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.85 81.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.87 -0.605 . . . . 1.17 110.892 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.7 mtm -69.12 -36.4 77.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.736 -0.665 . . . . 1.56 110.79 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.68 -35.84 65.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.4 -0.363 . . . . 1.42 111.686 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.19 -28.14 38.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 1.54 110.947 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.93 29.38 18.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.87 -0.681 . . . . 0.78 112.77 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 m -120.93 25.38 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.071 0.462 . . . . 1.36 110.329 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -59.21 -52.19 66.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.451 -0.795 . . . . 1.71 111.443 -178.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.436 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 2.7 t70 -61.77 -39.45 91.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.466 0.65 . . . . 1.91 110.883 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -65.41 -34.89 79.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.432 -0.804 . . . . 2.74 111.86 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.2 m -94.43 -9.38 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.608 0.596 . . . . 1.26 112.608 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.5 m -56.72 -48.54 77.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 1.46 111.867 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.45 -59.61 9.22 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.349 0.5 . . . . 1.26 112.349 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.76 -36.45 95.18 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.216 1.944 . . . . 0.65 113.164 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.45 -42.84 78.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.736 0.303 . . . . 1.34 110.747 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -64.55 -45.27 87.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.537 . . . . 0.58 110.309 179.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.432 ' CD ' ' HZ1' ' A' ' 98' ' ' LYS . 6.4 mm-40 -65.15 -46.97 78.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.759 -0.655 . . . . 1.7 111.409 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.77 -9.14 55.42 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 116.149 -0.478 . . . . 0.82 114.147 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.5 t -109.71 -36.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 117.346 0.573 . . . . 1.23 111.919 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -104.42 -40.69 5.98 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.243 0.831 . . . . 0.84 113.243 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HZ1' ' CD ' ' A' ' 94' ' ' GLU . 28.3 ttmt -83.02 -68.14 0.73 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.883 0.373 . . . . 1.96 111.306 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.46 -35.68 53.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.736 0.303 . . . . 1.86 111.045 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 60.65 29.99 19.4 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.752 -0.658 . . . . 1.73 110.72 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.79 -28.52 44.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.914 -0.584 . . . . 2.07 111.085 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 85.7 mt -74.85 101.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.266 -0.424 . . . . 1.38 110.182 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -116.24 -33.11 5.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 3.77 111.134 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.5 p -118.45 169.7 9.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.115 -0.493 . . . . 1.78 110.565 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.01 -28.61 69.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.413 0.625 . . . . 1.54 109.91 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -31.43 72.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.289 -0.869 . . . . 1.62 110.081 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -71.78 -36.27 70.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.651 -0.704 . . . . 1.89 110.231 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 mt -68.76 -42.07 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.815 -0.63 . . . . 1.44 109.696 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -57.4 -40.18 77.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.236 -0.893 . . . . 2.74 110.066 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.74 -38.15 86.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.549 -0.75 . . . . 1.95 111.734 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.13 -44.91 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 1.42 110.803 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -64.44 -40.1 95.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.92 110.865 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 83.6 mt -63.71 -38.3 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.129 0.49 . . . . 1.85 110.379 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -70.56 -31.2 68.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 2.37 110.981 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.76 -31.11 69.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 1.42 110.714 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.02 -0.26 3.25 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.762 -0.733 . . . . 1.15 112.732 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 45.3 mm -86.28 127.52 40.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.031 -0.359 . . . . 2.16 110.031 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -68.35 139.27 55.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.234 -0.284 . . . . 3.2 110.234 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.88 -43.56 81.61 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.926 -0.579 . . . . 1.25 112.497 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.25 -46.78 88.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.683 0.278 . . . . 2.98 110.912 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -62.84 -45.42 92.68 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.123 0.487 . . . . 2.52 110.195 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -63.58 -48.33 77.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.662 -0.699 . . . . 2.23 110.876 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.65 -35.33 79.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 2.3 110.906 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.71 91.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.039 0.447 . . . . 1.61 109.97 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.48 -33.32 60.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.692 -0.686 . . . . 1.48 110.065 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -60.24 -31.51 70.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.478 0.656 . . . . 1.43 110.179 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -104.42 20.77 17.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.384 -0.825 . . . . 1.63 110.909 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.1 m -93.95 144.79 25.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.06 0.457 . . . . 2.33 111.67 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -65.74 -35.57 81.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.487 -0.779 . . . . 4.45 110.61 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' A' ' 134' ' ' LEU . 63.4 t -53.73 -46.51 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 1.99 110.797 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.434 ' O ' HG21 ' A' ' 135' ' ' VAL . 75.8 t -67.49 -40.72 84.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.677 -0.692 . . . . 1.54 110.774 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -57.83 -46.33 84.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 2.84 111.117 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.3 m -66.16 -29.98 70.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.283 -0.417 . . . . 1.75 110.658 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 130' ' ' VAL . 86.4 mt -68.44 -40.67 81.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.853 -0.425 . . . . 1.53 109.853 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 131' ' ' VAL . 62.1 t -62.02 -44.03 98.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.99 -0.55 . . . . 1.31 110.21 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.76 99.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.738 -0.664 . . . . 1.52 111.046 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -66.55 -35.0 79.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.169 -0.469 . . . . 1.97 111.66 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.449 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 46.0 mt-30 -58.93 -53.22 60.84 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.879 0.371 . . . . 0.69 111.026 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -72.15 -36.51 69.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 2.82 110.976 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -58.37 -44.17 88.76 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.75 0.31 . . . . 2.37 110.912 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.488 ' O ' HG21 ' A' ' 145' ' ' VAL . . . -61.4 -44.76 96.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.955 -0.566 . . . . 1.2 110.77 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.14 90.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 1.12 111.366 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.19 -25.74 60.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 1.27 111.247 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.76 -36.12 32.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.272 -0.422 . . . . 1.39 111.261 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 141' ' ' ALA . 31.0 m -89.13 2.69 6.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.477 0.18 . . . . 1.98 111.373 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.407 ' HB3' ' NH2' ' A' ' 148' ' ' ARG . 38.5 mt-30 57.48 51.7 9.44 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.056 -0.52 . . . . 2.43 110.322 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.5 tp -54.57 120.39 6.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 1.32 111.982 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 148' ' ' ARG . 28.0 mmt180 -98.17 -45.94 6.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.93 -0.577 . . . . 4.87 110.713 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -107.9 161.16 13.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.106 -0.797 . . . . 0.82 111.106 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.508 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 2.4 t -68.95 -55.66 10.26 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.867 0.334 . . . . 1.16 111.73 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.508 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 5.9 Cg_endo -89.16 98.78 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.449 2.099 . . . . 0.73 112.123 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.51 151.23 40.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.261 -0.427 . . . . 1.07 110.645 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 34.9 ttm -122.92 133.95 54.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.04 -0.527 . . . . 1.09 110.805 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -123.02 129.83 52.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.72 -0.673 . . . . 0.66 109.543 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.3 118.32 47.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.917 0.389 . . . . 1.18 111.498 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.537 ' O ' ' HD3' ' A' ' 158' ' ' LYS . 28.6 m-20 58.8 17.88 5.58 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.028 -0.987 . . . . 1.24 112.178 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.4 24.75 67.88 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.039 -0.601 . . . . 0.56 112.14 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.537 ' HD3' ' O ' ' A' ' 156' ' ' ASN . 5.9 mppt? -126.45 -47.66 1.57 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.17 0.509 . . . . 2.21 111.218 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -101.47 126.59 48.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.866 -0.606 . . . . 1.61 111.475 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -103.83 138.47 40.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.453 -0.794 . . . . 1.14 109.865 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 mp -93.41 139.9 30.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.888 0.375 . . . . 1.83 111.163 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -118.07 109.91 40.4 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.85 110.547 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.44 -18.76 19.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.689 2.259 . . . . 0.71 112.712 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -83.56 -0.03 48.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.151 0.501 . . . . 2.48 110.924 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -117.19 22.07 10.56 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.981 -0.628 . . . . 0.6 111.644 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 47.1 mtt -120.53 -174.34 2.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.104 -0.332 . . . . 1.13 110.104 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.23 125.05 25.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.863 0.363 . . . . 1.54 110.114 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.25 31.78 6.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.444 0.64 . . . . 1.69 109.767 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -37.01 5.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.287 -0.87 . . . . 1.53 110.739 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -128.09 118.78 24.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 1.42 110.583 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.54 ' O ' HG22 ' A' ' 175' ' ' VAL . 10.3 mmt -54.08 -41.72 68.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.458 -0.792 . . . . 2.41 111.624 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -57.5 -46.85 83.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.837 0.351 . . . . 2.05 111.272 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.73 -46.87 90.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.948 -0.569 . . . . 1.24 110.755 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -54.29 -49.67 69.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.578 -0.283 . . . . 0.56 111.659 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 171' ' ' MET . 60.9 t -60.9 -45.08 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 1.15 111.552 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -70.7 -41.77 71.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.314 -0.403 . . . . 1.7 111.631 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -63.83 -42.38 97.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.513 . . . . 1.91 110.685 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.486 ' O ' HG21 ' A' ' 182' ' ' VAL . 21.4 t80 -59.57 -54.16 49.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.98 -0.555 . . . . 0.92 110.062 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.2 -34.01 75.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.73 -0.668 . . . . 1.02 111.395 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.8 -36.78 81.05 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.406 -0.361 . . . . 1.55 110.569 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.606 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 24.7 m -67.6 -41.71 83.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 1.17 109.97 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 178' ' ' TYR . 41.0 t -58.14 -50.4 78.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.022 -0.536 . . . . 1.14 110.389 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -59.93 -42.65 94.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.468 -0.787 . . . . 2.13 111.369 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -60.38 -42.96 96.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.326 -0.397 . . . . 1.25 110.537 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 181' ' ' THR . 53.8 mt -70.04 -33.92 72.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 1.22 110.712 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 25.4 m -66.94 -39.44 87.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.217 0.532 . . . . 1.38 110.188 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.687 -0.688 . . . . 2.26 110.294 179.343 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.009 0.433 . . . . 1.37 110.695 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -108.96 142.5 39.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.954 -0.566 . . . . 2.29 110.878 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.06 125.52 26.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.601 -0.727 . . . . 1.83 109.942 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.25 -20.38 35.43 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.992 -0.623 . . . . 0.78 111.96 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -109.12 -74.73 0.65 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.74 -0.27 . . . . 2.32 110.466 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -75.76 -43.53 46.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.27 -0.423 . . . . 1.46 110.904 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -138.54 154.21 48.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.302 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.89 133.19 54.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.283 -0.417 . . . . 1.51 111.046 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 m -84.52 127.42 34.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.278 -0.419 . . . . 1.54 111.711 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.78 137.02 34.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.602 -0.518 . . . . 1.36 109.602 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -75.68 -29.09 58.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 2.33 110.513 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -113.05 90.17 15.38 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 4.04 109.89 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.4 143.26 19.38 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.427 2.085 . . . . 1.06 112.593 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.7 t -76.61 127.44 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.51 -0.768 . . . . 1.3 111.412 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.06 121.28 26.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.06 -0.518 . . . . 1.48 110.557 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.0 19.94 44.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.72 . . . . 0.8 111.995 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.02 145.78 81.46 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.647 -0.277 . . . . 1.2 111.239 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.68 165.95 31.29 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.444 2.096 . . . . 0.63 111.985 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -56.62 -60.73 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 1.79 111.487 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.96 102.67 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.987 0.423 . . . . 1.11 110.539 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 47.3 tp -98.64 138.32 35.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.835 -0.62 . . . . 1.16 109.849 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -145.88 154.33 41.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.651 0.263 . . . . 1.61 110.799 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -130.04 157.6 41.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.066 -0.516 . . . . 0.61 110.343 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -168.38 177.5 5.32 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.089 -0.505 . . . . 0.67 110.554 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.415 ' HB2' HG23 ' A' ' 61' ' ' VAL . 2.5 t -156.75 132.87 9.74 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.213 -0.449 . . . . 1.52 110.849 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.488 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.9 m-85 -71.13 -16.71 62.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.834 -0.621 . . . . 0.71 109.826 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.48 ' CE2' ' HA2' ' A' ' 69' ' ' GLY . 97.1 m-85 -85.66 -4.0 59.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.567 -0.742 . . . . 2.16 111.32 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 53.3 t -115.49 122.63 32.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.393 -0.367 . . . . 0.89 110.764 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -65.94 -23.87 53.96 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.412 2.075 . . . . 0.86 112.027 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.419 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -60.49 -38.93 85.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 2.46 110.099 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.2 m -71.67 -34.77 69.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.998 -0.546 . . . . 0.5 110.725 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.88 -44.31 96.44 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.124 0.487 . . . . 2.22 110.455 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.457 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 13.8 tt0 -66.48 -36.58 83.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.526 . . . . 2.82 110.357 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -77.5 -25.82 50.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.067 -0.515 . . . . 1.05 111.46 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 4.4 tp10 -84.25 -50.61 7.71 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.599 0.592 . . . . 1.89 112.599 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.585 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 10.1 tp10 -97.37 -46.21 6.17 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.356 0.873 . . . . 2.0 113.356 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 48.8 t -69.68 -51.8 37.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.051 -0.659 . . . . 1.18 110.921 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 mt -86.52 -35.56 19.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.258 -0.428 . . . . 1.13 111.764 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.585 ' HD2' ' O ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER 60.63 41.62 15.04 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.59 -0.522 . . . . 1.19 109.59 -178.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.594 ' O ' HG23 ' A' ' 46' ' ' VAL . 42.7 mm -53.77 -68.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.845 -0.616 . . . . 1.13 112.169 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -51.92 -45.63 64.34 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.345 0.403 . . . . 1.37 111.943 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.407 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 30.5 t70 -65.69 -29.66 70.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.888 -0.596 . . . . 1.73 111.583 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 2.2 t-20 -77.73 -37.14 49.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 1.42 110.217 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 42' ' ' ILE . 43.2 t -60.32 -35.48 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.935 -0.575 . . . . 1.14 110.637 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' A' ' 44' ' ' ASP . 51.8 mttt -56.71 -36.65 69.92 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.393 -0.367 . . . . 1.96 111.44 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -77.72 -10.32 59.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 2.52 112.089 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -102.07 -32.95 9.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.475 -0.33 . . . . 1.93 110.759 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.4 mt -68.92 129.88 91.97 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.139 -0.482 . . . . 1.54 110.851 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.77 -171.43 0.86 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.645 2.23 . . . . 0.97 112.625 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -67.86 148.75 50.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 2.63 111.128 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.54 -19.03 30.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.934 -0.651 . . . . 0.82 113.195 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 t -89.72 132.8 33.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.106 0.479 . . . . 1.65 110.749 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -131.41 141.76 49.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.98 -0.554 . . . . 2.85 110.265 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 84.2 mtp -90.88 134.3 34.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 1.76 110.999 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.02 94.36 4.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.232 0.539 . . . . 1.15 110.167 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -92.08 118.37 30.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.737 -0.665 . . . . 1.3 110.665 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 9.5 m-30 -113.62 167.56 10.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 1.05 110.897 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -103.24 133.62 48.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.405 -0.361 . . . . 0.78 110.795 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.415 HG23 ' HB2' ' A' ' 27' ' ' SER . 33.0 m -74.8 149.27 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 1.37 110.314 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -109.42 27.24 9.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.856 0.36 . . . . 1.08 111.688 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -133.65 15.57 4.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.014 0.435 . . . . 0.87 110.995 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -137.92 103.23 4.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.15 -0.477 . . . . 1.67 110.073 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.63 9.33 2.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.602 -0.808 . . . . 0.78 112.534 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.76 -140.46 34.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.879 -0.676 . . . . 0.81 112.373 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.83 -34.34 33.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.036 0.446 . . . . 2.47 110.048 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.3 tp -67.35 -22.31 65.59 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.772 -0.649 . . . . 2.46 110.256 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.48 ' HA2' ' CE2' ' A' ' 29' ' ' PHE . . . -58.88 -37.05 90.16 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.671 -0.695 . . . . 0.72 111.876 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -68.66 -32.16 71.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.776 0.322 . . . . 3.18 110.776 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -40.49 97.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 1.65 110.265 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -26.57 62.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.089 -0.505 . . . . 1.65 110.459 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -62.57 -33.59 75.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.304 0.574 . . . . 1.19 109.759 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -77.84 -37.43 48.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.438 -0.801 . . . . 1.35 109.48 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.17 85.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.569 -0.741 . . . . 1.31 111.318 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -59.67 -36.43 76.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.111 -0.495 . . . . 0.59 110.597 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.27 83.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.11 -0.495 . . . . 1.33 110.083 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.1 -43.05 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.677 -0.692 . . . . 1.48 110.013 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.36 90.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.794 -0.639 . . . . 1.17 110.938 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 71.6 mtm -66.84 -35.66 80.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.95 -0.568 . . . . 1.56 110.652 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.33 -36.57 68.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.893 0.377 . . . . 1.42 110.882 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 mt -75.62 -44.22 43.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.22 -0.446 . . . . 1.54 110.763 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.69 37.38 3.72 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.272 -0.731 . . . . 0.78 111.272 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.27 29.11 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.966 0.413 . . . . 1.36 110.179 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.87 -65.76 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.281 -0.872 . . . . 1.71 112.158 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.31 -28.99 67.3 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.334 -0.394 . . . . 1.91 111.218 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -66.65 -44.68 81.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.815 -0.629 . . . . 2.74 111.474 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.81 -8.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.886 0.328 . . . . 1.26 111.886 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.6 m -58.25 -49.13 78.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.721 0.267 . . . . 1.46 111.721 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.427 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 46.3 t -61.36 -59.86 12.3 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.383 0.512 . . . . 1.26 112.383 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.427 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 12.2 Cg_endo -56.13 -34.19 92.26 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.198 1.932 . . . . 0.65 113.232 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.1 mt -70.8 -40.7 72.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.715 0.293 . . . . 1.34 110.719 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -64.24 -48.13 76.98 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.231 0.539 . . . . 0.58 110.442 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.9 -35.87 74.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.534 -0.757 . . . . 1.7 111.248 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.72 -25.69 70.59 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.917 -0.658 . . . . 0.82 113.106 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 64.7 t -100.65 -39.43 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.491 0.552 . . . . 1.23 112.491 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -94.57 -42.94 8.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.717 1.006 . . . . 0.84 113.717 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -78.97 -62.49 1.68 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.977 0.362 . . . . 1.96 111.977 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.04 -39.41 25.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.112 -0.494 . . . . 1.86 112.162 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 66.08 26.89 10.66 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.066 0.46 . . . . 1.73 110.288 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.33 -33.76 32.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.894 -0.594 . . . . 2.07 111.346 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.25 102.51 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.917 -0.583 . . . . 1.38 110.461 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mmm-85 -119.14 -8.12 10.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.848 -0.615 . . . . 3.77 110.448 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 m -149.77 172.59 14.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.226 -0.443 . . . . 1.78 110.696 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.8 -20.72 66.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.24 -0.436 . . . . 1.54 110.816 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -44.72 96.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.006 -0.543 . . . . 1.62 110.562 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.448 ' O ' HG22 ' A' ' 111' ' ' VAL . 13.2 m-20 -67.07 -40.29 87.03 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.98 -0.554 . . . . 1.89 109.851 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 54.6 mt -61.05 -46.1 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.654 -0.703 . . . . 1.44 110.171 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 113' ' ' ILE . 62.8 ttt180 -60.28 -41.22 92.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.943 -0.572 . . . . 2.74 109.723 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -59.48 -39.66 84.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.306 -0.861 . . . . 1.95 110.667 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 107' ' ' ASP . 73.2 t -60.09 -42.41 89.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 1.42 110.661 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -65.35 -39.75 92.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.92 110.457 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 65.7 mt -64.95 -33.77 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.316 0.579 . . . . 1.85 109.763 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -73.91 -8.39 55.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.541 -0.754 . . . . 2.37 110.654 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.32 2.57 42.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.07 -0.514 . . . . 1.42 110.311 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.81 39.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.821 -0.705 . . . . 1.15 113.193 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 38.2 mm -98.23 133.35 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.123 -0.325 . . . . 2.16 110.123 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -73.76 146.86 43.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.26 -0.427 . . . . 3.2 111.468 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.3 -35.27 91.32 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.894 -0.669 . . . . 1.25 112.024 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.53 -45.69 78.62 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.952 -0.388 . . . . 2.98 109.952 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -60.93 -45.08 96.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.552 -0.749 . . . . 2.52 109.686 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.409 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 53.9 t80 -63.05 -41.87 99.59 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.76 -0.655 . . . . 2.23 110.479 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.63 -44.15 93.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.831 0.348 . . . . 2.3 110.852 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.84 79.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 1.61 111.119 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.02 83.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 1.48 111.088 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -57.96 -36.92 73.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.308 -0.405 . . . . 1.43 111.074 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -109.58 32.04 5.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.371 -0.377 . . . . 1.63 111.47 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.9 p -92.09 157.75 16.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.766 0.317 . . . . 2.33 110.215 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -74.06 -32.46 63.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.556 -0.293 . . . . 4.45 110.359 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.3 t -58.4 -45.49 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.989 0.423 . . . . 1.99 110.181 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.454 ' O ' HG21 ' A' ' 135' ' ' VAL . 15.5 t -61.89 -38.48 80.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.561 -0.745 . . . . 1.54 110.537 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -56.43 -50.72 70.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 2.84 110.976 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -32.03 72.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 1.75 111.051 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.38 -32.43 66.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 1.53 110.773 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 131' ' ' VAL . 70.1 t -67.31 -47.03 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 1.31 110.073 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.08 85.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 1.52 111.233 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -64.12 -32.42 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.512 -0.313 . . . . 1.97 111.34 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.404 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 50.5 mt-30 -66.43 -42.27 87.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.409 -0.359 . . . . 0.69 110.551 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.41 -37.97 50.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 2.82 110.803 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 31.7 tttp -54.34 -50.26 67.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.325 -0.398 . . . . 2.37 110.809 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.419 ' O ' HG21 ' A' ' 145' ' ' VAL . . . -66.37 -46.55 76.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.162 -0.472 . . . . 1.2 111.522 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.65 83.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 1.12 112.104 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.81 -27.21 61.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.52 0.563 . . . . 1.27 112.52 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 3.3 t0 -78.12 -31.35 49.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.856 0.317 . . . . 1.39 111.856 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 141' ' ' ALA . 32.6 m -92.47 3.14 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.151 0.426 . . . . 1.98 112.151 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 60.4 51.6 5.23 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.262 0.553 . . . . 2.43 110.155 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.9 tp -62.18 106.61 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.479 -0.782 . . . . 1.32 111.404 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -104.19 -1.79 26.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.804 -0.635 . . . . 4.87 110.811 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -133.39 179.78 17.08 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.847 -0.692 . . . . 0.82 112.014 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.494 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 0.2 OUTLIER -97.85 -61.85 0.12 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 117.033 0.416 . . . . 1.16 111.411 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 3.9 Cg_endo -85.78 65.74 5.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.641 2.227 . . . . 0.73 111.814 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -109.35 138.7 45.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 1.07 110.67 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.498 ' SD ' HG22 ' A' ' 182' ' ' VAL . 29.4 ttm -115.62 137.98 51.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.947 -0.57 . . . . 1.09 110.168 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -127.74 131.31 49.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 0.66 110.392 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.59 117.79 45.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.573 -0.285 . . . . 1.18 110.705 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 60.63 13.87 4.57 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.733 -0.667 . . . . 1.24 111.601 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.31 23.99 68.7 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.047 -0.597 . . . . 0.56 111.759 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -124.65 -44.37 1.97 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.075 0.464 . . . . 2.21 110.758 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -102.1 125.13 48.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.936 -0.575 . . . . 1.61 110.604 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -105.68 138.85 41.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.196 -0.456 . . . . 1.14 109.862 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.6 mp -90.18 139.15 30.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.535 0.207 . . . . 1.83 110.726 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -114.9 113.12 44.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.43 . . . . 0.85 110.854 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.77 6.86 5.21 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.924 2.416 . . . . 0.71 112.56 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -113.33 20.98 15.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.323 -0.399 . . . . 2.48 110.763 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.11 33.39 1.92 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.02 -0.609 . . . . 0.6 111.935 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.9 mtt -124.84 -176.51 3.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.474 0.178 . . . . 1.13 110.542 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.05 127.58 32.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.138 0.494 . . . . 1.54 111.57 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 16.2 16.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.835 -0.621 . . . . 1.69 110.835 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -32.42 14.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.159 0.504 . . . . 1.53 110.401 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -139.42 125.16 19.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.04 -0.527 . . . . 1.42 110.127 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 56.4 ttm -62.37 -32.94 73.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.63 . . . . 2.41 111.443 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -63.32 -37.28 86.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.174 -0.466 . . . . 2.05 111.027 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.68 -41.83 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 1.24 110.509 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.84 -50.09 71.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.56 111.122 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.8 t -57.61 -51.09 74.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 1.15 111.688 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -42.12 83.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.995 -0.548 . . . . 1.7 112.119 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -62.09 -45.61 92.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.657 0.265 . . . . 1.91 110.979 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -57.71 -52.18 66.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.92 110.635 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.01 82.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 1.02 112.105 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.65 -32.95 73.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.646 0.26 . . . . 1.55 110.516 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 35.4 m -63.14 -40.07 96.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 1.17 110.188 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.498 HG22 ' SD ' ' A' ' 153' ' ' MET . 21.8 t -60.38 -52.92 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.269 0.557 . . . . 1.14 110.227 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -57.44 -39.83 77.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.961 -1.018 . . . . 2.13 111.007 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -64.51 -46.24 83.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.889 -0.596 . . . . 1.25 110.819 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.0 mt -66.56 -39.81 88.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.088 -0.506 . . . . 1.22 112.06 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.9 p -66.31 -23.75 66.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.038 0.447 . . . . 1.38 111.276 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.226 0.536 . . . . 2.26 110.338 179.606 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.757 0.313 . . . . 1.37 110.983 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -119.35 140.67 49.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.943 -0.571 . . . . 2.29 109.891 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -69.3 119.12 13.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.083 0.468 . . . . 1.83 110.036 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.56 -16.38 29.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.995 -0.842 . . . . 0.78 110.995 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 50.6 tptt -99.13 -80.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.637 -0.281 . . . . 2.32 110.57 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -86.79 -25.37 24.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 1.46 111.381 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -143.49 152.74 41.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.189 -0.3 . . . . 1.0 110.189 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 m -128.54 132.08 48.26 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.21 0.319 . . . . 1.51 110.639 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.4 m -75.68 125.56 29.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.362 -0.381 . . . . 1.54 110.175 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.26 127.31 32.26 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.792 0.329 . . . . 1.36 110.526 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.09 -39.46 93.21 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.627 -0.715 . . . . 2.33 110.33 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -122.18 84.01 45.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 4.04 109.893 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.36 155.11 70.43 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.485 2.124 . . . . 1.06 112.191 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.5 t -89.4 131.84 35.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.036 -0.529 . . . . 1.3 110.713 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.81 137.8 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.107 -0.497 . . . . 1.48 110.323 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.9 25.24 74.34 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.73 -0.748 . . . . 0.8 112.382 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.26 143.52 31.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.436 -0.209 . . . . 1.2 110.436 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 30.1 Cg_endo -66.27 162.05 37.79 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.373 2.049 . . . . 0.63 112.704 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -62.68 -44.92 95.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.612 -0.722 . . . . 1.79 110.705 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.8 t -120.52 100.77 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.702 -0.481 . . . . 1.11 109.702 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 26.5 tp -110.92 110.78 21.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.951 -0.568 . . . . 1.16 110.423 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -120.12 145.76 46.61 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.426 -0.352 . . . . 1.61 110.215 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 151' ' ' PRO . 97.2 m-85 -123.23 154.63 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.309 -0.405 . . . . 0.61 110.114 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.413 ' CE1' ' HD3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -170.24 177.99 3.97 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.005 0.431 . . . . 0.67 110.786 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.1 t -156.91 141.58 16.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 1.52 110.51 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.529 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 96.0 m-85 -73.4 -20.49 60.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.9 -0.591 . . . . 0.71 110.502 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' A' ' 72' ' ' LEU . 72.6 m-85 -85.35 -1.32 56.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 2.16 110.339 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.482 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 48.1 t -107.19 112.34 62.98 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.019 -0.537 . . . . 0.89 111.133 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -64.2 -24.54 65.61 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.216 1.944 . . . . 0.86 111.283 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -66.32 -29.37 69.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.369 -0.832 . . . . 2.46 110.236 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.0 m -83.66 -32.02 25.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.47 -0.567 . . . . 0.5 109.47 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.77 -49.1 79.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.304 -0.862 . . . . 2.22 110.063 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.494 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 22.5 tt0 -68.35 -32.34 72.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 2.82 110.726 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -66.66 -30.84 71.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.481 0.549 . . . . 1.05 112.481 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -108.65 -50.11 3.07 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.993 0.738 . . . . 1.89 112.993 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.63 -25.51 64.87 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.953 -0.467 . . . . 2.0 111.659 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 91.5 t -107.72 -56.44 4.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.796 -0.362 . . . . 1.18 111.498 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.8 mt -81.05 -33.55 33.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.928 0.344 . . . . 1.13 111.928 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 0.6 OUTLIER 58.9 63.45 1.64 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.848 0.459 . . . . 1.19 111.003 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.1 mm -71.36 -50.87 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.902 -0.59 . . . . 1.13 111.165 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 m -58.3 -49.33 77.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.314 -0.403 . . . . 1.37 110.999 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 26.0 t70 -61.26 -45.03 96.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.549 . . . . 1.73 110.888 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 0.7 OUTLIER -62.41 -41.56 98.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 1.42 110.794 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.515 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 39.6 t -66.44 -42.44 90.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 1.14 110.541 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.93 -31.63 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.738 0.304 . . . . 1.96 111.37 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 30.3 mttm -86.68 3.13 46.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.261 -0.427 . . . . 2.52 111.679 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -136.97 23.59 3.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 1.93 111.007 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 13.9 mt -99.73 145.5 30.25 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.396 -0.365 . . . . 1.54 110.383 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.21 165.48 31.34 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.718 2.279 . . . . 0.97 111.422 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.25 139.97 50.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.998 -0.546 . . . . 2.63 110.368 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.23 -9.15 78.03 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.931 -0.652 . . . . 0.82 112.118 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.95 98.63 7.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.853 0.359 . . . . 1.65 110.263 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.6 124.96 31.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.141 -0.481 . . . . 2.85 110.165 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -72.97 127.97 34.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.646 -0.501 . . . . 1.76 109.646 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 119.48 34.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.949 0.404 . . . . 1.15 110.757 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HD3' ' CE1' ' A' ' 26' ' ' PHE . 15.2 ttmm -114.04 119.57 37.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 1.3 110.16 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.466 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 13.1 m-30 -110.28 160.51 16.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.135 0.493 . . . . 1.05 111.55 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -104.85 134.76 47.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.661 -0.699 . . . . 0.78 110.618 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.7 m -88.7 155.05 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.587 -0.279 . . . . 1.37 110.61 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -105.21 -6.1 20.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.632 0.604 . . . . 1.08 112.632 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -89.97 15.5 9.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.427 0.632 . . . . 0.87 110.79 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.482 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -144.32 88.87 1.97 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.458 -0.792 . . . . 1.67 109.61 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.15 -7.27 0.29 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 121.09 -0.576 . . . . 0.78 112.547 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.44 -134.61 22.83 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.556 -0.831 . . . . 0.81 112.333 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -22.8 40.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.649 0.262 . . . . 2.47 110.793 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 tp -85.6 -11.62 53.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.097 0.475 . . . . 2.46 110.318 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.75 98.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.772 -0.727 . . . . 0.72 111.961 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -62.9 -40.09 96.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.067 0.461 . . . . 3.18 110.552 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.79 -49.06 79.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.678 -0.692 . . . . 1.65 111.158 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.405 HD11 ' CZ ' ' A' ' 29' ' ' PHE . 1.7 mt -66.29 -22.77 66.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 1.65 111.6 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 m -69.71 -40.39 76.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.917 0.389 . . . . 1.19 110.098 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -72.37 -38.91 68.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.98 -0.748 . . . . 1.35 108.98 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.88 99.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.418 -0.81 . . . . 1.31 110.935 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.434 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 66.6 t-105 -62.69 -38.21 89.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.735 -0.666 . . . . 0.59 110.714 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.13 -38.48 86.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 1.33 110.39 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.05 -41.73 92.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.121 0.486 . . . . 1.48 109.801 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.7 88.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.784 -0.644 . . . . 1.17 111.006 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.8 mtm -69.26 -33.42 73.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 1.56 111.149 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.92 -38.86 61.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.501 . . . . 1.42 110.584 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.6 mt -76.31 -32.75 58.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.094 -0.503 . . . . 1.54 110.926 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.27 39.54 6.0 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.772 -0.727 . . . . 0.78 111.581 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.6 m -130.09 30.32 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.832 0.349 . . . . 1.36 110.83 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 2.8 mp0 -59.77 -63.0 1.46 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.047 -0.524 . . . . 1.71 111.812 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.74 -33.33 61.04 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.188 -0.46 . . . . 1.91 111.172 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -66.17 -48.02 72.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.77 -0.65 . . . . 2.74 111.705 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.83 -10.6 11.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.062 0.764 . . . . 1.26 113.062 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.4 m -56.18 -51.76 66.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.219 0.452 . . . . 1.46 112.219 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.425 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 42.2 t -62.57 -59.22 13.35 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 112.547 0.573 . . . . 1.26 112.547 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.425 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 10.0 Cg_endo -54.7 -35.29 86.92 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.255 1.97 . . . . 0.65 113.059 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.9 mt -68.77 -47.92 65.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.514 0.197 . . . . 1.34 110.757 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.529 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -58.59 -49.43 77.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.165 0.507 . . . . 0.58 110.784 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.473 ' CD ' ' HZ3' ' A' ' 98' ' ' LYS . 5.8 mm-40 -64.41 -39.33 93.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.621 -0.718 . . . . 1.7 110.913 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.65 -18.03 71.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.998 -0.62 . . . . 0.82 113.469 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.7 t -101.55 -42.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.319 0.488 . . . . 1.23 112.319 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -98.72 -39.98 8.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.587 0.958 . . . . 0.84 113.587 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.473 ' HZ3' ' CD ' ' A' ' 94' ' ' GLU . 1.3 tttp -79.61 -70.79 0.49 Allowed 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.676 -0.41 . . . . 1.96 111.797 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.31 -26.4 46.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.676 -0.238 . . . . 1.86 111.532 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 56.38 28.45 13.53 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.606 0.567 . . . . 1.73 111.173 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -28.51 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.75 -0.659 . . . . 2.07 111.584 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.74 100.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.991 -0.374 . . . . 1.38 109.991 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -122.97 -3.59 8.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 3.77 110.967 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -149.45 166.1 30.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.319 -0.4 . . . . 1.78 110.068 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.93 67.85 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.51 -0.313 . . . . 1.54 111.335 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -36.66 78.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.246 -0.434 . . . . 1.62 110.785 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -70.67 -42.23 71.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.363 -0.606 . . . . 1.89 109.363 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.5 mt -62.17 -43.14 97.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.614 -0.721 . . . . 1.44 110.097 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.403 ' O ' HG13 ' A' ' 113' ' ' ILE . 74.2 ttt-85 -57.76 -44.2 85.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.572 -0.74 . . . . 2.74 110.211 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.7 -35.06 79.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.606 -0.724 . . . . 1.95 111.386 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.4 t -60.82 -42.75 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.029 0.442 . . . . 1.42 110.255 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -64.42 -39.9 94.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 0.92 110.394 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 65.4 mt -63.9 -36.47 76.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 1.85 110.126 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -68.03 -23.33 64.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.834 -0.621 . . . . 2.37 111.045 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.45 -7.47 58.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.42 111.522 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.96 5.75 28.72 Favored Glycine 0 C--O 1.234 0.136 0 C-N-CA 120.747 -0.739 . . . . 1.15 112.736 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 44.4 mm -92.44 124.89 45.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 122.742 -0.27 . . . . 2.16 110.364 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -65.52 134.3 53.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.307 -0.406 . . . . 3.2 110.42 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.32 -38.97 81.23 Favored Glycine 0 CA--C 1.517 0.207 0 O-C-N 123.479 0.487 . . . . 1.25 112.717 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.31 -36.59 80.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.528 0.204 . . . . 2.98 111.368 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -73.13 -41.88 63.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.041 0.448 . . . . 2.52 109.978 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -60.79 -44.3 97.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 2.23 110.21 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -61.63 -39.41 91.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.985 -0.552 . . . . 2.3 110.874 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.41 -47.42 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.749 -0.66 . . . . 1.61 110.607 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.1 -27.94 68.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.256 -0.429 . . . . 1.48 111.333 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -62.46 -28.82 70.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.139 0.495 . . . . 1.43 110.301 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -105.05 19.13 21.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.006 -0.543 . . . . 1.63 111.111 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.0 t -80.3 142.22 34.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.102 -0.499 . . . . 2.33 110.865 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -69.84 -32.26 70.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.198 0.523 . . . . 4.45 109.685 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.41 -44.87 99.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.717 -0.674 . . . . 1.99 109.804 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 135' ' ' VAL . 62.0 t -64.31 -41.48 92.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.412 -0.813 . . . . 1.54 110.332 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -57.29 -42.47 81.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.989 -0.55 . . . . 2.84 110.083 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 137' ' ' GLN . 12.1 t -66.38 -44.88 81.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.645 -0.707 . . . . 1.75 110.214 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.478 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 48.4 mt -59.2 -37.73 78.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 1.53 111.043 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 131' ' ' VAL . 77.2 t -61.94 -47.01 95.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.929 -0.397 . . . . 1.31 109.929 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.6 -39.14 92.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.84 -0.618 . . . . 1.52 110.812 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 133' ' ' SER . 78.6 mt-30 -60.49 -41.08 93.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 1.97 111.207 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 134' ' ' LEU . 49.7 mt-30 -63.75 -48.05 78.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.262 -0.426 . . . . 0.69 110.727 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -65.12 -41.2 95.1 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.025 -0.534 . . . . 2.82 110.44 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.7 tttm -61.92 -50.7 71.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.277 -0.874 . . . . 2.37 111.259 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.42 -44.98 92.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.46 . . . . 1.2 111.967 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.08 -36.51 83.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.487 -0.324 . . . . 1.12 111.689 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.88 -36.39 28.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.525 -0.307 . . . . 1.27 111.197 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -63.86 -49.73 71.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.413 -0.358 . . . . 1.39 110.997 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.63 -9.68 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 1.98 110.891 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.499 ' O ' ' HD2' ' A' ' 148' ' ' ARG . 89.5 mt-30 59.18 67.25 0.93 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.771 -0.65 . . . . 2.43 110.193 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 149' ' ' GLY . 14.0 tp -63.97 129.68 41.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.515 -0.766 . . . . 1.32 110.535 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 146' ' ' GLN . 1.2 mpt_? -96.74 -47.49 5.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.821 -0.627 . . . . 4.87 110.254 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.448 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . -98.05 -158.09 30.16 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.321 -0.712 . . . . 0.82 111.321 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.546 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 2.5 t -113.4 -57.41 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 117.221 0.511 . . . . 1.16 111.724 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 17.3 Cg_endo -92.64 82.34 0.24 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.601 2.201 . . . . 0.73 111.885 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.36 146.15 50.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.316 -0.402 . . . . 1.07 110.87 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 43.8 ttm -118.78 133.14 56.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.049 -0.523 . . . . 1.09 110.314 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.28 133.1 56.38 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.914 -0.585 . . . . 0.66 109.826 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.43 112.4 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.257 -0.429 . . . . 1.18 110.459 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 60.47 17.23 7.08 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.278 -0.873 . . . . 1.24 111.52 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.19 20.28 64.88 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.925 -0.58 . . . . 0.56 112.512 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -121.06 -38.35 2.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.886 0.374 . . . . 2.21 111.641 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -111.83 128.36 56.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.016 0.436 . . . . 1.61 110.898 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -105.15 138.4 41.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.667 -0.697 . . . . 1.14 110.438 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.23 134.97 33.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.528 -0.306 . . . . 1.83 110.325 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -115.6 100.79 53.96 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.774 0.321 . . . . 0.85 110.587 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.45 -16.87 34.7 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 122.363 2.042 . . . . 0.71 112.572 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -81.02 -6.48 58.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.948 0.404 . . . . 2.48 110.788 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -115.26 14.77 18.43 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.244 -0.742 . . . . 0.6 111.244 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.403 ' HB3' ' OE1' ' A' ' 177' ' ' GLN . 64.9 mtt -105.54 -174.52 2.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.543 -0.329 . . . . 1.13 110.187 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -71.25 111.8 6.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.226 0.536 . . . . 1.54 111.032 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.24 18.49 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.338 0.589 . . . . 1.69 109.795 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.99 -48.88 6.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.507 -0.77 . . . . 1.53 110.681 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -122.37 126.84 48.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.164 -0.471 . . . . 1.42 110.61 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.477 ' O ' HG23 ' A' ' 175' ' ' VAL . 39.3 mtt -62.19 -40.52 96.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.031 -0.531 . . . . 2.41 111.602 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -61.05 -42.01 97.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 2.05 110.604 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.8 t -67.74 -46.84 81.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.792 -0.64 . . . . 1.24 110.45 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -55.4 -49.34 72.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.777 -0.647 . . . . 0.56 111.856 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 171' ' ' MET . 80.8 t -55.73 -50.09 70.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.548 -0.296 . . . . 1.15 111.705 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -69.25 -35.06 75.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.375 -0.375 . . . . 1.7 111.082 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.403 ' OE1' ' HB3' ' A' ' 166' ' ' MET . 57.4 tt0 -63.57 -47.15 82.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.398 -0.365 . . . . 1.91 110.537 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.463 ' O ' HG23 ' A' ' 182' ' ' VAL . 17.7 t80 -57.54 -46.73 83.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.975 -0.557 . . . . 0.92 109.906 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.7 -41.1 88.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.638 -0.71 . . . . 1.02 111.46 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.55 -40.36 96.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.086 -0.506 . . . . 1.55 110.311 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.2 m -59.76 -42.03 92.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 1.17 110.575 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 178' ' ' TYR . 61.8 t -60.05 -53.17 52.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.293 -0.412 . . . . 1.14 110.523 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -59.83 -46.36 89.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.687 -0.688 . . . . 2.13 111.047 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -58.73 -45.6 89.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.838 -0.619 . . . . 1.25 111.484 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.36 -36.55 74.25 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.479 0.18 . . . . 1.22 111.401 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.7 m -64.37 -37.6 88.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.986 0.422 . . . . 1.38 110.879 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 2.26 111.139 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.532 0.206 . . . . 1.37 110.492 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -128.3 151.01 49.81 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.761 0.315 . . . . 2.29 110.746 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -65.95 123.37 19.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.783 -0.644 . . . . 1.83 111.011 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.0 -14.05 52.45 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.915 -0.584 . . . . 0.78 112.425 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -108.52 -73.31 0.69 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.95 -0.3 . . . . 2.32 111.137 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -91.54 -24.59 19.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.581 0.229 . . . . 1.46 111.41 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -145.7 158.82 43.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.147 -0.316 . . . . 1.0 110.147 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.95 122.96 31.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.958 0.409 . . . . 1.51 111.096 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.4 m -74.51 120.57 20.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.162 -0.472 . . . . 1.54 109.805 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.4 mt -72.58 136.69 45.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.024 0.44 . . . . 1.36 111.285 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -77.17 -31.7 55.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.972 -0.751 . . . . 2.33 108.972 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -120.2 83.42 32.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.26 -0.882 . . . . 4.04 110.096 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.12 163.4 38.25 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.382 2.055 . . . . 1.06 112.08 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.77 115.3 43.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.004 0.43 . . . . 1.3 110.647 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.43 111.84 12.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.807 -0.633 . . . . 1.48 110.496 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.37 20.88 9.22 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.771 -0.728 . . . . 0.8 112.245 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.88 154.27 55.37 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.452 -0.203 . . . . 1.2 110.452 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.49 161.31 42.66 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.12 1.88 . . . . 0.63 112.228 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -57.33 -56.53 20.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.836 -0.62 . . . . 1.79 111.487 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -112.27 96.35 4.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.134 0.493 . . . . 1.11 110.337 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.33 116.54 32.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.635 -0.711 . . . . 1.16 109.764 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -126.23 152.17 46.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.611 0.243 . . . . 1.61 110.822 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.23 156.61 42.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.61 -0.515 . . . . 0.61 109.61 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -169.06 175.95 5.54 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.019 0.438 . . . . 0.67 111.003 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.475 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 7.0 t -156.24 136.99 13.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.337 -0.392 . . . . 1.52 110.192 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -70.58 -15.76 62.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.921 -0.581 . . . . 0.71 110.957 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -88.9 -1.27 58.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 2.16 110.765 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.3 t -107.49 115.73 58.95 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.035 -0.357 . . . . 0.89 110.035 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -64.09 -26.42 65.58 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.372 2.048 . . . . 0.86 112.082 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -70.19 -27.37 64.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 2.46 110.096 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.1 m -71.9 -37.05 70.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.553 -0.536 . . . . 0.5 109.553 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -65.52 -36.48 83.95 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.28 0.562 . . . . 2.22 109.553 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.49 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 47.2 tt0 -65.36 -43.96 89.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.382 -0.826 . . . . 2.82 109.967 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.43 -32.75 68.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.061 -0.518 . . . . 1.05 111.964 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 3.2 tp10 -87.94 -50.79 6.2 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.432 0.901 . . . . 1.89 113.432 -177.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 27.1 tp10 -94.38 -34.33 12.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.738 1.014 . . . . 2.0 113.738 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 51.9 t -81.46 -51.98 14.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 121.578 -0.701 . . . . 1.18 110.914 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -92.18 -31.3 15.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.468 0.544 . . . . 1.13 112.468 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 6.7 m-70 60.0 48.62 8.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.484 -0.561 . . . . 1.19 109.484 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 46' ' ' VAL . 41.1 mm -53.16 -64.13 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.474 -0.784 . . . . 1.13 111.893 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -54.53 -31.66 56.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.284 0.476 . . . . 1.37 112.284 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.94 -37.98 72.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.806 0.336 . . . . 1.73 110.928 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.42 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 28.4 m-80 -72.88 -33.01 65.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 1.42 110.626 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 42' ' ' ILE . 62.1 t -60.47 -37.11 73.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.873 -0.603 . . . . 1.14 110.443 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -62.04 -25.04 67.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.984 -0.553 . . . . 1.96 111.726 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 45' ' ' ASN . 49.3 mtmt -83.04 -11.44 58.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.517 -0.311 . . . . 2.52 111.348 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -112.15 -20.84 11.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 111.828 0.307 . . . . 1.93 111.828 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.8 mt -74.6 132.73 77.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.699 0.285 . . . . 1.54 111.366 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.41 174.5 11.46 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.333 2.022 . . . . 0.97 112.013 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.06 144.81 55.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.14 -0.482 . . . . 2.63 111.158 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.02 -20.46 47.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.172 -0.537 . . . . 0.82 112.559 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.17 113.63 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.869 0.366 . . . . 1.65 110.603 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -97.95 151.77 19.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 2.85 109.841 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 96.2 mtp -108.57 146.17 33.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.47 -0.332 . . . . 1.76 110.359 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 m -135.07 110.71 9.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.824 0.345 . . . . 1.15 110.492 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -106.84 122.45 46.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.875 -0.602 . . . . 1.3 109.704 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.688 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 10.2 m-85 -111.5 159.19 18.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.93 0.395 . . . . 1.05 111.0 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.475 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 52.5 t-80 -104.62 134.64 47.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.491 . . . . 0.78 109.875 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 m -87.47 150.41 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.569 -0.287 . . . . 1.37 111.012 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.66 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 7.5 m-20 -99.44 1.32 44.04 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.36 0.504 . . . . 1.08 112.36 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -98.18 12.92 33.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.13 0.491 . . . . 0.87 111.296 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.13 99.63 3.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.256 -0.429 . . . . 1.67 110.726 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.96 -2.88 4.84 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.623 -0.799 . . . . 0.78 112.426 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.23 -138.91 31.46 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.209 -0.52 . . . . 0.81 112.145 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.98 -37.51 72.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.859 0.362 . . . . 2.47 111.133 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -70.61 -22.08 62.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 2.46 110.391 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.34 -32.48 84.33 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.5 -0.857 . . . . 0.72 111.132 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.66 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 33.4 mttm -66.7 -36.94 83.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.725 0.298 . . . . 3.18 110.807 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -67.0 -39.04 87.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.137 0.494 . . . . 1.65 110.294 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mt -66.25 -28.89 69.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 1.65 110.321 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.6 m -67.7 -36.72 81.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.191 0.52 . . . . 1.19 109.773 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -73.87 -41.61 61.96 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.81 -0.632 . . . . 1.35 109.623 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.82 95.24 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.82 -0.627 . . . . 1.31 110.835 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -61.12 -40.14 92.66 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.859 -0.609 . . . . 0.59 110.557 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.73 81.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.063 -0.517 . . . . 1.33 110.228 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.85 -46.23 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 1.48 109.979 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.86 84.69 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.87 -0.605 . . . . 1.17 111.3 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 69.1 mtm -67.97 -39.36 83.37 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.129 -0.487 . . . . 1.56 110.846 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.69 -25.56 63.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 1.42 111.371 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.0 mt -88.97 -46.84 8.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.127 -0.488 . . . . 1.54 110.997 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.43 41.92 2.11 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.113 -0.565 . . . . 0.78 111.862 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.83 26.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.977 0.418 . . . . 1.36 110.216 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.94 -53.61 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.519 -0.764 . . . . 1.71 111.708 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.04 -19.88 65.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.781 -0.645 . . . . 1.91 112.189 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -81.92 -22.26 36.88 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.949 0.351 . . . . 2.74 111.949 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.405 ' HA ' ' HG2' ' A' ' 91' ' ' PRO . 32.9 m -111.36 -6.74 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.231 0.826 . . . . 1.26 113.231 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -56.01 27.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.699 0.629 . . . . 1.46 112.699 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.9 t -60.29 -56.48 34.97 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 111.97 0.359 . . . . 1.26 111.97 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 9.4 Cg_endo -55.13 -37.79 93.91 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.465 2.11 . . . . 0.65 113.156 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.37 -42.22 65.5 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.962 -0.295 . . . . 1.34 110.443 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.88 -51.88 67.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.262 0.553 . . . . 0.58 110.802 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -70.86 -34.72 71.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.067 -0.515 . . . . 1.7 111.362 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.09 -23.02 72.85 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.866 -0.683 . . . . 0.82 113.068 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.92 -45.98 12.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.803 0.301 . . . . 1.23 111.703 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -89.23 -51.72 5.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.775 1.028 . . . . 0.84 113.775 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -74.39 -68.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.404 0.52 . . . . 1.96 112.404 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.464 ' HB ' ' OG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -72.4 -34.53 67.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.16 0.429 . . . . 1.86 112.16 -179.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 60.4 35.54 20.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.059 0.457 . . . . 1.73 110.744 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.464 ' OG1' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -83.75 -30.24 26.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.634 -0.712 . . . . 2.07 111.637 -179.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.461 HD13 HG22 ' A' ' 102' ' ' ILE . 70.5 mt -76.89 110.48 12.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.194 -0.457 . . . . 1.38 110.976 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -120.72 -11.44 9.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 3.77 109.874 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.0 m -150.93 171.48 17.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.006 -0.543 . . . . 1.78 110.339 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.12 -22.48 66.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.091 0.472 . . . . 1.54 111.013 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -42.78 92.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.693 -0.685 . . . . 1.62 111.207 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 111' ' ' VAL . 11.2 m-20 -65.43 -40.37 93.25 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.167 -0.47 . . . . 1.89 110.137 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 12.1 mt -62.52 -42.3 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.659 -0.7 . . . . 1.44 110.083 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -57.7 -41.93 82.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.301 -0.863 . . . . 2.74 110.908 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -66.79 -39.06 87.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 1.95 111.01 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 107' ' ' ASP . 89.1 t -59.83 -39.53 80.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.847 0.356 . . . . 1.42 110.526 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -65.87 -39.07 90.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.444 -0.344 . . . . 0.92 110.159 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 79.9 mt -65.59 -35.53 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.143 0.497 . . . . 1.85 109.686 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -65.66 -27.96 68.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.774 -0.648 . . . . 2.37 110.338 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.44 -13.04 58.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.599 -0.728 . . . . 1.42 111.116 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.38 6.86 17.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.555 -0.831 . . . . 1.15 113.408 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 43.1 mm -91.64 122.82 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.955 0.378 . . . . 2.16 110.054 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -65.03 136.06 56.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.477 -0.329 . . . . 3.2 110.792 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.4 -33.24 70.34 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 121.031 -0.604 . . . . 1.25 112.595 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -65.91 -42.8 89.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.285 0.564 . . . . 2.98 109.897 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.89 -41.83 86.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 2.52 109.711 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -60.0 -40.4 89.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.31 -0.859 . . . . 2.23 111.11 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.29 -40.31 95.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.385 -0.37 . . . . 2.3 110.918 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.4 89.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.61 111.115 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.44 -40.62 70.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.415 . . . . 1.48 110.654 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -58.39 -34.85 71.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.037 -0.529 . . . . 1.43 110.841 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -106.55 40.61 1.59 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.072 -0.513 . . . . 1.63 111.096 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 80.1 p -108.79 152.94 24.19 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.745 -0.382 . . . . 2.33 110.745 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -72.09 -32.84 67.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.416 . . . . 4.45 109.999 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 134' ' ' LEU . 60.3 t -58.9 -50.35 79.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.696 -0.684 . . . . 1.99 110.956 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.518 ' O ' HG21 ' A' ' 135' ' ' VAL . 24.8 t -60.22 -45.15 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 1.54 110.522 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -59.26 -38.72 80.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.254 -0.43 . . . . 2.84 110.481 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.04 -36.53 84.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.165 0.507 . . . . 1.75 109.961 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 130' ' ' VAL . 75.7 mt -72.34 -41.63 66.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.987 -0.551 . . . . 1.53 110.342 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.536 ' HA ' HE21 ' A' ' 138' ' ' GLN . 94.2 t -58.27 -47.17 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 1.31 111.084 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.71 83.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.106 -0.497 . . . . 1.52 111.093 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -70.08 -35.27 74.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 1.97 111.62 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.688 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 48.8 mt-30 -56.58 -54.56 44.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.144 -0.48 . . . . 0.69 111.085 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -71.58 -32.79 68.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.845 -0.616 . . . . 2.82 111.243 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 70.5 tttt -60.13 -48.27 82.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.323 -0.399 . . . . 2.37 110.805 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.03 99.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.16 -0.473 . . . . 1.2 110.986 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.51 -46.23 90.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 1.12 111.659 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.94 -6.45 57.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.306 0.484 . . . . 1.27 112.306 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -94.07 -27.88 16.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.057 0.456 . . . . 1.39 110.456 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.6 m -98.73 5.65 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.088 -0.505 . . . . 1.98 110.868 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 148' ' ' ARG . 62.7 mt-30 56.51 55.91 6.08 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.25 0.548 . . . . 2.43 109.974 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 44.3 tp -63.71 103.32 0.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.577 -0.738 . . . . 1.32 111.237 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 146' ' ' GLN . 51.1 mtt180 -100.51 40.84 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 4.87 110.199 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -174.13 -174.64 41.13 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.613 -0.995 . . . . 0.82 110.613 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.497 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.2 t -107.83 -58.46 0.05 OUTLIER Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 117.174 0.487 . . . . 1.16 111.562 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 18.4 Cg_endo -93.98 67.22 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.558 2.172 . . . . 0.73 112.313 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.07 143.29 45.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 1.07 110.759 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 45.4 ttm -113.82 138.41 50.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.106 -0.497 . . . . 1.09 110.68 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.49 125.29 44.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.638 -0.71 . . . . 0.66 109.659 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.5 t -88.57 112.87 24.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.552 -0.295 . . . . 1.18 111.347 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 58.37 17.3 4.67 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.842 0.714 . . . . 1.24 111.801 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.26 19.93 62.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.051 -0.595 . . . . 0.56 111.627 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -110.72 -38.07 5.25 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.874 0.369 . . . . 2.21 111.078 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -123.83 142.0 51.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.38 . . . . 1.61 111.254 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -107.59 142.95 36.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.749 -0.659 . . . . 1.14 109.614 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.7 mp -94.29 135.21 35.94 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.144 -0.317 . . . . 1.83 110.144 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -115.57 106.05 51.02 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.808 0.337 . . . . 0.85 110.974 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.43 -20.3 21.0 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.33 2.02 . . . . 0.71 112.266 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -77.0 5.98 7.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.034 -0.53 . . . . 2.48 110.996 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.4 22.07 4.46 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.192 -0.763 . . . . 0.6 111.192 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 66.0 mtt -109.19 -167.41 1.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.528 0.204 . . . . 1.13 110.777 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.04 130.7 41.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.291 0.567 . . . . 1.54 111.659 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.68 19.0 13.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.142 -0.935 . . . . 1.69 109.227 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.7 -46.07 8.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.408 -0.815 . . . . 1.53 110.368 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -146.49 130.65 17.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.118 -0.492 . . . . 1.42 110.252 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.474 ' O ' HG23 ' A' ' 175' ' ' VAL . 0.0 OUTLIER -60.56 -28.9 68.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 2.41 110.333 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.54 -31.28 70.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.49 0.662 . . . . 2.05 110.506 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 43.0 t -86.0 -43.52 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.806 -0.634 . . . . 1.24 109.677 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -52.11 -50.19 62.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.306 -0.861 . . . . 0.56 111.781 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 171' ' ' MET . 93.4 t -59.09 -50.21 80.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.249 -0.432 . . . . 1.15 111.564 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -63.29 -41.93 99.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.028 -0.533 . . . . 1.7 111.289 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -64.65 -43.84 92.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.552 -0.295 . . . . 1.91 110.774 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -57.44 -48.38 79.3 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.108 0.48 . . . . 0.92 110.262 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.6 -35.59 77.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.778 -0.647 . . . . 1.02 111.688 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.9 -36.39 80.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.502 -0.317 . . . . 1.55 110.688 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.5 m -59.14 -38.37 79.52 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.037 -0.528 . . . . 1.17 110.654 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.26 -53.08 53.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 1.14 110.196 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -58.11 -41.48 83.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.501 -0.772 . . . . 2.13 111.086 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -61.37 -44.28 97.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 1.25 111.179 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.42 -36.82 60.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.056 0.762 . . . . 1.22 113.056 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.3 p -63.02 -32.04 73.31 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.069 0.461 . . . . 1.38 110.959 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.041 -0.527 . . . . 2.26 110.217 -179.785 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.934 0.397 . . . . 1.37 109.976 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -94.35 145.93 24.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 2.29 110.854 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.16 128.86 36.99 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.978 -0.749 . . . . 1.83 108.978 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.07 1.26 72.96 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.542 -0.837 . . . . 0.78 111.075 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -118.04 -72.34 0.69 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.785 -0.45 . . . . 2.32 109.785 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -85.21 -39.09 18.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.054 0.454 . . . . 1.46 109.997 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -138.28 152.73 48.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.336 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.17 132.93 54.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.02 -0.536 . . . . 1.51 110.356 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 m -85.22 120.18 26.43 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.767 -0.457 . . . . 1.54 109.767 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 69.2 mt -74.2 146.69 43.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.147 -0.479 . . . . 1.36 110.957 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.8 -10.37 48.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.464 0.649 . . . . 2.33 109.293 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -118.63 83.55 22.25 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.314 -0.857 . . . . 4.04 109.51 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.62 121.68 8.4 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.125 1.883 . . . . 1.06 111.769 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.47 109.59 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.92 -0.582 . . . . 1.3 110.552 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.0 136.72 45.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.481 -0.781 . . . . 1.48 110.986 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.33 14.97 72.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.776 -0.726 . . . . 0.8 112.5 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 144.31 33.69 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.151 -0.315 . . . . 1.2 110.151 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.51 168.98 16.68 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.627 2.218 . . . . 0.63 112.018 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 22.1 mp0 -63.68 -53.0 58.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.043 -0.526 . . . . 1.79 111.013 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.59 103.3 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.862 0.363 . . . . 1.11 110.617 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.8 tp -108.39 127.99 54.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.044 -0.526 . . . . 1.16 110.564 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -128.71 142.95 50.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 1.61 110.135 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.64 152.2 37.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.367 -0.378 . . . . 0.61 110.062 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.98 174.14 9.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.298 0.57 . . . . 0.67 111.52 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.412 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 7.9 t -155.54 132.14 10.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.628 -0.715 . . . . 1.52 109.495 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.521 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 92.1 m-85 -67.36 -15.24 63.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.187 -0.461 . . . . 0.71 111.333 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.517 ' CE1' ' HA2' ' A' ' 69' ' ' GLY . 71.8 m-85 -86.31 -6.12 59.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 2.16 111.589 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 35.5 t -109.61 118.45 50.37 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.451 -0.34 . . . . 0.89 111.626 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.48 -25.63 76.0 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.406 2.07 . . . . 0.86 111.232 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -61.84 -30.12 70.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.571 -0.74 . . . . 2.46 110.251 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.5 m -79.27 -41.06 28.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.5 110.334 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.51 -35.17 76.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.137 0.494 . . . . 2.22 110.008 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.687 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 26.6 tt0 -67.04 -33.42 75.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.428 -0.806 . . . . 2.82 110.4 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.402 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.6 m-85 -86.51 -22.44 26.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.398 . . . . 1.05 110.768 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 12.8 tp10 -84.18 -62.62 1.52 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.019 -0.537 . . . . 1.89 112.41 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -92.41 -33.98 14.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.309 0.855 . . . . 2.0 113.309 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.687 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 73.9 t -76.72 -58.24 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.286 -0.566 . . . . 1.18 111.631 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -89.95 -26.19 20.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.415 0.524 . . . . 1.13 112.415 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 22.6 m-70 56.19 49.9 14.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.178 0.513 . . . . 1.19 110.492 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.402 HG13 ' CD2' ' A' ' 36' ' ' PHE . 42.4 mm -59.89 -51.69 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.739 -0.664 . . . . 1.13 111.862 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -56.46 -40.05 74.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.658 -0.246 . . . . 1.37 111.643 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.46 -47.63 75.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.112 0.482 . . . . 1.73 110.307 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -59.61 -42.41 92.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.565 -0.743 . . . . 1.42 110.968 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.641 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 53.8 t -61.53 -47.79 91.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.877 -0.601 . . . . 1.14 110.757 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -58.46 -33.08 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 1.96 111.74 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -79.17 -15.76 57.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 2.52 111.577 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -101.94 -23.99 14.06 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.81 0.338 . . . . 1.93 111.045 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 57.8 mt -64.82 137.34 97.11 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 1.54 111.1 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.49 172.04 16.5 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.584 2.189 . . . . 0.97 111.792 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.65 136.76 53.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.852 -0.613 . . . . 2.63 111.579 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.49 -23.2 36.69 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.806 -0.712 . . . . 0.82 112.904 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.25 130.35 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.913 0.387 . . . . 1.65 111.05 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -112.25 130.31 55.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 2.85 110.287 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.0 ttt -92.37 139.07 30.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 1.76 110.123 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.08 129.22 52.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.679 0.276 . . . . 1.15 111.3 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -115.07 121.81 44.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.856 -0.794 . . . . 1.3 108.856 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.473 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 10.5 m-30 -117.53 159.5 22.76 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.142 0.496 . . . . 1.05 112.075 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 48.6 t-80 -105.32 140.01 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.744 -0.662 . . . . 0.78 109.901 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.7 m -104.0 152.31 6.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.539 -0.3 . . . . 1.37 111.553 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.602 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 72.4 m-20 -96.11 -2.83 45.73 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.955 0.724 . . . . 1.08 112.955 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -87.89 4.06 46.13 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.166 -0.614 . . . . 0.87 111.603 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.73 107.8 5.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.626 -0.509 . . . . 1.67 109.626 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.65 -8.03 3.35 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.603 -0.726 . . . . 0.78 111.297 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.4 -131.75 24.71 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.326 -0.464 . . . . 0.81 112.597 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -74.11 -45.67 47.59 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.863 0.32 . . . . 2.47 111.863 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -73.34 -17.75 61.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.372 -0.376 . . . . 2.46 111.229 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.517 ' HA2' ' CE1' ' A' ' 29' ' ' PHE . . . -58.33 -32.54 68.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.787 -0.72 . . . . 0.72 112.585 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 86.8 mttt -71.5 -31.25 66.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.729 0.299 . . . . 3.18 111.718 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.92 -42.48 85.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.847 0.356 . . . . 1.65 110.703 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.432 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 1.3 mt -66.35 -24.26 66.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.145 -0.48 . . . . 1.65 110.93 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -68.87 -34.13 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.267 0.556 . . . . 1.19 109.83 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -76.43 -40.09 51.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.561 -0.745 . . . . 1.35 109.155 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.75 91.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.61 -0.723 . . . . 1.31 111.198 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -60.44 -38.0 82.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.59 110.502 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.88 90.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.899 -0.591 . . . . 1.33 110.197 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.82 -44.97 92.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.636 -0.711 . . . . 1.48 109.812 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.41 86.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.738 -0.665 . . . . 1.17 110.91 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.6 mtm -66.01 -44.08 85.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 1.56 111.042 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.3 -30.74 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.112 0.482 . . . . 1.42 111.221 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.7 mt -80.39 -41.99 23.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 1.54 110.843 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.22 11.22 34.47 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.573 -0.611 . . . . 0.78 111.573 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 m -105.78 27.4 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.792 0.329 . . . . 1.36 111.149 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -52.44 63.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 1.71 110.251 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.463 ' HA ' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -63.2 -34.42 77.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.503 0.668 . . . . 1.91 110.252 179.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -62.91 -33.88 76.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.298 -0.865 . . . . 2.74 111.454 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.6 m -106.35 10.4 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.433 0.531 . . . . 1.26 112.433 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 86' ' ' ASP . 59.6 m -64.1 -53.76 44.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.787 0.327 . . . . 1.46 111.637 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.456 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 58.4 t -63.79 -55.02 36.89 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.532 0.567 . . . . 1.26 112.532 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 11.3 Cg_endo -55.04 -37.24 93.98 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.302 2.001 . . . . 0.65 113.56 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.45 -32.54 68.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.681 0.277 . . . . 1.34 110.647 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.521 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -75.21 -53.34 8.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.273 0.558 . . . . 0.58 110.442 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.34 -39.9 94.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.81 -0.632 . . . . 1.7 110.961 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.97 -6.33 59.95 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.262 -0.494 . . . . 0.82 113.575 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.2 t -109.79 -40.3 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 117.489 0.644 . . . . 1.23 111.789 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.52 -48.43 5.01 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.035 0.754 . . . . 0.84 113.035 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -78.78 -70.34 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.772 0.286 . . . . 1.96 111.772 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -34.84 67.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.706 -0.224 . . . . 1.86 111.507 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 58.56 34.68 24.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.03 -0.532 . . . . 1.73 110.402 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -26.45 39.89 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.579 -0.737 . . . . 2.07 110.939 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.518 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 67.1 mt -87.17 100.35 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.114 -0.494 . . . . 1.38 110.411 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.518 ' HD2' ' O ' ' A' ' 102' ' ' ILE . 13.7 mmm180 -125.5 -12.22 6.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 3.77 110.334 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.6 p -139.88 168.28 20.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 1.78 110.498 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.7 -27.04 68.94 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.959 0.409 . . . . 1.54 110.984 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.5 m -62.85 -31.43 72.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 1.62 110.631 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 111' ' ' VAL . 33.4 m-20 -73.9 -44.52 54.94 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.661 -0.496 . . . . 1.89 109.661 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.5 mt -62.82 -41.9 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.808 -0.633 . . . . 1.44 110.124 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 ttm105 -60.72 -34.71 74.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.675 -0.693 . . . . 2.74 109.849 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.4 -41.56 69.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.626 -0.716 . . . . 1.95 111.44 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 107' ' ' ASP . 81.1 t -54.46 -45.43 70.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.747 0.308 . . . . 1.42 111.248 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -65.14 -41.48 94.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.92 111.072 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 80.4 mt -65.94 -41.55 90.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.994 0.426 . . . . 1.85 110.064 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -65.65 -30.35 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.71 -0.677 . . . . 2.37 110.354 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.97 -34.92 66.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 1.42 111.255 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 139.68 5.58 1.24 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.241 -0.98 . . . . 1.15 113.273 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 47.6 mm -94.06 123.57 46.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.671 -0.492 . . . . 2.16 109.671 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -61.25 137.55 58.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.594 -0.275 . . . . 3.2 110.498 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.63 -42.93 78.67 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.823 -0.626 . . . . 1.25 112.64 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.4 -45.48 92.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 2.98 110.68 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.49 -45.97 92.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.167 0.508 . . . . 2.52 110.067 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -62.79 -48.06 80.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.458 -0.792 . . . . 2.23 110.951 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.45 -36.13 81.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 2.3 111.047 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.16 86.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 1.61 109.782 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.07 -35.54 78.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.535 -0.757 . . . . 1.48 110.764 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -58.08 -36.32 72.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.104 0.478 . . . . 1.43 110.822 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -99.93 16.08 25.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.096 -0.502 . . . . 1.63 111.196 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.3 m -85.55 144.37 27.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 2.33 111.195 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.95 -36.9 85.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.839 -0.619 . . . . 4.45 110.864 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -56.19 -47.15 81.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 1.99 110.746 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.441 ' O ' HG21 ' A' ' 135' ' ' VAL . 17.6 t -63.83 -42.38 95.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 1.54 110.379 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -61.38 -33.75 74.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 2.84 110.549 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 63.8 m -71.86 -28.75 63.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.926 -0.579 . . . . 1.75 110.646 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.407 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 96.5 mt -74.57 -33.92 62.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.307 -0.406 . . . . 1.53 110.035 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 131' ' ' VAL . 50.5 t -61.43 -43.76 97.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.077 0.465 . . . . 1.31 110.11 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.48 95.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.585 -0.734 . . . . 1.52 111.19 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.43 -40.27 96.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.437 -0.347 . . . . 1.97 111.583 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.473 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 51.9 mt-30 -59.53 -52.54 65.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.69 111.152 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -71.69 -28.87 64.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.406 . . . . 2.82 111.768 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -63.89 -49.63 71.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.362 -0.381 . . . . 2.37 110.537 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.405 ' O ' HG21 ' A' ' 145' ' ' VAL . . . -62.17 -44.2 97.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.876 -0.602 . . . . 1.2 111.464 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.89 84.75 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.263 -0.426 . . . . 1.12 111.556 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.65 -41.24 63.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 1.27 110.813 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.48 -43.54 93.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.037 -0.528 . . . . 1.39 111.795 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 141' ' ' ALA . 32.2 m -79.84 -1.78 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 111.587 0.218 . . . . 1.98 111.587 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 53.98 59.91 3.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.326 0.584 . . . . 2.43 109.872 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.57 134.04 56.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.242 -0.89 . . . . 1.32 112.524 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.9 mmt-85 -106.61 -39.86 5.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.193 -0.912 . . . . 4.87 110.663 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -122.3 159.29 16.93 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.09 -0.804 . . . . 0.82 111.09 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.516 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.4 t -65.58 -57.62 13.96 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 112.26 0.467 . . . . 1.16 112.26 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.516 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.8 Cg_endo -85.5 89.47 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.526 2.15 . . . . 0.73 112.068 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -129.87 154.2 47.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.181 -0.463 . . . . 1.07 110.611 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.444 ' SD ' HG21 ' A' ' 182' ' ' VAL . 30.9 ttm -127.35 133.06 50.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.208 -0.451 . . . . 1.09 110.817 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.15 133.99 53.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.66 110.186 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 44.9 t -102.4 114.81 42.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.263 -0.426 . . . . 1.18 111.218 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 59.46 14.03 3.59 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.088 -0.96 . . . . 1.24 111.987 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 69.52 20.57 75.61 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.937 -0.649 . . . . 0.56 112.125 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -120.78 -45.81 2.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 2.21 111.235 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -106.39 129.84 54.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.972 -0.558 . . . . 1.61 111.14 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -106.86 138.55 42.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.636 -0.711 . . . . 1.14 109.652 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mp -90.96 132.54 35.9 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.619 -0.432 . . . . 1.83 110.3 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -111.53 97.63 37.32 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.283 -0.417 . . . . 0.85 110.403 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.92 -18.87 46.75 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.365 2.043 . . . . 0.71 111.818 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -78.23 -8.25 58.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 2.48 110.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -115.65 14.68 17.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.009 -0.615 . . . . 0.6 112.292 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 55.5 mtt -102.55 -178.81 3.79 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.151 -0.314 . . . . 1.13 110.151 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.2 119.56 15.5 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.363 0.601 . . . . 1.54 111.2 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.91 22.34 15.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.405 -0.816 . . . . 1.69 109.453 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.34 -51.4 5.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.326 -0.852 . . . . 1.53 110.035 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -118.47 121.66 40.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.984 -0.553 . . . . 1.42 110.185 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 46.2 mmm -59.32 -38.2 79.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 2.41 111.879 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.16 -27.94 68.4 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.117 0.484 . . . . 2.05 110.704 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 55.4 t -77.83 -46.06 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.571 -0.74 . . . . 1.24 109.634 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.58 -50.73 69.31 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.073 -0.512 . . . . 0.56 111.414 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.21 -44.93 77.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.212 -0.449 . . . . 1.15 111.242 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 21.9 mm-40 -71.59 -46.24 59.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.187 -0.46 . . . . 1.7 111.294 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.08 -45.95 82.9 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.215 0.322 . . . . 1.91 111.204 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.431 ' O ' HG22 ' A' ' 182' ' ' VAL . 19.0 t80 -59.4 -56.12 26.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.643 -0.253 . . . . 0.92 110.88 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.83 87.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.43 . . . . 1.02 112.087 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.3 OUTLIER -69.08 -33.87 74.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.687 -0.233 . . . . 1.55 111.056 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 86.4 m -64.78 -39.36 93.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.581 -0.526 . . . . 1.17 109.581 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.444 HG21 ' SD ' ' A' ' 153' ' ' MET . 11.7 t -60.41 -46.7 94.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.106 -0.497 . . . . 1.14 109.748 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -61.09 -41.62 97.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.826 -0.625 . . . . 2.13 110.477 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.65 -41.67 95.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 1.25 111.088 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.68 -38.08 34.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.292 -0.413 . . . . 1.22 112.056 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 51.0 m -63.18 -30.31 71.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 1.38 111.006 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 121.278 0.561 . . . . 2.26 110.182 179.958 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 121.008 0.432 . . . . 1.37 110.76 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -111.05 147.53 34.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.82 -0.627 . . . . 2.29 110.627 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.22 117.43 17.04 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.046 -0.525 . . . . 1.83 109.621 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.405 ' HA2' HG21 ' A' ' 10' ' ' THR . . . 111.59 -5.8 27.98 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.135 -0.786 . . . . 0.78 111.135 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -112.46 -80.89 0.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.515 0.198 . . . . 2.32 110.637 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -85.79 -27.71 24.99 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.912 0.387 . . . . 1.46 110.638 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -141.36 159.75 41.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.405 HG21 ' HA2' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -137.99 130.57 29.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.469 -0.332 . . . . 1.51 111.27 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -77.13 125.26 29.04 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.525 -0.546 . . . . 1.54 109.525 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.9 mt -71.0 147.01 49.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.938 0.399 . . . . 1.36 111.156 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.67 -38.91 53.7 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.005 -0.739 . . . . 2.33 109.005 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -117.21 104.34 50.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.115 -0.948 . . . . 4.04 109.343 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.39 143.25 34.61 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.227 1.952 . . . . 1.06 112.111 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.61 91.88 3.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 1.3 110.075 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.86 123.6 20.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.841 -0.618 . . . . 1.48 110.003 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.02 -5.92 42.79 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.839 -0.696 . . . . 0.8 111.922 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.31 155.28 93.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.571 0.224 . . . . 1.2 111.091 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -76.31 -177.09 3.44 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.662 2.241 . . . . 0.63 112.057 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.407 ' OE1' HG22 ' A' ' 54' ' ' VAL . 40.3 mt-30 -69.87 -52.4 25.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 1.79 110.994 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.0 t -123.26 105.1 15.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.25 0.547 . . . . 1.11 110.747 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 tp -105.54 119.6 39.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.982 -0.554 . . . . 1.16 109.738 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.482 ' OE1' ' HG3' ' A' ' 58' ' ' LYS . 17.6 tt0 -122.72 147.42 46.5 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.806 0.336 . . . . 1.61 110.297 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -122.29 151.87 40.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.131 -0.486 . . . . 0.61 110.655 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -167.64 169.61 11.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.67 110.855 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.434 ' HB2' HG21 ' A' ' 61' ' ' VAL . 3.4 t -152.47 135.72 15.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.273 -0.421 . . . . 1.52 110.371 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.44 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 90.6 m-85 -71.43 -15.59 62.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.099 -0.501 . . . . 0.71 110.232 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -90.55 0.51 57.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.977 -0.556 . . . . 2.16 110.679 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 51.1 t -109.45 114.93 56.82 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 116.017 -0.538 . . . . 0.89 110.603 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.493 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 19.7 Cg_endo -60.9 -26.75 83.67 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.588 2.192 . . . . 0.86 111.864 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -32.5 72.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.042 -0.526 . . . . 2.46 110.842 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.2 m -72.28 -33.38 67.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.25 -0.648 . . . . 0.5 109.25 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -66.13 -40.67 90.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.866 -0.79 . . . . 2.22 108.866 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.701 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 6.7 mt-30 -70.69 -37.55 73.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.588 -0.733 . . . . 2.82 110.791 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.96 -18.23 62.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.919 0.34 . . . . 1.05 111.919 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.74 -65.78 1.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.292 -0.563 . . . . 1.89 112.096 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.55 -27.71 66.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.15 0.5 . . . . 2.0 111.612 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.701 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 96.1 t -100.2 -59.53 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.715 -0.394 . . . . 1.18 111.992 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -85.03 -33.75 22.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.894 0.701 . . . . 1.13 112.894 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 61.63 46.34 7.3 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.098 0.475 . . . . 1.19 110.489 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 mm -58.72 -49.27 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.388 -0.823 . . . . 1.13 111.07 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.461 ' HA ' ' HE3' ' A' ' 56' ' ' MET . 1.9 m -63.75 -45.94 87.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 1.37 111.323 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.27 -33.55 76.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.115 -0.493 . . . . 1.73 111.756 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -75.41 -41.93 54.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.411 -0.359 . . . . 1.42 110.804 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 22.5 t -60.04 -41.01 84.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.91 -0.586 . . . . 1.14 110.602 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -54.82 -38.31 67.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 1.96 112.206 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -78.7 -10.91 59.93 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.588 0.588 . . . . 2.52 112.588 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.5 mtmm -120.13 19.94 12.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.896 0.379 . . . . 1.93 110.918 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 14.1 mt -89.77 136.23 29.6 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.021 -0.536 . . . . 1.54 110.508 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.47 153.73 69.09 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.542 2.161 . . . . 0.97 111.848 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.13 123.45 20.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.169 -0.468 . . . . 2.63 110.774 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.33 -11.78 43.62 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.775 -0.648 . . . . 0.82 111.546 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.407 HG22 ' OE1' ' A' ' 21' ' ' GLN . 83.4 t -88.52 115.89 29.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.025 0.441 . . . . 1.65 110.368 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -92.11 140.33 29.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.893 -0.594 . . . . 2.85 110.603 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.461 ' HE3' ' HA ' ' A' ' 43' ' ' SER . 11.5 ttt -100.73 119.14 38.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.097 -0.502 . . . . 1.76 110.215 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.91 99.98 9.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.173 -0.467 . . . . 1.15 111.236 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HG3' ' OE1' ' A' ' 24' ' ' GLU . 44.5 tttp -89.68 108.97 19.99 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.77 -0.826 . . . . 1.3 108.77 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.428 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 9.0 m-30 -106.72 153.02 23.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.417 0.627 . . . . 1.05 111.932 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -98.16 132.12 43.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.681 -0.69 . . . . 0.78 110.344 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.434 HG21 ' HB2' ' A' ' 27' ' ' SER . 5.3 m -80.75 156.73 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.793 -0.185 . . . . 1.37 110.574 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.512 ' ND2' ' HG2' ' A' ' 139' ' ' GLU . 13.0 m-20 -115.72 24.57 11.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.148 0.425 . . . . 1.08 112.148 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -117.89 8.03 12.51 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.229 -0.588 . . . . 0.87 111.282 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.9 mtp -141.45 107.69 5.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.856 -0.424 . . . . 1.67 109.856 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.18 -10.76 3.04 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.751 -0.659 . . . . 0.78 112.023 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.46 -142.57 29.27 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.763 -0.732 . . . . 0.81 112.363 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.58 -34.98 76.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.298 0.571 . . . . 2.47 110.816 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -75.71 -11.79 60.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 2.46 110.349 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.59 -46.39 93.85 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.044 -0.598 . . . . 0.72 112.496 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -67.97 -27.07 66.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.609 0.242 . . . . 3.18 111.46 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -43.81 93.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 1.65 110.753 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -24.47 64.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.793 -0.64 . . . . 1.65 111.185 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 m -66.01 -35.45 80.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.163 0.506 . . . . 1.19 110.472 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -76.06 -37.8 57.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 1.35 109.484 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.67 97.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.638 -0.71 . . . . 1.31 110.386 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -64.63 -36.65 84.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.444 -0.798 . . . . 0.59 110.579 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.72 88.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 1.33 109.991 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 58.6 t -66.54 -44.88 89.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.728 -0.669 . . . . 1.48 109.727 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.01 86.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.666 -0.697 . . . . 1.17 110.989 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.7 ttm -64.22 -44.22 92.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.868 -0.606 . . . . 1.56 110.756 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.18 83.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.589 . . . . 1.42 111.516 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 78.8 mt -77.21 -38.56 51.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.576 -0.284 . . . . 1.54 111.411 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.16 38.27 3.61 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.705 -0.76 . . . . 0.78 112.42 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.9 m -132.59 30.8 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.79 0.328 . . . . 1.36 110.482 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -53.66 -64.94 0.66 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.727 -0.669 . . . . 1.71 112.568 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -31.73 70.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 1.91 111.155 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -62.13 -38.79 90.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.955 -0.566 . . . . 2.74 111.866 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -98.91 -9.3 8.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.413 0.523 . . . . 1.26 112.413 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -58.16 -45.44 87.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.658 0.266 . . . . 1.46 111.643 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.45 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 77.0 t -64.63 -60.81 7.54 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.185 0.439 . . . . 1.26 112.185 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.45 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 11.9 Cg_endo -56.14 -33.26 89.8 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.983 1.789 . . . . 0.65 113.068 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.41 -46.27 67.24 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.836 -0.346 . . . . 1.34 110.356 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 m-85 -61.49 -48.22 82.09 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.318 0.58 . . . . 0.58 110.54 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.429 ' CD ' ' HZ3' ' A' ' 98' ' ' LYS . 12.2 mm-40 -62.84 -43.92 97.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.381 -0.827 . . . . 1.7 111.663 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.26 -16.46 77.1 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.097 -0.573 . . . . 0.82 113.802 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 55.0 t -100.01 -41.23 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.33 0.565 . . . . 1.23 112.424 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 31' ' ' PRO . 79.3 mt-30 -99.56 -42.34 6.96 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.009 1.114 . . . . 0.84 114.009 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.429 ' HZ3' ' CD ' ' A' ' 94' ' ' GLU . 34.9 ttmt -81.6 -68.05 0.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.585 -0.446 . . . . 1.96 111.784 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -34.59 62.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.094 -0.242 . . . . 1.86 110.851 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.537 ' HB3' ' NH2' ' A' ' 103' ' ' ARG . 78.9 mt-30 57.85 37.67 27.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.906 -0.588 . . . . 1.73 110.636 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.29 -20.72 27.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.127 -0.942 . . . . 2.07 110.896 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 83.2 mt -80.94 106.42 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.752 -0.658 . . . . 1.38 110.511 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.537 ' NH2' ' HB3' ' A' ' 100' ' ' GLN . 37.5 mmt180 -123.37 -20.14 5.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.587 -0.733 . . . . 3.77 110.76 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -133.29 172.85 12.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.828 0.346 . . . . 1.78 110.444 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.46 -26.39 67.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.023 0.44 . . . . 1.54 110.627 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -33.08 73.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.668 -0.696 . . . . 1.62 110.673 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -71.74 -39.25 70.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.962 -0.563 . . . . 1.89 109.735 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.1 mt -64.78 -41.58 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.875 -0.602 . . . . 1.44 109.744 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -58.77 -42.7 89.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.085 -0.961 . . . . 2.74 110.963 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -60.02 -40.96 91.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 1.95 111.149 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.3 t -56.6 -43.51 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 1.42 111.021 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -66.57 -37.65 85.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.92 110.513 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 88.1 mt -65.32 -41.93 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.074 0.464 . . . . 1.85 109.854 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -64.61 -26.6 68.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.547 -0.752 . . . . 2.37 110.723 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.97 -32.14 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 1.42 110.768 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.83 7.74 3.66 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.783 -0.722 . . . . 1.15 112.914 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.3 mm -87.94 137.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.097 -0.334 . . . . 2.16 110.097 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -70.26 133.73 47.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.05 -0.523 . . . . 3.2 110.099 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.92 -44.53 96.03 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.953 -0.641 . . . . 1.25 112.56 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.98 -37.82 88.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.323 . . . . 2.98 110.987 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.22 -42.22 84.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.263 0.554 . . . . 2.52 109.612 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -63.06 -46.86 85.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.492 -0.776 . . . . 2.23 110.382 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -64.31 -29.4 70.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.215 0.531 . . . . 2.3 110.635 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.14 62.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.906 -0.588 . . . . 1.61 110.372 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.34 -34.36 78.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 1.48 110.868 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -58.74 -26.7 64.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.846 -0.615 . . . . 1.43 110.513 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -102.05 26.11 7.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.89 -0.595 . . . . 1.63 111.635 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.9 t -101.55 143.43 31.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.906 0.384 . . . . 2.33 111.162 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -65.83 -28.36 68.93 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.57 -0.741 . . . . 4.45 110.874 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.11 -45.58 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.242 0.544 . . . . 1.99 109.547 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.563 ' O ' HG22 ' A' ' 135' ' ' VAL . 88.9 t -64.58 -44.09 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.396 -0.82 . . . . 1.54 110.038 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -55.61 -44.44 77.03 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.993 0.425 . . . . 2.84 110.682 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 52.3 m -66.06 -39.18 89.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.589 . . . . 1.75 110.74 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.7 mt -64.2 -37.99 89.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.376 -0.375 . . . . 1.53 110.791 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 131' ' ' VAL . 54.8 t -65.4 -44.7 94.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 1.31 109.949 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.16 78.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 1.52 110.901 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -62.05 -45.46 93.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 1.97 110.903 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.432 HE21 ' HA ' ' A' ' 135' ' ' VAL . 44.9 mt-30 -63.44 -41.05 98.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.69 110.897 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HG2' ' ND2' ' A' ' 62' ' ' ASN . 43.8 mt-10 -69.01 -40.29 78.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.072 -0.513 . . . . 2.82 111.325 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -72.05 -49.74 34.19 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.347 0.499 . . . . 2.37 112.347 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.82 -40.69 76.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.204 0.446 . . . . 1.2 112.204 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.5 -31.11 72.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.825 0.345 . . . . 1.12 111.675 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.13 -29.33 20.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.423 -0.353 . . . . 1.27 111.228 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -61.63 -50.61 71.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.995 0.426 . . . . 1.39 111.368 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.31 -8.8 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.945 -0.57 . . . . 1.98 111.547 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 64.18 74.93 0.39 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.384 0.612 . . . . 2.43 109.611 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.5 tp -80.23 123.96 28.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.679 -0.691 . . . . 1.32 111.888 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.26 -48.13 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.184 -0.673 . . . . 4.87 109.184 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.81 132.02 11.07 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.822 -0.911 . . . . 0.82 110.822 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.481 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 3.4 t -67.03 -52.44 31.09 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 112.584 0.587 . . . . 1.16 112.584 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 3.3 Cg_exo -79.55 76.79 4.36 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.11 1.874 . . . . 0.73 112.638 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.27 152.14 51.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 1.07 110.955 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 48.2 ttm -131.63 136.22 47.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.071 -0.513 . . . . 1.09 110.095 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -117.48 134.28 55.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.32 -0.4 . . . . 0.66 110.005 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 66.3 t -103.42 118.15 49.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.883 0.373 . . . . 1.18 110.565 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 64.67 5.35 2.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.491 -0.777 . . . . 1.24 111.658 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.2 15.41 74.62 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.032 -0.604 . . . . 0.56 112.158 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -119.92 -31.19 4.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.798 0.332 . . . . 2.21 111.227 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -118.41 139.12 51.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 1.61 110.549 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -117.09 138.67 51.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.916 -0.584 . . . . 1.14 110.319 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.9 mp -83.57 137.35 33.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.704 -0.48 . . . . 1.83 109.704 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -116.17 98.76 51.89 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.408 -0.36 . . . . 0.85 111.308 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.38 -14.13 33.8 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.374 2.049 . . . . 0.71 111.669 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -75.64 -6.73 51.84 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.159 -0.473 . . . . 2.48 110.975 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -128.87 19.2 5.55 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.773 -0.531 . . . . 0.6 111.773 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.3 mtt -99.02 -168.78 1.67 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.802 -0.199 . . . . 1.13 110.488 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.76 114.69 10.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.09 0.471 . . . . 1.54 110.533 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.86 33.37 5.25 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.728 0.775 . . . . 1.69 109.504 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.72 -47.81 2.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.119 -0.946 . . . . 1.53 111.018 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -114.45 118.8 34.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.788 0.328 . . . . 1.42 110.345 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.447 ' O ' HG23 ' A' ' 175' ' ' VAL . 12.6 mmt -59.76 -41.78 91.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 2.41 110.903 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.25 -33.11 75.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 2.05 111.643 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 77.0 t -79.18 -39.57 21.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.738 -0.21 . . . . 1.24 110.482 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -55.82 -50.14 71.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.596 -0.275 . . . . 0.56 111.159 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 171' ' ' MET . 46.6 t -58.39 -48.24 85.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 1.15 111.341 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -66.48 -39.55 88.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.891 -0.595 . . . . 1.7 111.423 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.61 -44.7 89.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.482 -0.326 . . . . 1.91 110.634 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.463 ' O ' HG22 ' A' ' 182' ' ' VAL . 2.5 t80 -54.9 -50.97 67.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.92 110.189 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.409 ' HA ' HG21 ' A' ' 46' ' ' VAL . . . -66.93 -38.19 85.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 1.02 112.041 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.19 -39.3 92.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.37 -0.377 . . . . 1.55 111.137 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 13.1 m -62.41 -36.96 83.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 1.17 110.116 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 178' ' ' TYR . 49.3 t -63.27 -48.76 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.047 0 CA-C-N 116.237 -0.438 . . . . 1.14 110.03 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -62.17 -40.17 95.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 2.13 110.743 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -64.39 -44.47 91.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.479 -0.328 . . . . 1.25 110.766 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.02 -32.34 71.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.475 -0.329 . . . . 1.22 111.274 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.2 m -75.54 -26.22 57.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 1.38 110.851 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 2.26 110.572 -179.832 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 N--CA 1.465 0.298 0 N-CA-C 110.25 -0.278 . . . . 1.37 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.0 142.96 49.75 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.334 -0.394 . . . . 2.29 110.87 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.32 123.59 24.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 1.83 110.366 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.97 -7.74 44.95 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.931 -0.577 . . . . 0.78 111.745 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.452 ' HB3' ' OE1' ' A' ' 8' ' ' GLN . 1.2 tttm -118.21 -75.85 0.58 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.612 0.244 . . . . 2.32 110.74 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.452 ' OE1' ' HB3' ' A' ' 7' ' ' LYS . 22.7 mp0 -76.6 -42.45 42.42 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.433 0.635 . . . . 1.46 110.175 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -134.16 163.99 28.36 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.394 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.4 115.91 12.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.716 0.294 . . . . 1.51 110.805 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.6 m -73.9 121.23 20.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.036 -0.529 . . . . 1.54 109.833 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.69 142.42 51.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.111 0.482 . . . . 1.36 111.667 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -74.17 -33.7 63.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.666 -0.697 . . . . 2.33 109.464 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -120.35 97.06 49.1 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.267 -0.879 . . . . 4.04 109.47 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.29 169.23 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.529 2.153 . . . . 1.06 112.554 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.69 117.12 49.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 1.3 110.464 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.43 131.9 35.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.821 0.343 . . . . 1.48 110.312 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.59 22.84 41.74 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.735 -0.745 . . . . 0.8 111.523 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.61 150.45 38.05 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.773 -0.214 . . . . 1.2 110.469 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.56 171.9 5.1 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.045 2.497 . . . . 0.63 113.077 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -71.0 -68.55 0.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.853 -0.612 . . . . 1.79 110.63 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.5 t -107.01 102.17 13.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.678 -0.49 . . . . 1.11 109.678 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 59' ' ' TYR . 18.5 tp -105.35 119.62 39.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.858 -0.61 . . . . 1.16 110.535 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -119.53 147.82 44.01 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.948 -0.39 . . . . 1.61 109.948 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.09 145.04 47.27 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.797 -0.446 . . . . 0.61 109.797 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -164.25 175.67 9.88 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.175 0.512 . . . . 0.67 110.799 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.412 ' HB2' HG23 ' A' ' 61' ' ' VAL . 3.3 t -156.53 137.82 13.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.547 -0.751 . . . . 1.52 109.998 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.554 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 71.1 m-85 -71.35 -14.69 62.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 0.71 110.572 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 71.7 m-85 -88.27 -5.92 58.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.871 -0.604 . . . . 2.16 110.45 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 13.2 t -104.73 113.4 64.96 Favored Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-O 120.961 0.41 . . . . 0.89 111.363 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 22.5 Cg_endo -64.69 -22.22 64.45 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.258 1.972 . . . . 0.86 110.429 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -67.25 -30.66 70.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.062 -0.972 . . . . 2.46 109.948 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.437 ' SG ' HG13 ' A' ' 150' ' ' VAL . 75.2 m -79.94 -38.94 31.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.411 -0.588 . . . . 0.5 109.411 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.76 -38.64 85.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 2.22 109.778 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.44 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 3.1 tp60 -60.38 -44.17 95.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.384 -0.825 . . . . 2.82 109.909 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.451 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.5 m-85 -74.39 -24.69 59.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.553 -0.748 . . . . 1.05 111.524 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -86.16 -49.89 7.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.543 0.571 . . . . 1.89 112.543 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -94.98 -38.69 10.55 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.569 0.951 . . . . 2.0 113.569 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 46.0 t -80.25 -53.43 12.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.023 -0.671 . . . . 1.18 111.882 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.7 mt -90.24 -29.18 18.35 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.768 -0.373 . . . . 1.13 111.986 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 56.69 48.67 15.88 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.477 0.656 . . . . 1.19 109.889 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.451 HG13 ' CD2' ' A' ' 36' ' ' PHE . 39.0 mm -59.89 -47.57 91.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.353 -0.84 . . . . 1.13 111.3 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.05 -48.31 64.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.326 0.391 . . . . 1.37 111.712 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.46 -47.05 87.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.906 -0.588 . . . . 1.73 110.375 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -60.67 -40.92 93.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 1.42 110.956 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.597 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 69.3 t -65.73 -48.88 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 1.14 110.616 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -56.4 -33.71 66.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.043 0.449 . . . . 1.96 111.594 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -81.41 -10.01 59.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 2.52 111.987 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.94 2.35 16.9 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.804 -0.358 . . . . 1.93 111.597 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 59.3 mt -79.62 131.99 62.95 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.333 -0.394 . . . . 1.54 110.331 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.01 164.51 35.34 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.645 2.23 . . . . 0.97 112.157 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -61.48 108.42 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.212 0.53 . . . . 2.63 111.759 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.74 -24.08 5.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.986 -0.625 . . . . 0.82 112.109 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.06 130.7 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.928 0.394 . . . . 1.65 110.757 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 56' ' ' MET . 11.9 ttmm -119.61 147.15 44.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.895 -0.593 . . . . 2.85 110.561 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.41 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 8.9 ttt -87.54 130.45 34.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.123 -0.49 . . . . 1.76 110.564 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.27 106.97 12.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.002 -0.544 . . . . 1.15 110.934 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -90.83 127.42 36.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.525 -0.307 . . . . 1.3 110.41 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CD2' ' HA ' ' A' ' 138' ' ' GLN . 5.2 m-30 -117.36 143.72 45.68 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.891 -0.411 . . . . 1.05 109.891 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -93.63 132.11 38.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.723 0.297 . . . . 0.78 110.988 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 27' ' ' SER . 5.6 m -76.18 150.18 6.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.992 -0.373 . . . . 1.37 109.992 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -103.87 -10.95 17.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.602 0.593 . . . . 1.08 112.602 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -89.46 20.02 4.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.037 0.384 . . . . 0.87 112.037 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.6 mtp -140.64 133.25 28.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.625 0.25 . . . . 1.67 110.425 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.43 3.5 56.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.779 -0.724 . . . . 0.78 112.07 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.09 -129.47 34.94 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.704 -0.76 . . . . 0.81 112.348 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.84 -35.28 57.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.773 0.321 . . . . 2.47 110.785 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.47 -22.0 65.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.961 -0.563 . . . . 2.46 110.527 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.54 89.19 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.703 -0.76 . . . . 0.72 111.362 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -69.98 -37.69 75.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.033 0.444 . . . . 3.18 110.549 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -62.82 -41.86 99.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.784 -0.643 . . . . 1.65 110.675 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.405 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 3.8 mt -70.69 -24.58 62.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.353 -0.385 . . . . 1.65 111.188 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.7 m -66.89 -36.95 83.44 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.135 0.493 . . . . 1.19 109.892 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -76.18 -40.97 51.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 1.35 109.988 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.57 95.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.97 -0.559 . . . . 1.31 111.014 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -61.47 -37.52 83.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 0.59 110.902 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.73 77.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.175 -0.466 . . . . 1.33 110.404 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.69 -44.36 82.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.81 -0.632 . . . . 1.48 110.124 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.66 84.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.686 -0.688 . . . . 1.17 111.668 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 44.9 mtm -67.43 -41.35 84.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.331 -0.395 . . . . 1.56 111.005 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.73 -32.94 73.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 1.42 111.124 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.18 -5.14 59.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.418 -0.355 . . . . 1.54 110.751 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.71 40.63 98.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.064 -0.589 . . . . 0.78 112.432 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.3 m -131.9 30.71 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.87 0.367 . . . . 1.36 110.756 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -53.85 52.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.801 -0.636 . . . . 1.71 110.792 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -30.81 70.12 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.235 0.54 . . . . 1.91 111.044 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -73.9 -24.5 59.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.894 -0.594 . . . . 2.74 112.205 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.429 ' HA ' ' HG2' ' A' ' 91' ' ' PRO . 27.6 m -108.73 -8.25 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 112.238 0.459 . . . . 1.26 112.238 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.4 m -55.88 -65.32 0.62 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.852 0.686 . . . . 1.46 112.852 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.475 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.7 t -60.39 -53.53 63.85 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 113.003 0.742 . . . . 1.26 113.003 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 9.8 Cg_endo -53.42 -38.61 82.99 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.16 1.907 . . . . 0.65 113.346 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.3 mt -69.8 -41.08 75.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.037 -0.357 . . . . 1.34 110.037 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.554 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 2.9 m-85 -60.29 -51.93 67.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.276 0.56 . . . . 0.58 110.269 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.3 -37.79 88.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.553 -0.749 . . . . 1.7 110.441 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.12 -8.17 68.94 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.107 -0.568 . . . . 0.82 113.687 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.6 t -112.21 -39.64 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.307 0.554 . . . . 1.23 112.205 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -98.71 -48.0 5.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.605 0.594 . . . . 0.84 112.605 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -74.53 -73.52 0.23 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.122 -0.49 . . . . 1.96 111.35 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -37.91 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.811 -0.631 . . . . 1.86 111.776 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 62.81 27.97 16.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 1.73 110.815 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -28.93 66.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.86 -0.609 . . . . 2.07 111.006 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.22 105.27 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.317 0.58 . . . . 1.38 110.809 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -121.95 -13.45 8.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 3.77 110.705 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 p -140.45 167.6 21.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 1.78 110.146 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.4 68.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.44 . . . . 1.54 110.105 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -31.85 72.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.384 -0.825 . . . . 1.62 110.559 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 111' ' ' VAL . 64.8 m-20 -71.72 -40.68 69.28 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.11 -0.496 . . . . 1.89 110.194 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 14.8 mt -60.68 -43.19 94.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.757 -0.656 . . . . 1.44 110.089 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -58.78 -36.22 74.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.425 -0.807 . . . . 2.74 110.439 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -68.81 -44.84 72.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.769 -0.651 . . . . 1.95 110.626 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 107' ' ' ASP . 43.8 t -59.22 -40.14 80.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 1.42 110.853 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -62.68 -42.38 99.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 0.92 110.397 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 87.0 mt -62.13 -37.25 77.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.193 0.52 . . . . 1.85 110.245 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.67 -14.31 62.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 2.37 111.152 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.35 -3.02 58.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.201 0.524 . . . . 1.42 110.482 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.92 16.04 26.98 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.802 -0.713 . . . . 1.15 111.942 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 44.8 mm -93.8 129.27 44.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 110.07 -0.344 . . . . 2.16 110.07 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -64.03 131.77 48.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.352 -0.385 . . . . 3.2 110.351 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.44 99.89 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.905 -0.664 . . . . 1.25 111.874 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -64.75 -37.13 86.57 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.657 -0.497 . . . . 2.98 109.657 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.51 -47.02 68.07 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.564 -0.744 . . . . 2.52 109.659 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -60.25 -40.44 90.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.759 -0.655 . . . . 2.23 110.924 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -61.31 -35.41 77.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.991 0.424 . . . . 2.3 111.17 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.33 -45.14 33.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 1.61 110.591 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.11 73.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.872 -0.604 . . . . 1.48 110.915 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -57.13 -33.32 67.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.012 -0.54 . . . . 1.43 110.908 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -111.62 21.67 15.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.274 -0.421 . . . . 1.63 111.256 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -76.91 142.25 40.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.127 -0.488 . . . . 2.33 110.908 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.26 -35.73 78.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.878 -0.601 . . . . 4.45 110.527 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.1 t -63.14 -46.33 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 1.99 109.996 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 135' ' ' VAL . 55.2 t -63.66 -45.66 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.539 -0.755 . . . . 1.54 110.381 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -59.73 -40.46 88.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 2.84 110.533 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.3 m -66.5 -30.74 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 1.75 110.675 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.2 mt -72.27 -38.12 68.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.337 . . . . 1.53 110.479 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 131' ' ' VAL . 57.4 t -59.36 -46.27 92.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.144 -0.48 . . . . 1.31 110.686 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.23 83.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.908 -0.587 . . . . 1.52 111.546 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -65.67 -39.09 90.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 1.97 111.265 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.519 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 50.9 mt-30 -60.97 -46.57 90.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.69 111.079 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -68.08 -44.18 76.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.229 -0.441 . . . . 2.82 111.09 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -60.34 -45.64 92.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.57 . . . . 2.37 111.473 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.437 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -58.69 -51.27 70.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.538 . . . . 1.2 111.427 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.38 86.4 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.935 0.346 . . . . 1.12 111.935 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.28 60.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.252 -0.431 . . . . 1.27 111.908 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.28 -43.17 98.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.02 0.748 . . . . 1.39 113.02 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 141' ' ' ALA . 19.1 m -79.67 1.22 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.358 0.503 . . . . 1.98 112.358 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.42 55.43 5.75 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.576 -0.527 . . . . 2.43 109.576 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.1 tp -61.25 114.63 3.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.587 -0.733 . . . . 1.32 111.302 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.7 mmm-85 -104.48 -38.94 6.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.357 -0.838 . . . . 4.87 109.898 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -104.88 142.54 15.5 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.095 -0.802 . . . . 0.82 111.095 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.532 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 16.5 t -69.96 -55.89 8.04 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 119.262 -0.399 . . . . 1.16 111.624 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.532 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 81.6 Cg_endo -83.46 62.11 7.23 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.942 1.761 . . . . 0.73 112.436 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.27 148.2 39.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.314 -0.403 . . . . 1.07 111.117 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 51.6 ttm -122.16 135.78 54.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 1.09 110.565 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -118.63 121.88 41.23 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.747 -0.66 . . . . 0.66 109.626 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.5 t -93.95 120.72 43.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.266 -0.424 . . . . 1.18 110.77 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 61.56 13.65 5.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.212 -0.904 . . . . 1.24 111.604 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.08 24.91 70.63 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.613 -0.595 . . . . 0.56 111.613 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -130.62 -43.07 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.912 0.387 . . . . 2.21 111.448 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -106.05 120.47 41.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.462 -0.336 . . . . 1.61 111.388 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -103.08 132.68 49.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.515 -0.55 . . . . 1.14 109.515 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.46 143.22 33.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.942 0.401 . . . . 1.83 110.628 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -119.52 95.56 49.31 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.992 -0.549 . . . . 0.85 110.145 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.79 -25.46 53.32 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.226 1.951 . . . . 0.71 112.622 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -71.99 -13.78 61.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 2.48 110.754 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.3 0.37 50.45 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.812 -0.708 . . . . 0.6 112.404 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.1 mtt -97.6 -172.25 2.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.636 0.255 . . . . 1.13 110.449 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.32 120.49 15.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 1.54 110.476 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.25 15.75 18.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.137 0.494 . . . . 1.69 110.733 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.51 -40.45 6.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 1.53 110.719 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -121.74 116.76 25.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.753 0.311 . . . . 1.42 110.858 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -55.06 -41.54 71.59 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.769 -0.65 . . . . 2.41 111.907 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -43.19 63.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.185 0.517 . . . . 2.05 111.43 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 33.1 t -74.26 -45.39 47.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.672 -0.694 . . . . 1.24 111.176 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -55.52 -50.56 69.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.329 -0.396 . . . . 0.56 111.443 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.19 -49.2 80.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 1.15 111.512 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 33.2 mm-40 -68.86 -44.76 72.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.485 -0.325 . . . . 1.7 111.608 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 2.4 mt-30 -56.83 -46.93 81.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.525 0.202 . . . . 1.91 111.367 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 182' ' ' VAL . 10.3 t80 -59.15 -54.15 50.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.808 0.337 . . . . 0.92 111.032 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.83 -37.46 87.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 1.02 112.206 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -67.44 -37.56 83.17 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.837 0.351 . . . . 1.55 110.637 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 94.8 m -62.26 -36.67 82.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 1.17 109.826 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 178' ' ' TYR . 92.8 t -58.93 -49.37 83.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.003 -0.544 . . . . 1.14 110.481 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 37.6 tttm -58.83 -43.18 90.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 2.13 110.975 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -61.96 -43.95 97.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 1.25 111.671 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.01 -34.7 64.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.051 0.389 . . . . 1.22 112.051 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.6 m -69.28 -29.67 67.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.11 0.481 . . . . 1.38 110.495 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.73 -0.668 . . . . 2.26 110.715 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.129 0.49 . . . . 1.37 111.185 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.08 139.64 53.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.459 -0.791 . . . . 2.29 110.015 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.42 121.35 15.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.044 0.45 . . . . 1.83 110.408 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.04 -18.93 28.19 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.744 -0.662 . . . . 0.78 111.758 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -100.97 -79.4 0.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.773 0.32 . . . . 2.32 110.872 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -83.77 -27.16 29.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.671 0.272 . . . . 1.46 111.341 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -145.72 153.5 41.03 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.11 130.48 49.92 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.394 -0.366 . . . . 1.51 110.841 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -81.81 120.41 25.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.884 -0.413 . . . . 1.54 109.884 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.0 mt -67.71 136.02 53.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.085 -0.507 . . . . 1.36 111.291 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.43 -26.92 52.0 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.259 -0.645 . . . . 2.33 109.259 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -120.92 88.61 44.75 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.399 -0.819 . . . . 4.04 109.544 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.6 162.47 32.97 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.769 2.313 . . . . 1.06 113.034 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.9 t -103.72 113.61 41.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.755 -0.657 . . . . 1.3 110.41 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.45 138.37 47.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.137 -0.483 . . . . 1.48 111.433 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.3 86.58 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.08 -0.581 . . . . 0.8 112.886 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.64 151.56 84.9 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.535 0.168 . . . . 1.2 110.666 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.11 173.67 10.05 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.288 1.992 . . . . 0.63 112.297 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.63 -46.29 72.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.091 -0.504 . . . . 1.79 110.784 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -127.56 105.0 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.812 0.339 . . . . 1.11 110.383 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.6 tp -108.25 121.03 44.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.928 -0.578 . . . . 1.16 109.726 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -123.92 145.51 49.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.447 -0.342 . . . . 1.61 110.506 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -121.15 147.27 45.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.079 -0.509 . . . . 0.61 109.981 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -167.68 178.95 5.05 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.056 -0.52 . . . . 0.67 111.024 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.41 ' HB2' HG22 ' A' ' 61' ' ' VAL . 7.8 t -158.94 138.36 11.57 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.01 -0.541 . . . . 1.52 110.001 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.558 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.3 m-85 -69.35 -18.84 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.11 0.481 . . . . 0.71 109.97 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.474 ' CE2' HD13 ' A' ' 72' ' ' LEU . 78.9 m-85 -83.65 -6.9 59.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.48 -0.782 . . . . 2.16 110.866 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.9 t -97.95 117.19 65.39 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 116.504 -0.316 . . . . 0.89 110.808 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.566 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 18.3 Cg_endo -62.05 -23.07 75.33 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.268 1.979 . . . . 0.86 112.019 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -34.8 64.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.037 -0.529 . . . . 2.46 110.652 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.1 m -71.39 -33.34 69.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.068 0.461 . . . . 0.5 110.259 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -63.26 -45.54 91.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.547 0.689 . . . . 2.22 109.298 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.599 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 8.8 tm0? -71.28 -37.67 71.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.948 -1.024 . . . . 2.82 111.182 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.3 -22.93 66.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.232 0.456 . . . . 1.05 112.232 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -108.71 -51.36 2.9 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.927 -0.709 . . . . 1.89 112.378 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -68.12 -27.69 66.67 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.879 -0.513 . . . . 2.0 111.65 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 78.7 t -102.86 -64.87 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.663 -0.244 . . . . 1.18 111.073 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.65 -38.49 67.66 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.702 0.26 . . . . 1.13 111.702 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 64.02 50.56 2.47 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.468 0.48 . . . . 1.19 110.455 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 46' ' ' VAL . 34.2 mm -61.47 -52.56 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.84 -0.618 . . . . 1.13 111.551 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.597 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 21.5 m -58.16 -52.18 66.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.488 0.185 . . . . 1.37 111.033 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 29.9 t70 -58.93 -39.33 81.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.582 -0.281 . . . . 1.73 111.687 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -71.54 -42.8 67.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.697 0.285 . . . . 1.42 110.632 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 37.5 t -59.49 -41.13 83.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 1.14 110.683 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 43' ' ' SER . 75.5 mttt -55.2 -36.7 66.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.896 0.379 . . . . 1.96 110.871 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 36.1 mttm -80.76 -13.23 59.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.12 -0.491 . . . . 2.52 112.218 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -109.88 8.23 24.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.579 0.228 . . . . 1.93 111.54 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 41.7 mt -96.09 136.7 21.94 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.889 -0.324 . . . . 1.54 111.643 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 50' ' ' LEU . 16.6 Cg_exo -67.54 177.47 3.97 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.537 2.158 . . . . 0.97 111.646 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -75.01 149.01 39.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.913 0.387 . . . . 2.63 110.631 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.14 -18.5 40.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.019 -0.61 . . . . 0.82 112.298 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 t -84.09 132.14 32.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.827 0.346 . . . . 1.65 110.613 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -117.45 136.77 52.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.402 -0.363 . . . . 2.85 110.805 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.1 mtp -82.79 113.68 20.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.534 . . . . 1.76 110.088 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.1 94.01 5.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.072 0.463 . . . . 1.15 110.747 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -89.91 116.82 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 1.3 109.937 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.469 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 4.8 m-30 -111.89 150.87 29.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.112 0.482 . . . . 1.05 111.304 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -100.3 128.06 46.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.922 -0.581 . . . . 0.78 110.604 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 27' ' ' SER . 8.1 m -80.38 152.71 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.507 -0.315 . . . . 1.37 110.54 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -103.62 -0.5 29.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.787 0.662 . . . . 1.08 112.787 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -96.3 16.93 17.01 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.699 -0.4 . . . . 0.87 110.984 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.53 107.47 5.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.355 -0.384 . . . . 1.67 110.47 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.56 18.68 1.58 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.886 -0.673 . . . . 0.78 112.941 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.53 -112.25 4.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.269 -0.491 . . . . 0.81 113.024 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.52 -31.03 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.608 0.242 . . . . 2.47 111.167 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.21 -17.37 63.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.831 0.348 . . . . 2.46 110.639 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.81 -33.48 78.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.988 -0.625 . . . . 0.72 111.664 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -66.65 -33.07 74.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.906 0.384 . . . . 3.18 110.506 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -74.09 -41.18 62.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 1.65 110.533 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.474 HD13 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -64.24 -27.98 69.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.32 -0.4 . . . . 1.65 111.045 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.3 m -65.18 -36.03 82.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.065 0.46 . . . . 1.19 110.263 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.437 ' O ' HG23 ' A' ' 78' ' ' VAL . 15.1 tt0 -75.81 -37.93 58.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.132 -0.692 . . . . 1.35 109.132 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.42 -44.85 95.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.55 -0.75 . . . . 1.31 110.444 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.538 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 69.6 t-105 -61.11 -36.03 78.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.333 -0.849 . . . . 0.59 110.764 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.59 -37.76 88.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 1.33 110.268 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 74' ' ' GLN . 57.0 t -65.68 -42.94 93.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 1.48 109.849 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.71 92.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.578 -0.737 . . . . 1.17 110.742 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 28.5 mtm -63.73 -39.14 93.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 1.56 111.196 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.07 -39.37 79.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.161 -0.472 . . . . 1.42 111.29 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.39 -29.35 47.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.242 -0.436 . . . . 1.54 111.36 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.74 10.41 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.692 -0.766 . . . . 0.78 111.964 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.98 26.08 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 110.548 -0.167 . . . . 1.36 110.548 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 3.5 mp0 -55.56 -61.99 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 1.71 111.249 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -37.87 67.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.002 -0.545 . . . . 1.91 111.98 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm -64.0 -33.4 75.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 2.74 112.084 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.2 m -101.17 -8.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.848 0.314 . . . . 1.26 111.848 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.9 m -58.19 -49.04 78.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.919 0.34 . . . . 1.46 111.919 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.46 -58.35 15.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 112.336 0.495 . . . . 1.26 112.336 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.46 -36.45 98.74 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.866 1.71 . . . . 0.65 113.221 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.84 -42.99 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.702 0.286 . . . . 1.34 110.279 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -62.69 -46.83 86.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.129 0.49 . . . . 0.58 110.722 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.06 -42.54 96.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.699 -0.682 . . . . 1.7 111.321 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.36 -14.13 68.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.955 -0.64 . . . . 0.82 113.527 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.1 -32.23 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 117.076 0.438 . . . . 1.23 112.025 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.566 ' OE1' ' HA ' ' A' ' 31' ' ' PRO . 53.2 mt-30 -113.89 -42.77 3.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.783 1.031 . . . . 0.84 113.783 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -69.25 -61.96 1.58 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.773 0.32 . . . . 1.96 111.246 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.8 p -92.84 -30.17 15.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.315 -0.402 . . . . 1.86 110.743 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 61.28 33.31 19.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.627 -0.715 . . . . 1.73 110.121 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.7 -31.75 41.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.295 -0.866 . . . . 2.07 111.239 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.9 mt -70.75 106.09 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 1.38 110.421 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -129.15 -11.72 4.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.391 -0.822 . . . . 3.77 110.494 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.3 m -134.4 165.91 24.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.949 -0.569 . . . . 1.78 110.293 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.17 64.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.1 0.476 . . . . 1.54 110.738 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -36.73 84.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.784 -0.644 . . . . 1.62 110.602 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 111' ' ' VAL . 15.9 m-20 -63.8 -46.28 85.89 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.307 -0.627 . . . . 1.89 109.307 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.0 mt -59.47 -39.73 79.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.541 -0.754 . . . . 1.44 110.482 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -62.19 -43.36 99.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.81 -0.632 . . . . 2.74 110.689 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -65.28 -33.86 76.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.286 -0.416 . . . . 1.95 110.639 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 107' ' ' ASP . 92.6 t -62.2 -43.99 98.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.963 -0.562 . . . . 1.42 110.279 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -63.92 -39.03 93.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.92 110.56 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 80.0 mt -64.65 -30.81 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.433 0.635 . . . . 1.85 109.897 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -77.1 -14.91 59.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.547 -0.752 . . . . 2.37 110.821 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.82 1.07 57.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.029 -0.532 . . . . 1.42 111.054 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.82 4.12 45.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 1.15 112.881 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 49.1 mm -91.05 148.09 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.096 -0.335 . . . . 2.16 110.096 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -88.76 150.65 22.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.385 -0.37 . . . . 3.2 110.859 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.58 -56.31 22.23 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.998 -0.546 . . . . 1.25 113.183 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.82 -32.66 70.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.967 0.413 . . . . 2.98 110.93 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.2 -42.6 96.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 2.52 109.779 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -69.38 -44.25 71.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.465 -0.788 . . . . 2.23 110.234 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -60.27 -39.94 88.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.146 -0.479 . . . . 2.3 110.877 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.62 -48.44 79.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.915 -0.584 . . . . 1.61 111.578 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.43 -33.43 72.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 1.48 111.673 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -56.7 -31.42 64.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 1.43 111.065 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -105.83 29.01 7.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.015 -0.538 . . . . 1.63 111.223 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.8 t -93.22 145.79 24.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.722 0.296 . . . . 2.33 110.626 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -61.65 -37.67 84.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 4.45 110.835 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.29 -42.05 86.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.217 0.532 . . . . 1.99 110.314 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 135' ' ' VAL . 44.8 t -67.3 -45.8 85.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.404 -0.816 . . . . 1.54 110.483 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -58.86 -38.23 78.3 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.264 -0.425 . . . . 2.84 110.875 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -43.24 71.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.073 -0.512 . . . . 1.75 110.425 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 34.6 mt -62.82 -38.16 89.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.438 . . . . 1.53 110.9 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 131' ' ' VAL . 61.7 t -60.12 -52.33 62.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.275 -0.421 . . . . 1.31 110.317 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.3 -37.25 74.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 1.52 111.367 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -65.07 -39.76 93.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.479 . . . . 1.97 111.293 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.469 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 53.0 mt-30 -60.53 -45.91 92.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.69 111.372 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -33.73 58.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.627 0.251 . . . . 2.82 111.149 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -65.69 -51.43 59.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.652 -0.249 . . . . 2.37 111.326 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.92 90.38 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.311 0.382 . . . . 1.2 111.468 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.26 86.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.399 -0.364 . . . . 1.12 111.404 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.08 -26.61 26.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.352 -0.385 . . . . 1.27 111.59 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -36.59 76.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.165 0.507 . . . . 1.39 110.637 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.68 -4.4 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.12 -0.491 . . . . 1.98 110.062 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.559 ' O ' ' HD3' ' A' ' 148' ' ' ARG . 88.8 mt-30 57.72 74.28 0.43 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.54 -0.755 . . . . 2.43 110.137 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tp -59.76 124.19 19.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.557 -0.747 . . . . 1.32 111.437 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.559 ' HD3' ' O ' ' A' ' 146' ' ' GLN . 1.6 mpp_? -103.45 18.65 21.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.182 0.515 . . . . 4.87 110.603 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -179.63 172.46 44.24 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.896 -0.882 . . . . 0.82 110.896 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.526 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.9 t -84.86 -56.79 0.39 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 117.324 0.562 . . . . 1.16 111.307 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.8 Cg_endo -82.2 88.92 1.24 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.149 1.9 . . . . 0.73 111.352 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.98 146.01 50.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.052 -0.522 . . . . 1.07 111.069 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.422 ' SD ' HG22 ' A' ' 182' ' ' VAL . 53.0 ttm -133.26 131.64 40.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.986 -0.375 . . . . 1.09 109.986 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -122.37 137.56 54.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.093 -0.503 . . . . 0.66 110.365 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.1 t -107.68 122.56 62.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.277 -0.42 . . . . 1.18 110.905 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 61.98 10.87 3.85 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.231 -0.895 . . . . 1.24 112.188 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 68.95 19.56 73.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.251 -0.499 . . . . 0.56 112.301 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -129.1 -41.11 1.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.392 . . . . 2.21 111.195 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -96.71 123.79 40.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.143 -0.48 . . . . 1.61 111.568 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -108.07 123.99 49.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.712 -0.676 . . . . 1.14 109.251 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.78 143.61 39.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.682 0.277 . . . . 1.83 111.118 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -119.43 96.75 50.01 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.173 0.511 . . . . 0.85 110.205 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.8 -19.29 41.15 Favored 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.443 2.095 . . . . 0.71 112.713 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -72.38 -22.23 61.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 2.48 111.284 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.27 21.04 34.06 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.646 -0.787 . . . . 0.6 112.056 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.0 mtt -106.29 -164.46 1.01 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.415 -0.217 . . . . 1.13 110.415 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.02 132.63 46.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 1.54 111.111 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.9 20.76 6.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.832 -0.622 . . . . 1.69 109.691 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.99 -41.84 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 1.53 110.914 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -126.8 126.42 43.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.119 -0.491 . . . . 1.42 110.169 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.485 ' O ' HG23 ' A' ' 175' ' ' VAL . 14.3 mmt -61.01 -44.32 97.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.948 -0.569 . . . . 2.41 110.573 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.588 ' O ' ' HG2' ' A' ' 176' ' ' GLN . 31.6 t70 -58.72 -45.36 89.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.75 -0.659 . . . . 2.05 111.199 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.85 -43.82 99.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.403 . . . . 1.24 110.718 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -57.32 -45.97 83.7 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.242 -0.435 . . . . 0.56 110.68 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 171' ' ' MET . 90.6 t -58.9 -47.42 89.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 1.15 110.93 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 172' ' ' ASP . 54.7 mm-40 -65.08 -48.71 72.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 1.7 110.776 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -58.6 -45.74 88.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 1.91 111.646 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -60.44 -50.41 73.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.92 111.002 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.98 87.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.882 0.372 . . . . 1.02 111.111 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.63 -37.85 88.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 1.55 110.006 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 58.3 m -59.98 -40.49 89.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.028 -0.533 . . . . 1.17 110.224 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.422 HG22 ' SD ' ' A' ' 153' ' ' MET . 41.9 t -60.67 -51.43 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 CA-C-N 115.828 -0.623 . . . . 1.14 110.165 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -60.31 -44.59 95.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.954 -0.566 . . . . 2.13 110.536 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -57.77 -44.63 86.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.5 -0.773 . . . . 1.25 111.041 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.14 -29.37 63.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.321 -0.4 . . . . 1.22 111.438 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 40.4 m -71.49 -34.55 70.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.409 -0.36 . . . . 1.38 110.819 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.229 -0.442 . . . . 2.26 110.798 -179.887 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.848 0.356 . . . . 1.37 110.711 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -119.43 148.36 43.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.345 -0.389 . . . . 2.29 110.94 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.97 130.2 41.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.935 -0.575 . . . . 1.83 109.693 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.15 -20.59 40.09 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.748 -0.941 . . . . 0.78 110.748 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.537 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 36.4 tptt -105.78 -77.3 0.59 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.755 -0.222 . . . . 2.32 110.809 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -80.04 -35.24 37.49 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.832 0.349 . . . . 1.46 111.477 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -140.76 156.08 46.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.733 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.82 129.73 46.01 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.119 -0.492 . . . . 1.51 110.048 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 m -77.84 121.04 23.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.017 0.437 . . . . 1.54 110.963 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.1 mt -68.57 127.31 32.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.751 -0.659 . . . . 1.36 110.829 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.13 -27.68 68.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.154 0.502 . . . . 2.33 110.746 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -120.86 96.7 48.62 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.983 -0.747 . . . . 4.04 108.983 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.1 153.25 36.52 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 122.555 2.17 . . . . 1.06 112.584 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -90.93 122.5 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.674 -0.694 . . . . 1.3 109.739 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.7 127.2 31.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.786 -0.643 . . . . 1.48 111.084 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.33 31.92 49.66 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.686 -0.768 . . . . 0.8 112.142 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.61 145.54 32.47 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.396 -0.224 . . . . 1.2 110.396 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.3 164.77 26.93 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.446 2.097 . . . . 0.63 112.432 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -58.34 -56.54 20.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.281 -0.872 . . . . 1.79 111.243 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.4 t -120.33 105.56 17.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.989 0.423 . . . . 1.11 110.185 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.5 tp -105.95 129.73 54.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.08 -0.509 . . . . 1.16 110.15 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HG2' ' N ' ' A' ' 25' ' ' PHE . 4.0 tt0 -127.58 149.44 50.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.455 -0.339 . . . . 1.61 110.456 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.496 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 61.3 m-85 -127.4 146.08 50.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.987 -0.551 . . . . 0.61 110.195 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -163.11 175.87 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.105 0.478 . . . . 0.67 110.906 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.44 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 8.6 t -156.13 141.59 17.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.923 -0.58 . . . . 1.52 109.967 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.401 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 88.0 m-85 -74.57 -8.58 56.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.959 -0.564 . . . . 0.71 110.751 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -101.37 8.12 42.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.224 -0.444 . . . . 2.16 111.002 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 20.8 t -111.65 119.63 44.36 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.62 -0.264 . . . . 0.89 111.202 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 22.0 Cg_endo -65.67 -21.99 58.2 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.402 2.068 . . . . 0.86 111.439 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 0.3 OUTLIER -64.14 -48.25 76.76 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.895 -0.593 . . . . 2.46 110.019 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 38.7 m -66.88 -31.82 72.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.984 -0.553 . . . . 0.5 110.394 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -60.07 -44.47 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.479 -0.563 . . . . 2.22 109.479 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 31' ' ' PRO . 34.8 mm-40 -73.38 -41.29 63.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.731 -0.668 . . . . 2.82 110.65 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.4 m-85 -63.76 -35.44 80.61 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.026 -0.534 . . . . 1.05 112.428 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . 5.2 mm-40 -93.3 -50.16 5.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.065 0.765 . . . . 1.89 113.065 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -77.36 -35.81 54.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.127 0.788 . . . . 2.0 113.127 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 53.9 t -94.61 -57.77 4.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.586 -0.446 . . . . 1.18 112.148 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.27 -26.57 33.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.061 0.763 . . . . 1.13 113.061 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 60.95 44.91 10.01 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.982 -0.377 . . . . 1.19 109.982 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.476 HG13 ' CD2' ' A' ' 36' ' ' PHE . 33.9 mm -57.11 -66.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.505 0.557 . . . . 1.13 112.505 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.419 ' HG ' ' CD ' ' A' ' 24' ' ' GLU . 16.0 m -62.01 -34.18 75.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 1.37 110.78 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.92 -45.6 93.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.814 -0.63 . . . . 1.73 110.143 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -69.45 -37.5 77.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 1.42 110.214 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 54.4 t -60.96 -42.31 92.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 1.14 110.433 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -63.22 -12.72 30.66 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.189 -0.459 . . . . 1.96 110.948 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -113.78 6.21 16.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.127 0.489 . . . . 2.52 111.192 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -116.29 -27.83 6.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.103 -0.499 . . . . 1.93 110.535 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 81.6 mt -66.24 145.1 98.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 1.54 111.224 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -78.0 170.85 18.16 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.36 2.04 . . . . 0.97 111.643 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.81 137.67 54.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 2.63 111.145 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.92 -21.79 43.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.093 -0.575 . . . . 0.82 112.038 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 t -92.83 108.09 19.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.865 0.364 . . . . 1.65 110.098 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -89.93 156.52 18.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 2.85 110.933 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 17.1 ttt -109.06 143.86 37.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.781 -0.645 . . . . 1.76 109.707 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.52 108.08 9.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 1.15 110.826 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.409 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 14.6 ttmm -94.17 116.85 29.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.725 -0.67 . . . . 1.3 110.154 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.523 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 10.0 m-30 -114.46 161.4 18.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.157 0.503 . . . . 1.05 111.688 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.44 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 43.2 t-80 -105.79 142.19 35.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.61 . . . . 0.78 111.002 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -97.62 149.58 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.794 0.33 . . . . 1.37 110.89 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -93.52 -16.47 24.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.837 0.68 . . . . 1.08 112.837 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -83.21 10.24 8.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.696 0.628 . . . . 0.87 112.696 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.1 96.17 3.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.973 0.416 . . . . 1.67 111.044 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.87 0.17 6.09 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.936 -0.649 . . . . 0.78 112.467 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.06 -129.34 43.52 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.283 -0.484 . . . . 0.81 112.647 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.62 -38.15 65.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.7 -0.482 . . . . 2.47 109.7 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.55 -26.94 68.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.573 -0.739 . . . . 2.46 109.897 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.84 -43.51 96.03 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.515 -0.766 . . . . 0.72 111.823 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -63.84 -35.55 81.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.207 -0.294 . . . . 3.18 110.207 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -43.22 99.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.394 0.616 . . . . 1.65 109.857 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.34 -34.38 78.0 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 115.549 -0.75 . . . . 1.65 110.689 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.6 m -62.11 -36.48 81.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.37 . . . . 1.19 111.101 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -76.43 -45.02 33.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.623 -0.262 . . . . 1.35 110.39 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.19 88.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.046 0.45 . . . . 1.31 110.677 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.496 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 66.5 t-105 -61.26 -37.69 84.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.543 -0.753 . . . . 0.59 110.961 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.5 -34.01 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 1.33 110.3 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.14 -41.66 89.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.945 -0.57 . . . . 1.48 109.62 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.52 81.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.479 -0.782 . . . . 1.17 111.08 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 29.4 mtm -68.41 -38.68 81.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.979 -0.555 . . . . 1.56 111.095 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.68 -31.41 70.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.191 -0.458 . . . . 1.42 111.877 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.72 -13.7 28.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.543 -0.299 . . . . 1.54 111.531 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.44 39.7 49.92 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.488 -0.863 . . . . 0.78 111.791 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.87 22.58 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.012 -0.366 . . . . 1.36 110.012 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.496 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -56.23 -59.92 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.662 -0.699 . . . . 1.71 111.406 -178.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.52 -19.15 64.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.531 . . . . 1.91 111.514 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -78.05 -39.78 40.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.334 -0.393 . . . . 2.74 111.442 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.5 m -94.72 -10.4 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.381 0.511 . . . . 1.26 112.381 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.1 m -59.26 -49.39 78.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.738 0.304 . . . . 1.46 111.558 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.413 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 47.1 t -62.46 -58.8 15.17 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 112.099 0.407 . . . . 1.26 112.099 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.413 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 15.6 Cg_endo -57.24 -33.39 95.94 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.059 1.839 . . . . 0.65 113.018 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.02 -46.97 48.98 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.974 -0.29 . . . . 1.34 110.701 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.401 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -58.59 -52.38 65.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.156 0.503 . . . . 0.58 110.779 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.52 -42.42 95.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.644 -0.707 . . . . 1.7 111.182 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.37 -14.22 71.54 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.217 -0.516 . . . . 0.82 114.232 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.21 -42.51 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.539 0.669 . . . . 1.23 112.276 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -99.6 -38.45 8.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.861 0.689 . . . . 0.84 112.861 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -78.7 -64.64 1.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.511 -0.476 . . . . 1.96 110.542 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -34.21 40.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.124 -0.489 . . . . 1.86 111.615 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 60.97 31.85 19.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.144 0.497 . . . . 1.73 110.819 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.35 -35.37 19.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.794 -0.639 . . . . 2.07 111.211 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 30.2 mt -79.33 96.97 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.838 -0.619 . . . . 1.38 110.971 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -135.25 22.16 3.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.026 0.441 . . . . 3.77 111.082 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.414 ' O ' HG13 ' A' ' 108' ' ' ILE . 83.6 p -159.49 160.38 34.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.035 -0.53 . . . . 1.78 109.717 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.39 -28.99 70.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.126 0.489 . . . . 1.54 110.392 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -61.21 -34.28 74.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.428 -0.806 . . . . 1.62 110.435 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 111' ' ' VAL . 56.9 m-20 -76.2 -47.59 23.51 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.898 -0.592 . . . . 1.89 109.589 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 104' ' ' SER . 27.5 mt -55.3 -46.41 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.67 -0.695 . . . . 1.44 111.156 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.493 ' O ' HG13 ' A' ' 113' ' ' ILE . 62.7 ttt-85 -59.13 -45.43 90.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.2 -0.455 . . . . 2.74 110.679 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.75 -42.04 99.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.304 -0.407 . . . . 1.95 110.904 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 107' ' ' ASP . 90.6 t -60.55 -44.79 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.222 -0.444 . . . . 1.42 110.595 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -62.5 -44.9 95.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.093 -0.503 . . . . 0.92 110.727 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 73.3 mt -63.68 -38.82 83.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 1.85 110.525 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -67.8 -31.67 71.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.47 . . . . 2.37 110.759 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.38 -8.1 53.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.313 -0.403 . . . . 1.42 111.591 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.37 0.74 26.46 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.475 -0.869 . . . . 1.15 112.98 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 3.3 mp -85.93 121.7 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.867 -0.42 . . . . 2.16 109.867 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -60.91 136.69 58.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.824 -0.625 . . . . 3.2 111.107 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.57 -41.92 98.97 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.609 -0.597 . . . . 1.25 111.609 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -65.74 -23.17 66.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 2.98 110.685 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -82.75 -45.33 14.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.97 -0.559 . . . . 2.52 109.515 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -63.55 -44.25 94.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.506 -0.77 . . . . 2.23 110.483 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.34 -43.16 96.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.978 0.418 . . . . 2.3 110.827 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.29 -47.6 83.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 1.61 110.624 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.05 -41.21 95.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 1.48 111.109 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -59.94 -30.02 68.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.43 111.504 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -96.15 -26.12 15.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.148 0.425 . . . . 1.63 112.148 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 m -65.22 149.42 49.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.321 0.581 . . . . 2.33 112.507 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -73.01 -21.14 60.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.513 -0.767 . . . . 4.45 111.723 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.87 -50.1 70.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.26 0.552 . . . . 1.99 110.101 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.543 ' O ' HG22 ' A' ' 135' ' ' VAL . 36.0 t -66.5 -41.69 88.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.419 -0.81 . . . . 1.54 110.414 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -56.87 -41.31 77.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.088 -0.505 . . . . 2.84 111.075 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.5 m -63.37 -39.41 94.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.983 -0.553 . . . . 1.75 110.202 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.44 -37.71 83.39 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.331 -0.395 . . . . 1.53 110.479 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.582 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 41.5 t -61.46 -51.68 70.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.023 -0.362 . . . . 1.31 110.023 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.56 69.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.772 -0.649 . . . . 1.52 111.048 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -66.31 -42.45 88.24 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.009 -0.541 . . . . 1.97 110.271 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.523 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 51.8 mt-30 -62.59 -48.15 80.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.833 -0.621 . . . . 0.69 109.919 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 29.0 mt-10 -62.37 -44.47 96.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.341 -0.845 . . . . 2.82 111.194 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -60.91 -46.99 88.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.849 -0.614 . . . . 2.37 111.514 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.55 -44.12 84.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.912 0.338 . . . . 1.2 111.912 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.38 -30.52 64.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.224 0.453 . . . . 1.12 112.224 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.4 -27.18 25.96 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.565 0.579 . . . . 1.27 112.565 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.17 -47.71 23.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.629 0.252 . . . . 1.39 110.565 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.5 p -80.76 -8.31 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.814 0.34 . . . . 1.98 110.764 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 58.21 58.53 3.45 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.735 -0.666 . . . . 2.43 110.435 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 149' ' ' GLY . 40.9 tp -67.13 111.74 4.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.461 -0.79 . . . . 1.32 110.803 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -87.31 -33.71 19.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.611 -0.722 . . . . 4.87 110.556 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . -93.9 173.61 33.56 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.989 -0.845 . . . . 0.82 110.989 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.549 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 4.6 t -102.89 -57.56 0.1 OUTLIER Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 117.865 0.832 . . . . 1.16 112.761 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 4.1 Cg_endo -85.27 70.16 5.27 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.231 1.954 . . . . 0.73 111.928 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.22 139.31 50.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.905 -0.589 . . . . 1.07 110.766 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 21.6 ttm -113.38 139.02 49.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.042 -0.526 . . . . 1.09 109.912 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -122.96 133.98 54.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.549 -0.296 . . . . 0.66 110.728 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.8 t -101.3 114.76 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.343 -0.389 . . . . 1.18 110.752 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.69 25.84 10.57 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.524 -0.762 . . . . 1.24 111.418 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.48 26.88 60.18 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.743 -0.662 . . . . 0.56 113.167 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -126.9 -39.23 1.97 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.099 0.407 . . . . 2.21 112.099 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -106.66 135.9 47.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.003 -0.279 . . . . 1.61 111.432 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -108.23 136.18 48.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.794 -0.639 . . . . 1.14 110.056 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.61 129.63 34.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.472 -0.331 . . . . 1.83 110.54 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -112.73 100.6 51.07 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.415 -0.357 . . . . 0.85 110.723 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.47 -15.32 34.4 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.685 2.257 . . . . 0.71 112.321 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -86.04 2.63 45.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.107 0.48 . . . . 2.48 111.02 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -105.15 16.38 45.98 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.006 -0.616 . . . . 0.6 111.592 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 40.1 mtt -127.67 166.21 18.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.0 -0.37 . . . . 1.13 110.0 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -80.81 133.4 35.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.381 -0.372 . . . . 1.54 111.132 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 -3.16 36.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.15 -0.477 . . . . 1.69 111.744 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 m -67.22 -36.21 81.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.874 0.368 . . . . 1.53 110.814 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -118.33 111.12 18.32 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.235 -0.654 . . . . 1.42 109.235 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 42.9 mtt -66.08 -40.83 91.14 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.488 0.551 . . . . 2.41 112.488 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.46 -50.28 74.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.808 0.337 . . . . 2.05 111.15 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.99 -38.91 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.967 -0.56 . . . . 1.24 110.472 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.81 -53.38 55.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.56 110.908 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 70.2 t -58.3 -48.32 85.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.98 -0.555 . . . . 1.15 111.312 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 61.6 mm-40 -64.67 -40.13 94.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.602 -0.272 . . . . 1.7 111.548 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -64.22 -43.89 93.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.069 -0.345 . . . . 1.91 110.069 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.405 ' O ' HG21 ' A' ' 182' ' ' VAL . 20.4 t80 -57.37 -54.23 49.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.92 110.289 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.83 85.09 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.97 -0.559 . . . . 1.02 111.787 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -67.21 -37.64 83.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.594 -0.276 . . . . 1.55 110.584 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 37.8 m -61.73 -42.6 99.17 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.047 0.451 . . . . 1.17 109.911 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 178' ' ' TYR . 49.0 t -61.49 -47.64 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.672 -0.695 . . . . 1.14 110.274 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 187' ' ' GLU . 34.4 tttp -56.84 -53.38 58.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.818 -0.628 . . . . 2.13 110.948 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -54.68 -41.66 70.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.423 -0.353 . . . . 1.25 111.33 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.55 -38.65 67.92 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.938 0.348 . . . . 1.22 111.938 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 35.2 p -65.86 -35.34 80.37 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.103 -0.239 . . . . 1.38 111.608 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 12.3 pt-20 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 121.105 0.478 . . . . 2.26 111.334 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.826 0.346 . . . . 1.37 110.322 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -110.22 140.96 43.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 2.29 109.812 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -69.88 122.01 18.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.531 -0.544 . . . . 1.83 109.531 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.94 -11.36 64.21 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.939 -0.648 . . . . 0.78 111.607 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -95.68 -83.16 0.37 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.493 0.187 . . . . 2.32 110.736 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HG2' HE21 ' A' ' 177' ' ' GLN . 23.9 mp0 -84.57 -25.31 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.08 0.467 . . . . 1.46 110.52 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -142.98 153.9 43.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.627 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.38 133.52 50.01 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.398 -0.364 . . . . 1.51 110.563 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.5 m -87.83 126.7 35.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.9 0.381 . . . . 1.54 111.051 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -85.51 140.84 30.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.448 -0.342 . . . . 1.36 110.39 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -20.28 46.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.981 0.419 . . . . 2.33 110.116 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -118.98 93.93 47.46 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.88 -0.6 . . . . 4.04 109.955 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.69 145.23 12.84 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.681 2.254 . . . . 1.06 112.847 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.1 t -80.56 113.84 20.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.828 -0.623 . . . . 1.3 110.22 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.0 128.77 37.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.424 . . . . 1.48 111.36 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.47 16.17 74.32 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.86 -0.609 . . . . 0.8 112.91 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.9 144.58 79.94 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.697 0.248 . . . . 1.2 110.616 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 14.8 Cg_endo -60.15 160.98 20.78 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.606 2.204 . . . . 0.63 112.051 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.475 ' NE2' ' HA ' ' A' ' 54' ' ' VAL . 46.4 mt-30 -57.1 -51.34 69.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.843 -0.617 . . . . 1.79 111.245 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.6 t -128.18 104.5 11.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.837 -0.431 . . . . 1.11 109.837 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 46.3 tp -102.97 132.89 48.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.632 -0.713 . . . . 1.16 110.746 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.89 150.82 49.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.366 -0.379 . . . . 1.61 110.065 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -122.71 148.29 45.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.465 -0.334 . . . . 0.61 110.72 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.01 173.55 15.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.136 -0.484 . . . . 0.67 110.591 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 61' ' ' VAL . 52.5 m -154.47 132.42 11.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.134 -0.484 . . . . 1.52 110.651 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.574 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 67.5 m-85 -66.81 -20.68 65.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.71 111.012 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.77 2.89 54.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 2.16 111.04 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 40.5 t -108.41 119.82 48.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.328 -0.396 . . . . 0.89 110.658 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.33 -27.73 63.42 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.615 2.21 . . . . 0.86 112.105 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 0.1 OUTLIER -64.85 -47.26 78.58 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.583 -0.735 . . . . 2.46 109.984 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.7 m -63.82 -37.31 86.9 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.801 0.334 . . . . 0.5 110.528 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -60.89 -51.98 66.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 2.22 109.942 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -65.0 -35.03 79.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.394 -0.821 . . . . 2.82 111.549 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.61 -29.69 70.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.928 0.714 . . . . 1.05 112.928 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -105.92 -35.32 7.34 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.705 -0.398 . . . . 1.89 111.397 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -43.35 60.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 2.0 111.847 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.81 -58.01 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.166 0.432 . . . . 1.18 112.166 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.3 mt -69.85 -37.24 76.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.37 0.507 . . . . 1.13 112.37 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 63.42 42.4 6.78 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.04 -0.356 . . . . 1.19 110.04 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.3 mm -61.38 -58.39 7.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.096 -0.502 . . . . 1.13 111.21 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.567 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 1.5 m -61.95 -44.31 97.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.745 -0.465 . . . . 1.37 109.745 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.515 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 24.1 t70 -54.99 -44.42 74.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.235 -0.893 . . . . 1.73 111.186 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -69.37 -43.53 73.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.631 -0.258 . . . . 1.42 111.051 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 54.9 t -58.87 -36.9 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.382 -0.372 . . . . 1.14 110.427 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 43' ' ' SER . 56.9 mttt -56.18 -31.76 63.72 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.361 -0.382 . . . . 1.96 111.202 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HE3' ' O ' ' A' ' 44' ' ' ASP . 16.6 mttt -109.73 8.9 24.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 2.52 111.705 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -121.58 21.03 11.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.69 0.281 . . . . 1.93 111.164 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 34.7 mt -104.83 153.03 39.62 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.434 -0.348 . . . . 1.54 110.738 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.17 161.17 38.68 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.722 2.281 . . . . 0.97 111.654 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.24 134.45 53.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.965 0.412 . . . . 2.63 110.916 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.53 -17.29 58.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.57 -0.824 . . . . 0.82 111.945 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.475 ' HA ' ' NE2' ' A' ' 21' ' ' GLN . 90.7 t -95.85 125.91 48.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 1.65 110.936 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -110.54 155.9 21.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.305 -0.407 . . . . 2.85 109.997 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.6 ttt -108.16 132.03 54.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.181 -0.463 . . . . 1.76 110.512 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.18 112.34 18.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.134 -0.485 . . . . 1.15 110.576 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -96.58 129.43 43.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.91 -0.586 . . . . 1.3 109.843 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 6.8 m-30 -118.16 160.95 20.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 1.05 111.634 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -111.54 133.12 54.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.644 -0.707 . . . . 0.78 110.224 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.529 HG22 ' OG ' ' A' ' 27' ' ' SER . 2.7 m -85.83 162.36 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.575 0.226 . . . . 1.37 110.591 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -113.34 21.4 15.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.388 0.514 . . . . 1.08 112.388 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -120.06 16.53 12.46 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.6 -0.44 . . . . 0.87 111.643 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 75.3 mmm -135.09 106.95 7.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.236 -0.438 . . . . 1.67 110.936 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.55 13.72 9.39 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.946 -0.645 . . . . 0.78 112.59 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.67 -147.89 31.5 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.455 -0.878 . . . . 0.81 111.854 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -81.99 -19.28 40.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 2.47 110.863 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.25 -16.32 63.42 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.397 0.617 . . . . 2.46 109.9 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.56 -30.36 77.38 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.502 -0.772 . . . . 0.72 111.422 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -64.0 -44.32 92.99 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.968 0.413 . . . . 3.18 110.106 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.25 -41.72 97.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.824 -0.626 . . . . 1.65 109.961 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.04 -32.52 74.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.706 -0.679 . . . . 1.65 110.827 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.4 m -68.67 -40.77 80.01 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.042 0.449 . . . . 1.19 110.365 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -42.81 71.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 1.35 109.762 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.21 92.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.925 -0.579 . . . . 1.31 110.942 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -62.53 -38.9 91.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.242 -0.435 . . . . 0.59 110.253 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.62 78.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.833 -0.432 . . . . 1.33 109.833 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.96 -44.11 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.729 -0.669 . . . . 1.48 109.575 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.83 -38.29 87.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.66 -0.7 . . . . 1.17 111.043 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.2 mtm -65.31 -25.97 67.85 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.825 0.345 . . . . 1.56 111.345 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.18 -29.52 24.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 1.42 110.718 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 68.6 mt -82.7 -36.0 26.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.898 -0.592 . . . . 1.54 111.368 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.49 23.51 21.28 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.886 -0.673 . . . . 0.78 112.635 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.53 ' O ' HG21 ' A' ' 88' ' ' VAL . 13.6 m -121.25 18.73 5.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 122.705 -0.291 . . . . 1.36 110.989 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.42 -60.59 3.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.559 -0.746 . . . . 1.71 111.749 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.25 -35.13 67.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.72 -0.673 . . . . 1.91 112.116 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -74.45 -43.29 56.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.011 0.374 . . . . 2.74 112.011 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 84' ' ' VAL . 28.6 m -80.68 -2.87 5.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.414 -0.514 . . . . 1.26 111.807 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 m -59.31 -48.25 82.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.823 0.305 . . . . 1.46 111.823 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.44 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 22.0 t -61.33 -59.09 14.69 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.191 0.441 . . . . 1.26 112.191 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.44 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 9.5 Cg_endo -54.39 -33.93 78.86 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.276 1.984 . . . . 0.65 112.446 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.531 HD13 ' CZ ' ' A' ' 28' ' ' PHE . 10.6 mt -66.88 -52.79 39.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.439 -0.346 . . . . 1.34 110.435 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.9 m-85 -58.21 -45.84 86.92 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.936 0.398 . . . . 0.58 110.401 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.456 ' CD ' ' HZ2' ' A' ' 98' ' ' LYS . 36.3 mt-10 -63.13 -48.53 78.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.716 -0.675 . . . . 1.7 110.426 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.31 -7.04 43.48 Favored Glycine 0 C--O 1.223 -0.579 0 CA-C-N 116.153 -0.476 . . . . 0.82 113.644 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 92' ' ' LEU . 50.2 t -105.14 -49.2 9.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 117.412 0.606 . . . . 1.23 112.014 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -99.42 -50.12 4.21 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.629 0.603 . . . . 0.84 112.629 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.456 ' HZ2' ' CD ' ' A' ' 94' ' ' GLU . 27.0 ttpt -69.14 -70.91 0.25 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.46 0.541 . . . . 1.96 112.46 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 101' ' ' THR . 0.2 OUTLIER -79.84 -31.89 40.55 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.259 0.466 . . . . 1.86 112.259 -178.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 64.58 29.36 13.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.096 0.474 . . . . 1.73 110.992 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.456 ' OG1' ' HB ' ' A' ' 99' ' ' THR . 0.2 OUTLIER -69.51 -31.25 69.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.572 -0.74 . . . . 2.07 111.328 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.406 ' HA ' ' CB ' ' A' ' 107' ' ' ASP . 48.6 mt -88.68 105.71 16.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.894 -0.594 . . . . 1.38 111.661 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -122.72 -12.02 8.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.458 -0.792 . . . . 3.77 109.095 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.0 164.41 30.68 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.868 -1.06 . . . . 1.78 109.704 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.06 -25.5 68.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 1.54 111.177 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -33.01 72.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 1.62 110.489 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' CB ' ' HA ' ' A' ' 102' ' ' ILE . 32.7 m-20 -72.55 -38.8 67.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.84 -0.618 . . . . 1.89 110.253 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.3 mt -62.04 -37.97 79.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.221 -0.659 . . . . 1.44 109.221 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.65 ' O ' HG12 ' A' ' 113' ' ' ILE . 72.8 ttt-85 -57.88 -47.2 83.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.845 -1.07 . . . . 2.74 110.357 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.93 -35.41 80.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.163 -0.471 . . . . 1.95 110.764 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.18 -43.34 97.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.053 0.454 . . . . 1.42 110.384 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.74 -41.0 96.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.077 -0.51 . . . . 0.92 110.309 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 109' ' ' ARG . 20.3 mm -64.49 -31.36 53.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.268 0.556 . . . . 1.85 109.733 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -69.25 -16.6 63.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.887 -0.597 . . . . 2.37 111.403 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.02 -5.63 47.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.406 -0.361 . . . . 1.42 111.389 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.8 4.11 29.98 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.462 -0.875 . . . . 1.15 112.616 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mm -80.41 138.07 20.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.698 -0.482 . . . . 2.16 109.698 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -75.12 150.82 38.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.657 -0.247 . . . . 3.2 110.452 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.3 -52.7 51.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.017 -0.611 . . . . 1.25 112.692 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.83 -20.76 65.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.62 0.23 . . . . 2.98 111.62 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -68.41 -49.19 61.79 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.216 0.532 . . . . 2.52 109.747 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.459 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 82.8 t80 -67.3 -42.43 83.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.382 -0.826 . . . . 2.23 109.807 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.33 -42.04 90.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 2.3 111.048 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.79 -46.39 72.1 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.026 -0.533 . . . . 1.61 110.846 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.21 89.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 1.48 111.526 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -56.63 -30.54 63.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.349 -0.387 . . . . 1.43 111.321 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -111.22 23.07 14.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.35 -0.386 . . . . 1.63 110.834 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.8 m -91.63 149.54 21.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.963 0.411 . . . . 2.33 111.655 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -65.21 -40.87 94.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.58 . . . . 4.45 110.484 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 81.1 t -55.66 -50.0 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 1.99 110.559 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.34 -46.88 91.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.666 -0.697 . . . . 1.54 111.091 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -55.57 -41.59 73.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.232 0.539 . . . . 2.84 110.919 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -68.05 -36.07 79.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.906 -0.588 . . . . 1.75 111.018 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.425 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 94.6 mt -67.39 -39.38 85.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.779 0.323 . . . . 1.53 110.657 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 81.2 t -60.29 -45.94 95.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.366 -0.379 . . . . 1.31 110.517 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.59 83.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 1.52 111.082 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -70.22 -34.32 72.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 1.97 110.627 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.458 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 47.6 mt-30 -63.99 -49.67 71.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.69 109.936 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.37 -33.7 76.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.496 -0.775 . . . . 2.82 110.207 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -67.01 -54.54 20.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.734 -0.666 . . . . 2.37 110.68 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -53.33 -48.23 68.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 1.2 112.22 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.29 94.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.934 0.397 . . . . 1.12 111.769 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.98 -31.98 39.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.007 0.373 . . . . 1.27 112.007 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -42.67 98.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.332 -0.394 . . . . 1.39 111.892 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 141' ' ' ALA . 35.3 m -85.6 -0.87 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.405 -0.361 . . . . 1.98 111.606 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 59.03 53.67 5.43 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.557 0.694 . . . . 2.43 109.989 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.5 tp -65.33 120.66 13.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.996 -1.002 . . . . 1.32 111.481 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -103.21 -34.32 8.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.063 -0.517 . . . . 4.87 110.085 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -95.93 -169.11 35.07 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 110.921 -0.872 . . . . 0.82 110.921 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.508 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 3.0 t -111.75 -56.85 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.304 -0.558 . . . . 1.16 111.435 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.508 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.1 Cg_endo -84.35 72.75 4.93 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.457 2.105 . . . . 0.73 111.701 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.5 144.78 46.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.051 -0.522 . . . . 1.07 110.922 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.2 ttm -121.47 133.02 55.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.165 -0.47 . . . . 1.09 110.102 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.95 124.65 43.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.213 -0.449 . . . . 0.66 109.92 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.33 117.1 32.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.889 0.376 . . . . 1.18 110.839 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 58.12 16.68 4.01 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.376 -0.829 . . . . 1.24 111.531 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.8 22.47 68.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.85 -0.691 . . . . 0.56 112.019 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -120.46 -42.06 2.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.08 0.467 . . . . 2.21 110.73 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -104.29 129.39 52.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 1.61 111.612 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -109.33 126.87 53.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.431 -0.804 . . . . 1.14 109.45 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.13 139.83 32.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.09 0.471 . . . . 1.83 111.09 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -114.33 100.91 53.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.872 -0.604 . . . . 0.85 109.91 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.58 -19.28 37.17 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.477 2.118 . . . . 0.71 112.568 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -80.9 -4.61 55.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.95 0.405 . . . . 2.48 110.674 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -115.3 26.99 8.77 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.808 -0.71 . . . . 0.6 112.004 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.3 mtt -115.12 166.93 11.28 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.656 -0.272 . . . . 1.13 110.349 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -71.48 100.34 2.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.147 0.499 . . . . 1.54 109.997 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.72 26.86 2.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.782 -0.644 . . . . 1.69 112.118 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.3 p -74.95 -35.47 62.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.452 0.644 . . . . 1.53 110.585 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -143.36 129.12 19.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.611 -0.722 . . . . 1.42 109.614 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.422 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.9 mmm -56.74 -34.51 67.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 2.41 111.378 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -39.97 89.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.331 0.586 . . . . 2.05 110.48 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.08 -43.65 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.65 -0.705 . . . . 1.24 110.551 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -53.5 -46.17 69.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.207 -0.906 . . . . 0.56 111.463 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 171' ' ' MET . 61.1 t -57.76 -51.48 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.416 . . . . 1.15 111.417 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 82.6 mm-40 -66.01 -44.8 83.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 1.7 111.458 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.433 HE21 ' HG2' ' A' ' 8' ' ' GLN . 52.8 tt0 -60.98 -45.68 93.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.653 -0.249 . . . . 1.91 111.17 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.411 ' O ' HG22 ' A' ' 182' ' ' VAL . 15.6 t80 -59.48 -53.04 62.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.877 0.37 . . . . 0.92 110.497 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.86 85.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 1.02 112.016 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 2.8 t0 -65.33 -36.56 84.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.046 0.45 . . . . 1.55 110.379 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 51.7 m -63.16 -42.46 99.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.868 -0.605 . . . . 1.17 109.925 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 178' ' ' TYR . 44.2 t -62.8 -42.49 96.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.158 -0.474 . . . . 1.14 110.33 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -62.37 -32.31 73.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.393 -0.821 . . . . 2.13 111.0 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.3 -46.3 20.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.278 -0.419 . . . . 1.25 110.817 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.58 -34.51 75.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.462 0.541 . . . . 1.22 112.462 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.5 p -71.61 -21.41 61.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.95 0.352 . . . . 1.38 111.95 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.104 0.478 . . . . 2.26 110.703 179.848 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.877 0.37 . . . . 4.48 110.778 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -91.79 130.66 37.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.904 -0.589 . . . . 4.33 109.844 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -131.09 120.04 22.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.757 0.313 . . . . 1.37 110.78 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -128.62 136.56 50.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.959 -0.564 . . . . 2.29 109.833 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.63 132.71 49.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 1.83 110.563 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.22 -14.07 55.13 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.866 -0.683 . . . . 0.78 111.917 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.494 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 41.2 tptt -115.38 -74.85 0.6 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.455 -0.202 . . . . 2.32 110.455 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -78.41 -41.73 32.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 1.46 111.027 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -136.85 164.28 28.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.156 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.24 123.84 18.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.136 -0.484 . . . . 1.51 110.284 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.9 m -76.9 127.95 33.67 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.854 -0.425 . . . . 1.54 109.854 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.55 140.97 37.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.813 0.339 . . . . 1.36 110.851 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -25.26 45.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.054 0.454 . . . . 2.33 110.01 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -109.35 90.16 8.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.642 -0.708 . . . . 4.04 109.244 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.24 148.72 30.95 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.525 2.15 . . . . 1.06 112.62 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.1 t -93.88 113.91 29.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.61 -0.723 . . . . 1.3 109.871 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.36 129.16 35.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.087 -0.506 . . . . 1.48 110.481 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.75 34.53 34.45 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.922 -0.656 . . . . 0.8 112.127 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.05 149.12 35.4 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.46 -0.2 . . . . 1.2 110.46 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.5 169.55 11.02 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.888 2.392 . . . . 0.63 112.711 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -65.84 -61.67 1.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.046 -0.524 . . . . 1.79 111.065 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.31 105.12 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.101 0.477 . . . . 1.11 110.747 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.7 tp -107.9 124.28 49.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.147 -0.479 . . . . 1.16 110.707 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -126.35 140.59 52.39 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.164 -0.471 . . . . 1.61 110.024 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -113.15 147.67 36.92 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.081 -0.34 . . . . 0.61 110.081 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.38 174.23 12.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.276 0.56 . . . . 0.67 111.396 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.2 t -153.62 139.26 17.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.439 -0.8 . . . . 1.52 109.079 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.487 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 97.3 m-85 -72.5 -15.0 61.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.947 0.404 . . . . 0.71 110.607 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.414 ' CE1' ' HA2' ' A' ' 69' ' ' GLY . 79.3 m-85 -89.19 -0.53 57.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.549 . . . . 2.16 110.419 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.3 t -108.25 112.61 61.15 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.954 -0.566 . . . . 0.89 111.104 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.55 -23.85 70.41 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.372 2.048 . . . . 0.86 110.935 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.543 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 7.9 t-80 -66.63 -28.71 68.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.459 -0.792 . . . . 2.46 109.932 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.46 -38.46 34.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.627 -0.509 . . . . 0.5 109.627 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -59.95 -38.15 81.6 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.259 0.552 . . . . 2.22 109.693 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.627 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 7.7 tt0 -66.7 -39.87 88.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.589 -0.732 . . . . 2.82 110.785 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -78.39 -26.4 46.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.556 -0.293 . . . . 1.05 111.333 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 3.6 tp10 -83.64 -55.02 4.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.529 0.566 . . . . 1.89 112.529 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.95 -48.54 6.47 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.929 0.714 . . . . 2.0 112.929 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 99.7 t -64.62 -54.61 28.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 121.75 -0.594 . . . . 1.18 111.608 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.9 mt -91.59 -31.39 15.91 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.536 0.569 . . . . 1.13 112.536 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 23.9 m-70 59.71 45.08 13.35 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.079 0.466 . . . . 1.19 110.017 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.8 -55.55 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.599 -0.728 . . . . 1.13 111.055 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 m -53.48 -47.76 69.52 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.502 0.501 . . . . 1.37 111.708 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.84 -43.97 97.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.513 -0.312 . . . . 1.73 111.226 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -65.24 -44.32 88.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.127 -0.488 . . . . 1.42 110.781 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.661 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 75.4 t -61.81 -47.1 94.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.984 -0.553 . . . . 1.14 110.638 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -53.57 -31.49 46.92 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.284 0.475 . . . . 1.96 112.284 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -89.67 -26.23 20.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.3 0.481 . . . . 2.52 112.3 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 55.2 mttt -84.79 -17.44 38.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.746 0.308 . . . . 1.93 111.568 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 86.4 mt -71.54 136.72 83.45 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.517 -0.311 . . . . 1.54 110.553 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.0 161.44 46.09 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.416 2.077 . . . . 0.97 111.968 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 128.87 38.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.944 0.402 . . . . 2.63 111.368 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.6 -17.06 23.59 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.824 -0.625 . . . . 0.82 112.093 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -98.4 122.01 49.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.642 0.258 . . . . 1.65 110.622 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -104.52 152.65 22.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.03 -0.359 . . . . 2.85 110.03 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 9.9 ttt -103.82 151.99 22.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.858 0.361 . . . . 1.76 110.318 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.79 124.74 22.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.013 -0.539 . . . . 1.15 110.066 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -114.43 119.4 36.76 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.548 -0.538 . . . . 1.3 109.548 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.449 ' CD2' ' HA ' ' A' ' 138' ' ' GLN . 8.0 m-30 -111.21 151.45 28.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.268 0.556 . . . . 1.05 111.873 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -102.25 130.26 48.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.383 -0.826 . . . . 0.78 109.855 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 m -86.78 159.42 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 111.475 0.176 . . . . 1.37 111.475 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.641 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 41.0 m-20 -107.62 -1.39 21.21 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.452 0.538 . . . . 1.08 112.452 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -96.35 10.68 37.29 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.681 -0.407 . . . . 0.87 111.543 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.86 102.06 4.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.839 0.352 . . . . 1.67 110.398 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.99 7.88 0.69 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.675 -0.693 . . . . 0.78 112.258 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.31 -116.64 8.18 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.941 -0.647 . . . . 0.81 112.408 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.48 -50.69 5.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.884 0.373 . . . . 2.47 111.0 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.52 -15.01 56.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.927 -0.579 . . . . 2.46 111.492 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.414 ' HA2' ' CE1' ' A' ' 29' ' ' PHE . . . -56.87 -31.97 61.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.087 -0.578 . . . . 0.72 112.548 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.641 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 85.2 mttt -74.91 -38.5 61.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.39 . . . . 3.18 110.794 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.34 -40.88 97.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 1.65 111.021 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.89 -26.66 65.22 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.876 -0.33 . . . . 1.65 111.229 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.2 m -66.88 -35.74 80.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.328 0.585 . . . . 1.19 109.492 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -73.48 -41.32 63.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 1.35 109.625 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.96 -41.54 99.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.542 -0.753 . . . . 1.31 110.76 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -61.01 -36.77 80.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.075 -0.511 . . . . 0.59 110.778 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.12 -39.04 93.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 1.33 110.111 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.81 -41.54 90.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.028 -0.533 . . . . 1.48 109.923 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.85 81.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.87 -0.605 . . . . 1.17 110.892 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.7 mtm -69.12 -36.4 77.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.736 -0.665 . . . . 1.56 110.79 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.68 -35.84 65.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.4 -0.363 . . . . 1.42 111.686 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.19 -28.14 38.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 1.54 110.947 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.93 29.38 18.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.87 -0.681 . . . . 0.78 112.77 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 m -120.93 25.38 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.071 0.462 . . . . 1.36 110.329 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -59.21 -52.19 66.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.451 -0.795 . . . . 1.71 111.443 -178.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.436 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 2.7 t70 -61.77 -39.45 91.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.466 0.65 . . . . 1.91 110.883 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -65.41 -34.89 79.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.432 -0.804 . . . . 2.74 111.86 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.2 m -94.43 -9.38 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.608 0.596 . . . . 1.26 112.608 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.5 m -56.72 -48.54 77.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 1.46 111.867 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.45 -59.61 9.22 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.349 0.5 . . . . 1.26 112.349 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.76 -36.45 95.18 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.216 1.944 . . . . 0.65 113.164 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.45 -42.84 78.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.736 0.303 . . . . 1.34 110.747 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -64.55 -45.27 87.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.537 . . . . 0.58 110.309 179.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' CD ' ' HZ1' ' A' ' 98' ' ' LYS . 6.4 mm-40 -65.15 -46.97 78.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.759 -0.655 . . . . 1.7 111.409 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.77 -9.14 55.42 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 116.149 -0.478 . . . . 0.82 114.147 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.5 t -109.71 -36.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 117.346 0.573 . . . . 1.23 111.919 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -104.42 -40.69 5.98 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.243 0.831 . . . . 0.84 113.243 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HZ1' ' CD ' ' A' ' 94' ' ' GLU . 28.3 ttmt -83.02 -68.14 0.73 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.883 0.373 . . . . 1.96 111.306 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.46 -35.68 53.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.736 0.303 . . . . 1.86 111.045 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 60.65 29.99 19.4 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.752 -0.658 . . . . 1.73 110.72 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.79 -28.52 44.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.914 -0.584 . . . . 2.07 111.085 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 85.7 mt -74.85 101.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.266 -0.424 . . . . 1.38 110.182 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -116.24 -33.11 5.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 3.77 111.134 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.5 p -118.45 169.7 9.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.115 -0.493 . . . . 1.78 110.565 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.01 -28.61 69.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.413 0.625 . . . . 1.54 109.91 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -31.43 72.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.289 -0.869 . . . . 1.62 110.081 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -71.78 -36.27 70.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.651 -0.704 . . . . 1.89 110.231 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 mt -68.76 -42.07 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.815 -0.63 . . . . 1.44 109.696 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -57.4 -40.18 77.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.236 -0.893 . . . . 2.74 110.066 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.74 -38.15 86.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.549 -0.75 . . . . 1.95 111.734 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.13 -44.91 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 1.42 110.803 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -64.44 -40.1 95.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.92 110.865 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 83.6 mt -63.71 -38.3 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.129 0.49 . . . . 1.85 110.379 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -70.56 -31.2 68.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 2.37 110.981 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.76 -31.11 69.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 1.42 110.714 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.02 -0.26 3.25 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.762 -0.733 . . . . 1.15 112.732 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 45.3 mm -86.28 127.52 40.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.031 -0.359 . . . . 2.16 110.031 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -68.35 139.27 55.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.234 -0.284 . . . . 3.2 110.234 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.88 -43.56 81.61 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.926 -0.579 . . . . 1.25 112.497 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.25 -46.78 88.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.683 0.278 . . . . 2.98 110.912 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -62.84 -45.42 92.68 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.123 0.487 . . . . 2.52 110.195 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -63.58 -48.33 77.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.662 -0.699 . . . . 2.23 110.876 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.65 -35.33 79.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 2.3 110.906 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.71 91.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.039 0.447 . . . . 1.61 109.97 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.48 -33.32 60.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.692 -0.686 . . . . 1.48 110.065 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -60.24 -31.51 70.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.478 0.656 . . . . 1.43 110.179 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -104.42 20.77 17.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.384 -0.825 . . . . 1.63 110.909 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.1 m -93.95 144.79 25.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.06 0.457 . . . . 2.33 111.67 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -65.74 -35.57 81.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.487 -0.779 . . . . 4.45 110.61 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.475 ' O ' ' HG ' ' A' ' 134' ' ' LEU . 63.4 t -53.73 -46.51 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 1.99 110.797 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.434 ' O ' HG21 ' A' ' 135' ' ' VAL . 75.8 t -67.49 -40.72 84.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.677 -0.692 . . . . 1.54 110.774 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -57.83 -46.33 84.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 2.84 111.117 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.3 m -66.16 -29.98 70.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.283 -0.417 . . . . 1.75 110.658 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 130' ' ' VAL . 86.4 mt -68.44 -40.67 81.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.853 -0.425 . . . . 1.53 109.853 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 131' ' ' VAL . 62.1 t -62.02 -44.03 98.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.99 -0.55 . . . . 1.31 110.21 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.76 99.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.738 -0.664 . . . . 1.52 111.046 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -66.55 -35.0 79.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.169 -0.469 . . . . 1.97 111.66 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.449 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 46.0 mt-30 -58.93 -53.22 60.84 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.879 0.371 . . . . 0.69 111.026 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -72.15 -36.51 69.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 2.82 110.976 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -58.37 -44.17 88.76 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.75 0.31 . . . . 2.37 110.912 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.488 ' O ' HG21 ' A' ' 145' ' ' VAL . . . -61.4 -44.76 96.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.955 -0.566 . . . . 1.2 110.77 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.14 90.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 1.12 111.366 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.19 -25.74 60.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 1.27 111.247 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.76 -36.12 32.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.272 -0.422 . . . . 1.39 111.261 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 141' ' ' ALA . 31.0 m -89.13 2.69 6.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.477 0.18 . . . . 1.98 111.373 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.407 ' HB3' ' NH2' ' A' ' 148' ' ' ARG . 38.5 mt-30 57.48 51.7 9.44 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.056 -0.52 . . . . 2.43 110.322 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.5 tp -54.57 120.39 6.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 1.32 111.982 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 148' ' ' ARG . 28.0 mmt180 -98.17 -45.94 6.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.93 -0.577 . . . . 4.87 110.713 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -107.9 161.16 13.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.106 -0.797 . . . . 0.82 111.106 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.508 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 2.4 t -68.95 -55.66 10.26 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.867 0.334 . . . . 1.16 111.73 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.508 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 5.9 Cg_endo -89.16 98.78 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.449 2.099 . . . . 0.73 112.123 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.51 151.23 40.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.261 -0.427 . . . . 1.07 110.645 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 34.9 ttm -122.92 133.95 54.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.04 -0.527 . . . . 1.09 110.805 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -123.02 129.83 52.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.72 -0.673 . . . . 0.66 109.543 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.3 118.32 47.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.917 0.389 . . . . 1.18 111.498 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.537 ' O ' ' HD3' ' A' ' 158' ' ' LYS . 28.6 m-20 58.8 17.88 5.58 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.028 -0.987 . . . . 1.24 112.178 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.4 24.75 67.88 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.039 -0.601 . . . . 0.56 112.14 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.537 ' HD3' ' O ' ' A' ' 156' ' ' ASN . 5.9 mppt? -126.45 -47.66 1.57 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.17 0.509 . . . . 2.21 111.218 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -101.47 126.59 48.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.866 -0.606 . . . . 1.61 111.475 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -103.83 138.47 40.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.453 -0.794 . . . . 1.14 109.865 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 mp -93.41 139.9 30.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.888 0.375 . . . . 1.83 111.163 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -118.07 109.91 40.4 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.85 110.547 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.44 -18.76 19.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.689 2.259 . . . . 0.71 112.712 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -83.56 -0.03 48.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.151 0.501 . . . . 2.48 110.924 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -117.19 22.07 10.56 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.981 -0.628 . . . . 0.6 111.644 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 47.1 mtt -120.53 -174.34 2.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.104 -0.332 . . . . 1.13 110.104 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.23 125.05 25.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.863 0.363 . . . . 1.54 110.114 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.25 31.78 6.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.444 0.64 . . . . 1.69 109.767 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -37.01 5.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.287 -0.87 . . . . 1.53 110.739 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -128.09 118.78 24.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 1.42 110.583 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.54 ' O ' HG22 ' A' ' 175' ' ' VAL . 10.3 mmt -54.08 -41.72 68.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.458 -0.792 . . . . 2.41 111.624 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -57.5 -46.85 83.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.837 0.351 . . . . 2.05 111.272 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.73 -46.87 90.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.948 -0.569 . . . . 1.24 110.755 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -54.29 -49.67 69.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.578 -0.283 . . . . 0.56 111.659 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 171' ' ' MET . 60.9 t -60.9 -45.08 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 1.15 111.552 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -70.7 -41.77 71.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.314 -0.403 . . . . 1.7 111.631 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -63.83 -42.38 97.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.513 . . . . 1.91 110.685 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.486 ' O ' HG21 ' A' ' 182' ' ' VAL . 21.4 t80 -59.57 -54.16 49.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.98 -0.555 . . . . 0.92 110.062 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.2 -34.01 75.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.73 -0.668 . . . . 1.02 111.395 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.8 -36.78 81.05 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.406 -0.361 . . . . 1.55 110.569 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.606 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 24.7 m -67.6 -41.71 83.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 1.17 109.97 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 178' ' ' TYR . 41.0 t -58.14 -50.4 78.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.022 -0.536 . . . . 1.14 110.389 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -59.93 -42.65 94.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.468 -0.787 . . . . 2.13 111.369 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -60.38 -42.96 96.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.326 -0.397 . . . . 1.25 110.537 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 181' ' ' THR . 53.8 mt -70.04 -33.92 72.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 1.22 110.712 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 25.4 m -66.94 -39.44 87.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.217 0.532 . . . . 1.38 110.188 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -91.0 23.04 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.687 -0.688 . . . . 2.26 110.294 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -109.37 -72.44 0.72 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.324 -0.398 . . . . 2.23 111.217 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.57 -0.728 . . . . 4.66 110.601 -179.087 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SFQ . . . . . 0.558 ' O4 ' ' N1 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.459 -0.2 . . . . 4.48 110.459 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.491 HE21 ' HG3' ' A' ' 4' ' ' GLU . 46.1 tp60 -85.32 123.31 30.65 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.171 -0.307 . . . . 4.33 110.171 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -127.79 100.27 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.009 0.433 . . . . 1.37 110.695 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.491 ' HG3' HE21 ' A' ' 2' ' ' GLN . 14.1 mt-10 -108.96 142.5 39.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.954 -0.566 . . . . 2.29 110.878 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.06 125.52 26.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.601 -0.727 . . . . 1.83 109.942 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.25 -20.38 35.43 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.992 -0.623 . . . . 0.78 111.96 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -109.12 -74.73 0.65 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.74 -0.27 . . . . 2.32 110.466 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -75.76 -43.53 46.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.27 -0.423 . . . . 1.46 110.904 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -138.54 154.21 48.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.302 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.89 133.19 54.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.283 -0.417 . . . . 1.51 111.046 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 m -84.52 127.42 34.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.278 -0.419 . . . . 1.54 111.711 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.78 137.02 34.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.602 -0.518 . . . . 1.36 109.602 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -75.68 -29.09 58.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 2.33 110.513 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -113.05 90.17 15.38 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 4.04 109.89 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.4 143.26 19.38 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.427 2.085 . . . . 1.06 112.593 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.7 t -76.61 127.44 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.51 -0.768 . . . . 1.3 111.412 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.06 121.28 26.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.06 -0.518 . . . . 1.48 110.557 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.0 19.94 44.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.72 . . . . 0.8 111.995 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.02 145.78 81.46 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.647 -0.277 . . . . 1.2 111.239 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.68 165.95 31.29 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.444 2.096 . . . . 0.63 111.985 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -56.62 -60.73 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 1.79 111.487 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.96 102.67 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.987 0.423 . . . . 1.11 110.539 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 47.3 tp -98.64 138.32 35.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.835 -0.62 . . . . 1.16 109.849 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -145.88 154.33 41.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.651 0.263 . . . . 1.61 110.799 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -130.04 157.6 41.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.066 -0.516 . . . . 0.61 110.343 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -168.38 177.5 5.32 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.089 -0.505 . . . . 0.67 110.554 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.415 ' HB2' HG23 ' A' ' 61' ' ' VAL . 2.5 t -156.75 132.87 9.74 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.213 -0.449 . . . . 1.52 110.849 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.488 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.9 m-85 -71.13 -16.71 62.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.834 -0.621 . . . . 0.71 109.826 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.48 ' CE2' ' HA2' ' A' ' 69' ' ' GLY . 97.1 m-85 -85.66 -4.0 59.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.567 -0.742 . . . . 2.16 111.32 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 53.3 t -115.49 122.63 32.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.393 -0.367 . . . . 0.89 110.764 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -65.94 -23.87 53.96 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.412 2.075 . . . . 0.86 112.027 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.548 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 0.0 OUTLIER -60.49 -38.93 85.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 2.46 110.099 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.2 m -71.67 -34.77 69.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.998 -0.546 . . . . 0.5 110.725 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.88 -44.31 96.44 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.124 0.487 . . . . 2.22 110.455 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.457 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 13.8 tt0 -66.48 -36.58 83.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.526 . . . . 2.82 110.357 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -77.5 -25.82 50.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.067 -0.515 . . . . 1.05 111.46 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 4.4 tp10 -84.25 -50.61 7.71 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.599 0.592 . . . . 1.89 112.599 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.585 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 10.1 tp10 -97.37 -46.21 6.17 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.356 0.873 . . . . 2.0 113.356 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 48.8 t -69.68 -51.8 37.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.051 -0.659 . . . . 1.18 110.921 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 mt -86.52 -35.56 19.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.258 -0.428 . . . . 1.13 111.764 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.585 ' HD2' ' O ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER 60.63 41.62 15.04 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.59 -0.522 . . . . 1.19 109.59 -178.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.594 ' O ' HG23 ' A' ' 46' ' ' VAL . 42.7 mm -53.77 -68.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.845 -0.616 . . . . 1.13 112.169 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 m -51.92 -45.63 64.34 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.345 0.403 . . . . 1.37 111.943 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.407 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 30.5 t70 -65.69 -29.66 70.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.888 -0.596 . . . . 1.73 111.583 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 2.2 t-20 -77.73 -37.14 49.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 1.42 110.217 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 42' ' ' ILE . 43.2 t -60.32 -35.48 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.935 -0.575 . . . . 1.14 110.637 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' A' ' 44' ' ' ASP . 51.8 mttt -56.71 -36.65 69.92 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.393 -0.367 . . . . 1.96 111.44 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -77.72 -10.32 59.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 2.52 112.089 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -102.07 -32.95 9.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.475 -0.33 . . . . 1.93 110.759 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.4 mt -68.92 129.88 91.97 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.139 -0.482 . . . . 1.54 110.851 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.77 -171.43 0.86 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.645 2.23 . . . . 0.97 112.625 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -67.86 148.75 50.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 2.63 111.128 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.54 -19.03 30.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.934 -0.651 . . . . 0.82 113.195 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.8 t -89.72 132.8 33.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.106 0.479 . . . . 1.65 110.749 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -131.41 141.76 49.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.98 -0.554 . . . . 2.85 110.265 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 84.2 mtp -90.88 134.3 34.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 1.76 110.999 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.02 94.36 4.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.232 0.539 . . . . 1.15 110.167 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -92.08 118.37 30.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.737 -0.665 . . . . 1.3 110.665 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 9.5 m-30 -113.62 167.56 10.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 1.05 110.897 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -103.24 133.62 48.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.405 -0.361 . . . . 0.78 110.795 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.415 HG23 ' HB2' ' A' ' 27' ' ' SER . 33.0 m -74.8 149.27 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 1.37 110.314 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -109.42 27.24 9.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.856 0.36 . . . . 1.08 111.688 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -133.65 15.57 4.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.014 0.435 . . . . 0.87 110.995 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -137.92 103.23 4.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.15 -0.477 . . . . 1.67 110.073 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.63 9.33 2.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.602 -0.808 . . . . 0.78 112.534 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.76 -140.46 34.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.879 -0.676 . . . . 0.81 112.373 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.83 -34.34 33.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.036 0.446 . . . . 2.47 110.048 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.3 tp -67.35 -22.31 65.59 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.772 -0.649 . . . . 2.46 110.256 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.48 ' HA2' ' CE2' ' A' ' 29' ' ' PHE . . . -58.88 -37.05 90.16 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.671 -0.695 . . . . 0.72 111.876 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -68.66 -32.16 71.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.776 0.322 . . . . 3.18 110.776 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -40.49 97.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 1.65 110.265 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -26.57 62.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.089 -0.505 . . . . 1.65 110.459 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -62.57 -33.59 75.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.304 0.574 . . . . 1.19 109.759 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -77.84 -37.43 48.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.438 -0.801 . . . . 1.35 109.48 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.17 85.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.569 -0.741 . . . . 1.31 111.318 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -59.67 -36.43 76.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.111 -0.495 . . . . 0.59 110.597 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.27 83.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.11 -0.495 . . . . 1.33 110.083 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.1 -43.05 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.677 -0.692 . . . . 1.48 110.013 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.36 90.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.794 -0.639 . . . . 1.17 110.938 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 71.6 mtm -66.84 -35.66 80.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.95 -0.568 . . . . 1.56 110.652 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.33 -36.57 68.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.893 0.377 . . . . 1.42 110.882 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 mt -75.62 -44.22 43.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.22 -0.446 . . . . 1.54 110.763 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.69 37.38 3.72 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.272 -0.731 . . . . 0.78 111.272 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.27 29.11 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.966 0.413 . . . . 1.36 110.179 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.87 -65.76 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.281 -0.872 . . . . 1.71 112.158 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.31 -28.99 67.3 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.334 -0.394 . . . . 1.91 111.218 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -66.65 -44.68 81.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.815 -0.629 . . . . 2.74 111.474 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.81 -8.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.886 0.328 . . . . 1.26 111.886 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.6 m -58.25 -49.13 78.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.721 0.267 . . . . 1.46 111.721 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.427 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 46.3 t -61.36 -59.86 12.3 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.383 0.512 . . . . 1.26 112.383 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.427 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 12.2 Cg_endo -56.13 -34.19 92.26 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.198 1.932 . . . . 0.65 113.232 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.1 mt -70.8 -40.7 72.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.715 0.293 . . . . 1.34 110.719 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -64.24 -48.13 76.98 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.231 0.539 . . . . 0.58 110.442 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.9 -35.87 74.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.534 -0.757 . . . . 1.7 111.248 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.72 -25.69 70.59 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.917 -0.658 . . . . 0.82 113.106 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 64.7 t -100.65 -39.43 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.491 0.552 . . . . 1.23 112.491 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -94.57 -42.94 8.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.717 1.006 . . . . 0.84 113.717 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -78.97 -62.49 1.68 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.977 0.362 . . . . 1.96 111.977 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.04 -39.41 25.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.112 -0.494 . . . . 1.86 112.162 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 66.08 26.89 10.66 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.066 0.46 . . . . 1.73 110.288 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.33 -33.76 32.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.894 -0.594 . . . . 2.07 111.346 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.25 102.51 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.917 -0.583 . . . . 1.38 110.461 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mmm-85 -119.14 -8.12 10.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.848 -0.615 . . . . 3.77 110.448 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 m -149.77 172.59 14.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.226 -0.443 . . . . 1.78 110.696 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.8 -20.72 66.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.24 -0.436 . . . . 1.54 110.816 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -44.72 96.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.006 -0.543 . . . . 1.62 110.562 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.448 ' O ' HG22 ' A' ' 111' ' ' VAL . 13.2 m-20 -67.07 -40.29 87.03 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.98 -0.554 . . . . 1.89 109.851 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 54.6 mt -61.05 -46.1 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.654 -0.703 . . . . 1.44 110.171 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 113' ' ' ILE . 62.8 ttt180 -60.28 -41.22 92.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.943 -0.572 . . . . 2.74 109.723 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -59.48 -39.66 84.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.306 -0.861 . . . . 1.95 110.667 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 107' ' ' ASP . 73.2 t -60.09 -42.41 89.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 1.42 110.661 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -65.35 -39.75 92.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.92 110.457 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 65.7 mt -64.95 -33.77 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.316 0.579 . . . . 1.85 109.763 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -73.91 -8.39 55.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.541 -0.754 . . . . 2.37 110.654 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.32 2.57 42.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.07 -0.514 . . . . 1.42 110.311 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.81 39.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.821 -0.705 . . . . 1.15 113.193 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 38.2 mm -98.23 133.35 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.123 -0.325 . . . . 2.16 110.123 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -73.76 146.86 43.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.26 -0.427 . . . . 3.2 111.468 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.3 -35.27 91.32 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.894 -0.669 . . . . 1.25 112.024 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.53 -45.69 78.62 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.952 -0.388 . . . . 2.98 109.952 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -60.93 -45.08 96.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.552 -0.749 . . . . 2.52 109.686 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.409 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 53.9 t80 -63.05 -41.87 99.59 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.76 -0.655 . . . . 2.23 110.479 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.63 -44.15 93.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.831 0.348 . . . . 2.3 110.852 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.84 79.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 1.61 111.119 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.02 83.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 1.48 111.088 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -57.96 -36.92 73.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.308 -0.405 . . . . 1.43 111.074 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -109.58 32.04 5.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.371 -0.377 . . . . 1.63 111.47 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.9 p -92.09 157.75 16.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.766 0.317 . . . . 2.33 110.215 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -74.06 -32.46 63.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.556 -0.293 . . . . 4.45 110.359 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.3 t -58.4 -45.49 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.989 0.423 . . . . 1.99 110.181 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.454 ' O ' HG21 ' A' ' 135' ' ' VAL . 15.5 t -61.89 -38.48 80.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.561 -0.745 . . . . 1.54 110.537 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -56.43 -50.72 70.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 2.84 110.976 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -32.03 72.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 1.75 111.051 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.38 -32.43 66.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 1.53 110.773 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 131' ' ' VAL . 70.1 t -67.31 -47.03 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 1.31 110.073 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.08 85.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 1.52 111.233 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -64.12 -32.42 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.512 -0.313 . . . . 1.97 111.34 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.404 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 50.5 mt-30 -66.43 -42.27 87.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.409 -0.359 . . . . 0.69 110.551 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.41 -37.97 50.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 2.82 110.803 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 31.7 tttp -54.34 -50.26 67.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.325 -0.398 . . . . 2.37 110.809 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.419 ' O ' HG21 ' A' ' 145' ' ' VAL . . . -66.37 -46.55 76.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.162 -0.472 . . . . 1.2 111.522 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.65 83.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 1.12 112.104 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.81 -27.21 61.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.52 0.563 . . . . 1.27 112.52 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 3.3 t0 -78.12 -31.35 49.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.856 0.317 . . . . 1.39 111.856 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 141' ' ' ALA . 32.6 m -92.47 3.14 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.151 0.426 . . . . 1.98 112.151 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 60.4 51.6 5.23 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.262 0.553 . . . . 2.43 110.155 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.9 tp -62.18 106.61 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.479 -0.782 . . . . 1.32 111.404 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -104.19 -1.79 26.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.804 -0.635 . . . . 4.87 110.811 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -133.39 179.78 17.08 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.847 -0.692 . . . . 0.82 112.014 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.494 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 0.2 OUTLIER -97.85 -61.85 0.12 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 117.033 0.416 . . . . 1.16 111.411 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 3.9 Cg_endo -85.78 65.74 5.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.641 2.227 . . . . 0.73 111.814 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -109.35 138.7 45.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 1.07 110.67 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.498 ' SD ' HG22 ' A' ' 182' ' ' VAL . 29.4 ttm -115.62 137.98 51.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.947 -0.57 . . . . 1.09 110.168 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -127.74 131.31 49.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 0.66 110.392 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.59 117.79 45.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.573 -0.285 . . . . 1.18 110.705 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 60.63 13.87 4.57 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.733 -0.667 . . . . 1.24 111.601 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.31 23.99 68.7 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.047 -0.597 . . . . 0.56 111.759 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -124.65 -44.37 1.97 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.075 0.464 . . . . 2.21 110.758 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -102.1 125.13 48.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.936 -0.575 . . . . 1.61 110.604 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -105.68 138.85 41.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.196 -0.456 . . . . 1.14 109.862 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.6 mp -90.18 139.15 30.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.535 0.207 . . . . 1.83 110.726 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -114.9 113.12 44.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.43 . . . . 0.85 110.854 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.77 6.86 5.21 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.924 2.416 . . . . 0.71 112.56 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -113.33 20.98 15.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.323 -0.399 . . . . 2.48 110.763 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.11 33.39 1.92 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.02 -0.609 . . . . 0.6 111.935 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.9 mtt -124.84 -176.51 3.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.474 0.178 . . . . 1.13 110.542 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.05 127.58 32.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.138 0.494 . . . . 1.54 111.57 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 16.2 16.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.835 -0.621 . . . . 1.69 110.835 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -32.42 14.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.159 0.504 . . . . 1.53 110.401 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -139.42 125.16 19.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.04 -0.527 . . . . 1.42 110.127 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 56.4 ttm -62.37 -32.94 73.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.63 . . . . 2.41 111.443 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -63.32 -37.28 86.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.174 -0.466 . . . . 2.05 111.027 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.68 -41.83 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 1.24 110.509 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.84 -50.09 71.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.56 111.122 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.8 t -57.61 -51.09 74.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 1.15 111.688 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -42.12 83.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.995 -0.548 . . . . 1.7 112.119 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -62.09 -45.61 92.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.657 0.265 . . . . 1.91 110.979 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -57.71 -52.18 66.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.92 110.635 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.01 82.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 1.02 112.105 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.65 -32.95 73.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.646 0.26 . . . . 1.55 110.516 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 35.4 m -63.14 -40.07 96.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 1.17 110.188 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.498 HG22 ' SD ' ' A' ' 153' ' ' MET . 21.8 t -60.38 -52.92 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.269 0.557 . . . . 1.14 110.227 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -57.44 -39.83 77.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.961 -1.018 . . . . 2.13 111.007 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -64.51 -46.24 83.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.889 -0.596 . . . . 1.25 110.819 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.0 mt -66.56 -39.81 88.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.088 -0.506 . . . . 1.22 112.06 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.9 p -66.31 -23.75 66.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.038 0.447 . . . . 1.38 111.276 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -102.2 4.97 39.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.226 0.536 . . . . 2.26 110.338 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.5 tttm -95.84 68.81 2.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.788 -0.642 . . . . 2.23 110.326 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.476 ' NZ ' ' HB3' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-N 115.564 -0.744 . . . . 4.66 110.35 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SFQ . . . . . 0.548 ' C13' ' HE2' ' A' ' 32' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.554 0.216 . . . . 4.48 110.613 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -76.51 119.56 20.52 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.935 -0.395 . . . . 4.33 109.935 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -125.54 140.96 52.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.757 0.313 . . . . 1.37 110.983 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -119.35 140.67 49.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.943 -0.571 . . . . 2.29 109.891 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -69.3 119.12 13.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.083 0.468 . . . . 1.83 110.036 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.56 -16.38 29.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.995 -0.842 . . . . 0.78 110.995 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 50.6 tptt -99.13 -80.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.637 -0.281 . . . . 2.32 110.57 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -86.79 -25.37 24.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 1.46 111.381 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -143.49 152.74 41.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.189 -0.3 . . . . 1.0 110.189 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 m -128.54 132.08 48.26 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.21 0.319 . . . . 1.51 110.639 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.4 m -75.68 125.56 29.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.362 -0.381 . . . . 1.54 110.175 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.26 127.31 32.26 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.792 0.329 . . . . 1.36 110.526 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.09 -39.46 93.21 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.627 -0.715 . . . . 2.33 110.33 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -122.18 84.01 45.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 4.04 109.893 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.36 155.11 70.43 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.485 2.124 . . . . 1.06 112.191 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.5 t -89.4 131.84 35.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.036 -0.529 . . . . 1.3 110.713 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.81 137.8 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.107 -0.497 . . . . 1.48 110.323 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.9 25.24 74.34 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.73 -0.748 . . . . 0.8 112.382 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.26 143.52 31.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.436 -0.209 . . . . 1.2 110.436 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 30.1 Cg_endo -66.27 162.05 37.79 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.373 2.049 . . . . 0.63 112.704 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -62.68 -44.92 95.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.612 -0.722 . . . . 1.79 110.705 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.8 t -120.52 100.77 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.702 -0.481 . . . . 1.11 109.702 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 26.5 tp -110.92 110.78 21.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.951 -0.568 . . . . 1.16 110.423 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -120.12 145.76 46.61 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.426 -0.352 . . . . 1.61 110.215 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 151' ' ' PRO . 97.2 m-85 -123.23 154.63 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.309 -0.405 . . . . 0.61 110.114 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.413 ' CE1' ' HD3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -170.24 177.99 3.97 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.005 0.431 . . . . 0.67 110.786 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.1 t -156.91 141.58 16.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 1.52 110.51 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.529 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 96.0 m-85 -73.4 -20.49 60.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.9 -0.591 . . . . 0.71 110.502 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CZ ' HD11 ' A' ' 72' ' ' LEU . 72.6 m-85 -85.35 -1.32 56.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 2.16 110.339 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.482 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 48.1 t -107.19 112.34 62.98 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.019 -0.537 . . . . 0.89 111.133 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -64.2 -24.54 65.61 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.216 1.944 . . . . 0.86 111.283 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.427 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 7.5 t-80 -66.32 -29.37 69.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.369 -0.832 . . . . 2.46 110.236 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.0 m -83.66 -32.02 25.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.47 -0.567 . . . . 0.5 109.47 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.77 -49.1 79.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.304 -0.862 . . . . 2.22 110.063 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.494 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 22.5 tt0 -68.35 -32.34 72.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 2.82 110.726 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -66.66 -30.84 71.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.481 0.549 . . . . 1.05 112.481 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -108.65 -50.11 3.07 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.993 0.738 . . . . 1.89 112.993 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.63 -25.51 64.87 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.953 -0.467 . . . . 2.0 111.659 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 91.5 t -107.72 -56.44 4.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.796 -0.362 . . . . 1.18 111.498 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.8 mt -81.05 -33.55 33.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.928 0.344 . . . . 1.13 111.928 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 0.6 OUTLIER 58.9 63.45 1.64 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.848 0.459 . . . . 1.19 111.003 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.1 mm -71.36 -50.87 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.902 -0.59 . . . . 1.13 111.165 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 m -58.3 -49.33 77.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.314 -0.403 . . . . 1.37 110.999 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 26.0 t70 -61.26 -45.03 96.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.549 . . . . 1.73 110.888 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 0.7 OUTLIER -62.41 -41.56 98.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 1.42 110.794 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.515 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 39.6 t -66.44 -42.44 90.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 1.14 110.541 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.93 -31.63 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.738 0.304 . . . . 1.96 111.37 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 30.3 mttm -86.68 3.13 46.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.261 -0.427 . . . . 2.52 111.679 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -136.97 23.59 3.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 1.93 111.007 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 13.9 mt -99.73 145.5 30.25 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.396 -0.365 . . . . 1.54 110.383 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -70.21 165.48 31.34 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.718 2.279 . . . . 0.97 111.422 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.25 139.97 50.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.998 -0.546 . . . . 2.63 110.368 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.23 -9.15 78.03 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.931 -0.652 . . . . 0.82 112.118 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.95 98.63 7.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.853 0.359 . . . . 1.65 110.263 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.6 124.96 31.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.141 -0.481 . . . . 2.85 110.165 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -72.97 127.97 34.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.646 -0.501 . . . . 1.76 109.646 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 119.48 34.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.949 0.404 . . . . 1.15 110.757 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.413 ' HD3' ' CE1' ' A' ' 26' ' ' PHE . 15.2 ttmm -114.04 119.57 37.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 1.3 110.16 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.466 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 13.1 m-30 -110.28 160.51 16.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.135 0.493 . . . . 1.05 111.55 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -104.85 134.76 47.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.661 -0.699 . . . . 0.78 110.618 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.7 m -88.7 155.05 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.587 -0.279 . . . . 1.37 110.61 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -105.21 -6.1 20.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.632 0.604 . . . . 1.08 112.632 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -89.97 15.5 9.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.427 0.632 . . . . 0.87 110.79 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.482 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -144.32 88.87 1.97 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.458 -0.792 . . . . 1.67 109.61 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.15 -7.27 0.29 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 121.09 -0.576 . . . . 0.78 112.547 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.44 -134.61 22.83 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.556 -0.831 . . . . 0.81 112.333 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -22.8 40.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.649 0.262 . . . . 2.47 110.793 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 tp -85.6 -11.62 53.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.097 0.475 . . . . 2.46 110.318 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.75 98.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.772 -0.727 . . . . 0.72 111.961 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -62.9 -40.09 96.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.067 0.461 . . . . 3.18 110.552 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.79 -49.06 79.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.678 -0.692 . . . . 1.65 111.158 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.405 HD11 ' CZ ' ' A' ' 29' ' ' PHE . 1.7 mt -66.29 -22.77 66.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 1.65 111.6 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 m -69.71 -40.39 76.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.917 0.389 . . . . 1.19 110.098 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -72.37 -38.91 68.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.98 -0.748 . . . . 1.35 108.98 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.88 99.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.418 -0.81 . . . . 1.31 110.935 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.434 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 66.6 t-105 -62.69 -38.21 89.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.735 -0.666 . . . . 0.59 110.714 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.13 -38.48 86.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 1.33 110.39 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.05 -41.73 92.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.121 0.486 . . . . 1.48 109.801 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.7 88.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.784 -0.644 . . . . 1.17 111.006 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.8 mtm -69.26 -33.42 73.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 1.56 111.149 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.92 -38.86 61.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.501 . . . . 1.42 110.584 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.6 mt -76.31 -32.75 58.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.094 -0.503 . . . . 1.54 110.926 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.27 39.54 6.0 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.772 -0.727 . . . . 0.78 111.581 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.6 m -130.09 30.32 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.832 0.349 . . . . 1.36 110.83 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 2.8 mp0 -59.77 -63.0 1.46 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.047 -0.524 . . . . 1.71 111.812 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.74 -33.33 61.04 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.188 -0.46 . . . . 1.91 111.172 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -66.17 -48.02 72.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.77 -0.65 . . . . 2.74 111.705 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.83 -10.6 11.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.062 0.764 . . . . 1.26 113.062 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.4 m -56.18 -51.76 66.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.219 0.452 . . . . 1.46 112.219 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.425 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 42.2 t -62.57 -59.22 13.35 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 112.547 0.573 . . . . 1.26 112.547 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 10.0 Cg_endo -54.7 -35.29 86.92 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.255 1.97 . . . . 0.65 113.059 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.9 mt -68.77 -47.92 65.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.514 0.197 . . . . 1.34 110.757 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.529 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -58.59 -49.43 77.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.165 0.507 . . . . 0.58 110.784 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.473 ' CD ' ' HZ3' ' A' ' 98' ' ' LYS . 5.8 mm-40 -64.41 -39.33 93.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.621 -0.718 . . . . 1.7 110.913 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.65 -18.03 71.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.998 -0.62 . . . . 0.82 113.469 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.7 t -101.55 -42.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.319 0.488 . . . . 1.23 112.319 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -98.72 -39.98 8.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.587 0.958 . . . . 0.84 113.587 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.473 ' HZ3' ' CD ' ' A' ' 94' ' ' GLU . 1.3 tttp -79.61 -70.79 0.49 Allowed 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.676 -0.41 . . . . 1.96 111.797 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.31 -26.4 46.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.676 -0.238 . . . . 1.86 111.532 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 56.38 28.45 13.53 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.606 0.567 . . . . 1.73 111.173 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -28.51 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.75 -0.659 . . . . 2.07 111.584 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.74 100.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.991 -0.374 . . . . 1.38 109.991 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -122.97 -3.59 8.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 3.77 110.967 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -149.45 166.1 30.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.319 -0.4 . . . . 1.78 110.068 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.93 67.85 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.51 -0.313 . . . . 1.54 111.335 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -36.66 78.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.246 -0.434 . . . . 1.62 110.785 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -70.67 -42.23 71.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.363 -0.606 . . . . 1.89 109.363 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.5 mt -62.17 -43.14 97.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.614 -0.721 . . . . 1.44 110.097 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.403 ' O ' HG13 ' A' ' 113' ' ' ILE . 74.2 ttt-85 -57.76 -44.2 85.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.572 -0.74 . . . . 2.74 110.211 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.7 -35.06 79.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.606 -0.724 . . . . 1.95 111.386 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.4 t -60.82 -42.75 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.029 0.442 . . . . 1.42 110.255 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -64.42 -39.9 94.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 0.92 110.394 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 65.4 mt -63.9 -36.47 76.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 1.85 110.126 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -68.03 -23.33 64.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.834 -0.621 . . . . 2.37 111.045 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.45 -7.47 58.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.42 111.522 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.96 5.75 28.72 Favored Glycine 0 C--O 1.234 0.136 0 C-N-CA 120.747 -0.739 . . . . 1.15 112.736 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 44.4 mm -92.44 124.89 45.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 122.742 -0.27 . . . . 2.16 110.364 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -65.52 134.3 53.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.307 -0.406 . . . . 3.2 110.42 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.32 -38.97 81.23 Favored Glycine 0 CA--C 1.517 0.207 0 O-C-N 123.479 0.487 . . . . 1.25 112.717 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.31 -36.59 80.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.528 0.204 . . . . 2.98 111.368 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -73.13 -41.88 63.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.041 0.448 . . . . 2.52 109.978 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -60.79 -44.3 97.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 2.23 110.21 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -61.63 -39.41 91.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.985 -0.552 . . . . 2.3 110.874 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.41 -47.42 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.749 -0.66 . . . . 1.61 110.607 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.1 -27.94 68.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.256 -0.429 . . . . 1.48 111.333 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -62.46 -28.82 70.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.139 0.495 . . . . 1.43 110.301 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -105.05 19.13 21.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.006 -0.543 . . . . 1.63 111.111 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.0 t -80.3 142.22 34.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.102 -0.499 . . . . 2.33 110.865 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -69.84 -32.26 70.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.198 0.523 . . . . 4.45 109.685 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.41 -44.87 99.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.717 -0.674 . . . . 1.99 109.804 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 135' ' ' VAL . 62.0 t -64.31 -41.48 92.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.412 -0.813 . . . . 1.54 110.332 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -57.29 -42.47 81.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.989 -0.55 . . . . 2.84 110.083 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 137' ' ' GLN . 12.1 t -66.38 -44.88 81.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.645 -0.707 . . . . 1.75 110.214 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.478 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 48.4 mt -59.2 -37.73 78.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 1.53 111.043 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 131' ' ' VAL . 77.2 t -61.94 -47.01 95.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.929 -0.397 . . . . 1.31 109.929 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.6 -39.14 92.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.84 -0.618 . . . . 1.52 110.812 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 133' ' ' SER . 78.6 mt-30 -60.49 -41.08 93.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 1.97 111.207 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 134' ' ' LEU . 49.7 mt-30 -63.75 -48.05 78.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.262 -0.426 . . . . 0.69 110.727 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -65.12 -41.2 95.1 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.025 -0.534 . . . . 2.82 110.44 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.7 tttm -61.92 -50.7 71.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.277 -0.874 . . . . 2.37 111.259 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.42 -44.98 92.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.46 . . . . 1.2 111.967 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.08 -36.51 83.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.487 -0.324 . . . . 1.12 111.689 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.88 -36.39 28.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.525 -0.307 . . . . 1.27 111.197 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -63.86 -49.73 71.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.413 -0.358 . . . . 1.39 110.997 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.63 -9.68 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 1.98 110.891 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.499 ' O ' ' HD2' ' A' ' 148' ' ' ARG . 89.5 mt-30 59.18 67.25 0.93 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.771 -0.65 . . . . 2.43 110.193 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 149' ' ' GLY . 14.0 tp -63.97 129.68 41.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.515 -0.766 . . . . 1.32 110.535 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 146' ' ' GLN . 1.2 mpt_? -96.74 -47.49 5.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.821 -0.627 . . . . 4.87 110.254 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.448 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . -98.05 -158.09 30.16 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.321 -0.712 . . . . 0.82 111.321 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.546 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 2.5 t -113.4 -57.41 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 117.221 0.511 . . . . 1.16 111.724 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 17.3 Cg_endo -92.64 82.34 0.24 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.601 2.201 . . . . 0.73 111.885 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.36 146.15 50.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.316 -0.402 . . . . 1.07 110.87 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 43.8 ttm -118.78 133.14 56.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.049 -0.523 . . . . 1.09 110.314 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.28 133.1 56.38 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.914 -0.585 . . . . 0.66 109.826 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.43 112.4 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.257 -0.429 . . . . 1.18 110.459 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 60.47 17.23 7.08 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.278 -0.873 . . . . 1.24 111.52 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.19 20.28 64.88 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.925 -0.58 . . . . 0.56 112.512 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -121.06 -38.35 2.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.886 0.374 . . . . 2.21 111.641 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -111.83 128.36 56.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.016 0.436 . . . . 1.61 110.898 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -105.15 138.4 41.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.667 -0.697 . . . . 1.14 110.438 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.23 134.97 33.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.528 -0.306 . . . . 1.83 110.325 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -115.6 100.79 53.96 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.774 0.321 . . . . 0.85 110.587 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.45 -16.87 34.7 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 122.363 2.042 . . . . 0.71 112.572 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -81.02 -6.48 58.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.948 0.404 . . . . 2.48 110.788 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -115.26 14.77 18.43 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.244 -0.742 . . . . 0.6 111.244 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.403 ' HB3' ' OE1' ' A' ' 177' ' ' GLN . 64.9 mtt -105.54 -174.52 2.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.543 -0.329 . . . . 1.13 110.187 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -71.25 111.8 6.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.226 0.536 . . . . 1.54 111.032 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.24 18.49 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.338 0.589 . . . . 1.69 109.795 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.99 -48.88 6.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.507 -0.77 . . . . 1.53 110.681 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -122.37 126.84 48.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.164 -0.471 . . . . 1.42 110.61 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.477 ' O ' HG23 ' A' ' 175' ' ' VAL . 39.3 mtt -62.19 -40.52 96.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.031 -0.531 . . . . 2.41 111.602 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -61.05 -42.01 97.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 2.05 110.604 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.8 t -67.74 -46.84 81.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.792 -0.64 . . . . 1.24 110.45 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -55.4 -49.34 72.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.777 -0.647 . . . . 0.56 111.856 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 171' ' ' MET . 80.8 t -55.73 -50.09 70.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.548 -0.296 . . . . 1.15 111.705 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -69.25 -35.06 75.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.375 -0.375 . . . . 1.7 111.082 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.403 ' OE1' ' HB3' ' A' ' 166' ' ' MET . 57.4 tt0 -63.57 -47.15 82.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.398 -0.365 . . . . 1.91 110.537 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.463 ' O ' HG23 ' A' ' 182' ' ' VAL . 17.7 t80 -57.54 -46.73 83.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.975 -0.557 . . . . 0.92 109.906 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.7 -41.1 88.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.638 -0.71 . . . . 1.02 111.46 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.55 -40.36 96.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.086 -0.506 . . . . 1.55 110.311 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.2 m -59.76 -42.03 92.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 1.17 110.575 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 178' ' ' TYR . 61.8 t -60.05 -53.17 52.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.293 -0.412 . . . . 1.14 110.523 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -59.83 -46.36 89.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.687 -0.688 . . . . 2.13 111.047 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.402 ' O ' ' HB2' ' A' ' 188' ' ' LYS . 88.6 t80 -58.73 -45.6 89.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.838 -0.619 . . . . 1.25 111.484 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.36 -36.55 74.25 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.479 0.18 . . . . 1.22 111.401 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.7 m -64.37 -37.6 88.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.986 0.422 . . . . 1.38 110.879 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -97.42 17.72 16.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 2.26 111.139 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 184' ' ' TYR . 44.1 tttm -94.08 76.99 4.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.116 0.484 . . . . 2.23 110.395 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.597 -0.716 . . . . 4.66 110.85 -179.753 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SFQ . . . . . 0.524 ' O4 ' ' N1 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.399 -0.223 . . . . 4.48 110.399 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -87.7 127.41 35.3 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.42 -0.215 . . . . 4.33 110.42 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -134.73 135.01 41.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.532 0.206 . . . . 1.37 110.492 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -128.3 151.01 49.81 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.761 0.315 . . . . 2.29 110.746 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -65.95 123.37 19.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.783 -0.644 . . . . 1.83 111.011 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.0 -14.05 52.45 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.915 -0.584 . . . . 0.78 112.425 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -108.52 -73.31 0.69 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.95 -0.3 . . . . 2.32 111.137 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -91.54 -24.59 19.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.581 0.229 . . . . 1.46 111.41 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -145.7 158.82 43.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.147 -0.316 . . . . 1.0 110.147 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.95 122.96 31.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.958 0.409 . . . . 1.51 111.096 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.4 m -74.51 120.57 20.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.162 -0.472 . . . . 1.54 109.805 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.4 mt -72.58 136.69 45.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.024 0.44 . . . . 1.36 111.285 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -77.17 -31.7 55.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.972 -0.751 . . . . 2.33 108.972 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -120.2 83.42 32.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.26 -0.882 . . . . 4.04 110.096 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.12 163.4 38.25 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.382 2.055 . . . . 1.06 112.08 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.77 115.3 43.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.004 0.43 . . . . 1.3 110.647 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.43 111.84 12.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.807 -0.633 . . . . 1.48 110.496 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.37 20.88 9.22 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.771 -0.728 . . . . 0.8 112.245 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.88 154.27 55.37 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.452 -0.203 . . . . 1.2 110.452 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.49 161.31 42.66 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.12 1.88 . . . . 0.63 112.228 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -57.33 -56.53 20.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.836 -0.62 . . . . 1.79 111.487 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -112.27 96.35 4.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.134 0.493 . . . . 1.11 110.337 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.33 116.54 32.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.635 -0.711 . . . . 1.16 109.764 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -126.23 152.17 46.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.611 0.243 . . . . 1.61 110.822 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.23 156.61 42.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.61 -0.515 . . . . 0.61 109.61 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -169.06 175.95 5.54 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.019 0.438 . . . . 0.67 111.003 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.475 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 7.0 t -156.24 136.99 13.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.337 -0.392 . . . . 1.52 110.192 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -70.58 -15.76 62.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.921 -0.581 . . . . 0.71 110.957 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -88.9 -1.27 58.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 2.16 110.765 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.3 t -107.49 115.73 58.95 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.035 -0.357 . . . . 0.89 110.035 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -64.09 -26.42 65.58 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.372 2.048 . . . . 0.86 112.082 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -70.19 -27.37 64.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 2.46 110.096 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.1 m -71.9 -37.05 70.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.553 -0.536 . . . . 0.5 109.553 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -65.52 -36.48 83.95 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.28 0.562 . . . . 2.22 109.553 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.49 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 47.2 tt0 -65.36 -43.96 89.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.382 -0.826 . . . . 2.82 109.967 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.43 -32.75 68.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.061 -0.518 . . . . 1.05 111.964 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 3.2 tp10 -87.94 -50.79 6.2 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.432 0.901 . . . . 1.89 113.432 -177.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.427 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 27.1 tp10 -94.38 -34.33 12.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.738 1.014 . . . . 2.0 113.738 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 51.9 t -81.46 -51.98 14.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 121.578 -0.701 . . . . 1.18 110.914 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -92.18 -31.3 15.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.468 0.544 . . . . 1.13 112.468 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 6.7 m-70 60.0 48.62 8.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.484 -0.561 . . . . 1.19 109.484 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 46' ' ' VAL . 41.1 mm -53.16 -64.13 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.474 -0.784 . . . . 1.13 111.893 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -54.53 -31.66 56.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.284 0.476 . . . . 1.37 112.284 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.94 -37.98 72.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.806 0.336 . . . . 1.73 110.928 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.42 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 28.4 m-80 -72.88 -33.01 65.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 1.42 110.626 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 42' ' ' ILE . 62.1 t -60.47 -37.11 73.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.873 -0.603 . . . . 1.14 110.443 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -62.04 -25.04 67.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.984 -0.553 . . . . 1.96 111.726 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 45' ' ' ASN . 49.3 mtmt -83.04 -11.44 58.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.517 -0.311 . . . . 2.52 111.348 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -112.15 -20.84 11.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 111.828 0.307 . . . . 1.93 111.828 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.8 mt -74.6 132.73 77.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.699 0.285 . . . . 1.54 111.366 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.41 174.5 11.46 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.333 2.022 . . . . 0.97 112.013 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.06 144.81 55.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.14 -0.482 . . . . 2.63 111.158 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.02 -20.46 47.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.172 -0.537 . . . . 0.82 112.559 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.17 113.63 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.869 0.366 . . . . 1.65 110.603 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -97.95 151.77 19.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 2.85 109.841 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 96.2 mtp -108.57 146.17 33.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.47 -0.332 . . . . 1.76 110.359 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 m -135.07 110.71 9.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.824 0.345 . . . . 1.15 110.492 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -106.84 122.45 46.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.875 -0.602 . . . . 1.3 109.704 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.688 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 10.2 m-85 -111.5 159.19 18.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.93 0.395 . . . . 1.05 111.0 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.475 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 52.5 t-80 -104.62 134.64 47.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.491 . . . . 0.78 109.875 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 m -87.47 150.41 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.569 -0.287 . . . . 1.37 111.012 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.66 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 7.5 m-20 -99.44 1.32 44.04 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.36 0.504 . . . . 1.08 112.36 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -98.18 12.92 33.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.13 0.491 . . . . 0.87 111.296 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.13 99.63 3.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.256 -0.429 . . . . 1.67 110.726 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.96 -2.88 4.84 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.623 -0.799 . . . . 0.78 112.426 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.23 -138.91 31.46 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.209 -0.52 . . . . 0.81 112.145 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.98 -37.51 72.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.859 0.362 . . . . 2.47 111.133 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -70.61 -22.08 62.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 2.46 110.391 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.34 -32.48 84.33 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.5 -0.857 . . . . 0.72 111.132 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.66 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 33.4 mttm -66.7 -36.94 83.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.725 0.298 . . . . 3.18 110.807 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -67.0 -39.04 87.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.137 0.494 . . . . 1.65 110.294 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mt -66.25 -28.89 69.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 1.65 110.321 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.6 m -67.7 -36.72 81.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.191 0.52 . . . . 1.19 109.773 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -73.87 -41.61 61.96 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.81 -0.632 . . . . 1.35 109.623 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.82 95.24 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.82 -0.627 . . . . 1.31 110.835 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -61.12 -40.14 92.66 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.859 -0.609 . . . . 0.59 110.557 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.73 81.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.063 -0.517 . . . . 1.33 110.228 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.85 -46.23 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 1.48 109.979 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.86 84.69 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.87 -0.605 . . . . 1.17 111.3 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 69.1 mtm -67.97 -39.36 83.37 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.129 -0.487 . . . . 1.56 110.846 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.69 -25.56 63.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 1.42 111.371 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.0 mt -88.97 -46.84 8.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.127 -0.488 . . . . 1.54 110.997 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.43 41.92 2.11 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.113 -0.565 . . . . 0.78 111.862 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.83 26.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.977 0.418 . . . . 1.36 110.216 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.94 -53.61 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.519 -0.764 . . . . 1.71 111.708 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.04 -19.88 65.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.781 -0.645 . . . . 1.91 112.189 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -81.92 -22.26 36.88 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.949 0.351 . . . . 2.74 111.949 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.405 ' HA ' ' HG2' ' A' ' 91' ' ' PRO . 32.9 m -111.36 -6.74 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.231 0.826 . . . . 1.26 113.231 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -56.01 27.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.699 0.629 . . . . 1.46 112.699 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.9 t -60.29 -56.48 34.97 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 111.97 0.359 . . . . 1.26 111.97 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 9.4 Cg_endo -55.13 -37.79 93.91 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.465 2.11 . . . . 0.65 113.156 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.37 -42.22 65.5 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.962 -0.295 . . . . 1.34 110.443 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.88 -51.88 67.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.262 0.553 . . . . 0.58 110.802 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -70.86 -34.72 71.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.067 -0.515 . . . . 1.7 111.362 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.09 -23.02 72.85 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.866 -0.683 . . . . 0.82 113.068 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.92 -45.98 12.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.803 0.301 . . . . 1.23 111.703 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -89.23 -51.72 5.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.775 1.028 . . . . 0.84 113.775 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -74.39 -68.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.404 0.52 . . . . 1.96 112.404 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.464 ' HB ' ' OG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -72.4 -34.53 67.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.16 0.429 . . . . 1.86 112.16 -179.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 60.4 35.54 20.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.059 0.457 . . . . 1.73 110.744 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.464 ' OG1' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -83.75 -30.24 26.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.634 -0.712 . . . . 2.07 111.637 -179.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.461 HD13 HG22 ' A' ' 102' ' ' ILE . 70.5 mt -76.89 110.48 12.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.194 -0.457 . . . . 1.38 110.976 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -120.72 -11.44 9.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 3.77 109.874 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.0 m -150.93 171.48 17.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.006 -0.543 . . . . 1.78 110.339 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.12 -22.48 66.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.091 0.472 . . . . 1.54 111.013 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -42.78 92.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.693 -0.685 . . . . 1.62 111.207 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 111' ' ' VAL . 11.2 m-20 -65.43 -40.37 93.25 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.167 -0.47 . . . . 1.89 110.137 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 12.1 mt -62.52 -42.3 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.659 -0.7 . . . . 1.44 110.083 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -57.7 -41.93 82.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.301 -0.863 . . . . 2.74 110.908 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -66.79 -39.06 87.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 1.95 111.01 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 107' ' ' ASP . 89.1 t -59.83 -39.53 80.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.847 0.356 . . . . 1.42 110.526 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -65.87 -39.07 90.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.444 -0.344 . . . . 0.92 110.159 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 79.9 mt -65.59 -35.53 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.143 0.497 . . . . 1.85 109.686 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -65.66 -27.96 68.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.774 -0.648 . . . . 2.37 110.338 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.44 -13.04 58.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.599 -0.728 . . . . 1.42 111.116 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.38 6.86 17.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.555 -0.831 . . . . 1.15 113.408 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 43.1 mm -91.64 122.82 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.955 0.378 . . . . 2.16 110.054 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -65.03 136.06 56.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.477 -0.329 . . . . 3.2 110.792 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.4 -33.24 70.34 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 121.031 -0.604 . . . . 1.25 112.595 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -65.91 -42.8 89.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.285 0.564 . . . . 2.98 109.897 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.89 -41.83 86.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 2.52 109.711 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -60.0 -40.4 89.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.31 -0.859 . . . . 2.23 111.11 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.29 -40.31 95.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.385 -0.37 . . . . 2.3 110.918 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.4 89.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.61 111.115 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.44 -40.62 70.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.415 . . . . 1.48 110.654 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -58.39 -34.85 71.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.037 -0.529 . . . . 1.43 110.841 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -106.55 40.61 1.59 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.072 -0.513 . . . . 1.63 111.096 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 80.1 p -108.79 152.94 24.19 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.745 -0.382 . . . . 2.33 110.745 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -72.09 -32.84 67.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.416 . . . . 4.45 109.999 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 134' ' ' LEU . 60.3 t -58.9 -50.35 79.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.696 -0.684 . . . . 1.99 110.956 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.518 ' O ' HG21 ' A' ' 135' ' ' VAL . 24.8 t -60.22 -45.15 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 1.54 110.522 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -59.26 -38.72 80.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.254 -0.43 . . . . 2.84 110.481 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.04 -36.53 84.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.165 0.507 . . . . 1.75 109.961 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 130' ' ' VAL . 75.7 mt -72.34 -41.63 66.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.987 -0.551 . . . . 1.53 110.342 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.536 ' HA ' HE21 ' A' ' 138' ' ' GLN . 94.2 t -58.27 -47.17 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 1.31 111.084 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.71 83.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.106 -0.497 . . . . 1.52 111.093 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -70.08 -35.27 74.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 1.97 111.62 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.688 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 48.8 mt-30 -56.58 -54.56 44.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.144 -0.48 . . . . 0.69 111.085 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -71.58 -32.79 68.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.845 -0.616 . . . . 2.82 111.243 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 70.5 tttt -60.13 -48.27 82.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.323 -0.399 . . . . 2.37 110.805 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.03 99.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.16 -0.473 . . . . 1.2 110.986 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.51 -46.23 90.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 1.12 111.659 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.94 -6.45 57.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.306 0.484 . . . . 1.27 112.306 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -94.07 -27.88 16.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.057 0.456 . . . . 1.39 110.456 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.6 m -98.73 5.65 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.088 -0.505 . . . . 1.98 110.868 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 148' ' ' ARG . 62.7 mt-30 56.51 55.91 6.08 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.25 0.548 . . . . 2.43 109.974 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 44.3 tp -63.71 103.32 0.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.577 -0.738 . . . . 1.32 111.237 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 146' ' ' GLN . 51.1 mtt180 -100.51 40.84 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 4.87 110.199 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -174.13 -174.64 41.13 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.613 -0.995 . . . . 0.82 110.613 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.497 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.2 t -107.83 -58.46 0.05 OUTLIER Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 117.174 0.487 . . . . 1.16 111.562 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 18.4 Cg_endo -93.98 67.22 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.558 2.172 . . . . 0.73 112.313 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.07 143.29 45.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 1.07 110.759 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 45.4 ttm -113.82 138.41 50.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.106 -0.497 . . . . 1.09 110.68 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.49 125.29 44.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.638 -0.71 . . . . 0.66 109.659 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.5 t -88.57 112.87 24.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.552 -0.295 . . . . 1.18 111.347 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 58.37 17.3 4.67 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.842 0.714 . . . . 1.24 111.801 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.26 19.93 62.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.051 -0.595 . . . . 0.56 111.627 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -110.72 -38.07 5.25 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.874 0.369 . . . . 2.21 111.078 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -123.83 142.0 51.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.38 . . . . 1.61 111.254 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -107.59 142.95 36.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.749 -0.659 . . . . 1.14 109.614 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.7 mp -94.29 135.21 35.94 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.144 -0.317 . . . . 1.83 110.144 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -115.57 106.05 51.02 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.808 0.337 . . . . 0.85 110.974 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.43 -20.3 21.0 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.33 2.02 . . . . 0.71 112.266 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -77.0 5.98 7.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.034 -0.53 . . . . 2.48 110.996 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.4 22.07 4.46 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.192 -0.763 . . . . 0.6 111.192 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 66.0 mtt -109.19 -167.41 1.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.528 0.204 . . . . 1.13 110.777 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.04 130.7 41.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.291 0.567 . . . . 1.54 111.659 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.68 19.0 13.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.142 -0.935 . . . . 1.69 109.227 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.7 -46.07 8.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.408 -0.815 . . . . 1.53 110.368 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -146.49 130.65 17.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.118 -0.492 . . . . 1.42 110.252 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.474 ' O ' HG23 ' A' ' 175' ' ' VAL . 0.0 OUTLIER -60.56 -28.9 68.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 2.41 110.333 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.54 -31.28 70.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.49 0.662 . . . . 2.05 110.506 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 43.0 t -86.0 -43.52 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.806 -0.634 . . . . 1.24 109.677 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -52.11 -50.19 62.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.306 -0.861 . . . . 0.56 111.781 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 171' ' ' MET . 93.4 t -59.09 -50.21 80.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.249 -0.432 . . . . 1.15 111.564 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -63.29 -41.93 99.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.028 -0.533 . . . . 1.7 111.289 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -64.65 -43.84 92.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.552 -0.295 . . . . 1.91 110.774 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -57.44 -48.38 79.3 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.108 0.48 . . . . 0.92 110.262 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.6 -35.59 77.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.778 -0.647 . . . . 1.02 111.688 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.9 -36.39 80.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.502 -0.317 . . . . 1.55 110.688 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.5 m -59.14 -38.37 79.52 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.037 -0.528 . . . . 1.17 110.654 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.26 -53.08 53.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 1.14 110.196 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -58.11 -41.48 83.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.501 -0.772 . . . . 2.13 111.086 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.612 ' O ' ' HB2' ' A' ' 188' ' ' LYS . 66.3 t80 -61.37 -44.28 97.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 1.25 111.179 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.42 -36.82 60.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.056 0.762 . . . . 1.22 113.056 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.3 p -63.02 -32.04 73.31 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.069 0.461 . . . . 1.38 110.959 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -103.44 20.24 18.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.041 -0.527 . . . . 2.26 110.217 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 184' ' ' TYR . 43.1 tttm -112.23 59.06 0.63 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.194 -0.457 . . . . 2.23 111.02 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.577 ' NZ ' ' HB3' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.246 0 CA-C-N 116.055 -0.521 . . . . 4.66 110.27 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SFQ . . . . . 0.484 ' H12' ' O2 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.628 0.252 . . . . 4.48 110.466 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -90.79 125.82 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.62 0.248 . . . . 4.33 111.187 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -128.15 108.25 10.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.934 0.397 . . . . 1.37 109.976 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -94.35 145.93 24.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 2.29 110.854 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.16 128.86 36.99 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.978 -0.749 . . . . 1.83 108.978 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.07 1.26 72.96 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.542 -0.837 . . . . 0.78 111.075 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -118.04 -72.34 0.69 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.785 -0.45 . . . . 2.32 109.785 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -85.21 -39.09 18.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.054 0.454 . . . . 1.46 109.997 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -138.28 152.73 48.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.336 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.17 132.93 54.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.02 -0.536 . . . . 1.51 110.356 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 m -85.22 120.18 26.43 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.767 -0.457 . . . . 1.54 109.767 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 69.2 mt -74.2 146.69 43.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.147 -0.479 . . . . 1.36 110.957 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.8 -10.37 48.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.464 0.649 . . . . 2.33 109.293 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -118.63 83.55 22.25 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.314 -0.857 . . . . 4.04 109.51 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.62 121.68 8.4 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.125 1.883 . . . . 1.06 111.769 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.47 109.59 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.92 -0.582 . . . . 1.3 110.552 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.0 136.72 45.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.481 -0.781 . . . . 1.48 110.986 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.33 14.97 72.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.776 -0.726 . . . . 0.8 112.5 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 144.31 33.69 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.151 -0.315 . . . . 1.2 110.151 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.51 168.98 16.68 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.627 2.218 . . . . 0.63 112.018 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 22.1 mp0 -63.68 -53.0 58.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.043 -0.526 . . . . 1.79 111.013 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.59 103.3 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.862 0.363 . . . . 1.11 110.617 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.8 tp -108.39 127.99 54.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.044 -0.526 . . . . 1.16 110.564 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -128.71 142.95 50.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 1.61 110.135 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.64 152.2 37.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.367 -0.378 . . . . 0.61 110.062 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.98 174.14 9.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.298 0.57 . . . . 0.67 111.52 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.412 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 7.9 t -155.54 132.14 10.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.628 -0.715 . . . . 1.52 109.495 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.521 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 92.1 m-85 -67.36 -15.24 63.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.187 -0.461 . . . . 0.71 111.333 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.517 ' CE1' ' HA2' ' A' ' 69' ' ' GLY . 71.8 m-85 -86.31 -6.12 59.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 2.16 111.589 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 35.5 t -109.61 118.45 50.37 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.451 -0.34 . . . . 0.89 111.626 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.48 -25.63 76.0 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.406 2.07 . . . . 0.86 111.232 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.503 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 6.4 t-80 -61.84 -30.12 70.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.571 -0.74 . . . . 2.46 110.251 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.5 m -79.27 -41.06 28.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.5 110.334 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.51 -35.17 76.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.137 0.494 . . . . 2.22 110.008 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.687 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 26.6 tt0 -67.04 -33.42 75.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.428 -0.806 . . . . 2.82 110.4 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.402 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.6 m-85 -86.51 -22.44 26.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.398 . . . . 1.05 110.768 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 12.8 tp10 -84.18 -62.62 1.52 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.019 -0.537 . . . . 1.89 112.41 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -92.41 -33.98 14.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.309 0.855 . . . . 2.0 113.309 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.687 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 73.9 t -76.72 -58.24 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.286 -0.566 . . . . 1.18 111.631 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -89.95 -26.19 20.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.415 0.524 . . . . 1.13 112.415 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 22.6 m-70 56.19 49.9 14.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.178 0.513 . . . . 1.19 110.492 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.402 HG13 ' CD2' ' A' ' 36' ' ' PHE . 42.4 mm -59.89 -51.69 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.739 -0.664 . . . . 1.13 111.862 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -56.46 -40.05 74.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.658 -0.246 . . . . 1.37 111.643 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.46 -47.63 75.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.112 0.482 . . . . 1.73 110.307 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -59.61 -42.41 92.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.565 -0.743 . . . . 1.42 110.968 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.641 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 53.8 t -61.53 -47.79 91.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.877 -0.601 . . . . 1.14 110.757 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -58.46 -33.08 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 1.96 111.74 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -79.17 -15.76 57.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 2.52 111.577 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -101.94 -23.99 14.06 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.81 0.338 . . . . 1.93 111.045 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 57.8 mt -64.82 137.34 97.11 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 1.54 111.1 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.49 172.04 16.5 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.584 2.189 . . . . 0.97 111.792 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.65 136.76 53.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.852 -0.613 . . . . 2.63 111.579 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.49 -23.2 36.69 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.806 -0.712 . . . . 0.82 112.904 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.25 130.35 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.913 0.387 . . . . 1.65 111.05 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -112.25 130.31 55.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 2.85 110.287 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.0 ttt -92.37 139.07 30.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 1.76 110.123 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.08 129.22 52.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.679 0.276 . . . . 1.15 111.3 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -115.07 121.81 44.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.856 -0.794 . . . . 1.3 108.856 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.473 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 10.5 m-30 -117.53 159.5 22.76 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.142 0.496 . . . . 1.05 112.075 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 48.6 t-80 -105.32 140.01 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.744 -0.662 . . . . 0.78 109.901 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.7 m -104.0 152.31 6.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.539 -0.3 . . . . 1.37 111.553 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.602 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 72.4 m-20 -96.11 -2.83 45.73 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.955 0.724 . . . . 1.08 112.955 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -87.89 4.06 46.13 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.166 -0.614 . . . . 0.87 111.603 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.73 107.8 5.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.626 -0.509 . . . . 1.67 109.626 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.65 -8.03 3.35 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.603 -0.726 . . . . 0.78 111.297 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.4 -131.75 24.71 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.326 -0.464 . . . . 0.81 112.597 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -74.11 -45.67 47.59 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.863 0.32 . . . . 2.47 111.863 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -73.34 -17.75 61.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.372 -0.376 . . . . 2.46 111.229 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.517 ' HA2' ' CE1' ' A' ' 29' ' ' PHE . . . -58.33 -32.54 68.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.787 -0.72 . . . . 0.72 112.585 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 86.8 mttt -71.5 -31.25 66.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.729 0.299 . . . . 3.18 111.718 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.92 -42.48 85.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.847 0.356 . . . . 1.65 110.703 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.432 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 1.3 mt -66.35 -24.26 66.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.145 -0.48 . . . . 1.65 110.93 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -68.87 -34.13 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.267 0.556 . . . . 1.19 109.83 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -76.43 -40.09 51.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.561 -0.745 . . . . 1.35 109.155 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.75 91.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.61 -0.723 . . . . 1.31 111.198 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -60.44 -38.0 82.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.59 110.502 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.06 -38.88 90.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.899 -0.591 . . . . 1.33 110.197 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.82 -44.97 92.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.636 -0.711 . . . . 1.48 109.812 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.41 86.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.738 -0.665 . . . . 1.17 110.91 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.6 mtm -66.01 -44.08 85.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 1.56 111.042 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.3 -30.74 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.112 0.482 . . . . 1.42 111.221 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.7 mt -80.39 -41.99 23.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 1.54 110.843 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.22 11.22 34.47 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.573 -0.611 . . . . 0.78 111.573 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 m -105.78 27.4 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.792 0.329 . . . . 1.36 111.149 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -52.44 63.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 1.71 110.251 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.463 ' HA ' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -63.2 -34.42 77.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.503 0.668 . . . . 1.91 110.252 179.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -62.91 -33.88 76.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.298 -0.865 . . . . 2.74 111.454 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.6 m -106.35 10.4 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.433 0.531 . . . . 1.26 112.433 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 86' ' ' ASP . 59.6 m -64.1 -53.76 44.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.787 0.327 . . . . 1.46 111.637 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.456 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 58.4 t -63.79 -55.02 36.89 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.532 0.567 . . . . 1.26 112.532 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 11.3 Cg_endo -55.04 -37.24 93.98 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.302 2.001 . . . . 0.65 113.56 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.45 -32.54 68.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.681 0.277 . . . . 1.34 110.647 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.521 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -75.21 -53.34 8.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.273 0.558 . . . . 0.58 110.442 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.34 -39.9 94.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.81 -0.632 . . . . 1.7 110.961 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.97 -6.33 59.95 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.262 -0.494 . . . . 0.82 113.575 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.2 t -109.79 -40.3 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 117.489 0.644 . . . . 1.23 111.789 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.52 -48.43 5.01 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.035 0.754 . . . . 0.84 113.035 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -78.78 -70.34 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.772 0.286 . . . . 1.96 111.772 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -34.84 67.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.706 -0.224 . . . . 1.86 111.507 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 58.56 34.68 24.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.03 -0.532 . . . . 1.73 110.402 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -26.45 39.89 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.579 -0.737 . . . . 2.07 110.939 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.518 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 67.1 mt -87.17 100.35 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.114 -0.494 . . . . 1.38 110.411 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.518 ' HD2' ' O ' ' A' ' 102' ' ' ILE . 13.7 mmm180 -125.5 -12.22 6.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 3.77 110.334 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.6 p -139.88 168.28 20.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 1.78 110.498 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.7 -27.04 68.94 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.959 0.409 . . . . 1.54 110.984 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.5 m -62.85 -31.43 72.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 1.62 110.631 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 111' ' ' VAL . 33.4 m-20 -73.9 -44.52 54.94 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.661 -0.496 . . . . 1.89 109.661 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.5 mt -62.82 -41.9 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.808 -0.633 . . . . 1.44 110.124 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 ttm105 -60.72 -34.71 74.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.675 -0.693 . . . . 2.74 109.849 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.4 -41.56 69.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.626 -0.716 . . . . 1.95 111.44 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 107' ' ' ASP . 81.1 t -54.46 -45.43 70.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.747 0.308 . . . . 1.42 111.248 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -65.14 -41.48 94.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.92 111.072 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 80.4 mt -65.94 -41.55 90.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.994 0.426 . . . . 1.85 110.064 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -65.65 -30.35 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.71 -0.677 . . . . 2.37 110.354 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.97 -34.92 66.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 1.42 111.255 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 139.68 5.58 1.24 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.241 -0.98 . . . . 1.15 113.273 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 47.6 mm -94.06 123.57 46.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.671 -0.492 . . . . 2.16 109.671 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -61.25 137.55 58.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.594 -0.275 . . . . 3.2 110.498 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.63 -42.93 78.67 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.823 -0.626 . . . . 1.25 112.64 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.4 -45.48 92.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 2.98 110.68 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.49 -45.97 92.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.167 0.508 . . . . 2.52 110.067 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -62.79 -48.06 80.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.458 -0.792 . . . . 2.23 110.951 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.45 -36.13 81.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 2.3 111.047 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.16 86.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 1.61 109.782 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.07 -35.54 78.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.535 -0.757 . . . . 1.48 110.764 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -58.08 -36.32 72.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.104 0.478 . . . . 1.43 110.822 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -99.93 16.08 25.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.096 -0.502 . . . . 1.63 111.196 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.3 m -85.55 144.37 27.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 2.33 111.195 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.95 -36.9 85.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.839 -0.619 . . . . 4.45 110.864 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -56.19 -47.15 81.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 1.99 110.746 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.441 ' O ' HG21 ' A' ' 135' ' ' VAL . 17.6 t -63.83 -42.38 95.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 1.54 110.379 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -61.38 -33.75 74.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 2.84 110.549 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 63.8 m -71.86 -28.75 63.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.926 -0.579 . . . . 1.75 110.646 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.407 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 96.5 mt -74.57 -33.92 62.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.307 -0.406 . . . . 1.53 110.035 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 131' ' ' VAL . 50.5 t -61.43 -43.76 97.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.077 0.465 . . . . 1.31 110.11 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.48 95.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.585 -0.734 . . . . 1.52 111.19 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.43 -40.27 96.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.437 -0.347 . . . . 1.97 111.583 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.473 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 51.9 mt-30 -59.53 -52.54 65.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.69 111.152 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -71.69 -28.87 64.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.406 . . . . 2.82 111.768 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -63.89 -49.63 71.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.362 -0.381 . . . . 2.37 110.537 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.405 ' O ' HG21 ' A' ' 145' ' ' VAL . . . -62.17 -44.2 97.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.876 -0.602 . . . . 1.2 111.464 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.89 84.75 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.263 -0.426 . . . . 1.12 111.556 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.65 -41.24 63.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 1.27 110.813 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.48 -43.54 93.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.037 -0.528 . . . . 1.39 111.795 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 141' ' ' ALA . 32.2 m -79.84 -1.78 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 111.587 0.218 . . . . 1.98 111.587 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 53.98 59.91 3.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.326 0.584 . . . . 2.43 109.872 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.57 134.04 56.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.242 -0.89 . . . . 1.32 112.524 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.9 mmt-85 -106.61 -39.86 5.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.193 -0.912 . . . . 4.87 110.663 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -122.3 159.29 16.93 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.09 -0.804 . . . . 0.82 111.09 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.516 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.4 t -65.58 -57.62 13.96 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 112.26 0.467 . . . . 1.16 112.26 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.516 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.8 Cg_endo -85.5 89.47 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.526 2.15 . . . . 0.73 112.068 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -129.87 154.2 47.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.181 -0.463 . . . . 1.07 110.611 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.444 ' SD ' HG21 ' A' ' 182' ' ' VAL . 30.9 ttm -127.35 133.06 50.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.208 -0.451 . . . . 1.09 110.817 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.15 133.99 53.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.66 110.186 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 44.9 t -102.4 114.81 42.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.263 -0.426 . . . . 1.18 111.218 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 59.46 14.03 3.59 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.088 -0.96 . . . . 1.24 111.987 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 69.52 20.57 75.61 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.937 -0.649 . . . . 0.56 112.125 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -120.78 -45.81 2.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 2.21 111.235 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -106.39 129.84 54.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.972 -0.558 . . . . 1.61 111.14 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -106.86 138.55 42.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.636 -0.711 . . . . 1.14 109.652 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mp -90.96 132.54 35.9 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.619 -0.432 . . . . 1.83 110.3 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -111.53 97.63 37.32 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.283 -0.417 . . . . 0.85 110.403 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.92 -18.87 46.75 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.365 2.043 . . . . 0.71 111.818 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -78.23 -8.25 58.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 2.48 110.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -115.65 14.68 17.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.009 -0.615 . . . . 0.6 112.292 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 55.5 mtt -102.55 -178.81 3.79 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.151 -0.314 . . . . 1.13 110.151 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.2 119.56 15.5 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.363 0.601 . . . . 1.54 111.2 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.91 22.34 15.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.405 -0.816 . . . . 1.69 109.453 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.34 -51.4 5.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.326 -0.852 . . . . 1.53 110.035 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -118.47 121.66 40.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.984 -0.553 . . . . 1.42 110.185 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 46.2 mmm -59.32 -38.2 79.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 2.41 111.879 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.16 -27.94 68.4 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.117 0.484 . . . . 2.05 110.704 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 55.4 t -77.83 -46.06 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.571 -0.74 . . . . 1.24 109.634 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.58 -50.73 69.31 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.073 -0.512 . . . . 0.56 111.414 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.21 -44.93 77.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.212 -0.449 . . . . 1.15 111.242 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 21.9 mm-40 -71.59 -46.24 59.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.187 -0.46 . . . . 1.7 111.294 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.08 -45.95 82.9 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.215 0.322 . . . . 1.91 111.204 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.431 ' O ' HG22 ' A' ' 182' ' ' VAL . 19.0 t80 -59.4 -56.12 26.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.643 -0.253 . . . . 0.92 110.88 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.83 87.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.43 . . . . 1.02 112.087 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.3 OUTLIER -69.08 -33.87 74.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.687 -0.233 . . . . 1.55 111.056 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 86.4 m -64.78 -39.36 93.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.581 -0.526 . . . . 1.17 109.581 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.444 HG21 ' SD ' ' A' ' 153' ' ' MET . 11.7 t -60.41 -46.7 94.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.106 -0.497 . . . . 1.14 109.748 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -61.09 -41.62 97.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.826 -0.625 . . . . 2.13 110.477 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.65 -41.67 95.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 1.25 111.088 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.68 -38.08 34.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.292 -0.413 . . . . 1.22 112.056 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 51.0 m -63.18 -30.31 71.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 1.38 111.006 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -106.32 26.53 9.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.278 0.561 . . . . 2.26 110.182 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -106.9 -60.2 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.387 -0.824 . . . . 2.23 110.057 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.391 -0.814 . . . . 4.66 110.056 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SFQ . . . . . 0.503 ' C13' ' HE2' ' A' ' 32' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.985 -0.376 . . . . 4.48 109.985 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.86 140.79 29.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.758 -0.46 . . . . 4.33 109.758 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -135.22 121.98 20.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.008 0.432 . . . . 1.37 110.76 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -111.05 147.53 34.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.82 -0.627 . . . . 2.29 110.627 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.22 117.43 17.04 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.046 -0.525 . . . . 1.83 109.621 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' HA2' HG21 ' A' ' 10' ' ' THR . . . 111.59 -5.8 27.98 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.135 -0.786 . . . . 0.78 111.135 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -112.46 -80.89 0.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.515 0.198 . . . . 2.32 110.637 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -85.79 -27.71 24.99 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.912 0.387 . . . . 1.46 110.638 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -141.36 159.75 41.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.405 HG21 ' HA2' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -137.99 130.57 29.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.469 -0.332 . . . . 1.51 111.27 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -77.13 125.26 29.04 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.525 -0.546 . . . . 1.54 109.525 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.9 mt -71.0 147.01 49.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.938 0.399 . . . . 1.36 111.156 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.67 -38.91 53.7 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.005 -0.739 . . . . 2.33 109.005 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -117.21 104.34 50.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.115 -0.948 . . . . 4.04 109.343 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.39 143.25 34.61 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.227 1.952 . . . . 1.06 112.111 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.61 91.88 3.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 1.3 110.075 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.86 123.6 20.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.841 -0.618 . . . . 1.48 110.003 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.02 -5.92 42.79 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.839 -0.696 . . . . 0.8 111.922 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.31 155.28 93.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.571 0.224 . . . . 1.2 111.091 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -76.31 -177.09 3.44 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.662 2.241 . . . . 0.63 112.057 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.407 ' OE1' HG22 ' A' ' 54' ' ' VAL . 40.3 mt-30 -69.87 -52.4 25.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 1.79 110.994 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.0 t -123.26 105.1 15.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.25 0.547 . . . . 1.11 110.747 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 tp -105.54 119.6 39.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.982 -0.554 . . . . 1.16 109.738 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.482 ' OE1' ' HG3' ' A' ' 58' ' ' LYS . 17.6 tt0 -122.72 147.42 46.5 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.806 0.336 . . . . 1.61 110.297 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -122.29 151.87 40.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.131 -0.486 . . . . 0.61 110.655 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -167.64 169.61 11.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.67 110.855 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.434 ' HB2' HG21 ' A' ' 61' ' ' VAL . 3.4 t -152.47 135.72 15.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.273 -0.421 . . . . 1.52 110.371 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.44 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 90.6 m-85 -71.43 -15.59 62.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.099 -0.501 . . . . 0.71 110.232 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -90.55 0.51 57.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.977 -0.556 . . . . 2.16 110.679 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 51.1 t -109.45 114.93 56.82 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 116.017 -0.538 . . . . 0.89 110.603 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.493 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 19.7 Cg_endo -60.9 -26.75 83.67 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.588 2.192 . . . . 0.86 111.864 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.63 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 0.1 OUTLIER -68.72 -32.5 72.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.042 -0.526 . . . . 2.46 110.842 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.2 m -72.28 -33.38 67.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.25 -0.648 . . . . 0.5 109.25 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -66.13 -40.67 90.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.866 -0.79 . . . . 2.22 108.866 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.701 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 6.7 mt-30 -70.69 -37.55 73.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.588 -0.733 . . . . 2.82 110.791 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.96 -18.23 62.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.919 0.34 . . . . 1.05 111.919 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.74 -65.78 1.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.292 -0.563 . . . . 1.89 112.096 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.55 -27.71 66.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.15 0.5 . . . . 2.0 111.612 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.701 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 96.1 t -100.2 -59.53 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.715 -0.394 . . . . 1.18 111.992 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -85.03 -33.75 22.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.894 0.701 . . . . 1.13 112.894 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 61.63 46.34 7.3 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.098 0.475 . . . . 1.19 110.489 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 mm -58.72 -49.27 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.388 -0.823 . . . . 1.13 111.07 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.461 ' HA ' ' HE3' ' A' ' 56' ' ' MET . 1.9 m -63.75 -45.94 87.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 1.37 111.323 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.27 -33.55 76.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.115 -0.493 . . . . 1.73 111.756 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -75.41 -41.93 54.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.411 -0.359 . . . . 1.42 110.804 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 22.5 t -60.04 -41.01 84.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.91 -0.586 . . . . 1.14 110.602 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -54.82 -38.31 67.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 1.96 112.206 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -78.7 -10.91 59.93 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.588 0.588 . . . . 2.52 112.588 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.5 mtmm -120.13 19.94 12.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.896 0.379 . . . . 1.93 110.918 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 14.1 mt -89.77 136.23 29.6 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.021 -0.536 . . . . 1.54 110.508 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.47 153.73 69.09 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.542 2.161 . . . . 0.97 111.848 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.13 123.45 20.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.169 -0.468 . . . . 2.63 110.774 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.33 -11.78 43.62 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.775 -0.648 . . . . 0.82 111.546 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.407 HG22 ' OE1' ' A' ' 21' ' ' GLN . 83.4 t -88.52 115.89 29.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.025 0.441 . . . . 1.65 110.368 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -92.11 140.33 29.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.893 -0.594 . . . . 2.85 110.603 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.461 ' HE3' ' HA ' ' A' ' 43' ' ' SER . 11.5 ttt -100.73 119.14 38.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.097 -0.502 . . . . 1.76 110.215 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.91 99.98 9.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.173 -0.467 . . . . 1.15 111.236 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HG3' ' OE1' ' A' ' 24' ' ' GLU . 44.5 tttp -89.68 108.97 19.99 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.77 -0.826 . . . . 1.3 108.77 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.428 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 9.0 m-30 -106.72 153.02 23.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.417 0.627 . . . . 1.05 111.932 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -98.16 132.12 43.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.681 -0.69 . . . . 0.78 110.344 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.434 HG21 ' HB2' ' A' ' 27' ' ' SER . 5.3 m -80.75 156.73 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.793 -0.185 . . . . 1.37 110.574 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.512 ' ND2' ' HG2' ' A' ' 139' ' ' GLU . 13.0 m-20 -115.72 24.57 11.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.148 0.425 . . . . 1.08 112.148 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -117.89 8.03 12.51 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.229 -0.588 . . . . 0.87 111.282 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.9 mtp -141.45 107.69 5.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.856 -0.424 . . . . 1.67 109.856 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.18 -10.76 3.04 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.751 -0.659 . . . . 0.78 112.023 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.46 -142.57 29.27 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.763 -0.732 . . . . 0.81 112.363 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.58 -34.98 76.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.298 0.571 . . . . 2.47 110.816 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -75.71 -11.79 60.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 2.46 110.349 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.59 -46.39 93.85 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.044 -0.598 . . . . 0.72 112.496 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -67.97 -27.07 66.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.609 0.242 . . . . 3.18 111.46 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -43.81 93.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 1.65 110.753 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -24.47 64.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.793 -0.64 . . . . 1.65 111.185 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 m -66.01 -35.45 80.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.163 0.506 . . . . 1.19 110.472 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -76.06 -37.8 57.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 1.35 109.484 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.67 97.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.638 -0.71 . . . . 1.31 110.386 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -64.63 -36.65 84.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.444 -0.798 . . . . 0.59 110.579 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.72 88.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 1.33 109.991 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 58.6 t -66.54 -44.88 89.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.728 -0.669 . . . . 1.48 109.727 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.01 86.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.666 -0.697 . . . . 1.17 110.989 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.7 ttm -64.22 -44.22 92.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.868 -0.606 . . . . 1.56 110.756 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.18 83.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.589 . . . . 1.42 111.516 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 78.8 mt -77.21 -38.56 51.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.576 -0.284 . . . . 1.54 111.411 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.16 38.27 3.61 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.705 -0.76 . . . . 0.78 112.42 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.9 m -132.59 30.8 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.79 0.328 . . . . 1.36 110.482 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -53.66 -64.94 0.66 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.727 -0.669 . . . . 1.71 112.568 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -31.73 70.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 1.91 111.155 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -62.13 -38.79 90.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.955 -0.566 . . . . 2.74 111.866 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -98.91 -9.3 8.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.413 0.523 . . . . 1.26 112.413 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -58.16 -45.44 87.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.658 0.266 . . . . 1.46 111.643 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.45 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 77.0 t -64.63 -60.81 7.54 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.185 0.439 . . . . 1.26 112.185 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.45 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 11.9 Cg_endo -56.14 -33.26 89.8 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.983 1.789 . . . . 0.65 113.068 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.41 -46.27 67.24 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.836 -0.346 . . . . 1.34 110.356 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 m-85 -61.49 -48.22 82.09 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.318 0.58 . . . . 0.58 110.54 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.429 ' CD ' ' HZ3' ' A' ' 98' ' ' LYS . 12.2 mm-40 -62.84 -43.92 97.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.381 -0.827 . . . . 1.7 111.663 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.26 -16.46 77.1 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.097 -0.573 . . . . 0.82 113.802 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 55.0 t -100.01 -41.23 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.33 0.565 . . . . 1.23 112.424 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 31' ' ' PRO . 79.3 mt-30 -99.56 -42.34 6.96 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.009 1.114 . . . . 0.84 114.009 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.429 ' HZ3' ' CD ' ' A' ' 94' ' ' GLU . 34.9 ttmt -81.6 -68.05 0.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.585 -0.446 . . . . 1.96 111.784 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -34.59 62.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.094 -0.242 . . . . 1.86 110.851 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.537 ' HB3' ' NH2' ' A' ' 103' ' ' ARG . 78.9 mt-30 57.85 37.67 27.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.906 -0.588 . . . . 1.73 110.636 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.29 -20.72 27.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.127 -0.942 . . . . 2.07 110.896 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 83.2 mt -80.94 106.42 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.752 -0.658 . . . . 1.38 110.511 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.537 ' NH2' ' HB3' ' A' ' 100' ' ' GLN . 37.5 mmt180 -123.37 -20.14 5.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.587 -0.733 . . . . 3.77 110.76 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -133.29 172.85 12.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.828 0.346 . . . . 1.78 110.444 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.46 -26.39 67.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.023 0.44 . . . . 1.54 110.627 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -33.08 73.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.668 -0.696 . . . . 1.62 110.673 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -71.74 -39.25 70.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.962 -0.563 . . . . 1.89 109.735 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.1 mt -64.78 -41.58 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.875 -0.602 . . . . 1.44 109.744 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -58.77 -42.7 89.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.085 -0.961 . . . . 2.74 110.963 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -60.02 -40.96 91.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 1.95 111.149 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.3 t -56.6 -43.51 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 1.42 111.021 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -66.57 -37.65 85.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.92 110.513 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 88.1 mt -65.32 -41.93 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.074 0.464 . . . . 1.85 109.854 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -64.61 -26.6 68.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.547 -0.752 . . . . 2.37 110.723 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.97 -32.14 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 1.42 110.768 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.83 7.74 3.66 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.783 -0.722 . . . . 1.15 112.914 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.3 mm -87.94 137.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.097 -0.334 . . . . 2.16 110.097 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -70.26 133.73 47.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.05 -0.523 . . . . 3.2 110.099 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.92 -44.53 96.03 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.953 -0.641 . . . . 1.25 112.56 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.98 -37.82 88.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.323 . . . . 2.98 110.987 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.22 -42.22 84.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.263 0.554 . . . . 2.52 109.612 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -63.06 -46.86 85.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.492 -0.776 . . . . 2.23 110.382 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -64.31 -29.4 70.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.215 0.531 . . . . 2.3 110.635 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.14 62.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.906 -0.588 . . . . 1.61 110.372 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.34 -34.36 78.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 1.48 110.868 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -58.74 -26.7 64.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.846 -0.615 . . . . 1.43 110.513 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -102.05 26.11 7.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.89 -0.595 . . . . 1.63 111.635 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.9 t -101.55 143.43 31.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.906 0.384 . . . . 2.33 111.162 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -65.83 -28.36 68.93 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.57 -0.741 . . . . 4.45 110.874 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.11 -45.58 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.242 0.544 . . . . 1.99 109.547 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.563 ' O ' HG22 ' A' ' 135' ' ' VAL . 88.9 t -64.58 -44.09 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.396 -0.82 . . . . 1.54 110.038 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -55.61 -44.44 77.03 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.993 0.425 . . . . 2.84 110.682 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 52.3 m -66.06 -39.18 89.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.589 . . . . 1.75 110.74 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.7 mt -64.2 -37.99 89.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.376 -0.375 . . . . 1.53 110.791 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 131' ' ' VAL . 54.8 t -65.4 -44.7 94.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 1.31 109.949 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.16 78.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 1.52 110.901 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -62.05 -45.46 93.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 1.97 110.903 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.432 HE21 ' HA ' ' A' ' 135' ' ' VAL . 44.9 mt-30 -63.44 -41.05 98.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.69 110.897 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HG2' ' ND2' ' A' ' 62' ' ' ASN . 43.8 mt-10 -69.01 -40.29 78.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.072 -0.513 . . . . 2.82 111.325 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -72.05 -49.74 34.19 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.347 0.499 . . . . 2.37 112.347 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.82 -40.69 76.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.204 0.446 . . . . 1.2 112.204 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.5 -31.11 72.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.825 0.345 . . . . 1.12 111.675 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.13 -29.33 20.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.423 -0.353 . . . . 1.27 111.228 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -61.63 -50.61 71.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.995 0.426 . . . . 1.39 111.368 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.31 -8.8 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.945 -0.57 . . . . 1.98 111.547 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 64.18 74.93 0.39 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.384 0.612 . . . . 2.43 109.611 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.5 tp -80.23 123.96 28.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.679 -0.691 . . . . 1.32 111.888 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.26 -48.13 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.184 -0.673 . . . . 4.87 109.184 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.81 132.02 11.07 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.822 -0.911 . . . . 0.82 110.822 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.481 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 3.4 t -67.03 -52.44 31.09 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 112.584 0.587 . . . . 1.16 112.584 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 3.3 Cg_exo -79.55 76.79 4.36 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.11 1.874 . . . . 0.73 112.638 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.27 152.14 51.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 1.07 110.955 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 48.2 ttm -131.63 136.22 47.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.071 -0.513 . . . . 1.09 110.095 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -117.48 134.28 55.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.32 -0.4 . . . . 0.66 110.005 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 66.3 t -103.42 118.15 49.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.883 0.373 . . . . 1.18 110.565 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 64.67 5.35 2.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.491 -0.777 . . . . 1.24 111.658 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.2 15.41 74.62 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.032 -0.604 . . . . 0.56 112.158 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -119.92 -31.19 4.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.798 0.332 . . . . 2.21 111.227 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -118.41 139.12 51.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 1.61 110.549 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -117.09 138.67 51.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.916 -0.584 . . . . 1.14 110.319 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.9 mp -83.57 137.35 33.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.704 -0.48 . . . . 1.83 109.704 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -116.17 98.76 51.89 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.408 -0.36 . . . . 0.85 111.308 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.38 -14.13 33.8 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.374 2.049 . . . . 0.71 111.669 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -75.64 -6.73 51.84 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.159 -0.473 . . . . 2.48 110.975 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -128.87 19.2 5.55 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.773 -0.531 . . . . 0.6 111.773 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.3 mtt -99.02 -168.78 1.67 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.802 -0.199 . . . . 1.13 110.488 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.76 114.69 10.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.09 0.471 . . . . 1.54 110.533 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.86 33.37 5.25 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.728 0.775 . . . . 1.69 109.504 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.72 -47.81 2.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.119 -0.946 . . . . 1.53 111.018 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -114.45 118.8 34.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.788 0.328 . . . . 1.42 110.345 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.447 ' O ' HG23 ' A' ' 175' ' ' VAL . 12.6 mmt -59.76 -41.78 91.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 2.41 110.903 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.25 -33.11 75.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 2.05 111.643 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 77.0 t -79.18 -39.57 21.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.738 -0.21 . . . . 1.24 110.482 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -55.82 -50.14 71.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.596 -0.275 . . . . 0.56 111.159 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 171' ' ' MET . 46.6 t -58.39 -48.24 85.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 1.15 111.341 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -66.48 -39.55 88.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.891 -0.595 . . . . 1.7 111.423 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.61 -44.7 89.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.482 -0.326 . . . . 1.91 110.634 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.463 ' O ' HG22 ' A' ' 182' ' ' VAL . 2.5 t80 -54.9 -50.97 67.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.92 110.189 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.409 ' HA ' HG21 ' A' ' 46' ' ' VAL . . . -66.93 -38.19 85.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 1.02 112.041 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.19 -39.3 92.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.37 -0.377 . . . . 1.55 111.137 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 13.1 m -62.41 -36.96 83.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 1.17 110.116 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 178' ' ' TYR . 49.3 t -63.27 -48.76 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.047 0 CA-C-N 116.237 -0.438 . . . . 1.14 110.03 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -62.17 -40.17 95.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 2.13 110.743 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -64.39 -44.47 91.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.479 -0.328 . . . . 1.25 110.766 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.02 -32.34 71.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.475 -0.329 . . . . 1.22 111.274 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.2 m -75.54 -26.22 57.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 1.38 110.851 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -98.69 14.76 27.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 2.26 110.572 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -89.67 99.69 12.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.613 -0.721 . . . . 2.23 109.802 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.357 -0.83 . . . . 4.66 110.463 -179.107 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SFQ . . . . . 0.63 ' C13' ' HE2' ' A' ' 32' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 110.061 -0.348 . . . . 4.48 110.061 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -96.39 128.28 43.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.094 -0.336 . . . . 4.33 110.094 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -134.98 131.61 37.37 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.25 -0.278 . . . . 1.37 110.25 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.0 142.96 49.75 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.334 -0.394 . . . . 2.29 110.87 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.32 123.59 24.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 1.83 110.366 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.97 -7.74 44.95 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.931 -0.577 . . . . 0.78 111.745 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.452 ' HB3' ' OE1' ' A' ' 8' ' ' GLN . 1.2 tttm -118.21 -75.85 0.58 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.612 0.244 . . . . 2.32 110.74 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.452 ' OE1' ' HB3' ' A' ' 7' ' ' LYS . 22.7 mp0 -76.6 -42.45 42.42 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.433 0.635 . . . . 1.46 110.175 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -134.16 163.99 28.36 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.394 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.4 115.91 12.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.716 0.294 . . . . 1.51 110.805 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.6 m -73.9 121.23 20.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.036 -0.529 . . . . 1.54 109.833 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.69 142.42 51.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.111 0.482 . . . . 1.36 111.667 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -74.17 -33.7 63.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.666 -0.697 . . . . 2.33 109.464 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -120.35 97.06 49.1 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.267 -0.879 . . . . 4.04 109.47 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.29 169.23 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.529 2.153 . . . . 1.06 112.554 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.69 117.12 49.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 1.3 110.464 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.43 131.9 35.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.821 0.343 . . . . 1.48 110.312 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.59 22.84 41.74 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.735 -0.745 . . . . 0.8 111.523 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.61 150.45 38.05 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.773 -0.214 . . . . 1.2 110.469 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.56 171.9 5.1 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.045 2.497 . . . . 0.63 113.077 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -71.0 -68.55 0.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.853 -0.612 . . . . 1.79 110.63 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.5 t -107.01 102.17 13.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.678 -0.49 . . . . 1.11 109.678 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 59' ' ' TYR . 18.5 tp -105.35 119.62 39.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.858 -0.61 . . . . 1.16 110.535 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -119.53 147.82 44.01 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.948 -0.39 . . . . 1.61 109.948 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.09 145.04 47.27 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.797 -0.446 . . . . 0.61 109.797 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -164.25 175.67 9.88 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.175 0.512 . . . . 0.67 110.799 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.412 ' HB2' HG23 ' A' ' 61' ' ' VAL . 3.3 t -156.53 137.82 13.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.547 -0.751 . . . . 1.52 109.998 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.554 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 71.1 m-85 -71.35 -14.69 62.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 0.71 110.572 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 71.7 m-85 -88.27 -5.92 58.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.871 -0.604 . . . . 2.16 110.45 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 13.2 t -104.73 113.4 64.96 Favored Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-O 120.961 0.41 . . . . 0.89 111.363 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 22.5 Cg_endo -64.69 -22.22 64.45 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.258 1.972 . . . . 0.86 110.429 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.62 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 7.9 t-80 -67.25 -30.66 70.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.062 -0.972 . . . . 2.46 109.948 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.437 ' SG ' HG13 ' A' ' 150' ' ' VAL . 75.2 m -79.94 -38.94 31.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.411 -0.588 . . . . 0.5 109.411 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.76 -38.64 85.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 2.22 109.778 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.44 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 3.1 tp60 -60.38 -44.17 95.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.384 -0.825 . . . . 2.82 109.909 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.451 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.5 m-85 -74.39 -24.69 59.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.553 -0.748 . . . . 1.05 111.524 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -86.16 -49.89 7.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.543 0.571 . . . . 1.89 112.543 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -94.98 -38.69 10.55 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.569 0.951 . . . . 2.0 113.569 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 46.0 t -80.25 -53.43 12.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.023 -0.671 . . . . 1.18 111.882 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.7 mt -90.24 -29.18 18.35 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.768 -0.373 . . . . 1.13 111.986 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 56.69 48.67 15.88 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.477 0.656 . . . . 1.19 109.889 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.451 HG13 ' CD2' ' A' ' 36' ' ' PHE . 39.0 mm -59.89 -47.57 91.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.353 -0.84 . . . . 1.13 111.3 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.05 -48.31 64.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.326 0.391 . . . . 1.37 111.712 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.46 -47.05 87.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.906 -0.588 . . . . 1.73 110.375 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -60.67 -40.92 93.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 1.42 110.956 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.597 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 69.3 t -65.73 -48.88 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 1.14 110.616 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -56.4 -33.71 66.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.043 0.449 . . . . 1.96 111.594 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -81.41 -10.01 59.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 2.52 111.987 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -111.94 2.35 16.9 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.804 -0.358 . . . . 1.93 111.597 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 59.3 mt -79.62 131.99 62.95 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.333 -0.394 . . . . 1.54 110.331 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.01 164.51 35.34 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.645 2.23 . . . . 0.97 112.157 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -61.48 108.42 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.212 0.53 . . . . 2.63 111.759 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.74 -24.08 5.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.986 -0.625 . . . . 0.82 112.109 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.06 130.7 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.928 0.394 . . . . 1.65 110.757 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 56' ' ' MET . 11.9 ttmm -119.61 147.15 44.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.895 -0.593 . . . . 2.85 110.561 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.41 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 8.9 ttt -87.54 130.45 34.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.123 -0.49 . . . . 1.76 110.564 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.27 106.97 12.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.002 -0.544 . . . . 1.15 110.934 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -90.83 127.42 36.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.525 -0.307 . . . . 1.3 110.41 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CD2' ' HA ' ' A' ' 138' ' ' GLN . 5.2 m-30 -117.36 143.72 45.68 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.891 -0.411 . . . . 1.05 109.891 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -93.63 132.11 38.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.723 0.297 . . . . 0.78 110.988 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 27' ' ' SER . 5.6 m -76.18 150.18 6.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.992 -0.373 . . . . 1.37 109.992 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -103.87 -10.95 17.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.602 0.593 . . . . 1.08 112.602 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -89.46 20.02 4.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.037 0.384 . . . . 0.87 112.037 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.6 mtp -140.64 133.25 28.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.625 0.25 . . . . 1.67 110.425 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.43 3.5 56.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.779 -0.724 . . . . 0.78 112.07 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.09 -129.47 34.94 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.704 -0.76 . . . . 0.81 112.348 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.84 -35.28 57.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.773 0.321 . . . . 2.47 110.785 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.47 -22.0 65.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.961 -0.563 . . . . 2.46 110.527 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.54 89.19 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.703 -0.76 . . . . 0.72 111.362 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -69.98 -37.69 75.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.033 0.444 . . . . 3.18 110.549 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -62.82 -41.86 99.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.784 -0.643 . . . . 1.65 110.675 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.405 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 3.8 mt -70.69 -24.58 62.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.353 -0.385 . . . . 1.65 111.188 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.7 m -66.89 -36.95 83.44 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.135 0.493 . . . . 1.19 109.892 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -76.18 -40.97 51.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 1.35 109.988 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.57 95.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.97 -0.559 . . . . 1.31 111.014 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -61.47 -37.52 83.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 0.59 110.902 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.97 -35.73 77.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.175 -0.466 . . . . 1.33 110.404 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.69 -44.36 82.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.81 -0.632 . . . . 1.48 110.124 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.66 84.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.686 -0.688 . . . . 1.17 111.668 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 44.9 mtm -67.43 -41.35 84.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.331 -0.395 . . . . 1.56 111.005 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.73 -32.94 73.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 1.42 111.124 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.18 -5.14 59.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.418 -0.355 . . . . 1.54 110.751 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.71 40.63 98.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.064 -0.589 . . . . 0.78 112.432 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.3 m -131.9 30.71 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.87 0.367 . . . . 1.36 110.756 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -53.85 52.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.801 -0.636 . . . . 1.71 110.792 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -30.81 70.12 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.235 0.54 . . . . 1.91 111.044 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -73.9 -24.5 59.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.894 -0.594 . . . . 2.74 112.205 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.429 ' HA ' ' HG2' ' A' ' 91' ' ' PRO . 27.6 m -108.73 -8.25 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 112.238 0.459 . . . . 1.26 112.238 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.4 m -55.88 -65.32 0.62 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.852 0.686 . . . . 1.46 112.852 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.475 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.7 t -60.39 -53.53 63.85 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 113.003 0.742 . . . . 1.26 113.003 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 9.8 Cg_endo -53.42 -38.61 82.99 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.16 1.907 . . . . 0.65 113.346 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.3 mt -69.8 -41.08 75.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.037 -0.357 . . . . 1.34 110.037 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.554 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 2.9 m-85 -60.29 -51.93 67.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.276 0.56 . . . . 0.58 110.269 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.3 -37.79 88.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.553 -0.749 . . . . 1.7 110.441 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.12 -8.17 68.94 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.107 -0.568 . . . . 0.82 113.687 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.6 t -112.21 -39.64 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.307 0.554 . . . . 1.23 112.205 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -98.71 -48.0 5.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.605 0.594 . . . . 0.84 112.605 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -74.53 -73.52 0.23 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.122 -0.49 . . . . 1.96 111.35 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -37.91 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.811 -0.631 . . . . 1.86 111.776 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 62.81 27.97 16.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 1.73 110.815 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -28.93 66.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.86 -0.609 . . . . 2.07 111.006 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.22 105.27 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.317 0.58 . . . . 1.38 110.809 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -121.95 -13.45 8.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 3.77 110.705 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 p -140.45 167.6 21.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 1.78 110.146 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.06 -27.4 68.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.44 . . . . 1.54 110.105 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -31.85 72.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.384 -0.825 . . . . 1.62 110.559 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 111' ' ' VAL . 64.8 m-20 -71.72 -40.68 69.28 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.11 -0.496 . . . . 1.89 110.194 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 14.8 mt -60.68 -43.19 94.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.757 -0.656 . . . . 1.44 110.089 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -58.78 -36.22 74.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.425 -0.807 . . . . 2.74 110.439 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -68.81 -44.84 72.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.769 -0.651 . . . . 1.95 110.626 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 107' ' ' ASP . 43.8 t -59.22 -40.14 80.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 1.42 110.853 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -62.68 -42.38 99.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 0.92 110.397 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 87.0 mt -62.13 -37.25 77.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.193 0.52 . . . . 1.85 110.245 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.67 -14.31 62.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 2.37 111.152 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.35 -3.02 58.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.201 0.524 . . . . 1.42 110.482 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.92 16.04 26.98 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.802 -0.713 . . . . 1.15 111.942 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 44.8 mm -93.8 129.27 44.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 110.07 -0.344 . . . . 2.16 110.07 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -64.03 131.77 48.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.352 -0.385 . . . . 3.2 110.351 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.44 99.89 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.905 -0.664 . . . . 1.25 111.874 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -64.75 -37.13 86.57 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.657 -0.497 . . . . 2.98 109.657 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.51 -47.02 68.07 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.564 -0.744 . . . . 2.52 109.659 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -60.25 -40.44 90.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.759 -0.655 . . . . 2.23 110.924 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -61.31 -35.41 77.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.991 0.424 . . . . 2.3 111.17 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.33 -45.14 33.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 1.61 110.591 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.11 73.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.872 -0.604 . . . . 1.48 110.915 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -57.13 -33.32 67.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.012 -0.54 . . . . 1.43 110.908 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -111.62 21.67 15.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.274 -0.421 . . . . 1.63 111.256 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -76.91 142.25 40.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.127 -0.488 . . . . 2.33 110.908 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.26 -35.73 78.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.878 -0.601 . . . . 4.45 110.527 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.1 t -63.14 -46.33 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 1.99 109.996 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 135' ' ' VAL . 55.2 t -63.66 -45.66 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.539 -0.755 . . . . 1.54 110.381 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -59.73 -40.46 88.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 2.84 110.533 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.3 m -66.5 -30.74 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 1.75 110.675 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.2 mt -72.27 -38.12 68.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.337 . . . . 1.53 110.479 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 131' ' ' VAL . 57.4 t -59.36 -46.27 92.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.144 -0.48 . . . . 1.31 110.686 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.23 83.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.908 -0.587 . . . . 1.52 111.546 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -65.67 -39.09 90.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 1.97 111.265 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.519 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 50.9 mt-30 -60.97 -46.57 90.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.69 111.079 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -68.08 -44.18 76.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.229 -0.441 . . . . 2.82 111.09 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -60.34 -45.64 92.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.57 . . . . 2.37 111.473 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.437 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -58.69 -51.27 70.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.538 . . . . 1.2 111.427 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.38 86.4 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.935 0.346 . . . . 1.12 111.935 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.28 60.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.252 -0.431 . . . . 1.27 111.908 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.28 -43.17 98.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.02 0.748 . . . . 1.39 113.02 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 141' ' ' ALA . 19.1 m -79.67 1.22 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.358 0.503 . . . . 1.98 112.358 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.42 55.43 5.75 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.576 -0.527 . . . . 2.43 109.576 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.1 tp -61.25 114.63 3.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.587 -0.733 . . . . 1.32 111.302 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.7 mmm-85 -104.48 -38.94 6.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.357 -0.838 . . . . 4.87 109.898 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -104.88 142.54 15.5 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.095 -0.802 . . . . 0.82 111.095 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.532 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 16.5 t -69.96 -55.89 8.04 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 119.262 -0.399 . . . . 1.16 111.624 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.532 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 81.6 Cg_endo -83.46 62.11 7.23 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.942 1.761 . . . . 0.73 112.436 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.27 148.2 39.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.314 -0.403 . . . . 1.07 111.117 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 51.6 ttm -122.16 135.78 54.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 1.09 110.565 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -118.63 121.88 41.23 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.747 -0.66 . . . . 0.66 109.626 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.5 t -93.95 120.72 43.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.266 -0.424 . . . . 1.18 110.77 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 61.56 13.65 5.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.212 -0.904 . . . . 1.24 111.604 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.08 24.91 70.63 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.613 -0.595 . . . . 0.56 111.613 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -130.62 -43.07 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.912 0.387 . . . . 2.21 111.448 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -106.05 120.47 41.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.462 -0.336 . . . . 1.61 111.388 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -103.08 132.68 49.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.515 -0.55 . . . . 1.14 109.515 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.46 143.22 33.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.942 0.401 . . . . 1.83 110.628 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -119.52 95.56 49.31 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.992 -0.549 . . . . 0.85 110.145 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.79 -25.46 53.32 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.226 1.951 . . . . 0.71 112.622 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -71.99 -13.78 61.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 2.48 110.754 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.3 0.37 50.45 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.812 -0.708 . . . . 0.6 112.404 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.1 mtt -97.6 -172.25 2.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.636 0.255 . . . . 1.13 110.449 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.32 120.49 15.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 1.54 110.476 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.25 15.75 18.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.137 0.494 . . . . 1.69 110.733 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.51 -40.45 6.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 1.53 110.719 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -121.74 116.76 25.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.753 0.311 . . . . 1.42 110.858 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -55.06 -41.54 71.59 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.769 -0.65 . . . . 2.41 111.907 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -43.19 63.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.185 0.517 . . . . 2.05 111.43 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 33.1 t -74.26 -45.39 47.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.672 -0.694 . . . . 1.24 111.176 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -55.52 -50.56 69.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.329 -0.396 . . . . 0.56 111.443 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.19 -49.2 80.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 1.15 111.512 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 33.2 mm-40 -68.86 -44.76 72.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.485 -0.325 . . . . 1.7 111.608 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 2.4 mt-30 -56.83 -46.93 81.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.525 0.202 . . . . 1.91 111.367 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 182' ' ' VAL . 10.3 t80 -59.15 -54.15 50.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.808 0.337 . . . . 0.92 111.032 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.83 -37.46 87.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 1.02 112.206 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -67.44 -37.56 83.17 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.837 0.351 . . . . 1.55 110.637 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 94.8 m -62.26 -36.67 82.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 1.17 109.826 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 178' ' ' TYR . 92.8 t -58.93 -49.37 83.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.003 -0.544 . . . . 1.14 110.481 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 37.6 tttm -58.83 -43.18 90.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 2.13 110.975 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -61.96 -43.95 97.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 1.25 111.671 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.01 -34.7 64.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.051 0.389 . . . . 1.22 112.051 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.6 m -69.28 -29.67 67.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.11 0.481 . . . . 1.38 110.495 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -97.43 6.18 48.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.73 -0.668 . . . . 2.26 110.715 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -86.62 70.8 10.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.006 -0.543 . . . . 2.23 110.071 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.6 pttm . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.557 -0.735 . . . . 4.66 109.617 179.466 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SFQ . . . . . 0.62 ' C13' ' HE2' ' A' ' 32' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.363 -0.236 . . . . 4.48 110.363 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -83.89 134.28 34.69 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.955 -0.387 . . . . 4.33 109.955 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -134.5 133.2 40.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.129 0.49 . . . . 1.37 111.185 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.08 139.64 53.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.459 -0.791 . . . . 2.29 110.015 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.42 121.35 15.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.044 0.45 . . . . 1.83 110.408 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.04 -18.93 28.19 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.744 -0.662 . . . . 0.78 111.758 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -100.97 -79.4 0.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.773 0.32 . . . . 2.32 110.872 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -83.77 -27.16 29.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.671 0.272 . . . . 1.46 111.341 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -145.72 153.5 41.03 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.11 130.48 49.92 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.394 -0.366 . . . . 1.51 110.841 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -81.81 120.41 25.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.884 -0.413 . . . . 1.54 109.884 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.0 mt -67.71 136.02 53.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.085 -0.507 . . . . 1.36 111.291 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.43 -26.92 52.0 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.259 -0.645 . . . . 2.33 109.259 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -120.92 88.61 44.75 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.399 -0.819 . . . . 4.04 109.544 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.6 162.47 32.97 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.769 2.313 . . . . 1.06 113.034 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.9 t -103.72 113.61 41.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.755 -0.657 . . . . 1.3 110.41 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.45 138.37 47.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.137 -0.483 . . . . 1.48 111.433 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.3 86.58 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.08 -0.581 . . . . 0.8 112.886 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.64 151.56 84.9 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.535 0.168 . . . . 1.2 110.666 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.11 173.67 10.05 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.288 1.992 . . . . 0.63 112.297 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.63 -46.29 72.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.091 -0.504 . . . . 1.79 110.784 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -127.56 105.0 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.812 0.339 . . . . 1.11 110.383 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.6 tp -108.25 121.03 44.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.928 -0.578 . . . . 1.16 109.726 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -123.92 145.51 49.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.447 -0.342 . . . . 1.61 110.506 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -121.15 147.27 45.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.079 -0.509 . . . . 0.61 109.981 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -167.68 178.95 5.05 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.056 -0.52 . . . . 0.67 111.024 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.41 ' HB2' HG22 ' A' ' 61' ' ' VAL . 7.8 t -158.94 138.36 11.57 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.01 -0.541 . . . . 1.52 110.001 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.558 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.3 m-85 -69.35 -18.84 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.11 0.481 . . . . 0.71 109.97 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.474 ' CE2' HD13 ' A' ' 72' ' ' LEU . 78.9 m-85 -83.65 -6.9 59.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.48 -0.782 . . . . 2.16 110.866 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.9 t -97.95 117.19 65.39 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 116.504 -0.316 . . . . 0.89 110.808 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.566 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 18.3 Cg_endo -62.05 -23.07 75.33 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.268 1.979 . . . . 0.86 112.019 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.564 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 0.4 OUTLIER -73.97 -34.8 64.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.037 -0.529 . . . . 2.46 110.652 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.1 m -71.39 -33.34 69.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.068 0.461 . . . . 0.5 110.259 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -63.26 -45.54 91.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.547 0.689 . . . . 2.22 109.298 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.599 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 8.8 tm0? -71.28 -37.67 71.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.948 -1.024 . . . . 2.82 111.182 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.3 -22.93 66.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.232 0.456 . . . . 1.05 112.232 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -108.71 -51.36 2.9 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.927 -0.709 . . . . 1.89 112.378 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -68.12 -27.69 66.67 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.879 -0.513 . . . . 2.0 111.65 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 78.7 t -102.86 -64.87 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.663 -0.244 . . . . 1.18 111.073 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.65 -38.49 67.66 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.702 0.26 . . . . 1.13 111.702 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 64.02 50.56 2.47 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.468 0.48 . . . . 1.19 110.455 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.417 ' O ' HG23 ' A' ' 46' ' ' VAL . 34.2 mm -61.47 -52.56 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.84 -0.618 . . . . 1.13 111.551 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.597 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 21.5 m -58.16 -52.18 66.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.488 0.185 . . . . 1.37 111.033 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 29.9 t70 -58.93 -39.33 81.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.582 -0.281 . . . . 1.73 111.687 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -71.54 -42.8 67.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.697 0.285 . . . . 1.42 110.632 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 37.5 t -59.49 -41.13 83.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 1.14 110.683 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 43' ' ' SER . 75.5 mttt -55.2 -36.7 66.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.896 0.379 . . . . 1.96 110.871 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 36.1 mttm -80.76 -13.23 59.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.12 -0.491 . . . . 2.52 112.218 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -109.88 8.23 24.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.579 0.228 . . . . 1.93 111.54 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 41.7 mt -96.09 136.7 21.94 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.889 -0.324 . . . . 1.54 111.643 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 50' ' ' LEU . 16.6 Cg_exo -67.54 177.47 3.97 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.537 2.158 . . . . 0.97 111.646 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -75.01 149.01 39.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.913 0.387 . . . . 2.63 110.631 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.14 -18.5 40.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.019 -0.61 . . . . 0.82 112.298 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 t -84.09 132.14 32.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.827 0.346 . . . . 1.65 110.613 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -117.45 136.77 52.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.402 -0.363 . . . . 2.85 110.805 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.1 mtp -82.79 113.68 20.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.534 . . . . 1.76 110.088 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.1 94.01 5.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.072 0.463 . . . . 1.15 110.747 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -89.91 116.82 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 1.3 109.937 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.469 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 4.8 m-30 -111.89 150.87 29.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.112 0.482 . . . . 1.05 111.304 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -100.3 128.06 46.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.922 -0.581 . . . . 0.78 110.604 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 27' ' ' SER . 8.1 m -80.38 152.71 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.507 -0.315 . . . . 1.37 110.54 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -103.62 -0.5 29.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.787 0.662 . . . . 1.08 112.787 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -96.3 16.93 17.01 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.699 -0.4 . . . . 0.87 110.984 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.53 107.47 5.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.355 -0.384 . . . . 1.67 110.47 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.56 18.68 1.58 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.886 -0.673 . . . . 0.78 112.941 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.53 -112.25 4.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.269 -0.491 . . . . 0.81 113.024 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.52 -31.03 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.608 0.242 . . . . 2.47 111.167 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.21 -17.37 63.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.831 0.348 . . . . 2.46 110.639 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.81 -33.48 78.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.988 -0.625 . . . . 0.72 111.664 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -66.65 -33.07 74.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.906 0.384 . . . . 3.18 110.506 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -74.09 -41.18 62.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 1.65 110.533 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.474 HD13 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -64.24 -27.98 69.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.32 -0.4 . . . . 1.65 111.045 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.3 m -65.18 -36.03 82.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.065 0.46 . . . . 1.19 110.263 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.437 ' O ' HG23 ' A' ' 78' ' ' VAL . 15.1 tt0 -75.81 -37.93 58.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.132 -0.692 . . . . 1.35 109.132 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.42 -44.85 95.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.55 -0.75 . . . . 1.31 110.444 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.538 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 69.6 t-105 -61.11 -36.03 78.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.333 -0.849 . . . . 0.59 110.764 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.59 -37.76 88.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 1.33 110.268 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 74' ' ' GLN . 57.0 t -65.68 -42.94 93.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 1.48 109.849 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.71 92.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.578 -0.737 . . . . 1.17 110.742 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 28.5 mtm -63.73 -39.14 93.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 1.56 111.196 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.07 -39.37 79.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.161 -0.472 . . . . 1.42 111.29 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.39 -29.35 47.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.242 -0.436 . . . . 1.54 111.36 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.74 10.41 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.692 -0.766 . . . . 0.78 111.964 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.98 26.08 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 110.548 -0.167 . . . . 1.36 110.548 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 3.5 mp0 -55.56 -61.99 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 1.71 111.249 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -37.87 67.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.002 -0.545 . . . . 1.91 111.98 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm -64.0 -33.4 75.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 2.74 112.084 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.2 m -101.17 -8.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.848 0.314 . . . . 1.26 111.848 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.9 m -58.19 -49.04 78.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.919 0.34 . . . . 1.46 111.919 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.46 -58.35 15.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 112.336 0.495 . . . . 1.26 112.336 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.46 -36.45 98.74 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.866 1.71 . . . . 0.65 113.221 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.84 -42.99 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.702 0.286 . . . . 1.34 110.279 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -62.69 -46.83 86.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.129 0.49 . . . . 0.58 110.722 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.06 -42.54 96.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.699 -0.682 . . . . 1.7 111.321 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.36 -14.13 68.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.955 -0.64 . . . . 0.82 113.527 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.1 -32.23 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 117.076 0.438 . . . . 1.23 112.025 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.566 ' OE1' ' HA ' ' A' ' 31' ' ' PRO . 53.2 mt-30 -113.89 -42.77 3.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.783 1.031 . . . . 0.84 113.783 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -69.25 -61.96 1.58 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.773 0.32 . . . . 1.96 111.246 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.8 p -92.84 -30.17 15.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.315 -0.402 . . . . 1.86 110.743 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 61.28 33.31 19.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.627 -0.715 . . . . 1.73 110.121 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.7 -31.75 41.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.295 -0.866 . . . . 2.07 111.239 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.9 mt -70.75 106.09 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 1.38 110.421 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -129.15 -11.72 4.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.391 -0.822 . . . . 3.77 110.494 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.3 m -134.4 165.91 24.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.949 -0.569 . . . . 1.78 110.293 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.17 64.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.1 0.476 . . . . 1.54 110.738 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -36.73 84.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.784 -0.644 . . . . 1.62 110.602 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 111' ' ' VAL . 15.9 m-20 -63.8 -46.28 85.89 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.307 -0.627 . . . . 1.89 109.307 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.0 mt -59.47 -39.73 79.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.541 -0.754 . . . . 1.44 110.482 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -62.19 -43.36 99.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.81 -0.632 . . . . 2.74 110.689 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -65.28 -33.86 76.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.286 -0.416 . . . . 1.95 110.639 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 107' ' ' ASP . 92.6 t -62.2 -43.99 98.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.963 -0.562 . . . . 1.42 110.279 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -63.92 -39.03 93.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.92 110.56 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 80.0 mt -64.65 -30.81 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.433 0.635 . . . . 1.85 109.897 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -77.1 -14.91 59.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.547 -0.752 . . . . 2.37 110.821 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.82 1.07 57.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.029 -0.532 . . . . 1.42 111.054 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.82 4.12 45.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 1.15 112.881 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 49.1 mm -91.05 148.09 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.096 -0.335 . . . . 2.16 110.096 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -88.76 150.65 22.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.385 -0.37 . . . . 3.2 110.859 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.58 -56.31 22.23 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.998 -0.546 . . . . 1.25 113.183 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.82 -32.66 70.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.967 0.413 . . . . 2.98 110.93 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.2 -42.6 96.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 2.52 109.779 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -69.38 -44.25 71.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.465 -0.788 . . . . 2.23 110.234 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -60.27 -39.94 88.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.146 -0.479 . . . . 2.3 110.877 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.62 -48.44 79.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.915 -0.584 . . . . 1.61 111.578 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.43 -33.43 72.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 1.48 111.673 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -56.7 -31.42 64.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 1.43 111.065 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -105.83 29.01 7.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.015 -0.538 . . . . 1.63 111.223 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.8 t -93.22 145.79 24.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.722 0.296 . . . . 2.33 110.626 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -61.65 -37.67 84.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 4.45 110.835 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.29 -42.05 86.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.217 0.532 . . . . 1.99 110.314 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 135' ' ' VAL . 44.8 t -67.3 -45.8 85.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.404 -0.816 . . . . 1.54 110.483 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -58.86 -38.23 78.3 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.264 -0.425 . . . . 2.84 110.875 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -43.24 71.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.073 -0.512 . . . . 1.75 110.425 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 34.6 mt -62.82 -38.16 89.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.438 . . . . 1.53 110.9 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 131' ' ' VAL . 61.7 t -60.12 -52.33 62.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.275 -0.421 . . . . 1.31 110.317 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.3 -37.25 74.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 1.52 111.367 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -65.07 -39.76 93.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.479 . . . . 1.97 111.293 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.469 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 53.0 mt-30 -60.53 -45.91 92.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.69 111.372 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -33.73 58.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.627 0.251 . . . . 2.82 111.149 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -65.69 -51.43 59.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.652 -0.249 . . . . 2.37 111.326 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.92 90.38 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.311 0.382 . . . . 1.2 111.468 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.26 86.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.399 -0.364 . . . . 1.12 111.404 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.08 -26.61 26.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.352 -0.385 . . . . 1.27 111.59 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -36.59 76.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.165 0.507 . . . . 1.39 110.637 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.68 -4.4 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.12 -0.491 . . . . 1.98 110.062 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.559 ' O ' ' HD3' ' A' ' 148' ' ' ARG . 88.8 mt-30 57.72 74.28 0.43 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.54 -0.755 . . . . 2.43 110.137 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tp -59.76 124.19 19.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.557 -0.747 . . . . 1.32 111.437 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.559 ' HD3' ' O ' ' A' ' 146' ' ' GLN . 1.6 mpp_? -103.45 18.65 21.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.182 0.515 . . . . 4.87 110.603 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -179.63 172.46 44.24 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.896 -0.882 . . . . 0.82 110.896 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.526 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.9 t -84.86 -56.79 0.39 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 117.324 0.562 . . . . 1.16 111.307 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.8 Cg_endo -82.2 88.92 1.24 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.149 1.9 . . . . 0.73 111.352 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.98 146.01 50.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.052 -0.522 . . . . 1.07 111.069 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.422 ' SD ' HG22 ' A' ' 182' ' ' VAL . 53.0 ttm -133.26 131.64 40.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.986 -0.375 . . . . 1.09 109.986 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -122.37 137.56 54.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.093 -0.503 . . . . 0.66 110.365 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.1 t -107.68 122.56 62.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.277 -0.42 . . . . 1.18 110.905 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 61.98 10.87 3.85 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.231 -0.895 . . . . 1.24 112.188 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 68.95 19.56 73.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.251 -0.499 . . . . 0.56 112.301 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -129.1 -41.11 1.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.392 . . . . 2.21 111.195 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -96.71 123.79 40.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.143 -0.48 . . . . 1.61 111.568 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -108.07 123.99 49.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.712 -0.676 . . . . 1.14 109.251 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.78 143.61 39.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.682 0.277 . . . . 1.83 111.118 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -119.43 96.75 50.01 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.173 0.511 . . . . 0.85 110.205 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.8 -19.29 41.15 Favored 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.443 2.095 . . . . 0.71 112.713 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -72.38 -22.23 61.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 2.48 111.284 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.27 21.04 34.06 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.646 -0.787 . . . . 0.6 112.056 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.0 mtt -106.29 -164.46 1.01 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.415 -0.217 . . . . 1.13 110.415 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.02 132.63 46.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 1.54 111.111 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.9 20.76 6.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.832 -0.622 . . . . 1.69 109.691 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.99 -41.84 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 1.53 110.914 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -126.8 126.42 43.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.119 -0.491 . . . . 1.42 110.169 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.485 ' O ' HG23 ' A' ' 175' ' ' VAL . 14.3 mmt -61.01 -44.32 97.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.948 -0.569 . . . . 2.41 110.573 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.588 ' O ' ' HG2' ' A' ' 176' ' ' GLN . 31.6 t70 -58.72 -45.36 89.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.75 -0.659 . . . . 2.05 111.199 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.85 -43.82 99.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.403 . . . . 1.24 110.718 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -57.32 -45.97 83.7 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.242 -0.435 . . . . 0.56 110.68 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 171' ' ' MET . 90.6 t -58.9 -47.42 89.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 1.15 110.93 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 172' ' ' ASP . 54.7 mm-40 -65.08 -48.71 72.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 1.7 110.776 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -58.6 -45.74 88.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 1.91 111.646 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -60.44 -50.41 73.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.92 111.002 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.98 87.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.882 0.372 . . . . 1.02 111.111 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.63 -37.85 88.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 1.55 110.006 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 58.3 m -59.98 -40.49 89.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.028 -0.533 . . . . 1.17 110.224 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.422 HG22 ' SD ' ' A' ' 153' ' ' MET . 41.9 t -60.67 -51.43 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 CA-C-N 115.828 -0.623 . . . . 1.14 110.165 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -60.31 -44.59 95.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.954 -0.566 . . . . 2.13 110.536 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -57.77 -44.63 86.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.5 -0.773 . . . . 1.25 111.041 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.14 -29.37 63.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.321 -0.4 . . . . 1.22 111.438 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 40.4 m -71.49 -34.55 70.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.409 -0.36 . . . . 1.38 110.819 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -96.17 6.08 49.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.229 -0.442 . . . . 2.26 110.798 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -79.61 111.25 15.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.02 0.438 . . . . 2.23 110.633 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp . . . . . 0 C--O 1.251 1.146 0 CA-C-N 115.742 -0.663 . . . . 4.66 110.113 179.685 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SFQ . . . . . 0.564 ' C13' ' HE2' ' A' ' 32' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.983 0.421 . . . . 4.48 110.353 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.35 -43.41 2.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 4.33 110.975 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -130.55 102.72 6.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.24 -0.436 . . . . 1.37 110.711 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -119.43 148.36 43.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.345 -0.389 . . . . 2.29 110.94 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.97 130.2 41.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.935 -0.575 . . . . 1.83 109.693 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.15 -20.59 40.09 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.748 -0.941 . . . . 0.78 110.748 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.537 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 36.4 tptt -105.78 -77.3 0.59 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.755 -0.222 . . . . 2.32 110.809 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -80.04 -35.24 37.49 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.832 0.349 . . . . 1.46 111.477 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -140.76 156.08 46.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.733 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.82 129.73 46.01 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.119 -0.492 . . . . 1.51 110.048 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 m -77.84 121.04 23.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.017 0.437 . . . . 1.54 110.963 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.1 mt -68.57 127.31 32.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.751 -0.659 . . . . 1.36 110.829 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.13 -27.68 68.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.154 0.502 . . . . 2.33 110.746 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -120.86 96.7 48.62 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.983 -0.747 . . . . 4.04 108.983 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.1 153.25 36.52 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 122.555 2.17 . . . . 1.06 112.584 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -90.93 122.5 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.674 -0.694 . . . . 1.3 109.739 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.7 127.2 31.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.786 -0.643 . . . . 1.48 111.084 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.33 31.92 49.66 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.686 -0.768 . . . . 0.8 112.142 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.61 145.54 32.47 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.396 -0.224 . . . . 1.2 110.396 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.3 164.77 26.93 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.446 2.097 . . . . 0.63 112.432 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -58.34 -56.54 20.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.281 -0.872 . . . . 1.79 111.243 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.4 t -120.33 105.56 17.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.989 0.423 . . . . 1.11 110.185 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.5 tp -105.95 129.73 54.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.08 -0.509 . . . . 1.16 110.15 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HG2' ' N ' ' A' ' 25' ' ' PHE . 4.0 tt0 -127.58 149.44 50.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.455 -0.339 . . . . 1.61 110.456 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.496 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 61.3 m-85 -127.4 146.08 50.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.987 -0.551 . . . . 0.61 110.195 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -163.11 175.87 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.105 0.478 . . . . 0.67 110.906 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.44 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 8.6 t -156.13 141.59 17.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.923 -0.58 . . . . 1.52 109.967 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.401 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 88.0 m-85 -74.57 -8.58 56.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.959 -0.564 . . . . 0.71 110.751 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -101.37 8.12 42.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.224 -0.444 . . . . 2.16 111.002 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 20.8 t -111.65 119.63 44.36 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.62 -0.264 . . . . 0.89 111.202 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 22.0 Cg_endo -65.67 -21.99 58.2 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.402 2.068 . . . . 0.86 111.439 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.684 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 0.3 OUTLIER -64.14 -48.25 76.76 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.895 -0.593 . . . . 2.46 110.019 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 38.7 m -66.88 -31.82 72.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.984 -0.553 . . . . 0.5 110.394 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -60.07 -44.47 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.479 -0.563 . . . . 2.22 109.479 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 31' ' ' PRO . 34.8 mm-40 -73.38 -41.29 63.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.731 -0.668 . . . . 2.82 110.65 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.4 m-85 -63.76 -35.44 80.61 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.026 -0.534 . . . . 1.05 112.428 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . 5.2 mm-40 -93.3 -50.16 5.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.065 0.765 . . . . 1.89 113.065 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -77.36 -35.81 54.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.127 0.788 . . . . 2.0 113.127 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 53.9 t -94.61 -57.77 4.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.586 -0.446 . . . . 1.18 112.148 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.469 HD11 ' O2 ' ' A' ' 201' ' ' SFQ . 70.7 mt -82.27 -26.57 33.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.061 0.763 . . . . 1.13 113.061 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 60.95 44.91 10.01 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.982 -0.377 . . . . 1.19 109.982 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.476 HG13 ' CD2' ' A' ' 36' ' ' PHE . 33.9 mm -57.11 -66.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.505 0.557 . . . . 1.13 112.505 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.419 ' HG ' ' CD ' ' A' ' 24' ' ' GLU . 16.0 m -62.01 -34.18 75.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 1.37 110.78 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.92 -45.6 93.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.814 -0.63 . . . . 1.73 110.143 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -69.45 -37.5 77.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 1.42 110.214 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 54.4 t -60.96 -42.31 92.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 1.14 110.433 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -63.22 -12.72 30.66 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.189 -0.459 . . . . 1.96 110.948 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -113.78 6.21 16.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.127 0.489 . . . . 2.52 111.192 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -116.29 -27.83 6.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.103 -0.499 . . . . 1.93 110.535 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 81.6 mt -66.24 145.1 98.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 1.54 111.224 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -78.0 170.85 18.16 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.36 2.04 . . . . 0.97 111.643 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.81 137.67 54.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 2.63 111.145 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.92 -21.79 43.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.093 -0.575 . . . . 0.82 112.038 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 t -92.83 108.09 19.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.865 0.364 . . . . 1.65 110.098 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -89.93 156.52 18.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 2.85 110.933 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 17.1 ttt -109.06 143.86 37.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.781 -0.645 . . . . 1.76 109.707 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.52 108.08 9.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 1.15 110.826 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.409 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 14.6 ttmm -94.17 116.85 29.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.725 -0.67 . . . . 1.3 110.154 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.523 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 10.0 m-30 -114.46 161.4 18.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.157 0.503 . . . . 1.05 111.688 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.44 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 43.2 t-80 -105.79 142.19 35.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.61 . . . . 0.78 111.002 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -97.62 149.58 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.794 0.33 . . . . 1.37 110.89 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -93.52 -16.47 24.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.837 0.68 . . . . 1.08 112.837 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -83.21 10.24 8.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.696 0.628 . . . . 0.87 112.696 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.1 96.17 3.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.973 0.416 . . . . 1.67 111.044 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.87 0.17 6.09 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.936 -0.649 . . . . 0.78 112.467 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.06 -129.34 43.52 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.283 -0.484 . . . . 0.81 112.647 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.62 -38.15 65.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.7 -0.482 . . . . 2.47 109.7 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.55 -26.94 68.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.573 -0.739 . . . . 2.46 109.897 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.84 -43.51 96.03 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.515 -0.766 . . . . 0.72 111.823 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -63.84 -35.55 81.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.207 -0.294 . . . . 3.18 110.207 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -43.22 99.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.394 0.616 . . . . 1.65 109.857 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.34 -34.38 78.0 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 115.549 -0.75 . . . . 1.65 110.689 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.6 m -62.11 -36.48 81.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.37 . . . . 1.19 111.101 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -76.43 -45.02 33.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.623 -0.262 . . . . 1.35 110.39 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.19 88.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.046 0.45 . . . . 1.31 110.677 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.496 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 66.5 t-105 -61.26 -37.69 84.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.543 -0.753 . . . . 0.59 110.961 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.5 -34.01 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 1.33 110.3 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.2 t -66.14 -41.66 89.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.945 -0.57 . . . . 1.48 109.62 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.52 81.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.479 -0.782 . . . . 1.17 111.08 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 29.4 mtm -68.41 -38.68 81.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.979 -0.555 . . . . 1.56 111.095 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.68 -31.41 70.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.191 -0.458 . . . . 1.42 111.877 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.72 -13.7 28.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.543 -0.299 . . . . 1.54 111.531 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.44 39.7 49.92 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.488 -0.863 . . . . 0.78 111.791 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.87 22.58 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.012 -0.366 . . . . 1.36 110.012 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.496 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -56.23 -59.92 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.662 -0.699 . . . . 1.71 111.406 -178.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.52 -19.15 64.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.531 . . . . 1.91 111.514 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -78.05 -39.78 40.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.334 -0.393 . . . . 2.74 111.442 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.5 m -94.72 -10.4 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.381 0.511 . . . . 1.26 112.381 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.1 m -59.26 -49.39 78.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.738 0.304 . . . . 1.46 111.558 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.413 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 47.1 t -62.46 -58.8 15.17 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 112.099 0.407 . . . . 1.26 112.099 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.413 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 15.6 Cg_endo -57.24 -33.39 95.94 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.059 1.839 . . . . 0.65 113.018 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.02 -46.97 48.98 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.974 -0.29 . . . . 1.34 110.701 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.401 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -58.59 -52.38 65.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.156 0.503 . . . . 0.58 110.779 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.52 -42.42 95.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.644 -0.707 . . . . 1.7 111.182 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.37 -14.22 71.54 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.217 -0.516 . . . . 0.82 114.232 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.21 -42.51 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.539 0.669 . . . . 1.23 112.276 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -99.6 -38.45 8.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.861 0.689 . . . . 0.84 112.861 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -78.7 -64.64 1.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.511 -0.476 . . . . 1.96 110.542 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -34.21 40.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.124 -0.489 . . . . 1.86 111.615 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 60.97 31.85 19.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.144 0.497 . . . . 1.73 110.819 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.35 -35.37 19.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.794 -0.639 . . . . 2.07 111.211 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 30.2 mt -79.33 96.97 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.838 -0.619 . . . . 1.38 110.971 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -135.25 22.16 3.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.026 0.441 . . . . 3.77 111.082 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.414 ' O ' HG13 ' A' ' 108' ' ' ILE . 83.6 p -159.49 160.38 34.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.035 -0.53 . . . . 1.78 109.717 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.39 -28.99 70.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.126 0.489 . . . . 1.54 110.392 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -61.21 -34.28 74.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.428 -0.806 . . . . 1.62 110.435 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 111' ' ' VAL . 56.9 m-20 -76.2 -47.59 23.51 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.898 -0.592 . . . . 1.89 109.589 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 104' ' ' SER . 27.5 mt -55.3 -46.41 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.67 -0.695 . . . . 1.44 111.156 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.493 ' O ' HG13 ' A' ' 113' ' ' ILE . 62.7 ttt-85 -59.13 -45.43 90.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.2 -0.455 . . . . 2.74 110.679 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.75 -42.04 99.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.304 -0.407 . . . . 1.95 110.904 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 107' ' ' ASP . 90.6 t -60.55 -44.79 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.222 -0.444 . . . . 1.42 110.595 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -62.5 -44.9 95.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.093 -0.503 . . . . 0.92 110.727 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 73.3 mt -63.68 -38.82 83.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 1.85 110.525 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -67.8 -31.67 71.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.47 . . . . 2.37 110.759 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.38 -8.1 53.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.313 -0.403 . . . . 1.42 111.591 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.37 0.74 26.46 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.475 -0.869 . . . . 1.15 112.98 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 3.3 mp -85.93 121.7 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.867 -0.42 . . . . 2.16 109.867 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -60.91 136.69 58.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.824 -0.625 . . . . 3.2 111.107 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.57 -41.92 98.97 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.609 -0.597 . . . . 1.25 111.609 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -65.74 -23.17 66.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 2.98 110.685 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -82.75 -45.33 14.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.97 -0.559 . . . . 2.52 109.515 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -63.55 -44.25 94.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.506 -0.77 . . . . 2.23 110.483 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.34 -43.16 96.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.978 0.418 . . . . 2.3 110.827 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.29 -47.6 83.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 1.61 110.624 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.05 -41.21 95.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 1.48 111.109 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -59.94 -30.02 68.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.43 111.504 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -96.15 -26.12 15.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.148 0.425 . . . . 1.63 112.148 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 m -65.22 149.42 49.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.321 0.581 . . . . 2.33 112.507 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -73.01 -21.14 60.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.513 -0.767 . . . . 4.45 111.723 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.87 -50.1 70.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.26 0.552 . . . . 1.99 110.101 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.543 ' O ' HG22 ' A' ' 135' ' ' VAL . 36.0 t -66.5 -41.69 88.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.419 -0.81 . . . . 1.54 110.414 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -56.87 -41.31 77.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.088 -0.505 . . . . 2.84 111.075 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.5 m -63.37 -39.41 94.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.983 -0.553 . . . . 1.75 110.202 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.44 -37.71 83.39 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.331 -0.395 . . . . 1.53 110.479 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.582 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 41.5 t -61.46 -51.68 70.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.023 -0.362 . . . . 1.31 110.023 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.56 69.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.772 -0.649 . . . . 1.52 111.048 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -66.31 -42.45 88.24 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.009 -0.541 . . . . 1.97 110.271 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.523 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 51.8 mt-30 -62.59 -48.15 80.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.833 -0.621 . . . . 0.69 109.919 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 29.0 mt-10 -62.37 -44.47 96.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.341 -0.845 . . . . 2.82 111.194 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -60.91 -46.99 88.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.849 -0.614 . . . . 2.37 111.514 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.55 -44.12 84.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.912 0.338 . . . . 1.2 111.912 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.38 -30.52 64.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.224 0.453 . . . . 1.12 112.224 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.4 -27.18 25.96 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.565 0.579 . . . . 1.27 112.565 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.17 -47.71 23.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.629 0.252 . . . . 1.39 110.565 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.5 p -80.76 -8.31 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.814 0.34 . . . . 1.98 110.764 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 58.21 58.53 3.45 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.735 -0.666 . . . . 2.43 110.435 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 149' ' ' GLY . 40.9 tp -67.13 111.74 4.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.461 -0.79 . . . . 1.32 110.803 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -87.31 -33.71 19.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.611 -0.722 . . . . 4.87 110.556 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . -93.9 173.61 33.56 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.989 -0.845 . . . . 0.82 110.989 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.549 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 4.6 t -102.89 -57.56 0.1 OUTLIER Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 117.865 0.832 . . . . 1.16 112.761 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 4.1 Cg_endo -85.27 70.16 5.27 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.231 1.954 . . . . 0.73 111.928 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.22 139.31 50.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.905 -0.589 . . . . 1.07 110.766 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 21.6 ttm -113.38 139.02 49.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.042 -0.526 . . . . 1.09 109.912 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -122.96 133.98 54.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.549 -0.296 . . . . 0.66 110.728 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.8 t -101.3 114.76 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.343 -0.389 . . . . 1.18 110.752 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.69 25.84 10.57 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.524 -0.762 . . . . 1.24 111.418 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.48 26.88 60.18 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.743 -0.662 . . . . 0.56 113.167 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -126.9 -39.23 1.97 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.099 0.407 . . . . 2.21 112.099 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -106.66 135.9 47.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.003 -0.279 . . . . 1.61 111.432 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -108.23 136.18 48.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.794 -0.639 . . . . 1.14 110.056 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.61 129.63 34.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.472 -0.331 . . . . 1.83 110.54 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -112.73 100.6 51.07 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.415 -0.357 . . . . 0.85 110.723 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.47 -15.32 34.4 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.685 2.257 . . . . 0.71 112.321 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -86.04 2.63 45.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.107 0.48 . . . . 2.48 111.02 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -105.15 16.38 45.98 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.006 -0.616 . . . . 0.6 111.592 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 40.1 mtt -127.67 166.21 18.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.0 -0.37 . . . . 1.13 110.0 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -80.81 133.4 35.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.381 -0.372 . . . . 1.54 111.132 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.475 ' O ' ' I1 ' ' A' ' 201' ' ' SFQ . 0.2 OUTLIER -98.78 -3.16 36.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.15 -0.477 . . . . 1.69 111.744 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 m -67.22 -36.21 81.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.874 0.368 . . . . 1.53 110.814 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -118.33 111.12 18.32 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.235 -0.654 . . . . 1.42 109.235 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 42.9 mtt -66.08 -40.83 91.14 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.488 0.551 . . . . 2.41 112.488 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.46 -50.28 74.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.808 0.337 . . . . 2.05 111.15 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.99 -38.91 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.967 -0.56 . . . . 1.24 110.472 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.81 -53.38 55.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.56 110.908 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 70.2 t -58.3 -48.32 85.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.98 -0.555 . . . . 1.15 111.312 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 61.6 mm-40 -64.67 -40.13 94.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.602 -0.272 . . . . 1.7 111.548 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -64.22 -43.89 93.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.069 -0.345 . . . . 1.91 110.069 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.405 ' O ' HG21 ' A' ' 182' ' ' VAL . 20.4 t80 -57.37 -54.23 49.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.92 110.289 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.83 85.09 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.97 -0.559 . . . . 1.02 111.787 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -67.21 -37.64 83.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.594 -0.276 . . . . 1.55 110.584 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 37.8 m -61.73 -42.6 99.17 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.047 0.451 . . . . 1.17 109.911 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 178' ' ' TYR . 49.0 t -61.49 -47.64 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.672 -0.695 . . . . 1.14 110.274 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 187' ' ' GLU . 34.4 tttp -56.84 -53.38 58.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.818 -0.628 . . . . 2.13 110.948 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -54.68 -41.66 70.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.423 -0.353 . . . . 1.25 111.33 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.55 -38.65 67.92 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.938 0.348 . . . . 1.22 111.938 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 35.2 p -65.86 -35.34 80.37 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.103 -0.239 . . . . 1.38 111.608 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 12.3 pt-20 -93.84 15.94 15.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.105 0.478 . . . . 2.26 111.334 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -115.55 105.77 13.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.224 -0.444 . . . . 2.23 110.26 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 40.8 tttp . . . . . 0 C--O 1.254 1.301 0 CA-C-O 118.267 -0.873 . . . . 4.66 110.604 -179.745 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SFQ . . . . . 0.684 ' C13' ' HE2' ' A' ' 32' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 110.334 -0.247 . . . . 4.48 110.334 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.62 131.51 40.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.671 -0.492 . . . . 4.33 109.671 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -134.09 112.03 10.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.826 0.346 . . . . 1.37 110.322 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -110.22 140.96 43.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 2.29 109.812 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -69.88 122.01 18.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.531 -0.544 . . . . 1.83 109.531 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.94 -11.36 64.21 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.939 -0.648 . . . . 0.78 111.607 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -95.68 -83.16 0.37 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.493 0.187 . . . . 2.32 110.736 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HG2' HE21 ' A' ' 177' ' ' GLN . 23.9 mp0 -84.57 -25.31 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.08 0.467 . . . . 1.46 110.52 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -142.98 153.9 43.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.819 -0.628 . . . . 1.0 109.627 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.38 133.52 50.01 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.398 -0.364 . . . . 1.51 110.563 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.5 m -87.83 126.7 35.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.9 0.381 . . . . 1.54 111.051 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -85.51 140.84 30.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.448 -0.342 . . . . 1.36 110.39 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -20.28 46.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.981 0.419 . . . . 2.33 110.116 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -118.98 93.93 47.46 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.88 -0.6 . . . . 4.04 109.955 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.69 145.23 12.84 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.681 2.254 . . . . 1.06 112.847 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.1 t -80.56 113.84 20.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.828 -0.623 . . . . 1.3 110.22 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.0 128.77 37.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.424 . . . . 1.48 111.36 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.47 16.17 74.32 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.86 -0.609 . . . . 0.8 112.91 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.9 144.58 79.94 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.697 0.248 . . . . 1.2 110.616 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 14.8 Cg_endo -60.15 160.98 20.78 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.606 2.204 . . . . 0.63 112.051 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.475 ' NE2' ' HA ' ' A' ' 54' ' ' VAL . 46.4 mt-30 -57.1 -51.34 69.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.843 -0.617 . . . . 1.79 111.245 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.6 t -128.18 104.5 11.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.837 -0.431 . . . . 1.11 109.837 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 46.3 tp -102.97 132.89 48.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.632 -0.713 . . . . 1.16 110.746 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.89 150.82 49.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.366 -0.379 . . . . 1.61 110.065 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -122.71 148.29 45.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.465 -0.334 . . . . 0.61 110.72 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.01 173.55 15.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.136 -0.484 . . . . 0.67 110.591 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 61' ' ' VAL . 52.5 m -154.47 132.42 11.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.134 -0.484 . . . . 1.52 110.651 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.574 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 67.5 m-85 -66.81 -20.68 65.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.71 111.012 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.77 2.89 54.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 2.16 111.04 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 40.5 t -108.41 119.82 48.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.328 -0.396 . . . . 0.89 110.658 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.33 -27.73 63.42 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.615 2.21 . . . . 0.86 112.105 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.58 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 0.1 OUTLIER -64.85 -47.26 78.58 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.583 -0.735 . . . . 2.46 109.984 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.7 m -63.82 -37.31 86.9 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.801 0.334 . . . . 0.5 110.528 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -60.89 -51.98 66.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 2.22 109.942 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -65.0 -35.03 79.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.394 -0.821 . . . . 2.82 111.549 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.61 -29.69 70.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.928 0.714 . . . . 1.05 112.928 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -105.92 -35.32 7.34 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.705 -0.398 . . . . 1.89 111.397 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -43.35 60.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 2.0 111.847 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.81 -58.01 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.166 0.432 . . . . 1.18 112.166 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.3 mt -69.85 -37.24 76.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.37 0.507 . . . . 1.13 112.37 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 63.42 42.4 6.78 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.04 -0.356 . . . . 1.19 110.04 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.3 mm -61.38 -58.39 7.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.096 -0.502 . . . . 1.13 111.21 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.567 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 1.5 m -61.95 -44.31 97.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.745 -0.465 . . . . 1.37 109.745 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.515 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 24.1 t70 -54.99 -44.42 74.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.235 -0.893 . . . . 1.73 111.186 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -69.37 -43.53 73.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.631 -0.258 . . . . 1.42 111.051 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 54.9 t -58.87 -36.9 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.382 -0.372 . . . . 1.14 110.427 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 43' ' ' SER . 56.9 mttt -56.18 -31.76 63.72 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.361 -0.382 . . . . 1.96 111.202 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.515 ' HE3' ' O ' ' A' ' 44' ' ' ASP . 16.6 mttt -109.73 8.9 24.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 2.52 111.705 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -121.58 21.03 11.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.69 0.281 . . . . 1.93 111.164 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 34.7 mt -104.83 153.03 39.62 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.434 -0.348 . . . . 1.54 110.738 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.17 161.17 38.68 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.722 2.281 . . . . 0.97 111.654 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.24 134.45 53.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.965 0.412 . . . . 2.63 110.916 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.53 -17.29 58.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.57 -0.824 . . . . 0.82 111.945 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.475 ' HA ' ' NE2' ' A' ' 21' ' ' GLN . 90.7 t -95.85 125.91 48.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 1.65 110.936 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -110.54 155.9 21.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.305 -0.407 . . . . 2.85 109.997 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.6 ttt -108.16 132.03 54.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.181 -0.463 . . . . 1.76 110.512 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.18 112.34 18.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.134 -0.485 . . . . 1.15 110.576 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -96.58 129.43 43.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.91 -0.586 . . . . 1.3 109.843 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 6.8 m-30 -118.16 160.95 20.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 1.05 111.634 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -111.54 133.12 54.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.644 -0.707 . . . . 0.78 110.224 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.529 HG22 ' OG ' ' A' ' 27' ' ' SER . 2.7 m -85.83 162.36 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.575 0.226 . . . . 1.37 110.591 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -113.34 21.4 15.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.388 0.514 . . . . 1.08 112.388 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -120.06 16.53 12.46 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.6 -0.44 . . . . 0.87 111.643 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 75.3 mmm -135.09 106.95 7.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.236 -0.438 . . . . 1.67 110.936 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.55 13.72 9.39 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.946 -0.645 . . . . 0.78 112.59 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.67 -147.89 31.5 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.455 -0.878 . . . . 0.81 111.854 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -81.99 -19.28 40.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 2.47 110.863 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.25 -16.32 63.42 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.397 0.617 . . . . 2.46 109.9 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.56 -30.36 77.38 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.502 -0.772 . . . . 0.72 111.422 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -64.0 -44.32 92.99 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.968 0.413 . . . . 3.18 110.106 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.25 -41.72 97.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.824 -0.626 . . . . 1.65 109.961 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.04 -32.52 74.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.706 -0.679 . . . . 1.65 110.827 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.4 m -68.67 -40.77 80.01 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.042 0.449 . . . . 1.19 110.365 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -42.81 71.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 1.35 109.762 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.21 92.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.925 -0.579 . . . . 1.31 110.942 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -62.53 -38.9 91.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.242 -0.435 . . . . 0.59 110.253 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.62 78.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.833 -0.432 . . . . 1.33 109.833 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.96 -44.11 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.729 -0.669 . . . . 1.48 109.575 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.83 -38.29 87.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.66 -0.7 . . . . 1.17 111.043 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.2 mtm -65.31 -25.97 67.85 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.825 0.345 . . . . 1.56 111.345 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.18 -29.52 24.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 1.42 110.718 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 68.6 mt -82.7 -36.0 26.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.898 -0.592 . . . . 1.54 111.368 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.49 23.51 21.28 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.886 -0.673 . . . . 0.78 112.635 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.53 ' O ' HG21 ' A' ' 88' ' ' VAL . 13.6 m -121.25 18.73 5.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 122.705 -0.291 . . . . 1.36 110.989 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.42 -60.59 3.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.559 -0.746 . . . . 1.71 111.749 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.25 -35.13 67.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.72 -0.673 . . . . 1.91 112.116 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -74.45 -43.29 56.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.011 0.374 . . . . 2.74 112.011 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 84' ' ' VAL . 28.6 m -80.68 -2.87 5.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.414 -0.514 . . . . 1.26 111.807 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 m -59.31 -48.25 82.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.823 0.305 . . . . 1.46 111.823 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.44 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 22.0 t -61.33 -59.09 14.69 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.191 0.441 . . . . 1.26 112.191 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.44 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 9.5 Cg_endo -54.39 -33.93 78.86 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.276 1.984 . . . . 0.65 112.446 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.531 HD13 ' CZ ' ' A' ' 28' ' ' PHE . 10.6 mt -66.88 -52.79 39.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.439 -0.346 . . . . 1.34 110.435 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.9 m-85 -58.21 -45.84 86.92 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.936 0.398 . . . . 0.58 110.401 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.456 ' CD ' ' HZ2' ' A' ' 98' ' ' LYS . 36.3 mt-10 -63.13 -48.53 78.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.716 -0.675 . . . . 1.7 110.426 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.31 -7.04 43.48 Favored Glycine 0 C--O 1.223 -0.579 0 CA-C-N 116.153 -0.476 . . . . 0.82 113.644 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 92' ' ' LEU . 50.2 t -105.14 -49.2 9.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 117.412 0.606 . . . . 1.23 112.014 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -99.42 -50.12 4.21 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.629 0.603 . . . . 0.84 112.629 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.456 ' HZ2' ' CD ' ' A' ' 94' ' ' GLU . 27.0 ttpt -69.14 -70.91 0.25 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.46 0.541 . . . . 1.96 112.46 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 101' ' ' THR . 0.2 OUTLIER -79.84 -31.89 40.55 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.259 0.466 . . . . 1.86 112.259 -178.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 64.58 29.36 13.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.096 0.474 . . . . 1.73 110.992 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.456 ' OG1' ' HB ' ' A' ' 99' ' ' THR . 0.2 OUTLIER -69.51 -31.25 69.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.572 -0.74 . . . . 2.07 111.328 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.406 ' HA ' ' CB ' ' A' ' 107' ' ' ASP . 48.6 mt -88.68 105.71 16.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.894 -0.594 . . . . 1.38 111.661 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -122.72 -12.02 8.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.458 -0.792 . . . . 3.77 109.095 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.0 164.41 30.68 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.868 -1.06 . . . . 1.78 109.704 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.06 -25.5 68.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 1.54 111.177 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -33.01 72.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 1.62 110.489 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' CB ' ' HA ' ' A' ' 102' ' ' ILE . 32.7 m-20 -72.55 -38.8 67.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.84 -0.618 . . . . 1.89 110.253 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.3 mt -62.04 -37.97 79.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.221 -0.659 . . . . 1.44 109.221 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.65 ' O ' HG12 ' A' ' 113' ' ' ILE . 72.8 ttt-85 -57.88 -47.2 83.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.845 -1.07 . . . . 2.74 110.357 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.93 -35.41 80.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.163 -0.471 . . . . 1.95 110.764 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.18 -43.34 97.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.053 0.454 . . . . 1.42 110.384 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.74 -41.0 96.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.077 -0.51 . . . . 0.92 110.309 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 109' ' ' ARG . 20.3 mm -64.49 -31.36 53.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.268 0.556 . . . . 1.85 109.733 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -69.25 -16.6 63.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.887 -0.597 . . . . 2.37 111.403 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.02 -5.63 47.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.406 -0.361 . . . . 1.42 111.389 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.8 4.11 29.98 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.462 -0.875 . . . . 1.15 112.616 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mm -80.41 138.07 20.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.698 -0.482 . . . . 2.16 109.698 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -75.12 150.82 38.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.657 -0.247 . . . . 3.2 110.452 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.3 -52.7 51.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.017 -0.611 . . . . 1.25 112.692 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.83 -20.76 65.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.62 0.23 . . . . 2.98 111.62 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -68.41 -49.19 61.79 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.216 0.532 . . . . 2.52 109.747 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.459 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 82.8 t80 -67.3 -42.43 83.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.382 -0.826 . . . . 2.23 109.807 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.33 -42.04 90.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 2.3 111.048 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.79 -46.39 72.1 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.026 -0.533 . . . . 1.61 110.846 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.21 89.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 1.48 111.526 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -56.63 -30.54 63.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.349 -0.387 . . . . 1.43 111.321 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -111.22 23.07 14.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.35 -0.386 . . . . 1.63 110.834 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.8 m -91.63 149.54 21.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.963 0.411 . . . . 2.33 111.655 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -65.21 -40.87 94.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.58 . . . . 4.45 110.484 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 81.1 t -55.66 -50.0 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 1.99 110.559 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.34 -46.88 91.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.666 -0.697 . . . . 1.54 111.091 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -55.57 -41.59 73.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.232 0.539 . . . . 2.84 110.919 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -68.05 -36.07 79.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.906 -0.588 . . . . 1.75 111.018 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.425 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 94.6 mt -67.39 -39.38 85.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.779 0.323 . . . . 1.53 110.657 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 81.2 t -60.29 -45.94 95.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.366 -0.379 . . . . 1.31 110.517 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.59 83.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 1.52 111.082 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -70.22 -34.32 72.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 1.97 110.627 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.458 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 47.6 mt-30 -63.99 -49.67 71.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.69 109.936 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.37 -33.7 76.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.496 -0.775 . . . . 2.82 110.207 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -67.01 -54.54 20.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.734 -0.666 . . . . 2.37 110.68 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -53.33 -48.23 68.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 1.2 112.22 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.29 94.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.934 0.397 . . . . 1.12 111.769 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.98 -31.98 39.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.007 0.373 . . . . 1.27 112.007 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -42.67 98.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.332 -0.394 . . . . 1.39 111.892 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 141' ' ' ALA . 35.3 m -85.6 -0.87 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.405 -0.361 . . . . 1.98 111.606 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 59.03 53.67 5.43 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.557 0.694 . . . . 2.43 109.989 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.5 tp -65.33 120.66 13.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.996 -1.002 . . . . 1.32 111.481 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -103.21 -34.32 8.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.063 -0.517 . . . . 4.87 110.085 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -95.93 -169.11 35.07 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 110.921 -0.872 . . . . 0.82 110.921 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.508 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 3.0 t -111.75 -56.85 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.304 -0.558 . . . . 1.16 111.435 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.508 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.1 Cg_endo -84.35 72.75 4.93 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.457 2.105 . . . . 0.73 111.701 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.5 144.78 46.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.051 -0.522 . . . . 1.07 110.922 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.2 ttm -121.47 133.02 55.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.165 -0.47 . . . . 1.09 110.102 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.95 124.65 43.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.213 -0.449 . . . . 0.66 109.92 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.33 117.1 32.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.889 0.376 . . . . 1.18 110.839 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 58.12 16.68 4.01 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.376 -0.829 . . . . 1.24 111.531 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.8 22.47 68.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.85 -0.691 . . . . 0.56 112.019 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -120.46 -42.06 2.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.08 0.467 . . . . 2.21 110.73 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -104.29 129.39 52.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 1.61 111.612 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -109.33 126.87 53.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.431 -0.804 . . . . 1.14 109.45 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.13 139.83 32.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.09 0.471 . . . . 1.83 111.09 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -114.33 100.91 53.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.872 -0.604 . . . . 0.85 109.91 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.58 -19.28 37.17 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.477 2.118 . . . . 0.71 112.568 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.457 HE21 ' C10' ' A' ' 201' ' ' SFQ . 5.6 mm-40 -80.9 -4.61 55.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.95 0.405 . . . . 2.48 110.674 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -115.3 26.99 8.77 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.808 -0.71 . . . . 0.6 112.004 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.3 mtt -115.12 166.93 11.28 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.656 -0.272 . . . . 1.13 110.349 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -71.48 100.34 2.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.147 0.499 . . . . 1.54 109.997 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.72 26.86 2.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.782 -0.644 . . . . 1.69 112.118 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.3 p -74.95 -35.47 62.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.452 0.644 . . . . 1.53 110.585 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -143.36 129.12 19.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.611 -0.722 . . . . 1.42 109.614 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.422 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.9 mmm -56.74 -34.51 67.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 2.41 111.378 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -39.97 89.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.331 0.586 . . . . 2.05 110.48 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 38.2 t -69.08 -43.65 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.65 -0.705 . . . . 1.24 110.551 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -53.5 -46.17 69.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.207 -0.906 . . . . 0.56 111.463 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 171' ' ' MET . 61.1 t -57.76 -51.48 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.416 . . . . 1.15 111.417 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 82.6 mm-40 -66.01 -44.8 83.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 1.7 111.458 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.433 HE21 ' HG2' ' A' ' 8' ' ' GLN . 52.8 tt0 -60.98 -45.68 93.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.653 -0.249 . . . . 1.91 111.17 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.411 ' O ' HG22 ' A' ' 182' ' ' VAL . 15.6 t80 -59.48 -53.04 62.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.877 0.37 . . . . 0.92 110.497 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.86 85.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 1.02 112.016 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 2.8 t0 -65.33 -36.56 84.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.046 0.45 . . . . 1.55 110.379 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 51.7 m -63.16 -42.46 99.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.868 -0.605 . . . . 1.17 109.925 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 178' ' ' TYR . 44.2 t -62.8 -42.49 96.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.158 -0.474 . . . . 1.14 110.33 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -62.37 -32.31 73.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.393 -0.821 . . . . 2.13 111.0 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.3 -46.3 20.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.278 -0.419 . . . . 1.25 110.817 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.58 -34.51 75.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.462 0.541 . . . . 1.22 112.462 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.5 p -71.61 -21.41 61.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.95 0.352 . . . . 1.38 111.95 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -103.7 -7.83 20.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.104 0.478 . . . . 2.26 110.703 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -79.49 -29.13 41.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.432 -0.803 . . . . 2.23 110.536 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.501 -0.761 . . . . 4.66 109.957 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SFQ . . . . . 0.58 ' C13' ' HE2' ' A' ' 32' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.757 0.313 . . . . 1.32 110.78 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -128.62 136.56 50.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.959 -0.564 . . . . 2.29 109.833 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.63 132.71 49.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 1.83 110.563 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.22 -14.07 55.13 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.866 -0.683 . . . . 0.78 111.917 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.5 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 41.2 tptt -115.38 -74.85 0.6 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.455 -0.202 . . . . 1.87 110.455 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -78.41 -41.73 32.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 1.46 111.027 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -136.85 164.28 28.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.307 -0.406 . . . . 0.79 110.156 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.24 123.84 18.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.136 -0.484 . . . . 0.9 110.284 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.9 m -76.9 127.95 33.67 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.854 -0.425 . . . . 1.11 109.854 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.55 140.97 37.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.813 0.339 . . . . 0.74 110.851 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -25.26 45.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.054 0.454 . . . . 2.33 110.01 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -109.35 90.16 8.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.642 -0.708 . . . . 3.64 109.244 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.24 148.72 30.95 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.525 2.15 . . . . 0.85 112.62 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.1 t -93.88 113.91 29.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.61 -0.723 . . . . 0.72 109.871 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.36 129.16 35.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.087 -0.506 . . . . 0.89 110.481 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.75 34.53 34.45 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.922 -0.656 . . . . 0.73 112.127 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.05 149.12 35.4 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.46 -0.2 . . . . 0.64 110.46 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.5 169.55 11.02 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.888 2.392 . . . . 0.56 112.711 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -65.84 -61.67 1.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.046 -0.524 . . . . 1.79 111.065 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.31 105.12 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.101 0.477 . . . . 0.45 110.747 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.7 tp -107.9 124.28 49.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.147 -0.479 . . . . 0.53 110.707 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -126.35 140.59 52.39 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.164 -0.471 . . . . 1.61 110.024 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -113.15 147.67 36.92 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.081 -0.34 . . . . 0.53 110.081 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.38 174.23 12.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.276 0.56 . . . . 0.55 111.396 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.2 t -153.62 139.26 17.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.439 -0.8 . . . . 0.96 109.079 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.498 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 97.3 m-85 -72.5 -15.0 61.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.947 0.404 . . . . 0.62 110.607 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CE1' ' HA2' ' A' ' 69' ' ' GLY . 79.3 m-85 -89.19 -0.53 57.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.549 . . . . 1.78 110.419 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 49.3 t -108.25 112.61 61.15 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.954 -0.566 . . . . 0.48 111.104 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 18.1 Cg_endo -63.55 -23.85 70.41 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.372 2.048 . . . . 0.7 110.935 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -66.63 -28.71 68.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.459 -0.792 . . . . 1.74 109.932 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.46 -38.46 34.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.627 -0.509 . . . . 0.37 109.627 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -59.95 -38.15 81.6 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.259 0.552 . . . . 1.44 109.693 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.636 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 7.7 tt0 -66.7 -39.87 88.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.589 -0.732 . . . . 2.27 110.785 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -78.39 -26.4 46.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.556 -0.293 . . . . 0.87 111.333 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 3.6 tp10 -83.64 -55.02 4.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.529 0.566 . . . . 1.89 112.529 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.95 -48.54 6.47 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.929 0.714 . . . . 2.0 112.929 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 99.7 t -64.62 -54.61 28.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 121.75 -0.594 . . . . 0.58 111.608 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.9 mt -91.59 -31.39 15.91 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.536 0.569 . . . . 0.41 112.536 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 23.9 m-70 59.71 45.08 13.35 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.079 0.466 . . . . 0.84 110.017 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 46' ' ' VAL . 44.3 mm -55.8 -55.55 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.599 -0.728 . . . . 0.41 111.055 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 m -53.48 -47.76 69.52 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.502 0.501 . . . . 1.03 111.708 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.84 -43.97 97.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.513 -0.312 . . . . 1.73 111.226 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -65.24 -44.32 88.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.127 -0.488 . . . . 1.19 110.781 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.671 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 75.4 t -61.81 -47.1 94.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.984 -0.553 . . . . 0.49 110.638 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -53.57 -31.49 46.92 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.284 0.475 . . . . 1.53 112.284 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -89.67 -26.23 20.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.3 0.481 . . . . 2.02 112.3 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 55.2 mttt -84.79 -17.44 38.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.746 0.308 . . . . 1.44 111.568 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 86.4 mt -71.54 136.72 83.45 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.553 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.0 161.44 46.09 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.416 2.077 . . . . 0.74 111.968 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 128.87 38.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.944 0.402 . . . . 2.63 111.368 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.6 -17.06 23.59 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.824 -0.625 . . . . 0.82 112.093 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -98.4 122.01 49.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.642 0.258 . . . . 1.03 110.622 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -104.52 152.65 22.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.03 -0.359 . . . . 2.51 110.03 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.4 ' HG2' ' N ' ' A' ' 57' ' ' THR . 9.9 ttt -103.82 151.99 22.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.858 0.361 . . . . 1.28 110.318 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.4 ' N ' ' HG2' ' A' ' 56' ' ' MET . 0.0 OUTLIER -136.79 124.74 22.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.013 -0.539 . . . . 0.61 110.066 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -114.43 119.4 36.76 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.548 -0.538 . . . . 0.86 109.548 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CD2' ' HA ' ' A' ' 138' ' ' GLN . 8.0 m-30 -111.21 151.45 28.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.268 0.556 . . . . 0.71 111.873 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -102.25 130.26 48.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.383 -0.826 . . . . 0.57 109.855 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 m -86.78 159.42 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 111.475 0.176 . . . . 0.68 111.475 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.648 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 41.0 m-20 -107.62 -1.39 21.21 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.452 0.538 . . . . 0.93 112.452 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -96.35 10.68 37.29 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.681 -0.407 . . . . 0.74 111.543 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.86 102.06 4.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.839 0.352 . . . . 1.09 110.398 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.99 7.88 0.69 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.675 -0.693 . . . . 0.78 112.258 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.31 -116.64 8.18 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.941 -0.647 . . . . 0.81 112.408 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.48 -50.69 5.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.884 0.373 . . . . 2.47 111.0 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.52 -15.01 56.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.927 -0.579 . . . . 1.94 111.492 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.426 ' HA2' ' CE1' ' A' ' 29' ' ' PHE . . . -56.87 -31.97 61.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.087 -0.578 . . . . 0.7 112.548 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.648 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 85.2 mttt -74.91 -38.5 61.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.39 . . . . 2.69 110.794 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.34 -40.88 97.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 1.65 111.021 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.89 -26.66 65.22 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.876 -0.33 . . . . 1.17 111.229 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.2 m -66.88 -35.74 80.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.328 0.585 . . . . 0.62 109.492 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -73.48 -41.32 63.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 1.21 109.625 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.96 -41.54 99.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.542 -0.753 . . . . 0.71 110.76 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -61.01 -36.77 80.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.075 -0.511 . . . . 0.59 110.778 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.12 -39.04 93.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.71 110.111 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.81 -41.54 90.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.028 -0.533 . . . . 0.84 109.923 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.85 81.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.87 -0.605 . . . . 0.66 110.892 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.7 mtm -69.12 -36.4 77.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.736 -0.665 . . . . 1.08 110.79 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.68 -35.84 65.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.4 -0.363 . . . . 0.99 111.686 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.19 -28.14 38.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.97 110.947 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.93 29.38 18.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.87 -0.681 . . . . 0.78 112.77 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 m -120.93 25.38 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.071 0.462 . . . . 0.81 110.329 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -59.21 -52.19 66.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.451 -0.795 . . . . 1.71 111.443 -178.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.426 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 2.7 t70 -61.77 -39.45 91.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.466 0.65 . . . . 1.91 110.883 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -65.41 -34.89 79.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.432 -0.804 . . . . 2.28 111.86 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.2 m -94.43 -9.38 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.608 0.596 . . . . 0.65 112.608 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.5 m -56.72 -48.54 77.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.98 111.867 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.412 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 99.0 t -65.45 -59.61 9.22 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.349 0.5 . . . . 0.62 112.349 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.412 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 11.7 Cg_endo -55.76 -36.45 95.18 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.216 1.944 . . . . 0.61 113.164 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.45 -42.84 78.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.736 0.303 . . . . 0.79 110.747 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -64.55 -45.27 87.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.537 . . . . 0.58 110.309 179.25 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.15 -46.97 78.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.759 -0.655 . . . . 1.7 111.409 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.77 -9.14 55.42 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 116.149 -0.478 . . . . 0.82 114.147 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.5 t -109.71 -36.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 117.346 0.573 . . . . 0.75 111.919 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -104.42 -40.69 5.98 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.243 0.831 . . . . 0.84 113.243 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -83.02 -68.14 0.73 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.883 0.373 . . . . 1.41 111.306 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.46 -35.68 53.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.736 0.303 . . . . 1.31 111.045 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 60.65 29.99 19.4 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.752 -0.658 . . . . 1.44 110.72 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.79 -28.52 44.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.914 -0.584 . . . . 1.57 111.085 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 85.7 mt -74.85 101.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.266 -0.424 . . . . 0.91 110.182 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -116.24 -33.11 5.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 3.22 111.134 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.5 p -118.45 169.7 9.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.115 -0.493 . . . . 1.51 110.565 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.01 -28.61 69.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.413 0.625 . . . . 1.08 109.91 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -31.43 72.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.289 -0.869 . . . . 1.43 110.081 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -71.78 -36.27 70.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.651 -0.704 . . . . 1.89 110.231 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 mt -68.76 -42.07 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.815 -0.63 . . . . 0.9 109.696 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -57.4 -40.18 77.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.236 -0.893 . . . . 2.19 110.066 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.74 -38.15 86.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.549 -0.75 . . . . 1.95 111.734 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.13 -44.91 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.88 110.803 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -64.44 -40.1 95.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.92 110.865 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 83.6 mt -63.71 -38.3 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.129 0.49 . . . . 1.33 110.379 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -70.56 -31.2 68.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 1.93 110.981 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.76 -31.11 69.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 1.1 110.714 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.02 -0.26 3.25 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.762 -0.733 . . . . 1.15 112.732 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 45.3 mm -86.28 127.52 40.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.031 -0.359 . . . . 1.61 110.031 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -68.35 139.27 55.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.234 -0.284 . . . . 2.73 110.234 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.88 -43.56 81.61 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.926 -0.579 . . . . 1.19 112.497 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.25 -46.78 88.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.683 0.278 . . . . 2.98 110.912 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -62.84 -45.42 92.68 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.123 0.487 . . . . 2.52 110.195 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -63.58 -48.33 77.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.662 -0.699 . . . . 1.51 110.876 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.65 -35.33 79.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 2.3 110.906 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.71 91.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.039 0.447 . . . . 1.23 109.97 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.48 -33.32 60.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.692 -0.686 . . . . 1.11 110.065 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -60.24 -31.51 70.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.478 0.656 . . . . 1.31 110.179 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -104.42 20.77 17.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.384 -0.825 . . . . 1.63 110.909 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.1 m -93.95 144.79 25.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.06 0.457 . . . . 2.04 111.67 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -65.74 -35.57 81.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.487 -0.779 . . . . 3.82 110.61 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 134' ' ' LEU . 63.4 t -53.73 -46.51 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 1.53 110.797 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 77' ' ' ALA . 75.8 t -67.49 -40.72 84.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.677 -0.692 . . . . 1.11 110.774 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -57.83 -46.33 84.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 2.43 111.117 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.3 m -66.16 -29.98 70.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.283 -0.417 . . . . 1.47 110.658 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 130' ' ' VAL . 86.4 mt -68.44 -40.67 81.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.853 -0.425 . . . . 0.93 109.853 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.467 ' HA ' HE21 ' A' ' 138' ' ' GLN . 62.1 t -62.02 -44.03 98.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.99 -0.55 . . . . 0.8 110.21 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.76 99.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.738 -0.664 . . . . 0.85 111.046 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -66.55 -35.0 79.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.169 -0.469 . . . . 1.39 111.66 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.467 HE21 ' HA ' ' A' ' 135' ' ' VAL . 46.0 mt-30 -58.93 -53.22 60.84 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.879 0.371 . . . . 0.61 111.026 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HG3' HD22 ' A' ' 62' ' ' ASN . 4.2 mm-40 -72.15 -36.51 69.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 2.82 110.976 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -58.37 -44.17 88.76 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.75 0.31 . . . . 1.95 110.912 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -61.4 -44.76 96.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.955 -0.566 . . . . 0.65 110.77 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.14 90.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.61 111.366 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.19 -25.74 60.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 0.72 111.247 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.76 -36.12 32.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.272 -0.422 . . . . 1.39 111.261 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 141' ' ' ALA . 31.0 m -89.13 2.69 6.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.477 0.18 . . . . 1.34 111.373 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.417 ' HB3' ' NH2' ' A' ' 148' ' ' ARG . 38.5 mt-30 57.48 51.7 9.44 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.056 -0.52 . . . . 1.95 110.322 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.5 tp -54.57 120.39 6.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.71 111.982 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.448 HH11 ' HD3' ' A' ' 148' ' ' ARG . 28.0 mmt180 -98.17 -45.94 6.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.93 -0.577 . . . . 4.16 110.713 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -107.9 161.16 13.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.106 -0.797 . . . . 0.68 111.106 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.506 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 2.4 t -68.95 -55.66 10.26 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.867 0.334 . . . . 0.49 111.73 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.506 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 5.9 Cg_endo -89.16 98.78 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.449 2.099 . . . . 0.56 112.123 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.51 151.23 40.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.261 -0.427 . . . . 0.63 110.645 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 34.9 ttm -122.92 133.95 54.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.04 -0.527 . . . . 0.42 110.805 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -123.02 129.83 52.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.72 -0.673 . . . . 0.52 109.543 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 185' ' ' LEU . 40.1 t -101.3 118.32 47.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.917 0.389 . . . . 0.55 111.498 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.55 ' O ' ' HD3' ' A' ' 158' ' ' LYS . 28.6 m-20 58.8 17.88 5.58 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.028 -0.987 . . . . 1.16 112.178 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.4 24.75 67.88 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.039 -0.601 . . . . 0.56 112.14 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.55 ' HD3' ' O ' ' A' ' 156' ' ' ASN . 5.9 mppt? -126.45 -47.66 1.57 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.17 0.509 . . . . 1.75 111.218 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -101.47 126.59 48.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.866 -0.606 . . . . 1.16 111.475 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -103.83 138.47 40.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.453 -0.794 . . . . 0.98 109.865 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 mp -93.41 139.9 30.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.888 0.375 . . . . 1.2 111.163 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -118.07 109.91 40.4 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.72 110.547 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.44 -18.76 19.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.689 2.259 . . . . 0.54 112.712 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -83.56 -0.03 48.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.151 0.501 . . . . 2.22 110.924 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -117.19 22.07 10.56 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.981 -0.628 . . . . 0.59 111.644 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 47.1 mtt -120.53 -174.34 2.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.104 -0.332 . . . . 0.57 110.104 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.23 125.05 25.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.863 0.363 . . . . 1.54 110.114 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.25 31.78 6.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.444 0.64 . . . . 1.16 109.767 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -37.01 5.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.287 -0.87 . . . . 1.53 110.739 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -128.09 118.78 24.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 1.21 110.583 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.514 ' O ' HG23 ' A' ' 175' ' ' VAL . 10.3 mmt -54.08 -41.72 68.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.458 -0.792 . . . . 1.96 111.624 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -57.5 -46.85 83.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.837 0.351 . . . . 2.05 111.272 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.73 -46.87 90.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.948 -0.569 . . . . 0.65 110.755 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -54.29 -49.67 69.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.578 -0.283 . . . . 0.47 111.659 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 171' ' ' MET . 60.9 t -60.9 -45.08 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 0.48 111.552 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -70.7 -41.77 71.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.314 -0.403 . . . . 1.7 111.631 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -63.83 -42.38 97.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.513 . . . . 1.32 110.685 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.561 ' O ' HG23 ' A' ' 182' ' ' VAL . 21.4 t80 -59.57 -54.16 49.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.98 -0.555 . . . . 0.46 110.062 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.2 -34.01 75.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.73 -0.668 . . . . 0.43 111.395 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.8 -36.78 81.05 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.406 -0.361 . . . . 1.55 110.569 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.616 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 24.7 m -67.6 -41.71 83.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.48 109.97 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 178' ' ' TYR . 41.0 t -58.14 -50.4 78.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.022 -0.536 . . . . 0.48 110.389 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -59.93 -42.65 94.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.468 -0.787 . . . . 1.59 111.369 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -60.38 -42.96 96.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.326 -0.397 . . . . 1.17 110.537 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 181' ' ' THR . 53.8 mt -70.04 -33.92 72.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.68 110.712 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 25.4 m -66.94 -39.44 87.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.217 0.532 . . . . 1.07 110.188 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.687 -0.688 . . . . 2.26 110.294 179.343 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.009 0.433 . . . . 1.32 110.695 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -108.96 142.5 39.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.954 -0.566 . . . . 2.29 110.878 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.06 125.52 26.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.601 -0.727 . . . . 1.83 109.942 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.25 -20.38 35.43 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.992 -0.623 . . . . 0.78 111.96 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -109.12 -74.73 0.65 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.74 -0.27 . . . . 1.87 110.466 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -75.76 -43.53 46.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.27 -0.423 . . . . 1.46 110.904 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -138.54 154.21 48.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.79 110.302 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.89 133.19 54.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.283 -0.417 . . . . 0.9 111.046 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 m -84.52 127.42 34.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.278 -0.419 . . . . 1.11 111.711 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.78 137.02 34.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.602 -0.518 . . . . 0.74 109.602 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -75.68 -29.09 58.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 2.33 110.513 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -113.05 90.17 15.38 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 3.64 109.89 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.4 143.26 19.38 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.427 2.085 . . . . 0.85 112.593 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 19' ' ' ALA . 47.7 t -76.61 127.44 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.51 -0.768 . . . . 0.72 111.412 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.06 121.28 26.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.06 -0.518 . . . . 0.89 110.557 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.0 19.94 44.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.72 . . . . 0.73 111.995 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . . . -75.02 145.78 81.46 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.647 -0.277 . . . . 0.64 111.239 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.68 165.95 31.29 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.444 2.096 . . . . 0.56 111.985 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -56.62 -60.73 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 1.79 111.487 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.96 102.67 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.987 0.423 . . . . 0.45 110.539 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 47.3 tp -98.64 138.32 35.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.835 -0.62 . . . . 0.53 109.849 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -145.88 154.33 41.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.651 0.263 . . . . 1.61 110.799 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -130.04 157.6 41.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.066 -0.516 . . . . 0.53 110.343 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -168.38 177.5 5.32 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.089 -0.505 . . . . 0.55 110.554 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.5 t -156.75 132.87 9.74 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.96 110.849 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.493 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.9 m-85 -71.13 -16.71 62.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.834 -0.621 . . . . 0.62 109.826 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.491 ' CE2' ' HA2' ' A' ' 69' ' ' GLY . 97.1 m-85 -85.66 -4.0 59.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.567 -0.742 . . . . 1.78 111.32 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 53.3 t -115.49 122.63 32.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.393 -0.367 . . . . 0.48 110.764 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -65.94 -23.87 53.96 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.412 2.075 . . . . 0.7 112.027 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -60.49 -38.93 85.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 1.74 110.099 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.2 m -71.67 -34.77 69.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.998 -0.546 . . . . 0.37 110.725 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.88 -44.31 96.44 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.124 0.487 . . . . 1.44 110.455 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.467 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 13.8 tt0 -66.48 -36.58 83.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.526 . . . . 2.27 110.357 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -77.5 -25.82 50.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.067 -0.515 . . . . 0.87 111.46 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 4.4 tp10 -84.25 -50.61 7.71 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.599 0.592 . . . . 1.89 112.599 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.584 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 10.1 tp10 -97.37 -46.21 6.17 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.356 0.873 . . . . 2.0 113.356 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 48.8 t -69.68 -51.8 37.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.051 -0.659 . . . . 0.58 110.921 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 mt -86.52 -35.56 19.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.258 -0.428 . . . . 0.41 111.764 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.584 ' HD2' ' O ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER 60.63 41.62 15.04 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.59 -0.522 . . . . 0.84 109.59 -178.766 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.631 ' O ' HG23 ' A' ' 46' ' ' VAL . 42.7 mm -53.77 -68.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.845 -0.616 . . . . 0.41 112.169 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 1.4 m -51.92 -45.63 64.34 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.345 0.403 . . . . 1.03 111.943 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 30.5 t70 -65.69 -29.66 70.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.888 -0.596 . . . . 1.73 111.583 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 2.2 t-20 -77.73 -37.14 49.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 1.19 110.217 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 42' ' ' ILE . 43.2 t -60.32 -35.48 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.935 -0.575 . . . . 0.49 110.637 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 43' ' ' SER . 51.8 mttt -56.71 -36.65 69.92 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.393 -0.367 . . . . 1.53 111.44 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -77.72 -10.32 59.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 2.02 112.089 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -102.07 -32.95 9.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.475 -0.33 . . . . 1.44 110.759 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.448 HD22 HG11 ' A' ' 54' ' ' VAL . 91.4 mt -68.92 129.88 91.97 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.77 -171.43 0.86 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.645 2.23 . . . . 0.74 112.625 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -67.86 148.75 50.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 2.63 111.128 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.54 -19.03 30.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.934 -0.651 . . . . 0.82 113.195 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 50' ' ' LEU . 5.8 t -89.72 132.8 33.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.106 0.479 . . . . 1.03 110.749 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -131.41 141.76 49.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.98 -0.554 . . . . 2.51 110.265 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 84.2 mtp -90.88 134.3 34.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 1.28 110.999 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.02 94.36 4.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.232 0.539 . . . . 0.61 110.167 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -92.08 118.37 30.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.737 -0.665 . . . . 0.86 110.665 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 9.5 m-30 -113.62 167.56 10.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 0.71 110.897 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -103.24 133.62 48.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.405 -0.361 . . . . 0.57 110.795 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.8 149.27 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 0.68 110.314 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -109.42 27.24 9.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.856 0.36 . . . . 0.93 111.688 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -133.65 15.57 4.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.014 0.435 . . . . 0.74 110.995 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -137.92 103.23 4.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.15 -0.477 . . . . 1.09 110.073 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.63 9.33 2.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.602 -0.808 . . . . 0.78 112.534 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.76 -140.46 34.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.879 -0.676 . . . . 0.81 112.373 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.83 -34.34 33.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.036 0.446 . . . . 2.47 110.048 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.3 tp -67.35 -22.31 65.59 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.772 -0.649 . . . . 1.94 110.256 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.491 ' HA2' ' CE2' ' A' ' 29' ' ' PHE . . . -58.88 -37.05 90.16 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.671 -0.695 . . . . 0.7 111.876 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -68.66 -32.16 71.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.776 0.322 . . . . 2.69 110.776 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -40.49 97.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 1.65 110.265 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.476 ' HG ' HD13 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -71.83 -26.57 62.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.089 -0.505 . . . . 1.17 110.459 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -62.57 -33.59 75.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.304 0.574 . . . . 0.62 109.759 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -77.84 -37.43 48.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.438 -0.801 . . . . 1.21 109.48 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.17 85.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.569 -0.741 . . . . 0.71 111.318 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -59.67 -36.43 76.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.111 -0.495 . . . . 0.59 110.597 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.84 -36.27 83.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.11 -0.495 . . . . 0.71 110.083 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.1 -43.05 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.677 -0.692 . . . . 0.84 110.013 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.36 90.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.794 -0.639 . . . . 0.66 110.938 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 71.6 mtm -66.84 -35.66 80.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.95 -0.568 . . . . 1.08 110.652 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.33 -36.57 68.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.893 0.377 . . . . 0.99 110.882 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 mt -75.62 -44.22 43.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.22 -0.446 . . . . 0.97 110.763 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.69 37.38 3.72 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.272 -0.731 . . . . 0.78 111.272 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.27 29.11 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.966 0.413 . . . . 0.81 110.179 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.87 -65.76 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.281 -0.872 . . . . 1.71 112.158 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.31 -28.99 67.3 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.334 -0.394 . . . . 1.91 111.218 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -66.65 -44.68 81.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.815 -0.629 . . . . 2.28 111.474 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.81 -8.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.886 0.328 . . . . 0.65 111.886 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.6 m -58.25 -49.13 78.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.721 0.267 . . . . 0.98 111.721 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.44 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 46.3 t -61.36 -59.86 12.3 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.383 0.512 . . . . 0.62 112.383 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.44 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 12.2 Cg_endo -56.13 -34.19 92.26 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.198 1.932 . . . . 0.61 113.232 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.1 mt -70.8 -40.7 72.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.715 0.293 . . . . 0.79 110.719 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -64.24 -48.13 76.98 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.231 0.539 . . . . 0.58 110.442 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.9 -35.87 74.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.534 -0.757 . . . . 1.7 111.248 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.72 -25.69 70.59 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.917 -0.658 . . . . 0.82 113.106 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 64.7 t -100.65 -39.43 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.491 0.552 . . . . 0.75 112.491 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -94.57 -42.94 8.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.717 1.006 . . . . 0.84 113.717 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -78.97 -62.49 1.68 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.977 0.362 . . . . 1.41 111.977 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.04 -39.41 25.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.112 -0.494 . . . . 1.31 112.162 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 66.08 26.89 10.66 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.066 0.46 . . . . 1.44 110.288 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.33 -33.76 32.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.894 -0.594 . . . . 1.57 111.346 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.25 102.51 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.917 -0.583 . . . . 0.91 110.461 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mmm-85 -119.14 -8.12 10.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.848 -0.615 . . . . 3.22 110.448 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 m -149.77 172.59 14.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.226 -0.443 . . . . 1.51 110.696 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.8 -20.72 66.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.24 -0.436 . . . . 1.08 110.816 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -44.72 96.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.006 -0.543 . . . . 1.43 110.562 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 111' ' ' VAL . 13.2 m-20 -67.07 -40.29 87.03 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.98 -0.554 . . . . 1.89 109.851 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.476 HD13 ' HG ' ' A' ' 72' ' ' LEU . 54.6 mt -61.05 -46.1 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.654 -0.703 . . . . 0.9 110.171 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 113' ' ' ILE . 62.8 ttt180 -60.28 -41.22 92.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.943 -0.572 . . . . 2.19 109.723 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -59.48 -39.66 84.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.306 -0.861 . . . . 1.95 110.667 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 107' ' ' ASP . 73.2 t -60.09 -42.41 89.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.88 110.661 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -65.35 -39.75 92.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.92 110.457 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 65.7 mt -64.95 -33.77 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.316 0.579 . . . . 1.33 109.763 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -73.91 -8.39 55.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.541 -0.754 . . . . 1.93 110.654 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.32 2.57 42.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.07 -0.514 . . . . 1.1 110.311 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.81 39.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.821 -0.705 . . . . 1.15 113.193 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 38.2 mm -98.23 133.35 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.123 -0.325 . . . . 1.61 110.123 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -73.76 146.86 43.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.26 -0.427 . . . . 2.73 111.468 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.3 -35.27 91.32 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.894 -0.669 . . . . 1.19 112.024 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.53 -45.69 78.62 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.952 -0.388 . . . . 2.98 109.952 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -60.93 -45.08 96.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.552 -0.749 . . . . 2.52 109.686 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.411 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 53.9 t80 -63.05 -41.87 99.59 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.76 -0.655 . . . . 1.51 110.479 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.63 -44.15 93.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.831 0.348 . . . . 2.3 110.852 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.84 79.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 1.23 111.119 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.02 83.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 1.11 111.088 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -57.96 -36.92 73.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.308 -0.405 . . . . 1.31 111.074 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -109.58 32.04 5.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.371 -0.377 . . . . 1.63 111.47 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.9 p -92.09 157.75 16.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.766 0.317 . . . . 2.04 110.215 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -74.06 -32.46 63.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.556 -0.293 . . . . 3.82 110.359 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.3 t -58.4 -45.49 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.989 0.423 . . . . 1.53 110.181 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 135' ' ' VAL . 15.5 t -61.89 -38.48 80.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.561 -0.745 . . . . 1.11 110.537 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -56.43 -50.72 70.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 2.43 110.976 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -32.03 72.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 1.47 111.051 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.38 -32.43 66.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.93 110.773 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.453 ' HA ' HE21 ' A' ' 138' ' ' GLN . 70.1 t -67.31 -47.03 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.8 110.073 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.08 85.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 0.85 111.233 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -64.12 -32.42 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.512 -0.313 . . . . 1.39 111.34 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.453 HE21 ' HA ' ' A' ' 135' ' ' VAL . 50.5 mt-30 -66.43 -42.27 87.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.409 -0.359 . . . . 0.61 110.551 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.41 -37.97 50.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 2.82 110.803 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 31.7 tttp -54.34 -50.26 67.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.325 -0.398 . . . . 1.95 110.809 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -66.37 -46.55 76.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.162 -0.472 . . . . 0.65 111.522 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.65 83.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 0.61 112.104 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.81 -27.21 61.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.52 0.563 . . . . 0.72 112.52 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 3.3 t0 -78.12 -31.35 49.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.856 0.317 . . . . 1.39 111.856 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 141' ' ' ALA . 32.6 m -92.47 3.14 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.151 0.426 . . . . 1.34 112.151 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 60.4 51.6 5.23 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.262 0.553 . . . . 1.95 110.155 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.9 tp -62.18 106.61 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.479 -0.782 . . . . 0.71 111.404 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -104.19 -1.79 26.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.804 -0.635 . . . . 4.16 110.811 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -133.39 179.78 17.08 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.847 -0.692 . . . . 0.68 112.014 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.501 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 0.2 OUTLIER -97.85 -61.85 0.12 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 117.033 0.416 . . . . 0.49 111.411 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 3.9 Cg_endo -85.78 65.74 5.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.641 2.227 . . . . 0.56 111.814 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -109.35 138.7 45.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.63 110.67 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 29.4 ttm -115.62 137.98 51.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.947 -0.57 . . . . 0.42 110.168 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -127.74 131.31 49.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 0.52 110.392 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.59 117.79 45.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.573 -0.285 . . . . 0.55 110.705 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 60.63 13.87 4.57 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.733 -0.667 . . . . 1.16 111.601 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.31 23.99 68.7 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.047 -0.597 . . . . 0.56 111.759 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -124.65 -44.37 1.97 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.075 0.464 . . . . 1.75 110.758 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -102.1 125.13 48.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.936 -0.575 . . . . 1.16 110.604 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -105.68 138.85 41.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.196 -0.456 . . . . 0.98 109.862 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.6 mp -90.18 139.15 30.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.535 0.207 . . . . 1.2 110.726 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -114.9 113.12 44.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.43 . . . . 0.72 110.854 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.77 6.86 5.21 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.924 2.416 . . . . 0.54 112.56 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -113.33 20.98 15.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.323 -0.399 . . . . 2.22 110.763 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.11 33.39 1.92 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.02 -0.609 . . . . 0.59 111.935 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.9 mtt -124.84 -176.51 3.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.474 0.178 . . . . 0.57 110.542 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.05 127.58 32.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.138 0.494 . . . . 1.54 111.57 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 16.2 16.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.835 -0.621 . . . . 1.16 110.835 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -32.42 14.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.159 0.504 . . . . 1.53 110.401 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -139.42 125.16 19.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.04 -0.527 . . . . 1.21 110.127 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.414 ' O ' HG23 ' A' ' 175' ' ' VAL . 56.4 ttm -62.37 -32.94 73.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.63 . . . . 1.96 111.443 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -63.32 -37.28 86.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.174 -0.466 . . . . 2.05 111.027 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.68 -41.83 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.65 110.509 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.84 -50.09 71.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.47 111.122 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 171' ' ' MET . 57.8 t -57.61 -51.09 74.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.48 111.688 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -42.12 83.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.995 -0.548 . . . . 1.7 112.119 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -62.09 -45.61 92.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.657 0.265 . . . . 1.32 110.979 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -57.71 -52.18 66.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.46 110.635 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.01 82.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.43 112.105 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.65 -32.95 73.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.646 0.26 . . . . 1.55 110.516 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 35.4 m -63.14 -40.07 96.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.48 110.188 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.38 -52.92 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.269 0.557 . . . . 0.48 110.227 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -57.44 -39.83 77.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.961 -1.018 . . . . 1.59 111.007 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -64.51 -46.24 83.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.889 -0.596 . . . . 1.17 110.819 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.0 mt -66.56 -39.81 88.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.088 -0.506 . . . . 0.68 112.06 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.9 p -66.31 -23.75 66.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.038 0.447 . . . . 1.07 111.276 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.226 0.536 . . . . 2.26 110.338 179.606 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.757 0.313 . . . . 1.32 110.983 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -119.35 140.67 49.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.943 -0.571 . . . . 2.29 109.891 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -69.3 119.12 13.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.083 0.468 . . . . 1.83 110.036 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.56 -16.38 29.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.995 -0.842 . . . . 0.78 110.995 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.464 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 50.6 tptt -99.13 -80.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.637 -0.281 . . . . 1.87 110.57 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -86.79 -25.37 24.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 1.46 111.381 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -143.49 152.74 41.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.189 -0.3 . . . . 0.79 110.189 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 m -128.54 132.08 48.26 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.21 0.319 . . . . 0.9 110.639 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.4 m -75.68 125.56 29.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.362 -0.381 . . . . 1.11 110.175 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.26 127.31 32.26 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.792 0.329 . . . . 0.74 110.526 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.09 -39.46 93.21 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.627 -0.715 . . . . 2.33 110.33 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -122.18 84.01 45.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 3.64 109.893 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.36 155.11 70.43 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.485 2.124 . . . . 0.85 112.191 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.5 t -89.4 131.84 35.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.036 -0.529 . . . . 0.72 110.713 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.81 137.8 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.107 -0.497 . . . . 0.89 110.323 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.9 25.24 74.34 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.73 -0.748 . . . . 0.73 112.382 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.26 143.52 31.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.436 -0.209 . . . . 0.64 110.436 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 30.1 Cg_endo -66.27 162.05 37.79 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.373 2.049 . . . . 0.56 112.704 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -62.68 -44.92 95.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.612 -0.722 . . . . 1.79 110.705 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.8 t -120.52 100.77 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.702 -0.481 . . . . 0.45 109.702 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.418 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 26.5 tp -110.92 110.78 21.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.951 -0.568 . . . . 0.53 110.423 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -120.12 145.76 46.61 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.426 -0.352 . . . . 1.61 110.215 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 151' ' ' PRO . 97.2 m-85 -123.23 154.63 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.309 -0.405 . . . . 0.53 110.114 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -170.24 177.99 3.97 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.005 0.431 . . . . 0.55 110.786 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.1 t -156.91 141.58 16.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 0.96 110.51 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.539 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 96.0 m-85 -73.4 -20.49 60.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.9 -0.591 . . . . 0.62 110.502 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CE2' HD12 ' A' ' 72' ' ' LEU . 72.6 m-85 -85.35 -1.32 56.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.78 110.339 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.47 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 48.1 t -107.19 112.34 62.98 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.019 -0.537 . . . . 0.48 111.133 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -64.2 -24.54 65.61 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.216 1.944 . . . . 0.7 111.283 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -66.32 -29.37 69.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.369 -0.832 . . . . 1.74 110.236 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.0 m -83.66 -32.02 25.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.47 -0.567 . . . . 0.37 109.47 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.77 -49.1 79.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.304 -0.862 . . . . 1.44 110.063 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.505 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 22.5 tt0 -68.35 -32.34 72.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 2.27 110.726 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.404 ' O ' HG12 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -66.66 -30.84 71.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.481 0.549 . . . . 0.87 112.481 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -108.65 -50.11 3.07 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.993 0.738 . . . . 1.89 112.993 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.63 -25.51 64.87 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.953 -0.467 . . . . 2.0 111.659 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 91.5 t -107.72 -56.44 4.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.796 -0.362 . . . . 0.58 111.498 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.8 mt -81.05 -33.55 33.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.928 0.344 . . . . 0.41 111.928 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 0.6 OUTLIER 58.9 63.45 1.64 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.848 0.459 . . . . 0.84 111.003 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 36' ' ' PHE . 49.1 mm -71.36 -50.87 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.902 -0.59 . . . . 0.41 111.165 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 m -58.3 -49.33 77.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.314 -0.403 . . . . 1.03 110.999 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 26.0 t70 -61.26 -45.03 96.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.549 . . . . 1.73 110.888 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 0.7 OUTLIER -62.41 -41.56 98.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 1.19 110.794 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 39.6 t -66.44 -42.44 90.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.49 110.541 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.93 -31.63 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.738 0.304 . . . . 1.53 111.37 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 30.3 mttm -86.68 3.13 46.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.261 -0.427 . . . . 2.02 111.679 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -136.97 23.59 3.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 1.44 111.007 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 13.9 mt -99.73 145.5 30.25 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.383 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 50' ' ' LEU . 10.4 Cg_exo -70.21 165.48 31.34 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.718 2.279 . . . . 0.74 111.422 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.25 139.97 50.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.998 -0.546 . . . . 2.63 110.368 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.23 -9.15 78.03 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.931 -0.652 . . . . 0.82 112.118 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.95 98.63 7.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.853 0.359 . . . . 1.03 110.263 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.6 124.96 31.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.141 -0.481 . . . . 2.51 110.165 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -72.97 127.97 34.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.646 -0.501 . . . . 1.28 109.646 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 119.48 34.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.949 0.404 . . . . 0.61 110.757 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HD3' ' CE1' ' A' ' 26' ' ' PHE . 15.2 ttmm -114.04 119.57 37.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.86 110.16 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 13.1 m-30 -110.28 160.51 16.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.135 0.493 . . . . 0.71 111.55 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -104.85 134.76 47.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.661 -0.699 . . . . 0.57 110.618 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.424 HG21 HG13 ' A' ' 150' ' ' VAL . 16.7 m -88.7 155.05 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.587 -0.279 . . . . 0.68 110.61 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -105.21 -6.1 20.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.632 0.604 . . . . 0.93 112.632 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -89.97 15.5 9.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.427 0.632 . . . . 0.74 110.79 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -144.32 88.87 1.97 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.458 -0.792 . . . . 1.09 109.61 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.15 -7.27 0.29 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 121.09 -0.576 . . . . 0.78 112.547 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.44 -134.61 22.83 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.556 -0.831 . . . . 0.81 112.333 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -22.8 40.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.649 0.262 . . . . 2.47 110.793 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 tp -85.6 -11.62 53.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.097 0.475 . . . . 1.94 110.318 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.75 98.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.772 -0.727 . . . . 0.7 111.961 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -62.9 -40.09 96.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.067 0.461 . . . . 2.69 110.552 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.79 -49.06 79.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.678 -0.692 . . . . 1.65 111.158 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.549 HD12 ' CE2' ' A' ' 29' ' ' PHE . 1.7 mt -66.29 -22.77 66.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 1.17 111.6 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 m -69.71 -40.39 76.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.917 0.389 . . . . 0.62 110.098 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -72.37 -38.91 68.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.98 -0.748 . . . . 1.21 108.98 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.88 99.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.418 -0.81 . . . . 0.71 110.935 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.441 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 66.6 t-105 -62.69 -38.21 89.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.735 -0.666 . . . . 0.59 110.714 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -61.13 -38.48 86.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.71 110.39 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.05 -41.73 92.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.121 0.486 . . . . 0.84 109.801 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.7 88.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.784 -0.644 . . . . 0.66 111.006 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.8 mtm -69.26 -33.42 73.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 1.08 111.149 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.92 -38.86 61.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.501 . . . . 0.99 110.584 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.6 mt -76.31 -32.75 58.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.094 -0.503 . . . . 0.97 110.926 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.27 39.54 6.0 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.772 -0.727 . . . . 0.78 111.581 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.6 m -130.09 30.32 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.832 0.349 . . . . 0.81 110.83 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.441 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 2.8 mp0 -59.77 -63.0 1.46 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.047 -0.524 . . . . 1.71 111.812 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.74 -33.33 61.04 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.188 -0.46 . . . . 1.91 111.172 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -66.17 -48.02 72.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.77 -0.65 . . . . 2.28 111.705 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.83 -10.6 11.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.062 0.764 . . . . 0.65 113.062 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.4 m -56.18 -51.76 66.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.219 0.452 . . . . 0.98 112.219 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.434 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 42.2 t -62.57 -59.22 13.35 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 112.547 0.573 . . . . 0.62 112.547 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 10.0 Cg_endo -54.7 -35.29 86.92 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.255 1.97 . . . . 0.61 113.059 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.9 mt -68.77 -47.92 65.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.514 0.197 . . . . 0.79 110.757 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.539 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -58.59 -49.43 77.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.165 0.507 . . . . 0.58 110.784 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.41 -39.33 93.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.621 -0.718 . . . . 1.7 110.913 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.65 -18.03 71.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.998 -0.62 . . . . 0.82 113.469 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.7 t -101.55 -42.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.319 0.488 . . . . 0.75 112.319 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -98.72 -39.98 8.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.587 0.958 . . . . 0.84 113.587 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -79.61 -70.79 0.49 Allowed 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.676 -0.41 . . . . 1.41 111.797 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.31 -26.4 46.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.676 -0.238 . . . . 1.31 111.532 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.42 ' HB3' HH21 ' A' ' 103' ' ' ARG . 58.7 mt-30 56.38 28.45 13.53 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.606 0.567 . . . . 1.44 111.173 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -28.51 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.75 -0.659 . . . . 1.57 111.584 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.74 100.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.991 -0.374 . . . . 0.91 109.991 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.42 HH21 ' HB3' ' A' ' 100' ' ' GLN . 26.1 mmt180 -122.97 -3.59 8.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 3.22 110.967 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -149.45 166.1 30.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.319 -0.4 . . . . 1.51 110.068 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.93 67.85 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.51 -0.313 . . . . 1.08 111.335 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -36.66 78.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.246 -0.434 . . . . 1.43 110.785 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -70.67 -42.23 71.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.363 -0.606 . . . . 1.89 109.363 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.5 mt -62.17 -43.14 97.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.614 -0.721 . . . . 0.9 110.097 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.402 ' O ' HG13 ' A' ' 113' ' ' ILE . 74.2 ttt-85 -57.76 -44.2 85.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.572 -0.74 . . . . 2.19 110.211 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.7 -35.06 79.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.606 -0.724 . . . . 1.95 111.386 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.4 t -60.82 -42.75 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.029 0.442 . . . . 0.88 110.255 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -64.42 -39.9 94.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 0.92 110.394 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.681 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 65.4 mt -63.9 -36.47 76.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 1.33 110.126 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -68.03 -23.33 64.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.834 -0.621 . . . . 1.93 111.045 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.45 -7.47 58.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.1 111.522 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.96 5.75 28.72 Favored Glycine 0 C--O 1.234 0.136 0 C-N-CA 120.747 -0.739 . . . . 1.15 112.736 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 44.4 mm -92.44 124.89 45.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 122.742 -0.27 . . . . 1.61 110.364 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -65.52 134.3 53.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.307 -0.406 . . . . 2.73 110.42 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.32 -38.97 81.23 Favored Glycine 0 CA--C 1.517 0.207 0 O-C-N 123.479 0.487 . . . . 1.19 112.717 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.31 -36.59 80.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.528 0.204 . . . . 2.98 111.368 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -73.13 -41.88 63.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.041 0.448 . . . . 2.52 109.978 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -60.79 -44.3 97.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 1.51 110.21 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -61.63 -39.41 91.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.985 -0.552 . . . . 2.3 110.874 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.41 -47.42 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.749 -0.66 . . . . 1.23 110.607 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.1 -27.94 68.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.256 -0.429 . . . . 1.11 111.333 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -62.46 -28.82 70.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.139 0.495 . . . . 1.31 110.301 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -105.05 19.13 21.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.006 -0.543 . . . . 1.63 111.111 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.0 t -80.3 142.22 34.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.102 -0.499 . . . . 2.04 110.865 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -69.84 -32.26 70.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.198 0.523 . . . . 3.82 109.685 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.41 -44.87 99.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.717 -0.674 . . . . 1.53 109.804 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.529 HG13 ' HB3' ' A' ' 77' ' ' ALA . 62.0 t -64.31 -41.48 92.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.412 -0.813 . . . . 1.11 110.332 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -57.29 -42.47 81.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.989 -0.55 . . . . 2.43 110.083 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 137' ' ' GLN . 12.1 t -66.38 -44.88 81.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.645 -0.707 . . . . 1.47 110.214 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 48.4 mt -59.2 -37.73 78.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 0.93 111.043 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.493 ' HA ' HE21 ' A' ' 138' ' ' GLN . 77.2 t -61.94 -47.01 95.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.929 -0.397 . . . . 0.8 109.929 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.6 -39.14 92.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.84 -0.618 . . . . 0.85 110.812 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 133' ' ' SER . 78.6 mt-30 -60.49 -41.08 93.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 1.39 111.207 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.493 HE21 ' HA ' ' A' ' 135' ' ' VAL . 49.7 mt-30 -63.75 -48.05 78.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.262 -0.426 . . . . 0.61 110.727 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 8.6 mt-10 -65.12 -41.2 95.1 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.025 -0.534 . . . . 2.82 110.44 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.7 tttm -61.92 -50.7 71.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.277 -0.874 . . . . 1.95 111.259 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.42 -44.98 92.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.46 . . . . 0.65 111.967 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.08 -36.51 83.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.487 -0.324 . . . . 0.61 111.689 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.88 -36.39 28.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.525 -0.307 . . . . 0.72 111.197 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -63.86 -49.73 71.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.413 -0.358 . . . . 1.39 110.997 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.63 -9.68 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 1.34 110.891 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.506 ' O ' ' HD2' ' A' ' 148' ' ' ARG . 89.5 mt-30 59.18 67.25 0.93 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.771 -0.65 . . . . 1.95 110.193 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 149' ' ' GLY . 14.0 tp -63.97 129.68 41.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.515 -0.766 . . . . 0.71 110.535 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.506 ' HD2' ' O ' ' A' ' 146' ' ' GLN . 1.2 mpt_? -96.74 -47.49 5.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.821 -0.627 . . . . 4.16 110.254 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . -98.05 -158.09 30.16 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.321 -0.712 . . . . 0.68 111.321 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.551 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 2.5 t -113.4 -57.41 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 117.221 0.511 . . . . 0.49 111.724 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 17.3 Cg_endo -92.64 82.34 0.24 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.601 2.201 . . . . 0.56 111.885 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.36 146.15 50.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.316 -0.402 . . . . 0.63 110.87 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 43.8 ttm -118.78 133.14 56.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.049 -0.523 . . . . 0.42 110.314 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.28 133.1 56.38 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.914 -0.585 . . . . 0.52 109.826 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.43 112.4 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.257 -0.429 . . . . 0.55 110.459 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 60.47 17.23 7.08 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.278 -0.873 . . . . 1.16 111.52 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.19 20.28 64.88 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.925 -0.58 . . . . 0.56 112.512 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -121.06 -38.35 2.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.886 0.374 . . . . 1.75 111.641 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -111.83 128.36 56.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.016 0.436 . . . . 1.16 110.898 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -105.15 138.4 41.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.667 -0.697 . . . . 0.98 110.438 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.23 134.97 33.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.528 -0.306 . . . . 1.2 110.325 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -115.6 100.79 53.96 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.774 0.321 . . . . 0.72 110.587 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.45 -16.87 34.7 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 122.363 2.042 . . . . 0.54 112.572 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -81.02 -6.48 58.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.948 0.404 . . . . 2.22 110.788 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -115.26 14.77 18.43 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.244 -0.742 . . . . 0.59 111.244 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' MET . . . . . 0.403 ' HB3' ' OE1' ' A' ' 177' ' ' GLN . 64.9 mtt -105.54 -174.52 2.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.543 -0.329 . . . . 0.57 110.187 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -71.25 111.8 6.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.226 0.536 . . . . 1.54 111.032 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.24 18.49 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.338 0.589 . . . . 1.16 109.795 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.99 -48.88 6.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.507 -0.77 . . . . 1.53 110.681 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -122.37 126.84 48.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.164 -0.471 . . . . 1.21 110.61 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.445 ' O ' HG23 ' A' ' 175' ' ' VAL . 39.3 mtt -62.19 -40.52 96.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.031 -0.531 . . . . 1.96 111.602 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -61.05 -42.01 97.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 2.05 110.604 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.8 t -67.74 -46.84 81.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.792 -0.64 . . . . 0.65 110.45 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -55.4 -49.34 72.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.777 -0.647 . . . . 0.47 111.856 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 171' ' ' MET . 80.8 t -55.73 -50.09 70.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.548 -0.296 . . . . 0.48 111.705 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -69.25 -35.06 75.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.375 -0.375 . . . . 1.7 111.082 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.403 ' OE1' ' HB3' ' A' ' 166' ' ' MET . 57.4 tt0 -63.57 -47.15 82.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.398 -0.365 . . . . 1.32 110.537 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' ' 182' ' ' VAL . 17.7 t80 -57.54 -46.73 83.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.975 -0.557 . . . . 0.46 109.906 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.7 -41.1 88.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.638 -0.71 . . . . 0.43 111.46 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.55 -40.36 96.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.086 -0.506 . . . . 1.55 110.311 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.2 m -59.76 -42.03 92.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.48 110.575 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 178' ' ' TYR . 61.8 t -60.05 -53.17 52.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.293 -0.412 . . . . 0.48 110.523 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -59.83 -46.36 89.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.687 -0.688 . . . . 1.59 111.047 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -58.73 -45.6 89.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.838 -0.619 . . . . 1.17 111.484 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.36 -36.55 74.25 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.479 0.18 . . . . 0.68 111.401 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.7 m -64.37 -37.6 88.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.986 0.422 . . . . 1.07 110.879 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 2.26 111.139 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.532 0.206 . . . . 1.32 110.492 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -128.3 151.01 49.81 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.761 0.315 . . . . 2.29 110.746 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -65.95 123.37 19.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.783 -0.644 . . . . 1.83 111.011 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.0 -14.05 52.45 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.915 -0.584 . . . . 0.78 112.425 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -108.52 -73.31 0.69 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.95 -0.3 . . . . 1.87 111.137 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -91.54 -24.59 19.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.581 0.229 . . . . 1.46 111.41 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -145.7 158.82 43.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.147 -0.316 . . . . 0.79 110.147 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.95 122.96 31.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.958 0.409 . . . . 0.9 111.096 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.4 m -74.51 120.57 20.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.162 -0.472 . . . . 1.11 109.805 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.4 mt -72.58 136.69 45.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.024 0.44 . . . . 0.74 111.285 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -77.17 -31.7 55.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.972 -0.751 . . . . 2.33 108.972 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -120.2 83.42 32.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.26 -0.882 . . . . 3.64 110.096 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.12 163.4 38.25 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.382 2.055 . . . . 0.85 112.08 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.77 115.3 43.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.004 0.43 . . . . 0.72 110.647 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.43 111.84 12.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.807 -0.633 . . . . 0.89 110.496 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.37 20.88 9.22 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.771 -0.728 . . . . 0.73 112.245 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.88 154.27 55.37 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.452 -0.203 . . . . 0.64 110.452 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.49 161.31 42.66 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.12 1.88 . . . . 0.56 112.228 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -57.33 -56.53 20.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.836 -0.62 . . . . 1.79 111.487 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.409 HG21 HD11 ' A' ' 50' ' ' LEU . 58.9 t -112.27 96.35 4.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.134 0.493 . . . . 0.45 110.337 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.33 116.54 32.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.635 -0.711 . . . . 0.53 109.764 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -126.23 152.17 46.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.611 0.243 . . . . 1.61 110.822 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.23 156.61 42.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.61 -0.515 . . . . 0.53 109.61 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -169.06 175.95 5.54 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.019 0.438 . . . . 0.55 111.003 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.493 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 7.0 t -156.24 136.99 13.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.337 -0.392 . . . . 0.96 110.192 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.409 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.1 m-85 -70.58 -15.76 62.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.921 -0.581 . . . . 0.62 110.957 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CE2' HD12 ' A' ' 72' ' ' LEU . 65.8 m-85 -88.9 -1.27 58.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 1.78 110.765 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.3 t -107.49 115.73 58.95 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.035 -0.357 . . . . 0.48 110.035 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -64.09 -26.42 65.58 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.372 2.048 . . . . 0.7 112.082 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -70.19 -27.37 64.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 1.74 110.096 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.1 m -71.9 -37.05 70.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.553 -0.536 . . . . 0.37 109.553 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -65.52 -36.48 83.95 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.28 0.562 . . . . 1.44 109.553 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.499 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 47.2 tt0 -65.36 -43.96 89.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.382 -0.826 . . . . 2.27 109.967 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.43 -32.75 68.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.061 -0.518 . . . . 0.87 111.964 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 3.2 tp10 -87.94 -50.79 6.2 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.432 0.901 . . . . 1.89 113.432 -177.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 27.1 tp10 -94.38 -34.33 12.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.738 1.014 . . . . 2.0 113.738 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 51.9 t -81.46 -51.98 14.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 121.578 -0.701 . . . . 0.58 110.914 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' HB3' HG22 ' A' ' 175' ' ' VAL . 79.8 mt -92.18 -31.3 15.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.468 0.544 . . . . 0.41 112.468 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 6.7 m-70 60.0 48.62 8.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.484 -0.561 . . . . 0.84 109.484 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.594 ' O ' HG23 ' A' ' 46' ' ' VAL . 41.1 mm -53.16 -64.13 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.474 -0.784 . . . . 0.41 111.893 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -54.53 -31.66 56.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.284 0.476 . . . . 1.03 112.284 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.94 -37.98 72.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.806 0.336 . . . . 1.73 110.928 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.456 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 28.4 m-80 -72.88 -33.01 65.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 1.19 110.626 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 42' ' ' ILE . 62.1 t -60.47 -37.11 73.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.873 -0.603 . . . . 0.49 110.443 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -62.04 -25.04 67.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.984 -0.553 . . . . 1.53 111.726 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 45' ' ' ASN . 49.3 mtmt -83.04 -11.44 58.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.517 -0.311 . . . . 2.02 111.348 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -112.15 -20.84 11.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 111.828 0.307 . . . . 1.44 111.828 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.409 HD11 HG21 ' A' ' 22' ' ' VAL . 85.8 mt -74.6 132.73 77.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.699 0.285 . . . . 1.0 111.366 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.41 174.5 11.46 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.333 2.022 . . . . 0.74 112.013 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.06 144.81 55.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.14 -0.482 . . . . 2.63 111.158 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.02 -20.46 47.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.172 -0.537 . . . . 0.82 112.559 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.17 113.63 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.869 0.366 . . . . 1.03 110.603 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -97.95 151.77 19.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 2.51 109.841 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 96.2 mtp -108.57 146.17 33.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.47 -0.332 . . . . 1.28 110.359 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 m -135.07 110.71 9.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.824 0.345 . . . . 0.61 110.492 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -106.84 122.45 46.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.875 -0.602 . . . . 0.86 109.704 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.7 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 10.2 m-85 -111.5 159.19 18.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.93 0.395 . . . . 0.71 111.0 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.493 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 52.5 t-80 -104.62 134.64 47.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.491 . . . . 0.57 109.875 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 m -87.47 150.41 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.569 -0.287 . . . . 0.68 111.012 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.667 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 7.5 m-20 -99.44 1.32 44.04 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.36 0.504 . . . . 0.93 112.36 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -98.18 12.92 33.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.13 0.491 . . . . 0.74 111.296 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.13 99.63 3.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.256 -0.429 . . . . 1.09 110.726 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.96 -2.88 4.84 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.623 -0.799 . . . . 0.78 112.426 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.23 -138.91 31.46 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.209 -0.52 . . . . 0.81 112.145 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.98 -37.51 72.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.859 0.362 . . . . 2.47 111.133 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -70.61 -22.08 62.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 1.94 110.391 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.34 -32.48 84.33 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.5 -0.857 . . . . 0.7 111.132 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.667 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 33.4 mttm -66.7 -36.94 83.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.725 0.298 . . . . 2.69 110.807 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -67.0 -39.04 87.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.137 0.494 . . . . 1.65 110.294 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.545 HD12 ' CE2' ' A' ' 29' ' ' PHE . 4.3 mt -66.25 -28.89 69.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 1.17 110.321 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.6 m -67.7 -36.72 81.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.191 0.52 . . . . 0.62 109.773 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -73.87 -41.61 61.96 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.81 -0.632 . . . . 1.21 109.623 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.82 95.24 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.82 -0.627 . . . . 0.71 110.835 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -61.12 -40.14 92.66 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.859 -0.609 . . . . 0.59 110.557 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.21 -35.73 81.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.063 -0.517 . . . . 0.71 110.228 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.85 -46.23 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.84 109.979 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.86 84.69 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.87 -0.605 . . . . 0.66 111.3 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 69.1 mtm -67.97 -39.36 83.37 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.129 -0.487 . . . . 1.08 110.846 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.69 -25.56 63.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 0.99 111.371 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.0 mt -88.97 -46.84 8.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.127 -0.488 . . . . 0.97 110.997 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.43 41.92 2.11 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.113 -0.565 . . . . 0.78 111.862 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.83 26.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.977 0.418 . . . . 0.81 110.216 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.94 -53.61 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.519 -0.764 . . . . 1.71 111.708 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.04 -19.88 65.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.781 -0.645 . . . . 1.91 112.189 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -81.92 -22.26 36.88 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.949 0.351 . . . . 2.28 111.949 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.441 ' HA ' ' HG2' ' A' ' 91' ' ' PRO . 32.9 m -111.36 -6.74 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.231 0.826 . . . . 0.65 113.231 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -56.01 27.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.699 0.629 . . . . 0.98 112.699 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.434 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.9 t -60.29 -56.48 34.97 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 111.97 0.359 . . . . 0.62 111.97 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.441 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 9.4 Cg_endo -55.13 -37.79 93.91 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.465 2.11 . . . . 0.61 113.156 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.37 -42.22 65.5 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.962 -0.295 . . . . 0.79 110.443 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -59.88 -51.88 67.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.262 0.553 . . . . 0.58 110.802 179.359 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -70.86 -34.72 71.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.067 -0.515 . . . . 1.7 111.362 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.09 -23.02 72.85 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.866 -0.683 . . . . 0.82 113.068 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.92 -45.98 12.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.803 0.301 . . . . 0.75 111.703 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -89.23 -51.72 5.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.775 1.028 . . . . 0.84 113.775 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -74.39 -68.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.404 0.52 . . . . 1.41 112.404 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.465 ' HB ' ' OG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -72.4 -34.53 67.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.16 0.429 . . . . 1.31 112.16 -179.086 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 60.4 35.54 20.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.059 0.457 . . . . 1.44 110.744 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.465 ' OG1' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -83.75 -30.24 26.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.634 -0.712 . . . . 1.57 111.637 -179.282 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.5 mt -76.89 110.48 12.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.194 -0.457 . . . . 0.91 110.976 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -120.72 -11.44 9.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 3.22 109.874 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.0 m -150.93 171.48 17.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.006 -0.543 . . . . 1.51 110.339 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -64.12 -22.48 66.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.091 0.472 . . . . 1.08 111.013 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -42.78 92.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.693 -0.685 . . . . 1.43 111.207 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.2 m-20 -65.43 -40.37 93.25 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.167 -0.47 . . . . 1.89 110.137 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 105' ' ' ALA . 12.1 mt -62.52 -42.3 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.659 -0.7 . . . . 0.9 110.083 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -57.7 -41.93 82.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.301 -0.863 . . . . 2.19 110.908 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -66.79 -39.06 87.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 1.95 111.01 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 107' ' ' ASP . 89.1 t -59.83 -39.53 80.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.847 0.356 . . . . 0.88 110.526 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -65.87 -39.07 90.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.444 -0.344 . . . . 0.92 110.159 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 79.9 mt -65.59 -35.53 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.143 0.497 . . . . 1.33 109.686 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -65.66 -27.96 68.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.774 -0.648 . . . . 1.93 110.338 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.44 -13.04 58.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.599 -0.728 . . . . 1.1 111.116 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.38 6.86 17.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.555 -0.831 . . . . 1.15 113.408 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 43.1 mm -91.64 122.82 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.955 0.378 . . . . 1.61 110.054 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -65.03 136.06 56.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.477 -0.329 . . . . 2.73 110.792 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.4 -33.24 70.34 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 121.031 -0.604 . . . . 1.19 112.595 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -65.91 -42.8 89.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.285 0.564 . . . . 2.98 109.897 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.89 -41.83 86.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 2.52 109.711 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -60.0 -40.4 89.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.31 -0.859 . . . . 1.51 111.11 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.29 -40.31 95.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.385 -0.37 . . . . 2.3 110.918 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.4 89.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.23 111.115 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.44 -40.62 70.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.415 . . . . 1.11 110.654 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -58.39 -34.85 71.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.037 -0.529 . . . . 1.31 110.841 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -106.55 40.61 1.59 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.072 -0.513 . . . . 1.63 111.096 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 80.1 p -108.79 152.94 24.19 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.745 -0.382 . . . . 2.04 110.745 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -72.09 -32.84 67.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.416 . . . . 3.82 109.999 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.461 ' O ' ' HG ' ' A' ' 134' ' ' LEU . 60.3 t -58.9 -50.35 79.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.696 -0.684 . . . . 1.53 110.956 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 135' ' ' VAL . 24.8 t -60.22 -45.15 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 1.11 110.522 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -59.26 -38.72 80.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.254 -0.43 . . . . 2.43 110.481 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.04 -36.53 84.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.165 0.507 . . . . 1.47 109.961 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 130' ' ' VAL . 75.7 mt -72.34 -41.63 66.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.987 -0.551 . . . . 0.93 110.342 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.613 ' HA ' HE21 ' A' ' 138' ' ' GLN . 94.2 t -58.27 -47.17 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.8 111.084 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.71 83.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.106 -0.497 . . . . 0.85 111.093 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -70.08 -35.27 74.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 1.39 111.62 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.7 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 48.8 mt-30 -56.58 -54.56 44.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.144 -0.48 . . . . 0.61 111.085 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -71.58 -32.79 68.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.845 -0.616 . . . . 2.82 111.243 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 70.5 tttt -60.13 -48.27 82.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.323 -0.399 . . . . 1.95 110.805 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.03 99.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.16 -0.473 . . . . 0.65 110.986 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.51 -46.23 90.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.61 111.659 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.94 -6.45 57.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.306 0.484 . . . . 0.72 112.306 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -94.07 -27.88 16.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.057 0.456 . . . . 1.39 110.456 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.6 m -98.73 5.65 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.088 -0.505 . . . . 1.34 110.868 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 148' ' ' ARG . 62.7 mt-30 56.51 55.91 6.08 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.25 0.548 . . . . 1.95 109.974 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 44.3 tp -63.71 103.32 0.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.577 -0.738 . . . . 0.71 111.237 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 146' ' ' GLN . 51.1 mtt180 -100.51 40.84 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 4.16 110.199 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -174.13 -174.64 41.13 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.613 -0.995 . . . . 0.68 110.613 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.504 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.2 t -107.83 -58.46 0.05 OUTLIER Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 117.174 0.487 . . . . 0.49 111.562 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.504 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 18.4 Cg_endo -93.98 67.22 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.558 2.172 . . . . 0.56 112.313 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.07 143.29 45.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.63 110.759 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 45.4 ttm -113.82 138.41 50.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.106 -0.497 . . . . 0.42 110.68 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.49 125.29 44.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.638 -0.71 . . . . 0.52 109.659 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.407 HG22 HG13 ' A' ' 182' ' ' VAL . 67.5 t -88.57 112.87 24.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.552 -0.295 . . . . 0.55 111.347 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 58.37 17.3 4.67 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.842 0.714 . . . . 1.16 111.801 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.26 19.93 62.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.051 -0.595 . . . . 0.56 111.627 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -110.72 -38.07 5.25 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.874 0.369 . . . . 1.75 111.078 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -123.83 142.0 51.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.38 . . . . 1.16 111.254 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -107.59 142.95 36.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.749 -0.659 . . . . 0.98 109.614 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.7 mp -94.29 135.21 35.94 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.144 -0.317 . . . . 1.2 110.144 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -115.57 106.05 51.02 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.808 0.337 . . . . 0.72 110.974 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.43 -20.3 21.0 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.33 2.02 . . . . 0.54 112.266 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -77.0 5.98 7.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.034 -0.53 . . . . 2.22 110.996 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.4 22.07 4.46 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.192 -0.763 . . . . 0.59 111.192 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 66.0 mtt -109.19 -167.41 1.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.528 0.204 . . . . 0.57 110.777 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.04 130.7 41.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.291 0.567 . . . . 1.54 111.659 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.68 19.0 13.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.142 -0.935 . . . . 1.16 109.227 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.7 -46.07 8.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.408 -0.815 . . . . 1.53 110.368 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -146.49 130.65 17.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.118 -0.492 . . . . 1.21 110.252 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.434 ' O ' HG23 ' A' ' 175' ' ' VAL . 0.0 OUTLIER -60.56 -28.9 68.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 1.96 110.333 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.54 -31.28 70.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.49 0.662 . . . . 2.05 110.506 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 43.0 t -86.0 -43.52 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.806 -0.634 . . . . 0.65 109.677 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -52.11 -50.19 62.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.306 -0.861 . . . . 0.47 111.781 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 40' ' ' LEU . 93.4 t -59.09 -50.21 80.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.249 -0.432 . . . . 0.48 111.564 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -63.29 -41.93 99.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.028 -0.533 . . . . 1.7 111.289 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -64.65 -43.84 92.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.552 -0.295 . . . . 1.32 110.774 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -57.44 -48.38 79.3 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.108 0.48 . . . . 0.46 110.262 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.6 -35.59 77.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.778 -0.647 . . . . 0.43 111.688 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.9 -36.39 80.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.502 -0.317 . . . . 1.55 110.688 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.5 m -59.14 -38.37 79.52 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.037 -0.528 . . . . 0.48 110.654 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.407 HG13 HG22 ' A' ' 155' ' ' VAL . 43.0 t -61.26 -53.08 53.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.48 110.196 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -58.11 -41.48 83.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.501 -0.772 . . . . 1.59 111.086 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -61.37 -44.28 97.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 1.17 111.179 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.42 -36.82 60.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.056 0.762 . . . . 0.68 113.056 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.3 p -63.02 -32.04 73.31 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.069 0.461 . . . . 1.07 110.959 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.041 -0.527 . . . . 2.26 110.217 -179.785 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.934 0.397 . . . . 1.32 109.976 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -94.35 145.93 24.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 2.29 110.854 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.16 128.86 36.99 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.978 -0.749 . . . . 1.83 108.978 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.07 1.26 72.96 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.542 -0.837 . . . . 0.78 111.075 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -118.04 -72.34 0.69 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.785 -0.45 . . . . 1.87 109.785 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -85.21 -39.09 18.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.054 0.454 . . . . 1.46 109.997 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -138.28 152.73 48.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.97 -0.559 . . . . 0.79 110.336 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.17 132.93 54.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.02 -0.536 . . . . 0.9 110.356 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 m -85.22 120.18 26.43 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.767 -0.457 . . . . 1.11 109.767 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 69.2 mt -74.2 146.69 43.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.147 -0.479 . . . . 0.74 110.957 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.8 -10.37 48.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.464 0.649 . . . . 2.33 109.293 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -118.63 83.55 22.25 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.314 -0.857 . . . . 3.64 109.51 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.62 121.68 8.4 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.125 1.883 . . . . 0.85 111.769 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.47 109.59 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.92 -0.582 . . . . 0.72 110.552 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.0 136.72 45.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.481 -0.781 . . . . 0.89 110.986 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.33 14.97 72.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.776 -0.726 . . . . 0.73 112.5 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 144.31 33.69 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.151 -0.315 . . . . 0.64 110.151 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.51 168.98 16.68 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.627 2.218 . . . . 0.56 112.018 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 22.1 mp0 -63.68 -53.0 58.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.043 -0.526 . . . . 1.79 111.013 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.59 103.3 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.862 0.363 . . . . 0.45 110.617 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.8 tp -108.39 127.99 54.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.044 -0.526 . . . . 0.53 110.564 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -128.71 142.95 50.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 1.61 110.135 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.64 152.2 37.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.367 -0.378 . . . . 0.53 110.062 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.98 174.14 9.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.298 0.57 . . . . 0.55 111.52 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.434 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 7.9 t -155.54 132.14 10.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.628 -0.715 . . . . 0.96 109.495 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.532 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 92.1 m-85 -67.36 -15.24 63.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.187 -0.461 . . . . 0.62 111.333 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.532 ' CE1' ' HA2' ' A' ' 69' ' ' GLY . 71.8 m-85 -86.31 -6.12 59.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 1.78 111.589 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 35.5 t -109.61 118.45 50.37 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.451 -0.34 . . . . 0.48 111.626 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.48 -25.63 76.0 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.406 2.07 . . . . 0.7 111.232 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -61.84 -30.12 70.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.571 -0.74 . . . . 1.74 110.251 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.5 m -79.27 -41.06 28.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.37 110.334 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.51 -35.17 76.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.137 0.494 . . . . 1.44 110.008 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.699 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 26.6 tt0 -67.04 -33.42 75.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.428 -0.806 . . . . 2.27 110.4 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.417 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.6 m-85 -86.51 -22.44 26.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.398 . . . . 0.87 110.768 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 12.8 tp10 -84.18 -62.62 1.52 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.019 -0.537 . . . . 1.89 112.41 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -92.41 -33.98 14.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.309 0.855 . . . . 2.0 113.309 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.699 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 73.9 t -76.72 -58.24 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.286 -0.566 . . . . 0.58 111.631 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -89.95 -26.19 20.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.415 0.524 . . . . 0.41 112.415 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 22.6 m-70 56.19 49.9 14.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.178 0.513 . . . . 0.84 110.492 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.417 HG13 ' CD2' ' A' ' 36' ' ' PHE . 42.4 mm -59.89 -51.69 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.739 -0.664 . . . . 0.41 111.862 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -56.46 -40.05 74.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.658 -0.246 . . . . 1.03 111.643 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.46 -47.63 75.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.112 0.482 . . . . 1.73 110.307 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -59.61 -42.41 92.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.565 -0.743 . . . . 1.19 110.968 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.656 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 53.8 t -61.53 -47.79 91.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.877 -0.601 . . . . 0.49 110.757 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -58.46 -33.08 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 1.53 111.74 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -79.17 -15.76 57.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 2.02 111.577 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -101.94 -23.99 14.06 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.81 0.338 . . . . 1.44 111.045 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 57.8 mt -64.82 137.34 97.11 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.1 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.49 172.04 16.5 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.584 2.189 . . . . 0.74 111.792 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.65 136.76 53.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.852 -0.613 . . . . 2.63 111.579 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.49 -23.2 36.69 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.806 -0.712 . . . . 0.82 112.904 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.25 130.35 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.913 0.387 . . . . 1.03 111.05 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -112.25 130.31 55.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 2.51 110.287 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.0 ttt -92.37 139.07 30.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 1.28 110.123 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.08 129.22 52.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.679 0.276 . . . . 0.61 111.3 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -115.07 121.81 44.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.856 -0.794 . . . . 0.86 108.856 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 10.5 m-30 -117.53 159.5 22.76 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.142 0.496 . . . . 0.71 112.075 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 48.6 t-80 -105.32 140.01 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.744 -0.662 . . . . 0.57 109.901 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.7 m -104.0 152.31 6.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.539 -0.3 . . . . 0.68 111.553 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.608 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 72.4 m-20 -96.11 -2.83 45.73 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.955 0.724 . . . . 0.93 112.955 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -87.89 4.06 46.13 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.166 -0.614 . . . . 0.74 111.603 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.73 107.8 5.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.626 -0.509 . . . . 1.09 109.626 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.65 -8.03 3.35 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.603 -0.726 . . . . 0.78 111.297 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.4 -131.75 24.71 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.326 -0.464 . . . . 0.81 112.597 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -74.11 -45.67 47.59 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.863 0.32 . . . . 2.47 111.863 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -73.34 -17.75 61.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.372 -0.376 . . . . 1.94 111.229 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.532 ' HA2' ' CE1' ' A' ' 29' ' ' PHE . . . -58.33 -32.54 68.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.787 -0.72 . . . . 0.7 112.585 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.608 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 86.8 mttt -71.5 -31.25 66.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.729 0.299 . . . . 2.69 111.718 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.92 -42.48 85.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.847 0.356 . . . . 1.65 110.703 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.448 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 1.3 mt -66.35 -24.26 66.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.145 -0.48 . . . . 1.17 110.93 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -68.87 -34.13 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.267 0.556 . . . . 0.62 109.83 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.402 ' HA ' HG22 ' A' ' 135' ' ' VAL . 41.1 tt0 -76.43 -40.09 51.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.561 -0.745 . . . . 1.21 109.155 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.75 91.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.61 -0.723 . . . . 0.71 111.198 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -60.44 -38.0 82.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.59 110.502 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -62.06 -38.88 90.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.899 -0.591 . . . . 0.71 110.197 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.82 -44.97 92.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.636 -0.711 . . . . 0.84 109.812 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.41 86.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.738 -0.665 . . . . 0.66 110.91 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.6 mtm -66.01 -44.08 85.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 1.08 111.042 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.3 -30.74 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.112 0.482 . . . . 0.99 111.221 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.7 mt -80.39 -41.99 23.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 0.97 110.843 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.22 11.22 34.47 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.573 -0.611 . . . . 0.78 111.573 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 m -105.78 27.4 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.792 0.329 . . . . 0.81 111.149 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -52.44 63.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 1.71 110.251 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.467 ' HA ' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -63.2 -34.42 77.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.503 0.668 . . . . 1.91 110.252 179.267 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -62.91 -33.88 76.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.298 -0.865 . . . . 2.28 111.454 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.6 m -106.35 10.4 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.433 0.531 . . . . 0.65 112.433 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 86' ' ' ASP . 59.6 m -64.1 -53.76 44.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.787 0.327 . . . . 0.98 111.637 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.461 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 58.4 t -63.79 -55.02 36.89 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.532 0.567 . . . . 0.62 112.532 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 11.3 Cg_endo -55.04 -37.24 93.98 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.302 2.001 . . . . 0.61 113.56 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.416 HD22 HD21 ' A' ' 72' ' ' LEU . 33.0 mt -71.45 -32.54 68.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.681 0.277 . . . . 0.79 110.647 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -75.21 -53.34 8.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.273 0.558 . . . . 0.58 110.442 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.34 -39.9 94.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.81 -0.632 . . . . 1.7 110.961 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.97 -6.33 59.95 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.262 -0.494 . . . . 0.82 113.575 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.2 t -109.79 -40.3 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 117.489 0.644 . . . . 0.75 111.789 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.52 -48.43 5.01 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.035 0.754 . . . . 0.84 113.035 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -78.78 -70.34 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.772 0.286 . . . . 1.41 111.772 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -34.84 67.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.706 -0.224 . . . . 1.31 111.507 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 58.56 34.68 24.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.03 -0.532 . . . . 1.44 110.402 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -26.45 39.89 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.579 -0.737 . . . . 1.57 110.939 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.526 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 67.1 mt -87.17 100.35 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.91 110.411 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.526 ' HD2' ' O ' ' A' ' 102' ' ' ILE . 13.7 mmm180 -125.5 -12.22 6.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 3.22 110.334 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.6 p -139.88 168.28 20.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 1.51 110.498 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.7 -27.04 68.94 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.959 0.409 . . . . 1.08 110.984 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.5 m -62.85 -31.43 72.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 1.43 110.631 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.475 ' O ' HG23 ' A' ' 111' ' ' VAL . 33.4 m-20 -73.9 -44.52 54.94 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.661 -0.496 . . . . 1.89 109.661 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.5 mt -62.82 -41.9 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.808 -0.633 . . . . 0.9 110.124 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 ttm105 -60.72 -34.71 74.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.675 -0.693 . . . . 2.19 109.849 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.4 -41.56 69.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.626 -0.716 . . . . 1.95 111.44 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 107' ' ' ASP . 81.1 t -54.46 -45.43 70.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.747 0.308 . . . . 0.88 111.248 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -65.14 -41.48 94.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.92 111.072 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 80.4 mt -65.94 -41.55 90.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.994 0.426 . . . . 1.33 110.064 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -65.65 -30.35 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.71 -0.677 . . . . 1.93 110.354 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.97 -34.92 66.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 1.1 111.255 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 139.68 5.58 1.24 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.241 -0.98 . . . . 1.15 113.273 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 47.6 mm -94.06 123.57 46.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.671 -0.492 . . . . 1.61 109.671 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -61.25 137.55 58.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.594 -0.275 . . . . 2.73 110.498 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.63 -42.93 78.67 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.823 -0.626 . . . . 1.19 112.64 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.4 -45.48 92.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 2.98 110.68 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.49 -45.97 92.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.167 0.508 . . . . 2.52 110.067 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -62.79 -48.06 80.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.458 -0.792 . . . . 1.51 110.951 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.45 -36.13 81.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 2.3 111.047 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.16 86.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 1.23 109.782 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.07 -35.54 78.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.535 -0.757 . . . . 1.11 110.764 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -58.08 -36.32 72.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.104 0.478 . . . . 1.31 110.822 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -99.93 16.08 25.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.096 -0.502 . . . . 1.63 111.196 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.3 m -85.55 144.37 27.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 2.04 111.195 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.95 -36.9 85.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.839 -0.619 . . . . 3.82 110.864 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -56.19 -47.15 81.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 1.53 110.746 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 77' ' ' ALA . 17.6 t -63.83 -42.38 95.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 1.11 110.379 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -61.38 -33.75 74.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 2.43 110.549 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 63.8 m -71.86 -28.75 63.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.926 -0.579 . . . . 1.47 110.646 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.405 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 96.5 mt -74.57 -33.92 62.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.307 -0.406 . . . . 0.93 110.035 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 131' ' ' VAL . 50.5 t -61.43 -43.76 97.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.077 0.465 . . . . 0.8 110.11 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.48 95.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.585 -0.734 . . . . 0.85 111.19 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -62.43 -40.27 96.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.437 -0.347 . . . . 1.39 111.583 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.488 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 51.9 mt-30 -59.53 -52.54 65.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.61 111.152 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -71.69 -28.87 64.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.406 . . . . 2.82 111.768 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -63.89 -49.63 71.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.362 -0.381 . . . . 1.95 110.537 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.477 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -62.17 -44.2 97.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.876 -0.602 . . . . 0.65 111.464 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.89 84.75 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.263 -0.426 . . . . 0.61 111.556 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.65 -41.24 63.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 0.72 110.813 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.48 -43.54 93.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.037 -0.528 . . . . 1.39 111.795 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 141' ' ' ALA . 32.2 m -79.84 -1.78 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 111.587 0.218 . . . . 1.34 111.587 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 53.98 59.91 3.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.326 0.584 . . . . 1.95 109.872 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 152' ' ' ALA . 11.7 tp -58.57 134.04 56.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.242 -0.89 . . . . 0.71 112.524 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.9 mmt-85 -106.61 -39.86 5.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.193 -0.912 . . . . 4.16 110.663 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -122.3 159.29 16.93 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.09 -0.804 . . . . 0.68 111.09 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.52 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.4 t -65.58 -57.62 13.96 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 112.26 0.467 . . . . 0.49 112.26 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.52 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.8 Cg_endo -85.5 89.47 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.526 2.15 . . . . 0.56 112.068 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' A' ' 147' ' ' LEU . . . -129.87 154.2 47.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.181 -0.463 . . . . 0.63 110.611 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 30.9 ttm -127.35 133.06 50.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.208 -0.451 . . . . 0.42 110.817 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.15 133.99 53.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.52 110.186 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 44.9 t -102.4 114.81 42.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.263 -0.426 . . . . 0.55 111.218 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 59.46 14.03 3.59 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.088 -0.96 . . . . 1.16 111.987 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 69.52 20.57 75.61 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.937 -0.649 . . . . 0.56 112.125 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -120.78 -45.81 2.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 1.75 111.235 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -106.39 129.84 54.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.972 -0.558 . . . . 1.16 111.14 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -106.86 138.55 42.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.636 -0.711 . . . . 0.98 109.652 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mp -90.96 132.54 35.9 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.619 -0.432 . . . . 1.2 110.3 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -111.53 97.63 37.32 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.283 -0.417 . . . . 0.72 110.403 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.92 -18.87 46.75 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.365 2.043 . . . . 0.54 111.818 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -78.23 -8.25 58.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 2.22 110.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -115.65 14.68 17.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.009 -0.615 . . . . 0.59 112.292 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 55.5 mtt -102.55 -178.81 3.79 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.151 -0.314 . . . . 0.57 110.151 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.2 119.56 15.5 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.363 0.601 . . . . 1.54 111.2 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.91 22.34 15.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.405 -0.816 . . . . 1.16 109.453 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.34 -51.4 5.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.326 -0.852 . . . . 1.53 110.035 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -118.47 121.66 40.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.984 -0.553 . . . . 1.21 110.185 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 46.2 mmm -59.32 -38.2 79.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 1.96 111.879 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.16 -27.94 68.4 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.117 0.484 . . . . 2.05 110.704 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 55.4 t -77.83 -46.06 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.571 -0.74 . . . . 0.65 109.634 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.58 -50.73 69.31 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.073 -0.512 . . . . 0.47 111.414 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.21 -44.93 77.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.212 -0.449 . . . . 0.48 111.242 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 21.9 mm-40 -71.59 -46.24 59.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.187 -0.46 . . . . 1.7 111.294 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.08 -45.95 82.9 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.215 0.322 . . . . 1.32 111.204 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.508 ' O ' HG23 ' A' ' 182' ' ' VAL . 19.0 t80 -59.4 -56.12 26.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.643 -0.253 . . . . 0.46 110.88 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.83 87.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.43 . . . . 0.43 112.087 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.3 OUTLIER -69.08 -33.87 74.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.687 -0.233 . . . . 1.55 111.056 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 86.4 m -64.78 -39.36 93.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.581 -0.526 . . . . 0.48 109.581 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 178' ' ' TYR . 11.7 t -60.41 -46.7 94.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.106 -0.497 . . . . 0.48 109.748 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -61.09 -41.62 97.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.826 -0.625 . . . . 1.59 110.477 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.65 -41.67 95.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 1.17 111.088 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.68 -38.08 34.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.292 -0.413 . . . . 0.68 112.056 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 51.0 m -63.18 -30.31 71.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 1.07 111.006 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 121.278 0.561 . . . . 2.26 110.182 179.958 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 121.008 0.432 . . . . 1.32 110.76 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -111.05 147.53 34.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.82 -0.627 . . . . 2.29 110.627 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.22 117.43 17.04 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.046 -0.525 . . . . 1.83 109.621 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA2' HG23 ' A' ' 10' ' ' THR . . . 111.59 -5.8 27.98 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.135 -0.786 . . . . 0.78 111.135 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -112.46 -80.89 0.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.515 0.198 . . . . 1.87 110.637 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -85.79 -27.71 24.99 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.912 0.387 . . . . 1.46 110.638 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -141.36 159.75 41.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.757 -0.46 . . . . 0.79 109.757 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.421 HG23 ' HA2' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -137.99 130.57 29.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.469 -0.332 . . . . 0.9 111.27 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -77.13 125.26 29.04 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.525 -0.546 . . . . 1.11 109.525 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.9 mt -71.0 147.01 49.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.938 0.399 . . . . 0.74 111.156 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.67 -38.91 53.7 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.005 -0.739 . . . . 2.33 109.005 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -117.21 104.34 50.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.115 -0.948 . . . . 3.64 109.343 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.39 143.25 34.61 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.227 1.952 . . . . 0.85 112.111 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.61 91.88 3.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 0.72 110.075 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.86 123.6 20.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.841 -0.618 . . . . 0.89 110.003 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.02 -5.92 42.79 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.839 -0.696 . . . . 0.73 111.922 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.31 155.28 93.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.571 0.224 . . . . 0.64 111.091 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -76.31 -177.09 3.44 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.662 2.241 . . . . 0.56 112.057 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.417 ' OE1' HG22 ' A' ' 54' ' ' VAL . 40.3 mt-30 -69.87 -52.4 25.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 1.79 110.994 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.0 t -123.26 105.1 15.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.25 0.547 . . . . 0.45 110.747 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 tp -105.54 119.6 39.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.982 -0.554 . . . . 0.53 109.738 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.484 ' OE1' ' HG3' ' A' ' 58' ' ' LYS . 17.6 tt0 -122.72 147.42 46.5 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.806 0.336 . . . . 1.61 110.297 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -122.29 151.87 40.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.131 -0.486 . . . . 0.53 110.655 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.402 ' HA ' HG12 ' A' ' 150' ' ' VAL . 0.7 OUTLIER -167.64 169.61 11.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.55 110.855 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.463 ' HB2' HG22 ' A' ' 61' ' ' VAL . 3.4 t -152.47 135.72 15.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.273 -0.421 . . . . 0.96 110.371 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.448 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 90.6 m-85 -71.43 -15.59 62.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.099 -0.501 . . . . 0.62 110.232 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -90.55 0.51 57.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.977 -0.556 . . . . 1.78 110.679 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 51.1 t -109.45 114.93 56.82 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 116.017 -0.538 . . . . 0.48 110.603 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 19.7 Cg_endo -60.9 -26.75 83.67 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.588 2.192 . . . . 0.7 111.864 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -32.5 72.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.042 -0.526 . . . . 1.74 110.842 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.2 m -72.28 -33.38 67.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.25 -0.648 . . . . 0.37 109.25 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -66.13 -40.67 90.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.866 -0.79 . . . . 1.44 108.866 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.714 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 6.7 mt-30 -70.69 -37.55 73.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.588 -0.733 . . . . 2.27 110.791 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.96 -18.23 62.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.919 0.34 . . . . 0.87 111.919 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.74 -65.78 1.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.292 -0.563 . . . . 1.89 112.096 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.55 -27.71 66.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.15 0.5 . . . . 2.0 111.612 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 96.1 t -100.2 -59.53 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.715 -0.394 . . . . 0.58 111.992 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -85.03 -33.75 22.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.894 0.701 . . . . 0.41 112.894 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 61.63 46.34 7.3 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.098 0.475 . . . . 0.84 110.489 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 mm -58.72 -49.27 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.388 -0.823 . . . . 0.41 111.07 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -63.75 -45.94 87.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 1.03 111.323 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.27 -33.55 76.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.115 -0.493 . . . . 1.73 111.756 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -75.41 -41.93 54.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.411 -0.359 . . . . 1.19 110.804 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.516 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 22.5 t -60.04 -41.01 84.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.91 -0.586 . . . . 0.49 110.602 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -54.82 -38.31 67.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 1.53 112.206 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -78.7 -10.91 59.93 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.588 0.588 . . . . 2.02 112.588 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.5 mtmm -120.13 19.94 12.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.896 0.379 . . . . 1.44 110.918 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 14.1 mt -89.77 136.23 29.6 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.508 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.47 153.73 69.09 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.542 2.161 . . . . 0.74 111.848 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.13 123.45 20.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.169 -0.468 . . . . 2.63 110.774 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.33 -11.78 43.62 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.775 -0.648 . . . . 0.82 111.546 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.417 HG22 ' OE1' ' A' ' 21' ' ' GLN . 83.4 t -88.52 115.89 29.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.025 0.441 . . . . 1.03 110.368 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -92.11 140.33 29.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.893 -0.594 . . . . 2.51 110.603 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.5 ttt -100.73 119.14 38.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.097 -0.502 . . . . 1.28 110.215 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.91 99.98 9.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.173 -0.467 . . . . 0.61 111.236 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HG3' ' OE1' ' A' ' 24' ' ' GLU . 44.5 tttp -89.68 108.97 19.99 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.77 -0.826 . . . . 0.86 108.77 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.443 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 9.0 m-30 -106.72 153.02 23.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.417 0.627 . . . . 0.71 111.932 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -98.16 132.12 43.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.681 -0.69 . . . . 0.57 110.344 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 27' ' ' SER . 5.3 m -80.75 156.73 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.793 -0.185 . . . . 0.68 110.574 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 139' ' ' GLU . 13.0 m-20 -115.72 24.57 11.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.148 0.425 . . . . 0.93 112.148 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -117.89 8.03 12.51 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.229 -0.588 . . . . 0.74 111.282 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.9 mtp -141.45 107.69 5.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.856 -0.424 . . . . 1.09 109.856 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.18 -10.76 3.04 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.751 -0.659 . . . . 0.78 112.023 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.46 -142.57 29.27 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.763 -0.732 . . . . 0.81 112.363 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.58 -34.98 76.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.298 0.571 . . . . 2.47 110.816 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -75.71 -11.79 60.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 1.94 110.349 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.59 -46.39 93.85 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.044 -0.598 . . . . 0.7 112.496 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -67.97 -27.07 66.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.609 0.242 . . . . 2.69 111.46 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -43.81 93.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 1.65 110.753 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -24.47 64.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.793 -0.64 . . . . 1.17 111.185 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 m -66.01 -35.45 80.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.163 0.506 . . . . 0.62 110.472 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -76.06 -37.8 57.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 1.21 109.484 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.67 97.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.638 -0.71 . . . . 0.71 110.386 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -64.63 -36.65 84.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.444 -0.798 . . . . 0.59 110.579 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.527 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -61.42 -38.72 88.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.71 109.991 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 58.6 t -66.54 -44.88 89.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.728 -0.669 . . . . 0.84 109.727 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.01 86.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.66 110.989 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.7 ttm -64.22 -44.22 92.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.868 -0.606 . . . . 1.08 110.756 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.18 83.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.589 . . . . 0.99 111.516 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 78.8 mt -77.21 -38.56 51.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.576 -0.284 . . . . 0.97 111.411 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.16 38.27 3.61 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.705 -0.76 . . . . 0.78 112.42 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.9 m -132.59 30.8 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.79 0.328 . . . . 0.81 110.482 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -53.66 -64.94 0.66 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.727 -0.669 . . . . 1.71 112.568 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -31.73 70.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 1.91 111.155 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -62.13 -38.79 90.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.955 -0.566 . . . . 2.28 111.866 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -98.91 -9.3 8.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.413 0.523 . . . . 0.65 112.413 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -58.16 -45.44 87.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.658 0.266 . . . . 0.98 111.643 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.461 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 77.0 t -64.63 -60.81 7.54 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.185 0.439 . . . . 0.62 112.185 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 11.9 Cg_endo -56.14 -33.26 89.8 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.983 1.789 . . . . 0.61 113.068 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.41 -46.27 67.24 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.836 -0.346 . . . . 0.79 110.356 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 m-85 -61.49 -48.22 82.09 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.318 0.58 . . . . 0.58 110.54 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -62.84 -43.92 97.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.381 -0.827 . . . . 1.7 111.663 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.26 -16.46 77.1 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.097 -0.573 . . . . 0.82 113.802 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.496 HG23 HD12 ' A' ' 102' ' ' ILE . 55.0 t -100.01 -41.23 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.33 0.565 . . . . 0.75 112.424 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 31' ' ' PRO . 79.3 mt-30 -99.56 -42.34 6.96 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.009 1.114 . . . . 0.84 114.009 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -81.6 -68.05 0.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.585 -0.446 . . . . 1.41 111.784 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -34.59 62.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.094 -0.242 . . . . 1.31 110.851 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.554 ' HB3' ' NH2' ' A' ' 103' ' ' ARG . 78.9 mt-30 57.85 37.67 27.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.906 -0.588 . . . . 1.44 110.636 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.29 -20.72 27.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.127 -0.942 . . . . 1.57 110.896 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 96' ' ' VAL . 83.2 mt -80.94 106.42 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.752 -0.658 . . . . 0.91 110.511 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.554 ' NH2' ' HB3' ' A' ' 100' ' ' GLN . 37.5 mmt180 -123.37 -20.14 5.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.587 -0.733 . . . . 3.22 110.76 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -133.29 172.85 12.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.828 0.346 . . . . 1.51 110.444 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.46 -26.39 67.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.023 0.44 . . . . 1.08 110.627 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -33.08 73.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.668 -0.696 . . . . 1.43 110.673 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -71.74 -39.25 70.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.962 -0.563 . . . . 1.89 109.735 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.1 mt -64.78 -41.58 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.875 -0.602 . . . . 0.9 109.744 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -58.77 -42.7 89.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.085 -0.961 . . . . 2.19 110.963 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -60.02 -40.96 91.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 1.95 111.149 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.3 t -56.6 -43.51 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 0.88 111.021 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -66.57 -37.65 85.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.92 110.513 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 88.1 mt -65.32 -41.93 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.074 0.464 . . . . 1.33 109.854 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -64.61 -26.6 68.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.547 -0.752 . . . . 1.93 110.723 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.97 -32.14 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 1.1 110.768 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.83 7.74 3.66 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.783 -0.722 . . . . 1.15 112.914 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.3 mm -87.94 137.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.097 -0.334 . . . . 1.61 110.097 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -70.26 133.73 47.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.05 -0.523 . . . . 2.73 110.099 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.92 -44.53 96.03 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.953 -0.641 . . . . 1.19 112.56 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.98 -37.82 88.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.323 . . . . 2.98 110.987 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.22 -42.22 84.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.263 0.554 . . . . 2.52 109.612 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -63.06 -46.86 85.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.492 -0.776 . . . . 1.51 110.382 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -64.31 -29.4 70.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.215 0.531 . . . . 2.3 110.635 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.14 62.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.906 -0.588 . . . . 1.23 110.372 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.34 -34.36 78.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 1.11 110.868 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -58.74 -26.7 64.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.846 -0.615 . . . . 1.31 110.513 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -102.05 26.11 7.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.89 -0.595 . . . . 1.63 111.635 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.9 t -101.55 143.43 31.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.906 0.384 . . . . 2.04 111.162 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -65.83 -28.36 68.93 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.57 -0.741 . . . . 3.82 110.874 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.11 -45.58 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.242 0.544 . . . . 1.53 109.547 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 135' ' ' VAL . 88.9 t -64.58 -44.09 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.396 -0.82 . . . . 1.11 110.038 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -55.61 -44.44 77.03 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.993 0.425 . . . . 2.43 110.682 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 52.3 m -66.06 -39.18 89.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.589 . . . . 1.47 110.74 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.7 mt -64.2 -37.99 89.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.376 -0.375 . . . . 0.93 110.791 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 131' ' ' VAL . 54.8 t -65.4 -44.7 94.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.8 109.949 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.16 78.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.85 110.901 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -62.05 -45.46 93.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 1.39 110.903 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.493 HE21 ' HA ' ' A' ' 135' ' ' VAL . 44.9 mt-30 -63.44 -41.05 98.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.61 110.897 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.518 ' HG2' ' ND2' ' A' ' 62' ' ' ASN . 43.8 mt-10 -69.01 -40.29 78.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.072 -0.513 . . . . 2.82 111.325 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -72.05 -49.74 34.19 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.347 0.499 . . . . 1.95 112.347 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.82 -40.69 76.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.204 0.446 . . . . 0.65 112.204 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.5 -31.11 72.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.825 0.345 . . . . 0.61 111.675 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.13 -29.33 20.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.423 -0.353 . . . . 0.72 111.228 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -61.63 -50.61 71.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.995 0.426 . . . . 1.39 111.368 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.31 -8.8 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.945 -0.57 . . . . 1.34 111.547 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 64.18 74.93 0.39 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.384 0.612 . . . . 1.95 109.611 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.5 tp -80.23 123.96 28.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.679 -0.691 . . . . 0.71 111.888 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.26 -48.13 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.184 -0.673 . . . . 4.16 109.184 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.81 132.02 11.07 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.822 -0.911 . . . . 0.68 110.822 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.488 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 3.4 t -67.03 -52.44 31.09 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 112.584 0.587 . . . . 0.49 112.584 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.488 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 3.3 Cg_exo -79.55 76.79 4.36 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.11 1.874 . . . . 0.56 112.638 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.27 152.14 51.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.63 110.955 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 48.2 ttm -131.63 136.22 47.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.071 -0.513 . . . . 0.42 110.095 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -117.48 134.28 55.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.32 -0.4 . . . . 0.52 110.005 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 66.3 t -103.42 118.15 49.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.883 0.373 . . . . 0.55 110.565 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 64.67 5.35 2.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.491 -0.777 . . . . 1.16 111.658 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.2 15.41 74.62 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.032 -0.604 . . . . 0.56 112.158 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -119.92 -31.19 4.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.798 0.332 . . . . 1.75 111.227 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -118.41 139.12 51.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 1.16 110.549 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -117.09 138.67 51.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.916 -0.584 . . . . 0.98 110.319 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.9 mp -83.57 137.35 33.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.704 -0.48 . . . . 1.2 109.704 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -116.17 98.76 51.89 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.408 -0.36 . . . . 0.72 111.308 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.38 -14.13 33.8 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.374 2.049 . . . . 0.54 111.669 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -75.64 -6.73 51.84 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.159 -0.473 . . . . 2.22 110.975 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -128.87 19.2 5.55 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.773 -0.531 . . . . 0.59 111.773 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.3 mtt -99.02 -168.78 1.67 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.802 -0.199 . . . . 0.57 110.488 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.76 114.69 10.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.09 0.471 . . . . 1.54 110.533 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.86 33.37 5.25 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.728 0.775 . . . . 1.16 109.504 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.72 -47.81 2.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.119 -0.946 . . . . 1.53 111.018 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -114.45 118.8 34.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.788 0.328 . . . . 1.21 110.345 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.429 ' O ' HG23 ' A' ' 175' ' ' VAL . 12.6 mmt -59.76 -41.78 91.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 1.96 110.903 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.25 -33.11 75.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 2.05 111.643 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 77.0 t -79.18 -39.57 21.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.738 -0.21 . . . . 0.65 110.482 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -55.82 -50.14 71.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.596 -0.275 . . . . 0.47 111.159 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 171' ' ' MET . 46.6 t -58.39 -48.24 85.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.48 111.341 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -66.48 -39.55 88.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.891 -0.595 . . . . 1.7 111.423 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.61 -44.7 89.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.482 -0.326 . . . . 1.32 110.634 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.481 ' O ' HG23 ' A' ' 182' ' ' VAL . 2.5 t80 -54.9 -50.97 67.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.46 110.189 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.445 ' HA ' HG22 ' A' ' 46' ' ' VAL . . . -66.93 -38.19 85.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.43 112.041 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.19 -39.3 92.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.37 -0.377 . . . . 1.55 111.137 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 13.1 m -62.41 -36.96 83.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.48 110.116 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 178' ' ' TYR . 49.3 t -63.27 -48.76 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.047 0 CA-C-N 116.237 -0.438 . . . . 0.48 110.03 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -62.17 -40.17 95.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 1.59 110.743 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -64.39 -44.47 91.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.479 -0.328 . . . . 1.17 110.766 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.02 -32.34 71.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.475 -0.329 . . . . 0.68 111.274 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.2 m -75.54 -26.22 57.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 1.07 110.851 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 2.26 110.572 -179.832 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 N--CA 1.465 0.298 0 N-CA-C 110.25 -0.278 . . . . 1.32 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.0 142.96 49.75 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.334 -0.394 . . . . 2.29 110.87 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.32 123.59 24.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 1.83 110.366 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.97 -7.74 44.95 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.931 -0.577 . . . . 0.78 111.745 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.453 ' HB3' ' OE1' ' A' ' 8' ' ' GLN . 1.2 tttm -118.21 -75.85 0.58 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.612 0.244 . . . . 1.87 110.74 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.453 ' OE1' ' HB3' ' A' ' 7' ' ' LYS . 22.7 mp0 -76.6 -42.45 42.42 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.433 0.635 . . . . 1.46 110.175 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -134.16 163.99 28.36 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.722 -0.672 . . . . 0.79 109.394 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.4 115.91 12.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.716 0.294 . . . . 0.9 110.805 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.6 m -73.9 121.23 20.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.036 -0.529 . . . . 1.11 109.833 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.69 142.42 51.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.111 0.482 . . . . 0.74 111.667 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -74.17 -33.7 63.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.666 -0.697 . . . . 2.33 109.464 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -120.35 97.06 49.1 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.267 -0.879 . . . . 3.64 109.47 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.29 169.23 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.529 2.153 . . . . 0.85 112.554 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.69 117.12 49.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 0.72 110.464 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.43 131.9 35.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.821 0.343 . . . . 0.89 110.312 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.59 22.84 41.74 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.735 -0.745 . . . . 0.73 111.523 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.61 150.45 38.05 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.773 -0.214 . . . . 0.64 110.469 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.56 171.9 5.1 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.045 2.497 . . . . 0.56 113.077 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -71.0 -68.55 0.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.853 -0.612 . . . . 1.79 110.63 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.5 t -107.01 102.17 13.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.678 -0.49 . . . . 0.45 109.678 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 59' ' ' TYR . 18.5 tp -105.35 119.62 39.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.858 -0.61 . . . . 0.53 110.535 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -119.53 147.82 44.01 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.948 -0.39 . . . . 1.61 109.948 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.09 145.04 47.27 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.797 -0.446 . . . . 0.53 109.797 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -164.25 175.67 9.88 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.175 0.512 . . . . 0.55 110.799 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.612 ' HB2' HG22 ' A' ' 61' ' ' VAL . 3.3 t -156.53 137.82 13.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.547 -0.751 . . . . 0.96 109.998 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.563 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 71.1 m-85 -71.35 -14.69 62.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 0.62 110.572 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.435 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 71.7 m-85 -88.27 -5.92 58.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.871 -0.604 . . . . 1.78 110.45 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 13.2 t -104.73 113.4 64.96 Favored Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-O 120.961 0.41 . . . . 0.48 111.363 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 22.5 Cg_endo -64.69 -22.22 64.45 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.258 1.972 . . . . 0.7 110.429 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -67.25 -30.66 70.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.062 -0.972 . . . . 1.74 109.948 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -79.94 -38.94 31.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.411 -0.588 . . . . 0.37 109.411 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.76 -38.64 85.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 1.44 109.778 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.443 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 3.1 tp60 -60.38 -44.17 95.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.384 -0.825 . . . . 2.27 109.909 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.467 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.5 m-85 -74.39 -24.69 59.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.553 -0.748 . . . . 0.87 111.524 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -86.16 -49.89 7.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.543 0.571 . . . . 1.89 112.543 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -94.98 -38.69 10.55 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.569 0.951 . . . . 2.0 113.569 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 46.0 t -80.25 -53.43 12.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.023 -0.671 . . . . 0.58 111.882 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.7 mt -90.24 -29.18 18.35 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.768 -0.373 . . . . 0.41 111.986 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 56.69 48.67 15.88 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.477 0.656 . . . . 0.84 109.889 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.467 HG13 ' CD2' ' A' ' 36' ' ' PHE . 39.0 mm -59.89 -47.57 91.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.353 -0.84 . . . . 0.41 111.3 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.05 -48.31 64.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.326 0.391 . . . . 1.03 111.712 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.46 -47.05 87.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.906 -0.588 . . . . 1.73 110.375 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -60.67 -40.92 93.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 1.19 110.956 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.604 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 69.3 t -65.73 -48.88 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.49 110.616 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -56.4 -33.71 66.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.043 0.449 . . . . 1.53 111.594 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -81.41 -10.01 59.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 2.02 111.987 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HD2' ' HB1' ' A' ' 179' ' ' ALA . 52.1 mttm -111.94 2.35 16.9 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.804 -0.358 . . . . 1.44 111.597 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 59.3 mt -79.62 131.99 62.95 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.331 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.01 164.51 35.34 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.645 2.23 . . . . 0.74 112.157 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -61.48 108.42 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.212 0.53 . . . . 2.63 111.759 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.74 -24.08 5.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.986 -0.625 . . . . 0.82 112.109 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.06 130.7 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.928 0.394 . . . . 1.03 110.757 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 56' ' ' MET . 11.9 ttmm -119.61 147.15 44.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.895 -0.593 . . . . 2.51 110.561 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.416 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 8.9 ttt -87.54 130.45 34.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.123 -0.49 . . . . 1.28 110.564 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.27 106.97 12.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.002 -0.544 . . . . 0.61 110.934 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -90.83 127.42 36.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.525 -0.307 . . . . 0.86 110.41 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' CD2' ' HA ' ' A' ' 138' ' ' GLN . 5.2 m-30 -117.36 143.72 45.68 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.891 -0.411 . . . . 0.71 109.891 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -93.63 132.11 38.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.723 0.297 . . . . 0.57 110.988 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 27' ' ' SER . 5.6 m -76.18 150.18 6.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.992 -0.373 . . . . 0.68 109.992 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -103.87 -10.95 17.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.602 0.593 . . . . 0.93 112.602 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -89.46 20.02 4.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.037 0.384 . . . . 0.74 112.037 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.488 ' SD ' HG21 ' A' ' 150' ' ' VAL . 20.6 mtp -140.64 133.25 28.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.625 0.25 . . . . 1.09 110.425 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.43 3.5 56.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.779 -0.724 . . . . 0.78 112.07 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.09 -129.47 34.94 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.704 -0.76 . . . . 0.81 112.348 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.84 -35.28 57.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.773 0.321 . . . . 2.47 110.785 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.47 -22.0 65.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.961 -0.563 . . . . 1.94 110.527 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.54 89.19 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.703 -0.76 . . . . 0.7 111.362 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -69.98 -37.69 75.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.033 0.444 . . . . 2.69 110.549 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -62.82 -41.86 99.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.784 -0.643 . . . . 1.65 110.675 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.435 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 3.8 mt -70.69 -24.58 62.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.353 -0.385 . . . . 1.17 111.188 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.7 m -66.89 -36.95 83.44 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.135 0.493 . . . . 0.62 109.892 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -76.18 -40.97 51.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 1.21 109.988 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.57 95.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.97 -0.559 . . . . 0.71 111.014 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -61.47 -37.52 83.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 0.59 110.902 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.562 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -60.97 -35.73 77.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.175 -0.466 . . . . 0.71 110.404 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.69 -44.36 82.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.81 -0.632 . . . . 0.84 110.124 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.66 84.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.686 -0.688 . . . . 0.66 111.668 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 44.9 mtm -67.43 -41.35 84.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.331 -0.395 . . . . 1.08 111.005 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.73 -32.94 73.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 0.99 111.124 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.18 -5.14 59.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.418 -0.355 . . . . 0.97 110.751 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.71 40.63 98.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.064 -0.589 . . . . 0.78 112.432 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.3 m -131.9 30.71 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.87 0.367 . . . . 0.81 110.756 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -60.5 -53.85 52.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.801 -0.636 . . . . 1.71 110.792 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -30.81 70.12 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.235 0.54 . . . . 1.91 111.044 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -73.9 -24.5 59.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.894 -0.594 . . . . 2.28 112.205 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.456 ' HA ' ' HG2' ' A' ' 91' ' ' PRO . 27.6 m -108.73 -8.25 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 112.238 0.459 . . . . 0.65 112.238 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.4 m -55.88 -65.32 0.62 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.852 0.686 . . . . 0.98 112.852 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.7 t -60.39 -53.53 63.85 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 113.003 0.742 . . . . 0.62 113.003 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 9.8 Cg_endo -53.42 -38.61 82.99 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.16 1.907 . . . . 0.61 113.346 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.3 mt -69.8 -41.08 75.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.037 -0.357 . . . . 0.79 110.037 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 2.9 m-85 -60.29 -51.93 67.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.276 0.56 . . . . 0.58 110.269 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.3 -37.79 88.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.553 -0.749 . . . . 1.7 110.441 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.12 -8.17 68.94 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.107 -0.568 . . . . 0.82 113.687 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.6 t -112.21 -39.64 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.307 0.554 . . . . 0.75 112.205 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -98.71 -48.0 5.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.605 0.594 . . . . 0.84 112.605 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -74.53 -73.52 0.23 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.122 -0.49 . . . . 1.41 111.35 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -37.91 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.811 -0.631 . . . . 1.31 111.776 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 62.81 27.97 16.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 1.44 110.815 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -28.93 66.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.86 -0.609 . . . . 1.57 111.006 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.22 105.27 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.317 0.58 . . . . 0.91 110.809 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -121.95 -13.45 8.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 3.22 110.705 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 p -140.45 167.6 21.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 1.51 110.146 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -66.06 -27.4 68.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.44 . . . . 1.08 110.105 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -31.85 72.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.384 -0.825 . . . . 1.43 110.559 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 111' ' ' VAL . 64.8 m-20 -71.72 -40.68 69.28 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.11 -0.496 . . . . 1.89 110.194 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 105' ' ' ALA . 14.8 mt -60.68 -43.19 94.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.757 -0.656 . . . . 0.9 110.089 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -58.78 -36.22 74.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.425 -0.807 . . . . 2.19 110.439 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -68.81 -44.84 72.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.769 -0.651 . . . . 1.95 110.626 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 107' ' ' ASP . 43.8 t -59.22 -40.14 80.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.88 110.853 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -62.68 -42.38 99.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 0.92 110.397 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 87.0 mt -62.13 -37.25 77.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.193 0.52 . . . . 1.33 110.245 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.67 -14.31 62.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 1.93 111.152 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.35 -3.02 58.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.201 0.524 . . . . 1.1 110.482 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.92 16.04 26.98 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.802 -0.713 . . . . 1.15 111.942 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 44.8 mm -93.8 129.27 44.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 110.07 -0.344 . . . . 1.61 110.07 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -64.03 131.77 48.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.352 -0.385 . . . . 2.73 110.351 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.44 99.89 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.905 -0.664 . . . . 1.19 111.874 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -64.75 -37.13 86.57 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.657 -0.497 . . . . 2.98 109.657 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.51 -47.02 68.07 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.564 -0.744 . . . . 2.52 109.659 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -60.25 -40.44 90.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.759 -0.655 . . . . 1.51 110.924 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -61.31 -35.41 77.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.991 0.424 . . . . 2.3 111.17 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.33 -45.14 33.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 1.23 110.591 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.11 73.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.872 -0.604 . . . . 1.11 110.915 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -57.13 -33.32 67.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.012 -0.54 . . . . 1.31 110.908 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -111.62 21.67 15.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.274 -0.421 . . . . 1.63 111.256 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -76.91 142.25 40.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.127 -0.488 . . . . 2.04 110.908 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.26 -35.73 78.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.878 -0.601 . . . . 3.82 110.527 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.1 t -63.14 -46.33 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 1.53 109.996 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.562 HG13 ' HB3' ' A' ' 77' ' ' ALA . 55.2 t -63.66 -45.66 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.539 -0.755 . . . . 1.11 110.381 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -59.73 -40.46 88.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 2.43 110.533 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.3 m -66.5 -30.74 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 1.47 110.675 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.2 mt -72.27 -38.12 68.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.337 . . . . 0.93 110.479 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 131' ' ' VAL . 57.4 t -59.36 -46.27 92.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.144 -0.48 . . . . 0.8 110.686 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.23 83.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.908 -0.587 . . . . 0.85 111.546 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -65.67 -39.09 90.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 1.39 111.265 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.528 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 50.9 mt-30 -60.97 -46.57 90.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.61 111.079 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -68.08 -44.18 76.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.229 -0.441 . . . . 2.82 111.09 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -60.34 -45.64 92.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.57 . . . . 1.95 111.473 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -58.69 -51.27 70.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.538 . . . . 0.65 111.427 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.38 86.4 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.935 0.346 . . . . 0.61 111.935 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.28 60.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.252 -0.431 . . . . 0.72 111.908 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.28 -43.17 98.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.02 0.748 . . . . 1.39 113.02 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 141' ' ' ALA . 19.1 m -79.67 1.22 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.358 0.503 . . . . 1.34 112.358 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.42 55.43 5.75 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.576 -0.527 . . . . 1.95 109.576 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.1 tp -61.25 114.63 3.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.587 -0.733 . . . . 0.71 111.302 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.7 mmm-85 -104.48 -38.94 6.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.357 -0.838 . . . . 4.16 109.898 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -104.88 142.54 15.5 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.095 -0.802 . . . . 0.68 111.095 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 16.5 t -69.96 -55.89 8.04 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 119.262 -0.399 . . . . 0.49 111.624 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 81.6 Cg_endo -83.46 62.11 7.23 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.942 1.761 . . . . 0.56 112.436 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.27 148.2 39.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.314 -0.403 . . . . 0.63 111.117 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 51.6 ttm -122.16 135.78 54.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.42 110.565 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -118.63 121.88 41.23 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.747 -0.66 . . . . 0.52 109.626 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.5 t -93.95 120.72 43.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.266 -0.424 . . . . 0.55 110.77 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 61.56 13.65 5.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.212 -0.904 . . . . 1.16 111.604 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.08 24.91 70.63 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.613 -0.595 . . . . 0.56 111.613 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -130.62 -43.07 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.912 0.387 . . . . 1.75 111.448 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -106.05 120.47 41.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.462 -0.336 . . . . 1.16 111.388 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -103.08 132.68 49.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.515 -0.55 . . . . 0.98 109.515 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.46 143.22 33.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.942 0.401 . . . . 1.2 110.628 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -119.52 95.56 49.31 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.992 -0.549 . . . . 0.72 110.145 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.79 -25.46 53.32 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.226 1.951 . . . . 0.54 112.622 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -71.99 -13.78 61.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 2.22 110.754 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.3 0.37 50.45 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.812 -0.708 . . . . 0.59 112.404 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.1 mtt -97.6 -172.25 2.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.57 110.449 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.32 120.49 15.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 1.54 110.476 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.25 15.75 18.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.137 0.494 . . . . 1.16 110.733 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.51 -40.45 6.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 1.53 110.719 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -121.74 116.76 25.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.753 0.311 . . . . 1.21 110.858 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -55.06 -41.54 71.59 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.769 -0.65 . . . . 1.96 111.907 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -43.19 63.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.185 0.517 . . . . 2.05 111.43 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 33.1 t -74.26 -45.39 47.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.672 -0.694 . . . . 0.65 111.176 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -55.52 -50.56 69.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.329 -0.396 . . . . 0.47 111.443 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.19 -49.2 80.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.48 111.512 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 33.2 mm-40 -68.86 -44.76 72.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.485 -0.325 . . . . 1.7 111.608 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 2.4 mt-30 -56.83 -46.93 81.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.525 0.202 . . . . 1.32 111.367 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 182' ' ' VAL . 10.3 t80 -59.15 -54.15 50.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.808 0.337 . . . . 0.46 111.032 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -64.83 -37.46 87.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 0.43 112.206 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -67.44 -37.56 83.17 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.837 0.351 . . . . 1.55 110.637 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 94.8 m -62.26 -36.67 82.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.48 109.826 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 178' ' ' TYR . 92.8 t -58.93 -49.37 83.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.003 -0.544 . . . . 0.48 110.481 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 37.6 tttm -58.83 -43.18 90.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 1.59 110.975 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -61.96 -43.95 97.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 1.17 111.671 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.01 -34.7 64.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.051 0.389 . . . . 0.68 112.051 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.6 m -69.28 -29.67 67.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.11 0.481 . . . . 1.07 110.495 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.73 -0.668 . . . . 2.26 110.715 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.129 0.49 . . . . 1.32 111.185 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.08 139.64 53.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.459 -0.791 . . . . 2.29 110.015 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.42 121.35 15.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.044 0.45 . . . . 1.83 110.408 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.04 -18.93 28.19 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.744 -0.662 . . . . 0.78 111.758 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -100.97 -79.4 0.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.773 0.32 . . . . 1.87 110.872 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -83.77 -27.16 29.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.671 0.272 . . . . 1.46 111.341 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -145.72 153.5 41.03 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.928 -0.397 . . . . 0.79 109.928 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.11 130.48 49.92 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.394 -0.366 . . . . 0.9 110.841 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -81.81 120.41 25.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.884 -0.413 . . . . 1.11 109.884 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.0 mt -67.71 136.02 53.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.085 -0.507 . . . . 0.74 111.291 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.43 -26.92 52.0 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.259 -0.645 . . . . 2.33 109.259 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -120.92 88.61 44.75 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.399 -0.819 . . . . 3.64 109.544 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.6 162.47 32.97 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.769 2.313 . . . . 0.85 113.034 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.9 t -103.72 113.61 41.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.755 -0.657 . . . . 0.72 110.41 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.45 138.37 47.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.137 -0.483 . . . . 0.89 111.433 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.3 86.58 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.08 -0.581 . . . . 0.73 112.886 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.64 151.56 84.9 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.535 0.168 . . . . 0.64 110.666 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.11 173.67 10.05 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.288 1.992 . . . . 0.56 112.297 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.63 -46.29 72.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.091 -0.504 . . . . 1.79 110.784 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -127.56 105.0 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.812 0.339 . . . . 0.45 110.383 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.6 tp -108.25 121.03 44.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.928 -0.578 . . . . 0.53 109.726 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -123.92 145.51 49.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.447 -0.342 . . . . 1.61 110.506 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -121.15 147.27 45.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.079 -0.509 . . . . 0.53 109.981 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -167.68 178.95 5.05 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.056 -0.52 . . . . 0.55 111.024 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.471 ' HB2' HG22 ' A' ' 61' ' ' VAL . 7.8 t -158.94 138.36 11.57 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.01 -0.541 . . . . 0.96 110.001 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.3 m-85 -69.35 -18.84 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.11 0.481 . . . . 0.62 109.97 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CE2' HD12 ' A' ' 72' ' ' LEU . 78.9 m-85 -83.65 -6.9 59.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.48 -0.782 . . . . 1.78 110.866 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.9 t -97.95 117.19 65.39 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 116.504 -0.316 . . . . 0.48 110.808 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.544 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 18.3 Cg_endo -62.05 -23.07 75.33 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.268 1.979 . . . . 0.7 112.019 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -34.8 64.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.037 -0.529 . . . . 1.74 110.652 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.1 m -71.39 -33.34 69.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.068 0.461 . . . . 0.37 110.259 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -63.26 -45.54 91.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.547 0.689 . . . . 1.44 109.298 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.604 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 8.8 tm0? -71.28 -37.67 71.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.948 -1.024 . . . . 2.27 111.182 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.3 -22.93 66.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.232 0.456 . . . . 0.87 112.232 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -108.71 -51.36 2.9 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.927 -0.709 . . . . 1.89 112.378 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -68.12 -27.69 66.67 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.879 -0.513 . . . . 2.0 111.65 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 78.7 t -102.86 -64.87 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.663 -0.244 . . . . 0.58 111.073 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.65 -38.49 67.66 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.702 0.26 . . . . 0.41 111.702 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 64.02 50.56 2.47 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.468 0.48 . . . . 0.84 110.455 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.47 -52.56 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.84 -0.618 . . . . 0.41 111.551 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.595 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 21.5 m -58.16 -52.18 66.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.488 0.185 . . . . 1.03 111.033 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 29.9 t70 -58.93 -39.33 81.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.582 -0.281 . . . . 1.73 111.687 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -71.54 -42.8 67.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.697 0.285 . . . . 1.19 110.632 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 37.5 t -59.49 -41.13 83.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.49 110.683 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 43' ' ' SER . 75.5 mttt -55.2 -36.7 66.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.896 0.379 . . . . 1.53 110.871 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 36.1 mttm -80.76 -13.23 59.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.12 -0.491 . . . . 2.02 112.218 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -109.88 8.23 24.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.579 0.228 . . . . 1.44 111.54 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 41.7 mt -96.09 136.7 21.94 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.889 -0.324 . . . . 1.0 111.643 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.54 177.47 3.97 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.537 2.158 . . . . 0.74 111.646 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -75.01 149.01 39.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.913 0.387 . . . . 2.63 110.631 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.14 -18.5 40.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.019 -0.61 . . . . 0.82 112.298 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 t -84.09 132.14 32.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.827 0.346 . . . . 1.03 110.613 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -117.45 136.77 52.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.402 -0.363 . . . . 2.51 110.805 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.1 mtp -82.79 113.68 20.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.534 . . . . 1.28 110.088 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.1 94.01 5.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.072 0.463 . . . . 0.61 110.747 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -89.91 116.82 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 0.86 109.937 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 4.8 m-30 -111.89 150.87 29.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.112 0.482 . . . . 0.71 111.304 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -100.3 128.06 46.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.922 -0.581 . . . . 0.57 110.604 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 27' ' ' SER . 8.1 m -80.38 152.71 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.507 -0.315 . . . . 0.68 110.54 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -103.62 -0.5 29.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.787 0.662 . . . . 0.93 112.787 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -96.3 16.93 17.01 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.699 -0.4 . . . . 0.74 110.984 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.53 107.47 5.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.355 -0.384 . . . . 1.09 110.47 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.56 18.68 1.58 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.886 -0.673 . . . . 0.78 112.941 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.53 -112.25 4.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.269 -0.491 . . . . 0.81 113.024 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.52 -31.03 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.608 0.242 . . . . 2.47 111.167 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.21 -17.37 63.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.831 0.348 . . . . 1.94 110.639 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.81 -33.48 78.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.988 -0.625 . . . . 0.7 111.664 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -66.65 -33.07 74.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.906 0.384 . . . . 2.69 110.506 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -74.09 -41.18 62.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 1.65 110.533 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.553 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -64.24 -27.98 69.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.32 -0.4 . . . . 1.17 111.045 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.3 m -65.18 -36.03 82.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.065 0.46 . . . . 0.62 110.263 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 78' ' ' VAL . 15.1 tt0 -75.81 -37.93 58.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.132 -0.692 . . . . 1.21 109.132 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.42 -44.85 95.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.55 -0.75 . . . . 0.71 110.444 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.544 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 69.6 t-105 -61.11 -36.03 78.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.333 -0.849 . . . . 0.59 110.764 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.508 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -64.59 -37.76 88.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 0.71 110.268 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 74' ' ' GLN . 57.0 t -65.68 -42.94 93.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 0.84 109.849 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.71 92.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.578 -0.737 . . . . 0.66 110.742 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 28.5 mtm -63.73 -39.14 93.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 1.08 111.196 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.07 -39.37 79.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.161 -0.472 . . . . 0.99 111.29 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.39 -29.35 47.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.242 -0.436 . . . . 0.97 111.36 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.74 10.41 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.692 -0.766 . . . . 0.78 111.964 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.98 26.08 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 110.548 -0.167 . . . . 0.81 110.548 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.544 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 3.5 mp0 -55.56 -61.99 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 1.71 111.249 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -37.87 67.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.002 -0.545 . . . . 1.91 111.98 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm -64.0 -33.4 75.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 2.28 112.084 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.2 m -101.17 -8.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.848 0.314 . . . . 0.65 111.848 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.9 m -58.19 -49.04 78.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.919 0.34 . . . . 0.98 111.919 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.46 -58.35 15.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 112.336 0.495 . . . . 0.62 112.336 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.46 -36.45 98.74 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.866 1.71 . . . . 0.61 113.221 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.84 -42.99 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.702 0.286 . . . . 0.79 110.279 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -62.69 -46.83 86.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.129 0.49 . . . . 0.58 110.722 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.06 -42.54 96.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.699 -0.682 . . . . 1.7 111.321 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.36 -14.13 68.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.955 -0.64 . . . . 0.82 113.527 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.1 -32.23 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 117.076 0.438 . . . . 0.75 112.025 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 31' ' ' PRO . 53.2 mt-30 -113.89 -42.77 3.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.783 1.031 . . . . 0.84 113.783 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -69.25 -61.96 1.58 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.773 0.32 . . . . 1.41 111.246 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.8 p -92.84 -30.17 15.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.315 -0.402 . . . . 1.31 110.743 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 61.28 33.31 19.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.627 -0.715 . . . . 1.44 110.121 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.7 -31.75 41.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.295 -0.866 . . . . 1.57 111.239 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.9 mt -70.75 106.09 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.91 110.421 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -129.15 -11.72 4.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.391 -0.822 . . . . 3.22 110.494 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.3 m -134.4 165.91 24.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.949 -0.569 . . . . 1.51 110.293 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.17 64.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.1 0.476 . . . . 1.08 110.738 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -36.73 84.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.784 -0.644 . . . . 1.43 110.602 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 111' ' ' VAL . 15.9 m-20 -63.8 -46.28 85.89 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.307 -0.627 . . . . 1.89 109.307 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.0 mt -59.47 -39.73 79.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.541 -0.754 . . . . 0.9 110.482 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -62.19 -43.36 99.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.81 -0.632 . . . . 2.19 110.689 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -65.28 -33.86 76.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.286 -0.416 . . . . 1.95 110.639 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 107' ' ' ASP . 92.6 t -62.2 -43.99 98.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.963 -0.562 . . . . 0.88 110.279 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -63.92 -39.03 93.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.92 110.56 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 80.0 mt -64.65 -30.81 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.433 0.635 . . . . 1.33 109.897 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -77.1 -14.91 59.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.547 -0.752 . . . . 1.93 110.821 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.82 1.07 57.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.029 -0.532 . . . . 1.1 111.054 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.82 4.12 45.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 1.15 112.881 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 49.1 mm -91.05 148.09 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.096 -0.335 . . . . 1.61 110.096 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -88.76 150.65 22.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.385 -0.37 . . . . 2.73 110.859 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.58 -56.31 22.23 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.998 -0.546 . . . . 1.19 113.183 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.82 -32.66 70.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.967 0.413 . . . . 2.98 110.93 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.2 -42.6 96.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 2.52 109.779 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -69.38 -44.25 71.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.465 -0.788 . . . . 1.51 110.234 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -60.27 -39.94 88.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.146 -0.479 . . . . 2.3 110.877 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.62 -48.44 79.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.915 -0.584 . . . . 1.23 111.578 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.43 -33.43 72.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 1.11 111.673 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -56.7 -31.42 64.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 1.31 111.065 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -105.83 29.01 7.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.015 -0.538 . . . . 1.63 111.223 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.8 t -93.22 145.79 24.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.722 0.296 . . . . 2.04 110.626 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -61.65 -37.67 84.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 3.82 110.835 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.29 -42.05 86.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.217 0.532 . . . . 1.53 110.314 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 77' ' ' ALA . 44.8 t -67.3 -45.8 85.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.404 -0.816 . . . . 1.11 110.483 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -58.86 -38.23 78.3 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.264 -0.425 . . . . 2.43 110.875 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -43.24 71.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.073 -0.512 . . . . 1.47 110.425 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.432 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 34.6 mt -62.82 -38.16 89.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.438 . . . . 0.93 110.9 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 131' ' ' VAL . 61.7 t -60.12 -52.33 62.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.275 -0.421 . . . . 0.8 110.317 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.3 -37.25 74.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 0.85 111.367 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -65.07 -39.76 93.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.479 . . . . 1.39 111.293 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.481 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 53.0 mt-30 -60.53 -45.91 92.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.61 111.372 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -33.73 58.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.627 0.251 . . . . 2.82 111.149 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -65.69 -51.43 59.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.652 -0.249 . . . . 1.95 111.326 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.92 90.38 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.311 0.382 . . . . 0.65 111.468 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.26 86.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.399 -0.364 . . . . 0.61 111.404 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.08 -26.61 26.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.352 -0.385 . . . . 0.72 111.59 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -36.59 76.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.165 0.507 . . . . 1.39 110.637 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.68 -4.4 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.12 -0.491 . . . . 1.34 110.062 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.576 ' O ' ' HD3' ' A' ' 148' ' ' ARG . 88.8 mt-30 57.72 74.28 0.43 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.54 -0.755 . . . . 1.95 110.137 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tp -59.76 124.19 19.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.557 -0.747 . . . . 0.71 111.437 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.576 ' HD3' ' O ' ' A' ' 146' ' ' GLN . 1.6 mpp_? -103.45 18.65 21.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.182 0.515 . . . . 4.16 110.603 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -179.63 172.46 44.24 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.896 -0.882 . . . . 0.68 110.896 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.526 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.9 t -84.86 -56.79 0.39 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 117.324 0.562 . . . . 0.49 111.307 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.8 Cg_endo -82.2 88.92 1.24 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.149 1.9 . . . . 0.56 111.352 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.98 146.01 50.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.052 -0.522 . . . . 0.63 111.069 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 53.0 ttm -133.26 131.64 40.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.986 -0.375 . . . . 0.42 109.986 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -122.37 137.56 54.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.093 -0.503 . . . . 0.52 110.365 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.1 t -107.68 122.56 62.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.277 -0.42 . . . . 0.55 110.905 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 61.98 10.87 3.85 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.231 -0.895 . . . . 1.16 112.188 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 68.95 19.56 73.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.251 -0.499 . . . . 0.56 112.301 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -129.1 -41.11 1.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.392 . . . . 1.75 111.195 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.424 ' HB3' HD13 ' A' ' 185' ' ' LEU . 48.0 m-85 -96.71 123.79 40.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.143 -0.48 . . . . 1.16 111.568 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -108.07 123.99 49.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.712 -0.676 . . . . 0.98 109.251 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.78 143.61 39.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.682 0.277 . . . . 1.2 111.118 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -119.43 96.75 50.01 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.173 0.511 . . . . 0.72 110.205 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.8 -19.29 41.15 Favored 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.443 2.095 . . . . 0.54 112.713 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -72.38 -22.23 61.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 2.22 111.284 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.27 21.04 34.06 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.646 -0.787 . . . . 0.59 112.056 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.0 mtt -106.29 -164.46 1.01 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.415 -0.217 . . . . 0.57 110.415 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.02 132.63 46.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 1.54 111.111 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.9 20.76 6.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.832 -0.622 . . . . 1.16 109.691 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.99 -41.84 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 1.53 110.914 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -126.8 126.42 43.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.119 -0.491 . . . . 1.21 110.169 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.477 ' O ' HG23 ' A' ' 175' ' ' VAL . 14.3 mmt -61.01 -44.32 97.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.948 -0.569 . . . . 1.96 110.573 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' A' ' 176' ' ' GLN . 31.6 t70 -58.72 -45.36 89.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.75 -0.659 . . . . 2.05 111.199 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.85 -43.82 99.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.403 . . . . 0.65 110.718 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -57.32 -45.97 83.7 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.242 -0.435 . . . . 0.47 110.68 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 171' ' ' MET . 90.6 t -58.9 -47.42 89.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.48 110.93 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 172' ' ' ASP . 54.7 mm-40 -65.08 -48.71 72.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 1.7 110.776 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -58.6 -45.74 88.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 1.32 111.646 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 182' ' ' VAL . 31.7 t80 -60.44 -50.41 73.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.46 111.002 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.98 87.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.43 111.111 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.63 -37.85 88.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 1.55 110.006 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 58.3 m -59.98 -40.49 89.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.028 -0.533 . . . . 0.48 110.224 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 178' ' ' TYR . 41.9 t -60.67 -51.43 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 CA-C-N 115.828 -0.623 . . . . 0.48 110.165 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -60.31 -44.59 95.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.954 -0.566 . . . . 1.59 110.536 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -57.77 -44.63 86.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.5 -0.773 . . . . 1.17 111.041 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 159' ' ' TYR . 96.0 mt -72.14 -29.37 63.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.321 -0.4 . . . . 0.68 111.438 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 40.4 m -71.49 -34.55 70.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.409 -0.36 . . . . 1.07 110.819 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.229 -0.442 . . . . 2.26 110.798 -179.887 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.848 0.356 . . . . 1.32 110.711 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -119.43 148.36 43.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.345 -0.389 . . . . 2.29 110.94 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.97 130.2 41.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.935 -0.575 . . . . 1.83 109.693 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.15 -20.59 40.09 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.748 -0.941 . . . . 0.78 110.748 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.549 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 36.4 tptt -105.78 -77.3 0.59 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.755 -0.222 . . . . 1.87 110.809 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -80.04 -35.24 37.49 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.832 0.349 . . . . 1.46 111.477 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -140.76 156.08 46.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.28 -0.418 . . . . 0.79 110.733 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.82 129.73 46.01 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.119 -0.492 . . . . 0.9 110.048 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 m -77.84 121.04 23.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.017 0.437 . . . . 1.11 110.963 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.1 mt -68.57 127.31 32.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.751 -0.659 . . . . 0.74 110.829 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.13 -27.68 68.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.154 0.502 . . . . 2.33 110.746 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -120.86 96.7 48.62 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.983 -0.747 . . . . 3.64 108.983 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HB3' ' HG2' ' A' ' 158' ' ' LYS . 65.1 Cg_endo -76.1 153.25 36.52 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 122.555 2.17 . . . . 0.85 112.584 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -90.93 122.5 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.674 -0.694 . . . . 0.72 109.739 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.7 127.2 31.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.786 -0.643 . . . . 0.89 111.084 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.33 31.92 49.66 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.686 -0.768 . . . . 0.73 112.142 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.61 145.54 32.47 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.396 -0.224 . . . . 0.64 110.396 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.3 164.77 26.93 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.446 2.097 . . . . 0.56 112.432 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -58.34 -56.54 20.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.281 -0.872 . . . . 1.79 111.243 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.4 t -120.33 105.56 17.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.989 0.423 . . . . 0.45 110.185 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.5 tp -105.95 129.73 54.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.08 -0.509 . . . . 0.53 110.15 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 25' ' ' PHE . 4.0 tt0 -127.58 149.44 50.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.455 -0.339 . . . . 1.61 110.456 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.495 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 61.3 m-85 -127.4 146.08 50.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.987 -0.551 . . . . 0.53 110.195 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -163.11 175.87 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.105 0.478 . . . . 0.55 110.906 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.46 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 8.6 t -156.13 141.59 17.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.923 -0.58 . . . . 0.96 109.967 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.411 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 88.0 m-85 -74.57 -8.58 56.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.959 -0.564 . . . . 0.62 110.751 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -101.37 8.12 42.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.224 -0.444 . . . . 1.78 111.002 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 20.8 t -111.65 119.63 44.36 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.62 -0.264 . . . . 0.48 111.202 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 22.0 Cg_endo -65.67 -21.99 58.2 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.402 2.068 . . . . 0.7 111.439 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.563 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 0.3 OUTLIER -64.14 -48.25 76.76 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.895 -0.593 . . . . 1.74 110.019 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 38.7 m -66.88 -31.82 72.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.984 -0.553 . . . . 0.37 110.394 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -60.07 -44.47 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.479 -0.563 . . . . 1.44 109.479 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 31' ' ' PRO . 34.8 mm-40 -73.38 -41.29 63.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.731 -0.668 . . . . 2.27 110.65 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.487 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.4 m-85 -63.76 -35.44 80.61 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.026 -0.534 . . . . 0.87 112.428 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -93.3 -50.16 5.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.065 0.765 . . . . 1.89 113.065 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -77.36 -35.81 54.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.127 0.788 . . . . 2.0 113.127 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 53.9 t -94.61 -57.77 4.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.586 -0.446 . . . . 0.58 112.148 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.27 -26.57 33.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.061 0.763 . . . . 0.41 113.061 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 60.95 44.91 10.01 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.982 -0.377 . . . . 0.84 109.982 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.487 HG13 ' CD2' ' A' ' 36' ' ' PHE . 33.9 mm -57.11 -66.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.505 0.557 . . . . 0.41 112.505 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.0 m -62.01 -34.18 75.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 1.03 110.78 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.92 -45.6 93.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.814 -0.63 . . . . 1.73 110.143 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -69.45 -37.5 77.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 1.19 110.214 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 54.4 t -60.96 -42.31 92.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 0.49 110.433 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -63.22 -12.72 30.66 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.189 -0.459 . . . . 1.53 110.948 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -113.78 6.21 16.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.127 0.489 . . . . 2.02 111.192 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -116.29 -27.83 6.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.103 -0.499 . . . . 1.44 110.535 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 81.6 mt -66.24 145.1 98.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.224 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -78.0 170.85 18.16 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.36 2.04 . . . . 0.74 111.643 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.81 137.67 54.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 2.63 111.145 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.92 -21.79 43.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.093 -0.575 . . . . 0.82 112.038 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 t -92.83 108.09 19.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.865 0.364 . . . . 1.03 110.098 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -89.93 156.52 18.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 2.51 110.933 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 17.1 ttt -109.06 143.86 37.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.781 -0.645 . . . . 1.28 109.707 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.52 108.08 9.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 0.61 110.826 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 14.6 ttmm -94.17 116.85 29.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.725 -0.67 . . . . 0.86 110.154 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 10.0 m-30 -114.46 161.4 18.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.157 0.503 . . . . 0.71 111.688 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.46 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 43.2 t-80 -105.79 142.19 35.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.61 . . . . 0.57 111.002 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -97.62 149.58 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.794 0.33 . . . . 0.68 110.89 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -93.52 -16.47 24.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.837 0.68 . . . . 0.93 112.837 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -83.21 10.24 8.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.696 0.628 . . . . 0.74 112.696 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.1 96.17 3.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.973 0.416 . . . . 1.09 111.044 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.87 0.17 6.09 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.936 -0.649 . . . . 0.78 112.467 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.06 -129.34 43.52 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.283 -0.484 . . . . 0.81 112.647 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.62 -38.15 65.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.7 -0.482 . . . . 2.47 109.7 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.55 -26.94 68.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.573 -0.739 . . . . 1.94 109.897 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.84 -43.51 96.03 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.515 -0.766 . . . . 0.7 111.823 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -63.84 -35.55 81.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.207 -0.294 . . . . 2.69 110.207 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -43.22 99.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.394 0.616 . . . . 1.65 109.857 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.34 -34.38 78.0 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 115.549 -0.75 . . . . 1.17 110.689 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.6 m -62.11 -36.48 81.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.37 . . . . 0.62 111.101 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.549 ' HA ' HG22 ' A' ' 135' ' ' VAL . 42.7 tt0 -76.43 -45.02 33.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.623 -0.262 . . . . 1.21 110.39 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.19 88.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.046 0.45 . . . . 0.71 110.677 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.508 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 66.5 t-105 -61.26 -37.69 84.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.543 -0.753 . . . . 0.59 110.961 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.644 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.5 -34.01 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.71 110.3 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.443 HG22 HG21 ' A' ' 131' ' ' VAL . 58.2 t -66.14 -41.66 89.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.945 -0.57 . . . . 0.84 109.62 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.52 81.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.479 -0.782 . . . . 0.66 111.08 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 29.4 mtm -68.41 -38.68 81.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.979 -0.555 . . . . 1.08 111.095 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.68 -31.41 70.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.191 -0.458 . . . . 0.99 111.877 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.72 -13.7 28.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.543 -0.299 . . . . 0.97 111.531 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.44 39.7 49.92 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.488 -0.863 . . . . 0.78 111.791 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.87 22.58 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.012 -0.366 . . . . 0.81 110.012 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.508 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -56.23 -59.92 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.662 -0.699 . . . . 1.71 111.406 -178.466 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.52 -19.15 64.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.531 . . . . 1.91 111.514 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -78.05 -39.78 40.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.334 -0.393 . . . . 2.28 111.442 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.5 m -94.72 -10.4 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.381 0.511 . . . . 0.65 112.381 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.1 m -59.26 -49.39 78.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.738 0.304 . . . . 0.98 111.558 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.425 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 47.1 t -62.46 -58.8 15.17 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 112.099 0.407 . . . . 0.62 112.099 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.425 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 15.6 Cg_endo -57.24 -33.39 95.94 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.059 1.839 . . . . 0.61 113.018 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.478 HD23 HD13 ' A' ' 102' ' ' ILE . 17.3 mt -73.02 -46.97 48.98 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.974 -0.29 . . . . 0.79 110.701 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -58.59 -52.38 65.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.156 0.503 . . . . 0.58 110.779 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.52 -42.42 95.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.644 -0.707 . . . . 1.7 111.182 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.37 -14.22 71.54 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.217 -0.516 . . . . 0.82 114.232 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.21 -42.51 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.539 0.669 . . . . 0.75 112.276 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -99.6 -38.45 8.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.861 0.689 . . . . 0.84 112.861 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -78.7 -64.64 1.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.511 -0.476 . . . . 1.41 110.542 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -34.21 40.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.124 -0.489 . . . . 1.31 111.615 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 60.97 31.85 19.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.144 0.497 . . . . 1.44 110.819 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.35 -35.37 19.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.794 -0.639 . . . . 1.57 111.211 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.478 HD13 HD23 ' A' ' 92' ' ' LEU . 30.2 mt -79.33 96.97 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.838 -0.619 . . . . 0.91 110.971 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -135.25 22.16 3.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.026 0.441 . . . . 3.22 111.082 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.416 ' O ' HG13 ' A' ' 108' ' ' ILE . 83.6 p -159.49 160.38 34.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.035 -0.53 . . . . 1.51 109.717 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.39 -28.99 70.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.126 0.489 . . . . 1.08 110.392 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -61.21 -34.28 74.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.428 -0.806 . . . . 1.43 110.435 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 111' ' ' VAL . 56.9 m-20 -76.2 -47.59 23.51 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.898 -0.592 . . . . 1.89 109.589 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 104' ' ' SER . 27.5 mt -55.3 -46.41 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.67 -0.695 . . . . 0.9 111.156 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 113' ' ' ILE . 62.7 ttt-85 -59.13 -45.43 90.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.2 -0.455 . . . . 2.19 110.679 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.75 -42.04 99.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.304 -0.407 . . . . 1.95 110.904 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 107' ' ' ASP . 90.6 t -60.55 -44.79 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.222 -0.444 . . . . 0.88 110.595 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.402 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 7.6 m-85 -62.5 -44.9 95.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.093 -0.503 . . . . 0.92 110.727 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 73.3 mt -63.68 -38.82 83.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 1.33 110.525 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -67.8 -31.67 71.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.47 . . . . 1.93 110.759 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.38 -8.1 53.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.313 -0.403 . . . . 1.1 111.591 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.37 0.74 26.46 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.475 -0.869 . . . . 1.15 112.98 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 3.3 mp -85.93 121.7 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.867 -0.42 . . . . 1.61 109.867 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -60.91 136.69 58.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.824 -0.625 . . . . 2.73 111.107 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.57 -41.92 98.97 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.609 -0.597 . . . . 1.19 111.609 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -65.74 -23.17 66.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 2.98 110.685 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -82.75 -45.33 14.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.97 -0.559 . . . . 2.52 109.515 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -63.55 -44.25 94.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.506 -0.77 . . . . 1.51 110.483 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.34 -43.16 96.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.978 0.418 . . . . 2.3 110.827 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.29 -47.6 83.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 1.23 110.624 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.05 -41.21 95.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 1.11 111.109 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -59.94 -30.02 68.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.31 111.504 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -96.15 -26.12 15.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.148 0.425 . . . . 1.63 112.148 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 m -65.22 149.42 49.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.321 0.581 . . . . 2.04 112.507 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -73.01 -21.14 60.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.513 -0.767 . . . . 3.82 111.723 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.87 -50.1 70.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.26 0.552 . . . . 1.53 110.101 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.644 HG13 ' HB3' ' A' ' 77' ' ' ALA . 36.0 t -66.5 -41.69 88.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.419 -0.81 . . . . 1.11 110.414 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -56.87 -41.31 77.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.088 -0.505 . . . . 2.43 111.075 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.5 m -63.37 -39.41 94.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.983 -0.553 . . . . 1.47 110.202 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.44 -37.71 83.39 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.331 -0.395 . . . . 0.93 110.479 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 131' ' ' VAL . 41.5 t -61.46 -51.68 70.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.023 -0.362 . . . . 0.8 110.023 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.56 69.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.772 -0.649 . . . . 0.85 111.048 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -66.31 -42.45 88.24 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.009 -0.541 . . . . 1.39 110.271 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.53 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 51.8 mt-30 -62.59 -48.15 80.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.833 -0.621 . . . . 0.61 109.919 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 29.0 mt-10 -62.37 -44.47 96.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.341 -0.845 . . . . 2.82 111.194 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -60.91 -46.99 88.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.849 -0.614 . . . . 1.95 111.514 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.55 -44.12 84.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.912 0.338 . . . . 0.65 111.912 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.38 -30.52 64.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.224 0.453 . . . . 0.61 112.224 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.4 -27.18 25.96 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.565 0.579 . . . . 0.72 112.565 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.17 -47.71 23.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.629 0.252 . . . . 1.39 110.565 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.5 p -80.76 -8.31 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.814 0.34 . . . . 1.34 110.764 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 58.21 58.53 3.45 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.735 -0.666 . . . . 1.95 110.435 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 149' ' ' GLY . 40.9 tp -67.13 111.74 4.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.461 -0.79 . . . . 0.71 110.803 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -87.31 -33.71 19.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.611 -0.722 . . . . 4.16 110.556 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.591 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . -93.9 173.61 33.56 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.989 -0.845 . . . . 0.68 110.989 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.557 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 4.6 t -102.89 -57.56 0.1 OUTLIER Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 117.865 0.832 . . . . 0.49 112.761 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 4.1 Cg_endo -85.27 70.16 5.27 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.231 1.954 . . . . 0.56 111.928 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.22 139.31 50.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.905 -0.589 . . . . 0.63 110.766 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 21.6 ttm -113.38 139.02 49.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.042 -0.526 . . . . 0.42 109.912 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -122.96 133.98 54.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.549 -0.296 . . . . 0.52 110.728 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.8 t -101.3 114.76 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.343 -0.389 . . . . 0.55 110.752 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.69 25.84 10.57 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.524 -0.762 . . . . 1.16 111.418 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.48 26.88 60.18 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.743 -0.662 . . . . 0.56 113.167 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 15' ' ' PRO . 30.1 mtmm -126.9 -39.23 1.97 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.099 0.407 . . . . 1.75 112.099 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -106.66 135.9 47.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.003 -0.279 . . . . 1.16 111.432 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -108.23 136.18 48.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.794 -0.639 . . . . 0.98 110.056 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.61 129.63 34.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.472 -0.331 . . . . 1.2 110.54 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -112.73 100.6 51.07 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.415 -0.357 . . . . 0.72 110.723 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.47 -15.32 34.4 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.685 2.257 . . . . 0.54 112.321 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -86.04 2.63 45.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.107 0.48 . . . . 2.22 111.02 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -105.15 16.38 45.98 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.006 -0.616 . . . . 0.59 111.592 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 40.1 mtt -127.67 166.21 18.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.0 -0.37 . . . . 0.57 110.0 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -80.81 133.4 35.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.381 -0.372 . . . . 1.54 111.132 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 -3.16 36.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.15 -0.477 . . . . 1.16 111.744 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 m -67.22 -36.21 81.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.874 0.368 . . . . 1.53 110.814 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -118.33 111.12 18.32 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.235 -0.654 . . . . 1.21 109.235 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 42.9 mtt -66.08 -40.83 91.14 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.488 0.551 . . . . 1.96 112.488 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.46 -50.28 74.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.808 0.337 . . . . 2.05 111.15 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.99 -38.91 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.967 -0.56 . . . . 0.65 110.472 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.81 -53.38 55.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.47 110.908 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 70.2 t -58.3 -48.32 85.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.98 -0.555 . . . . 0.48 111.312 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 61.6 mm-40 -64.67 -40.13 94.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.602 -0.272 . . . . 1.7 111.548 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.22 -43.89 93.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.069 -0.345 . . . . 1.32 110.069 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.427 ' O ' HG23 ' A' ' 182' ' ' VAL . 20.4 t80 -57.37 -54.23 49.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.46 110.289 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.83 85.09 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.97 -0.559 . . . . 0.43 111.787 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -67.21 -37.64 83.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.594 -0.276 . . . . 1.55 110.584 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 37.8 m -61.73 -42.6 99.17 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.047 0.451 . . . . 0.48 109.911 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 178' ' ' TYR . 49.0 t -61.49 -47.64 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.672 -0.695 . . . . 0.48 110.274 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 187' ' ' GLU . 34.4 tttp -56.84 -53.38 58.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.818 -0.628 . . . . 1.59 110.948 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -54.68 -41.66 70.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.423 -0.353 . . . . 1.17 111.33 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.55 -38.65 67.92 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.938 0.348 . . . . 0.68 111.938 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 35.2 p -65.86 -35.34 80.37 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.103 -0.239 . . . . 1.07 111.608 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 12.3 pt-20 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 121.105 0.478 . . . . 2.26 111.334 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.826 0.346 . . . . 1.32 110.322 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -110.22 140.96 43.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 2.29 109.812 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -69.88 122.01 18.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.531 -0.544 . . . . 1.83 109.531 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.579 ' HA2' HG23 ' A' ' 10' ' ' THR . . . 97.94 -11.36 64.21 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.939 -0.648 . . . . 0.78 111.607 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -95.68 -83.16 0.37 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.493 0.187 . . . . 1.87 110.736 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.495 ' HG2' HE21 ' A' ' 177' ' ' GLN . 23.9 mp0 -84.57 -25.31 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.08 0.467 . . . . 1.46 110.52 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -142.98 153.9 43.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.819 -0.628 . . . . 0.79 109.627 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.579 HG23 ' HA2' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -127.38 133.52 50.01 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.398 -0.364 . . . . 0.9 110.563 -179.696 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.5 m -87.83 126.7 35.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.9 0.381 . . . . 1.11 111.051 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -85.51 140.84 30.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.448 -0.342 . . . . 0.74 110.39 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -20.28 46.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.981 0.419 . . . . 2.33 110.116 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -118.98 93.93 47.46 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.88 -0.6 . . . . 3.64 109.955 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.69 145.23 12.84 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.681 2.254 . . . . 0.85 112.847 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.1 t -80.56 113.84 20.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.828 -0.623 . . . . 0.72 110.22 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.0 128.77 37.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.424 . . . . 0.89 111.36 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.47 16.17 74.32 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.86 -0.609 . . . . 0.73 112.91 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.9 144.58 79.94 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.697 0.248 . . . . 0.64 110.616 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 14.8 Cg_endo -60.15 160.98 20.78 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.606 2.204 . . . . 0.56 112.051 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.485 ' NE2' ' HA ' ' A' ' 54' ' ' VAL . 46.4 mt-30 -57.1 -51.34 69.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.843 -0.617 . . . . 1.79 111.245 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.6 t -128.18 104.5 11.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.837 -0.431 . . . . 0.45 109.837 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.544 HD21 ' HB1' ' A' ' 141' ' ' ALA . 46.3 tp -102.97 132.89 48.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.53 110.746 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.89 150.82 49.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.366 -0.379 . . . . 1.61 110.065 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -122.71 148.29 45.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.465 -0.334 . . . . 0.53 110.72 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.01 173.55 15.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.136 -0.484 . . . . 0.55 110.591 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.54 ' OG ' HG22 ' A' ' 61' ' ' VAL . 52.5 m -154.47 132.42 11.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.134 -0.484 . . . . 0.96 110.651 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.585 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 67.5 m-85 -66.81 -20.68 65.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.62 111.012 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.77 2.89 54.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 1.78 111.04 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 40.5 t -108.41 119.82 48.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.328 -0.396 . . . . 0.48 110.658 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.33 -27.73 63.42 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.615 2.21 . . . . 0.7 112.105 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 0.1 OUTLIER -64.85 -47.26 78.58 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.583 -0.735 . . . . 1.74 109.984 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.7 m -63.82 -37.31 86.9 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.801 0.334 . . . . 0.37 110.528 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -60.89 -51.98 66.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 1.44 109.942 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -65.0 -35.03 79.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.394 -0.821 . . . . 2.27 111.549 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.61 -29.69 70.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.928 0.714 . . . . 0.87 112.928 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -105.92 -35.32 7.34 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.705 -0.398 . . . . 1.89 111.397 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -43.35 60.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 2.0 111.847 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.81 -58.01 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.166 0.432 . . . . 0.58 112.166 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.3 mt -69.85 -37.24 76.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.37 0.507 . . . . 0.41 112.37 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 63.42 42.4 6.78 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.04 -0.356 . . . . 0.84 110.04 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.3 mm -61.38 -58.39 7.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.096 -0.502 . . . . 0.41 111.21 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.563 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 1.5 m -61.95 -44.31 97.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.745 -0.465 . . . . 1.03 109.745 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.52 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 24.1 t70 -54.99 -44.42 74.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.235 -0.893 . . . . 1.73 111.186 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -69.37 -43.53 73.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.631 -0.258 . . . . 1.19 111.051 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 54.9 t -58.87 -36.9 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.49 110.427 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 43' ' ' SER . 56.9 mttt -56.18 -31.76 63.72 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.361 -0.382 . . . . 1.53 111.202 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' A' ' 44' ' ' ASP . 16.6 mttt -109.73 8.9 24.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 2.02 111.705 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -121.58 21.03 11.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.69 0.281 . . . . 1.44 111.164 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 34.7 mt -104.83 153.03 39.62 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.738 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 50' ' ' LEU . 3.1 Cg_exo -75.17 161.17 38.68 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.722 2.281 . . . . 0.74 111.654 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.24 134.45 53.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.965 0.412 . . . . 2.63 110.916 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.53 -17.29 58.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.57 -0.824 . . . . 0.82 111.945 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.485 ' HA ' ' NE2' ' A' ' 21' ' ' GLN . 90.7 t -95.85 125.91 48.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 1.03 110.936 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -110.54 155.9 21.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.305 -0.407 . . . . 2.51 109.997 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.6 ttt -108.16 132.03 54.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.181 -0.463 . . . . 1.28 110.512 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.18 112.34 18.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.134 -0.485 . . . . 0.61 110.576 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -96.58 129.43 43.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.91 -0.586 . . . . 0.86 109.843 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.46 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 6.8 m-30 -118.16 160.95 20.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.71 111.634 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -111.54 133.12 54.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.644 -0.707 . . . . 0.57 110.224 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.54 HG22 ' OG ' ' A' ' 27' ' ' SER . 2.7 m -85.83 162.36 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.575 0.226 . . . . 0.68 110.591 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -113.34 21.4 15.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.388 0.514 . . . . 0.93 112.388 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -120.06 16.53 12.46 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.6 -0.44 . . . . 0.74 111.643 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 75.3 mmm -135.09 106.95 7.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.236 -0.438 . . . . 1.09 110.936 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.55 13.72 9.39 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.946 -0.645 . . . . 0.78 112.59 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.67 -147.89 31.5 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.455 -0.878 . . . . 0.81 111.854 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -81.99 -19.28 40.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 2.47 110.863 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.25 -16.32 63.42 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.397 0.617 . . . . 1.94 109.9 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.56 -30.36 77.38 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.502 -0.772 . . . . 0.7 111.422 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -64.0 -44.32 92.99 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.968 0.413 . . . . 2.69 110.106 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.25 -41.72 97.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.824 -0.626 . . . . 1.65 109.961 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.04 -32.52 74.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.706 -0.679 . . . . 1.17 110.827 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.4 m -68.67 -40.77 80.01 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.042 0.449 . . . . 0.62 110.365 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -42.81 71.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 1.21 109.762 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.21 92.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.925 -0.579 . . . . 0.71 110.942 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -62.53 -38.9 91.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.242 -0.435 . . . . 0.59 110.253 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.439 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.41 -34.62 78.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.833 -0.432 . . . . 0.71 109.833 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.96 -44.11 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.729 -0.669 . . . . 0.84 109.575 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.83 -38.29 87.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.66 -0.7 . . . . 0.66 111.043 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.2 mtm -65.31 -25.97 67.85 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.825 0.345 . . . . 1.08 111.345 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.18 -29.52 24.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.99 110.718 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 68.6 mt -82.7 -36.0 26.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.898 -0.592 . . . . 0.97 111.368 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.49 23.51 21.28 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.886 -0.673 . . . . 0.78 112.635 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 88' ' ' VAL . 13.6 m -121.25 18.73 5.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 122.705 -0.291 . . . . 0.81 110.989 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -53.42 -60.59 3.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.559 -0.746 . . . . 1.71 111.749 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.25 -35.13 67.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.72 -0.673 . . . . 1.91 112.116 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -74.45 -43.29 56.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.011 0.374 . . . . 2.28 112.011 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 84' ' ' VAL . 28.6 m -80.68 -2.87 5.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.414 -0.514 . . . . 0.65 111.807 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 m -59.31 -48.25 82.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.823 0.305 . . . . 0.98 111.823 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.449 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 22.0 t -61.33 -59.09 14.69 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.191 0.441 . . . . 0.62 112.191 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 9.5 Cg_endo -54.39 -33.93 78.86 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.276 1.984 . . . . 0.61 112.446 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 28' ' ' PHE . 10.6 mt -66.88 -52.79 39.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.439 -0.346 . . . . 0.79 110.435 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.9 m-85 -58.21 -45.84 86.92 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.936 0.398 . . . . 0.58 110.401 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.13 -48.53 78.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.716 -0.675 . . . . 1.7 110.426 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.31 -7.04 43.48 Favored Glycine 0 C--O 1.223 -0.579 0 CA-C-N 116.153 -0.476 . . . . 0.82 113.644 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 50.2 t -105.14 -49.2 9.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 117.412 0.606 . . . . 0.75 112.014 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -99.42 -50.12 4.21 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.629 0.603 . . . . 0.84 112.629 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -69.14 -70.91 0.25 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.46 0.541 . . . . 1.41 112.46 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.46 ' HB ' ' OG1' ' A' ' 101' ' ' THR . 0.2 OUTLIER -79.84 -31.89 40.55 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.259 0.466 . . . . 1.31 112.259 -178.266 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 64.58 29.36 13.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.096 0.474 . . . . 1.44 110.992 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.46 ' OG1' ' HB ' ' A' ' 99' ' ' THR . 0.2 OUTLIER -69.51 -31.25 69.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.57 111.328 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.409 ' HA ' ' CB ' ' A' ' 107' ' ' ASP . 48.6 mt -88.68 105.71 16.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.894 -0.594 . . . . 0.91 111.661 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -122.72 -12.02 8.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.458 -0.792 . . . . 3.22 109.095 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.0 164.41 30.68 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.868 -1.06 . . . . 1.51 109.704 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.06 -25.5 68.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 1.08 111.177 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -33.01 72.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 1.43 110.489 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.409 ' CB ' ' HA ' ' A' ' 102' ' ' ILE . 32.7 m-20 -72.55 -38.8 67.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.84 -0.618 . . . . 1.89 110.253 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 108' ' ' ILE . 9.3 mt -62.04 -37.97 79.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.221 -0.659 . . . . 0.9 109.221 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.657 ' O ' HG12 ' A' ' 113' ' ' ILE . 72.8 ttt-85 -57.88 -47.2 83.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.845 -1.07 . . . . 2.19 110.357 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.93 -35.41 80.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.163 -0.471 . . . . 1.95 110.764 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.18 -43.34 97.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.053 0.454 . . . . 0.88 110.384 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.74 -41.0 96.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.077 -0.51 . . . . 0.92 110.309 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.657 HG12 ' O ' ' A' ' 109' ' ' ARG . 20.3 mm -64.49 -31.36 53.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.268 0.556 . . . . 1.33 109.733 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -69.25 -16.6 63.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.887 -0.597 . . . . 1.93 111.403 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.02 -5.63 47.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.406 -0.361 . . . . 1.1 111.389 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.8 4.11 29.98 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.462 -0.875 . . . . 1.15 112.616 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mm -80.41 138.07 20.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.698 -0.482 . . . . 1.61 109.698 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 39.1 mttt -75.12 150.82 38.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.657 -0.247 . . . . 2.73 110.452 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.3 -52.7 51.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.017 -0.611 . . . . 1.19 112.692 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.83 -20.76 65.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.62 0.23 . . . . 2.98 111.62 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 10.8 tp10 -68.41 -49.19 61.79 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.216 0.532 . . . . 2.52 109.747 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 82.8 t80 -67.3 -42.43 83.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.382 -0.826 . . . . 1.51 109.807 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.33 -42.04 90.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 2.3 111.048 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.79 -46.39 72.1 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.026 -0.533 . . . . 1.23 110.846 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.21 89.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 1.11 111.526 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -56.63 -30.54 63.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.349 -0.387 . . . . 1.31 111.321 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -111.22 23.07 14.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.35 -0.386 . . . . 1.63 110.834 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.8 m -91.63 149.54 21.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.963 0.411 . . . . 2.04 111.655 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -65.21 -40.87 94.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.58 . . . . 3.82 110.484 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 81.1 t -55.66 -50.0 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 1.53 110.559 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 77' ' ' ALA . 54.3 t -64.34 -46.88 91.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.666 -0.697 . . . . 1.11 111.091 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -55.57 -41.59 73.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.232 0.539 . . . . 2.43 110.919 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -68.05 -36.07 79.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.906 -0.588 . . . . 1.47 111.018 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.426 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 94.6 mt -67.39 -39.38 85.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.779 0.323 . . . . 0.93 110.657 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 81.2 t -60.29 -45.94 95.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.366 -0.379 . . . . 0.8 110.517 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.59 83.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.85 111.082 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -70.22 -34.32 72.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 1.39 110.627 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.46 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 47.6 mt-30 -63.99 -49.67 71.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.61 109.936 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.37 -33.7 76.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.496 -0.775 . . . . 2.82 110.207 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -67.01 -54.54 20.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.734 -0.666 . . . . 1.95 110.68 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.544 ' HB1' HD21 ' A' ' 23' ' ' LEU . . . -53.33 -48.23 68.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 0.65 112.22 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.29 94.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.934 0.397 . . . . 0.61 111.769 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.98 -31.98 39.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.007 0.373 . . . . 0.72 112.007 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -42.67 98.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.332 -0.394 . . . . 1.39 111.892 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 141' ' ' ALA . 35.3 m -85.6 -0.87 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.405 -0.361 . . . . 1.34 111.606 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 59.03 53.67 5.43 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.557 0.694 . . . . 1.95 109.989 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.5 tp -65.33 120.66 13.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.996 -1.002 . . . . 0.71 111.481 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -103.21 -34.32 8.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.063 -0.517 . . . . 4.16 110.085 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -95.93 -169.11 35.07 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 110.921 -0.872 . . . . 0.68 110.921 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.522 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 3.0 t -111.75 -56.85 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.304 -0.558 . . . . 0.49 111.435 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.522 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.1 Cg_endo -84.35 72.75 4.93 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.457 2.105 . . . . 0.56 111.701 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.5 144.78 46.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.051 -0.522 . . . . 0.63 110.922 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.2 ttm -121.47 133.02 55.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.165 -0.47 . . . . 0.42 110.102 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.95 124.65 43.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.213 -0.449 . . . . 0.52 109.92 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.33 117.1 32.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.889 0.376 . . . . 0.55 110.839 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 58.12 16.68 4.01 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.376 -0.829 . . . . 1.16 111.531 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.8 22.47 68.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.85 -0.691 . . . . 0.56 112.019 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -120.46 -42.06 2.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.08 0.467 . . . . 1.75 110.73 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -104.29 129.39 52.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 1.16 111.612 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -109.33 126.87 53.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.431 -0.804 . . . . 0.98 109.45 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.13 139.83 32.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.09 0.471 . . . . 1.2 111.09 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -114.33 100.91 53.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.872 -0.604 . . . . 0.72 109.91 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.58 -19.28 37.17 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.477 2.118 . . . . 0.54 112.568 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -80.9 -4.61 55.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.95 0.405 . . . . 2.22 110.674 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -115.3 26.99 8.77 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.808 -0.71 . . . . 0.59 112.004 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.3 mtt -115.12 166.93 11.28 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.656 -0.272 . . . . 0.57 110.349 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -71.48 100.34 2.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.147 0.499 . . . . 1.54 109.997 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.72 26.86 2.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.782 -0.644 . . . . 1.16 112.118 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.3 p -74.95 -35.47 62.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.452 0.644 . . . . 1.53 110.585 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.437 ' HB3' HG23 ' A' ' 173' ' ' VAL . 21.0 t30 -143.36 129.12 19.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.611 -0.722 . . . . 1.21 109.614 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 175' ' ' VAL . 1.9 mmm -56.74 -34.51 67.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 1.96 111.378 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -39.97 89.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.331 0.586 . . . . 2.05 110.48 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 170' ' ' ASN . 38.2 t -69.08 -43.65 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.65 -0.705 . . . . 0.65 110.551 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -53.5 -46.17 69.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.207 -0.906 . . . . 0.47 111.463 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 171' ' ' MET . 61.1 t -57.76 -51.48 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.416 . . . . 0.48 111.417 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 82.6 mm-40 -66.01 -44.8 83.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 1.7 111.458 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.495 HE21 ' HG2' ' A' ' 8' ' ' GLN . 52.8 tt0 -60.98 -45.68 93.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.653 -0.249 . . . . 1.32 111.17 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 182' ' ' VAL . 15.6 t80 -59.48 -53.04 62.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.877 0.37 . . . . 0.46 110.497 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.86 85.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.43 112.016 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 2.8 t0 -65.33 -36.56 84.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.046 0.45 . . . . 1.55 110.379 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 51.7 m -63.16 -42.46 99.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.868 -0.605 . . . . 0.48 109.925 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 178' ' ' TYR . 44.2 t -62.8 -42.49 96.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.158 -0.474 . . . . 0.48 110.33 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -62.37 -32.31 73.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.393 -0.821 . . . . 1.59 111.0 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.3 -46.3 20.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.278 -0.419 . . . . 1.17 110.817 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.58 -34.51 75.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.462 0.541 . . . . 0.68 112.462 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.5 p -71.61 -21.41 61.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.95 0.352 . . . . 1.07 111.95 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.104 0.478 . . . . 2.26 110.703 179.848 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.877 0.37 . . . . 4.08 110.778 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -91.79 130.66 37.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.904 -0.589 . . . . 3.58 109.844 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -131.09 120.04 22.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.757 0.313 . . . . 1.32 110.78 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -128.62 136.56 50.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.959 -0.564 . . . . 2.29 109.833 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.63 132.71 49.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 1.83 110.563 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.22 -14.07 55.13 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.866 -0.683 . . . . 0.78 111.917 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.5 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 41.2 tptt -115.38 -74.85 0.6 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.455 -0.202 . . . . 1.87 110.455 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -78.41 -41.73 32.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 1.46 111.027 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -136.85 164.28 28.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.307 -0.406 . . . . 0.79 110.156 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.24 123.84 18.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.136 -0.484 . . . . 0.9 110.284 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.9 m -76.9 127.95 33.67 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.854 -0.425 . . . . 1.11 109.854 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.55 140.97 37.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.813 0.339 . . . . 0.74 110.851 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -25.26 45.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.054 0.454 . . . . 2.33 110.01 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -109.35 90.16 8.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.642 -0.708 . . . . 3.64 109.244 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.24 148.72 30.95 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.525 2.15 . . . . 0.85 112.62 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.1 t -93.88 113.91 29.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.61 -0.723 . . . . 0.72 109.871 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.36 129.16 35.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.087 -0.506 . . . . 0.89 110.481 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.75 34.53 34.45 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.922 -0.656 . . . . 0.73 112.127 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.05 149.12 35.4 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.46 -0.2 . . . . 0.64 110.46 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.5 169.55 11.02 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.888 2.392 . . . . 0.56 112.711 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -65.84 -61.67 1.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.046 -0.524 . . . . 1.79 111.065 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.31 105.12 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.101 0.477 . . . . 0.45 110.747 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.7 tp -107.9 124.28 49.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.147 -0.479 . . . . 0.53 110.707 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -126.35 140.59 52.39 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.164 -0.471 . . . . 1.61 110.024 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -113.15 147.67 36.92 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.081 -0.34 . . . . 0.53 110.081 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.38 174.23 12.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.276 0.56 . . . . 0.55 111.396 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.2 t -153.62 139.26 17.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.439 -0.8 . . . . 0.96 109.079 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.498 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 97.3 m-85 -72.5 -15.0 61.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.947 0.404 . . . . 0.62 110.607 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CE1' ' HA2' ' A' ' 69' ' ' GLY . 79.3 m-85 -89.19 -0.53 57.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.549 . . . . 1.78 110.419 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 49.3 t -108.25 112.61 61.15 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.954 -0.566 . . . . 0.48 111.104 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 18.1 Cg_endo -63.55 -23.85 70.41 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.372 2.048 . . . . 0.7 110.935 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -66.63 -28.71 68.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.459 -0.792 . . . . 1.74 109.932 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.46 -38.46 34.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.627 -0.509 . . . . 0.37 109.627 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -59.95 -38.15 81.6 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.259 0.552 . . . . 1.44 109.693 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.636 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 7.7 tt0 -66.7 -39.87 88.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.589 -0.732 . . . . 2.27 110.785 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -78.39 -26.4 46.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.556 -0.293 . . . . 0.87 111.333 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 3.6 tp10 -83.64 -55.02 4.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.529 0.566 . . . . 1.89 112.529 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.95 -48.54 6.47 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.929 0.714 . . . . 2.0 112.929 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 99.7 t -64.62 -54.61 28.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 121.75 -0.594 . . . . 0.58 111.608 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.9 mt -91.59 -31.39 15.91 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.536 0.569 . . . . 0.41 112.536 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 23.9 m-70 59.71 45.08 13.35 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.079 0.466 . . . . 0.84 110.017 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 46' ' ' VAL . 44.3 mm -55.8 -55.55 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.599 -0.728 . . . . 0.41 111.055 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 m -53.48 -47.76 69.52 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.502 0.501 . . . . 1.03 111.708 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.84 -43.97 97.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.513 -0.312 . . . . 1.73 111.226 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -65.24 -44.32 88.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.127 -0.488 . . . . 1.19 110.781 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.671 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 75.4 t -61.81 -47.1 94.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.984 -0.553 . . . . 0.49 110.638 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -53.57 -31.49 46.92 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.284 0.475 . . . . 1.53 112.284 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -89.67 -26.23 20.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.3 0.481 . . . . 2.02 112.3 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 55.2 mttt -84.79 -17.44 38.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.746 0.308 . . . . 1.44 111.568 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 86.4 mt -71.54 136.72 83.45 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.553 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.0 161.44 46.09 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.416 2.077 . . . . 0.74 111.968 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 128.87 38.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.944 0.402 . . . . 2.63 111.368 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.6 -17.06 23.59 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.824 -0.625 . . . . 0.82 112.093 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -98.4 122.01 49.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.642 0.258 . . . . 1.03 110.622 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -104.52 152.65 22.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.03 -0.359 . . . . 2.51 110.03 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.4 ' HG2' ' N ' ' A' ' 57' ' ' THR . 9.9 ttt -103.82 151.99 22.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.858 0.361 . . . . 1.28 110.318 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.4 ' N ' ' HG2' ' A' ' 56' ' ' MET . 0.0 OUTLIER -136.79 124.74 22.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.013 -0.539 . . . . 0.61 110.066 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -114.43 119.4 36.76 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.548 -0.538 . . . . 0.86 109.548 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CD2' ' HA ' ' A' ' 138' ' ' GLN . 8.0 m-30 -111.21 151.45 28.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.268 0.556 . . . . 0.71 111.873 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -102.25 130.26 48.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.383 -0.826 . . . . 0.57 109.855 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 m -86.78 159.42 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 111.475 0.176 . . . . 0.68 111.475 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.648 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 41.0 m-20 -107.62 -1.39 21.21 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.452 0.538 . . . . 0.93 112.452 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -96.35 10.68 37.29 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.681 -0.407 . . . . 0.74 111.543 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.86 102.06 4.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.839 0.352 . . . . 1.09 110.398 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.99 7.88 0.69 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.675 -0.693 . . . . 0.78 112.258 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.31 -116.64 8.18 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.941 -0.647 . . . . 0.81 112.408 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.48 -50.69 5.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.884 0.373 . . . . 2.47 111.0 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.52 -15.01 56.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.927 -0.579 . . . . 1.94 111.492 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.426 ' HA2' ' CE1' ' A' ' 29' ' ' PHE . . . -56.87 -31.97 61.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.087 -0.578 . . . . 0.7 112.548 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.648 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 85.2 mttt -74.91 -38.5 61.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.39 . . . . 2.69 110.794 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.34 -40.88 97.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 1.65 111.021 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.89 -26.66 65.22 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.876 -0.33 . . . . 1.17 111.229 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.2 m -66.88 -35.74 80.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.328 0.585 . . . . 0.62 109.492 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -73.48 -41.32 63.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 1.21 109.625 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.96 -41.54 99.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.542 -0.753 . . . . 0.71 110.76 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -61.01 -36.77 80.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.075 -0.511 . . . . 0.59 110.778 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.12 -39.04 93.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.71 110.111 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.81 -41.54 90.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.028 -0.533 . . . . 0.84 109.923 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.85 81.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.87 -0.605 . . . . 0.66 110.892 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.7 mtm -69.12 -36.4 77.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.736 -0.665 . . . . 1.08 110.79 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.68 -35.84 65.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.4 -0.363 . . . . 0.99 111.686 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.19 -28.14 38.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.97 110.947 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.93 29.38 18.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.87 -0.681 . . . . 0.78 112.77 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 m -120.93 25.38 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.071 0.462 . . . . 0.81 110.329 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -59.21 -52.19 66.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.451 -0.795 . . . . 1.71 111.443 -178.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.426 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 2.7 t70 -61.77 -39.45 91.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.466 0.65 . . . . 1.91 110.883 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -65.41 -34.89 79.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.432 -0.804 . . . . 2.28 111.86 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.2 m -94.43 -9.38 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.608 0.596 . . . . 0.65 112.608 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.5 m -56.72 -48.54 77.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.98 111.867 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.412 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 99.0 t -65.45 -59.61 9.22 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.349 0.5 . . . . 0.62 112.349 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.412 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 11.7 Cg_endo -55.76 -36.45 95.18 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.216 1.944 . . . . 0.61 113.164 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.45 -42.84 78.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.736 0.303 . . . . 0.79 110.747 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -64.55 -45.27 87.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.537 . . . . 0.58 110.309 179.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.15 -46.97 78.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.759 -0.655 . . . . 1.7 111.409 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.77 -9.14 55.42 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 116.149 -0.478 . . . . 0.82 114.147 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.5 t -109.71 -36.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 117.346 0.573 . . . . 0.75 111.919 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -104.42 -40.69 5.98 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.243 0.831 . . . . 0.84 113.243 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -83.02 -68.14 0.73 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.883 0.373 . . . . 1.41 111.306 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.46 -35.68 53.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.736 0.303 . . . . 1.31 111.045 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 60.65 29.99 19.4 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.752 -0.658 . . . . 1.44 110.72 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.79 -28.52 44.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.914 -0.584 . . . . 1.57 111.085 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 85.7 mt -74.85 101.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.266 -0.424 . . . . 0.91 110.182 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -116.24 -33.11 5.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 3.22 111.134 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.5 p -118.45 169.7 9.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.115 -0.493 . . . . 1.51 110.565 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.01 -28.61 69.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.413 0.625 . . . . 1.08 109.91 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -31.43 72.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.289 -0.869 . . . . 1.43 110.081 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -71.78 -36.27 70.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.651 -0.704 . . . . 1.89 110.231 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 mt -68.76 -42.07 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.815 -0.63 . . . . 0.9 109.696 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -57.4 -40.18 77.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.236 -0.893 . . . . 2.19 110.066 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.74 -38.15 86.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.549 -0.75 . . . . 1.95 111.734 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.13 -44.91 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.88 110.803 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -64.44 -40.1 95.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.92 110.865 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 83.6 mt -63.71 -38.3 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.129 0.49 . . . . 1.33 110.379 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -70.56 -31.2 68.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 1.93 110.981 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.76 -31.11 69.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 1.1 110.714 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.02 -0.26 3.25 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.762 -0.733 . . . . 1.15 112.732 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 45.3 mm -86.28 127.52 40.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.031 -0.359 . . . . 1.61 110.031 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -68.35 139.27 55.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.234 -0.284 . . . . 2.73 110.234 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.88 -43.56 81.61 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.926 -0.579 . . . . 1.19 112.497 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.25 -46.78 88.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.683 0.278 . . . . 2.98 110.912 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -62.84 -45.42 92.68 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.123 0.487 . . . . 2.52 110.195 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -63.58 -48.33 77.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.662 -0.699 . . . . 1.51 110.876 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.65 -35.33 79.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 2.3 110.906 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.71 91.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.039 0.447 . . . . 1.23 109.97 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.48 -33.32 60.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.692 -0.686 . . . . 1.11 110.065 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -60.24 -31.51 70.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.478 0.656 . . . . 1.31 110.179 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -104.42 20.77 17.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.384 -0.825 . . . . 1.63 110.909 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.1 m -93.95 144.79 25.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.06 0.457 . . . . 2.04 111.67 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -65.74 -35.57 81.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.487 -0.779 . . . . 3.82 110.61 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 134' ' ' LEU . 63.4 t -53.73 -46.51 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 1.53 110.797 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 77' ' ' ALA . 75.8 t -67.49 -40.72 84.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.677 -0.692 . . . . 1.11 110.774 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -57.83 -46.33 84.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 2.43 111.117 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.3 m -66.16 -29.98 70.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.283 -0.417 . . . . 1.47 110.658 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 130' ' ' VAL . 86.4 mt -68.44 -40.67 81.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.853 -0.425 . . . . 0.93 109.853 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.467 ' HA ' HE21 ' A' ' 138' ' ' GLN . 62.1 t -62.02 -44.03 98.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.99 -0.55 . . . . 0.8 110.21 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.76 99.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.738 -0.664 . . . . 0.85 111.046 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -66.55 -35.0 79.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.169 -0.469 . . . . 1.39 111.66 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.467 HE21 ' HA ' ' A' ' 135' ' ' VAL . 46.0 mt-30 -58.93 -53.22 60.84 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.879 0.371 . . . . 0.61 111.026 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HG3' HD22 ' A' ' 62' ' ' ASN . 4.2 mm-40 -72.15 -36.51 69.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 2.82 110.976 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -58.37 -44.17 88.76 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.75 0.31 . . . . 1.95 110.912 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -61.4 -44.76 96.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.955 -0.566 . . . . 0.65 110.77 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.14 90.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.61 111.366 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.19 -25.74 60.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 0.72 111.247 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.76 -36.12 32.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.272 -0.422 . . . . 1.39 111.261 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 141' ' ' ALA . 31.0 m -89.13 2.69 6.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.477 0.18 . . . . 1.34 111.373 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.417 ' HB3' ' NH2' ' A' ' 148' ' ' ARG . 38.5 mt-30 57.48 51.7 9.44 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.056 -0.52 . . . . 1.95 110.322 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.5 tp -54.57 120.39 6.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.71 111.982 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.448 HH11 ' HD3' ' A' ' 148' ' ' ARG . 28.0 mmt180 -98.17 -45.94 6.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.93 -0.577 . . . . 4.16 110.713 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -107.9 161.16 13.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.106 -0.797 . . . . 0.68 111.106 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.506 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 2.4 t -68.95 -55.66 10.26 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.867 0.334 . . . . 0.49 111.73 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.506 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 5.9 Cg_endo -89.16 98.78 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.449 2.099 . . . . 0.56 112.123 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.51 151.23 40.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.261 -0.427 . . . . 0.63 110.645 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 34.9 ttm -122.92 133.95 54.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.04 -0.527 . . . . 0.42 110.805 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -123.02 129.83 52.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.72 -0.673 . . . . 0.52 109.543 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 185' ' ' LEU . 40.1 t -101.3 118.32 47.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.917 0.389 . . . . 0.55 111.498 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.55 ' O ' ' HD3' ' A' ' 158' ' ' LYS . 28.6 m-20 58.8 17.88 5.58 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.028 -0.987 . . . . 1.16 112.178 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.4 24.75 67.88 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.039 -0.601 . . . . 0.56 112.14 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.55 ' HD3' ' O ' ' A' ' 156' ' ' ASN . 5.9 mppt? -126.45 -47.66 1.57 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.17 0.509 . . . . 1.75 111.218 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -101.47 126.59 48.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.866 -0.606 . . . . 1.16 111.475 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -103.83 138.47 40.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.453 -0.794 . . . . 0.98 109.865 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 mp -93.41 139.9 30.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.888 0.375 . . . . 1.2 111.163 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -118.07 109.91 40.4 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.72 110.547 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.44 -18.76 19.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.689 2.259 . . . . 0.54 112.712 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -83.56 -0.03 48.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.151 0.501 . . . . 2.22 110.924 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -117.19 22.07 10.56 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.981 -0.628 . . . . 0.59 111.644 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 47.1 mtt -120.53 -174.34 2.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.104 -0.332 . . . . 0.57 110.104 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.23 125.05 25.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.863 0.363 . . . . 1.54 110.114 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.25 31.78 6.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.444 0.64 . . . . 1.16 109.767 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -37.01 5.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.287 -0.87 . . . . 1.53 110.739 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -128.09 118.78 24.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 1.21 110.583 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.514 ' O ' HG23 ' A' ' 175' ' ' VAL . 10.3 mmt -54.08 -41.72 68.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.458 -0.792 . . . . 1.96 111.624 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -57.5 -46.85 83.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.837 0.351 . . . . 2.05 111.272 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.73 -46.87 90.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.948 -0.569 . . . . 0.65 110.755 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -54.29 -49.67 69.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.578 -0.283 . . . . 0.47 111.659 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 171' ' ' MET . 60.9 t -60.9 -45.08 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 0.48 111.552 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -70.7 -41.77 71.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.314 -0.403 . . . . 1.7 111.631 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -63.83 -42.38 97.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.513 . . . . 1.32 110.685 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.561 ' O ' HG23 ' A' ' 182' ' ' VAL . 21.4 t80 -59.57 -54.16 49.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.98 -0.555 . . . . 0.46 110.062 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.2 -34.01 75.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.73 -0.668 . . . . 0.43 111.395 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.8 -36.78 81.05 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.406 -0.361 . . . . 1.55 110.569 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.616 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 24.7 m -67.6 -41.71 83.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.48 109.97 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 178' ' ' TYR . 41.0 t -58.14 -50.4 78.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.022 -0.536 . . . . 0.48 110.389 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -59.93 -42.65 94.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.468 -0.787 . . . . 1.59 111.369 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -60.38 -42.96 96.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.326 -0.397 . . . . 1.17 110.537 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 181' ' ' THR . 53.8 mt -70.04 -33.92 72.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.68 110.712 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 25.4 m -66.94 -39.44 87.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.217 0.532 . . . . 1.07 110.188 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -91.0 23.04 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.687 -0.688 . . . . 2.26 110.294 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -109.37 -72.44 0.72 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.324 -0.398 . . . . 1.72 111.217 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.57 -0.728 . . . . 4.33 110.601 -179.087 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SFQ . . . . . 0.558 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.459 -0.2 . . . . 4.08 110.459 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -85.32 123.31 30.65 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.171 -0.307 . . . . 3.58 110.171 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -127.79 100.27 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.009 0.433 . . . . 1.32 110.695 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -108.96 142.5 39.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.954 -0.566 . . . . 2.29 110.878 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.06 125.52 26.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.601 -0.727 . . . . 1.83 109.942 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.25 -20.38 35.43 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.992 -0.623 . . . . 0.78 111.96 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -109.12 -74.73 0.65 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.74 -0.27 . . . . 1.87 110.466 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -75.76 -43.53 46.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.27 -0.423 . . . . 1.46 110.904 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -138.54 154.21 48.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.79 110.302 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.89 133.19 54.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.283 -0.417 . . . . 0.9 111.046 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 m -84.52 127.42 34.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.278 -0.419 . . . . 1.11 111.711 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.78 137.02 34.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.602 -0.518 . . . . 0.74 109.602 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -75.68 -29.09 58.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 2.33 110.513 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -113.05 90.17 15.38 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 3.64 109.89 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.4 143.26 19.38 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.427 2.085 . . . . 0.85 112.593 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 19' ' ' ALA . 47.7 t -76.61 127.44 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.51 -0.768 . . . . 0.72 111.412 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.06 121.28 26.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.06 -0.518 . . . . 0.89 110.557 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.0 19.94 44.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.72 . . . . 0.73 111.995 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . . . -75.02 145.78 81.46 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.647 -0.277 . . . . 0.64 111.239 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.68 165.95 31.29 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.444 2.096 . . . . 0.56 111.985 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -56.62 -60.73 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 1.79 111.487 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.96 102.67 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.987 0.423 . . . . 0.45 110.539 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 47.3 tp -98.64 138.32 35.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.835 -0.62 . . . . 0.53 109.849 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -145.88 154.33 41.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.651 0.263 . . . . 1.61 110.799 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -130.04 157.6 41.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.066 -0.516 . . . . 0.53 110.343 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -168.38 177.5 5.32 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.089 -0.505 . . . . 0.55 110.554 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.5 t -156.75 132.87 9.74 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.96 110.849 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.493 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.9 m-85 -71.13 -16.71 62.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.834 -0.621 . . . . 0.62 109.826 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.491 ' CE2' ' HA2' ' A' ' 69' ' ' GLY . 97.1 m-85 -85.66 -4.0 59.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.567 -0.742 . . . . 1.78 111.32 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 53.3 t -115.49 122.63 32.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.393 -0.367 . . . . 0.48 110.764 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -65.94 -23.87 53.96 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.412 2.075 . . . . 0.7 112.027 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -60.49 -38.93 85.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 1.74 110.099 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.2 m -71.67 -34.77 69.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.998 -0.546 . . . . 0.37 110.725 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.88 -44.31 96.44 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.124 0.487 . . . . 1.44 110.455 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.467 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 13.8 tt0 -66.48 -36.58 83.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.526 . . . . 2.27 110.357 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -77.5 -25.82 50.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.067 -0.515 . . . . 0.87 111.46 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 4.4 tp10 -84.25 -50.61 7.71 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.599 0.592 . . . . 1.89 112.599 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.584 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 10.1 tp10 -97.37 -46.21 6.17 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.356 0.873 . . . . 2.0 113.356 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 48.8 t -69.68 -51.8 37.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.051 -0.659 . . . . 0.58 110.921 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 mt -86.52 -35.56 19.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.258 -0.428 . . . . 0.41 111.764 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.584 ' HD2' ' O ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER 60.63 41.62 15.04 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.59 -0.522 . . . . 0.84 109.59 -178.766 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.631 ' O ' HG23 ' A' ' 46' ' ' VAL . 42.7 mm -53.77 -68.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.845 -0.616 . . . . 0.41 112.169 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 1.4 m -51.92 -45.63 64.34 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.345 0.403 . . . . 1.03 111.943 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 30.5 t70 -65.69 -29.66 70.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.888 -0.596 . . . . 1.73 111.583 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 2.2 t-20 -77.73 -37.14 49.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 1.19 110.217 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 42' ' ' ILE . 43.2 t -60.32 -35.48 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.935 -0.575 . . . . 0.49 110.637 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 43' ' ' SER . 51.8 mttt -56.71 -36.65 69.92 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.393 -0.367 . . . . 1.53 111.44 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -77.72 -10.32 59.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 2.02 112.089 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -102.07 -32.95 9.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.475 -0.33 . . . . 1.44 110.759 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.448 HD22 HG11 ' A' ' 54' ' ' VAL . 91.4 mt -68.92 129.88 91.97 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.77 -171.43 0.86 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.645 2.23 . . . . 0.74 112.625 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -67.86 148.75 50.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 2.63 111.128 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.54 -19.03 30.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.934 -0.651 . . . . 0.82 113.195 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 50' ' ' LEU . 5.8 t -89.72 132.8 33.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.106 0.479 . . . . 1.03 110.749 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -131.41 141.76 49.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.98 -0.554 . . . . 2.51 110.265 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 84.2 mtp -90.88 134.3 34.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 1.28 110.999 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.02 94.36 4.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.232 0.539 . . . . 0.61 110.167 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -92.08 118.37 30.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.737 -0.665 . . . . 0.86 110.665 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 9.5 m-30 -113.62 167.56 10.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 0.71 110.897 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -103.24 133.62 48.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.405 -0.361 . . . . 0.57 110.795 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.8 149.27 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 0.68 110.314 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -109.42 27.24 9.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.856 0.36 . . . . 0.93 111.688 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -133.65 15.57 4.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.014 0.435 . . . . 0.74 110.995 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -137.92 103.23 4.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.15 -0.477 . . . . 1.09 110.073 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.63 9.33 2.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.602 -0.808 . . . . 0.78 112.534 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.76 -140.46 34.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.879 -0.676 . . . . 0.81 112.373 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.83 -34.34 33.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.036 0.446 . . . . 2.47 110.048 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.3 tp -67.35 -22.31 65.59 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.772 -0.649 . . . . 1.94 110.256 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.491 ' HA2' ' CE2' ' A' ' 29' ' ' PHE . . . -58.88 -37.05 90.16 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.671 -0.695 . . . . 0.7 111.876 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -68.66 -32.16 71.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.776 0.322 . . . . 2.69 110.776 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -40.49 97.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 1.65 110.265 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.476 ' HG ' HD13 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -71.83 -26.57 62.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.089 -0.505 . . . . 1.17 110.459 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -62.57 -33.59 75.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.304 0.574 . . . . 0.62 109.759 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -77.84 -37.43 48.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.438 -0.801 . . . . 1.21 109.48 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.17 85.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.569 -0.741 . . . . 0.71 111.318 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -59.67 -36.43 76.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.111 -0.495 . . . . 0.59 110.597 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.84 -36.27 83.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.11 -0.495 . . . . 0.71 110.083 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.1 -43.05 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.677 -0.692 . . . . 0.84 110.013 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.36 90.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.794 -0.639 . . . . 0.66 110.938 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 71.6 mtm -66.84 -35.66 80.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.95 -0.568 . . . . 1.08 110.652 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.33 -36.57 68.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.893 0.377 . . . . 0.99 110.882 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 mt -75.62 -44.22 43.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.22 -0.446 . . . . 0.97 110.763 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.69 37.38 3.72 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.272 -0.731 . . . . 0.78 111.272 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.27 29.11 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.966 0.413 . . . . 0.81 110.179 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.87 -65.76 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.281 -0.872 . . . . 1.71 112.158 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.31 -28.99 67.3 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.334 -0.394 . . . . 1.91 111.218 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -66.65 -44.68 81.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.815 -0.629 . . . . 2.28 111.474 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.81 -8.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.886 0.328 . . . . 0.65 111.886 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.6 m -58.25 -49.13 78.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.721 0.267 . . . . 0.98 111.721 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.44 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 46.3 t -61.36 -59.86 12.3 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.383 0.512 . . . . 0.62 112.383 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.44 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 12.2 Cg_endo -56.13 -34.19 92.26 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.198 1.932 . . . . 0.61 113.232 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.1 mt -70.8 -40.7 72.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.715 0.293 . . . . 0.79 110.719 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -64.24 -48.13 76.98 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.231 0.539 . . . . 0.58 110.442 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.9 -35.87 74.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.534 -0.757 . . . . 1.7 111.248 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.72 -25.69 70.59 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.917 -0.658 . . . . 0.82 113.106 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 64.7 t -100.65 -39.43 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.491 0.552 . . . . 0.75 112.491 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -94.57 -42.94 8.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.717 1.006 . . . . 0.84 113.717 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -78.97 -62.49 1.68 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.977 0.362 . . . . 1.41 111.977 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.04 -39.41 25.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.112 -0.494 . . . . 1.31 112.162 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 66.08 26.89 10.66 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.066 0.46 . . . . 1.44 110.288 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.33 -33.76 32.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.894 -0.594 . . . . 1.57 111.346 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.25 102.51 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.917 -0.583 . . . . 0.91 110.461 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mmm-85 -119.14 -8.12 10.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.848 -0.615 . . . . 3.22 110.448 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 m -149.77 172.59 14.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.226 -0.443 . . . . 1.51 110.696 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.8 -20.72 66.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.24 -0.436 . . . . 1.08 110.816 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -44.72 96.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.006 -0.543 . . . . 1.43 110.562 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 111' ' ' VAL . 13.2 m-20 -67.07 -40.29 87.03 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.98 -0.554 . . . . 1.89 109.851 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.476 HD13 ' HG ' ' A' ' 72' ' ' LEU . 54.6 mt -61.05 -46.1 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.654 -0.703 . . . . 0.9 110.171 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 113' ' ' ILE . 62.8 ttt180 -60.28 -41.22 92.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.943 -0.572 . . . . 2.19 109.723 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -59.48 -39.66 84.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.306 -0.861 . . . . 1.95 110.667 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 107' ' ' ASP . 73.2 t -60.09 -42.41 89.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.88 110.661 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -65.35 -39.75 92.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.92 110.457 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 65.7 mt -64.95 -33.77 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.316 0.579 . . . . 1.33 109.763 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -73.91 -8.39 55.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.541 -0.754 . . . . 1.93 110.654 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.32 2.57 42.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.07 -0.514 . . . . 1.1 110.311 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.81 39.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.821 -0.705 . . . . 1.15 113.193 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 38.2 mm -98.23 133.35 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.123 -0.325 . . . . 1.61 110.123 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -73.76 146.86 43.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.26 -0.427 . . . . 2.73 111.468 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.3 -35.27 91.32 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.894 -0.669 . . . . 1.19 112.024 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.53 -45.69 78.62 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.952 -0.388 . . . . 2.98 109.952 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -60.93 -45.08 96.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.552 -0.749 . . . . 2.52 109.686 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.411 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 53.9 t80 -63.05 -41.87 99.59 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.76 -0.655 . . . . 1.51 110.479 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.63 -44.15 93.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.831 0.348 . . . . 2.3 110.852 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.84 79.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 1.23 111.119 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.02 83.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 1.11 111.088 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -57.96 -36.92 73.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.308 -0.405 . . . . 1.31 111.074 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -109.58 32.04 5.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.371 -0.377 . . . . 1.63 111.47 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.9 p -92.09 157.75 16.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.766 0.317 . . . . 2.04 110.215 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -74.06 -32.46 63.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.556 -0.293 . . . . 3.82 110.359 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.3 t -58.4 -45.49 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.989 0.423 . . . . 1.53 110.181 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 135' ' ' VAL . 15.5 t -61.89 -38.48 80.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.561 -0.745 . . . . 1.11 110.537 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -56.43 -50.72 70.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 2.43 110.976 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -32.03 72.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 1.47 111.051 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.38 -32.43 66.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.93 110.773 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.453 ' HA ' HE21 ' A' ' 138' ' ' GLN . 70.1 t -67.31 -47.03 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.8 110.073 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.08 85.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 0.85 111.233 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -64.12 -32.42 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.512 -0.313 . . . . 1.39 111.34 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.453 HE21 ' HA ' ' A' ' 135' ' ' VAL . 50.5 mt-30 -66.43 -42.27 87.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.409 -0.359 . . . . 0.61 110.551 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.41 -37.97 50.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 2.82 110.803 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 31.7 tttp -54.34 -50.26 67.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.325 -0.398 . . . . 1.95 110.809 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -66.37 -46.55 76.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.162 -0.472 . . . . 0.65 111.522 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.65 83.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 0.61 112.104 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.81 -27.21 61.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.52 0.563 . . . . 0.72 112.52 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 3.3 t0 -78.12 -31.35 49.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.856 0.317 . . . . 1.39 111.856 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 141' ' ' ALA . 32.6 m -92.47 3.14 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.151 0.426 . . . . 1.34 112.151 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 60.4 51.6 5.23 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.262 0.553 . . . . 1.95 110.155 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.9 tp -62.18 106.61 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.479 -0.782 . . . . 0.71 111.404 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -104.19 -1.79 26.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.804 -0.635 . . . . 4.16 110.811 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -133.39 179.78 17.08 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.847 -0.692 . . . . 0.68 112.014 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.501 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 0.2 OUTLIER -97.85 -61.85 0.12 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 117.033 0.416 . . . . 0.49 111.411 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 3.9 Cg_endo -85.78 65.74 5.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.641 2.227 . . . . 0.56 111.814 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -109.35 138.7 45.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.63 110.67 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 29.4 ttm -115.62 137.98 51.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.947 -0.57 . . . . 0.42 110.168 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -127.74 131.31 49.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 0.52 110.392 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.59 117.79 45.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.573 -0.285 . . . . 0.55 110.705 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 60.63 13.87 4.57 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.733 -0.667 . . . . 1.16 111.601 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.31 23.99 68.7 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.047 -0.597 . . . . 0.56 111.759 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -124.65 -44.37 1.97 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.075 0.464 . . . . 1.75 110.758 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -102.1 125.13 48.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.936 -0.575 . . . . 1.16 110.604 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -105.68 138.85 41.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.196 -0.456 . . . . 0.98 109.862 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.6 mp -90.18 139.15 30.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.535 0.207 . . . . 1.2 110.726 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -114.9 113.12 44.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.43 . . . . 0.72 110.854 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.77 6.86 5.21 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.924 2.416 . . . . 0.54 112.56 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -113.33 20.98 15.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.323 -0.399 . . . . 2.22 110.763 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.11 33.39 1.92 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.02 -0.609 . . . . 0.59 111.935 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.9 mtt -124.84 -176.51 3.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.474 0.178 . . . . 0.57 110.542 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.05 127.58 32.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.138 0.494 . . . . 1.54 111.57 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 16.2 16.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.835 -0.621 . . . . 1.16 110.835 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -32.42 14.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.159 0.504 . . . . 1.53 110.401 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -139.42 125.16 19.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.04 -0.527 . . . . 1.21 110.127 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.414 ' O ' HG23 ' A' ' 175' ' ' VAL . 56.4 ttm -62.37 -32.94 73.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.63 . . . . 1.96 111.443 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -63.32 -37.28 86.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.174 -0.466 . . . . 2.05 111.027 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.68 -41.83 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.65 110.509 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.84 -50.09 71.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.47 111.122 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 171' ' ' MET . 57.8 t -57.61 -51.09 74.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.48 111.688 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -42.12 83.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.995 -0.548 . . . . 1.7 112.119 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -62.09 -45.61 92.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.657 0.265 . . . . 1.32 110.979 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -57.71 -52.18 66.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.46 110.635 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.01 82.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.43 112.105 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.65 -32.95 73.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.646 0.26 . . . . 1.55 110.516 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 35.4 m -63.14 -40.07 96.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.48 110.188 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.38 -52.92 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.269 0.557 . . . . 0.48 110.227 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -57.44 -39.83 77.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.961 -1.018 . . . . 1.59 111.007 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -64.51 -46.24 83.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.889 -0.596 . . . . 1.17 110.819 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.0 mt -66.56 -39.81 88.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.088 -0.506 . . . . 0.68 112.06 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.9 p -66.31 -23.75 66.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.038 0.447 . . . . 1.07 111.276 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -102.2 4.97 39.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.226 0.536 . . . . 2.26 110.338 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.5 tttm -95.84 68.81 2.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.788 -0.642 . . . . 1.72 110.326 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.471 ' NZ ' ' HB3' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-N 115.564 -0.744 . . . . 4.33 110.35 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SFQ . . . . . 0.526 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.554 0.216 . . . . 4.08 110.613 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -76.51 119.56 20.52 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.935 -0.395 . . . . 3.58 109.935 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -125.54 140.96 52.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.757 0.313 . . . . 1.32 110.983 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -119.35 140.67 49.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.943 -0.571 . . . . 2.29 109.891 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -69.3 119.12 13.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.083 0.468 . . . . 1.83 110.036 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.56 -16.38 29.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.995 -0.842 . . . . 0.78 110.995 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 50.6 tptt -99.13 -80.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.637 -0.281 . . . . 1.87 110.57 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -86.79 -25.37 24.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 1.46 111.381 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -143.49 152.74 41.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.189 -0.3 . . . . 0.79 110.189 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 m -128.54 132.08 48.26 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.21 0.319 . . . . 0.9 110.639 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.4 m -75.68 125.56 29.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.362 -0.381 . . . . 1.11 110.175 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.26 127.31 32.26 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.792 0.329 . . . . 0.74 110.526 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.09 -39.46 93.21 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.627 -0.715 . . . . 2.33 110.33 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -122.18 84.01 45.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 3.64 109.893 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.36 155.11 70.43 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.485 2.124 . . . . 0.85 112.191 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.5 t -89.4 131.84 35.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.036 -0.529 . . . . 0.72 110.713 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.81 137.8 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.107 -0.497 . . . . 0.89 110.323 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.9 25.24 74.34 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.73 -0.748 . . . . 0.73 112.382 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.26 143.52 31.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.436 -0.209 . . . . 0.64 110.436 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 30.1 Cg_endo -66.27 162.05 37.79 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.373 2.049 . . . . 0.56 112.704 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -62.68 -44.92 95.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.612 -0.722 . . . . 1.79 110.705 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.8 t -120.52 100.77 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.702 -0.481 . . . . 0.45 109.702 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 26.5 tp -110.92 110.78 21.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.951 -0.568 . . . . 0.53 110.423 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -120.12 145.76 46.61 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.426 -0.352 . . . . 1.61 110.215 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 151' ' ' PRO . 97.2 m-85 -123.23 154.63 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.309 -0.405 . . . . 0.53 110.114 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -170.24 177.99 3.97 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.005 0.431 . . . . 0.55 110.786 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.1 t -156.91 141.58 16.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 0.96 110.51 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.539 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 96.0 m-85 -73.4 -20.49 60.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.9 -0.591 . . . . 0.62 110.502 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CE2' HD12 ' A' ' 72' ' ' LEU . 72.6 m-85 -85.35 -1.32 56.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.78 110.339 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.47 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 48.1 t -107.19 112.34 62.98 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.019 -0.537 . . . . 0.48 111.133 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -64.2 -24.54 65.61 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.216 1.944 . . . . 0.7 111.283 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -66.32 -29.37 69.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.369 -0.832 . . . . 1.74 110.236 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.0 m -83.66 -32.02 25.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.47 -0.567 . . . . 0.37 109.47 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.77 -49.1 79.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.304 -0.862 . . . . 1.44 110.063 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.505 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 22.5 tt0 -68.35 -32.34 72.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 2.27 110.726 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.404 ' O ' HG12 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -66.66 -30.84 71.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.481 0.549 . . . . 0.87 112.481 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -108.65 -50.11 3.07 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.993 0.738 . . . . 1.89 112.993 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.63 -25.51 64.87 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.953 -0.467 . . . . 2.0 111.659 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 91.5 t -107.72 -56.44 4.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.796 -0.362 . . . . 0.58 111.498 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.8 mt -81.05 -33.55 33.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.928 0.344 . . . . 0.41 111.928 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 0.6 OUTLIER 58.9 63.45 1.64 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.848 0.459 . . . . 0.84 111.003 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 36' ' ' PHE . 49.1 mm -71.36 -50.87 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.902 -0.59 . . . . 0.41 111.165 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 m -58.3 -49.33 77.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.314 -0.403 . . . . 1.03 110.999 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 26.0 t70 -61.26 -45.03 96.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.549 . . . . 1.73 110.888 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 0.7 OUTLIER -62.41 -41.56 98.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 1.19 110.794 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 39.6 t -66.44 -42.44 90.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.49 110.541 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.93 -31.63 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.738 0.304 . . . . 1.53 111.37 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 30.3 mttm -86.68 3.13 46.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.261 -0.427 . . . . 2.02 111.679 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -136.97 23.59 3.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 1.44 111.007 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 13.9 mt -99.73 145.5 30.25 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.383 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 50' ' ' LEU . 10.4 Cg_exo -70.21 165.48 31.34 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.718 2.279 . . . . 0.74 111.422 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.25 139.97 50.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.998 -0.546 . . . . 2.63 110.368 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.23 -9.15 78.03 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.931 -0.652 . . . . 0.82 112.118 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.95 98.63 7.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.853 0.359 . . . . 1.03 110.263 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.6 124.96 31.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.141 -0.481 . . . . 2.51 110.165 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -72.97 127.97 34.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.646 -0.501 . . . . 1.28 109.646 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 119.48 34.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.949 0.404 . . . . 0.61 110.757 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HD3' ' CE1' ' A' ' 26' ' ' PHE . 15.2 ttmm -114.04 119.57 37.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.86 110.16 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 13.1 m-30 -110.28 160.51 16.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.135 0.493 . . . . 0.71 111.55 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -104.85 134.76 47.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.661 -0.699 . . . . 0.57 110.618 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.424 HG21 HG13 ' A' ' 150' ' ' VAL . 16.7 m -88.7 155.05 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.587 -0.279 . . . . 0.68 110.61 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -105.21 -6.1 20.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.632 0.604 . . . . 0.93 112.632 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -89.97 15.5 9.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.427 0.632 . . . . 0.74 110.79 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -144.32 88.87 1.97 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.458 -0.792 . . . . 1.09 109.61 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.15 -7.27 0.29 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 121.09 -0.576 . . . . 0.78 112.547 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.44 -134.61 22.83 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.556 -0.831 . . . . 0.81 112.333 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -22.8 40.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.649 0.262 . . . . 2.47 110.793 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 tp -85.6 -11.62 53.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.097 0.475 . . . . 1.94 110.318 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.75 98.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.772 -0.727 . . . . 0.7 111.961 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -62.9 -40.09 96.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.067 0.461 . . . . 2.69 110.552 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.79 -49.06 79.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.678 -0.692 . . . . 1.65 111.158 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.549 HD12 ' CE2' ' A' ' 29' ' ' PHE . 1.7 mt -66.29 -22.77 66.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 1.17 111.6 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 m -69.71 -40.39 76.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.917 0.389 . . . . 0.62 110.098 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -72.37 -38.91 68.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.98 -0.748 . . . . 1.21 108.98 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.88 99.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.418 -0.81 . . . . 0.71 110.935 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.441 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 66.6 t-105 -62.69 -38.21 89.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.735 -0.666 . . . . 0.59 110.714 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -61.13 -38.48 86.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.71 110.39 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.05 -41.73 92.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.121 0.486 . . . . 0.84 109.801 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.7 88.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.784 -0.644 . . . . 0.66 111.006 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.8 mtm -69.26 -33.42 73.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 1.08 111.149 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.92 -38.86 61.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.501 . . . . 0.99 110.584 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.6 mt -76.31 -32.75 58.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.094 -0.503 . . . . 0.97 110.926 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.27 39.54 6.0 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.772 -0.727 . . . . 0.78 111.581 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.6 m -130.09 30.32 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.832 0.349 . . . . 0.81 110.83 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.441 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 2.8 mp0 -59.77 -63.0 1.46 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.047 -0.524 . . . . 1.71 111.812 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.74 -33.33 61.04 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.188 -0.46 . . . . 1.91 111.172 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -66.17 -48.02 72.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.77 -0.65 . . . . 2.28 111.705 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.83 -10.6 11.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.062 0.764 . . . . 0.65 113.062 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.4 m -56.18 -51.76 66.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.219 0.452 . . . . 0.98 112.219 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.434 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 42.2 t -62.57 -59.22 13.35 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 112.547 0.573 . . . . 0.62 112.547 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 10.0 Cg_endo -54.7 -35.29 86.92 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.255 1.97 . . . . 0.61 113.059 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.9 mt -68.77 -47.92 65.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.514 0.197 . . . . 0.79 110.757 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.539 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -58.59 -49.43 77.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.165 0.507 . . . . 0.58 110.784 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.41 -39.33 93.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.621 -0.718 . . . . 1.7 110.913 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.65 -18.03 71.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.998 -0.62 . . . . 0.82 113.469 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.7 t -101.55 -42.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.319 0.488 . . . . 0.75 112.319 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -98.72 -39.98 8.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.587 0.958 . . . . 0.84 113.587 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -79.61 -70.79 0.49 Allowed 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.676 -0.41 . . . . 1.41 111.797 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.31 -26.4 46.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.676 -0.238 . . . . 1.31 111.532 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.42 ' HB3' HH21 ' A' ' 103' ' ' ARG . 58.7 mt-30 56.38 28.45 13.53 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.606 0.567 . . . . 1.44 111.173 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -28.51 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.75 -0.659 . . . . 1.57 111.584 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.74 100.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.991 -0.374 . . . . 0.91 109.991 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.42 HH21 ' HB3' ' A' ' 100' ' ' GLN . 26.1 mmt180 -122.97 -3.59 8.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 3.22 110.967 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -149.45 166.1 30.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.319 -0.4 . . . . 1.51 110.068 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.93 67.85 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.51 -0.313 . . . . 1.08 111.335 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -36.66 78.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.246 -0.434 . . . . 1.43 110.785 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -70.67 -42.23 71.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.363 -0.606 . . . . 1.89 109.363 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.5 mt -62.17 -43.14 97.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.614 -0.721 . . . . 0.9 110.097 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.402 ' O ' HG13 ' A' ' 113' ' ' ILE . 74.2 ttt-85 -57.76 -44.2 85.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.572 -0.74 . . . . 2.19 110.211 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.7 -35.06 79.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.606 -0.724 . . . . 1.95 111.386 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.4 t -60.82 -42.75 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.029 0.442 . . . . 0.88 110.255 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -64.42 -39.9 94.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 0.92 110.394 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.681 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 65.4 mt -63.9 -36.47 76.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 1.33 110.126 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -68.03 -23.33 64.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.834 -0.621 . . . . 1.93 111.045 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.45 -7.47 58.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.1 111.522 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.96 5.75 28.72 Favored Glycine 0 C--O 1.234 0.136 0 C-N-CA 120.747 -0.739 . . . . 1.15 112.736 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 44.4 mm -92.44 124.89 45.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 122.742 -0.27 . . . . 1.61 110.364 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -65.52 134.3 53.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.307 -0.406 . . . . 2.73 110.42 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.32 -38.97 81.23 Favored Glycine 0 CA--C 1.517 0.207 0 O-C-N 123.479 0.487 . . . . 1.19 112.717 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.31 -36.59 80.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.528 0.204 . . . . 2.98 111.368 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -73.13 -41.88 63.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.041 0.448 . . . . 2.52 109.978 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -60.79 -44.3 97.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 1.51 110.21 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -61.63 -39.41 91.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.985 -0.552 . . . . 2.3 110.874 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.41 -47.42 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.749 -0.66 . . . . 1.23 110.607 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.1 -27.94 68.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.256 -0.429 . . . . 1.11 111.333 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -62.46 -28.82 70.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.139 0.495 . . . . 1.31 110.301 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -105.05 19.13 21.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.006 -0.543 . . . . 1.63 111.111 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.0 t -80.3 142.22 34.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.102 -0.499 . . . . 2.04 110.865 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -69.84 -32.26 70.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.198 0.523 . . . . 3.82 109.685 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.41 -44.87 99.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.717 -0.674 . . . . 1.53 109.804 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.529 HG13 ' HB3' ' A' ' 77' ' ' ALA . 62.0 t -64.31 -41.48 92.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.412 -0.813 . . . . 1.11 110.332 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -57.29 -42.47 81.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.989 -0.55 . . . . 2.43 110.083 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 137' ' ' GLN . 12.1 t -66.38 -44.88 81.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.645 -0.707 . . . . 1.47 110.214 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 48.4 mt -59.2 -37.73 78.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 0.93 111.043 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.493 ' HA ' HE21 ' A' ' 138' ' ' GLN . 77.2 t -61.94 -47.01 95.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.929 -0.397 . . . . 0.8 109.929 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.6 -39.14 92.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.84 -0.618 . . . . 0.85 110.812 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 133' ' ' SER . 78.6 mt-30 -60.49 -41.08 93.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 1.39 111.207 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.493 HE21 ' HA ' ' A' ' 135' ' ' VAL . 49.7 mt-30 -63.75 -48.05 78.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.262 -0.426 . . . . 0.61 110.727 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 8.6 mt-10 -65.12 -41.2 95.1 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.025 -0.534 . . . . 2.82 110.44 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.7 tttm -61.92 -50.7 71.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.277 -0.874 . . . . 1.95 111.259 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.42 -44.98 92.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.46 . . . . 0.65 111.967 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.08 -36.51 83.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.487 -0.324 . . . . 0.61 111.689 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.88 -36.39 28.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.525 -0.307 . . . . 0.72 111.197 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -63.86 -49.73 71.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.413 -0.358 . . . . 1.39 110.997 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.63 -9.68 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 1.34 110.891 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.506 ' O ' ' HD2' ' A' ' 148' ' ' ARG . 89.5 mt-30 59.18 67.25 0.93 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.771 -0.65 . . . . 1.95 110.193 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 149' ' ' GLY . 14.0 tp -63.97 129.68 41.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.515 -0.766 . . . . 0.71 110.535 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.506 ' HD2' ' O ' ' A' ' 146' ' ' GLN . 1.2 mpt_? -96.74 -47.49 5.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.821 -0.627 . . . . 4.16 110.254 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . -98.05 -158.09 30.16 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.321 -0.712 . . . . 0.68 111.321 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.551 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 2.5 t -113.4 -57.41 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 117.221 0.511 . . . . 0.49 111.724 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 17.3 Cg_endo -92.64 82.34 0.24 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.601 2.201 . . . . 0.56 111.885 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.36 146.15 50.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.316 -0.402 . . . . 0.63 110.87 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 43.8 ttm -118.78 133.14 56.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.049 -0.523 . . . . 0.42 110.314 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.28 133.1 56.38 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.914 -0.585 . . . . 0.52 109.826 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.43 112.4 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.257 -0.429 . . . . 0.55 110.459 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 60.47 17.23 7.08 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.278 -0.873 . . . . 1.16 111.52 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.19 20.28 64.88 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.925 -0.58 . . . . 0.56 112.512 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -121.06 -38.35 2.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.886 0.374 . . . . 1.75 111.641 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -111.83 128.36 56.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.016 0.436 . . . . 1.16 110.898 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -105.15 138.4 41.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.667 -0.697 . . . . 0.98 110.438 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.23 134.97 33.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.528 -0.306 . . . . 1.2 110.325 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -115.6 100.79 53.96 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.774 0.321 . . . . 0.72 110.587 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.45 -16.87 34.7 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 122.363 2.042 . . . . 0.54 112.572 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -81.02 -6.48 58.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.948 0.404 . . . . 2.22 110.788 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -115.26 14.77 18.43 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.244 -0.742 . . . . 0.59 111.244 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.403 ' HB3' ' OE1' ' A' ' 177' ' ' GLN . 64.9 mtt -105.54 -174.52 2.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.543 -0.329 . . . . 0.57 110.187 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -71.25 111.8 6.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.226 0.536 . . . . 1.54 111.032 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.24 18.49 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.338 0.589 . . . . 1.16 109.795 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.99 -48.88 6.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.507 -0.77 . . . . 1.53 110.681 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -122.37 126.84 48.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.164 -0.471 . . . . 1.21 110.61 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.445 ' O ' HG23 ' A' ' 175' ' ' VAL . 39.3 mtt -62.19 -40.52 96.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.031 -0.531 . . . . 1.96 111.602 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -61.05 -42.01 97.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 2.05 110.604 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.8 t -67.74 -46.84 81.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.792 -0.64 . . . . 0.65 110.45 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -55.4 -49.34 72.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.777 -0.647 . . . . 0.47 111.856 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 171' ' ' MET . 80.8 t -55.73 -50.09 70.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.548 -0.296 . . . . 0.48 111.705 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -69.25 -35.06 75.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.375 -0.375 . . . . 1.7 111.082 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.403 ' OE1' ' HB3' ' A' ' 166' ' ' MET . 57.4 tt0 -63.57 -47.15 82.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.398 -0.365 . . . . 1.32 110.537 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' ' 182' ' ' VAL . 17.7 t80 -57.54 -46.73 83.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.975 -0.557 . . . . 0.46 109.906 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.7 -41.1 88.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.638 -0.71 . . . . 0.43 111.46 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.55 -40.36 96.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.086 -0.506 . . . . 1.55 110.311 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.2 m -59.76 -42.03 92.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.48 110.575 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 178' ' ' TYR . 61.8 t -60.05 -53.17 52.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.293 -0.412 . . . . 0.48 110.523 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -59.83 -46.36 89.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.687 -0.688 . . . . 1.59 111.047 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 188' ' ' LYS . 88.6 t80 -58.73 -45.6 89.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.838 -0.619 . . . . 1.17 111.484 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.36 -36.55 74.25 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.479 0.18 . . . . 0.68 111.401 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.7 m -64.37 -37.6 88.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.986 0.422 . . . . 1.07 110.879 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -97.42 17.72 16.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 2.26 111.139 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 184' ' ' TYR . 44.1 tttm -94.08 76.99 4.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.116 0.484 . . . . 1.72 110.395 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.597 -0.716 . . . . 4.33 110.85 -179.753 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SFQ . . . . . 0.524 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.399 -0.223 . . . . 4.08 110.399 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -87.7 127.41 35.3 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.42 -0.215 . . . . 3.58 110.42 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -134.73 135.01 41.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.532 0.206 . . . . 1.32 110.492 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -128.3 151.01 49.81 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.761 0.315 . . . . 2.29 110.746 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -65.95 123.37 19.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.783 -0.644 . . . . 1.83 111.011 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.0 -14.05 52.45 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.915 -0.584 . . . . 0.78 112.425 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -108.52 -73.31 0.69 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.95 -0.3 . . . . 1.87 111.137 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -91.54 -24.59 19.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.581 0.229 . . . . 1.46 111.41 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -145.7 158.82 43.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.147 -0.316 . . . . 0.79 110.147 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.95 122.96 31.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.958 0.409 . . . . 0.9 111.096 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.4 m -74.51 120.57 20.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.162 -0.472 . . . . 1.11 109.805 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.4 mt -72.58 136.69 45.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.024 0.44 . . . . 0.74 111.285 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -77.17 -31.7 55.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.972 -0.751 . . . . 2.33 108.972 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -120.2 83.42 32.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.26 -0.882 . . . . 3.64 110.096 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.12 163.4 38.25 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.382 2.055 . . . . 0.85 112.08 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.77 115.3 43.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.004 0.43 . . . . 0.72 110.647 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.43 111.84 12.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.807 -0.633 . . . . 0.89 110.496 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.37 20.88 9.22 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.771 -0.728 . . . . 0.73 112.245 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.88 154.27 55.37 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.452 -0.203 . . . . 0.64 110.452 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.49 161.31 42.66 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.12 1.88 . . . . 0.56 112.228 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -57.33 -56.53 20.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.836 -0.62 . . . . 1.79 111.487 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.409 HG21 HD11 ' A' ' 50' ' ' LEU . 58.9 t -112.27 96.35 4.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.134 0.493 . . . . 0.45 110.337 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.33 116.54 32.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.635 -0.711 . . . . 0.53 109.764 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -126.23 152.17 46.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.611 0.243 . . . . 1.61 110.822 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.23 156.61 42.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.61 -0.515 . . . . 0.53 109.61 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -169.06 175.95 5.54 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.019 0.438 . . . . 0.55 111.003 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.493 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 7.0 t -156.24 136.99 13.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.337 -0.392 . . . . 0.96 110.192 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.409 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.1 m-85 -70.58 -15.76 62.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.921 -0.581 . . . . 0.62 110.957 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CE2' HD12 ' A' ' 72' ' ' LEU . 65.8 m-85 -88.9 -1.27 58.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 1.78 110.765 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.3 t -107.49 115.73 58.95 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.035 -0.357 . . . . 0.48 110.035 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -64.09 -26.42 65.58 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.372 2.048 . . . . 0.7 112.082 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -70.19 -27.37 64.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 1.74 110.096 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.1 m -71.9 -37.05 70.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.553 -0.536 . . . . 0.37 109.553 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -65.52 -36.48 83.95 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.28 0.562 . . . . 1.44 109.553 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.499 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 47.2 tt0 -65.36 -43.96 89.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.382 -0.826 . . . . 2.27 109.967 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.43 -32.75 68.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.061 -0.518 . . . . 0.87 111.964 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 3.2 tp10 -87.94 -50.79 6.2 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.432 0.901 . . . . 1.89 113.432 -177.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 27.1 tp10 -94.38 -34.33 12.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.738 1.014 . . . . 2.0 113.738 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 51.9 t -81.46 -51.98 14.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 121.578 -0.701 . . . . 0.58 110.914 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' HB3' HG22 ' A' ' 175' ' ' VAL . 79.8 mt -92.18 -31.3 15.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.468 0.544 . . . . 0.41 112.468 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 6.7 m-70 60.0 48.62 8.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.484 -0.561 . . . . 0.84 109.484 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.594 ' O ' HG23 ' A' ' 46' ' ' VAL . 41.1 mm -53.16 -64.13 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.474 -0.784 . . . . 0.41 111.893 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -54.53 -31.66 56.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.284 0.476 . . . . 1.03 112.284 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.94 -37.98 72.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.806 0.336 . . . . 1.73 110.928 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.456 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 28.4 m-80 -72.88 -33.01 65.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 1.19 110.626 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 42' ' ' ILE . 62.1 t -60.47 -37.11 73.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.873 -0.603 . . . . 0.49 110.443 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -62.04 -25.04 67.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.984 -0.553 . . . . 1.53 111.726 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 45' ' ' ASN . 49.3 mtmt -83.04 -11.44 58.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.517 -0.311 . . . . 2.02 111.348 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -112.15 -20.84 11.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 111.828 0.307 . . . . 1.44 111.828 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.409 HD11 HG21 ' A' ' 22' ' ' VAL . 85.8 mt -74.6 132.73 77.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.699 0.285 . . . . 1.0 111.366 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.41 174.5 11.46 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.333 2.022 . . . . 0.74 112.013 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.06 144.81 55.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.14 -0.482 . . . . 2.63 111.158 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.02 -20.46 47.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.172 -0.537 . . . . 0.82 112.559 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.17 113.63 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.869 0.366 . . . . 1.03 110.603 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -97.95 151.77 19.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 2.51 109.841 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 96.2 mtp -108.57 146.17 33.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.47 -0.332 . . . . 1.28 110.359 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 m -135.07 110.71 9.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.824 0.345 . . . . 0.61 110.492 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -106.84 122.45 46.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.875 -0.602 . . . . 0.86 109.704 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.7 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 10.2 m-85 -111.5 159.19 18.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.93 0.395 . . . . 0.71 111.0 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.493 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 52.5 t-80 -104.62 134.64 47.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.491 . . . . 0.57 109.875 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 m -87.47 150.41 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.569 -0.287 . . . . 0.68 111.012 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.667 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 7.5 m-20 -99.44 1.32 44.04 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.36 0.504 . . . . 0.93 112.36 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -98.18 12.92 33.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.13 0.491 . . . . 0.74 111.296 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.13 99.63 3.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.256 -0.429 . . . . 1.09 110.726 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.96 -2.88 4.84 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.623 -0.799 . . . . 0.78 112.426 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.23 -138.91 31.46 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.209 -0.52 . . . . 0.81 112.145 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.98 -37.51 72.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.859 0.362 . . . . 2.47 111.133 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -70.61 -22.08 62.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 1.94 110.391 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.34 -32.48 84.33 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.5 -0.857 . . . . 0.7 111.132 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.667 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 33.4 mttm -66.7 -36.94 83.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.725 0.298 . . . . 2.69 110.807 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -67.0 -39.04 87.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.137 0.494 . . . . 1.65 110.294 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.545 HD12 ' CE2' ' A' ' 29' ' ' PHE . 4.3 mt -66.25 -28.89 69.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 1.17 110.321 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.6 m -67.7 -36.72 81.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.191 0.52 . . . . 0.62 109.773 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -73.87 -41.61 61.96 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.81 -0.632 . . . . 1.21 109.623 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.82 95.24 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.82 -0.627 . . . . 0.71 110.835 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -61.12 -40.14 92.66 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.859 -0.609 . . . . 0.59 110.557 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.21 -35.73 81.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.063 -0.517 . . . . 0.71 110.228 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.85 -46.23 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.84 109.979 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.86 84.69 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.87 -0.605 . . . . 0.66 111.3 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 69.1 mtm -67.97 -39.36 83.37 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.129 -0.487 . . . . 1.08 110.846 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.69 -25.56 63.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 0.99 111.371 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.0 mt -88.97 -46.84 8.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.127 -0.488 . . . . 0.97 110.997 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.43 41.92 2.11 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.113 -0.565 . . . . 0.78 111.862 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.83 26.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.977 0.418 . . . . 0.81 110.216 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.94 -53.61 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.519 -0.764 . . . . 1.71 111.708 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.04 -19.88 65.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.781 -0.645 . . . . 1.91 112.189 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -81.92 -22.26 36.88 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.949 0.351 . . . . 2.28 111.949 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.441 ' HA ' ' HG2' ' A' ' 91' ' ' PRO . 32.9 m -111.36 -6.74 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.231 0.826 . . . . 0.65 113.231 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -56.01 27.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.699 0.629 . . . . 0.98 112.699 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.434 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.9 t -60.29 -56.48 34.97 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 111.97 0.359 . . . . 0.62 111.97 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.441 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 9.4 Cg_endo -55.13 -37.79 93.91 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.465 2.11 . . . . 0.61 113.156 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.37 -42.22 65.5 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.962 -0.295 . . . . 0.79 110.443 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -59.88 -51.88 67.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.262 0.553 . . . . 0.58 110.802 179.359 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -70.86 -34.72 71.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.067 -0.515 . . . . 1.7 111.362 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.09 -23.02 72.85 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.866 -0.683 . . . . 0.82 113.068 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.92 -45.98 12.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.803 0.301 . . . . 0.75 111.703 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -89.23 -51.72 5.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.775 1.028 . . . . 0.84 113.775 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -74.39 -68.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.404 0.52 . . . . 1.41 112.404 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.465 ' HB ' ' OG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -72.4 -34.53 67.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.16 0.429 . . . . 1.31 112.16 -179.086 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 60.4 35.54 20.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.059 0.457 . . . . 1.44 110.744 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.465 ' OG1' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -83.75 -30.24 26.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.634 -0.712 . . . . 1.57 111.637 -179.282 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.5 mt -76.89 110.48 12.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.194 -0.457 . . . . 0.91 110.976 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -120.72 -11.44 9.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 3.22 109.874 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.0 m -150.93 171.48 17.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.006 -0.543 . . . . 1.51 110.339 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -64.12 -22.48 66.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.091 0.472 . . . . 1.08 111.013 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -42.78 92.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.693 -0.685 . . . . 1.43 111.207 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.2 m-20 -65.43 -40.37 93.25 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.167 -0.47 . . . . 1.89 110.137 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 105' ' ' ALA . 12.1 mt -62.52 -42.3 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.659 -0.7 . . . . 0.9 110.083 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -57.7 -41.93 82.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.301 -0.863 . . . . 2.19 110.908 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -66.79 -39.06 87.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 1.95 111.01 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 107' ' ' ASP . 89.1 t -59.83 -39.53 80.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.847 0.356 . . . . 0.88 110.526 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -65.87 -39.07 90.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.444 -0.344 . . . . 0.92 110.159 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 79.9 mt -65.59 -35.53 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.143 0.497 . . . . 1.33 109.686 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -65.66 -27.96 68.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.774 -0.648 . . . . 1.93 110.338 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.44 -13.04 58.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.599 -0.728 . . . . 1.1 111.116 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.38 6.86 17.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.555 -0.831 . . . . 1.15 113.408 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 43.1 mm -91.64 122.82 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.955 0.378 . . . . 1.61 110.054 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -65.03 136.06 56.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.477 -0.329 . . . . 2.73 110.792 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.4 -33.24 70.34 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 121.031 -0.604 . . . . 1.19 112.595 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -65.91 -42.8 89.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.285 0.564 . . . . 2.98 109.897 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.89 -41.83 86.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 2.52 109.711 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -60.0 -40.4 89.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.31 -0.859 . . . . 1.51 111.11 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.29 -40.31 95.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.385 -0.37 . . . . 2.3 110.918 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.4 89.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.23 111.115 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.44 -40.62 70.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.415 . . . . 1.11 110.654 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -58.39 -34.85 71.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.037 -0.529 . . . . 1.31 110.841 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -106.55 40.61 1.59 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.072 -0.513 . . . . 1.63 111.096 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 80.1 p -108.79 152.94 24.19 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.745 -0.382 . . . . 2.04 110.745 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -72.09 -32.84 67.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.416 . . . . 3.82 109.999 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.461 ' O ' ' HG ' ' A' ' 134' ' ' LEU . 60.3 t -58.9 -50.35 79.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.696 -0.684 . . . . 1.53 110.956 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 135' ' ' VAL . 24.8 t -60.22 -45.15 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 1.11 110.522 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -59.26 -38.72 80.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.254 -0.43 . . . . 2.43 110.481 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.04 -36.53 84.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.165 0.507 . . . . 1.47 109.961 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 130' ' ' VAL . 75.7 mt -72.34 -41.63 66.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.987 -0.551 . . . . 0.93 110.342 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.613 ' HA ' HE21 ' A' ' 138' ' ' GLN . 94.2 t -58.27 -47.17 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.8 111.084 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.71 83.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.106 -0.497 . . . . 0.85 111.093 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -70.08 -35.27 74.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 1.39 111.62 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.7 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 48.8 mt-30 -56.58 -54.56 44.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.144 -0.48 . . . . 0.61 111.085 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -71.58 -32.79 68.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.845 -0.616 . . . . 2.82 111.243 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 70.5 tttt -60.13 -48.27 82.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.323 -0.399 . . . . 1.95 110.805 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.03 99.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.16 -0.473 . . . . 0.65 110.986 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.51 -46.23 90.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.61 111.659 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.94 -6.45 57.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.306 0.484 . . . . 0.72 112.306 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -94.07 -27.88 16.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.057 0.456 . . . . 1.39 110.456 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.6 m -98.73 5.65 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.088 -0.505 . . . . 1.34 110.868 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 148' ' ' ARG . 62.7 mt-30 56.51 55.91 6.08 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.25 0.548 . . . . 1.95 109.974 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 44.3 tp -63.71 103.32 0.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.577 -0.738 . . . . 0.71 111.237 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 146' ' ' GLN . 51.1 mtt180 -100.51 40.84 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 4.16 110.199 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -174.13 -174.64 41.13 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.613 -0.995 . . . . 0.68 110.613 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.504 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.2 t -107.83 -58.46 0.05 OUTLIER Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 117.174 0.487 . . . . 0.49 111.562 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.504 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 18.4 Cg_endo -93.98 67.22 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.558 2.172 . . . . 0.56 112.313 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.07 143.29 45.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.63 110.759 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 45.4 ttm -113.82 138.41 50.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.106 -0.497 . . . . 0.42 110.68 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.49 125.29 44.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.638 -0.71 . . . . 0.52 109.659 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.407 HG22 HG13 ' A' ' 182' ' ' VAL . 67.5 t -88.57 112.87 24.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.552 -0.295 . . . . 0.55 111.347 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 58.37 17.3 4.67 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.842 0.714 . . . . 1.16 111.801 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.26 19.93 62.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.051 -0.595 . . . . 0.56 111.627 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -110.72 -38.07 5.25 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.874 0.369 . . . . 1.75 111.078 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -123.83 142.0 51.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.38 . . . . 1.16 111.254 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -107.59 142.95 36.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.749 -0.659 . . . . 0.98 109.614 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.7 mp -94.29 135.21 35.94 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.144 -0.317 . . . . 1.2 110.144 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -115.57 106.05 51.02 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.808 0.337 . . . . 0.72 110.974 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.43 -20.3 21.0 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.33 2.02 . . . . 0.54 112.266 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -77.0 5.98 7.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.034 -0.53 . . . . 2.22 110.996 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.4 22.07 4.46 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.192 -0.763 . . . . 0.59 111.192 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 66.0 mtt -109.19 -167.41 1.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.528 0.204 . . . . 0.57 110.777 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.04 130.7 41.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.291 0.567 . . . . 1.54 111.659 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.68 19.0 13.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.142 -0.935 . . . . 1.16 109.227 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.7 -46.07 8.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.408 -0.815 . . . . 1.53 110.368 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -146.49 130.65 17.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.118 -0.492 . . . . 1.21 110.252 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.434 ' O ' HG23 ' A' ' 175' ' ' VAL . 0.0 OUTLIER -60.56 -28.9 68.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 1.96 110.333 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.54 -31.28 70.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.49 0.662 . . . . 2.05 110.506 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 43.0 t -86.0 -43.52 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.806 -0.634 . . . . 0.65 109.677 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -52.11 -50.19 62.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.306 -0.861 . . . . 0.47 111.781 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 40' ' ' LEU . 93.4 t -59.09 -50.21 80.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.249 -0.432 . . . . 0.48 111.564 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -63.29 -41.93 99.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.028 -0.533 . . . . 1.7 111.289 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -64.65 -43.84 92.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.552 -0.295 . . . . 1.32 110.774 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -57.44 -48.38 79.3 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.108 0.48 . . . . 0.46 110.262 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.6 -35.59 77.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.778 -0.647 . . . . 0.43 111.688 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.9 -36.39 80.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.502 -0.317 . . . . 1.55 110.688 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.5 m -59.14 -38.37 79.52 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.037 -0.528 . . . . 0.48 110.654 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.407 HG13 HG22 ' A' ' 155' ' ' VAL . 43.0 t -61.26 -53.08 53.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.48 110.196 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -58.11 -41.48 83.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.501 -0.772 . . . . 1.59 111.086 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.625 ' O ' ' HB2' ' A' ' 188' ' ' LYS . 66.3 t80 -61.37 -44.28 97.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 1.17 111.179 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.42 -36.82 60.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.056 0.762 . . . . 0.68 113.056 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.3 p -63.02 -32.04 73.31 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.069 0.461 . . . . 1.07 110.959 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -103.44 20.24 18.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.041 -0.527 . . . . 2.26 110.217 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.625 ' HB2' ' O ' ' A' ' 184' ' ' TYR . 43.1 tttm -112.23 59.06 0.63 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.194 -0.457 . . . . 1.72 111.02 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.578 ' NZ ' ' HB3' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.246 0 CA-C-N 116.055 -0.521 . . . . 4.33 110.27 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SFQ . . . . . 0.492 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.628 0.252 . . . . 4.08 110.466 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -90.79 125.82 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.62 0.248 . . . . 3.58 111.187 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -128.15 108.25 10.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.934 0.397 . . . . 1.32 109.976 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -94.35 145.93 24.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 2.29 110.854 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.16 128.86 36.99 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.978 -0.749 . . . . 1.83 108.978 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.07 1.26 72.96 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.542 -0.837 . . . . 0.78 111.075 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -118.04 -72.34 0.69 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.785 -0.45 . . . . 1.87 109.785 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -85.21 -39.09 18.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.054 0.454 . . . . 1.46 109.997 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -138.28 152.73 48.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.97 -0.559 . . . . 0.79 110.336 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.17 132.93 54.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.02 -0.536 . . . . 0.9 110.356 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 m -85.22 120.18 26.43 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.767 -0.457 . . . . 1.11 109.767 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 69.2 mt -74.2 146.69 43.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.147 -0.479 . . . . 0.74 110.957 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.8 -10.37 48.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.464 0.649 . . . . 2.33 109.293 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -118.63 83.55 22.25 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.314 -0.857 . . . . 3.64 109.51 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.62 121.68 8.4 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.125 1.883 . . . . 0.85 111.769 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.47 109.59 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.92 -0.582 . . . . 0.72 110.552 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.0 136.72 45.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.481 -0.781 . . . . 0.89 110.986 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.33 14.97 72.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.776 -0.726 . . . . 0.73 112.5 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 144.31 33.69 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.151 -0.315 . . . . 0.64 110.151 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.51 168.98 16.68 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.627 2.218 . . . . 0.56 112.018 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 22.1 mp0 -63.68 -53.0 58.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.043 -0.526 . . . . 1.79 111.013 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.59 103.3 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.862 0.363 . . . . 0.45 110.617 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.8 tp -108.39 127.99 54.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.044 -0.526 . . . . 0.53 110.564 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -128.71 142.95 50.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 1.61 110.135 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.64 152.2 37.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.367 -0.378 . . . . 0.53 110.062 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.98 174.14 9.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.298 0.57 . . . . 0.55 111.52 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.434 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 7.9 t -155.54 132.14 10.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.628 -0.715 . . . . 0.96 109.495 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.532 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 92.1 m-85 -67.36 -15.24 63.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.187 -0.461 . . . . 0.62 111.333 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.532 ' CE1' ' HA2' ' A' ' 69' ' ' GLY . 71.8 m-85 -86.31 -6.12 59.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 1.78 111.589 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 35.5 t -109.61 118.45 50.37 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.451 -0.34 . . . . 0.48 111.626 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.48 -25.63 76.0 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.406 2.07 . . . . 0.7 111.232 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -61.84 -30.12 70.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.571 -0.74 . . . . 1.74 110.251 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.5 m -79.27 -41.06 28.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.37 110.334 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.51 -35.17 76.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.137 0.494 . . . . 1.44 110.008 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.699 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 26.6 tt0 -67.04 -33.42 75.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.428 -0.806 . . . . 2.27 110.4 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.417 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.6 m-85 -86.51 -22.44 26.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.398 . . . . 0.87 110.768 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 12.8 tp10 -84.18 -62.62 1.52 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.019 -0.537 . . . . 1.89 112.41 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -92.41 -33.98 14.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.309 0.855 . . . . 2.0 113.309 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.699 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 73.9 t -76.72 -58.24 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.286 -0.566 . . . . 0.58 111.631 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -89.95 -26.19 20.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.415 0.524 . . . . 0.41 112.415 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 22.6 m-70 56.19 49.9 14.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.178 0.513 . . . . 0.84 110.492 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.417 HG13 ' CD2' ' A' ' 36' ' ' PHE . 42.4 mm -59.89 -51.69 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.739 -0.664 . . . . 0.41 111.862 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -56.46 -40.05 74.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.658 -0.246 . . . . 1.03 111.643 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.46 -47.63 75.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.112 0.482 . . . . 1.73 110.307 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -59.61 -42.41 92.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.565 -0.743 . . . . 1.19 110.968 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.656 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 53.8 t -61.53 -47.79 91.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.877 -0.601 . . . . 0.49 110.757 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -58.46 -33.08 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 1.53 111.74 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -79.17 -15.76 57.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 2.02 111.577 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -101.94 -23.99 14.06 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.81 0.338 . . . . 1.44 111.045 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 57.8 mt -64.82 137.34 97.11 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.1 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.49 172.04 16.5 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.584 2.189 . . . . 0.74 111.792 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.65 136.76 53.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.852 -0.613 . . . . 2.63 111.579 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.49 -23.2 36.69 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.806 -0.712 . . . . 0.82 112.904 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.25 130.35 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.913 0.387 . . . . 1.03 111.05 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -112.25 130.31 55.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 2.51 110.287 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.0 ttt -92.37 139.07 30.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 1.28 110.123 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.08 129.22 52.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.679 0.276 . . . . 0.61 111.3 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -115.07 121.81 44.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.856 -0.794 . . . . 0.86 108.856 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 10.5 m-30 -117.53 159.5 22.76 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.142 0.496 . . . . 0.71 112.075 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 48.6 t-80 -105.32 140.01 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.744 -0.662 . . . . 0.57 109.901 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.7 m -104.0 152.31 6.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.539 -0.3 . . . . 0.68 111.553 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.608 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 72.4 m-20 -96.11 -2.83 45.73 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.955 0.724 . . . . 0.93 112.955 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -87.89 4.06 46.13 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.166 -0.614 . . . . 0.74 111.603 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.73 107.8 5.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.626 -0.509 . . . . 1.09 109.626 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.65 -8.03 3.35 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.603 -0.726 . . . . 0.78 111.297 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.4 -131.75 24.71 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.326 -0.464 . . . . 0.81 112.597 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -74.11 -45.67 47.59 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.863 0.32 . . . . 2.47 111.863 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -73.34 -17.75 61.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.372 -0.376 . . . . 1.94 111.229 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.532 ' HA2' ' CE1' ' A' ' 29' ' ' PHE . . . -58.33 -32.54 68.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.787 -0.72 . . . . 0.7 112.585 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.608 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 86.8 mttt -71.5 -31.25 66.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.729 0.299 . . . . 2.69 111.718 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.92 -42.48 85.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.847 0.356 . . . . 1.65 110.703 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.448 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 1.3 mt -66.35 -24.26 66.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.145 -0.48 . . . . 1.17 110.93 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -68.87 -34.13 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.267 0.556 . . . . 0.62 109.83 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.402 ' HA ' HG22 ' A' ' 135' ' ' VAL . 41.1 tt0 -76.43 -40.09 51.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.561 -0.745 . . . . 1.21 109.155 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.75 91.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.61 -0.723 . . . . 0.71 111.198 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -60.44 -38.0 82.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.59 110.502 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -62.06 -38.88 90.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.899 -0.591 . . . . 0.71 110.197 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.82 -44.97 92.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.636 -0.711 . . . . 0.84 109.812 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.41 86.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.738 -0.665 . . . . 0.66 110.91 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.6 mtm -66.01 -44.08 85.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 1.08 111.042 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.3 -30.74 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.112 0.482 . . . . 0.99 111.221 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.7 mt -80.39 -41.99 23.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 0.97 110.843 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.22 11.22 34.47 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.573 -0.611 . . . . 0.78 111.573 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 m -105.78 27.4 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.792 0.329 . . . . 0.81 111.149 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -52.44 63.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 1.71 110.251 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.467 ' HA ' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -63.2 -34.42 77.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.503 0.668 . . . . 1.91 110.252 179.267 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -62.91 -33.88 76.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.298 -0.865 . . . . 2.28 111.454 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.6 m -106.35 10.4 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.433 0.531 . . . . 0.65 112.433 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 86' ' ' ASP . 59.6 m -64.1 -53.76 44.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.787 0.327 . . . . 0.98 111.637 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.461 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 58.4 t -63.79 -55.02 36.89 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.532 0.567 . . . . 0.62 112.532 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 11.3 Cg_endo -55.04 -37.24 93.98 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.302 2.001 . . . . 0.61 113.56 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.416 HD22 HD21 ' A' ' 72' ' ' LEU . 33.0 mt -71.45 -32.54 68.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.681 0.277 . . . . 0.79 110.647 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -75.21 -53.34 8.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.273 0.558 . . . . 0.58 110.442 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.34 -39.9 94.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.81 -0.632 . . . . 1.7 110.961 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.97 -6.33 59.95 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.262 -0.494 . . . . 0.82 113.575 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.2 t -109.79 -40.3 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 117.489 0.644 . . . . 0.75 111.789 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.52 -48.43 5.01 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.035 0.754 . . . . 0.84 113.035 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -78.78 -70.34 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.772 0.286 . . . . 1.41 111.772 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -34.84 67.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.706 -0.224 . . . . 1.31 111.507 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 58.56 34.68 24.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.03 -0.532 . . . . 1.44 110.402 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -26.45 39.89 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.579 -0.737 . . . . 1.57 110.939 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.526 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 67.1 mt -87.17 100.35 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.91 110.411 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.526 ' HD2' ' O ' ' A' ' 102' ' ' ILE . 13.7 mmm180 -125.5 -12.22 6.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 3.22 110.334 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.6 p -139.88 168.28 20.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 1.51 110.498 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.7 -27.04 68.94 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.959 0.409 . . . . 1.08 110.984 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.5 m -62.85 -31.43 72.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 1.43 110.631 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.475 ' O ' HG23 ' A' ' 111' ' ' VAL . 33.4 m-20 -73.9 -44.52 54.94 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.661 -0.496 . . . . 1.89 109.661 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.5 mt -62.82 -41.9 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.808 -0.633 . . . . 0.9 110.124 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 ttm105 -60.72 -34.71 74.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.675 -0.693 . . . . 2.19 109.849 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.4 -41.56 69.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.626 -0.716 . . . . 1.95 111.44 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 107' ' ' ASP . 81.1 t -54.46 -45.43 70.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.747 0.308 . . . . 0.88 111.248 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -65.14 -41.48 94.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.92 111.072 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 80.4 mt -65.94 -41.55 90.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.994 0.426 . . . . 1.33 110.064 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -65.65 -30.35 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.71 -0.677 . . . . 1.93 110.354 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.97 -34.92 66.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 1.1 111.255 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 139.68 5.58 1.24 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.241 -0.98 . . . . 1.15 113.273 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 47.6 mm -94.06 123.57 46.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.671 -0.492 . . . . 1.61 109.671 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -61.25 137.55 58.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.594 -0.275 . . . . 2.73 110.498 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.63 -42.93 78.67 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.823 -0.626 . . . . 1.19 112.64 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.4 -45.48 92.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 2.98 110.68 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.49 -45.97 92.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.167 0.508 . . . . 2.52 110.067 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -62.79 -48.06 80.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.458 -0.792 . . . . 1.51 110.951 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.45 -36.13 81.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 2.3 111.047 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.16 86.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 1.23 109.782 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.07 -35.54 78.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.535 -0.757 . . . . 1.11 110.764 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -58.08 -36.32 72.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.104 0.478 . . . . 1.31 110.822 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -99.93 16.08 25.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.096 -0.502 . . . . 1.63 111.196 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.3 m -85.55 144.37 27.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 2.04 111.195 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.95 -36.9 85.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.839 -0.619 . . . . 3.82 110.864 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -56.19 -47.15 81.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 1.53 110.746 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 77' ' ' ALA . 17.6 t -63.83 -42.38 95.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 1.11 110.379 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -61.38 -33.75 74.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 2.43 110.549 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 63.8 m -71.86 -28.75 63.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.926 -0.579 . . . . 1.47 110.646 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.405 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 96.5 mt -74.57 -33.92 62.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.307 -0.406 . . . . 0.93 110.035 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 131' ' ' VAL . 50.5 t -61.43 -43.76 97.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.077 0.465 . . . . 0.8 110.11 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.48 95.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.585 -0.734 . . . . 0.85 111.19 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -62.43 -40.27 96.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.437 -0.347 . . . . 1.39 111.583 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.488 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 51.9 mt-30 -59.53 -52.54 65.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.61 111.152 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -71.69 -28.87 64.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.406 . . . . 2.82 111.768 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -63.89 -49.63 71.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.362 -0.381 . . . . 1.95 110.537 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.477 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -62.17 -44.2 97.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.876 -0.602 . . . . 0.65 111.464 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.89 84.75 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.263 -0.426 . . . . 0.61 111.556 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.65 -41.24 63.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 0.72 110.813 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.48 -43.54 93.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.037 -0.528 . . . . 1.39 111.795 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 141' ' ' ALA . 32.2 m -79.84 -1.78 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 111.587 0.218 . . . . 1.34 111.587 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 53.98 59.91 3.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.326 0.584 . . . . 1.95 109.872 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 152' ' ' ALA . 11.7 tp -58.57 134.04 56.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.242 -0.89 . . . . 0.71 112.524 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.9 mmt-85 -106.61 -39.86 5.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.193 -0.912 . . . . 4.16 110.663 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -122.3 159.29 16.93 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.09 -0.804 . . . . 0.68 111.09 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.52 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.4 t -65.58 -57.62 13.96 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 112.26 0.467 . . . . 0.49 112.26 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.52 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.8 Cg_endo -85.5 89.47 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.526 2.15 . . . . 0.56 112.068 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' A' ' 147' ' ' LEU . . . -129.87 154.2 47.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.181 -0.463 . . . . 0.63 110.611 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 30.9 ttm -127.35 133.06 50.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.208 -0.451 . . . . 0.42 110.817 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.15 133.99 53.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.52 110.186 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 44.9 t -102.4 114.81 42.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.263 -0.426 . . . . 0.55 111.218 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 59.46 14.03 3.59 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.088 -0.96 . . . . 1.16 111.987 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 69.52 20.57 75.61 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.937 -0.649 . . . . 0.56 112.125 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -120.78 -45.81 2.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 1.75 111.235 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -106.39 129.84 54.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.972 -0.558 . . . . 1.16 111.14 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -106.86 138.55 42.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.636 -0.711 . . . . 0.98 109.652 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mp -90.96 132.54 35.9 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.619 -0.432 . . . . 1.2 110.3 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -111.53 97.63 37.32 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.283 -0.417 . . . . 0.72 110.403 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.92 -18.87 46.75 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.365 2.043 . . . . 0.54 111.818 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -78.23 -8.25 58.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 2.22 110.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -115.65 14.68 17.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.009 -0.615 . . . . 0.59 112.292 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 55.5 mtt -102.55 -178.81 3.79 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.151 -0.314 . . . . 0.57 110.151 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.2 119.56 15.5 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.363 0.601 . . . . 1.54 111.2 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.91 22.34 15.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.405 -0.816 . . . . 1.16 109.453 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.34 -51.4 5.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.326 -0.852 . . . . 1.53 110.035 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -118.47 121.66 40.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.984 -0.553 . . . . 1.21 110.185 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 46.2 mmm -59.32 -38.2 79.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 1.96 111.879 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.16 -27.94 68.4 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.117 0.484 . . . . 2.05 110.704 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 55.4 t -77.83 -46.06 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.571 -0.74 . . . . 0.65 109.634 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.58 -50.73 69.31 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.073 -0.512 . . . . 0.47 111.414 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.21 -44.93 77.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.212 -0.449 . . . . 0.48 111.242 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 21.9 mm-40 -71.59 -46.24 59.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.187 -0.46 . . . . 1.7 111.294 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.08 -45.95 82.9 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.215 0.322 . . . . 1.32 111.204 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.508 ' O ' HG23 ' A' ' 182' ' ' VAL . 19.0 t80 -59.4 -56.12 26.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.643 -0.253 . . . . 0.46 110.88 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.83 87.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.43 . . . . 0.43 112.087 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.3 OUTLIER -69.08 -33.87 74.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.687 -0.233 . . . . 1.55 111.056 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 86.4 m -64.78 -39.36 93.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.581 -0.526 . . . . 0.48 109.581 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 178' ' ' TYR . 11.7 t -60.41 -46.7 94.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.106 -0.497 . . . . 0.48 109.748 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -61.09 -41.62 97.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.826 -0.625 . . . . 1.59 110.477 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.65 -41.67 95.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 1.17 111.088 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.68 -38.08 34.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.292 -0.413 . . . . 0.68 112.056 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 51.0 m -63.18 -30.31 71.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 1.07 111.006 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -106.32 26.53 9.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.278 0.561 . . . . 2.26 110.182 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -106.9 -60.2 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.387 -0.824 . . . . 1.72 110.057 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.391 -0.814 . . . . 4.33 110.056 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SFQ . . . . . 0.533 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.985 -0.376 . . . . 4.08 109.985 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.86 140.79 29.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.758 -0.46 . . . . 3.58 109.758 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -135.22 121.98 20.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.008 0.432 . . . . 1.32 110.76 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -111.05 147.53 34.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.82 -0.627 . . . . 2.29 110.627 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.22 117.43 17.04 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.046 -0.525 . . . . 1.83 109.621 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA2' HG23 ' A' ' 10' ' ' THR . . . 111.59 -5.8 27.98 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.135 -0.786 . . . . 0.78 111.135 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -112.46 -80.89 0.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.515 0.198 . . . . 1.87 110.637 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -85.79 -27.71 24.99 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.912 0.387 . . . . 1.46 110.638 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -141.36 159.75 41.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.757 -0.46 . . . . 0.79 109.757 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.421 HG23 ' HA2' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -137.99 130.57 29.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.469 -0.332 . . . . 0.9 111.27 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -77.13 125.26 29.04 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.525 -0.546 . . . . 1.11 109.525 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.9 mt -71.0 147.01 49.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.938 0.399 . . . . 0.74 111.156 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.67 -38.91 53.7 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.005 -0.739 . . . . 2.33 109.005 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -117.21 104.34 50.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.115 -0.948 . . . . 3.64 109.343 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.39 143.25 34.61 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.227 1.952 . . . . 0.85 112.111 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.61 91.88 3.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 0.72 110.075 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.86 123.6 20.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.841 -0.618 . . . . 0.89 110.003 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.02 -5.92 42.79 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.839 -0.696 . . . . 0.73 111.922 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.31 155.28 93.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.571 0.224 . . . . 0.64 111.091 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -76.31 -177.09 3.44 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.662 2.241 . . . . 0.56 112.057 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.417 ' OE1' HG22 ' A' ' 54' ' ' VAL . 40.3 mt-30 -69.87 -52.4 25.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 1.79 110.994 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.0 t -123.26 105.1 15.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.25 0.547 . . . . 0.45 110.747 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 tp -105.54 119.6 39.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.982 -0.554 . . . . 0.53 109.738 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.484 ' OE1' ' HG3' ' A' ' 58' ' ' LYS . 17.6 tt0 -122.72 147.42 46.5 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.806 0.336 . . . . 1.61 110.297 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -122.29 151.87 40.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.131 -0.486 . . . . 0.53 110.655 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.402 ' HA ' HG12 ' A' ' 150' ' ' VAL . 0.7 OUTLIER -167.64 169.61 11.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.55 110.855 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.463 ' HB2' HG22 ' A' ' 61' ' ' VAL . 3.4 t -152.47 135.72 15.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.273 -0.421 . . . . 0.96 110.371 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.448 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 90.6 m-85 -71.43 -15.59 62.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.099 -0.501 . . . . 0.62 110.232 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -90.55 0.51 57.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.977 -0.556 . . . . 1.78 110.679 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 51.1 t -109.45 114.93 56.82 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 116.017 -0.538 . . . . 0.48 110.603 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 19.7 Cg_endo -60.9 -26.75 83.67 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.588 2.192 . . . . 0.7 111.864 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -32.5 72.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.042 -0.526 . . . . 1.74 110.842 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.2 m -72.28 -33.38 67.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.25 -0.648 . . . . 0.37 109.25 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -66.13 -40.67 90.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.866 -0.79 . . . . 1.44 108.866 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.714 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 6.7 mt-30 -70.69 -37.55 73.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.588 -0.733 . . . . 2.27 110.791 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.96 -18.23 62.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.919 0.34 . . . . 0.87 111.919 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.74 -65.78 1.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.292 -0.563 . . . . 1.89 112.096 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.55 -27.71 66.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.15 0.5 . . . . 2.0 111.612 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 96.1 t -100.2 -59.53 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.715 -0.394 . . . . 0.58 111.992 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -85.03 -33.75 22.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.894 0.701 . . . . 0.41 112.894 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 61.63 46.34 7.3 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.098 0.475 . . . . 0.84 110.489 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 mm -58.72 -49.27 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.388 -0.823 . . . . 0.41 111.07 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -63.75 -45.94 87.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 1.03 111.323 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.27 -33.55 76.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.115 -0.493 . . . . 1.73 111.756 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -75.41 -41.93 54.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.411 -0.359 . . . . 1.19 110.804 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.516 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 22.5 t -60.04 -41.01 84.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.91 -0.586 . . . . 0.49 110.602 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -54.82 -38.31 67.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 1.53 112.206 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -78.7 -10.91 59.93 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.588 0.588 . . . . 2.02 112.588 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.5 mtmm -120.13 19.94 12.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.896 0.379 . . . . 1.44 110.918 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 14.1 mt -89.77 136.23 29.6 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.508 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.47 153.73 69.09 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.542 2.161 . . . . 0.74 111.848 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.13 123.45 20.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.169 -0.468 . . . . 2.63 110.774 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.33 -11.78 43.62 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.775 -0.648 . . . . 0.82 111.546 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.417 HG22 ' OE1' ' A' ' 21' ' ' GLN . 83.4 t -88.52 115.89 29.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.025 0.441 . . . . 1.03 110.368 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -92.11 140.33 29.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.893 -0.594 . . . . 2.51 110.603 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.5 ttt -100.73 119.14 38.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.097 -0.502 . . . . 1.28 110.215 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.91 99.98 9.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.173 -0.467 . . . . 0.61 111.236 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HG3' ' OE1' ' A' ' 24' ' ' GLU . 44.5 tttp -89.68 108.97 19.99 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.77 -0.826 . . . . 0.86 108.77 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.443 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 9.0 m-30 -106.72 153.02 23.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.417 0.627 . . . . 0.71 111.932 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -98.16 132.12 43.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.681 -0.69 . . . . 0.57 110.344 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 27' ' ' SER . 5.3 m -80.75 156.73 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.793 -0.185 . . . . 0.68 110.574 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 139' ' ' GLU . 13.0 m-20 -115.72 24.57 11.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.148 0.425 . . . . 0.93 112.148 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -117.89 8.03 12.51 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.229 -0.588 . . . . 0.74 111.282 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.9 mtp -141.45 107.69 5.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.856 -0.424 . . . . 1.09 109.856 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.18 -10.76 3.04 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.751 -0.659 . . . . 0.78 112.023 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.46 -142.57 29.27 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.763 -0.732 . . . . 0.81 112.363 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.58 -34.98 76.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.298 0.571 . . . . 2.47 110.816 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -75.71 -11.79 60.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 1.94 110.349 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.59 -46.39 93.85 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.044 -0.598 . . . . 0.7 112.496 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -67.97 -27.07 66.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.609 0.242 . . . . 2.69 111.46 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -43.81 93.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 1.65 110.753 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -24.47 64.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.793 -0.64 . . . . 1.17 111.185 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 m -66.01 -35.45 80.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.163 0.506 . . . . 0.62 110.472 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -76.06 -37.8 57.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 1.21 109.484 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.67 97.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.638 -0.71 . . . . 0.71 110.386 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -64.63 -36.65 84.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.444 -0.798 . . . . 0.59 110.579 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.527 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -61.42 -38.72 88.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.71 109.991 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 58.6 t -66.54 -44.88 89.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.728 -0.669 . . . . 0.84 109.727 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.01 86.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.66 110.989 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.7 ttm -64.22 -44.22 92.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.868 -0.606 . . . . 1.08 110.756 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.18 83.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.589 . . . . 0.99 111.516 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 78.8 mt -77.21 -38.56 51.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.576 -0.284 . . . . 0.97 111.411 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.16 38.27 3.61 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.705 -0.76 . . . . 0.78 112.42 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.9 m -132.59 30.8 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.79 0.328 . . . . 0.81 110.482 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -53.66 -64.94 0.66 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.727 -0.669 . . . . 1.71 112.568 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -31.73 70.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 1.91 111.155 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -62.13 -38.79 90.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.955 -0.566 . . . . 2.28 111.866 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -98.91 -9.3 8.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.413 0.523 . . . . 0.65 112.413 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -58.16 -45.44 87.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.658 0.266 . . . . 0.98 111.643 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.461 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 77.0 t -64.63 -60.81 7.54 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.185 0.439 . . . . 0.62 112.185 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 11.9 Cg_endo -56.14 -33.26 89.8 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.983 1.789 . . . . 0.61 113.068 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.41 -46.27 67.24 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.836 -0.346 . . . . 0.79 110.356 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 m-85 -61.49 -48.22 82.09 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.318 0.58 . . . . 0.58 110.54 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -62.84 -43.92 97.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.381 -0.827 . . . . 1.7 111.663 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.26 -16.46 77.1 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.097 -0.573 . . . . 0.82 113.802 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.496 HG23 HD12 ' A' ' 102' ' ' ILE . 55.0 t -100.01 -41.23 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.33 0.565 . . . . 0.75 112.424 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 31' ' ' PRO . 79.3 mt-30 -99.56 -42.34 6.96 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.009 1.114 . . . . 0.84 114.009 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -81.6 -68.05 0.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.585 -0.446 . . . . 1.41 111.784 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -34.59 62.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.094 -0.242 . . . . 1.31 110.851 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.554 ' HB3' ' NH2' ' A' ' 103' ' ' ARG . 78.9 mt-30 57.85 37.67 27.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.906 -0.588 . . . . 1.44 110.636 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.29 -20.72 27.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.127 -0.942 . . . . 1.57 110.896 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 96' ' ' VAL . 83.2 mt -80.94 106.42 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.752 -0.658 . . . . 0.91 110.511 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.554 ' NH2' ' HB3' ' A' ' 100' ' ' GLN . 37.5 mmt180 -123.37 -20.14 5.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.587 -0.733 . . . . 3.22 110.76 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -133.29 172.85 12.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.828 0.346 . . . . 1.51 110.444 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.46 -26.39 67.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.023 0.44 . . . . 1.08 110.627 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -33.08 73.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.668 -0.696 . . . . 1.43 110.673 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -71.74 -39.25 70.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.962 -0.563 . . . . 1.89 109.735 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.1 mt -64.78 -41.58 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.875 -0.602 . . . . 0.9 109.744 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -58.77 -42.7 89.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.085 -0.961 . . . . 2.19 110.963 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -60.02 -40.96 91.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 1.95 111.149 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.3 t -56.6 -43.51 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 0.88 111.021 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -66.57 -37.65 85.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.92 110.513 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 88.1 mt -65.32 -41.93 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.074 0.464 . . . . 1.33 109.854 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -64.61 -26.6 68.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.547 -0.752 . . . . 1.93 110.723 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.97 -32.14 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 1.1 110.768 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.83 7.74 3.66 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.783 -0.722 . . . . 1.15 112.914 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.3 mm -87.94 137.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.097 -0.334 . . . . 1.61 110.097 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -70.26 133.73 47.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.05 -0.523 . . . . 2.73 110.099 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.92 -44.53 96.03 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.953 -0.641 . . . . 1.19 112.56 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.98 -37.82 88.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.323 . . . . 2.98 110.987 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.22 -42.22 84.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.263 0.554 . . . . 2.52 109.612 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -63.06 -46.86 85.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.492 -0.776 . . . . 1.51 110.382 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -64.31 -29.4 70.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.215 0.531 . . . . 2.3 110.635 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.14 62.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.906 -0.588 . . . . 1.23 110.372 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.34 -34.36 78.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 1.11 110.868 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -58.74 -26.7 64.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.846 -0.615 . . . . 1.31 110.513 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -102.05 26.11 7.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.89 -0.595 . . . . 1.63 111.635 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.9 t -101.55 143.43 31.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.906 0.384 . . . . 2.04 111.162 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -65.83 -28.36 68.93 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.57 -0.741 . . . . 3.82 110.874 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.11 -45.58 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.242 0.544 . . . . 1.53 109.547 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 135' ' ' VAL . 88.9 t -64.58 -44.09 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.396 -0.82 . . . . 1.11 110.038 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -55.61 -44.44 77.03 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.993 0.425 . . . . 2.43 110.682 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 52.3 m -66.06 -39.18 89.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.589 . . . . 1.47 110.74 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.7 mt -64.2 -37.99 89.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.376 -0.375 . . . . 0.93 110.791 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 131' ' ' VAL . 54.8 t -65.4 -44.7 94.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.8 109.949 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.16 78.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.85 110.901 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -62.05 -45.46 93.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 1.39 110.903 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.493 HE21 ' HA ' ' A' ' 135' ' ' VAL . 44.9 mt-30 -63.44 -41.05 98.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.61 110.897 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.518 ' HG2' ' ND2' ' A' ' 62' ' ' ASN . 43.8 mt-10 -69.01 -40.29 78.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.072 -0.513 . . . . 2.82 111.325 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -72.05 -49.74 34.19 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.347 0.499 . . . . 1.95 112.347 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.82 -40.69 76.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.204 0.446 . . . . 0.65 112.204 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.5 -31.11 72.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.825 0.345 . . . . 0.61 111.675 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.13 -29.33 20.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.423 -0.353 . . . . 0.72 111.228 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -61.63 -50.61 71.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.995 0.426 . . . . 1.39 111.368 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.31 -8.8 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.945 -0.57 . . . . 1.34 111.547 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 64.18 74.93 0.39 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.384 0.612 . . . . 1.95 109.611 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.5 tp -80.23 123.96 28.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.679 -0.691 . . . . 0.71 111.888 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.26 -48.13 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.184 -0.673 . . . . 4.16 109.184 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.81 132.02 11.07 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.822 -0.911 . . . . 0.68 110.822 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.488 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 3.4 t -67.03 -52.44 31.09 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 112.584 0.587 . . . . 0.49 112.584 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.488 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 3.3 Cg_exo -79.55 76.79 4.36 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.11 1.874 . . . . 0.56 112.638 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.27 152.14 51.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.63 110.955 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 48.2 ttm -131.63 136.22 47.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.071 -0.513 . . . . 0.42 110.095 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -117.48 134.28 55.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.32 -0.4 . . . . 0.52 110.005 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 66.3 t -103.42 118.15 49.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.883 0.373 . . . . 0.55 110.565 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 64.67 5.35 2.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.491 -0.777 . . . . 1.16 111.658 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.2 15.41 74.62 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.032 -0.604 . . . . 0.56 112.158 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -119.92 -31.19 4.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.798 0.332 . . . . 1.75 111.227 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -118.41 139.12 51.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 1.16 110.549 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -117.09 138.67 51.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.916 -0.584 . . . . 0.98 110.319 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.9 mp -83.57 137.35 33.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.704 -0.48 . . . . 1.2 109.704 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -116.17 98.76 51.89 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.408 -0.36 . . . . 0.72 111.308 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.38 -14.13 33.8 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.374 2.049 . . . . 0.54 111.669 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -75.64 -6.73 51.84 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.159 -0.473 . . . . 2.22 110.975 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -128.87 19.2 5.55 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.773 -0.531 . . . . 0.59 111.773 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.3 mtt -99.02 -168.78 1.67 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.802 -0.199 . . . . 0.57 110.488 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.76 114.69 10.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.09 0.471 . . . . 1.54 110.533 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.86 33.37 5.25 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.728 0.775 . . . . 1.16 109.504 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.72 -47.81 2.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.119 -0.946 . . . . 1.53 111.018 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -114.45 118.8 34.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.788 0.328 . . . . 1.21 110.345 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.429 ' O ' HG23 ' A' ' 175' ' ' VAL . 12.6 mmt -59.76 -41.78 91.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 1.96 110.903 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.25 -33.11 75.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 2.05 111.643 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 77.0 t -79.18 -39.57 21.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.738 -0.21 . . . . 0.65 110.482 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -55.82 -50.14 71.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.596 -0.275 . . . . 0.47 111.159 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 171' ' ' MET . 46.6 t -58.39 -48.24 85.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.48 111.341 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -66.48 -39.55 88.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.891 -0.595 . . . . 1.7 111.423 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.61 -44.7 89.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.482 -0.326 . . . . 1.32 110.634 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.481 ' O ' HG23 ' A' ' 182' ' ' VAL . 2.5 t80 -54.9 -50.97 67.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.46 110.189 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.445 ' HA ' HG22 ' A' ' 46' ' ' VAL . . . -66.93 -38.19 85.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.43 112.041 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.19 -39.3 92.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.37 -0.377 . . . . 1.55 111.137 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 13.1 m -62.41 -36.96 83.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.48 110.116 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 178' ' ' TYR . 49.3 t -63.27 -48.76 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.047 0 CA-C-N 116.237 -0.438 . . . . 0.48 110.03 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -62.17 -40.17 95.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 1.59 110.743 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -64.39 -44.47 91.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.479 -0.328 . . . . 1.17 110.766 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.02 -32.34 71.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.475 -0.329 . . . . 0.68 111.274 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.2 m -75.54 -26.22 57.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 1.07 110.851 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -98.69 14.76 27.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 2.26 110.572 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -89.67 99.69 12.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.613 -0.721 . . . . 1.72 109.802 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.357 -0.83 . . . . 4.33 110.463 -179.107 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SFQ . . . . . 0.519 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 110.061 -0.348 . . . . 4.08 110.061 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -96.39 128.28 43.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.094 -0.336 . . . . 3.58 110.094 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -134.98 131.61 37.37 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.25 -0.278 . . . . 1.32 110.25 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.0 142.96 49.75 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.334 -0.394 . . . . 2.29 110.87 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.32 123.59 24.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 1.83 110.366 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.97 -7.74 44.95 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.931 -0.577 . . . . 0.78 111.745 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' HB3' ' OE1' ' A' ' 8' ' ' GLN . 1.2 tttm -118.21 -75.85 0.58 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.612 0.244 . . . . 1.87 110.74 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.453 ' OE1' ' HB3' ' A' ' 7' ' ' LYS . 22.7 mp0 -76.6 -42.45 42.42 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.433 0.635 . . . . 1.46 110.175 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -134.16 163.99 28.36 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.722 -0.672 . . . . 0.79 109.394 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.4 115.91 12.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.716 0.294 . . . . 0.9 110.805 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.6 m -73.9 121.23 20.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.036 -0.529 . . . . 1.11 109.833 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.69 142.42 51.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.111 0.482 . . . . 0.74 111.667 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -74.17 -33.7 63.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.666 -0.697 . . . . 2.33 109.464 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -120.35 97.06 49.1 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.267 -0.879 . . . . 3.64 109.47 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.29 169.23 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.529 2.153 . . . . 0.85 112.554 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.69 117.12 49.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 0.72 110.464 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.43 131.9 35.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.821 0.343 . . . . 0.89 110.312 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.59 22.84 41.74 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.735 -0.745 . . . . 0.73 111.523 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.61 150.45 38.05 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.773 -0.214 . . . . 0.64 110.469 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.56 171.9 5.1 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.045 2.497 . . . . 0.56 113.077 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -71.0 -68.55 0.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.853 -0.612 . . . . 1.79 110.63 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.5 t -107.01 102.17 13.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.678 -0.49 . . . . 0.45 109.678 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 59' ' ' TYR . 18.5 tp -105.35 119.62 39.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.858 -0.61 . . . . 0.53 110.535 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -119.53 147.82 44.01 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.948 -0.39 . . . . 1.61 109.948 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.09 145.04 47.27 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.797 -0.446 . . . . 0.53 109.797 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -164.25 175.67 9.88 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.175 0.512 . . . . 0.55 110.799 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.612 ' HB2' HG22 ' A' ' 61' ' ' VAL . 3.3 t -156.53 137.82 13.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.547 -0.751 . . . . 0.96 109.998 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.563 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 71.1 m-85 -71.35 -14.69 62.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 0.62 110.572 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.435 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 71.7 m-85 -88.27 -5.92 58.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.871 -0.604 . . . . 1.78 110.45 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 13.2 t -104.73 113.4 64.96 Favored Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-O 120.961 0.41 . . . . 0.48 111.363 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 22.5 Cg_endo -64.69 -22.22 64.45 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.258 1.972 . . . . 0.7 110.429 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.561 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 7.9 t-80 -67.25 -30.66 70.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.062 -0.972 . . . . 1.74 109.948 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -79.94 -38.94 31.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.411 -0.588 . . . . 0.37 109.411 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.76 -38.64 85.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 1.44 109.778 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.443 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 3.1 tp60 -60.38 -44.17 95.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.384 -0.825 . . . . 2.27 109.909 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.467 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.5 m-85 -74.39 -24.69 59.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.553 -0.748 . . . . 0.87 111.524 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -86.16 -49.89 7.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.543 0.571 . . . . 1.89 112.543 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -94.98 -38.69 10.55 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.569 0.951 . . . . 2.0 113.569 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 46.0 t -80.25 -53.43 12.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.023 -0.671 . . . . 0.58 111.882 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.7 mt -90.24 -29.18 18.35 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.768 -0.373 . . . . 0.41 111.986 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 56.69 48.67 15.88 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.477 0.656 . . . . 0.84 109.889 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.467 HG13 ' CD2' ' A' ' 36' ' ' PHE . 39.0 mm -59.89 -47.57 91.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.353 -0.84 . . . . 0.41 111.3 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.05 -48.31 64.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.326 0.391 . . . . 1.03 111.712 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.46 -47.05 87.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.906 -0.588 . . . . 1.73 110.375 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -60.67 -40.92 93.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 1.19 110.956 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.604 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 69.3 t -65.73 -48.88 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.49 110.616 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -56.4 -33.71 66.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.043 0.449 . . . . 1.53 111.594 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -81.41 -10.01 59.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 2.02 111.987 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HD2' ' HB1' ' A' ' 179' ' ' ALA . 52.1 mttm -111.94 2.35 16.9 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.804 -0.358 . . . . 1.44 111.597 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 59.3 mt -79.62 131.99 62.95 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.331 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.01 164.51 35.34 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.645 2.23 . . . . 0.74 112.157 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -61.48 108.42 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.212 0.53 . . . . 2.63 111.759 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.74 -24.08 5.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.986 -0.625 . . . . 0.82 112.109 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.06 130.7 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.928 0.394 . . . . 1.03 110.757 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 56' ' ' MET . 11.9 ttmm -119.61 147.15 44.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.895 -0.593 . . . . 2.51 110.561 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.416 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 8.9 ttt -87.54 130.45 34.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.123 -0.49 . . . . 1.28 110.564 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.27 106.97 12.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.002 -0.544 . . . . 0.61 110.934 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -90.83 127.42 36.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.525 -0.307 . . . . 0.86 110.41 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' CD2' ' HA ' ' A' ' 138' ' ' GLN . 5.2 m-30 -117.36 143.72 45.68 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.891 -0.411 . . . . 0.71 109.891 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -93.63 132.11 38.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.723 0.297 . . . . 0.57 110.988 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 27' ' ' SER . 5.6 m -76.18 150.18 6.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.992 -0.373 . . . . 0.68 109.992 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -103.87 -10.95 17.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.602 0.593 . . . . 0.93 112.602 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -89.46 20.02 4.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.037 0.384 . . . . 0.74 112.037 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.488 ' SD ' HG21 ' A' ' 150' ' ' VAL . 20.6 mtp -140.64 133.25 28.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.625 0.25 . . . . 1.09 110.425 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.43 3.5 56.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.779 -0.724 . . . . 0.78 112.07 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.09 -129.47 34.94 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.704 -0.76 . . . . 0.81 112.348 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.84 -35.28 57.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.773 0.321 . . . . 2.47 110.785 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.47 -22.0 65.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.961 -0.563 . . . . 1.94 110.527 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.54 89.19 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.703 -0.76 . . . . 0.7 111.362 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -69.98 -37.69 75.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.033 0.444 . . . . 2.69 110.549 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -62.82 -41.86 99.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.784 -0.643 . . . . 1.65 110.675 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.435 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 3.8 mt -70.69 -24.58 62.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.353 -0.385 . . . . 1.17 111.188 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.7 m -66.89 -36.95 83.44 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.135 0.493 . . . . 0.62 109.892 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -76.18 -40.97 51.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 1.21 109.988 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.57 95.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.97 -0.559 . . . . 0.71 111.014 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -61.47 -37.52 83.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 0.59 110.902 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.562 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -60.97 -35.73 77.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.175 -0.466 . . . . 0.71 110.404 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.69 -44.36 82.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.81 -0.632 . . . . 0.84 110.124 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.66 84.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.686 -0.688 . . . . 0.66 111.668 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 44.9 mtm -67.43 -41.35 84.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.331 -0.395 . . . . 1.08 111.005 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.73 -32.94 73.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 0.99 111.124 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.18 -5.14 59.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.418 -0.355 . . . . 0.97 110.751 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.71 40.63 98.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.064 -0.589 . . . . 0.78 112.432 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.3 m -131.9 30.71 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.87 0.367 . . . . 0.81 110.756 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -60.5 -53.85 52.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.801 -0.636 . . . . 1.71 110.792 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -30.81 70.12 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.235 0.54 . . . . 1.91 111.044 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -73.9 -24.5 59.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.894 -0.594 . . . . 2.28 112.205 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.456 ' HA ' ' HG2' ' A' ' 91' ' ' PRO . 27.6 m -108.73 -8.25 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 112.238 0.459 . . . . 0.65 112.238 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.4 m -55.88 -65.32 0.62 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.852 0.686 . . . . 0.98 112.852 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.7 t -60.39 -53.53 63.85 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 113.003 0.742 . . . . 0.62 113.003 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 9.8 Cg_endo -53.42 -38.61 82.99 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.16 1.907 . . . . 0.61 113.346 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.3 mt -69.8 -41.08 75.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.037 -0.357 . . . . 0.79 110.037 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 2.9 m-85 -60.29 -51.93 67.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.276 0.56 . . . . 0.58 110.269 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.3 -37.79 88.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.553 -0.749 . . . . 1.7 110.441 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.12 -8.17 68.94 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.107 -0.568 . . . . 0.82 113.687 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.6 t -112.21 -39.64 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.307 0.554 . . . . 0.75 112.205 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -98.71 -48.0 5.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.605 0.594 . . . . 0.84 112.605 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -74.53 -73.52 0.23 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.122 -0.49 . . . . 1.41 111.35 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -37.91 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.811 -0.631 . . . . 1.31 111.776 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 62.81 27.97 16.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 1.44 110.815 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -28.93 66.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.86 -0.609 . . . . 1.57 111.006 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.22 105.27 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.317 0.58 . . . . 0.91 110.809 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -121.95 -13.45 8.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 3.22 110.705 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 p -140.45 167.6 21.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 1.51 110.146 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -66.06 -27.4 68.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.44 . . . . 1.08 110.105 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -31.85 72.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.384 -0.825 . . . . 1.43 110.559 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 111' ' ' VAL . 64.8 m-20 -71.72 -40.68 69.28 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.11 -0.496 . . . . 1.89 110.194 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 105' ' ' ALA . 14.8 mt -60.68 -43.19 94.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.757 -0.656 . . . . 0.9 110.089 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -58.78 -36.22 74.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.425 -0.807 . . . . 2.19 110.439 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -68.81 -44.84 72.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.769 -0.651 . . . . 1.95 110.626 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 107' ' ' ASP . 43.8 t -59.22 -40.14 80.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.88 110.853 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -62.68 -42.38 99.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 0.92 110.397 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 87.0 mt -62.13 -37.25 77.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.193 0.52 . . . . 1.33 110.245 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.67 -14.31 62.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 1.93 111.152 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.35 -3.02 58.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.201 0.524 . . . . 1.1 110.482 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.92 16.04 26.98 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.802 -0.713 . . . . 1.15 111.942 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 44.8 mm -93.8 129.27 44.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 110.07 -0.344 . . . . 1.61 110.07 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -64.03 131.77 48.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.352 -0.385 . . . . 2.73 110.351 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.44 99.89 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.905 -0.664 . . . . 1.19 111.874 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -64.75 -37.13 86.57 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.657 -0.497 . . . . 2.98 109.657 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.51 -47.02 68.07 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.564 -0.744 . . . . 2.52 109.659 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -60.25 -40.44 90.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.759 -0.655 . . . . 1.51 110.924 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -61.31 -35.41 77.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.991 0.424 . . . . 2.3 111.17 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.33 -45.14 33.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 1.23 110.591 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.11 73.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.872 -0.604 . . . . 1.11 110.915 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -57.13 -33.32 67.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.012 -0.54 . . . . 1.31 110.908 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -111.62 21.67 15.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.274 -0.421 . . . . 1.63 111.256 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -76.91 142.25 40.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.127 -0.488 . . . . 2.04 110.908 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.26 -35.73 78.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.878 -0.601 . . . . 3.82 110.527 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.1 t -63.14 -46.33 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 1.53 109.996 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.562 HG13 ' HB3' ' A' ' 77' ' ' ALA . 55.2 t -63.66 -45.66 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.539 -0.755 . . . . 1.11 110.381 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -59.73 -40.46 88.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 2.43 110.533 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.3 m -66.5 -30.74 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 1.47 110.675 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.2 mt -72.27 -38.12 68.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.337 . . . . 0.93 110.479 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 131' ' ' VAL . 57.4 t -59.36 -46.27 92.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.144 -0.48 . . . . 0.8 110.686 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.23 83.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.908 -0.587 . . . . 0.85 111.546 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -65.67 -39.09 90.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 1.39 111.265 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.528 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 50.9 mt-30 -60.97 -46.57 90.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.61 111.079 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -68.08 -44.18 76.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.229 -0.441 . . . . 2.82 111.09 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -60.34 -45.64 92.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.57 . . . . 1.95 111.473 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -58.69 -51.27 70.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.538 . . . . 0.65 111.427 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.38 86.4 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.935 0.346 . . . . 0.61 111.935 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.28 60.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.252 -0.431 . . . . 0.72 111.908 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.28 -43.17 98.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.02 0.748 . . . . 1.39 113.02 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 141' ' ' ALA . 19.1 m -79.67 1.22 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.358 0.503 . . . . 1.34 112.358 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.42 55.43 5.75 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.576 -0.527 . . . . 1.95 109.576 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.1 tp -61.25 114.63 3.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.587 -0.733 . . . . 0.71 111.302 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.7 mmm-85 -104.48 -38.94 6.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.357 -0.838 . . . . 4.16 109.898 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -104.88 142.54 15.5 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.095 -0.802 . . . . 0.68 111.095 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 16.5 t -69.96 -55.89 8.04 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 119.262 -0.399 . . . . 0.49 111.624 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 81.6 Cg_endo -83.46 62.11 7.23 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.942 1.761 . . . . 0.56 112.436 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.27 148.2 39.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.314 -0.403 . . . . 0.63 111.117 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 51.6 ttm -122.16 135.78 54.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.42 110.565 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -118.63 121.88 41.23 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.747 -0.66 . . . . 0.52 109.626 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.5 t -93.95 120.72 43.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.266 -0.424 . . . . 0.55 110.77 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 61.56 13.65 5.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.212 -0.904 . . . . 1.16 111.604 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.08 24.91 70.63 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.613 -0.595 . . . . 0.56 111.613 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -130.62 -43.07 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.912 0.387 . . . . 1.75 111.448 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -106.05 120.47 41.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.462 -0.336 . . . . 1.16 111.388 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -103.08 132.68 49.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.515 -0.55 . . . . 0.98 109.515 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.46 143.22 33.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.942 0.401 . . . . 1.2 110.628 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -119.52 95.56 49.31 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.992 -0.549 . . . . 0.72 110.145 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.79 -25.46 53.32 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.226 1.951 . . . . 0.54 112.622 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -71.99 -13.78 61.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 2.22 110.754 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.3 0.37 50.45 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.812 -0.708 . . . . 0.59 112.404 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.1 mtt -97.6 -172.25 2.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.57 110.449 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.32 120.49 15.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 1.54 110.476 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.25 15.75 18.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.137 0.494 . . . . 1.16 110.733 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.51 -40.45 6.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 1.53 110.719 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -121.74 116.76 25.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.753 0.311 . . . . 1.21 110.858 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -55.06 -41.54 71.59 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.769 -0.65 . . . . 1.96 111.907 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -43.19 63.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.185 0.517 . . . . 2.05 111.43 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 33.1 t -74.26 -45.39 47.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.672 -0.694 . . . . 0.65 111.176 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -55.52 -50.56 69.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.329 -0.396 . . . . 0.47 111.443 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.19 -49.2 80.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.48 111.512 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 33.2 mm-40 -68.86 -44.76 72.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.485 -0.325 . . . . 1.7 111.608 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 2.4 mt-30 -56.83 -46.93 81.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.525 0.202 . . . . 1.32 111.367 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 182' ' ' VAL . 10.3 t80 -59.15 -54.15 50.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.808 0.337 . . . . 0.46 111.032 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -64.83 -37.46 87.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 0.43 112.206 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -67.44 -37.56 83.17 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.837 0.351 . . . . 1.55 110.637 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 94.8 m -62.26 -36.67 82.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.48 109.826 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 178' ' ' TYR . 92.8 t -58.93 -49.37 83.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.003 -0.544 . . . . 0.48 110.481 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 37.6 tttm -58.83 -43.18 90.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 1.59 110.975 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -61.96 -43.95 97.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 1.17 111.671 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.01 -34.7 64.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.051 0.389 . . . . 0.68 112.051 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.6 m -69.28 -29.67 67.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.11 0.481 . . . . 1.07 110.495 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -97.43 6.18 48.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.73 -0.668 . . . . 2.26 110.715 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -86.62 70.8 10.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.006 -0.543 . . . . 1.72 110.071 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.6 pttm . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.557 -0.735 . . . . 4.33 109.617 179.466 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SFQ . . . . . 0.573 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.363 -0.236 . . . . 4.08 110.363 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -83.89 134.28 34.69 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.955 -0.387 . . . . 3.58 109.955 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -134.5 133.2 40.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.129 0.49 . . . . 1.32 111.185 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.08 139.64 53.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.459 -0.791 . . . . 2.29 110.015 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.42 121.35 15.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.044 0.45 . . . . 1.83 110.408 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.04 -18.93 28.19 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.744 -0.662 . . . . 0.78 111.758 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -100.97 -79.4 0.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.773 0.32 . . . . 1.87 110.872 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -83.77 -27.16 29.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.671 0.272 . . . . 1.46 111.341 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -145.72 153.5 41.03 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.928 -0.397 . . . . 0.79 109.928 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.11 130.48 49.92 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.394 -0.366 . . . . 0.9 110.841 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -81.81 120.41 25.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.884 -0.413 . . . . 1.11 109.884 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.0 mt -67.71 136.02 53.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.085 -0.507 . . . . 0.74 111.291 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.43 -26.92 52.0 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.259 -0.645 . . . . 2.33 109.259 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -120.92 88.61 44.75 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.399 -0.819 . . . . 3.64 109.544 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.6 162.47 32.97 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.769 2.313 . . . . 0.85 113.034 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.9 t -103.72 113.61 41.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.755 -0.657 . . . . 0.72 110.41 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.45 138.37 47.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.137 -0.483 . . . . 0.89 111.433 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.3 86.58 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.08 -0.581 . . . . 0.73 112.886 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.64 151.56 84.9 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.535 0.168 . . . . 0.64 110.666 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.11 173.67 10.05 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.288 1.992 . . . . 0.56 112.297 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.63 -46.29 72.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.091 -0.504 . . . . 1.79 110.784 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -127.56 105.0 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.812 0.339 . . . . 0.45 110.383 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.6 tp -108.25 121.03 44.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.928 -0.578 . . . . 0.53 109.726 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -123.92 145.51 49.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.447 -0.342 . . . . 1.61 110.506 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -121.15 147.27 45.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.079 -0.509 . . . . 0.53 109.981 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -167.68 178.95 5.05 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.056 -0.52 . . . . 0.55 111.024 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.471 ' HB2' HG22 ' A' ' 61' ' ' VAL . 7.8 t -158.94 138.36 11.57 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.01 -0.541 . . . . 0.96 110.001 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.3 m-85 -69.35 -18.84 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.11 0.481 . . . . 0.62 109.97 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CE2' HD12 ' A' ' 72' ' ' LEU . 78.9 m-85 -83.65 -6.9 59.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.48 -0.782 . . . . 1.78 110.866 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.9 t -97.95 117.19 65.39 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 116.504 -0.316 . . . . 0.48 110.808 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.544 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 18.3 Cg_endo -62.05 -23.07 75.33 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.268 1.979 . . . . 0.7 112.019 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.46 ' CE1' ' O4 ' ' A' ' 201' ' ' SFQ . 0.4 OUTLIER -73.97 -34.8 64.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.037 -0.529 . . . . 1.74 110.652 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.1 m -71.39 -33.34 69.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.068 0.461 . . . . 0.37 110.259 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -63.26 -45.54 91.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.547 0.689 . . . . 1.44 109.298 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.604 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 8.8 tm0? -71.28 -37.67 71.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.948 -1.024 . . . . 2.27 111.182 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.3 -22.93 66.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.232 0.456 . . . . 0.87 112.232 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -108.71 -51.36 2.9 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.927 -0.709 . . . . 1.89 112.378 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -68.12 -27.69 66.67 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.879 -0.513 . . . . 2.0 111.65 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 78.7 t -102.86 -64.87 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.663 -0.244 . . . . 0.58 111.073 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.65 -38.49 67.66 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.702 0.26 . . . . 0.41 111.702 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 64.02 50.56 2.47 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.468 0.48 . . . . 0.84 110.455 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.47 -52.56 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.84 -0.618 . . . . 0.41 111.551 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.595 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 21.5 m -58.16 -52.18 66.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.488 0.185 . . . . 1.03 111.033 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 29.9 t70 -58.93 -39.33 81.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.582 -0.281 . . . . 1.73 111.687 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -71.54 -42.8 67.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.697 0.285 . . . . 1.19 110.632 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 37.5 t -59.49 -41.13 83.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.49 110.683 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 43' ' ' SER . 75.5 mttt -55.2 -36.7 66.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.896 0.379 . . . . 1.53 110.871 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 36.1 mttm -80.76 -13.23 59.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.12 -0.491 . . . . 2.02 112.218 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -109.88 8.23 24.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.579 0.228 . . . . 1.44 111.54 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 41.7 mt -96.09 136.7 21.94 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.889 -0.324 . . . . 1.0 111.643 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.54 177.47 3.97 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.537 2.158 . . . . 0.74 111.646 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -75.01 149.01 39.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.913 0.387 . . . . 2.63 110.631 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.14 -18.5 40.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.019 -0.61 . . . . 0.82 112.298 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 t -84.09 132.14 32.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.827 0.346 . . . . 1.03 110.613 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -117.45 136.77 52.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.402 -0.363 . . . . 2.51 110.805 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.1 mtp -82.79 113.68 20.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.534 . . . . 1.28 110.088 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.1 94.01 5.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.072 0.463 . . . . 0.61 110.747 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -89.91 116.82 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 0.86 109.937 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 4.8 m-30 -111.89 150.87 29.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.112 0.482 . . . . 0.71 111.304 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -100.3 128.06 46.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.922 -0.581 . . . . 0.57 110.604 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 27' ' ' SER . 8.1 m -80.38 152.71 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.507 -0.315 . . . . 0.68 110.54 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -103.62 -0.5 29.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.787 0.662 . . . . 0.93 112.787 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -96.3 16.93 17.01 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.699 -0.4 . . . . 0.74 110.984 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.53 107.47 5.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.355 -0.384 . . . . 1.09 110.47 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.56 18.68 1.58 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.886 -0.673 . . . . 0.78 112.941 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.53 -112.25 4.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.269 -0.491 . . . . 0.81 113.024 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.52 -31.03 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.608 0.242 . . . . 2.47 111.167 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.21 -17.37 63.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.831 0.348 . . . . 1.94 110.639 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.81 -33.48 78.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.988 -0.625 . . . . 0.7 111.664 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -66.65 -33.07 74.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.906 0.384 . . . . 2.69 110.506 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -74.09 -41.18 62.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 1.65 110.533 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.553 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -64.24 -27.98 69.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.32 -0.4 . . . . 1.17 111.045 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.3 m -65.18 -36.03 82.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.065 0.46 . . . . 0.62 110.263 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 78' ' ' VAL . 15.1 tt0 -75.81 -37.93 58.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.132 -0.692 . . . . 1.21 109.132 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.42 -44.85 95.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.55 -0.75 . . . . 0.71 110.444 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.544 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 69.6 t-105 -61.11 -36.03 78.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.333 -0.849 . . . . 0.59 110.764 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.508 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -64.59 -37.76 88.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 0.71 110.268 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 74' ' ' GLN . 57.0 t -65.68 -42.94 93.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 0.84 109.849 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.71 92.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.578 -0.737 . . . . 0.66 110.742 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 28.5 mtm -63.73 -39.14 93.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 1.08 111.196 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.07 -39.37 79.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.161 -0.472 . . . . 0.99 111.29 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.39 -29.35 47.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.242 -0.436 . . . . 0.97 111.36 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.74 10.41 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.692 -0.766 . . . . 0.78 111.964 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.98 26.08 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 110.548 -0.167 . . . . 0.81 110.548 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.544 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 3.5 mp0 -55.56 -61.99 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 1.71 111.249 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -37.87 67.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.002 -0.545 . . . . 1.91 111.98 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm -64.0 -33.4 75.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 2.28 112.084 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.2 m -101.17 -8.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.848 0.314 . . . . 0.65 111.848 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.9 m -58.19 -49.04 78.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.919 0.34 . . . . 0.98 111.919 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.46 -58.35 15.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 112.336 0.495 . . . . 0.62 112.336 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.46 -36.45 98.74 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.866 1.71 . . . . 0.61 113.221 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.84 -42.99 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.702 0.286 . . . . 0.79 110.279 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -62.69 -46.83 86.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.129 0.49 . . . . 0.58 110.722 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.06 -42.54 96.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.699 -0.682 . . . . 1.7 111.321 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.36 -14.13 68.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.955 -0.64 . . . . 0.82 113.527 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.1 -32.23 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 117.076 0.438 . . . . 0.75 112.025 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 31' ' ' PRO . 53.2 mt-30 -113.89 -42.77 3.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.783 1.031 . . . . 0.84 113.783 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -69.25 -61.96 1.58 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.773 0.32 . . . . 1.41 111.246 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.8 p -92.84 -30.17 15.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.315 -0.402 . . . . 1.31 110.743 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 61.28 33.31 19.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.627 -0.715 . . . . 1.44 110.121 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.7 -31.75 41.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.295 -0.866 . . . . 1.57 111.239 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.9 mt -70.75 106.09 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.91 110.421 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -129.15 -11.72 4.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.391 -0.822 . . . . 3.22 110.494 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.3 m -134.4 165.91 24.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.949 -0.569 . . . . 1.51 110.293 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.17 64.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.1 0.476 . . . . 1.08 110.738 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -36.73 84.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.784 -0.644 . . . . 1.43 110.602 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 111' ' ' VAL . 15.9 m-20 -63.8 -46.28 85.89 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.307 -0.627 . . . . 1.89 109.307 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.0 mt -59.47 -39.73 79.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.541 -0.754 . . . . 0.9 110.482 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -62.19 -43.36 99.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.81 -0.632 . . . . 2.19 110.689 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -65.28 -33.86 76.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.286 -0.416 . . . . 1.95 110.639 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 107' ' ' ASP . 92.6 t -62.2 -43.99 98.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.963 -0.562 . . . . 0.88 110.279 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -63.92 -39.03 93.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.92 110.56 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 80.0 mt -64.65 -30.81 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.433 0.635 . . . . 1.33 109.897 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -77.1 -14.91 59.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.547 -0.752 . . . . 1.93 110.821 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.82 1.07 57.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.029 -0.532 . . . . 1.1 111.054 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.82 4.12 45.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 1.15 112.881 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 49.1 mm -91.05 148.09 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.096 -0.335 . . . . 1.61 110.096 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -88.76 150.65 22.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.385 -0.37 . . . . 2.73 110.859 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.58 -56.31 22.23 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.998 -0.546 . . . . 1.19 113.183 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.82 -32.66 70.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.967 0.413 . . . . 2.98 110.93 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.2 -42.6 96.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 2.52 109.779 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -69.38 -44.25 71.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.465 -0.788 . . . . 1.51 110.234 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -60.27 -39.94 88.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.146 -0.479 . . . . 2.3 110.877 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.62 -48.44 79.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.915 -0.584 . . . . 1.23 111.578 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.43 -33.43 72.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 1.11 111.673 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -56.7 -31.42 64.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 1.31 111.065 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -105.83 29.01 7.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.015 -0.538 . . . . 1.63 111.223 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.8 t -93.22 145.79 24.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.722 0.296 . . . . 2.04 110.626 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -61.65 -37.67 84.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 3.82 110.835 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.29 -42.05 86.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.217 0.532 . . . . 1.53 110.314 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 77' ' ' ALA . 44.8 t -67.3 -45.8 85.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.404 -0.816 . . . . 1.11 110.483 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -58.86 -38.23 78.3 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.264 -0.425 . . . . 2.43 110.875 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -43.24 71.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.073 -0.512 . . . . 1.47 110.425 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.432 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 34.6 mt -62.82 -38.16 89.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.438 . . . . 0.93 110.9 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 131' ' ' VAL . 61.7 t -60.12 -52.33 62.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.275 -0.421 . . . . 0.8 110.317 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.3 -37.25 74.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 0.85 111.367 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -65.07 -39.76 93.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.479 . . . . 1.39 111.293 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.481 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 53.0 mt-30 -60.53 -45.91 92.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.61 111.372 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -33.73 58.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.627 0.251 . . . . 2.82 111.149 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -65.69 -51.43 59.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.652 -0.249 . . . . 1.95 111.326 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.92 90.38 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.311 0.382 . . . . 0.65 111.468 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.26 86.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.399 -0.364 . . . . 0.61 111.404 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.08 -26.61 26.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.352 -0.385 . . . . 0.72 111.59 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -36.59 76.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.165 0.507 . . . . 1.39 110.637 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.68 -4.4 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.12 -0.491 . . . . 1.34 110.062 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.576 ' O ' ' HD3' ' A' ' 148' ' ' ARG . 88.8 mt-30 57.72 74.28 0.43 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.54 -0.755 . . . . 1.95 110.137 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tp -59.76 124.19 19.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.557 -0.747 . . . . 0.71 111.437 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.576 ' HD3' ' O ' ' A' ' 146' ' ' GLN . 1.6 mpp_? -103.45 18.65 21.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.182 0.515 . . . . 4.16 110.603 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -179.63 172.46 44.24 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.896 -0.882 . . . . 0.68 110.896 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.526 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.9 t -84.86 -56.79 0.39 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 117.324 0.562 . . . . 0.49 111.307 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.8 Cg_endo -82.2 88.92 1.24 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.149 1.9 . . . . 0.56 111.352 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.98 146.01 50.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.052 -0.522 . . . . 0.63 111.069 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 53.0 ttm -133.26 131.64 40.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.986 -0.375 . . . . 0.42 109.986 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -122.37 137.56 54.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.093 -0.503 . . . . 0.52 110.365 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.1 t -107.68 122.56 62.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.277 -0.42 . . . . 0.55 110.905 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 61.98 10.87 3.85 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.231 -0.895 . . . . 1.16 112.188 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 68.95 19.56 73.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.251 -0.499 . . . . 0.56 112.301 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -129.1 -41.11 1.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.392 . . . . 1.75 111.195 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.424 ' HB3' HD13 ' A' ' 185' ' ' LEU . 48.0 m-85 -96.71 123.79 40.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.143 -0.48 . . . . 1.16 111.568 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -108.07 123.99 49.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.712 -0.676 . . . . 0.98 109.251 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.78 143.61 39.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.682 0.277 . . . . 1.2 111.118 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -119.43 96.75 50.01 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.173 0.511 . . . . 0.72 110.205 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.8 -19.29 41.15 Favored 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.443 2.095 . . . . 0.54 112.713 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -72.38 -22.23 61.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 2.22 111.284 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.27 21.04 34.06 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.646 -0.787 . . . . 0.59 112.056 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.0 mtt -106.29 -164.46 1.01 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.415 -0.217 . . . . 0.57 110.415 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.02 132.63 46.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 1.54 111.111 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.9 20.76 6.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.832 -0.622 . . . . 1.16 109.691 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.99 -41.84 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 1.53 110.914 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -126.8 126.42 43.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.119 -0.491 . . . . 1.21 110.169 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.477 ' O ' HG23 ' A' ' 175' ' ' VAL . 14.3 mmt -61.01 -44.32 97.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.948 -0.569 . . . . 1.96 110.573 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' A' ' 176' ' ' GLN . 31.6 t70 -58.72 -45.36 89.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.75 -0.659 . . . . 2.05 111.199 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.85 -43.82 99.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.403 . . . . 0.65 110.718 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -57.32 -45.97 83.7 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.242 -0.435 . . . . 0.47 110.68 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 171' ' ' MET . 90.6 t -58.9 -47.42 89.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.48 110.93 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 172' ' ' ASP . 54.7 mm-40 -65.08 -48.71 72.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 1.7 110.776 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -58.6 -45.74 88.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 1.32 111.646 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 182' ' ' VAL . 31.7 t80 -60.44 -50.41 73.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.46 111.002 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.98 87.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.43 111.111 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.63 -37.85 88.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 1.55 110.006 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 58.3 m -59.98 -40.49 89.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.028 -0.533 . . . . 0.48 110.224 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 178' ' ' TYR . 41.9 t -60.67 -51.43 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 CA-C-N 115.828 -0.623 . . . . 0.48 110.165 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -60.31 -44.59 95.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.954 -0.566 . . . . 1.59 110.536 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -57.77 -44.63 86.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.5 -0.773 . . . . 1.17 111.041 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 159' ' ' TYR . 96.0 mt -72.14 -29.37 63.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.321 -0.4 . . . . 0.68 111.438 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 40.4 m -71.49 -34.55 70.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.409 -0.36 . . . . 1.07 110.819 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -96.17 6.08 49.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.229 -0.442 . . . . 2.26 110.798 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -79.61 111.25 15.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.02 0.438 . . . . 1.72 110.633 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp . . . . . 0 C--O 1.251 1.146 0 CA-C-N 115.742 -0.663 . . . . 4.33 110.113 179.685 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SFQ . . . . . 0.552 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.983 0.421 . . . . 4.08 110.353 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.35 -43.41 2.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 3.58 110.975 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -130.55 102.72 6.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.24 -0.436 . . . . 1.32 110.711 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -119.43 148.36 43.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.345 -0.389 . . . . 2.29 110.94 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.97 130.2 41.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.935 -0.575 . . . . 1.83 109.693 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.15 -20.59 40.09 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.748 -0.941 . . . . 0.78 110.748 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.549 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 36.4 tptt -105.78 -77.3 0.59 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.755 -0.222 . . . . 1.87 110.809 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -80.04 -35.24 37.49 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.832 0.349 . . . . 1.46 111.477 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -140.76 156.08 46.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.28 -0.418 . . . . 0.79 110.733 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.82 129.73 46.01 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.119 -0.492 . . . . 0.9 110.048 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 m -77.84 121.04 23.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.017 0.437 . . . . 1.11 110.963 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.1 mt -68.57 127.31 32.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.751 -0.659 . . . . 0.74 110.829 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.13 -27.68 68.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.154 0.502 . . . . 2.33 110.746 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -120.86 96.7 48.62 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.983 -0.747 . . . . 3.64 108.983 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HB3' ' HG2' ' A' ' 158' ' ' LYS . 65.1 Cg_endo -76.1 153.25 36.52 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 122.555 2.17 . . . . 0.85 112.584 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -90.93 122.5 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.674 -0.694 . . . . 0.72 109.739 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.7 127.2 31.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.786 -0.643 . . . . 0.89 111.084 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.33 31.92 49.66 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.686 -0.768 . . . . 0.73 112.142 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.61 145.54 32.47 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.396 -0.224 . . . . 0.64 110.396 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.3 164.77 26.93 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.446 2.097 . . . . 0.56 112.432 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -58.34 -56.54 20.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.281 -0.872 . . . . 1.79 111.243 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.4 t -120.33 105.56 17.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.989 0.423 . . . . 0.45 110.185 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.5 tp -105.95 129.73 54.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.08 -0.509 . . . . 0.53 110.15 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 25' ' ' PHE . 4.0 tt0 -127.58 149.44 50.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.455 -0.339 . . . . 1.61 110.456 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.495 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 61.3 m-85 -127.4 146.08 50.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.987 -0.551 . . . . 0.53 110.195 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -163.11 175.87 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.105 0.478 . . . . 0.55 110.906 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.46 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 8.6 t -156.13 141.59 17.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.923 -0.58 . . . . 0.96 109.967 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.411 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 88.0 m-85 -74.57 -8.58 56.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.959 -0.564 . . . . 0.62 110.751 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -101.37 8.12 42.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.224 -0.444 . . . . 1.78 111.002 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 20.8 t -111.65 119.63 44.36 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.62 -0.264 . . . . 0.48 111.202 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 22.0 Cg_endo -65.67 -21.99 58.2 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.402 2.068 . . . . 0.7 111.439 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.649 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 0.3 OUTLIER -64.14 -48.25 76.76 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.895 -0.593 . . . . 1.74 110.019 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 38.7 m -66.88 -31.82 72.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.984 -0.553 . . . . 0.37 110.394 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -60.07 -44.47 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.479 -0.563 . . . . 1.44 109.479 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 31' ' ' PRO . 34.8 mm-40 -73.38 -41.29 63.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.731 -0.668 . . . . 2.27 110.65 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.487 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.4 m-85 -63.76 -35.44 80.61 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.026 -0.534 . . . . 0.87 112.428 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -93.3 -50.16 5.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.065 0.765 . . . . 1.89 113.065 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -77.36 -35.81 54.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.127 0.788 . . . . 2.0 113.127 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 53.9 t -94.61 -57.77 4.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.586 -0.446 . . . . 0.58 112.148 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.513 HD11 ' O2 ' ' A' ' 201' ' ' SFQ . 70.7 mt -82.27 -26.57 33.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.061 0.763 . . . . 0.41 113.061 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 60.95 44.91 10.01 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.982 -0.377 . . . . 0.84 109.982 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.487 HG13 ' CD2' ' A' ' 36' ' ' PHE . 33.9 mm -57.11 -66.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.505 0.557 . . . . 0.41 112.505 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.0 m -62.01 -34.18 75.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 1.03 110.78 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.92 -45.6 93.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.814 -0.63 . . . . 1.73 110.143 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -69.45 -37.5 77.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 1.19 110.214 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 54.4 t -60.96 -42.31 92.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 0.49 110.433 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -63.22 -12.72 30.66 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.189 -0.459 . . . . 1.53 110.948 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -113.78 6.21 16.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.127 0.489 . . . . 2.02 111.192 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -116.29 -27.83 6.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.103 -0.499 . . . . 1.44 110.535 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 81.6 mt -66.24 145.1 98.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.224 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -78.0 170.85 18.16 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.36 2.04 . . . . 0.74 111.643 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.81 137.67 54.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 2.63 111.145 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.92 -21.79 43.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.093 -0.575 . . . . 0.82 112.038 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 t -92.83 108.09 19.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.865 0.364 . . . . 1.03 110.098 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -89.93 156.52 18.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 2.51 110.933 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 17.1 ttt -109.06 143.86 37.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.781 -0.645 . . . . 1.28 109.707 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.52 108.08 9.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 0.61 110.826 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 14.6 ttmm -94.17 116.85 29.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.725 -0.67 . . . . 0.86 110.154 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 10.0 m-30 -114.46 161.4 18.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.157 0.503 . . . . 0.71 111.688 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.46 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 43.2 t-80 -105.79 142.19 35.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.61 . . . . 0.57 111.002 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -97.62 149.58 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.794 0.33 . . . . 0.68 110.89 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -93.52 -16.47 24.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.837 0.68 . . . . 0.93 112.837 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -83.21 10.24 8.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.696 0.628 . . . . 0.74 112.696 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.1 96.17 3.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.973 0.416 . . . . 1.09 111.044 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.87 0.17 6.09 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.936 -0.649 . . . . 0.78 112.467 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.06 -129.34 43.52 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.283 -0.484 . . . . 0.81 112.647 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.62 -38.15 65.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.7 -0.482 . . . . 2.47 109.7 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.55 -26.94 68.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.573 -0.739 . . . . 1.94 109.897 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.84 -43.51 96.03 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.515 -0.766 . . . . 0.7 111.823 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -63.84 -35.55 81.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.207 -0.294 . . . . 2.69 110.207 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -43.22 99.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.394 0.616 . . . . 1.65 109.857 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.34 -34.38 78.0 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 115.549 -0.75 . . . . 1.17 110.689 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.6 m -62.11 -36.48 81.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.37 . . . . 0.62 111.101 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.549 ' HA ' HG22 ' A' ' 135' ' ' VAL . 42.7 tt0 -76.43 -45.02 33.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.623 -0.262 . . . . 1.21 110.39 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.19 88.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.046 0.45 . . . . 0.71 110.677 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.508 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 66.5 t-105 -61.26 -37.69 84.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.543 -0.753 . . . . 0.59 110.961 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.644 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.5 -34.01 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.71 110.3 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.443 HG22 HG21 ' A' ' 131' ' ' VAL . 58.2 t -66.14 -41.66 89.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.945 -0.57 . . . . 0.84 109.62 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.52 81.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.479 -0.782 . . . . 0.66 111.08 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 29.4 mtm -68.41 -38.68 81.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.979 -0.555 . . . . 1.08 111.095 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.68 -31.41 70.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.191 -0.458 . . . . 0.99 111.877 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.72 -13.7 28.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.543 -0.299 . . . . 0.97 111.531 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.44 39.7 49.92 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.488 -0.863 . . . . 0.78 111.791 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.87 22.58 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.012 -0.366 . . . . 0.81 110.012 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.508 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -56.23 -59.92 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.662 -0.699 . . . . 1.71 111.406 -178.466 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.52 -19.15 64.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.531 . . . . 1.91 111.514 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -78.05 -39.78 40.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.334 -0.393 . . . . 2.28 111.442 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.5 m -94.72 -10.4 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.381 0.511 . . . . 0.65 112.381 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.1 m -59.26 -49.39 78.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.738 0.304 . . . . 0.98 111.558 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.425 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 47.1 t -62.46 -58.8 15.17 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 112.099 0.407 . . . . 0.62 112.099 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 15.6 Cg_endo -57.24 -33.39 95.94 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.059 1.839 . . . . 0.61 113.018 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.478 HD23 HD13 ' A' ' 102' ' ' ILE . 17.3 mt -73.02 -46.97 48.98 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.974 -0.29 . . . . 0.79 110.701 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -58.59 -52.38 65.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.156 0.503 . . . . 0.58 110.779 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.52 -42.42 95.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.644 -0.707 . . . . 1.7 111.182 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.37 -14.22 71.54 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.217 -0.516 . . . . 0.82 114.232 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.21 -42.51 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.539 0.669 . . . . 0.75 112.276 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -99.6 -38.45 8.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.861 0.689 . . . . 0.84 112.861 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -78.7 -64.64 1.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.511 -0.476 . . . . 1.41 110.542 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -34.21 40.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.124 -0.489 . . . . 1.31 111.615 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 60.97 31.85 19.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.144 0.497 . . . . 1.44 110.819 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.35 -35.37 19.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.794 -0.639 . . . . 1.57 111.211 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.478 HD13 HD23 ' A' ' 92' ' ' LEU . 30.2 mt -79.33 96.97 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.838 -0.619 . . . . 0.91 110.971 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -135.25 22.16 3.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.026 0.441 . . . . 3.22 111.082 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.416 ' O ' HG13 ' A' ' 108' ' ' ILE . 83.6 p -159.49 160.38 34.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.035 -0.53 . . . . 1.51 109.717 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.39 -28.99 70.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.126 0.489 . . . . 1.08 110.392 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -61.21 -34.28 74.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.428 -0.806 . . . . 1.43 110.435 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 111' ' ' VAL . 56.9 m-20 -76.2 -47.59 23.51 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.898 -0.592 . . . . 1.89 109.589 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 104' ' ' SER . 27.5 mt -55.3 -46.41 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.67 -0.695 . . . . 0.9 111.156 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 113' ' ' ILE . 62.7 ttt-85 -59.13 -45.43 90.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.2 -0.455 . . . . 2.19 110.679 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.75 -42.04 99.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.304 -0.407 . . . . 1.95 110.904 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 107' ' ' ASP . 90.6 t -60.55 -44.79 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.222 -0.444 . . . . 0.88 110.595 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 7.6 m-85 -62.5 -44.9 95.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.093 -0.503 . . . . 0.92 110.727 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 73.3 mt -63.68 -38.82 83.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 1.33 110.525 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -67.8 -31.67 71.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.47 . . . . 1.93 110.759 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.38 -8.1 53.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.313 -0.403 . . . . 1.1 111.591 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.37 0.74 26.46 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.475 -0.869 . . . . 1.15 112.98 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 3.3 mp -85.93 121.7 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.867 -0.42 . . . . 1.61 109.867 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -60.91 136.69 58.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.824 -0.625 . . . . 2.73 111.107 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.57 -41.92 98.97 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.609 -0.597 . . . . 1.19 111.609 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -65.74 -23.17 66.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 2.98 110.685 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -82.75 -45.33 14.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.97 -0.559 . . . . 2.52 109.515 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -63.55 -44.25 94.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.506 -0.77 . . . . 1.51 110.483 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.34 -43.16 96.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.978 0.418 . . . . 2.3 110.827 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.29 -47.6 83.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 1.23 110.624 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.05 -41.21 95.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 1.11 111.109 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -59.94 -30.02 68.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.31 111.504 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -96.15 -26.12 15.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.148 0.425 . . . . 1.63 112.148 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 m -65.22 149.42 49.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.321 0.581 . . . . 2.04 112.507 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -73.01 -21.14 60.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.513 -0.767 . . . . 3.82 111.723 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.87 -50.1 70.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.26 0.552 . . . . 1.53 110.101 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.644 HG13 ' HB3' ' A' ' 77' ' ' ALA . 36.0 t -66.5 -41.69 88.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.419 -0.81 . . . . 1.11 110.414 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -56.87 -41.31 77.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.088 -0.505 . . . . 2.43 111.075 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.5 m -63.37 -39.41 94.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.983 -0.553 . . . . 1.47 110.202 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.44 -37.71 83.39 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.331 -0.395 . . . . 0.93 110.479 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 131' ' ' VAL . 41.5 t -61.46 -51.68 70.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.023 -0.362 . . . . 0.8 110.023 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.56 69.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.772 -0.649 . . . . 0.85 111.048 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -66.31 -42.45 88.24 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.009 -0.541 . . . . 1.39 110.271 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.53 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 51.8 mt-30 -62.59 -48.15 80.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.833 -0.621 . . . . 0.61 109.919 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 29.0 mt-10 -62.37 -44.47 96.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.341 -0.845 . . . . 2.82 111.194 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -60.91 -46.99 88.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.849 -0.614 . . . . 1.95 111.514 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.55 -44.12 84.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.912 0.338 . . . . 0.65 111.912 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.38 -30.52 64.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.224 0.453 . . . . 0.61 112.224 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.4 -27.18 25.96 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.565 0.579 . . . . 0.72 112.565 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.17 -47.71 23.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.629 0.252 . . . . 1.39 110.565 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.5 p -80.76 -8.31 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.814 0.34 . . . . 1.34 110.764 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 58.21 58.53 3.45 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.735 -0.666 . . . . 1.95 110.435 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 149' ' ' GLY . 40.9 tp -67.13 111.74 4.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.461 -0.79 . . . . 0.71 110.803 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -87.31 -33.71 19.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.611 -0.722 . . . . 4.16 110.556 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.591 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . -93.9 173.61 33.56 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.989 -0.845 . . . . 0.68 110.989 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.557 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 4.6 t -102.89 -57.56 0.1 OUTLIER Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 117.865 0.832 . . . . 0.49 112.761 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 4.1 Cg_endo -85.27 70.16 5.27 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.231 1.954 . . . . 0.56 111.928 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.22 139.31 50.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.905 -0.589 . . . . 0.63 110.766 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 21.6 ttm -113.38 139.02 49.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.042 -0.526 . . . . 0.42 109.912 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -122.96 133.98 54.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.549 -0.296 . . . . 0.52 110.728 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.8 t -101.3 114.76 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.343 -0.389 . . . . 0.55 110.752 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.69 25.84 10.57 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.524 -0.762 . . . . 1.16 111.418 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.48 26.88 60.18 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.743 -0.662 . . . . 0.56 113.167 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 15' ' ' PRO . 30.1 mtmm -126.9 -39.23 1.97 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.099 0.407 . . . . 1.75 112.099 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -106.66 135.9 47.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.003 -0.279 . . . . 1.16 111.432 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -108.23 136.18 48.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.794 -0.639 . . . . 0.98 110.056 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.61 129.63 34.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.472 -0.331 . . . . 1.2 110.54 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -112.73 100.6 51.07 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.415 -0.357 . . . . 0.72 110.723 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.47 -15.32 34.4 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.685 2.257 . . . . 0.54 112.321 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -86.04 2.63 45.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.107 0.48 . . . . 2.22 111.02 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -105.15 16.38 45.98 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.006 -0.616 . . . . 0.59 111.592 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 40.1 mtt -127.67 166.21 18.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.0 -0.37 . . . . 0.57 110.0 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -80.81 133.4 35.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.381 -0.372 . . . . 1.54 111.132 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.475 ' O ' ' I1 ' ' A' ' 201' ' ' SFQ . 0.2 OUTLIER -98.78 -3.16 36.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.15 -0.477 . . . . 1.16 111.744 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 m -67.22 -36.21 81.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.874 0.368 . . . . 1.53 110.814 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -118.33 111.12 18.32 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.235 -0.654 . . . . 1.21 109.235 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 42.9 mtt -66.08 -40.83 91.14 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.488 0.551 . . . . 1.96 112.488 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.46 -50.28 74.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.808 0.337 . . . . 2.05 111.15 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.99 -38.91 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.967 -0.56 . . . . 0.65 110.472 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.81 -53.38 55.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.47 110.908 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 70.2 t -58.3 -48.32 85.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.98 -0.555 . . . . 0.48 111.312 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 61.6 mm-40 -64.67 -40.13 94.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.602 -0.272 . . . . 1.7 111.548 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.22 -43.89 93.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.069 -0.345 . . . . 1.32 110.069 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.427 ' O ' HG23 ' A' ' 182' ' ' VAL . 20.4 t80 -57.37 -54.23 49.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.46 110.289 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.83 85.09 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.97 -0.559 . . . . 0.43 111.787 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -67.21 -37.64 83.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.594 -0.276 . . . . 1.55 110.584 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 37.8 m -61.73 -42.6 99.17 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.047 0.451 . . . . 0.48 109.911 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 178' ' ' TYR . 49.0 t -61.49 -47.64 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.672 -0.695 . . . . 0.48 110.274 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 187' ' ' GLU . 34.4 tttp -56.84 -53.38 58.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.818 -0.628 . . . . 1.59 110.948 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -54.68 -41.66 70.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.423 -0.353 . . . . 1.17 111.33 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.55 -38.65 67.92 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.938 0.348 . . . . 0.68 111.938 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 35.2 p -65.86 -35.34 80.37 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.103 -0.239 . . . . 1.07 111.608 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 12.3 pt-20 -93.84 15.94 15.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.105 0.478 . . . . 2.26 111.334 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -115.55 105.77 13.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.224 -0.444 . . . . 1.72 110.26 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 40.8 tttp . . . . . 0 C--O 1.254 1.301 0 CA-C-O 118.267 -0.873 . . . . 4.33 110.604 -179.745 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SFQ . . . . . 0.649 ' C13' ' HE2' ' A' ' 32' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 110.334 -0.247 . . . . 4.08 110.334 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.62 131.51 40.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.671 -0.492 . . . . 3.58 109.671 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -134.09 112.03 10.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.826 0.346 . . . . 1.32 110.322 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -110.22 140.96 43.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 2.29 109.812 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -69.88 122.01 18.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.531 -0.544 . . . . 1.83 109.531 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.579 ' HA2' HG23 ' A' ' 10' ' ' THR . . . 97.94 -11.36 64.21 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.939 -0.648 . . . . 0.78 111.607 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -95.68 -83.16 0.37 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.493 0.187 . . . . 1.87 110.736 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.495 ' HG2' HE21 ' A' ' 177' ' ' GLN . 23.9 mp0 -84.57 -25.31 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.08 0.467 . . . . 1.46 110.52 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -142.98 153.9 43.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.819 -0.628 . . . . 0.79 109.627 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.579 HG23 ' HA2' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -127.38 133.52 50.01 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.398 -0.364 . . . . 0.9 110.563 -179.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.5 m -87.83 126.7 35.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.9 0.381 . . . . 1.11 111.051 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -85.51 140.84 30.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.448 -0.342 . . . . 0.74 110.39 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -20.28 46.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.981 0.419 . . . . 2.33 110.116 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -118.98 93.93 47.46 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.88 -0.6 . . . . 3.64 109.955 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.69 145.23 12.84 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.681 2.254 . . . . 0.85 112.847 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.1 t -80.56 113.84 20.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.828 -0.623 . . . . 0.72 110.22 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.0 128.77 37.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.424 . . . . 0.89 111.36 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.47 16.17 74.32 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.86 -0.609 . . . . 0.73 112.91 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.9 144.58 79.94 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.697 0.248 . . . . 0.64 110.616 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 14.8 Cg_endo -60.15 160.98 20.78 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.606 2.204 . . . . 0.56 112.051 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.485 ' NE2' ' HA ' ' A' ' 54' ' ' VAL . 46.4 mt-30 -57.1 -51.34 69.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.843 -0.617 . . . . 1.79 111.245 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.6 t -128.18 104.5 11.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.837 -0.431 . . . . 0.45 109.837 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.544 HD21 ' HB1' ' A' ' 141' ' ' ALA . 46.3 tp -102.97 132.89 48.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.53 110.746 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.89 150.82 49.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.366 -0.379 . . . . 1.61 110.065 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -122.71 148.29 45.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.465 -0.334 . . . . 0.53 110.72 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.01 173.55 15.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.136 -0.484 . . . . 0.55 110.591 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.54 ' OG ' HG22 ' A' ' 61' ' ' VAL . 52.5 m -154.47 132.42 11.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.134 -0.484 . . . . 0.96 110.651 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.585 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 67.5 m-85 -66.81 -20.68 65.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.62 111.012 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.77 2.89 54.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 1.78 111.04 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 40.5 t -108.41 119.82 48.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.328 -0.396 . . . . 0.48 110.658 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.33 -27.73 63.42 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.615 2.21 . . . . 0.7 112.105 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.494 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 0.1 OUTLIER -64.85 -47.26 78.58 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.583 -0.735 . . . . 1.74 109.984 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.7 m -63.82 -37.31 86.9 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.801 0.334 . . . . 0.37 110.528 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -60.89 -51.98 66.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 1.44 109.942 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -65.0 -35.03 79.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.394 -0.821 . . . . 2.27 111.549 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.61 -29.69 70.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.928 0.714 . . . . 0.87 112.928 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -105.92 -35.32 7.34 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.705 -0.398 . . . . 1.89 111.397 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -43.35 60.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 2.0 111.847 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.81 -58.01 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.166 0.432 . . . . 0.58 112.166 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.3 mt -69.85 -37.24 76.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.37 0.507 . . . . 0.41 112.37 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 63.42 42.4 6.78 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.04 -0.356 . . . . 0.84 110.04 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.3 mm -61.38 -58.39 7.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.096 -0.502 . . . . 0.41 111.21 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.563 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 1.5 m -61.95 -44.31 97.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.745 -0.465 . . . . 1.03 109.745 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.52 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 24.1 t70 -54.99 -44.42 74.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.235 -0.893 . . . . 1.73 111.186 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -69.37 -43.53 73.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.631 -0.258 . . . . 1.19 111.051 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 54.9 t -58.87 -36.9 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.49 110.427 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 43' ' ' SER . 56.9 mttt -56.18 -31.76 63.72 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.361 -0.382 . . . . 1.53 111.202 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' A' ' 44' ' ' ASP . 16.6 mttt -109.73 8.9 24.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 2.02 111.705 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -121.58 21.03 11.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.69 0.281 . . . . 1.44 111.164 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 34.7 mt -104.83 153.03 39.62 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.738 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 50' ' ' LEU . 3.1 Cg_exo -75.17 161.17 38.68 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.722 2.281 . . . . 0.74 111.654 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.24 134.45 53.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.965 0.412 . . . . 2.63 110.916 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.53 -17.29 58.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.57 -0.824 . . . . 0.82 111.945 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.485 ' HA ' ' NE2' ' A' ' 21' ' ' GLN . 90.7 t -95.85 125.91 48.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 1.03 110.936 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -110.54 155.9 21.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.305 -0.407 . . . . 2.51 109.997 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.6 ttt -108.16 132.03 54.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.181 -0.463 . . . . 1.28 110.512 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.18 112.34 18.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.134 -0.485 . . . . 0.61 110.576 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -96.58 129.43 43.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.91 -0.586 . . . . 0.86 109.843 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.46 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 6.8 m-30 -118.16 160.95 20.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.71 111.634 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -111.54 133.12 54.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.644 -0.707 . . . . 0.57 110.224 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.54 HG22 ' OG ' ' A' ' 27' ' ' SER . 2.7 m -85.83 162.36 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.575 0.226 . . . . 0.68 110.591 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -113.34 21.4 15.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.388 0.514 . . . . 0.93 112.388 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -120.06 16.53 12.46 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.6 -0.44 . . . . 0.74 111.643 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 75.3 mmm -135.09 106.95 7.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.236 -0.438 . . . . 1.09 110.936 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.55 13.72 9.39 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.946 -0.645 . . . . 0.78 112.59 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.67 -147.89 31.5 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.455 -0.878 . . . . 0.81 111.854 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -81.99 -19.28 40.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 2.47 110.863 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.25 -16.32 63.42 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.397 0.617 . . . . 1.94 109.9 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.56 -30.36 77.38 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.502 -0.772 . . . . 0.7 111.422 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -64.0 -44.32 92.99 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.968 0.413 . . . . 2.69 110.106 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.25 -41.72 97.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.824 -0.626 . . . . 1.65 109.961 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.04 -32.52 74.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.706 -0.679 . . . . 1.17 110.827 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.4 m -68.67 -40.77 80.01 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.042 0.449 . . . . 0.62 110.365 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -42.81 71.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 1.21 109.762 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.21 92.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.925 -0.579 . . . . 0.71 110.942 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -62.53 -38.9 91.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.242 -0.435 . . . . 0.59 110.253 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.439 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.41 -34.62 78.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.833 -0.432 . . . . 0.71 109.833 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.96 -44.11 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.729 -0.669 . . . . 0.84 109.575 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.83 -38.29 87.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.66 -0.7 . . . . 0.66 111.043 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.2 mtm -65.31 -25.97 67.85 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.825 0.345 . . . . 1.08 111.345 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.18 -29.52 24.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.99 110.718 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 68.6 mt -82.7 -36.0 26.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.898 -0.592 . . . . 0.97 111.368 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.49 23.51 21.28 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.886 -0.673 . . . . 0.78 112.635 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 88' ' ' VAL . 13.6 m -121.25 18.73 5.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 122.705 -0.291 . . . . 0.81 110.989 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -53.42 -60.59 3.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.559 -0.746 . . . . 1.71 111.749 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.25 -35.13 67.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.72 -0.673 . . . . 1.91 112.116 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -74.45 -43.29 56.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.011 0.374 . . . . 2.28 112.011 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 84' ' ' VAL . 28.6 m -80.68 -2.87 5.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.414 -0.514 . . . . 0.65 111.807 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 m -59.31 -48.25 82.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.823 0.305 . . . . 0.98 111.823 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.449 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 22.0 t -61.33 -59.09 14.69 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.191 0.441 . . . . 0.62 112.191 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 9.5 Cg_endo -54.39 -33.93 78.86 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.276 1.984 . . . . 0.61 112.446 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 28' ' ' PHE . 10.6 mt -66.88 -52.79 39.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.439 -0.346 . . . . 0.79 110.435 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.9 m-85 -58.21 -45.84 86.92 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.936 0.398 . . . . 0.58 110.401 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.13 -48.53 78.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.716 -0.675 . . . . 1.7 110.426 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.31 -7.04 43.48 Favored Glycine 0 C--O 1.223 -0.579 0 CA-C-N 116.153 -0.476 . . . . 0.82 113.644 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 50.2 t -105.14 -49.2 9.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 117.412 0.606 . . . . 0.75 112.014 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -99.42 -50.12 4.21 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.629 0.603 . . . . 0.84 112.629 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -69.14 -70.91 0.25 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.46 0.541 . . . . 1.41 112.46 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.46 ' HB ' ' OG1' ' A' ' 101' ' ' THR . 0.2 OUTLIER -79.84 -31.89 40.55 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.259 0.466 . . . . 1.31 112.259 -178.266 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 64.58 29.36 13.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.096 0.474 . . . . 1.44 110.992 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.46 ' OG1' ' HB ' ' A' ' 99' ' ' THR . 0.2 OUTLIER -69.51 -31.25 69.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.57 111.328 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.409 ' HA ' ' CB ' ' A' ' 107' ' ' ASP . 48.6 mt -88.68 105.71 16.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.894 -0.594 . . . . 0.91 111.661 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -122.72 -12.02 8.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.458 -0.792 . . . . 3.22 109.095 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.0 164.41 30.68 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.868 -1.06 . . . . 1.51 109.704 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.06 -25.5 68.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 1.08 111.177 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -33.01 72.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 1.43 110.489 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.409 ' CB ' ' HA ' ' A' ' 102' ' ' ILE . 32.7 m-20 -72.55 -38.8 67.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.84 -0.618 . . . . 1.89 110.253 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 108' ' ' ILE . 9.3 mt -62.04 -37.97 79.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.221 -0.659 . . . . 0.9 109.221 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.657 ' O ' HG12 ' A' ' 113' ' ' ILE . 72.8 ttt-85 -57.88 -47.2 83.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.845 -1.07 . . . . 2.19 110.357 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.93 -35.41 80.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.163 -0.471 . . . . 1.95 110.764 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.18 -43.34 97.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.053 0.454 . . . . 0.88 110.384 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.74 -41.0 96.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.077 -0.51 . . . . 0.92 110.309 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.657 HG12 ' O ' ' A' ' 109' ' ' ARG . 20.3 mm -64.49 -31.36 53.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.268 0.556 . . . . 1.33 109.733 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -69.25 -16.6 63.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.887 -0.597 . . . . 1.93 111.403 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.02 -5.63 47.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.406 -0.361 . . . . 1.1 111.389 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.8 4.11 29.98 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.462 -0.875 . . . . 1.15 112.616 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mm -80.41 138.07 20.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.698 -0.482 . . . . 1.61 109.698 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 39.1 mttt -75.12 150.82 38.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.657 -0.247 . . . . 2.73 110.452 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.3 -52.7 51.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.017 -0.611 . . . . 1.19 112.692 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.83 -20.76 65.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.62 0.23 . . . . 2.98 111.62 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 10.8 tp10 -68.41 -49.19 61.79 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.216 0.532 . . . . 2.52 109.747 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 82.8 t80 -67.3 -42.43 83.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.382 -0.826 . . . . 1.51 109.807 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.33 -42.04 90.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 2.3 111.048 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.79 -46.39 72.1 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.026 -0.533 . . . . 1.23 110.846 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.21 89.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 1.11 111.526 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -56.63 -30.54 63.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.349 -0.387 . . . . 1.31 111.321 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -111.22 23.07 14.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.35 -0.386 . . . . 1.63 110.834 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.8 m -91.63 149.54 21.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.963 0.411 . . . . 2.04 111.655 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -65.21 -40.87 94.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.58 . . . . 3.82 110.484 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 81.1 t -55.66 -50.0 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 1.53 110.559 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 77' ' ' ALA . 54.3 t -64.34 -46.88 91.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.666 -0.697 . . . . 1.11 111.091 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -55.57 -41.59 73.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.232 0.539 . . . . 2.43 110.919 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -68.05 -36.07 79.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.906 -0.588 . . . . 1.47 111.018 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.426 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 94.6 mt -67.39 -39.38 85.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.779 0.323 . . . . 0.93 110.657 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 81.2 t -60.29 -45.94 95.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.366 -0.379 . . . . 0.8 110.517 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.59 83.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.85 111.082 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -70.22 -34.32 72.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 1.39 110.627 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.46 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 47.6 mt-30 -63.99 -49.67 71.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.61 109.936 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.37 -33.7 76.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.496 -0.775 . . . . 2.82 110.207 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -67.01 -54.54 20.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.734 -0.666 . . . . 1.95 110.68 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.544 ' HB1' HD21 ' A' ' 23' ' ' LEU . . . -53.33 -48.23 68.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 0.65 112.22 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.29 94.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.934 0.397 . . . . 0.61 111.769 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.98 -31.98 39.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.007 0.373 . . . . 0.72 112.007 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -42.67 98.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.332 -0.394 . . . . 1.39 111.892 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 141' ' ' ALA . 35.3 m -85.6 -0.87 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.405 -0.361 . . . . 1.34 111.606 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 59.03 53.67 5.43 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.557 0.694 . . . . 1.95 109.989 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.5 tp -65.33 120.66 13.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.996 -1.002 . . . . 0.71 111.481 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -103.21 -34.32 8.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.063 -0.517 . . . . 4.16 110.085 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -95.93 -169.11 35.07 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 110.921 -0.872 . . . . 0.68 110.921 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.522 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 3.0 t -111.75 -56.85 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.304 -0.558 . . . . 0.49 111.435 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.522 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.1 Cg_endo -84.35 72.75 4.93 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.457 2.105 . . . . 0.56 111.701 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.5 144.78 46.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.051 -0.522 . . . . 0.63 110.922 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.2 ttm -121.47 133.02 55.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.165 -0.47 . . . . 0.42 110.102 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.95 124.65 43.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.213 -0.449 . . . . 0.52 109.92 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.33 117.1 32.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.889 0.376 . . . . 0.55 110.839 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 58.12 16.68 4.01 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.376 -0.829 . . . . 1.16 111.531 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.8 22.47 68.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.85 -0.691 . . . . 0.56 112.019 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -120.46 -42.06 2.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.08 0.467 . . . . 1.75 110.73 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -104.29 129.39 52.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 1.16 111.612 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -109.33 126.87 53.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.431 -0.804 . . . . 0.98 109.45 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.13 139.83 32.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.09 0.471 . . . . 1.2 111.09 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -114.33 100.91 53.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.872 -0.604 . . . . 0.72 109.91 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.58 -19.28 37.17 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.477 2.118 . . . . 0.54 112.568 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -80.9 -4.61 55.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.95 0.405 . . . . 2.22 110.674 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -115.3 26.99 8.77 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.808 -0.71 . . . . 0.59 112.004 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.3 mtt -115.12 166.93 11.28 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.656 -0.272 . . . . 0.57 110.349 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -71.48 100.34 2.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.147 0.499 . . . . 1.54 109.997 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.72 26.86 2.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.782 -0.644 . . . . 1.16 112.118 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.3 p -74.95 -35.47 62.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.452 0.644 . . . . 1.53 110.585 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.437 ' HB3' HG23 ' A' ' 173' ' ' VAL . 21.0 t30 -143.36 129.12 19.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.611 -0.722 . . . . 1.21 109.614 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 175' ' ' VAL . 1.9 mmm -56.74 -34.51 67.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 1.96 111.378 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -39.97 89.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.331 0.586 . . . . 2.05 110.48 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 170' ' ' ASN . 38.2 t -69.08 -43.65 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.65 -0.705 . . . . 0.65 110.551 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -53.5 -46.17 69.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.207 -0.906 . . . . 0.47 111.463 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 171' ' ' MET . 61.1 t -57.76 -51.48 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.416 . . . . 0.48 111.417 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 82.6 mm-40 -66.01 -44.8 83.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 1.7 111.458 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.495 HE21 ' HG2' ' A' ' 8' ' ' GLN . 52.8 tt0 -60.98 -45.68 93.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.653 -0.249 . . . . 1.32 111.17 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 182' ' ' VAL . 15.6 t80 -59.48 -53.04 62.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.877 0.37 . . . . 0.46 110.497 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.86 85.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.43 112.016 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 2.8 t0 -65.33 -36.56 84.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.046 0.45 . . . . 1.55 110.379 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 51.7 m -63.16 -42.46 99.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.868 -0.605 . . . . 0.48 109.925 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 178' ' ' TYR . 44.2 t -62.8 -42.49 96.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.158 -0.474 . . . . 0.48 110.33 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -62.37 -32.31 73.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.393 -0.821 . . . . 1.59 111.0 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.3 -46.3 20.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.278 -0.419 . . . . 1.17 110.817 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.58 -34.51 75.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.462 0.541 . . . . 0.68 112.462 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.5 p -71.61 -21.41 61.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.95 0.352 . . . . 1.07 111.95 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -103.7 -7.83 20.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.104 0.478 . . . . 2.26 110.703 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -79.49 -29.13 41.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.432 -0.803 . . . . 1.72 110.536 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.501 -0.761 . . . . 4.33 109.957 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SFQ . . . . . 0.558 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.757 0.313 . . . . 1.32 110.78 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -128.62 136.56 50.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.959 -0.564 . . . . 2.29 109.833 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.63 132.71 49.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 1.83 110.563 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.22 -14.07 55.13 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.866 -0.683 . . . . 0.78 111.917 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.5 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 41.2 tptt -115.38 -74.85 0.6 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.455 -0.202 . . . . 1.87 110.455 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -78.41 -41.73 32.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 1.46 111.027 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -136.85 164.28 28.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.307 -0.406 . . . . 0.79 110.156 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.24 123.84 18.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.136 -0.484 . . . . 0.9 110.284 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.9 m -76.9 127.95 33.67 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.854 -0.425 . . . . 1.11 109.854 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.55 140.97 37.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.813 0.339 . . . . 0.74 110.851 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -25.26 45.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.054 0.454 . . . . 2.33 110.01 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -109.35 90.16 8.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.642 -0.708 . . . . 3.64 109.244 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.24 148.72 30.95 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.525 2.15 . . . . 0.85 112.62 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.1 t -93.88 113.91 29.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.61 -0.723 . . . . 0.72 109.871 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.36 129.16 35.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.087 -0.506 . . . . 0.89 110.481 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.75 34.53 34.45 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.922 -0.656 . . . . 0.73 112.127 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.05 149.12 35.4 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.46 -0.2 . . . . 0.64 110.46 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.5 169.55 11.02 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.888 2.392 . . . . 0.56 112.711 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -65.84 -61.67 1.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.046 -0.524 . . . . 1.79 111.065 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.31 105.12 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.101 0.477 . . . . 0.45 110.747 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.7 tp -107.9 124.28 49.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.147 -0.479 . . . . 0.53 110.707 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -126.35 140.59 52.39 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.164 -0.471 . . . . 1.61 110.024 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -113.15 147.67 36.92 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.081 -0.34 . . . . 0.53 110.081 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.38 174.23 12.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.276 0.56 . . . . 0.55 111.396 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.2 t -153.62 139.26 17.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.439 -0.8 . . . . 0.96 109.079 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.498 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 97.3 m-85 -72.5 -15.0 61.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.947 0.404 . . . . 0.62 110.607 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CE1' ' HA2' ' A' ' 69' ' ' GLY . 79.3 m-85 -89.19 -0.53 57.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.549 . . . . 1.78 110.419 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 49.3 t -108.25 112.61 61.15 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.954 -0.566 . . . . 0.48 111.104 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 18.1 Cg_endo -63.55 -23.85 70.41 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.372 2.048 . . . . 0.7 110.935 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -66.63 -28.71 68.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.459 -0.792 . . . . 1.74 109.932 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.46 -38.46 34.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.627 -0.509 . . . . 0.37 109.627 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -59.95 -38.15 81.6 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.259 0.552 . . . . 1.44 109.693 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.636 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 7.7 tt0 -66.7 -39.87 88.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.589 -0.732 . . . . 2.27 110.785 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -78.39 -26.4 46.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.556 -0.293 . . . . 0.87 111.333 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 3.6 tp10 -83.64 -55.02 4.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.529 0.566 . . . . 1.89 112.529 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.95 -48.54 6.47 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.929 0.714 . . . . 2.0 112.929 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 99.7 t -64.62 -54.61 28.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 121.75 -0.594 . . . . 0.58 111.608 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.9 mt -91.59 -31.39 15.91 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.536 0.569 . . . . 0.41 112.536 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 23.9 m-70 59.71 45.08 13.35 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.079 0.466 . . . . 0.84 110.017 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 46' ' ' VAL . 44.3 mm -55.8 -55.55 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.599 -0.728 . . . . 0.41 111.055 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 m -53.48 -47.76 69.52 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.502 0.501 . . . . 1.03 111.708 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.84 -43.97 97.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.513 -0.312 . . . . 1.73 111.226 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -65.24 -44.32 88.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.127 -0.488 . . . . 1.19 110.781 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.671 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 75.4 t -61.81 -47.1 94.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.984 -0.553 . . . . 0.49 110.638 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -53.57 -31.49 46.92 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.284 0.475 . . . . 1.53 112.284 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -89.67 -26.23 20.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.3 0.481 . . . . 2.02 112.3 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 55.2 mttt -84.79 -17.44 38.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.746 0.308 . . . . 1.44 111.568 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 86.4 mt -71.54 136.72 83.45 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.553 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.0 161.44 46.09 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.416 2.077 . . . . 0.74 111.968 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 128.87 38.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.944 0.402 . . . . 2.63 111.368 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.6 -17.06 23.59 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.824 -0.625 . . . . 0.82 112.093 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -98.4 122.01 49.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.642 0.258 . . . . 1.03 110.622 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -104.52 152.65 22.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.03 -0.359 . . . . 2.51 110.03 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.4 ' HG2' ' N ' ' A' ' 57' ' ' THR . 9.9 ttt -103.82 151.99 22.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.858 0.361 . . . . 1.28 110.318 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.4 ' N ' ' HG2' ' A' ' 56' ' ' MET . 0.0 OUTLIER -136.79 124.74 22.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.013 -0.539 . . . . 0.61 110.066 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -114.43 119.4 36.76 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.548 -0.538 . . . . 0.86 109.548 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CD2' ' HA ' ' A' ' 138' ' ' GLN . 8.0 m-30 -111.21 151.45 28.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.268 0.556 . . . . 0.71 111.873 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -102.25 130.26 48.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.383 -0.826 . . . . 0.57 109.855 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 m -86.78 159.42 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 111.475 0.176 . . . . 0.68 111.475 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.648 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 41.0 m-20 -107.62 -1.39 21.21 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.452 0.538 . . . . 0.93 112.452 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -96.35 10.68 37.29 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.681 -0.407 . . . . 0.74 111.543 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.86 102.06 4.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.839 0.352 . . . . 1.09 110.398 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.99 7.88 0.69 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.675 -0.693 . . . . 0.78 112.258 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.31 -116.64 8.18 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.941 -0.647 . . . . 0.81 112.408 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.48 -50.69 5.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.884 0.373 . . . . 2.47 111.0 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.52 -15.01 56.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.927 -0.579 . . . . 1.94 111.492 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.426 ' HA2' ' CE1' ' A' ' 29' ' ' PHE . . . -56.87 -31.97 61.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.087 -0.578 . . . . 0.7 112.548 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.648 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 85.2 mttt -74.91 -38.5 61.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.39 . . . . 2.69 110.794 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.34 -40.88 97.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 1.65 111.021 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.89 -26.66 65.22 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.876 -0.33 . . . . 1.17 111.229 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.2 m -66.88 -35.74 80.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.328 0.585 . . . . 0.62 109.492 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -73.48 -41.32 63.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 1.21 109.625 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.96 -41.54 99.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.542 -0.753 . . . . 0.71 110.76 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -61.01 -36.77 80.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.075 -0.511 . . . . 0.59 110.778 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.12 -39.04 93.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.71 110.111 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.81 -41.54 90.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.028 -0.533 . . . . 0.84 109.923 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.85 81.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.87 -0.605 . . . . 0.66 110.892 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.7 mtm -69.12 -36.4 77.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.736 -0.665 . . . . 1.08 110.79 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.68 -35.84 65.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.4 -0.363 . . . . 0.99 111.686 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.19 -28.14 38.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.97 110.947 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.93 29.38 18.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.87 -0.681 . . . . 0.78 112.77 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 m -120.93 25.38 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.071 0.462 . . . . 0.81 110.329 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -59.21 -52.19 66.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.451 -0.795 . . . . 1.71 111.443 -178.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.426 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 2.7 t70 -61.77 -39.45 91.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.466 0.65 . . . . 1.91 110.883 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -65.41 -34.89 79.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.432 -0.804 . . . . 2.28 111.86 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.2 m -94.43 -9.38 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.608 0.596 . . . . 0.65 112.608 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.5 m -56.72 -48.54 77.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.98 111.867 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.412 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 99.0 t -65.45 -59.61 9.22 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.349 0.5 . . . . 0.62 112.349 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.412 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 11.7 Cg_endo -55.76 -36.45 95.18 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.216 1.944 . . . . 0.61 113.164 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.45 -42.84 78.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.736 0.303 . . . . 0.79 110.747 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -64.55 -45.27 87.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.537 . . . . 0.58 110.309 179.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.15 -46.97 78.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.759 -0.655 . . . . 1.7 111.409 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.77 -9.14 55.42 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 116.149 -0.478 . . . . 0.82 114.147 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.5 t -109.71 -36.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 117.346 0.573 . . . . 0.75 111.919 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -104.42 -40.69 5.98 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.243 0.831 . . . . 0.84 113.243 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -83.02 -68.14 0.73 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.883 0.373 . . . . 1.41 111.306 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.46 -35.68 53.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.736 0.303 . . . . 1.31 111.045 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 60.65 29.99 19.4 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.752 -0.658 . . . . 1.44 110.72 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.79 -28.52 44.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.914 -0.584 . . . . 1.57 111.085 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 85.7 mt -74.85 101.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.266 -0.424 . . . . 0.91 110.182 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -116.24 -33.11 5.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 3.22 111.134 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.5 p -118.45 169.7 9.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.115 -0.493 . . . . 1.51 110.565 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.01 -28.61 69.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.413 0.625 . . . . 1.08 109.91 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -31.43 72.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.289 -0.869 . . . . 1.43 110.081 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -71.78 -36.27 70.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.651 -0.704 . . . . 1.89 110.231 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 mt -68.76 -42.07 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.815 -0.63 . . . . 0.9 109.696 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -57.4 -40.18 77.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.236 -0.893 . . . . 2.19 110.066 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.74 -38.15 86.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.549 -0.75 . . . . 1.95 111.734 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.13 -44.91 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.88 110.803 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -64.44 -40.1 95.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.92 110.865 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 83.6 mt -63.71 -38.3 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.129 0.49 . . . . 1.33 110.379 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -70.56 -31.2 68.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 1.93 110.981 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.76 -31.11 69.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 1.1 110.714 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.02 -0.26 3.25 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.762 -0.733 . . . . 1.15 112.732 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 45.3 mm -86.28 127.52 40.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.031 -0.359 . . . . 1.61 110.031 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -68.35 139.27 55.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.234 -0.284 . . . . 2.73 110.234 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.88 -43.56 81.61 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.926 -0.579 . . . . 1.19 112.497 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.25 -46.78 88.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.683 0.278 . . . . 2.98 110.912 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -62.84 -45.42 92.68 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.123 0.487 . . . . 2.52 110.195 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -63.58 -48.33 77.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.662 -0.699 . . . . 1.51 110.876 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.65 -35.33 79.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 2.3 110.906 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.71 91.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.039 0.447 . . . . 1.23 109.97 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.48 -33.32 60.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.692 -0.686 . . . . 1.11 110.065 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -60.24 -31.51 70.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.478 0.656 . . . . 1.31 110.179 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -104.42 20.77 17.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.384 -0.825 . . . . 1.63 110.909 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.1 m -93.95 144.79 25.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.06 0.457 . . . . 2.04 111.67 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -65.74 -35.57 81.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.487 -0.779 . . . . 3.82 110.61 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 134' ' ' LEU . 63.4 t -53.73 -46.51 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 1.53 110.797 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 77' ' ' ALA . 75.8 t -67.49 -40.72 84.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.677 -0.692 . . . . 1.11 110.774 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -57.83 -46.33 84.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 2.43 111.117 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.3 m -66.16 -29.98 70.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.283 -0.417 . . . . 1.47 110.658 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 130' ' ' VAL . 86.4 mt -68.44 -40.67 81.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.853 -0.425 . . . . 0.93 109.853 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.467 ' HA ' HE21 ' A' ' 138' ' ' GLN . 62.1 t -62.02 -44.03 98.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.99 -0.55 . . . . 0.8 110.21 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.76 99.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.738 -0.664 . . . . 0.85 111.046 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -66.55 -35.0 79.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.169 -0.469 . . . . 1.39 111.66 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.467 HE21 ' HA ' ' A' ' 135' ' ' VAL . 46.0 mt-30 -58.93 -53.22 60.84 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.879 0.371 . . . . 0.61 111.026 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HG3' HD22 ' A' ' 62' ' ' ASN . 4.2 mm-40 -72.15 -36.51 69.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 2.82 110.976 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -58.37 -44.17 88.76 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.75 0.31 . . . . 1.95 110.912 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -61.4 -44.76 96.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.955 -0.566 . . . . 0.65 110.77 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.14 90.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.61 111.366 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.19 -25.74 60.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 0.72 111.247 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.76 -36.12 32.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.272 -0.422 . . . . 1.39 111.261 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 141' ' ' ALA . 31.0 m -89.13 2.69 6.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.477 0.18 . . . . 1.34 111.373 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.417 ' HB3' ' NH2' ' A' ' 148' ' ' ARG . 38.5 mt-30 57.48 51.7 9.44 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.056 -0.52 . . . . 1.95 110.322 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.5 tp -54.57 120.39 6.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.71 111.982 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.448 HH11 ' HD3' ' A' ' 148' ' ' ARG . 28.0 mmt180 -98.17 -45.94 6.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.93 -0.577 . . . . 4.16 110.713 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -107.9 161.16 13.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.106 -0.797 . . . . 0.68 111.106 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.506 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 2.4 t -68.95 -55.66 10.26 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.867 0.334 . . . . 0.49 111.73 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.506 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 5.9 Cg_endo -89.16 98.78 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.449 2.099 . . . . 0.56 112.123 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.51 151.23 40.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.261 -0.427 . . . . 0.63 110.645 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 34.9 ttm -122.92 133.95 54.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.04 -0.527 . . . . 0.42 110.805 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -123.02 129.83 52.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.72 -0.673 . . . . 0.52 109.543 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 185' ' ' LEU . 40.1 t -101.3 118.32 47.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.917 0.389 . . . . 0.55 111.498 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.55 ' O ' ' HD3' ' A' ' 158' ' ' LYS . 28.6 m-20 58.8 17.88 5.58 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.028 -0.987 . . . . 1.16 112.178 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.4 24.75 67.88 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.039 -0.601 . . . . 0.56 112.14 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.55 ' HD3' ' O ' ' A' ' 156' ' ' ASN . 5.9 mppt? -126.45 -47.66 1.57 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.17 0.509 . . . . 1.75 111.218 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -101.47 126.59 48.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.866 -0.606 . . . . 1.16 111.475 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -103.83 138.47 40.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.453 -0.794 . . . . 0.98 109.865 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 mp -93.41 139.9 30.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.888 0.375 . . . . 1.2 111.163 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -118.07 109.91 40.4 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.72 110.547 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.44 -18.76 19.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.689 2.259 . . . . 0.54 112.712 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -83.56 -0.03 48.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.151 0.501 . . . . 2.22 110.924 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -117.19 22.07 10.56 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.981 -0.628 . . . . 0.59 111.644 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 47.1 mtt -120.53 -174.34 2.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.104 -0.332 . . . . 0.57 110.104 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.23 125.05 25.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.863 0.363 . . . . 1.54 110.114 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.25 31.78 6.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.444 0.64 . . . . 1.16 109.767 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -37.01 5.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.287 -0.87 . . . . 1.53 110.739 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -128.09 118.78 24.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 1.21 110.583 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.514 ' O ' HG23 ' A' ' 175' ' ' VAL . 10.3 mmt -54.08 -41.72 68.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.458 -0.792 . . . . 1.96 111.624 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -57.5 -46.85 83.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.837 0.351 . . . . 2.05 111.272 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.73 -46.87 90.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.948 -0.569 . . . . 0.65 110.755 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -54.29 -49.67 69.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.578 -0.283 . . . . 0.47 111.659 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 171' ' ' MET . 60.9 t -60.9 -45.08 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 0.48 111.552 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -70.7 -41.77 71.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.314 -0.403 . . . . 1.7 111.631 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -63.83 -42.38 97.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.513 . . . . 1.32 110.685 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.561 ' O ' HG23 ' A' ' 182' ' ' VAL . 21.4 t80 -59.57 -54.16 49.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.98 -0.555 . . . . 0.46 110.062 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.2 -34.01 75.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.73 -0.668 . . . . 0.43 111.395 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.8 -36.78 81.05 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.406 -0.361 . . . . 1.55 110.569 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.616 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 24.7 m -67.6 -41.71 83.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.48 109.97 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 178' ' ' TYR . 41.0 t -58.14 -50.4 78.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.022 -0.536 . . . . 0.48 110.389 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -59.93 -42.65 94.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.468 -0.787 . . . . 1.59 111.369 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -60.38 -42.96 96.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.326 -0.397 . . . . 1.17 110.537 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 181' ' ' THR . 53.8 mt -70.04 -33.92 72.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.68 110.712 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 25.4 m -66.94 -39.44 87.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.217 0.532 . . . . 1.07 110.188 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.687 -0.688 . . . . 2.26 110.294 179.343 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.009 0.433 . . . . 1.32 110.695 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -108.96 142.5 39.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.954 -0.566 . . . . 2.29 110.878 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.06 125.52 26.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.601 -0.727 . . . . 1.83 109.942 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.25 -20.38 35.43 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.992 -0.623 . . . . 0.78 111.96 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -109.12 -74.73 0.65 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.74 -0.27 . . . . 1.87 110.466 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -75.76 -43.53 46.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.27 -0.423 . . . . 1.46 110.904 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -138.54 154.21 48.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.79 110.302 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.89 133.19 54.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.283 -0.417 . . . . 0.9 111.046 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 m -84.52 127.42 34.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.278 -0.419 . . . . 1.11 111.711 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.78 137.02 34.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.602 -0.518 . . . . 0.74 109.602 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -75.68 -29.09 58.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 2.33 110.513 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -113.05 90.17 15.38 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 3.64 109.89 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.4 143.26 19.38 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.427 2.085 . . . . 0.85 112.593 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 19' ' ' ALA . 47.7 t -76.61 127.44 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.51 -0.768 . . . . 0.72 111.412 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.06 121.28 26.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.06 -0.518 . . . . 0.89 110.557 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.0 19.94 44.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.72 . . . . 0.73 111.995 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . . . -75.02 145.78 81.46 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.647 -0.277 . . . . 0.64 111.239 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.68 165.95 31.29 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.444 2.096 . . . . 0.56 111.985 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -56.62 -60.73 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 1.79 111.487 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.96 102.67 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.987 0.423 . . . . 0.45 110.539 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 47.3 tp -98.64 138.32 35.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.835 -0.62 . . . . 0.53 109.849 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -145.88 154.33 41.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.651 0.263 . . . . 1.61 110.799 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -130.04 157.6 41.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.066 -0.516 . . . . 0.53 110.343 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -168.38 177.5 5.32 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.089 -0.505 . . . . 0.55 110.554 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.5 t -156.75 132.87 9.74 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.96 110.849 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.493 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.9 m-85 -71.13 -16.71 62.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.834 -0.621 . . . . 0.62 109.826 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.491 ' CE2' ' HA2' ' A' ' 69' ' ' GLY . 97.1 m-85 -85.66 -4.0 59.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.567 -0.742 . . . . 1.78 111.32 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 53.3 t -115.49 122.63 32.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.393 -0.367 . . . . 0.48 110.764 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -65.94 -23.87 53.96 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.412 2.075 . . . . 0.7 112.027 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -60.49 -38.93 85.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 1.74 110.099 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.2 m -71.67 -34.77 69.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.998 -0.546 . . . . 0.37 110.725 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.88 -44.31 96.44 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.124 0.487 . . . . 1.44 110.455 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.467 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 13.8 tt0 -66.48 -36.58 83.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.526 . . . . 2.27 110.357 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -77.5 -25.82 50.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.067 -0.515 . . . . 0.87 111.46 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 4.4 tp10 -84.25 -50.61 7.71 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.599 0.592 . . . . 1.89 112.599 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.584 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 10.1 tp10 -97.37 -46.21 6.17 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.356 0.873 . . . . 2.0 113.356 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 48.8 t -69.68 -51.8 37.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.051 -0.659 . . . . 0.58 110.921 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 mt -86.52 -35.56 19.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.258 -0.428 . . . . 0.41 111.764 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.584 ' HD2' ' O ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER 60.63 41.62 15.04 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.59 -0.522 . . . . 0.84 109.59 -178.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.631 ' O ' HG23 ' A' ' 46' ' ' VAL . 42.7 mm -53.77 -68.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.845 -0.616 . . . . 0.41 112.169 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 1.4 m -51.92 -45.63 64.34 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.345 0.403 . . . . 1.03 111.943 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 30.5 t70 -65.69 -29.66 70.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.888 -0.596 . . . . 1.73 111.583 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 2.2 t-20 -77.73 -37.14 49.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 1.19 110.217 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 42' ' ' ILE . 43.2 t -60.32 -35.48 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.935 -0.575 . . . . 0.49 110.637 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 43' ' ' SER . 51.8 mttt -56.71 -36.65 69.92 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.393 -0.367 . . . . 1.53 111.44 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -77.72 -10.32 59.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 2.02 112.089 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -102.07 -32.95 9.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.475 -0.33 . . . . 1.44 110.759 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.448 HD22 HG11 ' A' ' 54' ' ' VAL . 91.4 mt -68.92 129.88 91.97 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.77 -171.43 0.86 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.645 2.23 . . . . 0.74 112.625 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -67.86 148.75 50.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 2.63 111.128 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.54 -19.03 30.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.934 -0.651 . . . . 0.82 113.195 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 50' ' ' LEU . 5.8 t -89.72 132.8 33.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.106 0.479 . . . . 1.03 110.749 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -131.41 141.76 49.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.98 -0.554 . . . . 2.51 110.265 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 84.2 mtp -90.88 134.3 34.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 1.28 110.999 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.02 94.36 4.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.232 0.539 . . . . 0.61 110.167 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -92.08 118.37 30.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.737 -0.665 . . . . 0.86 110.665 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 9.5 m-30 -113.62 167.56 10.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 0.71 110.897 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -103.24 133.62 48.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.405 -0.361 . . . . 0.57 110.795 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.8 149.27 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 0.68 110.314 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -109.42 27.24 9.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.856 0.36 . . . . 0.93 111.688 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -133.65 15.57 4.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.014 0.435 . . . . 0.74 110.995 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -137.92 103.23 4.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.15 -0.477 . . . . 1.09 110.073 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.63 9.33 2.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.602 -0.808 . . . . 0.78 112.534 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.76 -140.46 34.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.879 -0.676 . . . . 0.81 112.373 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.83 -34.34 33.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.036 0.446 . . . . 2.47 110.048 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.3 tp -67.35 -22.31 65.59 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.772 -0.649 . . . . 1.94 110.256 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.491 ' HA2' ' CE2' ' A' ' 29' ' ' PHE . . . -58.88 -37.05 90.16 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.671 -0.695 . . . . 0.7 111.876 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -68.66 -32.16 71.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.776 0.322 . . . . 2.69 110.776 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -40.49 97.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 1.65 110.265 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.476 ' HG ' HD13 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -71.83 -26.57 62.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.089 -0.505 . . . . 1.17 110.459 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -62.57 -33.59 75.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.304 0.574 . . . . 0.62 109.759 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -77.84 -37.43 48.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.438 -0.801 . . . . 1.21 109.48 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.17 85.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.569 -0.741 . . . . 0.71 111.318 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -59.67 -36.43 76.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.111 -0.495 . . . . 0.59 110.597 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.84 -36.27 83.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.11 -0.495 . . . . 0.71 110.083 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.1 -43.05 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.677 -0.692 . . . . 0.84 110.013 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.36 90.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.794 -0.639 . . . . 0.66 110.938 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 71.6 mtm -66.84 -35.66 80.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.95 -0.568 . . . . 1.08 110.652 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.33 -36.57 68.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.893 0.377 . . . . 0.99 110.882 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 mt -75.62 -44.22 43.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.22 -0.446 . . . . 0.97 110.763 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.69 37.38 3.72 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.272 -0.731 . . . . 0.78 111.272 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.27 29.11 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.966 0.413 . . . . 0.81 110.179 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.87 -65.76 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.281 -0.872 . . . . 1.71 112.158 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.31 -28.99 67.3 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.334 -0.394 . . . . 1.91 111.218 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -66.65 -44.68 81.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.815 -0.629 . . . . 2.28 111.474 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.81 -8.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.886 0.328 . . . . 0.65 111.886 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.6 m -58.25 -49.13 78.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.721 0.267 . . . . 0.98 111.721 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.44 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 46.3 t -61.36 -59.86 12.3 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.383 0.512 . . . . 0.62 112.383 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.44 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 12.2 Cg_endo -56.13 -34.19 92.26 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.198 1.932 . . . . 0.61 113.232 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.1 mt -70.8 -40.7 72.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.715 0.293 . . . . 0.79 110.719 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -64.24 -48.13 76.98 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.231 0.539 . . . . 0.58 110.442 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.9 -35.87 74.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.534 -0.757 . . . . 1.7 111.248 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.72 -25.69 70.59 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.917 -0.658 . . . . 0.82 113.106 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 64.7 t -100.65 -39.43 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.491 0.552 . . . . 0.75 112.491 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -94.57 -42.94 8.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.717 1.006 . . . . 0.84 113.717 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -78.97 -62.49 1.68 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.977 0.362 . . . . 1.41 111.977 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.04 -39.41 25.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.112 -0.494 . . . . 1.31 112.162 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 66.08 26.89 10.66 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.066 0.46 . . . . 1.44 110.288 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.33 -33.76 32.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.894 -0.594 . . . . 1.57 111.346 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.25 102.51 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.917 -0.583 . . . . 0.91 110.461 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mmm-85 -119.14 -8.12 10.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.848 -0.615 . . . . 3.22 110.448 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 m -149.77 172.59 14.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.226 -0.443 . . . . 1.51 110.696 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.8 -20.72 66.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.24 -0.436 . . . . 1.08 110.816 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -44.72 96.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.006 -0.543 . . . . 1.43 110.562 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 111' ' ' VAL . 13.2 m-20 -67.07 -40.29 87.03 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.98 -0.554 . . . . 1.89 109.851 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.476 HD13 ' HG ' ' A' ' 72' ' ' LEU . 54.6 mt -61.05 -46.1 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.654 -0.703 . . . . 0.9 110.171 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 113' ' ' ILE . 62.8 ttt180 -60.28 -41.22 92.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.943 -0.572 . . . . 2.19 109.723 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -59.48 -39.66 84.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.306 -0.861 . . . . 1.95 110.667 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 107' ' ' ASP . 73.2 t -60.09 -42.41 89.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.88 110.661 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -65.35 -39.75 92.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.92 110.457 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 65.7 mt -64.95 -33.77 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.316 0.579 . . . . 1.33 109.763 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -73.91 -8.39 55.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.541 -0.754 . . . . 1.93 110.654 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.32 2.57 42.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.07 -0.514 . . . . 1.1 110.311 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.81 39.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.821 -0.705 . . . . 1.15 113.193 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 38.2 mm -98.23 133.35 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.123 -0.325 . . . . 1.61 110.123 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -73.76 146.86 43.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.26 -0.427 . . . . 2.73 111.468 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.3 -35.27 91.32 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.894 -0.669 . . . . 1.19 112.024 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.53 -45.69 78.62 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.952 -0.388 . . . . 2.98 109.952 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -60.93 -45.08 96.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.552 -0.749 . . . . 2.52 109.686 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.411 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 53.9 t80 -63.05 -41.87 99.59 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.76 -0.655 . . . . 1.51 110.479 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.63 -44.15 93.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.831 0.348 . . . . 2.3 110.852 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.84 79.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 1.23 111.119 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.02 83.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 1.11 111.088 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -57.96 -36.92 73.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.308 -0.405 . . . . 1.31 111.074 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -109.58 32.04 5.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.371 -0.377 . . . . 1.63 111.47 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.9 p -92.09 157.75 16.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.766 0.317 . . . . 2.04 110.215 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -74.06 -32.46 63.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.556 -0.293 . . . . 3.82 110.359 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.3 t -58.4 -45.49 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.989 0.423 . . . . 1.53 110.181 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 135' ' ' VAL . 15.5 t -61.89 -38.48 80.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.561 -0.745 . . . . 1.11 110.537 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -56.43 -50.72 70.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 2.43 110.976 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -32.03 72.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 1.47 111.051 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.38 -32.43 66.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.93 110.773 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.453 ' HA ' HE21 ' A' ' 138' ' ' GLN . 70.1 t -67.31 -47.03 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.8 110.073 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.08 85.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 0.85 111.233 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -64.12 -32.42 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.512 -0.313 . . . . 1.39 111.34 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.453 HE21 ' HA ' ' A' ' 135' ' ' VAL . 50.5 mt-30 -66.43 -42.27 87.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.409 -0.359 . . . . 0.61 110.551 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.41 -37.97 50.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 2.82 110.803 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 31.7 tttp -54.34 -50.26 67.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.325 -0.398 . . . . 1.95 110.809 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -66.37 -46.55 76.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.162 -0.472 . . . . 0.65 111.522 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.65 83.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 0.61 112.104 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.81 -27.21 61.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.52 0.563 . . . . 0.72 112.52 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 3.3 t0 -78.12 -31.35 49.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.856 0.317 . . . . 1.39 111.856 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 141' ' ' ALA . 32.6 m -92.47 3.14 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.151 0.426 . . . . 1.34 112.151 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 60.4 51.6 5.23 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.262 0.553 . . . . 1.95 110.155 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.9 tp -62.18 106.61 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.479 -0.782 . . . . 0.71 111.404 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -104.19 -1.79 26.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.804 -0.635 . . . . 4.16 110.811 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -133.39 179.78 17.08 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.847 -0.692 . . . . 0.68 112.014 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.501 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 0.2 OUTLIER -97.85 -61.85 0.12 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 117.033 0.416 . . . . 0.49 111.411 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 3.9 Cg_endo -85.78 65.74 5.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.641 2.227 . . . . 0.56 111.814 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -109.35 138.7 45.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.63 110.67 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 29.4 ttm -115.62 137.98 51.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.947 -0.57 . . . . 0.42 110.168 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -127.74 131.31 49.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 0.52 110.392 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.59 117.79 45.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.573 -0.285 . . . . 0.55 110.705 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 60.63 13.87 4.57 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.733 -0.667 . . . . 1.16 111.601 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.31 23.99 68.7 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.047 -0.597 . . . . 0.56 111.759 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -124.65 -44.37 1.97 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.075 0.464 . . . . 1.75 110.758 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -102.1 125.13 48.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.936 -0.575 . . . . 1.16 110.604 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -105.68 138.85 41.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.196 -0.456 . . . . 0.98 109.862 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.6 mp -90.18 139.15 30.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.535 0.207 . . . . 1.2 110.726 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -114.9 113.12 44.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.43 . . . . 0.72 110.854 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.77 6.86 5.21 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.924 2.416 . . . . 0.54 112.56 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -113.33 20.98 15.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.323 -0.399 . . . . 2.22 110.763 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.11 33.39 1.92 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.02 -0.609 . . . . 0.59 111.935 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.9 mtt -124.84 -176.51 3.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.474 0.178 . . . . 0.57 110.542 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.05 127.58 32.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.138 0.494 . . . . 1.54 111.57 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 16.2 16.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.835 -0.621 . . . . 1.16 110.835 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -32.42 14.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.159 0.504 . . . . 1.53 110.401 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -139.42 125.16 19.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.04 -0.527 . . . . 1.21 110.127 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.414 ' O ' HG23 ' A' ' 175' ' ' VAL . 56.4 ttm -62.37 -32.94 73.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.63 . . . . 1.96 111.443 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -63.32 -37.28 86.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.174 -0.466 . . . . 2.05 111.027 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.68 -41.83 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.65 110.509 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.84 -50.09 71.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.47 111.122 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 171' ' ' MET . 57.8 t -57.61 -51.09 74.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.48 111.688 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -42.12 83.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.995 -0.548 . . . . 1.7 112.119 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -62.09 -45.61 92.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.657 0.265 . . . . 1.32 110.979 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -57.71 -52.18 66.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.46 110.635 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.01 82.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.43 112.105 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.65 -32.95 73.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.646 0.26 . . . . 1.55 110.516 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 35.4 m -63.14 -40.07 96.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.48 110.188 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.38 -52.92 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.269 0.557 . . . . 0.48 110.227 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -57.44 -39.83 77.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.961 -1.018 . . . . 1.59 111.007 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -64.51 -46.24 83.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.889 -0.596 . . . . 1.17 110.819 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.0 mt -66.56 -39.81 88.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.088 -0.506 . . . . 0.68 112.06 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.9 p -66.31 -23.75 66.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.038 0.447 . . . . 1.07 111.276 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.226 0.536 . . . . 2.26 110.338 179.606 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.757 0.313 . . . . 1.32 110.983 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -119.35 140.67 49.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.943 -0.571 . . . . 2.29 109.891 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -69.3 119.12 13.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.083 0.468 . . . . 1.83 110.036 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.56 -16.38 29.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.995 -0.842 . . . . 0.78 110.995 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.464 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 50.6 tptt -99.13 -80.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.637 -0.281 . . . . 1.87 110.57 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -86.79 -25.37 24.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 1.46 111.381 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -143.49 152.74 41.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.189 -0.3 . . . . 0.79 110.189 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 m -128.54 132.08 48.26 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.21 0.319 . . . . 0.9 110.639 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.4 m -75.68 125.56 29.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.362 -0.381 . . . . 1.11 110.175 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.26 127.31 32.26 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.792 0.329 . . . . 0.74 110.526 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.09 -39.46 93.21 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.627 -0.715 . . . . 2.33 110.33 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -122.18 84.01 45.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 3.64 109.893 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.36 155.11 70.43 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.485 2.124 . . . . 0.85 112.191 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.5 t -89.4 131.84 35.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.036 -0.529 . . . . 0.72 110.713 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.81 137.8 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.107 -0.497 . . . . 0.89 110.323 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.9 25.24 74.34 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.73 -0.748 . . . . 0.73 112.382 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.26 143.52 31.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.436 -0.209 . . . . 0.64 110.436 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 30.1 Cg_endo -66.27 162.05 37.79 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.373 2.049 . . . . 0.56 112.704 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -62.68 -44.92 95.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.612 -0.722 . . . . 1.79 110.705 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.8 t -120.52 100.77 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.702 -0.481 . . . . 0.45 109.702 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.418 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 26.5 tp -110.92 110.78 21.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.951 -0.568 . . . . 0.53 110.423 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -120.12 145.76 46.61 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.426 -0.352 . . . . 1.61 110.215 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 151' ' ' PRO . 97.2 m-85 -123.23 154.63 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.309 -0.405 . . . . 0.53 110.114 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -170.24 177.99 3.97 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.005 0.431 . . . . 0.55 110.786 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.1 t -156.91 141.58 16.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 0.96 110.51 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.539 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 96.0 m-85 -73.4 -20.49 60.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.9 -0.591 . . . . 0.62 110.502 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CE2' HD12 ' A' ' 72' ' ' LEU . 72.6 m-85 -85.35 -1.32 56.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.78 110.339 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.47 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 48.1 t -107.19 112.34 62.98 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.019 -0.537 . . . . 0.48 111.133 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -64.2 -24.54 65.61 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.216 1.944 . . . . 0.7 111.283 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -66.32 -29.37 69.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.369 -0.832 . . . . 1.74 110.236 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.0 m -83.66 -32.02 25.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.47 -0.567 . . . . 0.37 109.47 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.77 -49.1 79.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.304 -0.862 . . . . 1.44 110.063 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.505 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 22.5 tt0 -68.35 -32.34 72.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 2.27 110.726 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.404 ' O ' HG12 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -66.66 -30.84 71.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.481 0.549 . . . . 0.87 112.481 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -108.65 -50.11 3.07 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.993 0.738 . . . . 1.89 112.993 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.63 -25.51 64.87 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.953 -0.467 . . . . 2.0 111.659 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 91.5 t -107.72 -56.44 4.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.796 -0.362 . . . . 0.58 111.498 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.8 mt -81.05 -33.55 33.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.928 0.344 . . . . 0.41 111.928 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 0.6 OUTLIER 58.9 63.45 1.64 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.848 0.459 . . . . 0.84 111.003 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 36' ' ' PHE . 49.1 mm -71.36 -50.87 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.902 -0.59 . . . . 0.41 111.165 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 m -58.3 -49.33 77.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.314 -0.403 . . . . 1.03 110.999 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 26.0 t70 -61.26 -45.03 96.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.549 . . . . 1.73 110.888 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 0.7 OUTLIER -62.41 -41.56 98.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 1.19 110.794 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 39.6 t -66.44 -42.44 90.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.49 110.541 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.93 -31.63 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.738 0.304 . . . . 1.53 111.37 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 30.3 mttm -86.68 3.13 46.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.261 -0.427 . . . . 2.02 111.679 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -136.97 23.59 3.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 1.44 111.007 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 13.9 mt -99.73 145.5 30.25 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.383 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 50' ' ' LEU . 10.4 Cg_exo -70.21 165.48 31.34 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.718 2.279 . . . . 0.74 111.422 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.25 139.97 50.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.998 -0.546 . . . . 2.63 110.368 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.23 -9.15 78.03 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.931 -0.652 . . . . 0.82 112.118 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.95 98.63 7.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.853 0.359 . . . . 1.03 110.263 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.6 124.96 31.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.141 -0.481 . . . . 2.51 110.165 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -72.97 127.97 34.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.646 -0.501 . . . . 1.28 109.646 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 119.48 34.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.949 0.404 . . . . 0.61 110.757 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HD3' ' CE1' ' A' ' 26' ' ' PHE . 15.2 ttmm -114.04 119.57 37.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.86 110.16 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 13.1 m-30 -110.28 160.51 16.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.135 0.493 . . . . 0.71 111.55 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -104.85 134.76 47.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.661 -0.699 . . . . 0.57 110.618 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.424 HG21 HG13 ' A' ' 150' ' ' VAL . 16.7 m -88.7 155.05 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.587 -0.279 . . . . 0.68 110.61 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -105.21 -6.1 20.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.632 0.604 . . . . 0.93 112.632 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -89.97 15.5 9.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.427 0.632 . . . . 0.74 110.79 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -144.32 88.87 1.97 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.458 -0.792 . . . . 1.09 109.61 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.15 -7.27 0.29 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 121.09 -0.576 . . . . 0.78 112.547 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.44 -134.61 22.83 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.556 -0.831 . . . . 0.81 112.333 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -22.8 40.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.649 0.262 . . . . 2.47 110.793 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 tp -85.6 -11.62 53.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.097 0.475 . . . . 1.94 110.318 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.75 98.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.772 -0.727 . . . . 0.7 111.961 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -62.9 -40.09 96.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.067 0.461 . . . . 2.69 110.552 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.79 -49.06 79.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.678 -0.692 . . . . 1.65 111.158 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.549 HD12 ' CE2' ' A' ' 29' ' ' PHE . 1.7 mt -66.29 -22.77 66.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 1.17 111.6 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 m -69.71 -40.39 76.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.917 0.389 . . . . 0.62 110.098 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -72.37 -38.91 68.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.98 -0.748 . . . . 1.21 108.98 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.88 99.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.418 -0.81 . . . . 0.71 110.935 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.441 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 66.6 t-105 -62.69 -38.21 89.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.735 -0.666 . . . . 0.59 110.714 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -61.13 -38.48 86.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.71 110.39 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.05 -41.73 92.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.121 0.486 . . . . 0.84 109.801 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.7 88.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.784 -0.644 . . . . 0.66 111.006 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.8 mtm -69.26 -33.42 73.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 1.08 111.149 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.92 -38.86 61.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.501 . . . . 0.99 110.584 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.6 mt -76.31 -32.75 58.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.094 -0.503 . . . . 0.97 110.926 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.27 39.54 6.0 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.772 -0.727 . . . . 0.78 111.581 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.6 m -130.09 30.32 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.832 0.349 . . . . 0.81 110.83 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.441 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 2.8 mp0 -59.77 -63.0 1.46 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.047 -0.524 . . . . 1.71 111.812 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.74 -33.33 61.04 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.188 -0.46 . . . . 1.91 111.172 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -66.17 -48.02 72.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.77 -0.65 . . . . 2.28 111.705 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.83 -10.6 11.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.062 0.764 . . . . 0.65 113.062 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.4 m -56.18 -51.76 66.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.219 0.452 . . . . 0.98 112.219 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.434 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 42.2 t -62.57 -59.22 13.35 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 112.547 0.573 . . . . 0.62 112.547 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 10.0 Cg_endo -54.7 -35.29 86.92 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.255 1.97 . . . . 0.61 113.059 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.9 mt -68.77 -47.92 65.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.514 0.197 . . . . 0.79 110.757 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.539 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -58.59 -49.43 77.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.165 0.507 . . . . 0.58 110.784 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.41 -39.33 93.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.621 -0.718 . . . . 1.7 110.913 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.65 -18.03 71.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.998 -0.62 . . . . 0.82 113.469 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.7 t -101.55 -42.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.319 0.488 . . . . 0.75 112.319 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -98.72 -39.98 8.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.587 0.958 . . . . 0.84 113.587 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -79.61 -70.79 0.49 Allowed 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.676 -0.41 . . . . 1.41 111.797 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.31 -26.4 46.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.676 -0.238 . . . . 1.31 111.532 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.42 ' HB3' HH21 ' A' ' 103' ' ' ARG . 58.7 mt-30 56.38 28.45 13.53 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.606 0.567 . . . . 1.44 111.173 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -28.51 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.75 -0.659 . . . . 1.57 111.584 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.74 100.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.991 -0.374 . . . . 0.91 109.991 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.42 HH21 ' HB3' ' A' ' 100' ' ' GLN . 26.1 mmt180 -122.97 -3.59 8.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 3.22 110.967 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -149.45 166.1 30.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.319 -0.4 . . . . 1.51 110.068 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.93 67.85 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.51 -0.313 . . . . 1.08 111.335 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -36.66 78.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.246 -0.434 . . . . 1.43 110.785 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -70.67 -42.23 71.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.363 -0.606 . . . . 1.89 109.363 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.5 mt -62.17 -43.14 97.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.614 -0.721 . . . . 0.9 110.097 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.402 ' O ' HG13 ' A' ' 113' ' ' ILE . 74.2 ttt-85 -57.76 -44.2 85.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.572 -0.74 . . . . 2.19 110.211 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.7 -35.06 79.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.606 -0.724 . . . . 1.95 111.386 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.4 t -60.82 -42.75 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.029 0.442 . . . . 0.88 110.255 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -64.42 -39.9 94.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 0.92 110.394 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.681 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 65.4 mt -63.9 -36.47 76.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 1.33 110.126 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -68.03 -23.33 64.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.834 -0.621 . . . . 1.93 111.045 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.45 -7.47 58.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.1 111.522 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.96 5.75 28.72 Favored Glycine 0 C--O 1.234 0.136 0 C-N-CA 120.747 -0.739 . . . . 1.15 112.736 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 44.4 mm -92.44 124.89 45.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 122.742 -0.27 . . . . 1.61 110.364 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -65.52 134.3 53.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.307 -0.406 . . . . 2.73 110.42 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.32 -38.97 81.23 Favored Glycine 0 CA--C 1.517 0.207 0 O-C-N 123.479 0.487 . . . . 1.19 112.717 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.31 -36.59 80.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.528 0.204 . . . . 2.98 111.368 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -73.13 -41.88 63.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.041 0.448 . . . . 2.52 109.978 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -60.79 -44.3 97.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 1.51 110.21 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -61.63 -39.41 91.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.985 -0.552 . . . . 2.3 110.874 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.41 -47.42 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.749 -0.66 . . . . 1.23 110.607 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.1 -27.94 68.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.256 -0.429 . . . . 1.11 111.333 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -62.46 -28.82 70.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.139 0.495 . . . . 1.31 110.301 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -105.05 19.13 21.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.006 -0.543 . . . . 1.63 111.111 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.0 t -80.3 142.22 34.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.102 -0.499 . . . . 2.04 110.865 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -69.84 -32.26 70.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.198 0.523 . . . . 3.82 109.685 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.41 -44.87 99.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.717 -0.674 . . . . 1.53 109.804 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.529 HG13 ' HB3' ' A' ' 77' ' ' ALA . 62.0 t -64.31 -41.48 92.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.412 -0.813 . . . . 1.11 110.332 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -57.29 -42.47 81.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.989 -0.55 . . . . 2.43 110.083 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 137' ' ' GLN . 12.1 t -66.38 -44.88 81.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.645 -0.707 . . . . 1.47 110.214 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 48.4 mt -59.2 -37.73 78.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 0.93 111.043 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.493 ' HA ' HE21 ' A' ' 138' ' ' GLN . 77.2 t -61.94 -47.01 95.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.929 -0.397 . . . . 0.8 109.929 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.6 -39.14 92.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.84 -0.618 . . . . 0.85 110.812 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 133' ' ' SER . 78.6 mt-30 -60.49 -41.08 93.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 1.39 111.207 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.493 HE21 ' HA ' ' A' ' 135' ' ' VAL . 49.7 mt-30 -63.75 -48.05 78.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.262 -0.426 . . . . 0.61 110.727 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 8.6 mt-10 -65.12 -41.2 95.1 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.025 -0.534 . . . . 2.82 110.44 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.7 tttm -61.92 -50.7 71.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.277 -0.874 . . . . 1.95 111.259 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.42 -44.98 92.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.46 . . . . 0.65 111.967 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.08 -36.51 83.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.487 -0.324 . . . . 0.61 111.689 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.88 -36.39 28.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.525 -0.307 . . . . 0.72 111.197 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -63.86 -49.73 71.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.413 -0.358 . . . . 1.39 110.997 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.63 -9.68 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 1.34 110.891 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.506 ' O ' ' HD2' ' A' ' 148' ' ' ARG . 89.5 mt-30 59.18 67.25 0.93 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.771 -0.65 . . . . 1.95 110.193 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 149' ' ' GLY . 14.0 tp -63.97 129.68 41.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.515 -0.766 . . . . 0.71 110.535 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.506 ' HD2' ' O ' ' A' ' 146' ' ' GLN . 1.2 mpt_? -96.74 -47.49 5.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.821 -0.627 . . . . 4.16 110.254 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . -98.05 -158.09 30.16 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.321 -0.712 . . . . 0.68 111.321 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.551 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 2.5 t -113.4 -57.41 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 117.221 0.511 . . . . 0.49 111.724 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 17.3 Cg_endo -92.64 82.34 0.24 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.601 2.201 . . . . 0.56 111.885 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.36 146.15 50.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.316 -0.402 . . . . 0.63 110.87 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 43.8 ttm -118.78 133.14 56.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.049 -0.523 . . . . 0.42 110.314 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.28 133.1 56.38 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.914 -0.585 . . . . 0.52 109.826 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.43 112.4 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.257 -0.429 . . . . 0.55 110.459 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 60.47 17.23 7.08 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.278 -0.873 . . . . 1.16 111.52 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.19 20.28 64.88 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.925 -0.58 . . . . 0.56 112.512 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -121.06 -38.35 2.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.886 0.374 . . . . 1.75 111.641 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -111.83 128.36 56.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.016 0.436 . . . . 1.16 110.898 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -105.15 138.4 41.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.667 -0.697 . . . . 0.98 110.438 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.23 134.97 33.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.528 -0.306 . . . . 1.2 110.325 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -115.6 100.79 53.96 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.774 0.321 . . . . 0.72 110.587 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.45 -16.87 34.7 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 122.363 2.042 . . . . 0.54 112.572 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -81.02 -6.48 58.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.948 0.404 . . . . 2.22 110.788 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -115.26 14.77 18.43 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.244 -0.742 . . . . 0.59 111.244 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . 0.403 ' HB3' ' OE1' ' A' ' 177' ' ' GLN . 64.9 mtt -105.54 -174.52 2.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.543 -0.329 . . . . 0.57 110.187 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -71.25 111.8 6.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.226 0.536 . . . . 1.54 111.032 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.24 18.49 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.338 0.589 . . . . 1.16 109.795 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.99 -48.88 6.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.507 -0.77 . . . . 1.53 110.681 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -122.37 126.84 48.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.164 -0.471 . . . . 1.21 110.61 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.445 ' O ' HG23 ' A' ' 175' ' ' VAL . 39.3 mtt -62.19 -40.52 96.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.031 -0.531 . . . . 1.96 111.602 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -61.05 -42.01 97.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 2.05 110.604 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.8 t -67.74 -46.84 81.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.792 -0.64 . . . . 0.65 110.45 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -55.4 -49.34 72.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.777 -0.647 . . . . 0.47 111.856 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 171' ' ' MET . 80.8 t -55.73 -50.09 70.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.548 -0.296 . . . . 0.48 111.705 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -69.25 -35.06 75.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.375 -0.375 . . . . 1.7 111.082 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.403 ' OE1' ' HB3' ' A' ' 166' ' ' MET . 57.4 tt0 -63.57 -47.15 82.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.398 -0.365 . . . . 1.32 110.537 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' ' 182' ' ' VAL . 17.7 t80 -57.54 -46.73 83.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.975 -0.557 . . . . 0.46 109.906 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.7 -41.1 88.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.638 -0.71 . . . . 0.43 111.46 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.55 -40.36 96.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.086 -0.506 . . . . 1.55 110.311 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.2 m -59.76 -42.03 92.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.48 110.575 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 178' ' ' TYR . 61.8 t -60.05 -53.17 52.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.293 -0.412 . . . . 0.48 110.523 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -59.83 -46.36 89.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.687 -0.688 . . . . 1.59 111.047 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -58.73 -45.6 89.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.838 -0.619 . . . . 1.17 111.484 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.36 -36.55 74.25 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.479 0.18 . . . . 0.68 111.401 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.7 m -64.37 -37.6 88.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.986 0.422 . . . . 1.07 110.879 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 2.26 111.139 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.532 0.206 . . . . 1.32 110.492 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -128.3 151.01 49.81 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.761 0.315 . . . . 2.29 110.746 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -65.95 123.37 19.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.783 -0.644 . . . . 1.83 111.011 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.0 -14.05 52.45 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.915 -0.584 . . . . 0.78 112.425 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -108.52 -73.31 0.69 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.95 -0.3 . . . . 1.87 111.137 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -91.54 -24.59 19.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.581 0.229 . . . . 1.46 111.41 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -145.7 158.82 43.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.147 -0.316 . . . . 0.79 110.147 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.95 122.96 31.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.958 0.409 . . . . 0.9 111.096 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.4 m -74.51 120.57 20.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.162 -0.472 . . . . 1.11 109.805 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.4 mt -72.58 136.69 45.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.024 0.44 . . . . 0.74 111.285 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -77.17 -31.7 55.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.972 -0.751 . . . . 2.33 108.972 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -120.2 83.42 32.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.26 -0.882 . . . . 3.64 110.096 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.12 163.4 38.25 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.382 2.055 . . . . 0.85 112.08 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.77 115.3 43.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.004 0.43 . . . . 0.72 110.647 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.43 111.84 12.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.807 -0.633 . . . . 0.89 110.496 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.37 20.88 9.22 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.771 -0.728 . . . . 0.73 112.245 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.88 154.27 55.37 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.452 -0.203 . . . . 0.64 110.452 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.49 161.31 42.66 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.12 1.88 . . . . 0.56 112.228 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -57.33 -56.53 20.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.836 -0.62 . . . . 1.79 111.487 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.409 HG21 HD11 ' A' ' 50' ' ' LEU . 58.9 t -112.27 96.35 4.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.134 0.493 . . . . 0.45 110.337 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.33 116.54 32.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.635 -0.711 . . . . 0.53 109.764 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -126.23 152.17 46.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.611 0.243 . . . . 1.61 110.822 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.23 156.61 42.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.61 -0.515 . . . . 0.53 109.61 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -169.06 175.95 5.54 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.019 0.438 . . . . 0.55 111.003 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.493 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 7.0 t -156.24 136.99 13.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.337 -0.392 . . . . 0.96 110.192 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.409 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.1 m-85 -70.58 -15.76 62.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.921 -0.581 . . . . 0.62 110.957 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CE2' HD12 ' A' ' 72' ' ' LEU . 65.8 m-85 -88.9 -1.27 58.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 1.78 110.765 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.3 t -107.49 115.73 58.95 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.035 -0.357 . . . . 0.48 110.035 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -64.09 -26.42 65.58 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.372 2.048 . . . . 0.7 112.082 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -70.19 -27.37 64.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 1.74 110.096 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.1 m -71.9 -37.05 70.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.553 -0.536 . . . . 0.37 109.553 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -65.52 -36.48 83.95 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.28 0.562 . . . . 1.44 109.553 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.499 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 47.2 tt0 -65.36 -43.96 89.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.382 -0.826 . . . . 2.27 109.967 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.43 -32.75 68.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.061 -0.518 . . . . 0.87 111.964 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 3.2 tp10 -87.94 -50.79 6.2 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.432 0.901 . . . . 1.89 113.432 -177.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 27.1 tp10 -94.38 -34.33 12.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.738 1.014 . . . . 2.0 113.738 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 51.9 t -81.46 -51.98 14.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 121.578 -0.701 . . . . 0.58 110.914 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' HB3' HG22 ' A' ' 175' ' ' VAL . 79.8 mt -92.18 -31.3 15.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.468 0.544 . . . . 0.41 112.468 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 6.7 m-70 60.0 48.62 8.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.484 -0.561 . . . . 0.84 109.484 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.594 ' O ' HG23 ' A' ' 46' ' ' VAL . 41.1 mm -53.16 -64.13 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.474 -0.784 . . . . 0.41 111.893 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -54.53 -31.66 56.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.284 0.476 . . . . 1.03 112.284 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.94 -37.98 72.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.806 0.336 . . . . 1.73 110.928 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.456 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 28.4 m-80 -72.88 -33.01 65.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 1.19 110.626 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 42' ' ' ILE . 62.1 t -60.47 -37.11 73.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.873 -0.603 . . . . 0.49 110.443 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -62.04 -25.04 67.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.984 -0.553 . . . . 1.53 111.726 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 45' ' ' ASN . 49.3 mtmt -83.04 -11.44 58.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.517 -0.311 . . . . 2.02 111.348 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -112.15 -20.84 11.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 111.828 0.307 . . . . 1.44 111.828 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.409 HD11 HG21 ' A' ' 22' ' ' VAL . 85.8 mt -74.6 132.73 77.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.699 0.285 . . . . 1.0 111.366 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.41 174.5 11.46 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.333 2.022 . . . . 0.74 112.013 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.06 144.81 55.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.14 -0.482 . . . . 2.63 111.158 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.02 -20.46 47.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.172 -0.537 . . . . 0.82 112.559 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.17 113.63 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.869 0.366 . . . . 1.03 110.603 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -97.95 151.77 19.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 2.51 109.841 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 96.2 mtp -108.57 146.17 33.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.47 -0.332 . . . . 1.28 110.359 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 m -135.07 110.71 9.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.824 0.345 . . . . 0.61 110.492 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -106.84 122.45 46.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.875 -0.602 . . . . 0.86 109.704 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.7 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 10.2 m-85 -111.5 159.19 18.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.93 0.395 . . . . 0.71 111.0 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.493 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 52.5 t-80 -104.62 134.64 47.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.491 . . . . 0.57 109.875 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 m -87.47 150.41 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.569 -0.287 . . . . 0.68 111.012 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.667 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 7.5 m-20 -99.44 1.32 44.04 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.36 0.504 . . . . 0.93 112.36 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -98.18 12.92 33.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.13 0.491 . . . . 0.74 111.296 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.13 99.63 3.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.256 -0.429 . . . . 1.09 110.726 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.96 -2.88 4.84 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.623 -0.799 . . . . 0.78 112.426 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.23 -138.91 31.46 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.209 -0.52 . . . . 0.81 112.145 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.98 -37.51 72.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.859 0.362 . . . . 2.47 111.133 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -70.61 -22.08 62.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 1.94 110.391 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.34 -32.48 84.33 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.5 -0.857 . . . . 0.7 111.132 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.667 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 33.4 mttm -66.7 -36.94 83.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.725 0.298 . . . . 2.69 110.807 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -67.0 -39.04 87.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.137 0.494 . . . . 1.65 110.294 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.545 HD12 ' CE2' ' A' ' 29' ' ' PHE . 4.3 mt -66.25 -28.89 69.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 1.17 110.321 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.6 m -67.7 -36.72 81.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.191 0.52 . . . . 0.62 109.773 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -73.87 -41.61 61.96 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.81 -0.632 . . . . 1.21 109.623 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.82 95.24 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.82 -0.627 . . . . 0.71 110.835 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -61.12 -40.14 92.66 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.859 -0.609 . . . . 0.59 110.557 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.21 -35.73 81.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.063 -0.517 . . . . 0.71 110.228 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.85 -46.23 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.84 109.979 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.86 84.69 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.87 -0.605 . . . . 0.66 111.3 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 69.1 mtm -67.97 -39.36 83.37 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.129 -0.487 . . . . 1.08 110.846 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.69 -25.56 63.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 0.99 111.371 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.0 mt -88.97 -46.84 8.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.127 -0.488 . . . . 0.97 110.997 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.43 41.92 2.11 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.113 -0.565 . . . . 0.78 111.862 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.83 26.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.977 0.418 . . . . 0.81 110.216 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.94 -53.61 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.519 -0.764 . . . . 1.71 111.708 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.04 -19.88 65.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.781 -0.645 . . . . 1.91 112.189 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -81.92 -22.26 36.88 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.949 0.351 . . . . 2.28 111.949 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.441 ' HA ' ' HG2' ' A' ' 91' ' ' PRO . 32.9 m -111.36 -6.74 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.231 0.826 . . . . 0.65 113.231 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -56.01 27.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.699 0.629 . . . . 0.98 112.699 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.434 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.9 t -60.29 -56.48 34.97 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 111.97 0.359 . . . . 0.62 111.97 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.441 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 9.4 Cg_endo -55.13 -37.79 93.91 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.465 2.11 . . . . 0.61 113.156 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.37 -42.22 65.5 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.962 -0.295 . . . . 0.79 110.443 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -59.88 -51.88 67.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.262 0.553 . . . . 0.58 110.802 179.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -70.86 -34.72 71.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.067 -0.515 . . . . 1.7 111.362 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.09 -23.02 72.85 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.866 -0.683 . . . . 0.82 113.068 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.92 -45.98 12.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.803 0.301 . . . . 0.75 111.703 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -89.23 -51.72 5.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.775 1.028 . . . . 0.84 113.775 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -74.39 -68.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.404 0.52 . . . . 1.41 112.404 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.465 ' HB ' ' OG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -72.4 -34.53 67.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.16 0.429 . . . . 1.31 112.16 -179.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 60.4 35.54 20.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.059 0.457 . . . . 1.44 110.744 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.465 ' OG1' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -83.75 -30.24 26.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.634 -0.712 . . . . 1.57 111.637 -179.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.5 mt -76.89 110.48 12.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.194 -0.457 . . . . 0.91 110.976 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -120.72 -11.44 9.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 3.22 109.874 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.0 m -150.93 171.48 17.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.006 -0.543 . . . . 1.51 110.339 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -64.12 -22.48 66.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.091 0.472 . . . . 1.08 111.013 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -42.78 92.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.693 -0.685 . . . . 1.43 111.207 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.2 m-20 -65.43 -40.37 93.25 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.167 -0.47 . . . . 1.89 110.137 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 105' ' ' ALA . 12.1 mt -62.52 -42.3 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.659 -0.7 . . . . 0.9 110.083 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -57.7 -41.93 82.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.301 -0.863 . . . . 2.19 110.908 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -66.79 -39.06 87.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 1.95 111.01 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 107' ' ' ASP . 89.1 t -59.83 -39.53 80.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.847 0.356 . . . . 0.88 110.526 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -65.87 -39.07 90.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.444 -0.344 . . . . 0.92 110.159 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 79.9 mt -65.59 -35.53 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.143 0.497 . . . . 1.33 109.686 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -65.66 -27.96 68.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.774 -0.648 . . . . 1.93 110.338 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.44 -13.04 58.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.599 -0.728 . . . . 1.1 111.116 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.38 6.86 17.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.555 -0.831 . . . . 1.15 113.408 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 43.1 mm -91.64 122.82 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.955 0.378 . . . . 1.61 110.054 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -65.03 136.06 56.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.477 -0.329 . . . . 2.73 110.792 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.4 -33.24 70.34 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 121.031 -0.604 . . . . 1.19 112.595 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -65.91 -42.8 89.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.285 0.564 . . . . 2.98 109.897 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.89 -41.83 86.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 2.52 109.711 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -60.0 -40.4 89.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.31 -0.859 . . . . 1.51 111.11 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.29 -40.31 95.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.385 -0.37 . . . . 2.3 110.918 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.4 89.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.23 111.115 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.44 -40.62 70.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.415 . . . . 1.11 110.654 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -58.39 -34.85 71.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.037 -0.529 . . . . 1.31 110.841 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -106.55 40.61 1.59 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.072 -0.513 . . . . 1.63 111.096 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 80.1 p -108.79 152.94 24.19 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.745 -0.382 . . . . 2.04 110.745 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -72.09 -32.84 67.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.416 . . . . 3.82 109.999 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.461 ' O ' ' HG ' ' A' ' 134' ' ' LEU . 60.3 t -58.9 -50.35 79.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.696 -0.684 . . . . 1.53 110.956 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 135' ' ' VAL . 24.8 t -60.22 -45.15 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 1.11 110.522 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -59.26 -38.72 80.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.254 -0.43 . . . . 2.43 110.481 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.04 -36.53 84.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.165 0.507 . . . . 1.47 109.961 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 130' ' ' VAL . 75.7 mt -72.34 -41.63 66.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.987 -0.551 . . . . 0.93 110.342 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.613 ' HA ' HE21 ' A' ' 138' ' ' GLN . 94.2 t -58.27 -47.17 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.8 111.084 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.71 83.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.106 -0.497 . . . . 0.85 111.093 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -70.08 -35.27 74.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 1.39 111.62 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.7 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 48.8 mt-30 -56.58 -54.56 44.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.144 -0.48 . . . . 0.61 111.085 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -71.58 -32.79 68.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.845 -0.616 . . . . 2.82 111.243 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 70.5 tttt -60.13 -48.27 82.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.323 -0.399 . . . . 1.95 110.805 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.03 99.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.16 -0.473 . . . . 0.65 110.986 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.51 -46.23 90.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.61 111.659 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.94 -6.45 57.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.306 0.484 . . . . 0.72 112.306 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -94.07 -27.88 16.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.057 0.456 . . . . 1.39 110.456 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.6 m -98.73 5.65 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.088 -0.505 . . . . 1.34 110.868 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 148' ' ' ARG . 62.7 mt-30 56.51 55.91 6.08 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.25 0.548 . . . . 1.95 109.974 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 44.3 tp -63.71 103.32 0.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.577 -0.738 . . . . 0.71 111.237 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 146' ' ' GLN . 51.1 mtt180 -100.51 40.84 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 4.16 110.199 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -174.13 -174.64 41.13 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.613 -0.995 . . . . 0.68 110.613 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.504 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.2 t -107.83 -58.46 0.05 OUTLIER Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 117.174 0.487 . . . . 0.49 111.562 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.504 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 18.4 Cg_endo -93.98 67.22 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.558 2.172 . . . . 0.56 112.313 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.07 143.29 45.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.63 110.759 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 45.4 ttm -113.82 138.41 50.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.106 -0.497 . . . . 0.42 110.68 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.49 125.29 44.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.638 -0.71 . . . . 0.52 109.659 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.407 HG22 HG13 ' A' ' 182' ' ' VAL . 67.5 t -88.57 112.87 24.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.552 -0.295 . . . . 0.55 111.347 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 58.37 17.3 4.67 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.842 0.714 . . . . 1.16 111.801 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.26 19.93 62.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.051 -0.595 . . . . 0.56 111.627 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -110.72 -38.07 5.25 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.874 0.369 . . . . 1.75 111.078 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -123.83 142.0 51.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.38 . . . . 1.16 111.254 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -107.59 142.95 36.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.749 -0.659 . . . . 0.98 109.614 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.7 mp -94.29 135.21 35.94 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.144 -0.317 . . . . 1.2 110.144 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -115.57 106.05 51.02 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.808 0.337 . . . . 0.72 110.974 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.43 -20.3 21.0 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.33 2.02 . . . . 0.54 112.266 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -77.0 5.98 7.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.034 -0.53 . . . . 2.22 110.996 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.4 22.07 4.46 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.192 -0.763 . . . . 0.59 111.192 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 66.0 mtt -109.19 -167.41 1.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.528 0.204 . . . . 0.57 110.777 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.04 130.7 41.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.291 0.567 . . . . 1.54 111.659 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.68 19.0 13.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.142 -0.935 . . . . 1.16 109.227 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.7 -46.07 8.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.408 -0.815 . . . . 1.53 110.368 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -146.49 130.65 17.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.118 -0.492 . . . . 1.21 110.252 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.434 ' O ' HG23 ' A' ' 175' ' ' VAL . 0.0 OUTLIER -60.56 -28.9 68.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 1.96 110.333 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.54 -31.28 70.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.49 0.662 . . . . 2.05 110.506 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 43.0 t -86.0 -43.52 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.806 -0.634 . . . . 0.65 109.677 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -52.11 -50.19 62.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.306 -0.861 . . . . 0.47 111.781 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 40' ' ' LEU . 93.4 t -59.09 -50.21 80.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.249 -0.432 . . . . 0.48 111.564 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -63.29 -41.93 99.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.028 -0.533 . . . . 1.7 111.289 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -64.65 -43.84 92.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.552 -0.295 . . . . 1.32 110.774 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -57.44 -48.38 79.3 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.108 0.48 . . . . 0.46 110.262 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.6 -35.59 77.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.778 -0.647 . . . . 0.43 111.688 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.9 -36.39 80.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.502 -0.317 . . . . 1.55 110.688 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.5 m -59.14 -38.37 79.52 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.037 -0.528 . . . . 0.48 110.654 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.407 HG13 HG22 ' A' ' 155' ' ' VAL . 43.0 t -61.26 -53.08 53.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.48 110.196 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -58.11 -41.48 83.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.501 -0.772 . . . . 1.59 111.086 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -61.37 -44.28 97.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 1.17 111.179 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.42 -36.82 60.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.056 0.762 . . . . 0.68 113.056 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.3 p -63.02 -32.04 73.31 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.069 0.461 . . . . 1.07 110.959 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.041 -0.527 . . . . 2.26 110.217 -179.785 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.934 0.397 . . . . 1.32 109.976 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -94.35 145.93 24.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 2.29 110.854 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.16 128.86 36.99 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.978 -0.749 . . . . 1.83 108.978 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.07 1.26 72.96 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.542 -0.837 . . . . 0.78 111.075 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -118.04 -72.34 0.69 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.785 -0.45 . . . . 1.87 109.785 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -85.21 -39.09 18.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.054 0.454 . . . . 1.46 109.997 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -138.28 152.73 48.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.97 -0.559 . . . . 0.79 110.336 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.17 132.93 54.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.02 -0.536 . . . . 0.9 110.356 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 m -85.22 120.18 26.43 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.767 -0.457 . . . . 1.11 109.767 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 69.2 mt -74.2 146.69 43.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.147 -0.479 . . . . 0.74 110.957 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.8 -10.37 48.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.464 0.649 . . . . 2.33 109.293 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -118.63 83.55 22.25 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.314 -0.857 . . . . 3.64 109.51 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.62 121.68 8.4 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.125 1.883 . . . . 0.85 111.769 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.47 109.59 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.92 -0.582 . . . . 0.72 110.552 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.0 136.72 45.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.481 -0.781 . . . . 0.89 110.986 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.33 14.97 72.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.776 -0.726 . . . . 0.73 112.5 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 144.31 33.69 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.151 -0.315 . . . . 0.64 110.151 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.51 168.98 16.68 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.627 2.218 . . . . 0.56 112.018 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 22.1 mp0 -63.68 -53.0 58.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.043 -0.526 . . . . 1.79 111.013 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.59 103.3 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.862 0.363 . . . . 0.45 110.617 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.8 tp -108.39 127.99 54.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.044 -0.526 . . . . 0.53 110.564 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -128.71 142.95 50.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 1.61 110.135 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.64 152.2 37.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.367 -0.378 . . . . 0.53 110.062 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.98 174.14 9.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.298 0.57 . . . . 0.55 111.52 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.434 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 7.9 t -155.54 132.14 10.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.628 -0.715 . . . . 0.96 109.495 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.532 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 92.1 m-85 -67.36 -15.24 63.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.187 -0.461 . . . . 0.62 111.333 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.532 ' CE1' ' HA2' ' A' ' 69' ' ' GLY . 71.8 m-85 -86.31 -6.12 59.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 1.78 111.589 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 35.5 t -109.61 118.45 50.37 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.451 -0.34 . . . . 0.48 111.626 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.48 -25.63 76.0 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.406 2.07 . . . . 0.7 111.232 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -61.84 -30.12 70.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.571 -0.74 . . . . 1.74 110.251 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.5 m -79.27 -41.06 28.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.37 110.334 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.51 -35.17 76.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.137 0.494 . . . . 1.44 110.008 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.699 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 26.6 tt0 -67.04 -33.42 75.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.428 -0.806 . . . . 2.27 110.4 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.417 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.6 m-85 -86.51 -22.44 26.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.398 . . . . 0.87 110.768 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 12.8 tp10 -84.18 -62.62 1.52 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.019 -0.537 . . . . 1.89 112.41 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -92.41 -33.98 14.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.309 0.855 . . . . 2.0 113.309 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.699 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 73.9 t -76.72 -58.24 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.286 -0.566 . . . . 0.58 111.631 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -89.95 -26.19 20.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.415 0.524 . . . . 0.41 112.415 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 22.6 m-70 56.19 49.9 14.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.178 0.513 . . . . 0.84 110.492 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.417 HG13 ' CD2' ' A' ' 36' ' ' PHE . 42.4 mm -59.89 -51.69 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.739 -0.664 . . . . 0.41 111.862 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -56.46 -40.05 74.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.658 -0.246 . . . . 1.03 111.643 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.46 -47.63 75.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.112 0.482 . . . . 1.73 110.307 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -59.61 -42.41 92.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.565 -0.743 . . . . 1.19 110.968 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.656 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 53.8 t -61.53 -47.79 91.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.877 -0.601 . . . . 0.49 110.757 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -58.46 -33.08 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 1.53 111.74 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -79.17 -15.76 57.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 2.02 111.577 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -101.94 -23.99 14.06 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.81 0.338 . . . . 1.44 111.045 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 57.8 mt -64.82 137.34 97.11 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.1 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.49 172.04 16.5 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.584 2.189 . . . . 0.74 111.792 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.65 136.76 53.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.852 -0.613 . . . . 2.63 111.579 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.49 -23.2 36.69 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.806 -0.712 . . . . 0.82 112.904 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.25 130.35 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.913 0.387 . . . . 1.03 111.05 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -112.25 130.31 55.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 2.51 110.287 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.0 ttt -92.37 139.07 30.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 1.28 110.123 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.08 129.22 52.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.679 0.276 . . . . 0.61 111.3 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -115.07 121.81 44.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.856 -0.794 . . . . 0.86 108.856 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 10.5 m-30 -117.53 159.5 22.76 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.142 0.496 . . . . 0.71 112.075 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 48.6 t-80 -105.32 140.01 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.744 -0.662 . . . . 0.57 109.901 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.7 m -104.0 152.31 6.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.539 -0.3 . . . . 0.68 111.553 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.608 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 72.4 m-20 -96.11 -2.83 45.73 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.955 0.724 . . . . 0.93 112.955 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -87.89 4.06 46.13 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.166 -0.614 . . . . 0.74 111.603 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.73 107.8 5.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.626 -0.509 . . . . 1.09 109.626 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.65 -8.03 3.35 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.603 -0.726 . . . . 0.78 111.297 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.4 -131.75 24.71 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.326 -0.464 . . . . 0.81 112.597 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -74.11 -45.67 47.59 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.863 0.32 . . . . 2.47 111.863 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -73.34 -17.75 61.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.372 -0.376 . . . . 1.94 111.229 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.532 ' HA2' ' CE1' ' A' ' 29' ' ' PHE . . . -58.33 -32.54 68.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.787 -0.72 . . . . 0.7 112.585 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.608 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 86.8 mttt -71.5 -31.25 66.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.729 0.299 . . . . 2.69 111.718 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.92 -42.48 85.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.847 0.356 . . . . 1.65 110.703 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.448 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 1.3 mt -66.35 -24.26 66.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.145 -0.48 . . . . 1.17 110.93 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -68.87 -34.13 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.267 0.556 . . . . 0.62 109.83 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.402 ' HA ' HG22 ' A' ' 135' ' ' VAL . 41.1 tt0 -76.43 -40.09 51.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.561 -0.745 . . . . 1.21 109.155 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.75 91.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.61 -0.723 . . . . 0.71 111.198 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -60.44 -38.0 82.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.59 110.502 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -62.06 -38.88 90.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.899 -0.591 . . . . 0.71 110.197 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.82 -44.97 92.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.636 -0.711 . . . . 0.84 109.812 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.41 86.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.738 -0.665 . . . . 0.66 110.91 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.6 mtm -66.01 -44.08 85.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 1.08 111.042 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.3 -30.74 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.112 0.482 . . . . 0.99 111.221 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.7 mt -80.39 -41.99 23.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 0.97 110.843 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.22 11.22 34.47 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.573 -0.611 . . . . 0.78 111.573 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 m -105.78 27.4 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.792 0.329 . . . . 0.81 111.149 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -52.44 63.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 1.71 110.251 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.467 ' HA ' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -63.2 -34.42 77.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.503 0.668 . . . . 1.91 110.252 179.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -62.91 -33.88 76.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.298 -0.865 . . . . 2.28 111.454 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.6 m -106.35 10.4 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.433 0.531 . . . . 0.65 112.433 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 86' ' ' ASP . 59.6 m -64.1 -53.76 44.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.787 0.327 . . . . 0.98 111.637 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.461 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 58.4 t -63.79 -55.02 36.89 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.532 0.567 . . . . 0.62 112.532 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 11.3 Cg_endo -55.04 -37.24 93.98 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.302 2.001 . . . . 0.61 113.56 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.416 HD22 HD21 ' A' ' 72' ' ' LEU . 33.0 mt -71.45 -32.54 68.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.681 0.277 . . . . 0.79 110.647 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -75.21 -53.34 8.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.273 0.558 . . . . 0.58 110.442 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.34 -39.9 94.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.81 -0.632 . . . . 1.7 110.961 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.97 -6.33 59.95 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.262 -0.494 . . . . 0.82 113.575 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.2 t -109.79 -40.3 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 117.489 0.644 . . . . 0.75 111.789 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.52 -48.43 5.01 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.035 0.754 . . . . 0.84 113.035 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -78.78 -70.34 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.772 0.286 . . . . 1.41 111.772 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -34.84 67.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.706 -0.224 . . . . 1.31 111.507 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 58.56 34.68 24.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.03 -0.532 . . . . 1.44 110.402 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -26.45 39.89 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.579 -0.737 . . . . 1.57 110.939 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.526 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 67.1 mt -87.17 100.35 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.91 110.411 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.526 ' HD2' ' O ' ' A' ' 102' ' ' ILE . 13.7 mmm180 -125.5 -12.22 6.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 3.22 110.334 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.6 p -139.88 168.28 20.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 1.51 110.498 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.7 -27.04 68.94 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.959 0.409 . . . . 1.08 110.984 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.5 m -62.85 -31.43 72.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 1.43 110.631 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.475 ' O ' HG23 ' A' ' 111' ' ' VAL . 33.4 m-20 -73.9 -44.52 54.94 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.661 -0.496 . . . . 1.89 109.661 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.5 mt -62.82 -41.9 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.808 -0.633 . . . . 0.9 110.124 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 ttm105 -60.72 -34.71 74.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.675 -0.693 . . . . 2.19 109.849 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.4 -41.56 69.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.626 -0.716 . . . . 1.95 111.44 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 107' ' ' ASP . 81.1 t -54.46 -45.43 70.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.747 0.308 . . . . 0.88 111.248 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -65.14 -41.48 94.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.92 111.072 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 80.4 mt -65.94 -41.55 90.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.994 0.426 . . . . 1.33 110.064 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -65.65 -30.35 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.71 -0.677 . . . . 1.93 110.354 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.97 -34.92 66.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 1.1 111.255 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 139.68 5.58 1.24 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.241 -0.98 . . . . 1.15 113.273 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 47.6 mm -94.06 123.57 46.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.671 -0.492 . . . . 1.61 109.671 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -61.25 137.55 58.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.594 -0.275 . . . . 2.73 110.498 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.63 -42.93 78.67 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.823 -0.626 . . . . 1.19 112.64 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.4 -45.48 92.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 2.98 110.68 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.49 -45.97 92.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.167 0.508 . . . . 2.52 110.067 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -62.79 -48.06 80.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.458 -0.792 . . . . 1.51 110.951 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.45 -36.13 81.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 2.3 111.047 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.16 86.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 1.23 109.782 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.07 -35.54 78.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.535 -0.757 . . . . 1.11 110.764 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -58.08 -36.32 72.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.104 0.478 . . . . 1.31 110.822 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -99.93 16.08 25.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.096 -0.502 . . . . 1.63 111.196 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.3 m -85.55 144.37 27.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 2.04 111.195 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.95 -36.9 85.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.839 -0.619 . . . . 3.82 110.864 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -56.19 -47.15 81.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 1.53 110.746 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 77' ' ' ALA . 17.6 t -63.83 -42.38 95.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 1.11 110.379 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -61.38 -33.75 74.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 2.43 110.549 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 63.8 m -71.86 -28.75 63.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.926 -0.579 . . . . 1.47 110.646 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.405 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 96.5 mt -74.57 -33.92 62.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.307 -0.406 . . . . 0.93 110.035 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 131' ' ' VAL . 50.5 t -61.43 -43.76 97.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.077 0.465 . . . . 0.8 110.11 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.48 95.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.585 -0.734 . . . . 0.85 111.19 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.43 -40.27 96.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.437 -0.347 . . . . 1.39 111.583 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.488 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 51.9 mt-30 -59.53 -52.54 65.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.61 111.152 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -71.69 -28.87 64.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.406 . . . . 2.82 111.768 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -63.89 -49.63 71.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.362 -0.381 . . . . 1.95 110.537 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.477 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -62.17 -44.2 97.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.876 -0.602 . . . . 0.65 111.464 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.89 84.75 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.263 -0.426 . . . . 0.61 111.556 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.65 -41.24 63.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 0.72 110.813 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.48 -43.54 93.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.037 -0.528 . . . . 1.39 111.795 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 141' ' ' ALA . 32.2 m -79.84 -1.78 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 111.587 0.218 . . . . 1.34 111.587 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 53.98 59.91 3.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.326 0.584 . . . . 1.95 109.872 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 152' ' ' ALA . 11.7 tp -58.57 134.04 56.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.242 -0.89 . . . . 0.71 112.524 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.9 mmt-85 -106.61 -39.86 5.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.193 -0.912 . . . . 4.16 110.663 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -122.3 159.29 16.93 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.09 -0.804 . . . . 0.68 111.09 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.52 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.4 t -65.58 -57.62 13.96 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 112.26 0.467 . . . . 0.49 112.26 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.52 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.8 Cg_endo -85.5 89.47 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.526 2.15 . . . . 0.56 112.068 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' A' ' 147' ' ' LEU . . . -129.87 154.2 47.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.181 -0.463 . . . . 0.63 110.611 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 30.9 ttm -127.35 133.06 50.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.208 -0.451 . . . . 0.42 110.817 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.15 133.99 53.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.52 110.186 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 44.9 t -102.4 114.81 42.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.263 -0.426 . . . . 0.55 111.218 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 59.46 14.03 3.59 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.088 -0.96 . . . . 1.16 111.987 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 69.52 20.57 75.61 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.937 -0.649 . . . . 0.56 112.125 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -120.78 -45.81 2.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 1.75 111.235 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -106.39 129.84 54.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.972 -0.558 . . . . 1.16 111.14 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -106.86 138.55 42.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.636 -0.711 . . . . 0.98 109.652 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mp -90.96 132.54 35.9 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.619 -0.432 . . . . 1.2 110.3 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -111.53 97.63 37.32 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.283 -0.417 . . . . 0.72 110.403 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.92 -18.87 46.75 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.365 2.043 . . . . 0.54 111.818 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -78.23 -8.25 58.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 2.22 110.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -115.65 14.68 17.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.009 -0.615 . . . . 0.59 112.292 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 55.5 mtt -102.55 -178.81 3.79 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.151 -0.314 . . . . 0.57 110.151 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.2 119.56 15.5 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.363 0.601 . . . . 1.54 111.2 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.91 22.34 15.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.405 -0.816 . . . . 1.16 109.453 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.34 -51.4 5.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.326 -0.852 . . . . 1.53 110.035 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -118.47 121.66 40.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.984 -0.553 . . . . 1.21 110.185 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 46.2 mmm -59.32 -38.2 79.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 1.96 111.879 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.16 -27.94 68.4 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.117 0.484 . . . . 2.05 110.704 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 55.4 t -77.83 -46.06 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.571 -0.74 . . . . 0.65 109.634 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.58 -50.73 69.31 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.073 -0.512 . . . . 0.47 111.414 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.21 -44.93 77.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.212 -0.449 . . . . 0.48 111.242 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 21.9 mm-40 -71.59 -46.24 59.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.187 -0.46 . . . . 1.7 111.294 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.08 -45.95 82.9 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.215 0.322 . . . . 1.32 111.204 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.508 ' O ' HG23 ' A' ' 182' ' ' VAL . 19.0 t80 -59.4 -56.12 26.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.643 -0.253 . . . . 0.46 110.88 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.83 87.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.43 . . . . 0.43 112.087 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.3 OUTLIER -69.08 -33.87 74.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.687 -0.233 . . . . 1.55 111.056 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 86.4 m -64.78 -39.36 93.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.581 -0.526 . . . . 0.48 109.581 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 178' ' ' TYR . 11.7 t -60.41 -46.7 94.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.106 -0.497 . . . . 0.48 109.748 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -61.09 -41.62 97.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.826 -0.625 . . . . 1.59 110.477 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.65 -41.67 95.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 1.17 111.088 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.68 -38.08 34.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.292 -0.413 . . . . 0.68 112.056 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 51.0 m -63.18 -30.31 71.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 1.07 111.006 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 121.278 0.561 . . . . 2.26 110.182 179.958 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 121.008 0.432 . . . . 1.32 110.76 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -111.05 147.53 34.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.82 -0.627 . . . . 2.29 110.627 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.22 117.43 17.04 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.046 -0.525 . . . . 1.83 109.621 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA2' HG23 ' A' ' 10' ' ' THR . . . 111.59 -5.8 27.98 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.135 -0.786 . . . . 0.78 111.135 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -112.46 -80.89 0.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.515 0.198 . . . . 1.87 110.637 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -85.79 -27.71 24.99 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.912 0.387 . . . . 1.46 110.638 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -141.36 159.75 41.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.757 -0.46 . . . . 0.79 109.757 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.421 HG23 ' HA2' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -137.99 130.57 29.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.469 -0.332 . . . . 0.9 111.27 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -77.13 125.26 29.04 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.525 -0.546 . . . . 1.11 109.525 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.9 mt -71.0 147.01 49.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.938 0.399 . . . . 0.74 111.156 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.67 -38.91 53.7 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.005 -0.739 . . . . 2.33 109.005 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -117.21 104.34 50.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.115 -0.948 . . . . 3.64 109.343 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.39 143.25 34.61 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.227 1.952 . . . . 0.85 112.111 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.61 91.88 3.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 0.72 110.075 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.86 123.6 20.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.841 -0.618 . . . . 0.89 110.003 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.02 -5.92 42.79 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.839 -0.696 . . . . 0.73 111.922 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.31 155.28 93.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.571 0.224 . . . . 0.64 111.091 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -76.31 -177.09 3.44 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.662 2.241 . . . . 0.56 112.057 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.417 ' OE1' HG22 ' A' ' 54' ' ' VAL . 40.3 mt-30 -69.87 -52.4 25.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 1.79 110.994 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.0 t -123.26 105.1 15.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.25 0.547 . . . . 0.45 110.747 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 tp -105.54 119.6 39.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.982 -0.554 . . . . 0.53 109.738 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.484 ' OE1' ' HG3' ' A' ' 58' ' ' LYS . 17.6 tt0 -122.72 147.42 46.5 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.806 0.336 . . . . 1.61 110.297 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -122.29 151.87 40.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.131 -0.486 . . . . 0.53 110.655 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.402 ' HA ' HG12 ' A' ' 150' ' ' VAL . 0.7 OUTLIER -167.64 169.61 11.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.55 110.855 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.463 ' HB2' HG22 ' A' ' 61' ' ' VAL . 3.4 t -152.47 135.72 15.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.273 -0.421 . . . . 0.96 110.371 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.448 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 90.6 m-85 -71.43 -15.59 62.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.099 -0.501 . . . . 0.62 110.232 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -90.55 0.51 57.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.977 -0.556 . . . . 1.78 110.679 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 51.1 t -109.45 114.93 56.82 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 116.017 -0.538 . . . . 0.48 110.603 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 19.7 Cg_endo -60.9 -26.75 83.67 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.588 2.192 . . . . 0.7 111.864 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -32.5 72.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.042 -0.526 . . . . 1.74 110.842 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.2 m -72.28 -33.38 67.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.25 -0.648 . . . . 0.37 109.25 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -66.13 -40.67 90.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.866 -0.79 . . . . 1.44 108.866 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.714 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 6.7 mt-30 -70.69 -37.55 73.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.588 -0.733 . . . . 2.27 110.791 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.96 -18.23 62.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.919 0.34 . . . . 0.87 111.919 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.74 -65.78 1.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.292 -0.563 . . . . 1.89 112.096 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.55 -27.71 66.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.15 0.5 . . . . 2.0 111.612 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 96.1 t -100.2 -59.53 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.715 -0.394 . . . . 0.58 111.992 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -85.03 -33.75 22.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.894 0.701 . . . . 0.41 112.894 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 61.63 46.34 7.3 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.098 0.475 . . . . 0.84 110.489 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 mm -58.72 -49.27 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.388 -0.823 . . . . 0.41 111.07 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -63.75 -45.94 87.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 1.03 111.323 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.27 -33.55 76.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.115 -0.493 . . . . 1.73 111.756 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -75.41 -41.93 54.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.411 -0.359 . . . . 1.19 110.804 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.516 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 22.5 t -60.04 -41.01 84.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.91 -0.586 . . . . 0.49 110.602 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -54.82 -38.31 67.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 1.53 112.206 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -78.7 -10.91 59.93 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.588 0.588 . . . . 2.02 112.588 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.5 mtmm -120.13 19.94 12.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.896 0.379 . . . . 1.44 110.918 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 14.1 mt -89.77 136.23 29.6 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.508 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.47 153.73 69.09 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.542 2.161 . . . . 0.74 111.848 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.13 123.45 20.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.169 -0.468 . . . . 2.63 110.774 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.33 -11.78 43.62 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.775 -0.648 . . . . 0.82 111.546 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.417 HG22 ' OE1' ' A' ' 21' ' ' GLN . 83.4 t -88.52 115.89 29.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.025 0.441 . . . . 1.03 110.368 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -92.11 140.33 29.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.893 -0.594 . . . . 2.51 110.603 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.5 ttt -100.73 119.14 38.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.097 -0.502 . . . . 1.28 110.215 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.91 99.98 9.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.173 -0.467 . . . . 0.61 111.236 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HG3' ' OE1' ' A' ' 24' ' ' GLU . 44.5 tttp -89.68 108.97 19.99 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.77 -0.826 . . . . 0.86 108.77 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.443 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 9.0 m-30 -106.72 153.02 23.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.417 0.627 . . . . 0.71 111.932 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -98.16 132.12 43.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.681 -0.69 . . . . 0.57 110.344 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 27' ' ' SER . 5.3 m -80.75 156.73 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.793 -0.185 . . . . 0.68 110.574 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 139' ' ' GLU . 13.0 m-20 -115.72 24.57 11.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.148 0.425 . . . . 0.93 112.148 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -117.89 8.03 12.51 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.229 -0.588 . . . . 0.74 111.282 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.9 mtp -141.45 107.69 5.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.856 -0.424 . . . . 1.09 109.856 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.18 -10.76 3.04 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.751 -0.659 . . . . 0.78 112.023 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.46 -142.57 29.27 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.763 -0.732 . . . . 0.81 112.363 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.58 -34.98 76.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.298 0.571 . . . . 2.47 110.816 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -75.71 -11.79 60.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 1.94 110.349 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.59 -46.39 93.85 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.044 -0.598 . . . . 0.7 112.496 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -67.97 -27.07 66.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.609 0.242 . . . . 2.69 111.46 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -43.81 93.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 1.65 110.753 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -24.47 64.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.793 -0.64 . . . . 1.17 111.185 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 m -66.01 -35.45 80.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.163 0.506 . . . . 0.62 110.472 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -76.06 -37.8 57.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 1.21 109.484 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.67 97.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.638 -0.71 . . . . 0.71 110.386 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -64.63 -36.65 84.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.444 -0.798 . . . . 0.59 110.579 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.527 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -61.42 -38.72 88.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.71 109.991 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 58.6 t -66.54 -44.88 89.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.728 -0.669 . . . . 0.84 109.727 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.01 86.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.66 110.989 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.7 ttm -64.22 -44.22 92.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.868 -0.606 . . . . 1.08 110.756 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.18 83.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.589 . . . . 0.99 111.516 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 78.8 mt -77.21 -38.56 51.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.576 -0.284 . . . . 0.97 111.411 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.16 38.27 3.61 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.705 -0.76 . . . . 0.78 112.42 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.9 m -132.59 30.8 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.79 0.328 . . . . 0.81 110.482 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -53.66 -64.94 0.66 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.727 -0.669 . . . . 1.71 112.568 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -31.73 70.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 1.91 111.155 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -62.13 -38.79 90.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.955 -0.566 . . . . 2.28 111.866 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -98.91 -9.3 8.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.413 0.523 . . . . 0.65 112.413 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -58.16 -45.44 87.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.658 0.266 . . . . 0.98 111.643 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.461 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 77.0 t -64.63 -60.81 7.54 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.185 0.439 . . . . 0.62 112.185 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 11.9 Cg_endo -56.14 -33.26 89.8 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.983 1.789 . . . . 0.61 113.068 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.41 -46.27 67.24 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.836 -0.346 . . . . 0.79 110.356 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 m-85 -61.49 -48.22 82.09 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.318 0.58 . . . . 0.58 110.54 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -62.84 -43.92 97.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.381 -0.827 . . . . 1.7 111.663 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.26 -16.46 77.1 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.097 -0.573 . . . . 0.82 113.802 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.496 HG23 HD12 ' A' ' 102' ' ' ILE . 55.0 t -100.01 -41.23 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.33 0.565 . . . . 0.75 112.424 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 31' ' ' PRO . 79.3 mt-30 -99.56 -42.34 6.96 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.009 1.114 . . . . 0.84 114.009 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -81.6 -68.05 0.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.585 -0.446 . . . . 1.41 111.784 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -34.59 62.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.094 -0.242 . . . . 1.31 110.851 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.554 ' HB3' ' NH2' ' A' ' 103' ' ' ARG . 78.9 mt-30 57.85 37.67 27.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.906 -0.588 . . . . 1.44 110.636 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.29 -20.72 27.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.127 -0.942 . . . . 1.57 110.896 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 96' ' ' VAL . 83.2 mt -80.94 106.42 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.752 -0.658 . . . . 0.91 110.511 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.554 ' NH2' ' HB3' ' A' ' 100' ' ' GLN . 37.5 mmt180 -123.37 -20.14 5.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.587 -0.733 . . . . 3.22 110.76 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -133.29 172.85 12.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.828 0.346 . . . . 1.51 110.444 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.46 -26.39 67.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.023 0.44 . . . . 1.08 110.627 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -33.08 73.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.668 -0.696 . . . . 1.43 110.673 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -71.74 -39.25 70.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.962 -0.563 . . . . 1.89 109.735 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.1 mt -64.78 -41.58 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.875 -0.602 . . . . 0.9 109.744 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -58.77 -42.7 89.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.085 -0.961 . . . . 2.19 110.963 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -60.02 -40.96 91.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 1.95 111.149 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.3 t -56.6 -43.51 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 0.88 111.021 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -66.57 -37.65 85.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.92 110.513 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 88.1 mt -65.32 -41.93 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.074 0.464 . . . . 1.33 109.854 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -64.61 -26.6 68.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.547 -0.752 . . . . 1.93 110.723 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.97 -32.14 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 1.1 110.768 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.83 7.74 3.66 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.783 -0.722 . . . . 1.15 112.914 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.3 mm -87.94 137.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.097 -0.334 . . . . 1.61 110.097 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -70.26 133.73 47.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.05 -0.523 . . . . 2.73 110.099 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.92 -44.53 96.03 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.953 -0.641 . . . . 1.19 112.56 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.98 -37.82 88.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.323 . . . . 2.98 110.987 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.22 -42.22 84.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.263 0.554 . . . . 2.52 109.612 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -63.06 -46.86 85.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.492 -0.776 . . . . 1.51 110.382 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -64.31 -29.4 70.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.215 0.531 . . . . 2.3 110.635 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.14 62.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.906 -0.588 . . . . 1.23 110.372 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.34 -34.36 78.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 1.11 110.868 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -58.74 -26.7 64.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.846 -0.615 . . . . 1.31 110.513 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -102.05 26.11 7.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.89 -0.595 . . . . 1.63 111.635 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.9 t -101.55 143.43 31.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.906 0.384 . . . . 2.04 111.162 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -65.83 -28.36 68.93 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.57 -0.741 . . . . 3.82 110.874 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.11 -45.58 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.242 0.544 . . . . 1.53 109.547 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 135' ' ' VAL . 88.9 t -64.58 -44.09 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.396 -0.82 . . . . 1.11 110.038 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -55.61 -44.44 77.03 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.993 0.425 . . . . 2.43 110.682 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 52.3 m -66.06 -39.18 89.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.589 . . . . 1.47 110.74 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.7 mt -64.2 -37.99 89.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.376 -0.375 . . . . 0.93 110.791 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 131' ' ' VAL . 54.8 t -65.4 -44.7 94.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.8 109.949 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.16 78.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.85 110.901 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -62.05 -45.46 93.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 1.39 110.903 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.493 HE21 ' HA ' ' A' ' 135' ' ' VAL . 44.9 mt-30 -63.44 -41.05 98.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.61 110.897 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.518 ' HG2' ' ND2' ' A' ' 62' ' ' ASN . 43.8 mt-10 -69.01 -40.29 78.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.072 -0.513 . . . . 2.82 111.325 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -72.05 -49.74 34.19 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.347 0.499 . . . . 1.95 112.347 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.82 -40.69 76.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.204 0.446 . . . . 0.65 112.204 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.5 -31.11 72.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.825 0.345 . . . . 0.61 111.675 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.13 -29.33 20.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.423 -0.353 . . . . 0.72 111.228 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -61.63 -50.61 71.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.995 0.426 . . . . 1.39 111.368 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.31 -8.8 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.945 -0.57 . . . . 1.34 111.547 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 64.18 74.93 0.39 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.384 0.612 . . . . 1.95 109.611 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.5 tp -80.23 123.96 28.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.679 -0.691 . . . . 0.71 111.888 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.26 -48.13 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.184 -0.673 . . . . 4.16 109.184 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.81 132.02 11.07 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.822 -0.911 . . . . 0.68 110.822 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.488 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 3.4 t -67.03 -52.44 31.09 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 112.584 0.587 . . . . 0.49 112.584 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.488 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 3.3 Cg_exo -79.55 76.79 4.36 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.11 1.874 . . . . 0.56 112.638 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.27 152.14 51.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.63 110.955 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 48.2 ttm -131.63 136.22 47.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.071 -0.513 . . . . 0.42 110.095 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -117.48 134.28 55.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.32 -0.4 . . . . 0.52 110.005 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 66.3 t -103.42 118.15 49.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.883 0.373 . . . . 0.55 110.565 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 64.67 5.35 2.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.491 -0.777 . . . . 1.16 111.658 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.2 15.41 74.62 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.032 -0.604 . . . . 0.56 112.158 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -119.92 -31.19 4.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.798 0.332 . . . . 1.75 111.227 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -118.41 139.12 51.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 1.16 110.549 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -117.09 138.67 51.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.916 -0.584 . . . . 0.98 110.319 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.9 mp -83.57 137.35 33.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.704 -0.48 . . . . 1.2 109.704 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -116.17 98.76 51.89 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.408 -0.36 . . . . 0.72 111.308 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.38 -14.13 33.8 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.374 2.049 . . . . 0.54 111.669 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -75.64 -6.73 51.84 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.159 -0.473 . . . . 2.22 110.975 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -128.87 19.2 5.55 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.773 -0.531 . . . . 0.59 111.773 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.3 mtt -99.02 -168.78 1.67 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.802 -0.199 . . . . 0.57 110.488 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.76 114.69 10.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.09 0.471 . . . . 1.54 110.533 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.86 33.37 5.25 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.728 0.775 . . . . 1.16 109.504 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.72 -47.81 2.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.119 -0.946 . . . . 1.53 111.018 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -114.45 118.8 34.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.788 0.328 . . . . 1.21 110.345 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.429 ' O ' HG23 ' A' ' 175' ' ' VAL . 12.6 mmt -59.76 -41.78 91.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 1.96 110.903 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.25 -33.11 75.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 2.05 111.643 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 77.0 t -79.18 -39.57 21.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.738 -0.21 . . . . 0.65 110.482 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -55.82 -50.14 71.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.596 -0.275 . . . . 0.47 111.159 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 171' ' ' MET . 46.6 t -58.39 -48.24 85.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.48 111.341 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -66.48 -39.55 88.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.891 -0.595 . . . . 1.7 111.423 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.61 -44.7 89.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.482 -0.326 . . . . 1.32 110.634 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.481 ' O ' HG23 ' A' ' 182' ' ' VAL . 2.5 t80 -54.9 -50.97 67.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.46 110.189 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.445 ' HA ' HG22 ' A' ' 46' ' ' VAL . . . -66.93 -38.19 85.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.43 112.041 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.19 -39.3 92.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.37 -0.377 . . . . 1.55 111.137 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 13.1 m -62.41 -36.96 83.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.48 110.116 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 178' ' ' TYR . 49.3 t -63.27 -48.76 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.047 0 CA-C-N 116.237 -0.438 . . . . 0.48 110.03 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -62.17 -40.17 95.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 1.59 110.743 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -64.39 -44.47 91.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.479 -0.328 . . . . 1.17 110.766 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.02 -32.34 71.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.475 -0.329 . . . . 0.68 111.274 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.2 m -75.54 -26.22 57.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 1.07 110.851 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 2.26 110.572 -179.832 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 N--CA 1.465 0.298 0 N-CA-C 110.25 -0.278 . . . . 1.32 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.0 142.96 49.75 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.334 -0.394 . . . . 2.29 110.87 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.32 123.59 24.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 1.83 110.366 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.97 -7.74 44.95 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.931 -0.577 . . . . 0.78 111.745 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.453 ' HB3' ' OE1' ' A' ' 8' ' ' GLN . 1.2 tttm -118.21 -75.85 0.58 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.612 0.244 . . . . 1.87 110.74 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.453 ' OE1' ' HB3' ' A' ' 7' ' ' LYS . 22.7 mp0 -76.6 -42.45 42.42 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.433 0.635 . . . . 1.46 110.175 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -134.16 163.99 28.36 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.722 -0.672 . . . . 0.79 109.394 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.4 115.91 12.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.716 0.294 . . . . 0.9 110.805 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.6 m -73.9 121.23 20.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.036 -0.529 . . . . 1.11 109.833 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.69 142.42 51.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.111 0.482 . . . . 0.74 111.667 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -74.17 -33.7 63.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.666 -0.697 . . . . 2.33 109.464 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -120.35 97.06 49.1 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.267 -0.879 . . . . 3.64 109.47 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.29 169.23 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.529 2.153 . . . . 0.85 112.554 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.69 117.12 49.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 0.72 110.464 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.43 131.9 35.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.821 0.343 . . . . 0.89 110.312 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.59 22.84 41.74 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.735 -0.745 . . . . 0.73 111.523 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.61 150.45 38.05 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.773 -0.214 . . . . 0.64 110.469 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.56 171.9 5.1 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.045 2.497 . . . . 0.56 113.077 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -71.0 -68.55 0.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.853 -0.612 . . . . 1.79 110.63 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.5 t -107.01 102.17 13.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.678 -0.49 . . . . 0.45 109.678 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 59' ' ' TYR . 18.5 tp -105.35 119.62 39.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.858 -0.61 . . . . 0.53 110.535 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -119.53 147.82 44.01 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.948 -0.39 . . . . 1.61 109.948 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.09 145.04 47.27 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.797 -0.446 . . . . 0.53 109.797 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -164.25 175.67 9.88 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.175 0.512 . . . . 0.55 110.799 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.612 ' HB2' HG22 ' A' ' 61' ' ' VAL . 3.3 t -156.53 137.82 13.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.547 -0.751 . . . . 0.96 109.998 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.563 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 71.1 m-85 -71.35 -14.69 62.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 0.62 110.572 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.435 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 71.7 m-85 -88.27 -5.92 58.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.871 -0.604 . . . . 1.78 110.45 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 13.2 t -104.73 113.4 64.96 Favored Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-O 120.961 0.41 . . . . 0.48 111.363 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 22.5 Cg_endo -64.69 -22.22 64.45 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.258 1.972 . . . . 0.7 110.429 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -67.25 -30.66 70.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.062 -0.972 . . . . 1.74 109.948 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -79.94 -38.94 31.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.411 -0.588 . . . . 0.37 109.411 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.76 -38.64 85.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 1.44 109.778 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.443 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 3.1 tp60 -60.38 -44.17 95.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.384 -0.825 . . . . 2.27 109.909 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.467 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.5 m-85 -74.39 -24.69 59.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.553 -0.748 . . . . 0.87 111.524 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -86.16 -49.89 7.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.543 0.571 . . . . 1.89 112.543 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -94.98 -38.69 10.55 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.569 0.951 . . . . 2.0 113.569 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 46.0 t -80.25 -53.43 12.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.023 -0.671 . . . . 0.58 111.882 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.7 mt -90.24 -29.18 18.35 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.768 -0.373 . . . . 0.41 111.986 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 56.69 48.67 15.88 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.477 0.656 . . . . 0.84 109.889 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.467 HG13 ' CD2' ' A' ' 36' ' ' PHE . 39.0 mm -59.89 -47.57 91.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.353 -0.84 . . . . 0.41 111.3 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.05 -48.31 64.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.326 0.391 . . . . 1.03 111.712 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.46 -47.05 87.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.906 -0.588 . . . . 1.73 110.375 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -60.67 -40.92 93.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 1.19 110.956 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.604 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 69.3 t -65.73 -48.88 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.49 110.616 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -56.4 -33.71 66.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.043 0.449 . . . . 1.53 111.594 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -81.41 -10.01 59.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 2.02 111.987 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HD2' ' HB1' ' A' ' 179' ' ' ALA . 52.1 mttm -111.94 2.35 16.9 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.804 -0.358 . . . . 1.44 111.597 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 59.3 mt -79.62 131.99 62.95 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.331 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.01 164.51 35.34 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.645 2.23 . . . . 0.74 112.157 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -61.48 108.42 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.212 0.53 . . . . 2.63 111.759 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.74 -24.08 5.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.986 -0.625 . . . . 0.82 112.109 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.06 130.7 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.928 0.394 . . . . 1.03 110.757 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 56' ' ' MET . 11.9 ttmm -119.61 147.15 44.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.895 -0.593 . . . . 2.51 110.561 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.416 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 8.9 ttt -87.54 130.45 34.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.123 -0.49 . . . . 1.28 110.564 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.27 106.97 12.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.002 -0.544 . . . . 0.61 110.934 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -90.83 127.42 36.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.525 -0.307 . . . . 0.86 110.41 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' CD2' ' HA ' ' A' ' 138' ' ' GLN . 5.2 m-30 -117.36 143.72 45.68 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.891 -0.411 . . . . 0.71 109.891 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -93.63 132.11 38.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.723 0.297 . . . . 0.57 110.988 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 27' ' ' SER . 5.6 m -76.18 150.18 6.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.992 -0.373 . . . . 0.68 109.992 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -103.87 -10.95 17.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.602 0.593 . . . . 0.93 112.602 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -89.46 20.02 4.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.037 0.384 . . . . 0.74 112.037 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.488 ' SD ' HG21 ' A' ' 150' ' ' VAL . 20.6 mtp -140.64 133.25 28.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.625 0.25 . . . . 1.09 110.425 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.43 3.5 56.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.779 -0.724 . . . . 0.78 112.07 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.09 -129.47 34.94 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.704 -0.76 . . . . 0.81 112.348 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.84 -35.28 57.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.773 0.321 . . . . 2.47 110.785 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.47 -22.0 65.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.961 -0.563 . . . . 1.94 110.527 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.54 89.19 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.703 -0.76 . . . . 0.7 111.362 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -69.98 -37.69 75.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.033 0.444 . . . . 2.69 110.549 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -62.82 -41.86 99.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.784 -0.643 . . . . 1.65 110.675 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.435 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 3.8 mt -70.69 -24.58 62.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.353 -0.385 . . . . 1.17 111.188 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.7 m -66.89 -36.95 83.44 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.135 0.493 . . . . 0.62 109.892 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -76.18 -40.97 51.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 1.21 109.988 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.57 95.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.97 -0.559 . . . . 0.71 111.014 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -61.47 -37.52 83.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 0.59 110.902 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.562 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -60.97 -35.73 77.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.175 -0.466 . . . . 0.71 110.404 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.69 -44.36 82.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.81 -0.632 . . . . 0.84 110.124 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.66 84.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.686 -0.688 . . . . 0.66 111.668 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 44.9 mtm -67.43 -41.35 84.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.331 -0.395 . . . . 1.08 111.005 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.73 -32.94 73.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 0.99 111.124 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.18 -5.14 59.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.418 -0.355 . . . . 0.97 110.751 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.71 40.63 98.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.064 -0.589 . . . . 0.78 112.432 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.3 m -131.9 30.71 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.87 0.367 . . . . 0.81 110.756 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -60.5 -53.85 52.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.801 -0.636 . . . . 1.71 110.792 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -30.81 70.12 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.235 0.54 . . . . 1.91 111.044 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -73.9 -24.5 59.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.894 -0.594 . . . . 2.28 112.205 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.456 ' HA ' ' HG2' ' A' ' 91' ' ' PRO . 27.6 m -108.73 -8.25 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 112.238 0.459 . . . . 0.65 112.238 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.4 m -55.88 -65.32 0.62 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.852 0.686 . . . . 0.98 112.852 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.7 t -60.39 -53.53 63.85 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 113.003 0.742 . . . . 0.62 113.003 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 9.8 Cg_endo -53.42 -38.61 82.99 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.16 1.907 . . . . 0.61 113.346 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.3 mt -69.8 -41.08 75.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.037 -0.357 . . . . 0.79 110.037 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 2.9 m-85 -60.29 -51.93 67.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.276 0.56 . . . . 0.58 110.269 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.3 -37.79 88.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.553 -0.749 . . . . 1.7 110.441 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.12 -8.17 68.94 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.107 -0.568 . . . . 0.82 113.687 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.6 t -112.21 -39.64 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.307 0.554 . . . . 0.75 112.205 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -98.71 -48.0 5.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.605 0.594 . . . . 0.84 112.605 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -74.53 -73.52 0.23 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.122 -0.49 . . . . 1.41 111.35 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -37.91 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.811 -0.631 . . . . 1.31 111.776 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 62.81 27.97 16.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 1.44 110.815 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -28.93 66.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.86 -0.609 . . . . 1.57 111.006 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.22 105.27 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.317 0.58 . . . . 0.91 110.809 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -121.95 -13.45 8.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 3.22 110.705 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 p -140.45 167.6 21.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 1.51 110.146 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -66.06 -27.4 68.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.44 . . . . 1.08 110.105 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -31.85 72.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.384 -0.825 . . . . 1.43 110.559 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 111' ' ' VAL . 64.8 m-20 -71.72 -40.68 69.28 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.11 -0.496 . . . . 1.89 110.194 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 105' ' ' ALA . 14.8 mt -60.68 -43.19 94.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.757 -0.656 . . . . 0.9 110.089 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -58.78 -36.22 74.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.425 -0.807 . . . . 2.19 110.439 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -68.81 -44.84 72.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.769 -0.651 . . . . 1.95 110.626 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 107' ' ' ASP . 43.8 t -59.22 -40.14 80.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.88 110.853 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -62.68 -42.38 99.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 0.92 110.397 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 87.0 mt -62.13 -37.25 77.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.193 0.52 . . . . 1.33 110.245 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.67 -14.31 62.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 1.93 111.152 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.35 -3.02 58.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.201 0.524 . . . . 1.1 110.482 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.92 16.04 26.98 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.802 -0.713 . . . . 1.15 111.942 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 44.8 mm -93.8 129.27 44.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 110.07 -0.344 . . . . 1.61 110.07 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -64.03 131.77 48.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.352 -0.385 . . . . 2.73 110.351 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.44 99.89 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.905 -0.664 . . . . 1.19 111.874 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -64.75 -37.13 86.57 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.657 -0.497 . . . . 2.98 109.657 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.51 -47.02 68.07 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.564 -0.744 . . . . 2.52 109.659 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -60.25 -40.44 90.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.759 -0.655 . . . . 1.51 110.924 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -61.31 -35.41 77.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.991 0.424 . . . . 2.3 111.17 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.33 -45.14 33.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 1.23 110.591 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.11 73.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.872 -0.604 . . . . 1.11 110.915 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -57.13 -33.32 67.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.012 -0.54 . . . . 1.31 110.908 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -111.62 21.67 15.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.274 -0.421 . . . . 1.63 111.256 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -76.91 142.25 40.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.127 -0.488 . . . . 2.04 110.908 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.26 -35.73 78.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.878 -0.601 . . . . 3.82 110.527 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.1 t -63.14 -46.33 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 1.53 109.996 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.562 HG13 ' HB3' ' A' ' 77' ' ' ALA . 55.2 t -63.66 -45.66 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.539 -0.755 . . . . 1.11 110.381 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -59.73 -40.46 88.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 2.43 110.533 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.3 m -66.5 -30.74 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 1.47 110.675 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.2 mt -72.27 -38.12 68.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.337 . . . . 0.93 110.479 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 131' ' ' VAL . 57.4 t -59.36 -46.27 92.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.144 -0.48 . . . . 0.8 110.686 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.23 83.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.908 -0.587 . . . . 0.85 111.546 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -65.67 -39.09 90.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 1.39 111.265 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.528 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 50.9 mt-30 -60.97 -46.57 90.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.61 111.079 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -68.08 -44.18 76.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.229 -0.441 . . . . 2.82 111.09 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -60.34 -45.64 92.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.57 . . . . 1.95 111.473 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -58.69 -51.27 70.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.538 . . . . 0.65 111.427 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.38 86.4 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.935 0.346 . . . . 0.61 111.935 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.28 60.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.252 -0.431 . . . . 0.72 111.908 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.28 -43.17 98.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.02 0.748 . . . . 1.39 113.02 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 141' ' ' ALA . 19.1 m -79.67 1.22 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.358 0.503 . . . . 1.34 112.358 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.42 55.43 5.75 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.576 -0.527 . . . . 1.95 109.576 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.1 tp -61.25 114.63 3.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.587 -0.733 . . . . 0.71 111.302 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.7 mmm-85 -104.48 -38.94 6.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.357 -0.838 . . . . 4.16 109.898 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -104.88 142.54 15.5 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.095 -0.802 . . . . 0.68 111.095 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 16.5 t -69.96 -55.89 8.04 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 119.262 -0.399 . . . . 0.49 111.624 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 81.6 Cg_endo -83.46 62.11 7.23 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.942 1.761 . . . . 0.56 112.436 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.27 148.2 39.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.314 -0.403 . . . . 0.63 111.117 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 51.6 ttm -122.16 135.78 54.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.42 110.565 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -118.63 121.88 41.23 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.747 -0.66 . . . . 0.52 109.626 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.5 t -93.95 120.72 43.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.266 -0.424 . . . . 0.55 110.77 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 61.56 13.65 5.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.212 -0.904 . . . . 1.16 111.604 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.08 24.91 70.63 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.613 -0.595 . . . . 0.56 111.613 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -130.62 -43.07 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.912 0.387 . . . . 1.75 111.448 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -106.05 120.47 41.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.462 -0.336 . . . . 1.16 111.388 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -103.08 132.68 49.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.515 -0.55 . . . . 0.98 109.515 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.46 143.22 33.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.942 0.401 . . . . 1.2 110.628 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -119.52 95.56 49.31 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.992 -0.549 . . . . 0.72 110.145 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.79 -25.46 53.32 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.226 1.951 . . . . 0.54 112.622 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -71.99 -13.78 61.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 2.22 110.754 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.3 0.37 50.45 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.812 -0.708 . . . . 0.59 112.404 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.1 mtt -97.6 -172.25 2.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.57 110.449 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.32 120.49 15.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 1.54 110.476 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.25 15.75 18.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.137 0.494 . . . . 1.16 110.733 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.51 -40.45 6.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 1.53 110.719 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -121.74 116.76 25.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.753 0.311 . . . . 1.21 110.858 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -55.06 -41.54 71.59 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.769 -0.65 . . . . 1.96 111.907 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -43.19 63.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.185 0.517 . . . . 2.05 111.43 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 33.1 t -74.26 -45.39 47.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.672 -0.694 . . . . 0.65 111.176 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -55.52 -50.56 69.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.329 -0.396 . . . . 0.47 111.443 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.19 -49.2 80.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.48 111.512 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 33.2 mm-40 -68.86 -44.76 72.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.485 -0.325 . . . . 1.7 111.608 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 2.4 mt-30 -56.83 -46.93 81.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.525 0.202 . . . . 1.32 111.367 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 182' ' ' VAL . 10.3 t80 -59.15 -54.15 50.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.808 0.337 . . . . 0.46 111.032 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -64.83 -37.46 87.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 0.43 112.206 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -67.44 -37.56 83.17 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.837 0.351 . . . . 1.55 110.637 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 94.8 m -62.26 -36.67 82.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.48 109.826 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 178' ' ' TYR . 92.8 t -58.93 -49.37 83.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.003 -0.544 . . . . 0.48 110.481 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 37.6 tttm -58.83 -43.18 90.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 1.59 110.975 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -61.96 -43.95 97.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 1.17 111.671 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.01 -34.7 64.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.051 0.389 . . . . 0.68 112.051 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.6 m -69.28 -29.67 67.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.11 0.481 . . . . 1.07 110.495 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.73 -0.668 . . . . 2.26 110.715 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.129 0.49 . . . . 1.32 111.185 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.08 139.64 53.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.459 -0.791 . . . . 2.29 110.015 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.42 121.35 15.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.044 0.45 . . . . 1.83 110.408 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.04 -18.93 28.19 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.744 -0.662 . . . . 0.78 111.758 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -100.97 -79.4 0.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.773 0.32 . . . . 1.87 110.872 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -83.77 -27.16 29.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.671 0.272 . . . . 1.46 111.341 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -145.72 153.5 41.03 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.928 -0.397 . . . . 0.79 109.928 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.11 130.48 49.92 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.394 -0.366 . . . . 0.9 110.841 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -81.81 120.41 25.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.884 -0.413 . . . . 1.11 109.884 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.0 mt -67.71 136.02 53.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.085 -0.507 . . . . 0.74 111.291 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.43 -26.92 52.0 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.259 -0.645 . . . . 2.33 109.259 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -120.92 88.61 44.75 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.399 -0.819 . . . . 3.64 109.544 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.6 162.47 32.97 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.769 2.313 . . . . 0.85 113.034 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.9 t -103.72 113.61 41.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.755 -0.657 . . . . 0.72 110.41 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.45 138.37 47.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.137 -0.483 . . . . 0.89 111.433 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.3 86.58 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.08 -0.581 . . . . 0.73 112.886 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.64 151.56 84.9 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.535 0.168 . . . . 0.64 110.666 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.11 173.67 10.05 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.288 1.992 . . . . 0.56 112.297 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.63 -46.29 72.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.091 -0.504 . . . . 1.79 110.784 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -127.56 105.0 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.812 0.339 . . . . 0.45 110.383 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.6 tp -108.25 121.03 44.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.928 -0.578 . . . . 0.53 109.726 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -123.92 145.51 49.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.447 -0.342 . . . . 1.61 110.506 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -121.15 147.27 45.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.079 -0.509 . . . . 0.53 109.981 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -167.68 178.95 5.05 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.056 -0.52 . . . . 0.55 111.024 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.471 ' HB2' HG22 ' A' ' 61' ' ' VAL . 7.8 t -158.94 138.36 11.57 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.01 -0.541 . . . . 0.96 110.001 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.3 m-85 -69.35 -18.84 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.11 0.481 . . . . 0.62 109.97 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CE2' HD12 ' A' ' 72' ' ' LEU . 78.9 m-85 -83.65 -6.9 59.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.48 -0.782 . . . . 1.78 110.866 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.9 t -97.95 117.19 65.39 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 116.504 -0.316 . . . . 0.48 110.808 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.544 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 18.3 Cg_endo -62.05 -23.07 75.33 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.268 1.979 . . . . 0.7 112.019 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -34.8 64.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.037 -0.529 . . . . 1.74 110.652 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.1 m -71.39 -33.34 69.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.068 0.461 . . . . 0.37 110.259 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -63.26 -45.54 91.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.547 0.689 . . . . 1.44 109.298 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.604 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 8.8 tm0? -71.28 -37.67 71.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.948 -1.024 . . . . 2.27 111.182 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.3 -22.93 66.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.232 0.456 . . . . 0.87 112.232 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -108.71 -51.36 2.9 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.927 -0.709 . . . . 1.89 112.378 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -68.12 -27.69 66.67 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.879 -0.513 . . . . 2.0 111.65 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 78.7 t -102.86 -64.87 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.663 -0.244 . . . . 0.58 111.073 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.65 -38.49 67.66 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.702 0.26 . . . . 0.41 111.702 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 64.02 50.56 2.47 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.468 0.48 . . . . 0.84 110.455 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.47 -52.56 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.84 -0.618 . . . . 0.41 111.551 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.595 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 21.5 m -58.16 -52.18 66.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.488 0.185 . . . . 1.03 111.033 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 29.9 t70 -58.93 -39.33 81.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.582 -0.281 . . . . 1.73 111.687 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -71.54 -42.8 67.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.697 0.285 . . . . 1.19 110.632 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 37.5 t -59.49 -41.13 83.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.49 110.683 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 43' ' ' SER . 75.5 mttt -55.2 -36.7 66.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.896 0.379 . . . . 1.53 110.871 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 36.1 mttm -80.76 -13.23 59.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.12 -0.491 . . . . 2.02 112.218 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -109.88 8.23 24.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.579 0.228 . . . . 1.44 111.54 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 41.7 mt -96.09 136.7 21.94 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.889 -0.324 . . . . 1.0 111.643 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.54 177.47 3.97 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.537 2.158 . . . . 0.74 111.646 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -75.01 149.01 39.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.913 0.387 . . . . 2.63 110.631 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.14 -18.5 40.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.019 -0.61 . . . . 0.82 112.298 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 t -84.09 132.14 32.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.827 0.346 . . . . 1.03 110.613 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -117.45 136.77 52.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.402 -0.363 . . . . 2.51 110.805 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.1 mtp -82.79 113.68 20.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.534 . . . . 1.28 110.088 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.1 94.01 5.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.072 0.463 . . . . 0.61 110.747 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -89.91 116.82 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 0.86 109.937 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 4.8 m-30 -111.89 150.87 29.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.112 0.482 . . . . 0.71 111.304 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -100.3 128.06 46.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.922 -0.581 . . . . 0.57 110.604 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 27' ' ' SER . 8.1 m -80.38 152.71 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.507 -0.315 . . . . 0.68 110.54 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -103.62 -0.5 29.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.787 0.662 . . . . 0.93 112.787 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -96.3 16.93 17.01 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.699 -0.4 . . . . 0.74 110.984 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.53 107.47 5.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.355 -0.384 . . . . 1.09 110.47 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.56 18.68 1.58 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.886 -0.673 . . . . 0.78 112.941 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.53 -112.25 4.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.269 -0.491 . . . . 0.81 113.024 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.52 -31.03 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.608 0.242 . . . . 2.47 111.167 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.21 -17.37 63.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.831 0.348 . . . . 1.94 110.639 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.81 -33.48 78.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.988 -0.625 . . . . 0.7 111.664 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -66.65 -33.07 74.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.906 0.384 . . . . 2.69 110.506 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -74.09 -41.18 62.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 1.65 110.533 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.553 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -64.24 -27.98 69.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.32 -0.4 . . . . 1.17 111.045 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.3 m -65.18 -36.03 82.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.065 0.46 . . . . 0.62 110.263 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 78' ' ' VAL . 15.1 tt0 -75.81 -37.93 58.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.132 -0.692 . . . . 1.21 109.132 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.42 -44.85 95.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.55 -0.75 . . . . 0.71 110.444 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.544 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 69.6 t-105 -61.11 -36.03 78.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.333 -0.849 . . . . 0.59 110.764 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.508 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -64.59 -37.76 88.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 0.71 110.268 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 74' ' ' GLN . 57.0 t -65.68 -42.94 93.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 0.84 109.849 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.71 92.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.578 -0.737 . . . . 0.66 110.742 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 28.5 mtm -63.73 -39.14 93.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 1.08 111.196 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.07 -39.37 79.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.161 -0.472 . . . . 0.99 111.29 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.39 -29.35 47.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.242 -0.436 . . . . 0.97 111.36 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.74 10.41 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.692 -0.766 . . . . 0.78 111.964 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.98 26.08 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 110.548 -0.167 . . . . 0.81 110.548 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.544 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 3.5 mp0 -55.56 -61.99 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 1.71 111.249 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -37.87 67.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.002 -0.545 . . . . 1.91 111.98 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm -64.0 -33.4 75.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 2.28 112.084 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.2 m -101.17 -8.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.848 0.314 . . . . 0.65 111.848 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.9 m -58.19 -49.04 78.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.919 0.34 . . . . 0.98 111.919 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.46 -58.35 15.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 112.336 0.495 . . . . 0.62 112.336 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.46 -36.45 98.74 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.866 1.71 . . . . 0.61 113.221 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.84 -42.99 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.702 0.286 . . . . 0.79 110.279 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -62.69 -46.83 86.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.129 0.49 . . . . 0.58 110.722 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.06 -42.54 96.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.699 -0.682 . . . . 1.7 111.321 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.36 -14.13 68.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.955 -0.64 . . . . 0.82 113.527 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.1 -32.23 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 117.076 0.438 . . . . 0.75 112.025 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 31' ' ' PRO . 53.2 mt-30 -113.89 -42.77 3.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.783 1.031 . . . . 0.84 113.783 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -69.25 -61.96 1.58 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.773 0.32 . . . . 1.41 111.246 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.8 p -92.84 -30.17 15.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.315 -0.402 . . . . 1.31 110.743 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 61.28 33.31 19.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.627 -0.715 . . . . 1.44 110.121 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.7 -31.75 41.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.295 -0.866 . . . . 1.57 111.239 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.9 mt -70.75 106.09 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.91 110.421 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -129.15 -11.72 4.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.391 -0.822 . . . . 3.22 110.494 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.3 m -134.4 165.91 24.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.949 -0.569 . . . . 1.51 110.293 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.17 64.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.1 0.476 . . . . 1.08 110.738 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -36.73 84.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.784 -0.644 . . . . 1.43 110.602 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 111' ' ' VAL . 15.9 m-20 -63.8 -46.28 85.89 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.307 -0.627 . . . . 1.89 109.307 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.0 mt -59.47 -39.73 79.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.541 -0.754 . . . . 0.9 110.482 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -62.19 -43.36 99.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.81 -0.632 . . . . 2.19 110.689 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -65.28 -33.86 76.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.286 -0.416 . . . . 1.95 110.639 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 107' ' ' ASP . 92.6 t -62.2 -43.99 98.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.963 -0.562 . . . . 0.88 110.279 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -63.92 -39.03 93.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.92 110.56 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 80.0 mt -64.65 -30.81 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.433 0.635 . . . . 1.33 109.897 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -77.1 -14.91 59.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.547 -0.752 . . . . 1.93 110.821 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.82 1.07 57.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.029 -0.532 . . . . 1.1 111.054 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.82 4.12 45.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 1.15 112.881 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 49.1 mm -91.05 148.09 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.096 -0.335 . . . . 1.61 110.096 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -88.76 150.65 22.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.385 -0.37 . . . . 2.73 110.859 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.58 -56.31 22.23 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.998 -0.546 . . . . 1.19 113.183 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.82 -32.66 70.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.967 0.413 . . . . 2.98 110.93 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.2 -42.6 96.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 2.52 109.779 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -69.38 -44.25 71.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.465 -0.788 . . . . 1.51 110.234 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -60.27 -39.94 88.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.146 -0.479 . . . . 2.3 110.877 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.62 -48.44 79.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.915 -0.584 . . . . 1.23 111.578 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.43 -33.43 72.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 1.11 111.673 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -56.7 -31.42 64.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 1.31 111.065 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -105.83 29.01 7.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.015 -0.538 . . . . 1.63 111.223 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.8 t -93.22 145.79 24.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.722 0.296 . . . . 2.04 110.626 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -61.65 -37.67 84.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 3.82 110.835 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.29 -42.05 86.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.217 0.532 . . . . 1.53 110.314 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 77' ' ' ALA . 44.8 t -67.3 -45.8 85.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.404 -0.816 . . . . 1.11 110.483 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -58.86 -38.23 78.3 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.264 -0.425 . . . . 2.43 110.875 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -43.24 71.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.073 -0.512 . . . . 1.47 110.425 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.432 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 34.6 mt -62.82 -38.16 89.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.438 . . . . 0.93 110.9 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 131' ' ' VAL . 61.7 t -60.12 -52.33 62.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.275 -0.421 . . . . 0.8 110.317 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.3 -37.25 74.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 0.85 111.367 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -65.07 -39.76 93.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.479 . . . . 1.39 111.293 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.481 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 53.0 mt-30 -60.53 -45.91 92.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.61 111.372 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -33.73 58.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.627 0.251 . . . . 2.82 111.149 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -65.69 -51.43 59.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.652 -0.249 . . . . 1.95 111.326 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.92 90.38 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.311 0.382 . . . . 0.65 111.468 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.26 86.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.399 -0.364 . . . . 0.61 111.404 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.08 -26.61 26.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.352 -0.385 . . . . 0.72 111.59 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -36.59 76.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.165 0.507 . . . . 1.39 110.637 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.68 -4.4 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.12 -0.491 . . . . 1.34 110.062 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.576 ' O ' ' HD3' ' A' ' 148' ' ' ARG . 88.8 mt-30 57.72 74.28 0.43 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.54 -0.755 . . . . 1.95 110.137 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tp -59.76 124.19 19.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.557 -0.747 . . . . 0.71 111.437 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.576 ' HD3' ' O ' ' A' ' 146' ' ' GLN . 1.6 mpp_? -103.45 18.65 21.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.182 0.515 . . . . 4.16 110.603 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -179.63 172.46 44.24 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.896 -0.882 . . . . 0.68 110.896 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.526 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.9 t -84.86 -56.79 0.39 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 117.324 0.562 . . . . 0.49 111.307 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.8 Cg_endo -82.2 88.92 1.24 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.149 1.9 . . . . 0.56 111.352 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.98 146.01 50.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.052 -0.522 . . . . 0.63 111.069 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 53.0 ttm -133.26 131.64 40.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.986 -0.375 . . . . 0.42 109.986 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -122.37 137.56 54.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.093 -0.503 . . . . 0.52 110.365 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.1 t -107.68 122.56 62.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.277 -0.42 . . . . 0.55 110.905 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 61.98 10.87 3.85 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.231 -0.895 . . . . 1.16 112.188 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 68.95 19.56 73.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.251 -0.499 . . . . 0.56 112.301 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -129.1 -41.11 1.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.392 . . . . 1.75 111.195 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.424 ' HB3' HD13 ' A' ' 185' ' ' LEU . 48.0 m-85 -96.71 123.79 40.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.143 -0.48 . . . . 1.16 111.568 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -108.07 123.99 49.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.712 -0.676 . . . . 0.98 109.251 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.78 143.61 39.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.682 0.277 . . . . 1.2 111.118 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -119.43 96.75 50.01 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.173 0.511 . . . . 0.72 110.205 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.8 -19.29 41.15 Favored 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.443 2.095 . . . . 0.54 112.713 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -72.38 -22.23 61.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 2.22 111.284 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.27 21.04 34.06 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.646 -0.787 . . . . 0.59 112.056 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.0 mtt -106.29 -164.46 1.01 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.415 -0.217 . . . . 0.57 110.415 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.02 132.63 46.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 1.54 111.111 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.9 20.76 6.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.832 -0.622 . . . . 1.16 109.691 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.99 -41.84 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 1.53 110.914 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -126.8 126.42 43.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.119 -0.491 . . . . 1.21 110.169 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.477 ' O ' HG23 ' A' ' 175' ' ' VAL . 14.3 mmt -61.01 -44.32 97.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.948 -0.569 . . . . 1.96 110.573 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' A' ' 176' ' ' GLN . 31.6 t70 -58.72 -45.36 89.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.75 -0.659 . . . . 2.05 111.199 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.85 -43.82 99.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.403 . . . . 0.65 110.718 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -57.32 -45.97 83.7 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.242 -0.435 . . . . 0.47 110.68 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 171' ' ' MET . 90.6 t -58.9 -47.42 89.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.48 110.93 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 172' ' ' ASP . 54.7 mm-40 -65.08 -48.71 72.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 1.7 110.776 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -58.6 -45.74 88.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 1.32 111.646 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 182' ' ' VAL . 31.7 t80 -60.44 -50.41 73.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.46 111.002 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.98 87.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.43 111.111 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.63 -37.85 88.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 1.55 110.006 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 58.3 m -59.98 -40.49 89.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.028 -0.533 . . . . 0.48 110.224 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 178' ' ' TYR . 41.9 t -60.67 -51.43 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 CA-C-N 115.828 -0.623 . . . . 0.48 110.165 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -60.31 -44.59 95.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.954 -0.566 . . . . 1.59 110.536 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -57.77 -44.63 86.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.5 -0.773 . . . . 1.17 111.041 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 159' ' ' TYR . 96.0 mt -72.14 -29.37 63.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.321 -0.4 . . . . 0.68 111.438 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 40.4 m -71.49 -34.55 70.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.409 -0.36 . . . . 1.07 110.819 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.229 -0.442 . . . . 2.26 110.798 -179.887 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.848 0.356 . . . . 1.32 110.711 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -119.43 148.36 43.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.345 -0.389 . . . . 2.29 110.94 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.97 130.2 41.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.935 -0.575 . . . . 1.83 109.693 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.15 -20.59 40.09 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.748 -0.941 . . . . 0.78 110.748 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.549 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 36.4 tptt -105.78 -77.3 0.59 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.755 -0.222 . . . . 1.87 110.809 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -80.04 -35.24 37.49 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.832 0.349 . . . . 1.46 111.477 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -140.76 156.08 46.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.28 -0.418 . . . . 0.79 110.733 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.82 129.73 46.01 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.119 -0.492 . . . . 0.9 110.048 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 m -77.84 121.04 23.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.017 0.437 . . . . 1.11 110.963 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.1 mt -68.57 127.31 32.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.751 -0.659 . . . . 0.74 110.829 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.13 -27.68 68.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.154 0.502 . . . . 2.33 110.746 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -120.86 96.7 48.62 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.983 -0.747 . . . . 3.64 108.983 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HB3' ' HG2' ' A' ' 158' ' ' LYS . 65.1 Cg_endo -76.1 153.25 36.52 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 122.555 2.17 . . . . 0.85 112.584 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -90.93 122.5 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.674 -0.694 . . . . 0.72 109.739 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.7 127.2 31.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.786 -0.643 . . . . 0.89 111.084 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.33 31.92 49.66 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.686 -0.768 . . . . 0.73 112.142 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.61 145.54 32.47 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.396 -0.224 . . . . 0.64 110.396 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.3 164.77 26.93 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.446 2.097 . . . . 0.56 112.432 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -58.34 -56.54 20.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.281 -0.872 . . . . 1.79 111.243 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.4 t -120.33 105.56 17.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.989 0.423 . . . . 0.45 110.185 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.5 tp -105.95 129.73 54.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.08 -0.509 . . . . 0.53 110.15 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 25' ' ' PHE . 4.0 tt0 -127.58 149.44 50.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.455 -0.339 . . . . 1.61 110.456 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.495 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 61.3 m-85 -127.4 146.08 50.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.987 -0.551 . . . . 0.53 110.195 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -163.11 175.87 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.105 0.478 . . . . 0.55 110.906 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.46 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 8.6 t -156.13 141.59 17.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.923 -0.58 . . . . 0.96 109.967 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.411 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 88.0 m-85 -74.57 -8.58 56.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.959 -0.564 . . . . 0.62 110.751 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -101.37 8.12 42.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.224 -0.444 . . . . 1.78 111.002 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 20.8 t -111.65 119.63 44.36 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.62 -0.264 . . . . 0.48 111.202 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 22.0 Cg_endo -65.67 -21.99 58.2 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.402 2.068 . . . . 0.7 111.439 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.563 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 0.3 OUTLIER -64.14 -48.25 76.76 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.895 -0.593 . . . . 1.74 110.019 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 38.7 m -66.88 -31.82 72.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.984 -0.553 . . . . 0.37 110.394 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -60.07 -44.47 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.479 -0.563 . . . . 1.44 109.479 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 31' ' ' PRO . 34.8 mm-40 -73.38 -41.29 63.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.731 -0.668 . . . . 2.27 110.65 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.487 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.4 m-85 -63.76 -35.44 80.61 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.026 -0.534 . . . . 0.87 112.428 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -93.3 -50.16 5.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.065 0.765 . . . . 1.89 113.065 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -77.36 -35.81 54.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.127 0.788 . . . . 2.0 113.127 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 53.9 t -94.61 -57.77 4.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.586 -0.446 . . . . 0.58 112.148 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.27 -26.57 33.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.061 0.763 . . . . 0.41 113.061 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 60.95 44.91 10.01 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.982 -0.377 . . . . 0.84 109.982 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.487 HG13 ' CD2' ' A' ' 36' ' ' PHE . 33.9 mm -57.11 -66.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.505 0.557 . . . . 0.41 112.505 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.0 m -62.01 -34.18 75.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 1.03 110.78 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.92 -45.6 93.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.814 -0.63 . . . . 1.73 110.143 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -69.45 -37.5 77.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 1.19 110.214 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 54.4 t -60.96 -42.31 92.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 0.49 110.433 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -63.22 -12.72 30.66 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.189 -0.459 . . . . 1.53 110.948 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -113.78 6.21 16.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.127 0.489 . . . . 2.02 111.192 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -116.29 -27.83 6.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.103 -0.499 . . . . 1.44 110.535 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 81.6 mt -66.24 145.1 98.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.224 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -78.0 170.85 18.16 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.36 2.04 . . . . 0.74 111.643 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.81 137.67 54.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 2.63 111.145 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.92 -21.79 43.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.093 -0.575 . . . . 0.82 112.038 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 t -92.83 108.09 19.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.865 0.364 . . . . 1.03 110.098 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -89.93 156.52 18.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 2.51 110.933 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 17.1 ttt -109.06 143.86 37.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.781 -0.645 . . . . 1.28 109.707 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.52 108.08 9.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 0.61 110.826 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 14.6 ttmm -94.17 116.85 29.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.725 -0.67 . . . . 0.86 110.154 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 10.0 m-30 -114.46 161.4 18.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.157 0.503 . . . . 0.71 111.688 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.46 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 43.2 t-80 -105.79 142.19 35.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.61 . . . . 0.57 111.002 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -97.62 149.58 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.794 0.33 . . . . 0.68 110.89 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -93.52 -16.47 24.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.837 0.68 . . . . 0.93 112.837 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -83.21 10.24 8.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.696 0.628 . . . . 0.74 112.696 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.1 96.17 3.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.973 0.416 . . . . 1.09 111.044 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.87 0.17 6.09 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.936 -0.649 . . . . 0.78 112.467 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.06 -129.34 43.52 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.283 -0.484 . . . . 0.81 112.647 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.62 -38.15 65.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.7 -0.482 . . . . 2.47 109.7 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.55 -26.94 68.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.573 -0.739 . . . . 1.94 109.897 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.84 -43.51 96.03 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.515 -0.766 . . . . 0.7 111.823 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -63.84 -35.55 81.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.207 -0.294 . . . . 2.69 110.207 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -43.22 99.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.394 0.616 . . . . 1.65 109.857 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.34 -34.38 78.0 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 115.549 -0.75 . . . . 1.17 110.689 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.6 m -62.11 -36.48 81.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.37 . . . . 0.62 111.101 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.549 ' HA ' HG22 ' A' ' 135' ' ' VAL . 42.7 tt0 -76.43 -45.02 33.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.623 -0.262 . . . . 1.21 110.39 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.19 88.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.046 0.45 . . . . 0.71 110.677 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.508 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 66.5 t-105 -61.26 -37.69 84.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.543 -0.753 . . . . 0.59 110.961 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.644 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.5 -34.01 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.71 110.3 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.443 HG22 HG21 ' A' ' 131' ' ' VAL . 58.2 t -66.14 -41.66 89.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.945 -0.57 . . . . 0.84 109.62 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.52 81.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.479 -0.782 . . . . 0.66 111.08 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 29.4 mtm -68.41 -38.68 81.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.979 -0.555 . . . . 1.08 111.095 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.68 -31.41 70.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.191 -0.458 . . . . 0.99 111.877 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.72 -13.7 28.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.543 -0.299 . . . . 0.97 111.531 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.44 39.7 49.92 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.488 -0.863 . . . . 0.78 111.791 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.87 22.58 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.012 -0.366 . . . . 0.81 110.012 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.508 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -56.23 -59.92 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.662 -0.699 . . . . 1.71 111.406 -178.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.52 -19.15 64.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.531 . . . . 1.91 111.514 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -78.05 -39.78 40.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.334 -0.393 . . . . 2.28 111.442 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.5 m -94.72 -10.4 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.381 0.511 . . . . 0.65 112.381 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.1 m -59.26 -49.39 78.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.738 0.304 . . . . 0.98 111.558 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.425 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 47.1 t -62.46 -58.8 15.17 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 112.099 0.407 . . . . 0.62 112.099 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.425 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 15.6 Cg_endo -57.24 -33.39 95.94 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.059 1.839 . . . . 0.61 113.018 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.478 HD23 HD13 ' A' ' 102' ' ' ILE . 17.3 mt -73.02 -46.97 48.98 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.974 -0.29 . . . . 0.79 110.701 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -58.59 -52.38 65.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.156 0.503 . . . . 0.58 110.779 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.52 -42.42 95.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.644 -0.707 . . . . 1.7 111.182 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.37 -14.22 71.54 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.217 -0.516 . . . . 0.82 114.232 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.21 -42.51 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.539 0.669 . . . . 0.75 112.276 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -99.6 -38.45 8.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.861 0.689 . . . . 0.84 112.861 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -78.7 -64.64 1.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.511 -0.476 . . . . 1.41 110.542 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -34.21 40.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.124 -0.489 . . . . 1.31 111.615 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 60.97 31.85 19.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.144 0.497 . . . . 1.44 110.819 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.35 -35.37 19.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.794 -0.639 . . . . 1.57 111.211 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.478 HD13 HD23 ' A' ' 92' ' ' LEU . 30.2 mt -79.33 96.97 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.838 -0.619 . . . . 0.91 110.971 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -135.25 22.16 3.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.026 0.441 . . . . 3.22 111.082 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.416 ' O ' HG13 ' A' ' 108' ' ' ILE . 83.6 p -159.49 160.38 34.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.035 -0.53 . . . . 1.51 109.717 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.39 -28.99 70.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.126 0.489 . . . . 1.08 110.392 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -61.21 -34.28 74.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.428 -0.806 . . . . 1.43 110.435 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 111' ' ' VAL . 56.9 m-20 -76.2 -47.59 23.51 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.898 -0.592 . . . . 1.89 109.589 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 104' ' ' SER . 27.5 mt -55.3 -46.41 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.67 -0.695 . . . . 0.9 111.156 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 113' ' ' ILE . 62.7 ttt-85 -59.13 -45.43 90.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.2 -0.455 . . . . 2.19 110.679 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.75 -42.04 99.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.304 -0.407 . . . . 1.95 110.904 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 107' ' ' ASP . 90.6 t -60.55 -44.79 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.222 -0.444 . . . . 0.88 110.595 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.402 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 7.6 m-85 -62.5 -44.9 95.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.093 -0.503 . . . . 0.92 110.727 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 73.3 mt -63.68 -38.82 83.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 1.33 110.525 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -67.8 -31.67 71.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.47 . . . . 1.93 110.759 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.38 -8.1 53.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.313 -0.403 . . . . 1.1 111.591 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.37 0.74 26.46 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.475 -0.869 . . . . 1.15 112.98 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 3.3 mp -85.93 121.7 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.867 -0.42 . . . . 1.61 109.867 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -60.91 136.69 58.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.824 -0.625 . . . . 2.73 111.107 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.57 -41.92 98.97 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.609 -0.597 . . . . 1.19 111.609 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -65.74 -23.17 66.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 2.98 110.685 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -82.75 -45.33 14.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.97 -0.559 . . . . 2.52 109.515 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -63.55 -44.25 94.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.506 -0.77 . . . . 1.51 110.483 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.34 -43.16 96.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.978 0.418 . . . . 2.3 110.827 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.29 -47.6 83.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 1.23 110.624 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.05 -41.21 95.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 1.11 111.109 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -59.94 -30.02 68.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.31 111.504 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -96.15 -26.12 15.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.148 0.425 . . . . 1.63 112.148 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 m -65.22 149.42 49.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.321 0.581 . . . . 2.04 112.507 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -73.01 -21.14 60.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.513 -0.767 . . . . 3.82 111.723 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.87 -50.1 70.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.26 0.552 . . . . 1.53 110.101 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.644 HG13 ' HB3' ' A' ' 77' ' ' ALA . 36.0 t -66.5 -41.69 88.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.419 -0.81 . . . . 1.11 110.414 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -56.87 -41.31 77.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.088 -0.505 . . . . 2.43 111.075 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.5 m -63.37 -39.41 94.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.983 -0.553 . . . . 1.47 110.202 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.44 -37.71 83.39 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.331 -0.395 . . . . 0.93 110.479 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 131' ' ' VAL . 41.5 t -61.46 -51.68 70.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.023 -0.362 . . . . 0.8 110.023 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.56 69.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.772 -0.649 . . . . 0.85 111.048 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -66.31 -42.45 88.24 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.009 -0.541 . . . . 1.39 110.271 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.53 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 51.8 mt-30 -62.59 -48.15 80.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.833 -0.621 . . . . 0.61 109.919 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 29.0 mt-10 -62.37 -44.47 96.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.341 -0.845 . . . . 2.82 111.194 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -60.91 -46.99 88.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.849 -0.614 . . . . 1.95 111.514 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.55 -44.12 84.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.912 0.338 . . . . 0.65 111.912 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.38 -30.52 64.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.224 0.453 . . . . 0.61 112.224 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.4 -27.18 25.96 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.565 0.579 . . . . 0.72 112.565 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.17 -47.71 23.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.629 0.252 . . . . 1.39 110.565 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.5 p -80.76 -8.31 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.814 0.34 . . . . 1.34 110.764 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 58.21 58.53 3.45 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.735 -0.666 . . . . 1.95 110.435 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 149' ' ' GLY . 40.9 tp -67.13 111.74 4.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.461 -0.79 . . . . 0.71 110.803 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -87.31 -33.71 19.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.611 -0.722 . . . . 4.16 110.556 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.591 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . -93.9 173.61 33.56 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.989 -0.845 . . . . 0.68 110.989 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.557 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 4.6 t -102.89 -57.56 0.1 OUTLIER Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 117.865 0.832 . . . . 0.49 112.761 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 4.1 Cg_endo -85.27 70.16 5.27 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.231 1.954 . . . . 0.56 111.928 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.22 139.31 50.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.905 -0.589 . . . . 0.63 110.766 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 21.6 ttm -113.38 139.02 49.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.042 -0.526 . . . . 0.42 109.912 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -122.96 133.98 54.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.549 -0.296 . . . . 0.52 110.728 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.8 t -101.3 114.76 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.343 -0.389 . . . . 0.55 110.752 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.69 25.84 10.57 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.524 -0.762 . . . . 1.16 111.418 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.48 26.88 60.18 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.743 -0.662 . . . . 0.56 113.167 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 15' ' ' PRO . 30.1 mtmm -126.9 -39.23 1.97 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.099 0.407 . . . . 1.75 112.099 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -106.66 135.9 47.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.003 -0.279 . . . . 1.16 111.432 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -108.23 136.18 48.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.794 -0.639 . . . . 0.98 110.056 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.61 129.63 34.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.472 -0.331 . . . . 1.2 110.54 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -112.73 100.6 51.07 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.415 -0.357 . . . . 0.72 110.723 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.47 -15.32 34.4 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.685 2.257 . . . . 0.54 112.321 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -86.04 2.63 45.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.107 0.48 . . . . 2.22 111.02 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -105.15 16.38 45.98 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.006 -0.616 . . . . 0.59 111.592 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 40.1 mtt -127.67 166.21 18.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.0 -0.37 . . . . 0.57 110.0 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -80.81 133.4 35.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.381 -0.372 . . . . 1.54 111.132 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 -3.16 36.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.15 -0.477 . . . . 1.16 111.744 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 m -67.22 -36.21 81.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.874 0.368 . . . . 1.53 110.814 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -118.33 111.12 18.32 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.235 -0.654 . . . . 1.21 109.235 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 42.9 mtt -66.08 -40.83 91.14 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.488 0.551 . . . . 1.96 112.488 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.46 -50.28 74.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.808 0.337 . . . . 2.05 111.15 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.99 -38.91 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.967 -0.56 . . . . 0.65 110.472 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.81 -53.38 55.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.47 110.908 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 70.2 t -58.3 -48.32 85.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.98 -0.555 . . . . 0.48 111.312 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 61.6 mm-40 -64.67 -40.13 94.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.602 -0.272 . . . . 1.7 111.548 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -64.22 -43.89 93.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.069 -0.345 . . . . 1.32 110.069 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.427 ' O ' HG23 ' A' ' 182' ' ' VAL . 20.4 t80 -57.37 -54.23 49.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.46 110.289 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.83 85.09 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.97 -0.559 . . . . 0.43 111.787 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -67.21 -37.64 83.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.594 -0.276 . . . . 1.55 110.584 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 37.8 m -61.73 -42.6 99.17 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.047 0.451 . . . . 0.48 109.911 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 178' ' ' TYR . 49.0 t -61.49 -47.64 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.672 -0.695 . . . . 0.48 110.274 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 187' ' ' GLU . 34.4 tttp -56.84 -53.38 58.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.818 -0.628 . . . . 1.59 110.948 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -54.68 -41.66 70.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.423 -0.353 . . . . 1.17 111.33 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.55 -38.65 67.92 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.938 0.348 . . . . 0.68 111.938 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 35.2 p -65.86 -35.34 80.37 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.103 -0.239 . . . . 1.07 111.608 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 12.3 pt-20 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 121.105 0.478 . . . . 2.26 111.334 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.826 0.346 . . . . 1.32 110.322 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -110.22 140.96 43.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 2.29 109.812 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -69.88 122.01 18.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.531 -0.544 . . . . 1.83 109.531 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.579 ' HA2' HG23 ' A' ' 10' ' ' THR . . . 97.94 -11.36 64.21 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.939 -0.648 . . . . 0.78 111.607 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -95.68 -83.16 0.37 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.493 0.187 . . . . 1.87 110.736 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.495 ' HG2' HE21 ' A' ' 177' ' ' GLN . 23.9 mp0 -84.57 -25.31 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.08 0.467 . . . . 1.46 110.52 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -142.98 153.9 43.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.819 -0.628 . . . . 0.79 109.627 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.579 HG23 ' HA2' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -127.38 133.52 50.01 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.398 -0.364 . . . . 0.9 110.563 -179.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.5 m -87.83 126.7 35.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.9 0.381 . . . . 1.11 111.051 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -85.51 140.84 30.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.448 -0.342 . . . . 0.74 110.39 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -20.28 46.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.981 0.419 . . . . 2.33 110.116 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -118.98 93.93 47.46 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.88 -0.6 . . . . 3.64 109.955 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.69 145.23 12.84 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.681 2.254 . . . . 0.85 112.847 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.1 t -80.56 113.84 20.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.828 -0.623 . . . . 0.72 110.22 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.0 128.77 37.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.424 . . . . 0.89 111.36 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.47 16.17 74.32 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.86 -0.609 . . . . 0.73 112.91 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.9 144.58 79.94 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.697 0.248 . . . . 0.64 110.616 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 14.8 Cg_endo -60.15 160.98 20.78 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.606 2.204 . . . . 0.56 112.051 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.485 ' NE2' ' HA ' ' A' ' 54' ' ' VAL . 46.4 mt-30 -57.1 -51.34 69.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.843 -0.617 . . . . 1.79 111.245 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.6 t -128.18 104.5 11.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.837 -0.431 . . . . 0.45 109.837 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.544 HD21 ' HB1' ' A' ' 141' ' ' ALA . 46.3 tp -102.97 132.89 48.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.53 110.746 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.89 150.82 49.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.366 -0.379 . . . . 1.61 110.065 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -122.71 148.29 45.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.465 -0.334 . . . . 0.53 110.72 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.01 173.55 15.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.136 -0.484 . . . . 0.55 110.591 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.54 ' OG ' HG22 ' A' ' 61' ' ' VAL . 52.5 m -154.47 132.42 11.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.134 -0.484 . . . . 0.96 110.651 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.585 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 67.5 m-85 -66.81 -20.68 65.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.62 111.012 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.77 2.89 54.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 1.78 111.04 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 40.5 t -108.41 119.82 48.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.328 -0.396 . . . . 0.48 110.658 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.33 -27.73 63.42 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.615 2.21 . . . . 0.7 112.105 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 0.1 OUTLIER -64.85 -47.26 78.58 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.583 -0.735 . . . . 1.74 109.984 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.7 m -63.82 -37.31 86.9 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.801 0.334 . . . . 0.37 110.528 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -60.89 -51.98 66.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 1.44 109.942 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -65.0 -35.03 79.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.394 -0.821 . . . . 2.27 111.549 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.61 -29.69 70.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.928 0.714 . . . . 0.87 112.928 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -105.92 -35.32 7.34 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.705 -0.398 . . . . 1.89 111.397 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -43.35 60.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 2.0 111.847 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.81 -58.01 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.166 0.432 . . . . 0.58 112.166 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.3 mt -69.85 -37.24 76.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.37 0.507 . . . . 0.41 112.37 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 63.42 42.4 6.78 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.04 -0.356 . . . . 0.84 110.04 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.3 mm -61.38 -58.39 7.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.096 -0.502 . . . . 0.41 111.21 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.563 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 1.5 m -61.95 -44.31 97.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.745 -0.465 . . . . 1.03 109.745 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.52 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 24.1 t70 -54.99 -44.42 74.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.235 -0.893 . . . . 1.73 111.186 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -69.37 -43.53 73.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.631 -0.258 . . . . 1.19 111.051 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 54.9 t -58.87 -36.9 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.49 110.427 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 43' ' ' SER . 56.9 mttt -56.18 -31.76 63.72 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.361 -0.382 . . . . 1.53 111.202 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' A' ' 44' ' ' ASP . 16.6 mttt -109.73 8.9 24.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 2.02 111.705 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -121.58 21.03 11.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.69 0.281 . . . . 1.44 111.164 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 34.7 mt -104.83 153.03 39.62 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.738 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 50' ' ' LEU . 3.1 Cg_exo -75.17 161.17 38.68 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.722 2.281 . . . . 0.74 111.654 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.24 134.45 53.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.965 0.412 . . . . 2.63 110.916 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.53 -17.29 58.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.57 -0.824 . . . . 0.82 111.945 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.485 ' HA ' ' NE2' ' A' ' 21' ' ' GLN . 90.7 t -95.85 125.91 48.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 1.03 110.936 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -110.54 155.9 21.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.305 -0.407 . . . . 2.51 109.997 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.6 ttt -108.16 132.03 54.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.181 -0.463 . . . . 1.28 110.512 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.18 112.34 18.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.134 -0.485 . . . . 0.61 110.576 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -96.58 129.43 43.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.91 -0.586 . . . . 0.86 109.843 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.46 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 6.8 m-30 -118.16 160.95 20.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.71 111.634 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -111.54 133.12 54.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.644 -0.707 . . . . 0.57 110.224 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.54 HG22 ' OG ' ' A' ' 27' ' ' SER . 2.7 m -85.83 162.36 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.575 0.226 . . . . 0.68 110.591 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -113.34 21.4 15.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.388 0.514 . . . . 0.93 112.388 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -120.06 16.53 12.46 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.6 -0.44 . . . . 0.74 111.643 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 75.3 mmm -135.09 106.95 7.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.236 -0.438 . . . . 1.09 110.936 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.55 13.72 9.39 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.946 -0.645 . . . . 0.78 112.59 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.67 -147.89 31.5 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.455 -0.878 . . . . 0.81 111.854 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -81.99 -19.28 40.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 2.47 110.863 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.25 -16.32 63.42 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.397 0.617 . . . . 1.94 109.9 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.56 -30.36 77.38 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.502 -0.772 . . . . 0.7 111.422 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -64.0 -44.32 92.99 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.968 0.413 . . . . 2.69 110.106 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.25 -41.72 97.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.824 -0.626 . . . . 1.65 109.961 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.04 -32.52 74.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.706 -0.679 . . . . 1.17 110.827 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.4 m -68.67 -40.77 80.01 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.042 0.449 . . . . 0.62 110.365 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -42.81 71.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 1.21 109.762 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.21 92.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.925 -0.579 . . . . 0.71 110.942 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -62.53 -38.9 91.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.242 -0.435 . . . . 0.59 110.253 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.439 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.41 -34.62 78.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.833 -0.432 . . . . 0.71 109.833 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.96 -44.11 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.729 -0.669 . . . . 0.84 109.575 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.83 -38.29 87.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.66 -0.7 . . . . 0.66 111.043 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.2 mtm -65.31 -25.97 67.85 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.825 0.345 . . . . 1.08 111.345 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.18 -29.52 24.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.99 110.718 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 68.6 mt -82.7 -36.0 26.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.898 -0.592 . . . . 0.97 111.368 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.49 23.51 21.28 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.886 -0.673 . . . . 0.78 112.635 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 88' ' ' VAL . 13.6 m -121.25 18.73 5.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 122.705 -0.291 . . . . 0.81 110.989 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -53.42 -60.59 3.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.559 -0.746 . . . . 1.71 111.749 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.25 -35.13 67.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.72 -0.673 . . . . 1.91 112.116 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -74.45 -43.29 56.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.011 0.374 . . . . 2.28 112.011 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 84' ' ' VAL . 28.6 m -80.68 -2.87 5.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.414 -0.514 . . . . 0.65 111.807 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 m -59.31 -48.25 82.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.823 0.305 . . . . 0.98 111.823 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.449 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 22.0 t -61.33 -59.09 14.69 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.191 0.441 . . . . 0.62 112.191 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 9.5 Cg_endo -54.39 -33.93 78.86 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.276 1.984 . . . . 0.61 112.446 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 28' ' ' PHE . 10.6 mt -66.88 -52.79 39.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.439 -0.346 . . . . 0.79 110.435 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.9 m-85 -58.21 -45.84 86.92 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.936 0.398 . . . . 0.58 110.401 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.13 -48.53 78.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.716 -0.675 . . . . 1.7 110.426 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.31 -7.04 43.48 Favored Glycine 0 C--O 1.223 -0.579 0 CA-C-N 116.153 -0.476 . . . . 0.82 113.644 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 50.2 t -105.14 -49.2 9.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 117.412 0.606 . . . . 0.75 112.014 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -99.42 -50.12 4.21 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.629 0.603 . . . . 0.84 112.629 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -69.14 -70.91 0.25 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.46 0.541 . . . . 1.41 112.46 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.46 ' HB ' ' OG1' ' A' ' 101' ' ' THR . 0.2 OUTLIER -79.84 -31.89 40.55 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.259 0.466 . . . . 1.31 112.259 -178.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 64.58 29.36 13.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.096 0.474 . . . . 1.44 110.992 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.46 ' OG1' ' HB ' ' A' ' 99' ' ' THR . 0.2 OUTLIER -69.51 -31.25 69.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.57 111.328 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.409 ' HA ' ' CB ' ' A' ' 107' ' ' ASP . 48.6 mt -88.68 105.71 16.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.894 -0.594 . . . . 0.91 111.661 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -122.72 -12.02 8.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.458 -0.792 . . . . 3.22 109.095 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.0 164.41 30.68 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.868 -1.06 . . . . 1.51 109.704 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.06 -25.5 68.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 1.08 111.177 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -33.01 72.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 1.43 110.489 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.409 ' CB ' ' HA ' ' A' ' 102' ' ' ILE . 32.7 m-20 -72.55 -38.8 67.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.84 -0.618 . . . . 1.89 110.253 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 108' ' ' ILE . 9.3 mt -62.04 -37.97 79.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.221 -0.659 . . . . 0.9 109.221 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.657 ' O ' HG12 ' A' ' 113' ' ' ILE . 72.8 ttt-85 -57.88 -47.2 83.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.845 -1.07 . . . . 2.19 110.357 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.93 -35.41 80.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.163 -0.471 . . . . 1.95 110.764 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.18 -43.34 97.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.053 0.454 . . . . 0.88 110.384 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.74 -41.0 96.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.077 -0.51 . . . . 0.92 110.309 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.657 HG12 ' O ' ' A' ' 109' ' ' ARG . 20.3 mm -64.49 -31.36 53.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.268 0.556 . . . . 1.33 109.733 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -69.25 -16.6 63.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.887 -0.597 . . . . 1.93 111.403 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.02 -5.63 47.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.406 -0.361 . . . . 1.1 111.389 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.8 4.11 29.98 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.462 -0.875 . . . . 1.15 112.616 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mm -80.41 138.07 20.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.698 -0.482 . . . . 1.61 109.698 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 39.1 mttt -75.12 150.82 38.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.657 -0.247 . . . . 2.73 110.452 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.3 -52.7 51.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.017 -0.611 . . . . 1.19 112.692 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.83 -20.76 65.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.62 0.23 . . . . 2.98 111.62 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 10.8 tp10 -68.41 -49.19 61.79 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.216 0.532 . . . . 2.52 109.747 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 82.8 t80 -67.3 -42.43 83.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.382 -0.826 . . . . 1.51 109.807 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.33 -42.04 90.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 2.3 111.048 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.79 -46.39 72.1 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.026 -0.533 . . . . 1.23 110.846 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.21 89.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 1.11 111.526 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -56.63 -30.54 63.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.349 -0.387 . . . . 1.31 111.321 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -111.22 23.07 14.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.35 -0.386 . . . . 1.63 110.834 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.8 m -91.63 149.54 21.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.963 0.411 . . . . 2.04 111.655 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -65.21 -40.87 94.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.58 . . . . 3.82 110.484 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 81.1 t -55.66 -50.0 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 1.53 110.559 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 77' ' ' ALA . 54.3 t -64.34 -46.88 91.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.666 -0.697 . . . . 1.11 111.091 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -55.57 -41.59 73.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.232 0.539 . . . . 2.43 110.919 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -68.05 -36.07 79.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.906 -0.588 . . . . 1.47 111.018 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.426 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 94.6 mt -67.39 -39.38 85.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.779 0.323 . . . . 0.93 110.657 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 81.2 t -60.29 -45.94 95.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.366 -0.379 . . . . 0.8 110.517 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.59 83.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.85 111.082 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -70.22 -34.32 72.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 1.39 110.627 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.46 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 47.6 mt-30 -63.99 -49.67 71.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.61 109.936 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.37 -33.7 76.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.496 -0.775 . . . . 2.82 110.207 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -67.01 -54.54 20.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.734 -0.666 . . . . 1.95 110.68 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.544 ' HB1' HD21 ' A' ' 23' ' ' LEU . . . -53.33 -48.23 68.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 0.65 112.22 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.29 94.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.934 0.397 . . . . 0.61 111.769 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.98 -31.98 39.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.007 0.373 . . . . 0.72 112.007 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -42.67 98.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.332 -0.394 . . . . 1.39 111.892 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 141' ' ' ALA . 35.3 m -85.6 -0.87 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.405 -0.361 . . . . 1.34 111.606 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 59.03 53.67 5.43 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.557 0.694 . . . . 1.95 109.989 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.5 tp -65.33 120.66 13.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.996 -1.002 . . . . 0.71 111.481 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -103.21 -34.32 8.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.063 -0.517 . . . . 4.16 110.085 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -95.93 -169.11 35.07 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 110.921 -0.872 . . . . 0.68 110.921 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.522 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 3.0 t -111.75 -56.85 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.304 -0.558 . . . . 0.49 111.435 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.522 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.1 Cg_endo -84.35 72.75 4.93 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.457 2.105 . . . . 0.56 111.701 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.5 144.78 46.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.051 -0.522 . . . . 0.63 110.922 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.2 ttm -121.47 133.02 55.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.165 -0.47 . . . . 0.42 110.102 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.95 124.65 43.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.213 -0.449 . . . . 0.52 109.92 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.33 117.1 32.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.889 0.376 . . . . 0.55 110.839 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 58.12 16.68 4.01 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.376 -0.829 . . . . 1.16 111.531 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.8 22.47 68.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.85 -0.691 . . . . 0.56 112.019 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -120.46 -42.06 2.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.08 0.467 . . . . 1.75 110.73 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -104.29 129.39 52.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 1.16 111.612 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -109.33 126.87 53.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.431 -0.804 . . . . 0.98 109.45 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.13 139.83 32.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.09 0.471 . . . . 1.2 111.09 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -114.33 100.91 53.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.872 -0.604 . . . . 0.72 109.91 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.58 -19.28 37.17 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.477 2.118 . . . . 0.54 112.568 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -80.9 -4.61 55.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.95 0.405 . . . . 2.22 110.674 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -115.3 26.99 8.77 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.808 -0.71 . . . . 0.59 112.004 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.3 mtt -115.12 166.93 11.28 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.656 -0.272 . . . . 0.57 110.349 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -71.48 100.34 2.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.147 0.499 . . . . 1.54 109.997 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.72 26.86 2.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.782 -0.644 . . . . 1.16 112.118 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.3 p -74.95 -35.47 62.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.452 0.644 . . . . 1.53 110.585 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.437 ' HB3' HG23 ' A' ' 173' ' ' VAL . 21.0 t30 -143.36 129.12 19.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.611 -0.722 . . . . 1.21 109.614 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 175' ' ' VAL . 1.9 mmm -56.74 -34.51 67.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 1.96 111.378 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -39.97 89.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.331 0.586 . . . . 2.05 110.48 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 170' ' ' ASN . 38.2 t -69.08 -43.65 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.65 -0.705 . . . . 0.65 110.551 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -53.5 -46.17 69.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.207 -0.906 . . . . 0.47 111.463 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 171' ' ' MET . 61.1 t -57.76 -51.48 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.416 . . . . 0.48 111.417 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 82.6 mm-40 -66.01 -44.8 83.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 1.7 111.458 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.495 HE21 ' HG2' ' A' ' 8' ' ' GLN . 52.8 tt0 -60.98 -45.68 93.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.653 -0.249 . . . . 1.32 111.17 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 182' ' ' VAL . 15.6 t80 -59.48 -53.04 62.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.877 0.37 . . . . 0.46 110.497 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.86 85.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.43 112.016 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 2.8 t0 -65.33 -36.56 84.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.046 0.45 . . . . 1.55 110.379 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 51.7 m -63.16 -42.46 99.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.868 -0.605 . . . . 0.48 109.925 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 178' ' ' TYR . 44.2 t -62.8 -42.49 96.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.158 -0.474 . . . . 0.48 110.33 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -62.37 -32.31 73.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.393 -0.821 . . . . 1.59 111.0 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.3 -46.3 20.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.278 -0.419 . . . . 1.17 110.817 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.58 -34.51 75.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.462 0.541 . . . . 0.68 112.462 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.5 p -71.61 -21.41 61.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.95 0.352 . . . . 1.07 111.95 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.104 0.478 . . . . 2.26 110.703 179.848 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 120.877 0.37 . . . . 4.08 110.778 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -91.79 130.66 37.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.904 -0.589 . . . . 3.58 109.844 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -131.09 120.04 22.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.757 0.313 . . . . 1.32 110.78 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -128.62 136.56 50.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.959 -0.564 . . . . 2.29 109.833 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.63 132.71 49.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 1.83 110.563 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 103.22 -14.07 55.13 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.866 -0.683 . . . . 0.78 111.917 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.5 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 41.2 tptt -115.38 -74.85 0.6 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.455 -0.202 . . . . 1.87 110.455 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -78.41 -41.73 32.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 1.46 111.027 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -136.85 164.28 28.67 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.307 -0.406 . . . . 0.79 110.156 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.24 123.84 18.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.136 -0.484 . . . . 0.9 110.284 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.9 m -76.9 127.95 33.67 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.854 -0.425 . . . . 1.11 109.854 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.55 140.97 37.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.813 0.339 . . . . 0.74 110.851 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -25.26 45.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.054 0.454 . . . . 2.33 110.01 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -109.35 90.16 8.04 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.642 -0.708 . . . . 3.64 109.244 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.24 148.72 30.95 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.525 2.15 . . . . 0.85 112.62 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.1 t -93.88 113.91 29.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.61 -0.723 . . . . 0.72 109.871 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.36 129.16 35.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.087 -0.506 . . . . 0.89 110.481 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.75 34.53 34.45 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.922 -0.656 . . . . 0.73 112.127 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.05 149.12 35.4 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.46 -0.2 . . . . 0.64 110.46 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.5 169.55 11.02 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.888 2.392 . . . . 0.56 112.711 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -65.84 -61.67 1.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.046 -0.524 . . . . 1.79 111.065 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.31 105.12 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.101 0.477 . . . . 0.45 110.747 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.7 tp -107.9 124.28 49.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.147 -0.479 . . . . 0.53 110.707 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -126.35 140.59 52.39 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.164 -0.471 . . . . 1.61 110.024 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -113.15 147.67 36.92 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.081 -0.34 . . . . 0.53 110.081 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.38 174.23 12.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.276 0.56 . . . . 0.55 111.396 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.2 t -153.62 139.26 17.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.439 -0.8 . . . . 0.96 109.079 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.498 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 97.3 m-85 -72.5 -15.0 61.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.947 0.404 . . . . 0.62 110.607 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CE1' ' HA2' ' A' ' 69' ' ' GLY . 79.3 m-85 -89.19 -0.53 57.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.991 -0.549 . . . . 1.78 110.419 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 49.3 t -108.25 112.61 61.15 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.954 -0.566 . . . . 0.48 111.104 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 18.1 Cg_endo -63.55 -23.85 70.41 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.372 2.048 . . . . 0.7 110.935 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -66.63 -28.71 68.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.459 -0.792 . . . . 1.74 109.932 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.46 -38.46 34.51 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.627 -0.509 . . . . 0.37 109.627 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -59.95 -38.15 81.6 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.259 0.552 . . . . 1.44 109.693 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.636 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 7.7 tt0 -66.7 -39.87 88.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.589 -0.732 . . . . 2.27 110.785 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -78.39 -26.4 46.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.556 -0.293 . . . . 0.87 111.333 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 3.6 tp10 -83.64 -55.02 4.51 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.529 0.566 . . . . 1.89 112.529 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.95 -48.54 6.47 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.929 0.714 . . . . 2.0 112.929 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 99.7 t -64.62 -54.61 28.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 121.75 -0.594 . . . . 0.58 111.608 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.9 mt -91.59 -31.39 15.91 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.536 0.569 . . . . 0.41 112.536 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.531 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 23.9 m-70 59.71 45.08 13.35 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.079 0.466 . . . . 0.84 110.017 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.407 ' O ' HG23 ' A' ' 46' ' ' VAL . 44.3 mm -55.8 -55.55 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.599 -0.728 . . . . 0.41 111.055 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 m -53.48 -47.76 69.52 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.502 0.501 . . . . 1.03 111.708 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -60.84 -43.97 97.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.513 -0.312 . . . . 1.73 111.226 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -65.24 -44.32 88.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.127 -0.488 . . . . 1.19 110.781 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.671 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 75.4 t -61.81 -47.1 94.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.984 -0.553 . . . . 0.49 110.638 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -53.57 -31.49 46.92 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.284 0.475 . . . . 1.53 112.284 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -89.67 -26.23 20.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.3 0.481 . . . . 2.02 112.3 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 55.2 mttt -84.79 -17.44 38.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.746 0.308 . . . . 1.44 111.568 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 86.4 mt -71.54 136.72 83.45 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.553 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.0 161.44 46.09 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.416 2.077 . . . . 0.74 111.968 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.37 128.87 38.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.944 0.402 . . . . 2.63 111.368 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.6 -17.06 23.59 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.824 -0.625 . . . . 0.82 112.093 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.3 t -98.4 122.01 49.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.642 0.258 . . . . 1.03 110.622 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -104.52 152.65 22.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.03 -0.359 . . . . 2.51 110.03 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.4 ' HG2' ' N ' ' A' ' 57' ' ' THR . 9.9 ttt -103.82 151.99 22.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.858 0.361 . . . . 1.28 110.318 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.4 ' N ' ' HG2' ' A' ' 56' ' ' MET . 0.0 OUTLIER -136.79 124.74 22.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.013 -0.539 . . . . 0.61 110.066 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -114.43 119.4 36.76 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.548 -0.538 . . . . 0.86 109.548 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CD2' ' HA ' ' A' ' 138' ' ' GLN . 8.0 m-30 -111.21 151.45 28.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.268 0.556 . . . . 0.71 111.873 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -102.25 130.26 48.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.383 -0.826 . . . . 0.57 109.855 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 m -86.78 159.42 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 111.475 0.176 . . . . 0.68 111.475 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.648 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 41.0 m-20 -107.62 -1.39 21.21 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.452 0.538 . . . . 0.93 112.452 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -96.35 10.68 37.29 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.681 -0.407 . . . . 0.74 111.543 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.86 102.06 4.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.839 0.352 . . . . 1.09 110.398 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.99 7.88 0.69 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.675 -0.693 . . . . 0.78 112.258 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.31 -116.64 8.18 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.941 -0.647 . . . . 0.81 112.408 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.48 -50.69 5.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.884 0.373 . . . . 2.47 111.0 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.52 -15.01 56.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.927 -0.579 . . . . 1.94 111.492 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.426 ' HA2' ' CE1' ' A' ' 29' ' ' PHE . . . -56.87 -31.97 61.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.087 -0.578 . . . . 0.7 112.548 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.648 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 85.2 mttt -74.91 -38.5 61.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.39 . . . . 2.69 110.794 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.34 -40.88 97.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.032 -0.531 . . . . 1.65 111.021 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.89 -26.66 65.22 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.876 -0.33 . . . . 1.17 111.229 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.2 m -66.88 -35.74 80.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.328 0.585 . . . . 0.62 109.492 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -73.48 -41.32 63.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 1.21 109.625 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.96 -41.54 99.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.542 -0.753 . . . . 0.71 110.76 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -61.01 -36.77 80.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.075 -0.511 . . . . 0.59 110.778 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.12 -39.04 93.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.003 -0.544 . . . . 0.71 110.111 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.81 -41.54 90.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.028 -0.533 . . . . 0.84 109.923 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.85 81.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.87 -0.605 . . . . 0.66 110.892 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.7 mtm -69.12 -36.4 77.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.736 -0.665 . . . . 1.08 110.79 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.68 -35.84 65.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.4 -0.363 . . . . 0.99 111.686 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.19 -28.14 38.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.97 110.947 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.93 29.38 18.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.87 -0.681 . . . . 0.78 112.77 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 m -120.93 25.38 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.071 0.462 . . . . 0.81 110.329 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -59.21 -52.19 66.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.451 -0.795 . . . . 1.71 111.443 -178.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.426 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 2.7 t70 -61.77 -39.45 91.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.466 0.65 . . . . 1.91 110.883 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.9 mmmm -65.41 -34.89 79.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.432 -0.804 . . . . 2.28 111.86 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.2 m -94.43 -9.38 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.608 0.596 . . . . 0.65 112.608 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.5 m -56.72 -48.54 77.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.98 111.867 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.412 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 99.0 t -65.45 -59.61 9.22 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.349 0.5 . . . . 0.62 112.349 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.412 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 11.7 Cg_endo -55.76 -36.45 95.18 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.216 1.944 . . . . 0.61 113.164 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.7 mt -68.45 -42.84 78.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.736 0.303 . . . . 0.79 110.747 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.498 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -64.55 -45.27 87.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.537 . . . . 0.58 110.309 179.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -65.15 -46.97 78.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.759 -0.655 . . . . 1.7 111.409 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.77 -9.14 55.42 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 116.149 -0.478 . . . . 0.82 114.147 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.5 t -109.71 -36.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 117.346 0.573 . . . . 0.75 111.919 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -104.42 -40.69 5.98 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.243 0.831 . . . . 0.84 113.243 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -83.02 -68.14 0.73 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.883 0.373 . . . . 1.41 111.306 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.46 -35.68 53.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.736 0.303 . . . . 1.31 111.045 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 60.65 29.99 19.4 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.752 -0.658 . . . . 1.44 110.72 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.79 -28.52 44.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.914 -0.584 . . . . 1.57 111.085 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 85.7 mt -74.85 101.98 2.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.266 -0.424 . . . . 0.91 110.182 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -116.24 -33.11 5.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 3.22 111.134 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.5 p -118.45 169.7 9.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.115 -0.493 . . . . 1.51 110.565 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.01 -28.61 69.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.413 0.625 . . . . 1.08 109.91 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -31.43 72.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.289 -0.869 . . . . 1.43 110.081 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -71.78 -36.27 70.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.651 -0.704 . . . . 1.89 110.231 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 mt -68.76 -42.07 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.815 -0.63 . . . . 0.9 109.696 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.7 ttm105 -57.4 -40.18 77.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.236 -0.893 . . . . 2.19 110.066 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.74 -38.15 86.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.549 -0.75 . . . . 1.95 111.734 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.13 -44.91 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.88 110.803 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -64.44 -40.1 95.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.92 110.865 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 83.6 mt -63.71 -38.3 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.129 0.49 . . . . 1.33 110.379 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -70.56 -31.2 68.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 1.93 110.981 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.76 -31.11 69.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 1.1 110.714 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.02 -0.26 3.25 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.762 -0.733 . . . . 1.15 112.732 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.65 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 45.3 mm -86.28 127.52 40.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.031 -0.359 . . . . 1.61 110.031 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -68.35 139.27 55.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.234 -0.284 . . . . 2.73 110.234 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.88 -43.56 81.61 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.926 -0.579 . . . . 1.19 112.497 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.25 -46.78 88.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.683 0.278 . . . . 2.98 110.912 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -62.84 -45.42 92.68 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.123 0.487 . . . . 2.52 110.195 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -63.58 -48.33 77.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.662 -0.699 . . . . 1.51 110.876 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.65 -35.33 79.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 2.3 110.906 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.71 91.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.039 0.447 . . . . 1.23 109.97 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -75.48 -33.32 60.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.692 -0.686 . . . . 1.11 110.065 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -60.24 -31.51 70.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.478 0.656 . . . . 1.31 110.179 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -104.42 20.77 17.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.384 -0.825 . . . . 1.63 110.909 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.1 m -93.95 144.79 25.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.06 0.457 . . . . 2.04 111.67 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -65.74 -35.57 81.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.487 -0.779 . . . . 3.82 110.61 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 134' ' ' LEU . 63.4 t -53.73 -46.51 62.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 1.53 110.797 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 77' ' ' ALA . 75.8 t -67.49 -40.72 84.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.677 -0.692 . . . . 1.11 110.774 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -57.83 -46.33 84.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 2.43 111.117 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.3 m -66.16 -29.98 70.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.283 -0.417 . . . . 1.47 110.658 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 130' ' ' VAL . 86.4 mt -68.44 -40.67 81.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.853 -0.425 . . . . 0.93 109.853 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.467 ' HA ' HE21 ' A' ' 138' ' ' GLN . 62.1 t -62.02 -44.03 98.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.99 -0.55 . . . . 0.8 110.21 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.76 99.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.738 -0.664 . . . . 0.85 111.046 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -66.55 -35.0 79.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.169 -0.469 . . . . 1.39 111.66 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.467 HE21 ' HA ' ' A' ' 135' ' ' VAL . 46.0 mt-30 -58.93 -53.22 60.84 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.879 0.371 . . . . 0.61 111.026 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HG3' HD22 ' A' ' 62' ' ' ASN . 4.2 mm-40 -72.15 -36.51 69.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 2.82 110.976 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -58.37 -44.17 88.76 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.75 0.31 . . . . 1.95 110.912 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -61.4 -44.76 96.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.955 -0.566 . . . . 0.65 110.77 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.14 90.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 0.61 111.366 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.19 -25.74 60.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 0.72 111.247 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.76 -36.12 32.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.272 -0.422 . . . . 1.39 111.261 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 141' ' ' ALA . 31.0 m -89.13 2.69 6.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.477 0.18 . . . . 1.34 111.373 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.417 ' HB3' ' NH2' ' A' ' 148' ' ' ARG . 38.5 mt-30 57.48 51.7 9.44 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.056 -0.52 . . . . 1.95 110.322 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.5 tp -54.57 120.39 6.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.71 111.982 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.448 HH11 ' HD3' ' A' ' 148' ' ' ARG . 28.0 mmt180 -98.17 -45.94 6.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.93 -0.577 . . . . 4.16 110.713 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -107.9 161.16 13.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.106 -0.797 . . . . 0.68 111.106 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.506 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 2.4 t -68.95 -55.66 10.26 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.867 0.334 . . . . 0.49 111.73 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.506 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 5.9 Cg_endo -89.16 98.78 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.449 2.099 . . . . 0.56 112.123 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.51 151.23 40.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.261 -0.427 . . . . 0.63 110.645 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 34.9 ttm -122.92 133.95 54.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.04 -0.527 . . . . 0.42 110.805 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -123.02 129.83 52.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.72 -0.673 . . . . 0.52 109.543 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 185' ' ' LEU . 40.1 t -101.3 118.32 47.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.917 0.389 . . . . 0.55 111.498 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.55 ' O ' ' HD3' ' A' ' 158' ' ' LYS . 28.6 m-20 58.8 17.88 5.58 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.028 -0.987 . . . . 1.16 112.178 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.4 24.75 67.88 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.039 -0.601 . . . . 0.56 112.14 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.55 ' HD3' ' O ' ' A' ' 156' ' ' ASN . 5.9 mppt? -126.45 -47.66 1.57 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.17 0.509 . . . . 1.75 111.218 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -101.47 126.59 48.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.866 -0.606 . . . . 1.16 111.475 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -103.83 138.47 40.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.453 -0.794 . . . . 0.98 109.865 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.0 mp -93.41 139.9 30.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.888 0.375 . . . . 1.2 111.163 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -118.07 109.91 40.4 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.72 110.547 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -74.44 -18.76 19.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.689 2.259 . . . . 0.54 112.712 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -83.56 -0.03 48.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.151 0.501 . . . . 2.22 110.924 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -117.19 22.07 10.56 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.981 -0.628 . . . . 0.59 111.644 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 47.1 mtt -120.53 -174.34 2.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.104 -0.332 . . . . 0.57 110.104 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.23 125.05 25.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.863 0.363 . . . . 1.54 110.114 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.25 31.78 6.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.444 0.64 . . . . 1.16 109.767 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -37.01 5.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.287 -0.87 . . . . 1.53 110.739 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -128.09 118.78 24.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.372 . . . . 1.21 110.583 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.514 ' O ' HG23 ' A' ' 175' ' ' VAL . 10.3 mmt -54.08 -41.72 68.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.458 -0.792 . . . . 1.96 111.624 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -57.5 -46.85 83.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.837 0.351 . . . . 2.05 111.272 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.73 -46.87 90.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.948 -0.569 . . . . 0.65 110.755 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -54.29 -49.67 69.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.578 -0.283 . . . . 0.47 111.659 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 171' ' ' MET . 60.9 t -60.9 -45.08 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 0.48 111.552 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -70.7 -41.77 71.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.314 -0.403 . . . . 1.7 111.631 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -63.83 -42.38 97.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.513 . . . . 1.32 110.685 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.561 ' O ' HG23 ' A' ' 182' ' ' VAL . 21.4 t80 -59.57 -54.16 49.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.98 -0.555 . . . . 0.46 110.062 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.2 -34.01 75.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.73 -0.668 . . . . 0.43 111.395 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.8 -36.78 81.05 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.406 -0.361 . . . . 1.55 110.569 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.616 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 24.7 m -67.6 -41.71 83.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.48 109.97 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 178' ' ' TYR . 41.0 t -58.14 -50.4 78.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.022 -0.536 . . . . 0.48 110.389 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -59.93 -42.65 94.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.468 -0.787 . . . . 1.59 111.369 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -60.38 -42.96 96.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.326 -0.397 . . . . 1.17 110.537 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 181' ' ' THR . 53.8 mt -70.04 -33.92 72.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.68 110.712 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 25.4 m -66.94 -39.44 87.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.217 0.532 . . . . 1.07 110.188 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -91.0 23.04 3.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.687 -0.688 . . . . 2.26 110.294 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -109.37 -72.44 0.72 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.324 -0.398 . . . . 1.72 111.217 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.57 -0.728 . . . . 4.33 110.601 -179.087 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SFQ . . . . . 0.558 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.459 -0.2 . . . . 4.08 110.459 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.553 HE21 ' HG3' ' A' ' 4' ' ' GLU . 46.1 tp60 -85.32 123.31 30.65 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.171 -0.307 . . . . 3.58 110.171 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -127.79 100.27 5.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.009 0.433 . . . . 1.32 110.695 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.553 ' HG3' HE21 ' A' ' 2' ' ' GLN . 14.1 mt-10 -108.96 142.5 39.51 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.954 -0.566 . . . . 2.29 110.878 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.06 125.52 26.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.601 -0.727 . . . . 1.83 109.942 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.25 -20.38 35.43 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.992 -0.623 . . . . 0.78 111.96 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -109.12 -74.73 0.65 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.74 -0.27 . . . . 1.87 110.466 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -75.76 -43.53 46.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.27 -0.423 . . . . 1.46 110.904 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -138.54 154.21 48.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.039 -0.528 . . . . 0.79 110.302 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.89 133.19 54.86 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.283 -0.417 . . . . 0.9 111.046 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 m -84.52 127.42 34.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.278 -0.419 . . . . 1.11 111.711 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.1 mt -82.78 137.02 34.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.602 -0.518 . . . . 0.74 109.602 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -75.68 -29.09 58.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 2.33 110.513 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -113.05 90.17 15.38 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 3.64 109.89 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.4 143.26 19.38 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.427 2.085 . . . . 0.85 112.593 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 19' ' ' ALA . 47.7 t -76.61 127.44 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.51 -0.768 . . . . 0.72 111.412 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.06 121.28 26.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.06 -0.518 . . . . 0.89 110.557 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.0 19.94 44.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.72 . . . . 0.73 111.995 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HB2' ' HB ' ' A' ' 16' ' ' VAL . . . -75.02 145.78 81.46 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.647 -0.277 . . . . 0.64 111.239 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.68 165.95 31.29 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.444 2.096 . . . . 0.56 111.985 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -56.62 -60.73 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 1.79 111.487 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -119.96 102.67 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.987 0.423 . . . . 0.45 110.539 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 47.3 tp -98.64 138.32 35.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.835 -0.62 . . . . 0.53 109.849 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -145.88 154.33 41.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.651 0.263 . . . . 1.61 110.799 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -130.04 157.6 41.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.066 -0.516 . . . . 0.53 110.343 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -168.38 177.5 5.32 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.089 -0.505 . . . . 0.55 110.554 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.5 t -156.75 132.87 9.74 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.96 110.849 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.493 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.9 m-85 -71.13 -16.71 62.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.834 -0.621 . . . . 0.62 109.826 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.491 ' CE2' ' HA2' ' A' ' 69' ' ' GLY . 97.1 m-85 -85.66 -4.0 59.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.567 -0.742 . . . . 1.78 111.32 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 53.3 t -115.49 122.63 32.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.393 -0.367 . . . . 0.48 110.764 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -65.94 -23.87 53.96 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.412 2.075 . . . . 0.7 112.027 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -60.49 -38.93 85.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 1.74 110.099 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.2 m -71.67 -34.77 69.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.998 -0.546 . . . . 0.37 110.725 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.88 -44.31 96.44 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.124 0.487 . . . . 1.44 110.455 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.467 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 13.8 tt0 -66.48 -36.58 83.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.526 . . . . 2.27 110.357 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -77.5 -25.82 50.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.067 -0.515 . . . . 0.87 111.46 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 4.4 tp10 -84.25 -50.61 7.71 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.599 0.592 . . . . 1.89 112.599 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.584 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 10.1 tp10 -97.37 -46.21 6.17 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.356 0.873 . . . . 2.0 113.356 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 48.8 t -69.68 -51.8 37.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.051 -0.659 . . . . 0.58 110.921 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 mt -86.52 -35.56 19.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.258 -0.428 . . . . 0.41 111.764 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.584 ' HD2' ' O ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER 60.63 41.62 15.04 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.59 -0.522 . . . . 0.84 109.59 -178.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.631 ' O ' HG23 ' A' ' 46' ' ' VAL . 42.7 mm -53.77 -68.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.845 -0.616 . . . . 0.41 112.169 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 1.4 m -51.92 -45.63 64.34 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.345 0.403 . . . . 1.03 111.943 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' HA ' ' HE3' ' A' ' 47' ' ' LYS . 30.5 t70 -65.69 -29.66 70.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.888 -0.596 . . . . 1.73 111.583 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 2.2 t-20 -77.73 -37.14 49.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 1.19 110.217 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 42' ' ' ILE . 43.2 t -60.32 -35.48 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.935 -0.575 . . . . 0.49 110.637 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 43' ' ' SER . 51.8 mttt -56.71 -36.65 69.92 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.393 -0.367 . . . . 1.53 111.44 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -77.72 -10.32 59.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 2.02 112.089 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -102.07 -32.95 9.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.475 -0.33 . . . . 1.44 110.759 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.448 HD22 HG11 ' A' ' 54' ' ' VAL . 91.4 mt -68.92 129.88 91.97 Favored Pre-proline 0 C--O 1.234 0.278 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.77 -171.43 0.86 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.645 2.23 . . . . 0.74 112.625 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -67.86 148.75 50.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 2.63 111.128 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.54 -19.03 30.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.934 -0.651 . . . . 0.82 113.195 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 50' ' ' LEU . 5.8 t -89.72 132.8 33.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.106 0.479 . . . . 1.03 110.749 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -131.41 141.76 49.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.98 -0.554 . . . . 2.51 110.265 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 84.2 mtp -90.88 134.3 34.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 1.28 110.999 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.02 94.36 4.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.232 0.539 . . . . 0.61 110.167 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -92.08 118.37 30.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.737 -0.665 . . . . 0.86 110.665 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 9.5 m-30 -113.62 167.56 10.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 0.71 110.897 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -103.24 133.62 48.01 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.405 -0.361 . . . . 0.57 110.795 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.8 149.27 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 0.68 110.314 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -109.42 27.24 9.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.856 0.36 . . . . 0.93 111.688 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -133.65 15.57 4.0 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.014 0.435 . . . . 0.74 110.995 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -137.92 103.23 4.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.15 -0.477 . . . . 1.09 110.073 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.63 9.33 2.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.602 -0.808 . . . . 0.78 112.534 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.76 -140.46 34.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.879 -0.676 . . . . 0.81 112.373 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.83 -34.34 33.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.036 0.446 . . . . 2.47 110.048 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.3 tp -67.35 -22.31 65.59 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.772 -0.649 . . . . 1.94 110.256 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.491 ' HA2' ' CE2' ' A' ' 29' ' ' PHE . . . -58.88 -37.05 90.16 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.671 -0.695 . . . . 0.7 111.876 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -68.66 -32.16 71.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.776 0.322 . . . . 2.69 110.776 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -40.49 97.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 1.65 110.265 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.476 ' HG ' HD13 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -71.83 -26.57 62.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.089 -0.505 . . . . 1.17 110.459 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.8 m -62.57 -33.59 75.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.304 0.574 . . . . 0.62 109.759 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -77.84 -37.43 48.44 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.438 -0.801 . . . . 1.21 109.48 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.17 85.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.569 -0.741 . . . . 0.71 111.318 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -59.67 -36.43 76.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.111 -0.495 . . . . 0.59 110.597 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.84 -36.27 83.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.11 -0.495 . . . . 0.71 110.083 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -65.1 -43.05 95.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.677 -0.692 . . . . 0.84 110.013 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.63 -39.36 90.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.794 -0.639 . . . . 0.66 110.938 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 71.6 mtm -66.84 -35.66 80.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.95 -0.568 . . . . 1.08 110.652 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.33 -36.57 68.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.893 0.377 . . . . 0.99 110.882 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 mt -75.62 -44.22 43.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.22 -0.446 . . . . 0.97 110.763 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.69 37.38 3.72 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.272 -0.731 . . . . 0.78 111.272 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.27 29.11 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.966 0.413 . . . . 0.81 110.179 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.87 -65.76 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.281 -0.872 . . . . 1.71 112.158 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.31 -28.99 67.3 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.334 -0.394 . . . . 1.91 111.218 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mmtm -66.65 -44.68 81.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.815 -0.629 . . . . 2.28 111.474 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.81 -8.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.886 0.328 . . . . 0.65 111.886 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.6 m -58.25 -49.13 78.19 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.721 0.267 . . . . 0.98 111.721 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.44 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 46.3 t -61.36 -59.86 12.3 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.383 0.512 . . . . 0.62 112.383 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.44 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 12.2 Cg_endo -56.13 -34.19 92.26 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.198 1.932 . . . . 0.61 113.232 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.1 mt -70.8 -40.7 72.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.715 0.293 . . . . 0.79 110.719 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.493 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -64.24 -48.13 76.98 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.231 0.539 . . . . 0.58 110.442 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.9 -35.87 74.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.534 -0.757 . . . . 1.7 111.248 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.72 -25.69 70.59 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.917 -0.658 . . . . 0.82 113.106 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 64.7 t -100.65 -39.43 7.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.491 0.552 . . . . 0.75 112.491 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -94.57 -42.94 8.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.717 1.006 . . . . 0.84 113.717 -177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -78.97 -62.49 1.68 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.977 0.362 . . . . 1.41 111.977 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.04 -39.41 25.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.112 -0.494 . . . . 1.31 112.162 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 66.08 26.89 10.66 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.066 0.46 . . . . 1.44 110.288 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.33 -33.76 32.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.894 -0.594 . . . . 1.57 111.346 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.25 102.51 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.917 -0.583 . . . . 0.91 110.461 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mmm-85 -119.14 -8.12 10.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.848 -0.615 . . . . 3.22 110.448 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 m -149.77 172.59 14.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.226 -0.443 . . . . 1.51 110.696 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.8 -20.72 66.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.24 -0.436 . . . . 1.08 110.816 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -44.72 96.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.006 -0.543 . . . . 1.43 110.562 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 111' ' ' VAL . 13.2 m-20 -67.07 -40.29 87.03 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.98 -0.554 . . . . 1.89 109.851 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.476 HD13 ' HG ' ' A' ' 72' ' ' LEU . 54.6 mt -61.05 -46.1 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.654 -0.703 . . . . 0.9 110.171 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.413 ' O ' HG13 ' A' ' 113' ' ' ILE . 62.8 ttt180 -60.28 -41.22 92.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.943 -0.572 . . . . 2.19 109.723 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -59.48 -39.66 84.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.306 -0.861 . . . . 1.95 110.667 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 107' ' ' ASP . 73.2 t -60.09 -42.41 89.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.88 110.661 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -65.35 -39.75 92.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.92 110.457 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 65.7 mt -64.95 -33.77 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.316 0.579 . . . . 1.33 109.763 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -73.91 -8.39 55.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.541 -0.754 . . . . 1.93 110.654 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.32 2.57 42.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.07 -0.514 . . . . 1.1 110.311 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.81 39.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.821 -0.705 . . . . 1.15 113.193 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 38.2 mm -98.23 133.35 40.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 110.123 -0.325 . . . . 1.61 110.123 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -73.76 146.86 43.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.26 -0.427 . . . . 2.73 111.468 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.3 -35.27 91.32 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.894 -0.669 . . . . 1.19 112.024 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.53 -45.69 78.62 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.952 -0.388 . . . . 2.98 109.952 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -60.93 -45.08 96.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.552 -0.749 . . . . 2.52 109.686 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.411 ' CD1' ' HG3' ' A' ' 109' ' ' ARG . 53.9 t80 -63.05 -41.87 99.59 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.76 -0.655 . . . . 1.51 110.479 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.63 -44.15 93.56 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.831 0.348 . . . . 2.3 110.852 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.3 -45.84 79.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 1.23 111.119 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.02 83.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 1.11 111.088 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -57.96 -36.92 73.24 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.308 -0.405 . . . . 1.31 111.074 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -109.58 32.04 5.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.371 -0.377 . . . . 1.63 111.47 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.9 p -92.09 157.75 16.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.766 0.317 . . . . 2.04 110.215 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -74.06 -32.46 63.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.556 -0.293 . . . . 3.82 110.359 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.3 t -58.4 -45.49 89.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.989 0.423 . . . . 1.53 110.181 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 135' ' ' VAL . 15.5 t -61.89 -38.48 80.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.561 -0.745 . . . . 1.11 110.537 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -56.43 -50.72 70.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 2.43 110.976 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.51 -32.03 72.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 1.47 111.051 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.38 -32.43 66.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.93 110.773 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.453 ' HA ' HE21 ' A' ' 138' ' ' GLN . 70.1 t -67.31 -47.03 82.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.8 110.073 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.08 85.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 0.85 111.233 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -64.12 -32.42 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.512 -0.313 . . . . 1.39 111.34 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.453 HE21 ' HA ' ' A' ' 135' ' ' VAL . 50.5 mt-30 -66.43 -42.27 87.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.409 -0.359 . . . . 0.61 110.551 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.41 -37.97 50.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 2.82 110.803 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 31.7 tttp -54.34 -50.26 67.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.325 -0.398 . . . . 1.95 110.809 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -66.37 -46.55 76.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.162 -0.472 . . . . 0.65 111.522 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.65 83.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 0.61 112.104 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.81 -27.21 61.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.52 0.563 . . . . 0.72 112.52 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 3.3 t0 -78.12 -31.35 49.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.856 0.317 . . . . 1.39 111.856 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 141' ' ' ALA . 32.6 m -92.47 3.14 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.151 0.426 . . . . 1.34 112.151 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 60.4 51.6 5.23 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.262 0.553 . . . . 1.95 110.155 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.9 tp -62.18 106.61 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.479 -0.782 . . . . 0.71 111.404 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -104.19 -1.79 26.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.804 -0.635 . . . . 4.16 110.811 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -133.39 179.78 17.08 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.847 -0.692 . . . . 0.68 112.014 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.501 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 0.2 OUTLIER -97.85 -61.85 0.12 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 117.033 0.416 . . . . 0.49 111.411 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 3.9 Cg_endo -85.78 65.74 5.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.641 2.227 . . . . 0.56 111.814 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -109.35 138.7 45.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.081 -0.509 . . . . 0.63 110.67 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 29.4 ttm -115.62 137.98 51.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.947 -0.57 . . . . 0.42 110.168 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -127.74 131.31 49.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 0.52 110.392 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.59 117.79 45.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.573 -0.285 . . . . 0.55 110.705 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 60.63 13.87 4.57 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.733 -0.667 . . . . 1.16 111.601 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.31 23.99 68.7 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.047 -0.597 . . . . 0.56 111.759 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -124.65 -44.37 1.97 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.075 0.464 . . . . 1.75 110.758 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -102.1 125.13 48.71 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.936 -0.575 . . . . 1.16 110.604 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -105.68 138.85 41.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.196 -0.456 . . . . 0.98 109.862 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.6 mp -90.18 139.15 30.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.535 0.207 . . . . 1.2 110.726 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -114.9 113.12 44.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.255 -0.43 . . . . 0.72 110.854 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -80.77 6.86 5.21 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.924 2.416 . . . . 0.54 112.56 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -113.33 20.98 15.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.323 -0.399 . . . . 2.22 110.763 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -142.11 33.39 1.92 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.02 -0.609 . . . . 0.59 111.935 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 67.9 mtt -124.84 -176.51 3.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.474 0.178 . . . . 0.57 110.542 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.05 127.58 32.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.138 0.494 . . . . 1.54 111.57 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 16.2 16.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.835 -0.621 . . . . 1.16 110.835 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.35 -32.42 14.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.159 0.504 . . . . 1.53 110.401 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -139.42 125.16 19.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.04 -0.527 . . . . 1.21 110.127 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.414 ' O ' HG23 ' A' ' 175' ' ' VAL . 56.4 ttm -62.37 -32.94 73.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.815 -0.63 . . . . 1.96 111.443 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -63.32 -37.28 86.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.174 -0.466 . . . . 2.05 111.027 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.68 -41.83 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.65 110.509 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.84 -50.09 71.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.984 -0.553 . . . . 0.47 111.122 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 171' ' ' MET . 57.8 t -57.61 -51.09 74.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.48 111.688 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -42.12 83.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.995 -0.548 . . . . 1.7 112.119 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -62.09 -45.61 92.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.657 0.265 . . . . 1.32 110.979 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -57.71 -52.18 66.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.46 110.635 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.01 82.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.43 112.105 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.65 -32.95 73.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.646 0.26 . . . . 1.55 110.516 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 35.4 m -63.14 -40.07 96.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.48 110.188 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.38 -52.92 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.269 0.557 . . . . 0.48 110.227 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -57.44 -39.83 77.12 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.961 -1.018 . . . . 1.59 111.007 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -64.51 -46.24 83.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.889 -0.596 . . . . 1.17 110.819 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.0 mt -66.56 -39.81 88.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.088 -0.506 . . . . 0.68 112.06 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.9 p -66.31 -23.75 66.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.038 0.447 . . . . 1.07 111.276 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -102.2 4.97 39.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.226 0.536 . . . . 2.26 110.338 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.5 tttm -95.84 68.81 2.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.788 -0.642 . . . . 1.72 110.326 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.471 ' NZ ' ' HB3' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-N 115.564 -0.744 . . . . 4.33 110.35 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SFQ . . . . . 0.526 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.554 0.216 . . . . 4.08 110.613 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -76.51 119.56 20.52 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.935 -0.395 . . . . 3.58 109.935 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -125.54 140.96 52.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.757 0.313 . . . . 1.32 110.983 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -119.35 140.67 49.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.943 -0.571 . . . . 2.29 109.891 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -69.3 119.12 13.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.083 0.468 . . . . 1.83 110.036 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.56 -16.38 29.0 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.995 -0.842 . . . . 0.78 110.995 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 50.6 tptt -99.13 -80.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.637 -0.281 . . . . 1.87 110.57 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -86.79 -25.37 24.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 1.46 111.381 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -143.49 152.74 41.86 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.189 -0.3 . . . . 0.79 110.189 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 m -128.54 132.08 48.26 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.21 0.319 . . . . 0.9 110.639 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.4 m -75.68 125.56 29.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.362 -0.381 . . . . 1.11 110.175 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.26 127.31 32.26 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.792 0.329 . . . . 0.74 110.526 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -65.09 -39.46 93.21 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.627 -0.715 . . . . 2.33 110.33 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -122.18 84.01 45.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 3.64 109.893 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.36 155.11 70.43 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.485 2.124 . . . . 0.85 112.191 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.5 t -89.4 131.84 35.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.036 -0.529 . . . . 0.72 110.713 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.81 137.8 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.107 -0.497 . . . . 0.89 110.323 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.9 25.24 74.34 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.73 -0.748 . . . . 0.73 112.382 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.26 143.52 31.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.436 -0.209 . . . . 0.64 110.436 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 30.1 Cg_endo -66.27 162.05 37.79 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.373 2.049 . . . . 0.56 112.704 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -62.68 -44.92 95.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.612 -0.722 . . . . 1.79 110.705 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.8 t -120.52 100.77 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.702 -0.481 . . . . 0.45 109.702 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 26.5 tp -110.92 110.78 21.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.951 -0.568 . . . . 0.53 110.423 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -120.12 145.76 46.61 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.426 -0.352 . . . . 1.61 110.215 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 151' ' ' PRO . 97.2 m-85 -123.23 154.63 38.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.309 -0.405 . . . . 0.53 110.114 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.428 ' CE1' ' HD3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -170.24 177.99 3.97 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.005 0.431 . . . . 0.55 110.786 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.1 t -156.91 141.58 16.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.981 -0.554 . . . . 0.96 110.51 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.539 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 96.0 m-85 -73.4 -20.49 60.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.9 -0.591 . . . . 0.62 110.502 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CE2' HD12 ' A' ' 72' ' ' LEU . 72.6 m-85 -85.35 -1.32 56.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.964 -0.562 . . . . 1.78 110.339 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.47 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 48.1 t -107.19 112.34 62.98 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.019 -0.537 . . . . 0.48 111.133 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -64.2 -24.54 65.61 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.216 1.944 . . . . 0.7 111.283 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -66.32 -29.37 69.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.369 -0.832 . . . . 1.74 110.236 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.0 m -83.66 -32.02 25.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.47 -0.567 . . . . 0.37 109.47 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -59.77 -49.1 79.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.304 -0.862 . . . . 1.44 110.063 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.505 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 22.5 tt0 -68.35 -32.34 72.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 2.27 110.726 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.404 ' O ' HG12 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -66.66 -30.84 71.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.481 0.549 . . . . 0.87 112.481 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -108.65 -50.11 3.07 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.993 0.738 . . . . 1.89 112.993 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.63 -25.51 64.87 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.953 -0.467 . . . . 2.0 111.659 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 91.5 t -107.72 -56.44 4.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.796 -0.362 . . . . 0.58 111.498 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.8 mt -81.05 -33.55 33.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.928 0.344 . . . . 0.41 111.928 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 0.6 OUTLIER 58.9 63.45 1.64 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.848 0.459 . . . . 0.84 111.003 -179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 36' ' ' PHE . 49.1 mm -71.36 -50.87 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.902 -0.59 . . . . 0.41 111.165 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 m -58.3 -49.33 77.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.314 -0.403 . . . . 1.03 110.999 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 26.0 t70 -61.26 -45.03 96.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.549 . . . . 1.73 110.888 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 0.7 OUTLIER -62.41 -41.56 98.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 1.19 110.794 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 39.6 t -66.44 -42.44 90.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.952 -0.567 . . . . 0.49 110.541 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -58.93 -31.63 68.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.738 0.304 . . . . 1.53 111.37 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 30.3 mttm -86.68 3.13 46.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.261 -0.427 . . . . 2.02 111.679 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -136.97 23.59 3.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 1.44 111.007 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 13.9 mt -99.73 145.5 30.25 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.383 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 50' ' ' LEU . 10.4 Cg_exo -70.21 165.48 31.34 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.718 2.279 . . . . 0.74 111.422 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.25 139.97 50.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.998 -0.546 . . . . 2.63 110.368 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.23 -9.15 78.03 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.931 -0.652 . . . . 0.82 112.118 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.95 98.63 7.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.853 0.359 . . . . 1.03 110.263 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.6 124.96 31.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.141 -0.481 . . . . 2.51 110.165 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -72.97 127.97 34.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.646 -0.501 . . . . 1.28 109.646 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 119.48 34.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.949 0.404 . . . . 0.61 110.757 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HD3' ' CE1' ' A' ' 26' ' ' PHE . 15.2 ttmm -114.04 119.57 37.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.86 110.16 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 13.1 m-30 -110.28 160.51 16.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.135 0.493 . . . . 0.71 111.55 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -104.85 134.76 47.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.661 -0.699 . . . . 0.57 110.618 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.424 HG21 HG13 ' A' ' 150' ' ' VAL . 16.7 m -88.7 155.05 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.587 -0.279 . . . . 0.68 110.61 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -105.21 -6.1 20.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.632 0.604 . . . . 0.93 112.632 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -89.97 15.5 9.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.427 0.632 . . . . 0.74 110.79 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -144.32 88.87 1.97 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.458 -0.792 . . . . 1.09 109.61 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.15 -7.27 0.29 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 121.09 -0.576 . . . . 0.78 112.547 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.44 -134.61 22.83 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.556 -0.831 . . . . 0.81 112.333 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -22.8 40.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.649 0.262 . . . . 2.47 110.793 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.4 tp -85.6 -11.62 53.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.097 0.475 . . . . 1.94 110.318 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.75 98.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.772 -0.727 . . . . 0.7 111.961 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -62.9 -40.09 96.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.067 0.461 . . . . 2.69 110.552 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.79 -49.06 79.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.678 -0.692 . . . . 1.65 111.158 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.549 HD12 ' CE2' ' A' ' 29' ' ' PHE . 1.7 mt -66.29 -22.77 66.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 1.17 111.6 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 m -69.71 -40.39 76.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.917 0.389 . . . . 0.62 110.098 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -72.37 -38.91 68.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.98 -0.748 . . . . 1.21 108.98 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.88 99.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.418 -0.81 . . . . 0.71 110.935 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.441 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 66.6 t-105 -62.69 -38.21 89.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.735 -0.666 . . . . 0.59 110.714 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -61.13 -38.48 86.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.71 110.39 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.05 -41.73 92.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.121 0.486 . . . . 0.84 109.801 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.41 -38.7 88.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.784 -0.644 . . . . 0.66 111.006 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.8 mtm -69.26 -33.42 73.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 1.08 111.149 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.92 -38.86 61.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.501 . . . . 0.99 110.584 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.6 mt -76.31 -32.75 58.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.094 -0.503 . . . . 0.97 110.926 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.27 39.54 6.0 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.772 -0.727 . . . . 0.78 111.581 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.6 m -130.09 30.32 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.832 0.349 . . . . 0.81 110.83 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.441 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 2.8 mp0 -59.77 -63.0 1.46 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.047 -0.524 . . . . 1.71 111.812 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.74 -33.33 61.04 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.188 -0.46 . . . . 1.91 111.172 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -66.17 -48.02 72.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.77 -0.65 . . . . 2.28 111.705 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.83 -10.6 11.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 113.062 0.764 . . . . 0.65 113.062 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.4 m -56.18 -51.76 66.83 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.219 0.452 . . . . 0.98 112.219 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.434 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 42.2 t -62.57 -59.22 13.35 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 112.547 0.573 . . . . 0.62 112.547 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 10.0 Cg_endo -54.7 -35.29 86.92 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.255 1.97 . . . . 0.61 113.059 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.9 mt -68.77 -47.92 65.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.514 0.197 . . . . 0.79 110.757 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.539 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -58.59 -49.43 77.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.165 0.507 . . . . 0.58 110.784 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.41 -39.33 93.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.621 -0.718 . . . . 1.7 110.913 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.65 -18.03 71.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.998 -0.62 . . . . 0.82 113.469 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.7 t -101.55 -42.23 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.319 0.488 . . . . 0.75 112.319 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -98.72 -39.98 8.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.587 0.958 . . . . 0.84 113.587 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -79.61 -70.79 0.49 Allowed 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.676 -0.41 . . . . 1.41 111.797 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.31 -26.4 46.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.676 -0.238 . . . . 1.31 111.532 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.42 ' HB3' HH21 ' A' ' 103' ' ' ARG . 58.7 mt-30 56.38 28.45 13.53 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.606 0.567 . . . . 1.44 111.173 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -28.51 34.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.75 -0.659 . . . . 1.57 111.584 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.74 100.06 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.991 -0.374 . . . . 0.91 109.991 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.42 HH21 ' HB3' ' A' ' 100' ' ' GLN . 26.1 mmt180 -122.97 -3.59 8.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 3.22 110.967 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.0 m -149.45 166.1 30.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.319 -0.4 . . . . 1.51 110.068 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.93 -26.93 67.85 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.51 -0.313 . . . . 1.08 111.335 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -36.66 78.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.246 -0.434 . . . . 1.43 110.785 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -70.67 -42.23 71.01 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.363 -0.606 . . . . 1.89 109.363 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.5 mt -62.17 -43.14 97.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.614 -0.721 . . . . 0.9 110.097 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.402 ' O ' HG13 ' A' ' 113' ' ' ILE . 74.2 ttt-85 -57.76 -44.2 85.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.572 -0.74 . . . . 2.19 110.211 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.7 -35.06 79.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.606 -0.724 . . . . 1.95 111.386 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.4 t -60.82 -42.75 93.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.029 0.442 . . . . 0.88 110.255 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -64.42 -39.9 94.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 0.92 110.394 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.681 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 65.4 mt -63.9 -36.47 76.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 1.33 110.126 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -68.03 -23.33 64.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.834 -0.621 . . . . 1.93 111.045 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.45 -7.47 58.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.1 111.522 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.96 5.75 28.72 Favored Glycine 0 C--O 1.234 0.136 0 C-N-CA 120.747 -0.739 . . . . 1.15 112.736 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 44.4 mm -92.44 124.89 45.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 122.742 -0.27 . . . . 1.61 110.364 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -65.52 134.3 53.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.307 -0.406 . . . . 2.73 110.42 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.32 -38.97 81.23 Favored Glycine 0 CA--C 1.517 0.207 0 O-C-N 123.479 0.487 . . . . 1.19 112.717 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.31 -36.59 80.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.528 0.204 . . . . 2.98 111.368 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -73.13 -41.88 63.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.041 0.448 . . . . 2.52 109.978 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -60.79 -44.3 97.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.865 -0.607 . . . . 1.51 110.21 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -61.63 -39.41 91.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.985 -0.552 . . . . 2.3 110.874 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.41 -47.42 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.749 -0.66 . . . . 1.23 110.607 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -66.1 -27.94 68.44 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.256 -0.429 . . . . 1.11 111.333 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -62.46 -28.82 70.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.139 0.495 . . . . 1.31 110.301 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -105.05 19.13 21.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.006 -0.543 . . . . 1.63 111.111 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.0 t -80.3 142.22 34.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.102 -0.499 . . . . 2.04 110.865 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -69.84 -32.26 70.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.198 0.523 . . . . 3.82 109.685 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.41 -44.87 99.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.717 -0.674 . . . . 1.53 109.804 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.529 HG13 ' HB3' ' A' ' 77' ' ' ALA . 62.0 t -64.31 -41.48 92.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.412 -0.813 . . . . 1.11 110.332 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -57.29 -42.47 81.76 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.989 -0.55 . . . . 2.43 110.083 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 137' ' ' GLN . 12.1 t -66.38 -44.88 81.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.645 -0.707 . . . . 1.47 110.214 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 48.4 mt -59.2 -37.73 78.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 0.93 111.043 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.493 ' HA ' HE21 ' A' ' 138' ' ' GLN . 77.2 t -61.94 -47.01 95.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.929 -0.397 . . . . 0.8 109.929 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.6 -39.14 92.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.84 -0.618 . . . . 0.85 110.812 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 133' ' ' SER . 78.6 mt-30 -60.49 -41.08 93.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 1.39 111.207 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.493 HE21 ' HA ' ' A' ' 135' ' ' VAL . 49.7 mt-30 -63.75 -48.05 78.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.262 -0.426 . . . . 0.61 110.727 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 8.6 mt-10 -65.12 -41.2 95.1 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.025 -0.534 . . . . 2.82 110.44 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.7 tttm -61.92 -50.7 71.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.277 -0.874 . . . . 1.95 111.259 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.42 -44.98 92.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.46 . . . . 0.65 111.967 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.08 -36.51 83.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.487 -0.324 . . . . 0.61 111.689 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.88 -36.39 28.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.525 -0.307 . . . . 0.72 111.197 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -63.86 -49.73 71.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.413 -0.358 . . . . 1.39 110.997 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.7 p -79.63 -9.68 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.515 . . . . 1.34 110.891 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.506 ' O ' ' HD2' ' A' ' 148' ' ' ARG . 89.5 mt-30 59.18 67.25 0.93 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.771 -0.65 . . . . 1.95 110.193 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 149' ' ' GLY . 14.0 tp -63.97 129.68 41.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.515 -0.766 . . . . 0.71 110.535 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.506 ' HD2' ' O ' ' A' ' 146' ' ' GLN . 1.2 mpt_? -96.74 -47.49 5.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.821 -0.627 . . . . 4.16 110.254 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . -98.05 -158.09 30.16 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.321 -0.712 . . . . 0.68 111.321 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.551 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 2.5 t -113.4 -57.41 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 117.221 0.511 . . . . 0.49 111.724 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 17.3 Cg_endo -92.64 82.34 0.24 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.601 2.201 . . . . 0.56 111.885 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.36 146.15 50.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.316 -0.402 . . . . 0.63 110.87 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 43.8 ttm -118.78 133.14 56.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.049 -0.523 . . . . 0.42 110.314 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.28 133.1 56.38 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.914 -0.585 . . . . 0.52 109.826 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.43 112.4 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.257 -0.429 . . . . 0.55 110.459 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 60.47 17.23 7.08 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.278 -0.873 . . . . 1.16 111.52 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.19 20.28 64.88 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.925 -0.58 . . . . 0.56 112.512 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -121.06 -38.35 2.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.886 0.374 . . . . 1.75 111.641 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -111.83 128.36 56.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.016 0.436 . . . . 1.16 110.898 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -105.15 138.4 41.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.667 -0.697 . . . . 0.98 110.438 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.23 134.97 33.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.528 -0.306 . . . . 1.2 110.325 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -115.6 100.79 53.96 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.774 0.321 . . . . 0.72 110.587 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.45 -16.87 34.7 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 122.363 2.042 . . . . 0.54 112.572 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -81.02 -6.48 58.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.948 0.404 . . . . 2.22 110.788 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -115.26 14.77 18.43 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.244 -0.742 . . . . 0.59 111.244 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.403 ' HB3' ' OE1' ' A' ' 177' ' ' GLN . 64.9 mtt -105.54 -174.52 2.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.543 -0.329 . . . . 0.57 110.187 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -71.25 111.8 6.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.226 0.536 . . . . 1.54 111.032 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.24 18.49 22.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.338 0.589 . . . . 1.16 109.795 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.99 -48.88 6.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.507 -0.77 . . . . 1.53 110.681 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -122.37 126.84 48.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.164 -0.471 . . . . 1.21 110.61 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.445 ' O ' HG23 ' A' ' 175' ' ' VAL . 39.3 mtt -62.19 -40.52 96.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.031 -0.531 . . . . 1.96 111.602 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -61.05 -42.01 97.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 2.05 110.604 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.8 t -67.74 -46.84 81.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.792 -0.64 . . . . 0.65 110.45 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -55.4 -49.34 72.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.777 -0.647 . . . . 0.47 111.856 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 171' ' ' MET . 80.8 t -55.73 -50.09 70.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.548 -0.296 . . . . 0.48 111.705 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -69.25 -35.06 75.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.375 -0.375 . . . . 1.7 111.082 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.403 ' OE1' ' HB3' ' A' ' 166' ' ' MET . 57.4 tt0 -63.57 -47.15 82.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.398 -0.365 . . . . 1.32 110.537 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' ' 182' ' ' VAL . 17.7 t80 -57.54 -46.73 83.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.975 -0.557 . . . . 0.46 109.906 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.7 -41.1 88.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.638 -0.71 . . . . 0.43 111.46 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -62.55 -40.36 96.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.086 -0.506 . . . . 1.55 110.311 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.2 m -59.76 -42.03 92.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.48 110.575 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 178' ' ' TYR . 61.8 t -60.05 -53.17 52.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.293 -0.412 . . . . 0.48 110.523 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -59.83 -46.36 89.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.687 -0.688 . . . . 1.59 111.047 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 188' ' ' LYS . 88.6 t80 -58.73 -45.6 89.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.838 -0.619 . . . . 1.17 111.484 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.36 -36.55 74.25 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.479 0.18 . . . . 0.68 111.401 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 46.7 m -64.37 -37.6 88.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.986 0.422 . . . . 1.07 110.879 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -97.42 17.72 16.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 2.26 111.139 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 184' ' ' TYR . 44.1 tttm -94.08 76.99 4.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.116 0.484 . . . . 1.72 110.395 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.597 -0.716 . . . . 4.33 110.85 -179.753 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SFQ . . . . . 0.524 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.399 -0.223 . . . . 4.08 110.399 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -87.7 127.41 35.3 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.42 -0.215 . . . . 3.58 110.42 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -134.73 135.01 41.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.532 0.206 . . . . 1.32 110.492 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -128.3 151.01 49.81 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.761 0.315 . . . . 2.29 110.746 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -65.95 123.37 19.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.783 -0.644 . . . . 1.83 111.011 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.0 -14.05 52.45 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.915 -0.584 . . . . 0.78 112.425 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -108.52 -73.31 0.69 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 120.95 -0.3 . . . . 1.87 111.137 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -91.54 -24.59 19.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.581 0.229 . . . . 1.46 111.41 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -145.7 158.82 43.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.147 -0.316 . . . . 0.79 110.147 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.95 122.96 31.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.958 0.409 . . . . 0.9 111.096 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.4 m -74.51 120.57 20.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.162 -0.472 . . . . 1.11 109.805 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.4 mt -72.58 136.69 45.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.024 0.44 . . . . 0.74 111.285 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -77.17 -31.7 55.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.972 -0.751 . . . . 2.33 108.972 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -120.2 83.42 32.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.26 -0.882 . . . . 3.64 110.096 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.12 163.4 38.25 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.382 2.055 . . . . 0.85 112.08 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.5 t -101.77 115.3 43.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.004 0.43 . . . . 0.72 110.647 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.43 111.84 12.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.807 -0.633 . . . . 0.89 110.496 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.37 20.88 9.22 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.771 -0.728 . . . . 0.73 112.245 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.88 154.27 55.37 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.452 -0.203 . . . . 0.64 110.452 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.49 161.31 42.66 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.12 1.88 . . . . 0.56 112.228 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -57.33 -56.53 20.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.836 -0.62 . . . . 1.79 111.487 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.409 HG21 HD11 ' A' ' 50' ' ' LEU . 58.9 t -112.27 96.35 4.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.134 0.493 . . . . 0.45 110.337 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.33 116.54 32.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.635 -0.711 . . . . 0.53 109.764 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -126.23 152.17 46.43 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.611 0.243 . . . . 1.61 110.822 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.23 156.61 42.69 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.61 -0.515 . . . . 0.53 109.61 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -169.06 175.95 5.54 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.019 0.438 . . . . 0.55 111.003 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.493 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 7.0 t -156.24 136.99 13.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.337 -0.392 . . . . 0.96 110.192 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.409 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.1 m-85 -70.58 -15.76 62.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.921 -0.581 . . . . 0.62 110.957 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CE2' HD12 ' A' ' 72' ' ' LEU . 65.8 m-85 -88.9 -1.27 58.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.208 -0.451 . . . . 1.78 110.765 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.3 t -107.49 115.73 58.95 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.035 -0.357 . . . . 0.48 110.035 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -64.09 -26.42 65.58 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.372 2.048 . . . . 0.7 112.082 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -70.19 -27.37 64.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 1.74 110.096 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.1 m -71.9 -37.05 70.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.553 -0.536 . . . . 0.37 109.553 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -65.52 -36.48 83.95 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.28 0.562 . . . . 1.44 109.553 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.499 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 47.2 tt0 -65.36 -43.96 89.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.382 -0.826 . . . . 2.27 109.967 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.43 -32.75 68.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.061 -0.518 . . . . 0.87 111.964 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 3.2 tp10 -87.94 -50.79 6.2 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.432 0.901 . . . . 1.89 113.432 -177.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 27.1 tp10 -94.38 -34.33 12.82 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.738 1.014 . . . . 2.0 113.738 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 51.9 t -81.46 -51.98 14.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 121.578 -0.701 . . . . 0.58 110.914 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' HB3' HG22 ' A' ' 175' ' ' VAL . 79.8 mt -92.18 -31.3 15.52 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.468 0.544 . . . . 0.41 112.468 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 6.7 m-70 60.0 48.62 8.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.484 -0.561 . . . . 0.84 109.484 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.594 ' O ' HG23 ' A' ' 46' ' ' VAL . 41.1 mm -53.16 -64.13 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.474 -0.784 . . . . 0.41 111.893 -178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -54.53 -31.66 56.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.284 0.476 . . . . 1.03 112.284 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.94 -37.98 72.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.806 0.336 . . . . 1.73 110.928 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.456 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 28.4 m-80 -72.88 -33.01 65.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 1.19 110.626 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 42' ' ' ILE . 62.1 t -60.47 -37.11 73.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.873 -0.603 . . . . 0.49 110.443 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -62.04 -25.04 67.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.984 -0.553 . . . . 1.53 111.726 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 45' ' ' ASN . 49.3 mtmt -83.04 -11.44 58.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.517 -0.311 . . . . 2.02 111.348 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -112.15 -20.84 11.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 111.828 0.307 . . . . 1.44 111.828 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.409 HD11 HG21 ' A' ' 22' ' ' VAL . 85.8 mt -74.6 132.73 77.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.699 0.285 . . . . 1.0 111.366 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.41 174.5 11.46 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.333 2.022 . . . . 0.74 112.013 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -67.06 144.81 55.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.14 -0.482 . . . . 2.63 111.158 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.02 -20.46 47.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.172 -0.537 . . . . 0.82 112.559 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.17 113.63 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 120.869 0.366 . . . . 1.03 110.603 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -97.95 151.77 19.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.045 -0.525 . . . . 2.51 109.841 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 96.2 mtp -108.57 146.17 33.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.47 -0.332 . . . . 1.28 110.359 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.9 m -135.07 110.71 9.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.824 0.345 . . . . 0.61 110.492 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -106.84 122.45 46.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.875 -0.602 . . . . 0.86 109.704 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.7 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 10.2 m-85 -111.5 159.19 18.33 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.93 0.395 . . . . 0.71 111.0 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.493 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 52.5 t-80 -104.62 134.64 47.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.491 . . . . 0.57 109.875 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 m -87.47 150.41 3.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.569 -0.287 . . . . 0.68 111.012 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.667 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 7.5 m-20 -99.44 1.32 44.04 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.36 0.504 . . . . 0.93 112.36 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -98.18 12.92 33.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.13 0.491 . . . . 0.74 111.296 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.13 99.63 3.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.256 -0.429 . . . . 1.09 110.726 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.96 -2.88 4.84 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.623 -0.799 . . . . 0.78 112.426 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.23 -138.91 31.46 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.209 -0.52 . . . . 0.81 112.145 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.98 -37.51 72.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.859 0.362 . . . . 2.47 111.133 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -70.61 -22.08 62.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 1.94 110.391 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.34 -32.48 84.33 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.5 -0.857 . . . . 0.7 111.132 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.667 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 33.4 mttm -66.7 -36.94 83.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.725 0.298 . . . . 2.69 110.807 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -67.0 -39.04 87.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.137 0.494 . . . . 1.65 110.294 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.545 HD12 ' CE2' ' A' ' 29' ' ' PHE . 4.3 mt -66.25 -28.89 69.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.964 -0.562 . . . . 1.17 110.321 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 51.6 m -67.7 -36.72 81.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.191 0.52 . . . . 0.62 109.773 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -73.87 -41.61 61.96 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.81 -0.632 . . . . 1.21 109.623 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.82 95.24 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.82 -0.627 . . . . 0.71 110.835 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -61.12 -40.14 92.66 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.859 -0.609 . . . . 0.59 110.557 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.524 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.21 -35.73 81.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.063 -0.517 . . . . 0.71 110.228 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.85 -46.23 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.944 -0.571 . . . . 0.84 109.979 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.86 84.69 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.87 -0.605 . . . . 0.66 111.3 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 69.1 mtm -67.97 -39.36 83.37 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.129 -0.487 . . . . 1.08 110.846 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.69 -25.56 63.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 0.99 111.371 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 98.0 mt -88.97 -46.84 8.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.127 -0.488 . . . . 0.97 110.997 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.43 41.92 2.11 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.113 -0.565 . . . . 0.78 111.862 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.83 26.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.977 0.418 . . . . 0.81 110.216 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.94 -53.61 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.519 -0.764 . . . . 1.71 111.708 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.04 -19.88 65.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.781 -0.645 . . . . 1.91 112.189 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -81.92 -22.26 36.88 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.949 0.351 . . . . 2.28 111.949 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.441 ' HA ' ' HG2' ' A' ' 91' ' ' PRO . 32.9 m -111.36 -6.74 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 113.231 0.826 . . . . 0.65 113.231 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -56.01 27.73 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.699 0.629 . . . . 0.98 112.699 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.434 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.9 t -60.29 -56.48 34.97 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 111.97 0.359 . . . . 0.62 111.97 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.441 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 9.4 Cg_endo -55.13 -37.79 93.91 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.465 2.11 . . . . 0.61 113.156 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.8 mt -72.37 -42.22 65.5 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.962 -0.295 . . . . 0.79 110.443 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -59.88 -51.88 67.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.262 0.553 . . . . 0.58 110.802 179.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -70.86 -34.72 71.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.067 -0.515 . . . . 1.7 111.362 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.09 -23.02 72.85 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.866 -0.683 . . . . 0.82 113.068 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.92 -45.98 12.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.803 0.301 . . . . 0.75 111.703 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -89.23 -51.72 5.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.775 1.028 . . . . 0.84 113.775 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -74.39 -68.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.404 0.52 . . . . 1.41 112.404 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.465 ' HB ' ' OG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -72.4 -34.53 67.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.16 0.429 . . . . 1.31 112.16 -179.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 60.4 35.54 20.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.059 0.457 . . . . 1.44 110.744 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.465 ' OG1' ' HB ' ' A' ' 99' ' ' THR . 0.0 OUTLIER -83.75 -30.24 26.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.634 -0.712 . . . . 1.57 111.637 -179.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.5 mt -76.89 110.48 12.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.194 -0.457 . . . . 0.91 110.976 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -120.72 -11.44 9.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 3.22 109.874 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.0 m -150.93 171.48 17.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.006 -0.543 . . . . 1.51 110.339 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -64.12 -22.48 66.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.091 0.472 . . . . 1.08 111.013 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -42.78 92.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.693 -0.685 . . . . 1.43 111.207 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.2 m-20 -65.43 -40.37 93.25 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.167 -0.47 . . . . 1.89 110.137 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 105' ' ' ALA . 12.1 mt -62.52 -42.3 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.659 -0.7 . . . . 0.9 110.083 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -57.7 -41.93 82.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.301 -0.863 . . . . 2.19 110.908 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -66.79 -39.06 87.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 1.95 111.01 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 107' ' ' ASP . 89.1 t -59.83 -39.53 80.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.847 0.356 . . . . 0.88 110.526 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -65.87 -39.07 90.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.444 -0.344 . . . . 0.92 110.159 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 79.9 mt -65.59 -35.53 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.143 0.497 . . . . 1.33 109.686 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -65.66 -27.96 68.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.774 -0.648 . . . . 1.93 110.338 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.44 -13.04 58.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.599 -0.728 . . . . 1.1 111.116 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.38 6.86 17.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.555 -0.831 . . . . 1.15 113.408 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 43.1 mm -91.64 122.82 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.955 0.378 . . . . 1.61 110.054 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -65.03 136.06 56.32 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.477 -0.329 . . . . 2.73 110.792 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.4 -33.24 70.34 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 121.031 -0.604 . . . . 1.19 112.595 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -65.91 -42.8 89.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.285 0.564 . . . . 2.98 109.897 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.89 -41.83 86.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 2.52 109.711 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -60.0 -40.4 89.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.31 -0.859 . . . . 1.51 111.11 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -64.29 -40.31 95.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.385 -0.37 . . . . 2.3 110.918 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.4 89.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.23 111.115 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.44 -40.62 70.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.415 . . . . 1.11 110.654 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -58.39 -34.85 71.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.037 -0.529 . . . . 1.31 110.841 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -106.55 40.61 1.59 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.072 -0.513 . . . . 1.63 111.096 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 80.1 p -108.79 152.94 24.19 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.745 -0.382 . . . . 2.04 110.745 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -72.09 -32.84 67.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.416 . . . . 3.82 109.999 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.461 ' O ' ' HG ' ' A' ' 134' ' ' LEU . 60.3 t -58.9 -50.35 79.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.696 -0.684 . . . . 1.53 110.956 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 135' ' ' VAL . 24.8 t -60.22 -45.15 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 1.11 110.522 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -59.26 -38.72 80.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.254 -0.43 . . . . 2.43 110.481 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.04 -36.53 84.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.165 0.507 . . . . 1.47 109.961 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 130' ' ' VAL . 75.7 mt -72.34 -41.63 66.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.987 -0.551 . . . . 0.93 110.342 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.613 ' HA ' HE21 ' A' ' 138' ' ' GLN . 94.2 t -58.27 -47.17 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 0.8 111.084 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.71 83.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.106 -0.497 . . . . 0.85 111.093 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -70.08 -35.27 74.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 1.39 111.62 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.7 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 48.8 mt-30 -56.58 -54.56 44.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.144 -0.48 . . . . 0.61 111.085 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -71.58 -32.79 68.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.845 -0.616 . . . . 2.82 111.243 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 70.5 tttt -60.13 -48.27 82.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.323 -0.399 . . . . 1.95 110.805 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.86 -43.03 99.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.16 -0.473 . . . . 0.65 110.986 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.51 -46.23 90.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.61 111.659 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.94 -6.45 57.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.306 0.484 . . . . 0.72 112.306 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -94.07 -27.88 16.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.057 0.456 . . . . 1.39 110.456 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.6 m -98.73 5.65 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.088 -0.505 . . . . 1.34 110.868 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 148' ' ' ARG . 62.7 mt-30 56.51 55.91 6.08 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.25 0.548 . . . . 1.95 109.974 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 44.3 tp -63.71 103.32 0.54 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.577 -0.738 . . . . 0.71 111.237 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 146' ' ' GLN . 51.1 mtt180 -100.51 40.84 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.858 -0.61 . . . . 4.16 110.199 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -174.13 -174.64 41.13 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.613 -0.995 . . . . 0.68 110.613 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.504 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.2 t -107.83 -58.46 0.05 OUTLIER Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 117.174 0.487 . . . . 0.49 111.562 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.504 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 18.4 Cg_endo -93.98 67.22 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.558 2.172 . . . . 0.56 112.313 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.07 143.29 45.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.214 -0.448 . . . . 0.63 110.759 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 45.4 ttm -113.82 138.41 50.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.106 -0.497 . . . . 0.42 110.68 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.49 125.29 44.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.638 -0.71 . . . . 0.52 109.659 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.407 HG22 HG13 ' A' ' 182' ' ' VAL . 67.5 t -88.57 112.87 24.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.552 -0.295 . . . . 0.55 111.347 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 58.37 17.3 4.67 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.842 0.714 . . . . 1.16 111.801 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 63.26 19.93 62.44 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.051 -0.595 . . . . 0.56 111.627 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -110.72 -38.07 5.25 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.874 0.369 . . . . 1.75 111.078 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -123.83 142.0 51.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.38 . . . . 1.16 111.254 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -107.59 142.95 36.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.749 -0.659 . . . . 0.98 109.614 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.7 mp -94.29 135.21 35.94 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.144 -0.317 . . . . 1.2 110.144 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -115.57 106.05 51.02 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.808 0.337 . . . . 0.72 110.974 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.43 -20.3 21.0 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.33 2.02 . . . . 0.54 112.266 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -77.0 5.98 7.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.034 -0.53 . . . . 2.22 110.996 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.4 22.07 4.46 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.192 -0.763 . . . . 0.59 111.192 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 66.0 mtt -109.19 -167.41 1.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.528 0.204 . . . . 0.57 110.777 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.04 130.7 41.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.291 0.567 . . . . 1.54 111.659 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.68 19.0 13.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.142 -0.935 . . . . 1.16 109.227 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.7 -46.07 8.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.408 -0.815 . . . . 1.53 110.368 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -146.49 130.65 17.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.118 -0.492 . . . . 1.21 110.252 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.434 ' O ' HG23 ' A' ' 175' ' ' VAL . 0.0 OUTLIER -60.56 -28.9 68.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 1.96 110.333 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.54 -31.28 70.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.49 0.662 . . . . 2.05 110.506 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 43.0 t -86.0 -43.52 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.806 -0.634 . . . . 0.65 109.677 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -52.11 -50.19 62.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.306 -0.861 . . . . 0.47 111.781 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 40' ' ' LEU . 93.4 t -59.09 -50.21 80.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.249 -0.432 . . . . 0.48 111.564 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -63.29 -41.93 99.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.028 -0.533 . . . . 1.7 111.289 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -64.65 -43.84 92.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.552 -0.295 . . . . 1.32 110.774 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -57.44 -48.38 79.3 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.108 0.48 . . . . 0.46 110.262 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.6 -35.59 77.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.778 -0.647 . . . . 0.43 111.688 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.9 -36.39 80.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.502 -0.317 . . . . 1.55 110.688 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.5 m -59.14 -38.37 79.52 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.037 -0.528 . . . . 0.48 110.654 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.407 HG13 HG22 ' A' ' 155' ' ' VAL . 43.0 t -61.26 -53.08 53.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.005 -0.543 . . . . 0.48 110.196 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -58.11 -41.48 83.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.501 -0.772 . . . . 1.59 111.086 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.625 ' O ' ' HB2' ' A' ' 188' ' ' LYS . 66.3 t80 -61.37 -44.28 97.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 1.17 111.179 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.42 -36.82 60.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.056 0.762 . . . . 0.68 113.056 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.3 p -63.02 -32.04 73.31 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.069 0.461 . . . . 1.07 110.959 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -103.44 20.24 18.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.041 -0.527 . . . . 2.26 110.217 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.625 ' HB2' ' O ' ' A' ' 184' ' ' TYR . 43.1 tttm -112.23 59.06 0.63 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.194 -0.457 . . . . 1.72 111.02 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.578 ' NZ ' ' HB3' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.246 0 CA-C-N 116.055 -0.521 . . . . 4.33 110.27 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SFQ . . . . . 0.492 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.628 0.252 . . . . 4.08 110.466 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -90.79 125.82 35.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.62 0.248 . . . . 3.58 111.187 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -128.15 108.25 10.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.934 0.397 . . . . 1.32 109.976 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -94.35 145.93 24.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 2.29 110.854 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -72.16 128.86 36.99 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.978 -0.749 . . . . 1.83 108.978 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.07 1.26 72.96 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.542 -0.837 . . . . 0.78 111.075 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -118.04 -72.34 0.69 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.785 -0.45 . . . . 1.87 109.785 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -85.21 -39.09 18.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.054 0.454 . . . . 1.46 109.997 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -138.28 152.73 48.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.97 -0.559 . . . . 0.79 110.336 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.17 132.93 54.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.02 -0.536 . . . . 0.9 110.356 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 m -85.22 120.18 26.43 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.767 -0.457 . . . . 1.11 109.767 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 69.2 mt -74.2 146.69 43.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.147 -0.479 . . . . 0.74 110.957 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.8 -10.37 48.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.464 0.649 . . . . 2.33 109.293 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -118.63 83.55 22.25 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.314 -0.857 . . . . 3.64 109.51 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.62 121.68 8.4 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.125 1.883 . . . . 0.85 111.769 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.47 109.59 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.92 -0.582 . . . . 0.72 110.552 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.0 136.72 45.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.481 -0.781 . . . . 0.89 110.986 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.33 14.97 72.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.776 -0.726 . . . . 0.73 112.5 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.41 144.31 33.69 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 110.151 -0.315 . . . . 0.64 110.151 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.51 168.98 16.68 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.627 2.218 . . . . 0.56 112.018 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 22.1 mp0 -63.68 -53.0 58.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.043 -0.526 . . . . 1.79 111.013 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.59 103.3 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.862 0.363 . . . . 0.45 110.617 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.8 tp -108.39 127.99 54.37 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.044 -0.526 . . . . 0.53 110.564 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -128.71 142.95 50.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 1.61 110.135 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.64 152.2 37.47 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.367 -0.378 . . . . 0.53 110.062 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.98 174.14 9.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.298 0.57 . . . . 0.55 111.52 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.434 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 7.9 t -155.54 132.14 10.45 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.628 -0.715 . . . . 0.96 109.495 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.532 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 92.1 m-85 -67.36 -15.24 63.57 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.187 -0.461 . . . . 0.62 111.333 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.532 ' CE1' ' HA2' ' A' ' 69' ' ' GLY . 71.8 m-85 -86.31 -6.12 59.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 1.78 111.589 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 35.5 t -109.61 118.45 50.37 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.451 -0.34 . . . . 0.48 111.626 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.48 -25.63 76.0 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.406 2.07 . . . . 0.7 111.232 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -61.84 -30.12 70.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.571 -0.74 . . . . 1.74 110.251 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.5 m -79.27 -41.06 28.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.046 -0.524 . . . . 0.37 110.334 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.51 -35.17 76.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.137 0.494 . . . . 1.44 110.008 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.699 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 26.6 tt0 -67.04 -33.42 75.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.428 -0.806 . . . . 2.27 110.4 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.417 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.6 m-85 -86.51 -22.44 26.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.935 0.398 . . . . 0.87 110.768 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 12.8 tp10 -84.18 -62.62 1.52 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.019 -0.537 . . . . 1.89 112.41 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -92.41 -33.98 14.33 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.309 0.855 . . . . 2.0 113.309 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.699 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 73.9 t -76.72 -58.24 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.286 -0.566 . . . . 0.58 111.631 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -89.95 -26.19 20.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.415 0.524 . . . . 0.41 112.415 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 22.6 m-70 56.19 49.9 14.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.178 0.513 . . . . 0.84 110.492 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.417 HG13 ' CD2' ' A' ' 36' ' ' PHE . 42.4 mm -59.89 -51.69 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.739 -0.664 . . . . 0.41 111.862 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 m -56.46 -40.05 74.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.658 -0.246 . . . . 1.03 111.643 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -65.46 -47.63 75.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.112 0.482 . . . . 1.73 110.307 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -59.61 -42.41 92.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.565 -0.743 . . . . 1.19 110.968 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.656 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 53.8 t -61.53 -47.79 91.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.877 -0.601 . . . . 0.49 110.757 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -58.46 -33.08 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.812 0.339 . . . . 1.53 111.74 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -79.17 -15.76 57.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 2.02 111.577 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 mmtt -101.94 -23.99 14.06 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.81 0.338 . . . . 1.44 111.045 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 57.8 mt -64.82 137.34 97.11 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.1 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.49 172.04 16.5 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.584 2.189 . . . . 0.74 111.792 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.65 136.76 53.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.852 -0.613 . . . . 2.63 111.579 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.49 -23.2 36.69 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.806 -0.712 . . . . 0.82 112.904 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.25 130.35 35.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.913 0.387 . . . . 1.03 111.05 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -112.25 130.31 55.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 2.51 110.287 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.0 ttt -92.37 139.07 30.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 1.28 110.123 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.08 129.22 52.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.679 0.276 . . . . 0.61 111.3 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -115.07 121.81 44.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.856 -0.794 . . . . 0.86 108.856 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 10.5 m-30 -117.53 159.5 22.76 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.142 0.496 . . . . 0.71 112.075 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 48.6 t-80 -105.32 140.01 39.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.744 -0.662 . . . . 0.57 109.901 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.7 m -104.0 152.31 6.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.539 -0.3 . . . . 0.68 111.553 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.608 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 72.4 m-20 -96.11 -2.83 45.73 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.955 0.724 . . . . 0.93 112.955 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -87.89 4.06 46.13 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.166 -0.614 . . . . 0.74 111.603 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.73 107.8 5.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.626 -0.509 . . . . 1.09 109.626 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.65 -8.03 3.35 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.603 -0.726 . . . . 0.78 111.297 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.4 -131.75 24.71 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.326 -0.464 . . . . 0.81 112.597 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -74.11 -45.67 47.59 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.863 0.32 . . . . 2.47 111.863 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.3 tp -73.34 -17.75 61.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.372 -0.376 . . . . 1.94 111.229 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.532 ' HA2' ' CE1' ' A' ' 29' ' ' PHE . . . -58.33 -32.54 68.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.787 -0.72 . . . . 0.7 112.585 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.608 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 86.8 mttt -71.5 -31.25 66.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.729 0.299 . . . . 2.69 111.718 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.92 -42.48 85.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.847 0.356 . . . . 1.65 110.703 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.448 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 1.3 mt -66.35 -24.26 66.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.145 -0.48 . . . . 1.17 110.93 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -68.87 -34.13 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.267 0.556 . . . . 0.62 109.83 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.402 ' HA ' HG22 ' A' ' 135' ' ' VAL . 41.1 tt0 -76.43 -40.09 51.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.561 -0.745 . . . . 1.21 109.155 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.75 91.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.61 -0.723 . . . . 0.71 111.198 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -60.44 -38.0 82.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.59 110.502 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -62.06 -38.88 90.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.899 -0.591 . . . . 0.71 110.197 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.82 -44.97 92.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.636 -0.711 . . . . 0.84 109.812 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.41 86.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.738 -0.665 . . . . 0.66 110.91 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.6 mtm -66.01 -44.08 85.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 1.08 111.042 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.3 -30.74 69.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.112 0.482 . . . . 0.99 111.221 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.7 mt -80.39 -41.99 23.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 0.97 110.843 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.22 11.22 34.47 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.573 -0.611 . . . . 0.78 111.573 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 m -105.78 27.4 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.792 0.329 . . . . 0.81 111.149 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -52.44 63.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 1.71 110.251 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.467 ' HA ' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -63.2 -34.42 77.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.503 0.668 . . . . 1.91 110.252 179.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -62.91 -33.88 76.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.298 -0.865 . . . . 2.28 111.454 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.6 m -106.35 10.4 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.433 0.531 . . . . 0.65 112.433 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 86' ' ' ASP . 59.6 m -64.1 -53.76 44.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.787 0.327 . . . . 0.98 111.637 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.461 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 58.4 t -63.79 -55.02 36.89 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 112.532 0.567 . . . . 0.62 112.532 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 11.3 Cg_endo -55.04 -37.24 93.98 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.302 2.001 . . . . 0.61 113.56 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.416 HD22 HD21 ' A' ' 72' ' ' LEU . 33.0 mt -71.45 -32.54 68.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.681 0.277 . . . . 0.79 110.647 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -75.21 -53.34 8.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.273 0.558 . . . . 0.58 110.442 179.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.34 -39.9 94.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.81 -0.632 . . . . 1.7 110.961 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.97 -6.33 59.95 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.262 -0.494 . . . . 0.82 113.575 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.2 t -109.79 -40.3 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 117.489 0.644 . . . . 0.75 111.789 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -98.52 -48.43 5.01 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.035 0.754 . . . . 0.84 113.035 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -78.78 -70.34 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.772 0.286 . . . . 1.41 111.772 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.49 -34.84 67.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.706 -0.224 . . . . 1.31 111.507 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 58.56 34.68 24.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.03 -0.532 . . . . 1.44 110.402 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -26.45 39.89 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.579 -0.737 . . . . 1.57 110.939 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.526 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 67.1 mt -87.17 100.35 9.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.91 110.411 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.526 ' HD2' ' O ' ' A' ' 102' ' ' ILE . 13.7 mmm180 -125.5 -12.22 6.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 3.22 110.334 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.6 p -139.88 168.28 20.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 1.51 110.498 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.7 -27.04 68.94 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.959 0.409 . . . . 1.08 110.984 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.5 m -62.85 -31.43 72.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 1.43 110.631 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.475 ' O ' HG23 ' A' ' 111' ' ' VAL . 33.4 m-20 -73.9 -44.52 54.94 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.661 -0.496 . . . . 1.89 109.661 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.5 mt -62.82 -41.9 94.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.808 -0.633 . . . . 0.9 110.124 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.1 ttm105 -60.72 -34.71 74.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.675 -0.693 . . . . 2.19 109.849 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.4 -41.56 69.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.626 -0.716 . . . . 1.95 111.44 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 107' ' ' ASP . 81.1 t -54.46 -45.43 70.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.747 0.308 . . . . 0.88 111.248 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -65.14 -41.48 94.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.92 111.072 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 80.4 mt -65.94 -41.55 90.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.994 0.426 . . . . 1.33 110.064 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -65.65 -30.35 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.71 -0.677 . . . . 1.93 110.354 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.97 -34.92 66.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.043 -0.526 . . . . 1.1 111.255 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 139.68 5.58 1.24 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.241 -0.98 . . . . 1.15 113.273 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 47.6 mm -94.06 123.57 46.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.671 -0.492 . . . . 1.61 109.671 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -61.25 137.55 58.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.594 -0.275 . . . . 2.73 110.498 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.63 -42.93 78.67 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.823 -0.626 . . . . 1.19 112.64 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.4 -45.48 92.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 2.98 110.68 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.49 -45.97 92.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.167 0.508 . . . . 2.52 110.067 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -62.79 -48.06 80.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.458 -0.792 . . . . 1.51 110.951 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.45 -36.13 81.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.252 -0.431 . . . . 2.3 111.047 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.16 86.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 1.23 109.782 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.07 -35.54 78.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.535 -0.757 . . . . 1.11 110.764 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -58.08 -36.32 72.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.104 0.478 . . . . 1.31 110.822 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -99.93 16.08 25.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.096 -0.502 . . . . 1.63 111.196 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.3 m -85.55 144.37 27.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 2.04 111.195 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -64.95 -36.9 85.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.839 -0.619 . . . . 3.82 110.864 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.7 t -56.19 -47.15 81.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 1.53 110.746 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 77' ' ' ALA . 17.6 t -63.83 -42.38 95.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 1.11 110.379 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -61.38 -33.75 74.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 2.43 110.549 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 63.8 m -71.86 -28.75 63.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.926 -0.579 . . . . 1.47 110.646 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.405 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 96.5 mt -74.57 -33.92 62.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.307 -0.406 . . . . 0.93 110.035 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 131' ' ' VAL . 50.5 t -61.43 -43.76 97.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.077 0.465 . . . . 0.8 110.11 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.89 -40.48 95.17 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.585 -0.734 . . . . 0.85 111.19 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -62.43 -40.27 96.03 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.437 -0.347 . . . . 1.39 111.583 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.488 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 51.9 mt-30 -59.53 -52.54 65.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.61 111.152 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -71.69 -28.87 64.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.306 -0.406 . . . . 2.82 111.768 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -63.89 -49.63 71.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.362 -0.381 . . . . 1.95 110.537 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.477 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -62.17 -44.2 97.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.876 -0.602 . . . . 0.65 111.464 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.26 -37.89 84.75 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.263 -0.426 . . . . 0.61 111.556 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -73.65 -41.24 63.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 0.72 110.813 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.48 -43.54 93.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.037 -0.528 . . . . 1.39 111.795 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 141' ' ' ALA . 32.2 m -79.84 -1.78 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 111.587 0.218 . . . . 1.34 111.587 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 53.98 59.91 3.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.326 0.584 . . . . 1.95 109.872 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 152' ' ' ALA . 11.7 tp -58.57 134.04 56.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.242 -0.89 . . . . 0.71 112.524 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.9 mmt-85 -106.61 -39.86 5.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.193 -0.912 . . . . 4.16 110.663 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -122.3 159.29 16.93 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.09 -0.804 . . . . 0.68 111.09 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.52 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.4 t -65.58 -57.62 13.96 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 112.26 0.467 . . . . 0.49 112.26 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.52 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.8 Cg_endo -85.5 89.47 0.79 Allowed 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.526 2.15 . . . . 0.56 112.068 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' A' ' 147' ' ' LEU . . . -129.87 154.2 47.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.181 -0.463 . . . . 0.63 110.611 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 30.9 ttm -127.35 133.06 50.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.208 -0.451 . . . . 0.42 110.817 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.15 133.99 53.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.52 110.186 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 44.9 t -102.4 114.81 42.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.263 -0.426 . . . . 0.55 111.218 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 59.46 14.03 3.59 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.088 -0.96 . . . . 1.16 111.987 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 69.52 20.57 75.61 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.937 -0.649 . . . . 0.56 112.125 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -120.78 -45.81 2.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 1.75 111.235 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -106.39 129.84 54.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.972 -0.558 . . . . 1.16 111.14 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -106.86 138.55 42.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.636 -0.711 . . . . 0.98 109.652 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.5 mp -90.96 132.54 35.9 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.619 -0.432 . . . . 1.2 110.3 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -111.53 97.63 37.32 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.283 -0.417 . . . . 0.72 110.403 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.92 -18.87 46.75 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.365 2.043 . . . . 0.54 111.818 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -78.23 -8.25 58.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 2.22 110.556 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -115.65 14.68 17.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.009 -0.615 . . . . 0.59 112.292 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 55.5 mtt -102.55 -178.81 3.79 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.151 -0.314 . . . . 0.57 110.151 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.2 119.56 15.5 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.363 0.601 . . . . 1.54 111.2 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.91 22.34 15.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.405 -0.816 . . . . 1.16 109.453 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.34 -51.4 5.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.326 -0.852 . . . . 1.53 110.035 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -118.47 121.66 40.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.984 -0.553 . . . . 1.21 110.185 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 46.2 mmm -59.32 -38.2 79.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.812 -0.631 . . . . 1.96 111.879 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.16 -27.94 68.4 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.117 0.484 . . . . 2.05 110.704 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 55.4 t -77.83 -46.06 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.571 -0.74 . . . . 0.65 109.634 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.58 -50.73 69.31 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.073 -0.512 . . . . 0.47 111.414 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.21 -44.93 77.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.212 -0.449 . . . . 0.48 111.242 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 21.9 mm-40 -71.59 -46.24 59.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.187 -0.46 . . . . 1.7 111.294 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.08 -45.95 82.9 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 123.215 0.322 . . . . 1.32 111.204 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.508 ' O ' HG23 ' A' ' 182' ' ' VAL . 19.0 t80 -59.4 -56.12 26.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.643 -0.253 . . . . 0.46 110.88 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.83 87.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.43 . . . . 0.43 112.087 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.3 OUTLIER -69.08 -33.87 74.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.687 -0.233 . . . . 1.55 111.056 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 86.4 m -64.78 -39.36 93.47 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.581 -0.526 . . . . 0.48 109.581 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 178' ' ' TYR . 11.7 t -60.41 -46.7 94.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.106 -0.497 . . . . 0.48 109.748 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -61.09 -41.62 97.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.826 -0.625 . . . . 1.59 110.477 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.65 -41.67 95.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 1.17 111.088 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.68 -38.08 34.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.292 -0.413 . . . . 0.68 112.056 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 51.0 m -63.18 -30.31 71.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 1.07 111.006 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -106.32 26.53 9.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.278 0.561 . . . . 2.26 110.182 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -106.9 -60.2 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.387 -0.824 . . . . 1.72 110.057 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.391 -0.814 . . . . 4.33 110.056 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SFQ . . . . . 0.533 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.985 -0.376 . . . . 4.08 109.985 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -89.86 140.79 29.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.758 -0.46 . . . . 3.58 109.758 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -135.22 121.98 20.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.008 0.432 . . . . 1.32 110.76 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -111.05 147.53 34.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.82 -0.627 . . . . 2.29 110.627 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.22 117.43 17.04 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.046 -0.525 . . . . 1.83 109.621 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' HA2' HG23 ' A' ' 10' ' ' THR . . . 111.59 -5.8 27.98 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.135 -0.786 . . . . 0.78 111.135 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -112.46 -80.89 0.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.515 0.198 . . . . 1.87 110.637 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -85.79 -27.71 24.99 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.912 0.387 . . . . 1.46 110.638 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -141.36 159.75 41.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.757 -0.46 . . . . 0.79 109.757 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.421 HG23 ' HA2' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -137.99 130.57 29.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.469 -0.332 . . . . 0.9 111.27 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -77.13 125.26 29.04 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.525 -0.546 . . . . 1.11 109.525 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.9 mt -71.0 147.01 49.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.938 0.399 . . . . 0.74 111.156 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.67 -38.91 53.7 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.005 -0.739 . . . . 2.33 109.005 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -117.21 104.34 50.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.115 -0.948 . . . . 3.64 109.343 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.39 143.25 34.61 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.227 1.952 . . . . 0.85 112.111 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.61 91.88 3.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 0.72 110.075 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.86 123.6 20.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.841 -0.618 . . . . 0.89 110.003 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.02 -5.92 42.79 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.839 -0.696 . . . . 0.73 111.922 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.31 155.28 93.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.571 0.224 . . . . 0.64 111.091 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -76.31 -177.09 3.44 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.662 2.241 . . . . 0.56 112.057 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.417 ' OE1' HG22 ' A' ' 54' ' ' VAL . 40.3 mt-30 -69.87 -52.4 25.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 1.79 110.994 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.0 t -123.26 105.1 15.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.25 0.547 . . . . 0.45 110.747 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 tp -105.54 119.6 39.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.982 -0.554 . . . . 0.53 109.738 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.484 ' OE1' ' HG3' ' A' ' 58' ' ' LYS . 17.6 tt0 -122.72 147.42 46.5 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.806 0.336 . . . . 1.61 110.297 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -122.29 151.87 40.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.131 -0.486 . . . . 0.53 110.655 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.402 ' HA ' HG12 ' A' ' 150' ' ' VAL . 0.7 OUTLIER -167.64 169.61 11.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.55 110.855 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.463 ' HB2' HG22 ' A' ' 61' ' ' VAL . 3.4 t -152.47 135.72 15.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.273 -0.421 . . . . 0.96 110.371 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.448 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 90.6 m-85 -71.43 -15.59 62.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.099 -0.501 . . . . 0.62 110.232 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -90.55 0.51 57.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.977 -0.556 . . . . 1.78 110.679 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 51.1 t -109.45 114.93 56.82 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 116.017 -0.538 . . . . 0.48 110.603 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 19.7 Cg_endo -60.9 -26.75 83.67 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.588 2.192 . . . . 0.7 111.864 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -32.5 72.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.042 -0.526 . . . . 1.74 110.842 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.2 m -72.28 -33.38 67.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.25 -0.648 . . . . 0.37 109.25 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -66.13 -40.67 90.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.866 -0.79 . . . . 1.44 108.866 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.714 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 6.7 mt-30 -70.69 -37.55 73.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.588 -0.733 . . . . 2.27 110.791 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.96 -18.23 62.01 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.919 0.34 . . . . 0.87 111.919 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.74 -65.78 1.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.292 -0.563 . . . . 1.89 112.096 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.55 -27.71 66.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.15 0.5 . . . . 2.0 111.612 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.714 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 96.1 t -100.2 -59.53 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.715 -0.394 . . . . 0.58 111.992 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.4 mt -85.03 -33.75 22.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.894 0.701 . . . . 0.41 112.894 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 61.63 46.34 7.3 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.098 0.475 . . . . 0.84 110.489 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.4 mm -58.72 -49.27 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.388 -0.823 . . . . 0.41 111.07 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 m -63.75 -45.94 87.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 1.03 111.323 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.27 -33.55 76.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.115 -0.493 . . . . 1.73 111.756 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -75.41 -41.93 54.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.411 -0.359 . . . . 1.19 110.804 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.516 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 22.5 t -60.04 -41.01 84.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.91 -0.586 . . . . 0.49 110.602 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -54.82 -38.31 67.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 1.53 112.206 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -78.7 -10.91 59.93 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.588 0.588 . . . . 2.02 112.588 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.5 mtmm -120.13 19.94 12.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.896 0.379 . . . . 1.44 110.918 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 14.1 mt -89.77 136.23 29.6 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.508 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.47 153.73 69.09 Favored 'Trans proline' 0 CA--C 1.529 0.236 0 C-N-CA 122.542 2.161 . . . . 0.74 111.848 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.13 123.45 20.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.169 -0.468 . . . . 2.63 110.774 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.33 -11.78 43.62 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.775 -0.648 . . . . 0.82 111.546 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.417 HG22 ' OE1' ' A' ' 21' ' ' GLN . 83.4 t -88.52 115.89 29.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.025 0.441 . . . . 1.03 110.368 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -92.11 140.33 29.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.893 -0.594 . . . . 2.51 110.603 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.5 ttt -100.73 119.14 38.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.097 -0.502 . . . . 1.28 110.215 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.91 99.98 9.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.173 -0.467 . . . . 0.61 111.236 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HG3' ' OE1' ' A' ' 24' ' ' GLU . 44.5 tttp -89.68 108.97 19.99 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.77 -0.826 . . . . 0.86 108.77 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.443 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 9.0 m-30 -106.72 153.02 23.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.417 0.627 . . . . 0.71 111.932 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -98.16 132.12 43.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.681 -0.69 . . . . 0.57 110.344 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 27' ' ' SER . 5.3 m -80.75 156.73 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.793 -0.185 . . . . 0.68 110.574 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.518 ' ND2' ' HG2' ' A' ' 139' ' ' GLU . 13.0 m-20 -115.72 24.57 11.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.148 0.425 . . . . 0.93 112.148 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -117.89 8.03 12.51 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.229 -0.588 . . . . 0.74 111.282 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.9 mtp -141.45 107.69 5.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.856 -0.424 . . . . 1.09 109.856 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.18 -10.76 3.04 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.751 -0.659 . . . . 0.78 112.023 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.46 -142.57 29.27 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.763 -0.732 . . . . 0.81 112.363 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.58 -34.98 76.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.298 0.571 . . . . 2.47 110.816 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -75.71 -11.79 60.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 1.94 110.349 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.59 -46.39 93.85 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.044 -0.598 . . . . 0.7 112.496 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -67.97 -27.07 66.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.609 0.242 . . . . 2.69 111.46 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -43.81 93.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 1.65 110.753 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -24.47 64.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.793 -0.64 . . . . 1.17 111.185 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 m -66.01 -35.45 80.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.163 0.506 . . . . 0.62 110.472 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -76.06 -37.8 57.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 1.21 109.484 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.67 97.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.638 -0.71 . . . . 0.71 110.386 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -64.63 -36.65 84.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.444 -0.798 . . . . 0.59 110.579 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.527 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -61.42 -38.72 88.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.71 109.991 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 58.6 t -66.54 -44.88 89.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.728 -0.669 . . . . 0.84 109.727 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.01 86.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.666 -0.697 . . . . 0.66 110.989 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.7 ttm -64.22 -44.22 92.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.868 -0.606 . . . . 1.08 110.756 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.18 83.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.589 . . . . 0.99 111.516 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 78' ' ' VAL . 78.8 mt -77.21 -38.56 51.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.576 -0.284 . . . . 0.97 111.411 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.16 38.27 3.61 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.705 -0.76 . . . . 0.78 112.42 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.9 m -132.59 30.8 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.79 0.328 . . . . 0.81 110.482 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -53.66 -64.94 0.66 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.727 -0.669 . . . . 1.71 112.568 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -31.73 70.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.908 0.385 . . . . 1.91 111.155 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -62.13 -38.79 90.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.955 -0.566 . . . . 2.28 111.866 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.2 m -98.91 -9.3 8.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.413 0.523 . . . . 0.65 112.413 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -58.16 -45.44 87.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.658 0.266 . . . . 0.98 111.643 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.461 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 77.0 t -64.63 -60.81 7.54 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.185 0.439 . . . . 0.62 112.185 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 11.9 Cg_endo -56.14 -33.26 89.8 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.983 1.789 . . . . 0.61 113.068 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.5 mt -69.41 -46.27 67.24 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.836 -0.346 . . . . 0.79 110.356 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 m-85 -61.49 -48.22 82.09 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.318 0.58 . . . . 0.58 110.54 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -62.84 -43.92 97.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.381 -0.827 . . . . 1.7 111.663 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.26 -16.46 77.1 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.097 -0.573 . . . . 0.82 113.802 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.496 HG23 HD12 ' A' ' 102' ' ' ILE . 55.0 t -100.01 -41.23 9.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 117.33 0.565 . . . . 0.75 112.424 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 31' ' ' PRO . 79.3 mt-30 -99.56 -42.34 6.96 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.009 1.114 . . . . 0.84 114.009 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -81.6 -68.05 0.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.585 -0.446 . . . . 1.41 111.784 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.93 -34.59 62.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.094 -0.242 . . . . 1.31 110.851 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.554 ' HB3' ' NH2' ' A' ' 103' ' ' ARG . 78.9 mt-30 57.85 37.67 27.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.906 -0.588 . . . . 1.44 110.636 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.29 -20.72 27.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.127 -0.942 . . . . 1.57 110.896 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 96' ' ' VAL . 83.2 mt -80.94 106.42 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.752 -0.658 . . . . 0.91 110.511 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.554 ' NH2' ' HB3' ' A' ' 100' ' ' GLN . 37.5 mmt180 -123.37 -20.14 5.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.587 -0.733 . . . . 3.22 110.76 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -133.29 172.85 12.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.828 0.346 . . . . 1.51 110.444 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.46 -26.39 67.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.023 0.44 . . . . 1.08 110.627 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -33.08 73.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.668 -0.696 . . . . 1.43 110.673 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -71.74 -39.25 70.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.962 -0.563 . . . . 1.89 109.735 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.1 mt -64.78 -41.58 92.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.875 -0.602 . . . . 0.9 109.744 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -58.77 -42.7 89.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.085 -0.961 . . . . 2.19 110.963 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -60.02 -40.96 91.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 1.95 111.149 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.3 t -56.6 -43.51 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 0.88 111.021 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -66.57 -37.65 85.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.347 -0.388 . . . . 0.92 110.513 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 88.1 mt -65.32 -41.93 92.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.074 0.464 . . . . 1.33 109.854 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -64.61 -26.6 68.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.547 -0.752 . . . . 1.93 110.723 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.97 -32.14 57.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 1.1 110.768 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.83 7.74 3.66 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.783 -0.722 . . . . 1.15 112.914 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.3 mm -87.94 137.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 110.097 -0.334 . . . . 1.61 110.097 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -70.26 133.73 47.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.05 -0.523 . . . . 2.73 110.099 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.92 -44.53 96.03 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.953 -0.641 . . . . 1.19 112.56 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.98 -37.82 88.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.323 . . . . 2.98 110.987 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.22 -42.22 84.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.263 0.554 . . . . 2.52 109.612 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -63.06 -46.86 85.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.492 -0.776 . . . . 1.51 110.382 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -64.31 -29.4 70.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.215 0.531 . . . . 2.3 110.635 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.14 62.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.906 -0.588 . . . . 1.23 110.372 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.34 -34.36 78.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 1.11 110.868 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -58.74 -26.7 64.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.846 -0.615 . . . . 1.31 110.513 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -102.05 26.11 7.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.89 -0.595 . . . . 1.63 111.635 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.9 t -101.55 143.43 31.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.906 0.384 . . . . 2.04 111.162 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -65.83 -28.36 68.93 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.57 -0.741 . . . . 3.82 110.874 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.11 -45.58 98.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.242 0.544 . . . . 1.53 109.547 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 135' ' ' VAL . 88.9 t -64.58 -44.09 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.396 -0.82 . . . . 1.11 110.038 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -55.61 -44.44 77.03 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.993 0.425 . . . . 2.43 110.682 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 52.3 m -66.06 -39.18 89.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.589 . . . . 1.47 110.74 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 40.7 mt -64.2 -37.99 89.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.376 -0.375 . . . . 0.93 110.791 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 131' ' ' VAL . 54.8 t -65.4 -44.7 94.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.8 109.949 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.73 -36.16 78.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.718 -0.674 . . . . 0.85 110.901 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -62.05 -45.46 93.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 1.39 110.903 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.493 HE21 ' HA ' ' A' ' 135' ' ' VAL . 44.9 mt-30 -63.44 -41.05 98.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.61 110.897 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.518 ' HG2' ' ND2' ' A' ' 62' ' ' ASN . 43.8 mt-10 -69.01 -40.29 78.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.072 -0.513 . . . . 2.82 111.325 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -72.05 -49.74 34.19 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.347 0.499 . . . . 1.95 112.347 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.82 -40.69 76.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.204 0.446 . . . . 0.65 112.204 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.5 -31.11 72.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.825 0.345 . . . . 0.61 111.675 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -88.13 -29.33 20.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.423 -0.353 . . . . 0.72 111.228 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -61.63 -50.61 71.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.995 0.426 . . . . 1.39 111.368 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.31 -8.8 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.945 -0.57 . . . . 1.34 111.547 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 64.18 74.93 0.39 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.384 0.612 . . . . 1.95 109.611 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.5 tp -80.23 123.96 28.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.679 -0.691 . . . . 0.71 111.888 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.26 -48.13 3.94 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.184 -0.673 . . . . 4.16 109.184 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.81 132.02 11.07 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.822 -0.911 . . . . 0.68 110.822 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.488 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 3.4 t -67.03 -52.44 31.09 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 112.584 0.587 . . . . 0.49 112.584 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.488 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 3.3 Cg_exo -79.55 76.79 4.36 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.11 1.874 . . . . 0.56 112.638 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.27 152.14 51.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.63 110.955 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 48.2 ttm -131.63 136.22 47.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.071 -0.513 . . . . 0.42 110.095 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -117.48 134.28 55.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.32 -0.4 . . . . 0.52 110.005 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 66.3 t -103.42 118.15 49.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.883 0.373 . . . . 0.55 110.565 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 64.67 5.35 2.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.491 -0.777 . . . . 1.16 111.658 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.2 15.41 74.62 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.032 -0.604 . . . . 0.56 112.158 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -119.92 -31.19 4.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.798 0.332 . . . . 1.75 111.227 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -118.41 139.12 51.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 1.16 110.549 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -117.09 138.67 51.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.916 -0.584 . . . . 0.98 110.319 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.9 mp -83.57 137.35 33.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.704 -0.48 . . . . 1.2 109.704 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -116.17 98.76 51.89 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.408 -0.36 . . . . 0.72 111.308 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.38 -14.13 33.8 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.374 2.049 . . . . 0.54 111.669 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -75.64 -6.73 51.84 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.159 -0.473 . . . . 2.22 110.975 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -128.87 19.2 5.55 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.773 -0.531 . . . . 0.59 111.773 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 50.3 mtt -99.02 -168.78 1.67 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.802 -0.199 . . . . 0.57 110.488 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -71.76 114.69 10.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.09 0.471 . . . . 1.54 110.533 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.86 33.37 5.25 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.728 0.775 . . . . 1.16 109.504 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.72 -47.81 2.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.119 -0.946 . . . . 1.53 111.018 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -114.45 118.8 34.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.788 0.328 . . . . 1.21 110.345 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.429 ' O ' HG23 ' A' ' 175' ' ' VAL . 12.6 mmt -59.76 -41.78 91.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 1.96 110.903 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.25 -33.11 75.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.801 -0.636 . . . . 2.05 111.643 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 77.0 t -79.18 -39.57 21.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.738 -0.21 . . . . 0.65 110.482 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -55.82 -50.14 71.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.596 -0.275 . . . . 0.47 111.159 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 171' ' ' MET . 46.6 t -58.39 -48.24 85.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.48 111.341 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -66.48 -39.55 88.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.891 -0.595 . . . . 1.7 111.423 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.61 -44.7 89.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.482 -0.326 . . . . 1.32 110.634 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.481 ' O ' HG23 ' A' ' 182' ' ' VAL . 2.5 t80 -54.9 -50.97 67.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.46 110.189 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.445 ' HA ' HG22 ' A' ' 46' ' ' VAL . . . -66.93 -38.19 85.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.43 112.041 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.19 -39.3 92.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.37 -0.377 . . . . 1.55 111.137 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 13.1 m -62.41 -36.96 83.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.48 110.116 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 178' ' ' TYR . 49.3 t -63.27 -48.76 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.047 0 CA-C-N 116.237 -0.438 . . . . 0.48 110.03 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -62.17 -40.17 95.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 1.59 110.743 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -64.39 -44.47 91.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.479 -0.328 . . . . 1.17 110.766 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.02 -32.34 71.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.475 -0.329 . . . . 0.68 111.274 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.2 m -75.54 -26.22 57.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 1.07 110.851 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -98.69 14.76 27.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 2.26 110.572 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -89.67 99.69 12.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.613 -0.721 . . . . 1.72 109.802 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.357 -0.83 . . . . 4.33 110.463 -179.107 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SFQ . . . . . 0.519 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 110.061 -0.348 . . . . 4.08 110.061 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -96.39 128.28 43.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.094 -0.336 . . . . 3.58 110.094 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -134.98 131.61 37.37 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.25 -0.278 . . . . 1.32 110.25 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.0 142.96 49.75 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.334 -0.394 . . . . 2.29 110.87 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -74.32 123.59 24.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 1.83 110.366 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.97 -7.74 44.95 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.931 -0.577 . . . . 0.78 111.745 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' HB3' ' OE1' ' A' ' 8' ' ' GLN . 1.2 tttm -118.21 -75.85 0.58 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.612 0.244 . . . . 1.87 110.74 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.453 ' OE1' ' HB3' ' A' ' 7' ' ' LYS . 22.7 mp0 -76.6 -42.45 42.42 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.433 0.635 . . . . 1.46 110.175 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -134.16 163.99 28.36 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.722 -0.672 . . . . 0.79 109.394 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.4 115.91 12.82 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.716 0.294 . . . . 0.9 110.805 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.6 m -73.9 121.23 20.61 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.036 -0.529 . . . . 1.11 109.833 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.69 142.42 51.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.111 0.482 . . . . 0.74 111.667 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -74.17 -33.7 63.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.666 -0.697 . . . . 2.33 109.464 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -120.35 97.06 49.1 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.267 -0.879 . . . . 3.64 109.47 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.29 169.23 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.529 2.153 . . . . 0.85 112.554 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.6 t -104.69 117.12 49.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.897 -0.592 . . . . 0.72 110.464 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.43 131.9 35.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.821 0.343 . . . . 0.89 110.312 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.59 22.84 41.74 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.735 -0.745 . . . . 0.73 111.523 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.61 150.45 38.05 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.773 -0.214 . . . . 0.64 110.469 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.56 171.9 5.1 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.045 2.497 . . . . 0.56 113.077 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -71.0 -68.55 0.43 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.853 -0.612 . . . . 1.79 110.63 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.5 t -107.01 102.17 13.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.678 -0.49 . . . . 0.45 109.678 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 59' ' ' TYR . 18.5 tp -105.35 119.62 39.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.858 -0.61 . . . . 0.53 110.535 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -119.53 147.82 44.01 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.948 -0.39 . . . . 1.61 109.948 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.09 145.04 47.27 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.797 -0.446 . . . . 0.53 109.797 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -164.25 175.67 9.88 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.175 0.512 . . . . 0.55 110.799 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.612 ' HB2' HG22 ' A' ' 61' ' ' VAL . 3.3 t -156.53 137.82 13.82 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.547 -0.751 . . . . 0.96 109.998 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.563 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 71.1 m-85 -71.35 -14.69 62.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 0.62 110.572 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.435 ' CZ ' HD12 ' A' ' 72' ' ' LEU . 71.7 m-85 -88.27 -5.92 58.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.871 -0.604 . . . . 1.78 110.45 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 13.2 t -104.73 113.4 64.96 Favored Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-O 120.961 0.41 . . . . 0.48 111.363 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 22.5 Cg_endo -64.69 -22.22 64.45 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.258 1.972 . . . . 0.7 110.429 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.413 ' NE2' ' O4 ' ' A' ' 201' ' ' SFQ . 7.9 t-80 -67.25 -30.66 70.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.062 -0.972 . . . . 1.74 109.948 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -79.94 -38.94 31.31 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.411 -0.588 . . . . 0.37 109.411 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.76 -38.64 85.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 1.44 109.778 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.443 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 3.1 tp60 -60.38 -44.17 95.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.384 -0.825 . . . . 2.27 109.909 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.467 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.5 m-85 -74.39 -24.69 59.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.553 -0.748 . . . . 0.87 111.524 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -86.16 -49.89 7.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.543 0.571 . . . . 1.89 112.543 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -94.98 -38.69 10.55 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.569 0.951 . . . . 2.0 113.569 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 46.0 t -80.25 -53.43 12.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 120.023 -0.671 . . . . 0.58 111.882 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.7 mt -90.24 -29.18 18.35 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.768 -0.373 . . . . 0.41 111.986 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 56.69 48.67 15.88 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.477 0.656 . . . . 0.84 109.889 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.467 HG13 ' CD2' ' A' ' 36' ' ' PHE . 39.0 mm -59.89 -47.57 91.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.353 -0.84 . . . . 0.41 111.3 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.05 -48.31 64.66 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.326 0.391 . . . . 1.03 111.712 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.46 -47.05 87.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.906 -0.588 . . . . 1.73 110.375 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -60.67 -40.92 93.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 1.19 110.956 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.604 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 69.3 t -65.73 -48.88 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.49 110.616 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -56.4 -33.71 66.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.043 0.449 . . . . 1.53 111.594 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -81.41 -10.01 59.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 2.02 111.987 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HD2' ' HB1' ' A' ' 179' ' ' ALA . 52.1 mttm -111.94 2.35 16.9 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.804 -0.358 . . . . 1.44 111.597 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 59.3 mt -79.62 131.99 62.95 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.331 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.01 164.51 35.34 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.645 2.23 . . . . 0.74 112.157 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -61.48 108.42 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.212 0.53 . . . . 2.63 111.759 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.74 -24.08 5.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.986 -0.625 . . . . 0.82 112.109 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.06 130.7 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.928 0.394 . . . . 1.03 110.757 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 56' ' ' MET . 11.9 ttmm -119.61 147.15 44.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.895 -0.593 . . . . 2.51 110.561 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.416 ' N ' ' HG2' ' A' ' 55' ' ' LYS . 8.9 ttt -87.54 130.45 34.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.123 -0.49 . . . . 1.28 110.564 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.27 106.97 12.41 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.002 -0.544 . . . . 0.61 110.934 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -90.83 127.42 36.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.525 -0.307 . . . . 0.86 110.41 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' CD2' ' HA ' ' A' ' 138' ' ' GLN . 5.2 m-30 -117.36 143.72 45.68 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.891 -0.411 . . . . 0.71 109.891 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -93.63 132.11 38.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.723 0.297 . . . . 0.57 110.988 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 27' ' ' SER . 5.6 m -76.18 150.18 6.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.992 -0.373 . . . . 0.68 109.992 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -103.87 -10.95 17.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.602 0.593 . . . . 0.93 112.602 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -89.46 20.02 4.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.037 0.384 . . . . 0.74 112.037 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.488 ' SD ' HG21 ' A' ' 150' ' ' VAL . 20.6 mtp -140.64 133.25 28.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.625 0.25 . . . . 1.09 110.425 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.43 3.5 56.41 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.779 -0.724 . . . . 0.78 112.07 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.09 -129.47 34.94 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.704 -0.76 . . . . 0.81 112.348 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -76.84 -35.28 57.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.773 0.321 . . . . 2.47 110.785 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.6 tp -67.47 -22.0 65.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.961 -0.563 . . . . 1.94 110.527 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.54 89.19 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.703 -0.76 . . . . 0.7 111.362 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -69.98 -37.69 75.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.033 0.444 . . . . 2.69 110.549 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -62.82 -41.86 99.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.784 -0.643 . . . . 1.65 110.675 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.435 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 3.8 mt -70.69 -24.58 62.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.353 -0.385 . . . . 1.17 111.188 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.7 m -66.89 -36.95 83.44 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.135 0.493 . . . . 0.62 109.892 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -76.18 -40.97 51.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 1.21 109.988 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.57 95.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.97 -0.559 . . . . 0.71 111.014 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -61.47 -37.52 83.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.939 -0.573 . . . . 0.59 110.902 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.562 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -60.97 -35.73 77.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.175 -0.466 . . . . 0.71 110.404 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.69 -44.36 82.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.81 -0.632 . . . . 0.84 110.124 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.66 84.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.686 -0.688 . . . . 0.66 111.668 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 44.9 mtm -67.43 -41.35 84.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.331 -0.395 . . . . 1.08 111.005 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.73 -32.94 73.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 0.99 111.124 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.18 -5.14 59.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.418 -0.355 . . . . 0.97 110.751 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.71 40.63 98.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.064 -0.589 . . . . 0.78 112.432 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.3 m -131.9 30.71 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.87 0.367 . . . . 0.81 110.756 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -60.5 -53.85 52.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.801 -0.636 . . . . 1.71 110.792 -179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.65 -30.81 70.12 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.235 0.54 . . . . 1.91 111.044 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -73.9 -24.5 59.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.894 -0.594 . . . . 2.28 112.205 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.456 ' HA ' ' HG2' ' A' ' 91' ' ' PRO . 27.6 m -108.73 -8.25 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 112.238 0.459 . . . . 0.65 112.238 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 99.4 m -55.88 -65.32 0.62 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.852 0.686 . . . . 0.98 112.852 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.7 t -60.39 -53.53 63.85 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 113.003 0.742 . . . . 0.62 113.003 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 9.8 Cg_endo -53.42 -38.61 82.99 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.16 1.907 . . . . 0.61 113.346 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.3 mt -69.8 -41.08 75.54 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.037 -0.357 . . . . 0.79 110.037 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 2.9 m-85 -60.29 -51.93 67.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.276 0.56 . . . . 0.58 110.269 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.3 -37.79 88.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.553 -0.749 . . . . 1.7 110.441 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.12 -8.17 68.94 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.107 -0.568 . . . . 0.82 113.687 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.6 t -112.21 -39.64 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.307 0.554 . . . . 0.75 112.205 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -98.71 -48.0 5.11 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.605 0.594 . . . . 0.84 112.605 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -74.53 -73.52 0.23 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.122 -0.49 . . . . 1.41 111.35 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -37.91 62.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.811 -0.631 . . . . 1.31 111.776 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 62.81 27.97 16.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 1.44 110.815 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -28.93 66.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.86 -0.609 . . . . 1.57 111.006 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 86.5 mt -81.22 105.27 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.317 0.58 . . . . 0.91 110.809 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -121.95 -13.45 8.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 3.22 110.705 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 p -140.45 167.6 21.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.931 -0.577 . . . . 1.51 110.146 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -66.06 -27.4 68.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.44 . . . . 1.08 110.105 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -31.85 72.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.384 -0.825 . . . . 1.43 110.559 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 111' ' ' VAL . 64.8 m-20 -71.72 -40.68 69.28 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.11 -0.496 . . . . 1.89 110.194 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 105' ' ' ALA . 14.8 mt -60.68 -43.19 94.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.757 -0.656 . . . . 0.9 110.089 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -58.78 -36.22 74.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.425 -0.807 . . . . 2.19 110.439 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -68.81 -44.84 72.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.769 -0.651 . . . . 1.95 110.626 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 107' ' ' ASP . 43.8 t -59.22 -40.14 80.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.01 -0.541 . . . . 0.88 110.853 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -62.68 -42.38 99.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 0.92 110.397 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 87.0 mt -62.13 -37.25 77.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.193 0.52 . . . . 1.33 110.245 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -69.67 -14.31 62.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.928 -0.578 . . . . 1.93 111.152 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.35 -3.02 58.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.201 0.524 . . . . 1.1 110.482 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.92 16.04 26.98 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.802 -0.713 . . . . 1.15 111.942 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 44.8 mm -93.8 129.27 44.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 110.07 -0.344 . . . . 1.61 110.07 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -64.03 131.77 48.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.352 -0.385 . . . . 2.73 110.351 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.44 99.89 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.905 -0.664 . . . . 1.19 111.874 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -64.75 -37.13 86.57 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.657 -0.497 . . . . 2.98 109.657 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.51 -47.02 68.07 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.564 -0.744 . . . . 2.52 109.659 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -60.25 -40.44 90.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.759 -0.655 . . . . 1.51 110.924 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -61.31 -35.41 77.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.991 0.424 . . . . 2.3 111.17 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.33 -45.14 33.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 1.23 110.591 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.11 73.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.872 -0.604 . . . . 1.11 110.915 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -57.13 -33.32 67.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.012 -0.54 . . . . 1.31 110.908 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -111.62 21.67 15.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.274 -0.421 . . . . 1.63 111.256 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.0 t -76.91 142.25 40.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.127 -0.488 . . . . 2.04 110.908 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.26 -35.73 78.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.878 -0.601 . . . . 3.82 110.527 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.1 t -63.14 -46.33 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 1.53 109.996 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.562 HG13 ' HB3' ' A' ' 77' ' ' ALA . 55.2 t -63.66 -45.66 96.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.539 -0.755 . . . . 1.11 110.381 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -59.73 -40.46 88.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 2.43 110.533 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.3 m -66.5 -30.74 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 1.47 110.675 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.2 mt -72.27 -38.12 68.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.337 . . . . 0.93 110.479 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 131' ' ' VAL . 57.4 t -59.36 -46.27 92.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.144 -0.48 . . . . 0.8 110.686 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.23 83.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.908 -0.587 . . . . 0.85 111.546 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -65.67 -39.09 90.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 1.39 111.265 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.528 ' HA ' ' CD2' ' A' ' 59' ' ' TYR . 50.9 mt-30 -60.97 -46.57 90.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.61 111.079 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -68.08 -44.18 76.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.229 -0.441 . . . . 2.82 111.09 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.2 tttp -60.34 -45.64 92.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.57 . . . . 1.95 111.473 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -58.69 -51.27 70.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.538 . . . . 0.65 111.427 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.38 86.4 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.935 0.346 . . . . 0.61 111.935 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.28 60.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.252 -0.431 . . . . 0.72 111.908 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.28 -43.17 98.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.02 0.748 . . . . 1.39 113.02 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 141' ' ' ALA . 19.1 m -79.67 1.22 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.358 0.503 . . . . 1.34 112.358 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.42 55.43 5.75 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.576 -0.527 . . . . 1.95 109.576 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.1 tp -61.25 114.63 3.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.587 -0.733 . . . . 0.71 111.302 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.7 mmm-85 -104.48 -38.94 6.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.357 -0.838 . . . . 4.16 109.898 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -104.88 142.54 15.5 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.095 -0.802 . . . . 0.68 111.095 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 16.5 t -69.96 -55.89 8.04 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 119.262 -0.399 . . . . 0.49 111.624 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 81.6 Cg_endo -83.46 62.11 7.23 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.942 1.761 . . . . 0.56 112.436 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.27 148.2 39.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.314 -0.403 . . . . 0.63 111.117 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 51.6 ttm -122.16 135.78 54.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.065 -0.516 . . . . 0.42 110.565 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -118.63 121.88 41.23 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.747 -0.66 . . . . 0.52 109.626 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.5 t -93.95 120.72 43.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.266 -0.424 . . . . 0.55 110.77 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 61.56 13.65 5.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.212 -0.904 . . . . 1.16 111.604 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 65.08 24.91 70.63 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.613 -0.595 . . . . 0.56 111.613 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -130.62 -43.07 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.912 0.387 . . . . 1.75 111.448 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -106.05 120.47 41.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.462 -0.336 . . . . 1.16 111.388 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -103.08 132.68 49.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.515 -0.55 . . . . 0.98 109.515 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.46 143.22 33.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.942 0.401 . . . . 1.2 110.628 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -119.52 95.56 49.31 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.992 -0.549 . . . . 0.72 110.145 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.79 -25.46 53.32 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.226 1.951 . . . . 0.54 112.622 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -71.99 -13.78 61.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 2.22 110.754 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.3 0.37 50.45 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.812 -0.708 . . . . 0.59 112.404 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 64.1 mtt -97.6 -172.25 2.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.57 110.449 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -69.32 120.49 15.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 1.54 110.476 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.25 15.75 18.07 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.137 0.494 . . . . 1.16 110.733 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.51 -40.45 6.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 1.53 110.719 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -121.74 116.76 25.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.753 0.311 . . . . 1.21 110.858 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -55.06 -41.54 71.59 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.769 -0.65 . . . . 1.96 111.907 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -43.19 63.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.185 0.517 . . . . 2.05 111.43 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 33.1 t -74.26 -45.39 47.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.672 -0.694 . . . . 0.65 111.176 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -55.52 -50.56 69.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.329 -0.396 . . . . 0.47 111.443 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.19 -49.2 80.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.48 111.512 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 33.2 mm-40 -68.86 -44.76 72.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.485 -0.325 . . . . 1.7 111.608 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 2.4 mt-30 -56.83 -46.93 81.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.525 0.202 . . . . 1.32 111.367 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.42 ' O ' HG23 ' A' ' 182' ' ' VAL . 10.3 t80 -59.15 -54.15 50.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.808 0.337 . . . . 0.46 111.032 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -64.83 -37.46 87.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 0.43 112.206 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -67.44 -37.56 83.17 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.837 0.351 . . . . 1.55 110.637 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 94.8 m -62.26 -36.67 82.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.48 109.826 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 178' ' ' TYR . 92.8 t -58.93 -49.37 83.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.003 -0.544 . . . . 0.48 110.481 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 37.6 tttm -58.83 -43.18 90.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 1.59 110.975 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -61.96 -43.95 97.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 1.17 111.671 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.01 -34.7 64.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.051 0.389 . . . . 0.68 112.051 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.6 m -69.28 -29.67 67.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.11 0.481 . . . . 1.07 110.495 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -97.43 6.18 48.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.73 -0.668 . . . . 2.26 110.715 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -86.62 70.8 10.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.006 -0.543 . . . . 1.72 110.071 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.6 pttm . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.557 -0.735 . . . . 4.33 109.617 179.466 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SFQ . . . . . 0.573 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.363 -0.236 . . . . 4.08 110.363 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -83.89 134.28 34.69 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.955 -0.387 . . . . 3.58 109.955 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -134.5 133.2 40.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.129 0.49 . . . . 1.32 111.185 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.08 139.64 53.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.459 -0.791 . . . . 2.29 110.015 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.42 121.35 15.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.044 0.45 . . . . 1.83 110.408 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.04 -18.93 28.19 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.744 -0.662 . . . . 0.78 111.758 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -100.97 -79.4 0.51 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.773 0.32 . . . . 1.87 110.872 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -83.77 -27.16 29.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.671 0.272 . . . . 1.46 111.341 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -145.72 153.5 41.03 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.928 -0.397 . . . . 0.79 109.928 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.11 130.48 49.92 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.394 -0.366 . . . . 0.9 110.841 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -81.81 120.41 25.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.884 -0.413 . . . . 1.11 109.884 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.0 mt -67.71 136.02 53.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.085 -0.507 . . . . 0.74 111.291 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.43 -26.92 52.0 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.259 -0.645 . . . . 2.33 109.259 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -120.92 88.61 44.75 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.399 -0.819 . . . . 3.64 109.544 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.6 162.47 32.97 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.769 2.313 . . . . 0.85 113.034 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.9 t -103.72 113.61 41.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.755 -0.657 . . . . 0.72 110.41 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.45 138.37 47.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.137 -0.483 . . . . 0.89 111.433 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.62 9.3 86.58 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.08 -0.581 . . . . 0.73 112.886 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.64 151.56 84.9 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.535 0.168 . . . . 0.64 110.666 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.11 173.67 10.05 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.288 1.992 . . . . 0.56 112.297 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -67.63 -46.29 72.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.091 -0.504 . . . . 1.79 110.784 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -127.56 105.0 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.812 0.339 . . . . 0.45 110.383 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.6 tp -108.25 121.03 44.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.928 -0.578 . . . . 0.53 109.726 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -123.92 145.51 49.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.447 -0.342 . . . . 1.61 110.506 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -121.15 147.27 45.81 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.079 -0.509 . . . . 0.53 109.981 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -167.68 178.95 5.05 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.056 -0.52 . . . . 0.55 111.024 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.471 ' HB2' HG22 ' A' ' 61' ' ' VAL . 7.8 t -158.94 138.36 11.57 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.01 -0.541 . . . . 0.96 110.001 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 91.3 m-85 -69.35 -18.84 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.11 0.481 . . . . 0.62 109.97 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.553 ' CE2' HD12 ' A' ' 72' ' ' LEU . 78.9 m-85 -83.65 -6.9 59.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.48 -0.782 . . . . 1.78 110.866 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.9 t -97.95 117.19 65.39 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 116.504 -0.316 . . . . 0.48 110.808 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.544 ' HA ' ' OE1' ' A' ' 97' ' ' GLN . 18.3 Cg_endo -62.05 -23.07 75.33 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.268 1.979 . . . . 0.7 112.019 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.46 ' CE1' ' O4 ' ' A' ' 201' ' ' SFQ . 0.4 OUTLIER -73.97 -34.8 64.38 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.037 -0.529 . . . . 1.74 110.652 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.1 m -71.39 -33.34 69.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.068 0.461 . . . . 0.37 110.259 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -63.26 -45.54 91.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.547 0.689 . . . . 1.44 109.298 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.604 ' O ' ' HB ' ' A' ' 39' ' ' VAL . 8.8 tm0? -71.28 -37.67 71.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.948 -1.024 . . . . 2.27 111.182 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -66.3 -22.93 66.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.232 0.456 . . . . 0.87 112.232 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -108.71 -51.36 2.9 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.927 -0.709 . . . . 1.89 112.378 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -68.12 -27.69 66.67 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.879 -0.513 . . . . 2.0 111.65 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 78.7 t -102.86 -64.87 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.663 -0.244 . . . . 0.58 111.073 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 mt -72.65 -38.49 67.66 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.702 0.26 . . . . 0.41 111.702 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 64.02 50.56 2.47 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.468 0.48 . . . . 0.84 110.455 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.47 -52.56 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.84 -0.618 . . . . 0.41 111.551 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.595 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 21.5 m -58.16 -52.18 66.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.488 0.185 . . . . 1.03 111.033 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 29.9 t70 -58.93 -39.33 81.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.582 -0.281 . . . . 1.73 111.687 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -71.54 -42.8 67.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.697 0.285 . . . . 1.19 110.632 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 37.5 t -59.49 -41.13 83.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.263 -0.426 . . . . 0.49 110.683 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 43' ' ' SER . 75.5 mttt -55.2 -36.7 66.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.896 0.379 . . . . 1.53 110.871 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 36.1 mttm -80.76 -13.23 59.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.12 -0.491 . . . . 2.02 112.218 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -109.88 8.23 24.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.579 0.228 . . . . 1.44 111.54 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 41.7 mt -96.09 136.7 21.94 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 120.889 -0.324 . . . . 1.0 111.643 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.54 177.47 3.97 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.537 2.158 . . . . 0.74 111.646 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -75.01 149.01 39.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.913 0.387 . . . . 2.63 110.631 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.14 -18.5 40.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.019 -0.61 . . . . 0.82 112.298 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 t -84.09 132.14 32.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.827 0.346 . . . . 1.03 110.613 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -117.45 136.77 52.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.402 -0.363 . . . . 2.51 110.805 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.1 mtp -82.79 113.68 20.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.534 . . . . 1.28 110.088 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.1 94.01 5.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.072 0.463 . . . . 0.61 110.747 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -89.91 116.82 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 0.86 109.937 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 4.8 m-30 -111.89 150.87 29.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.112 0.482 . . . . 0.71 111.304 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -100.3 128.06 46.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.922 -0.581 . . . . 0.57 110.604 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 27' ' ' SER . 8.1 m -80.38 152.71 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.507 -0.315 . . . . 0.68 110.54 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -103.62 -0.5 29.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.787 0.662 . . . . 0.93 112.787 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -96.3 16.93 17.01 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.699 -0.4 . . . . 0.74 110.984 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.53 107.47 5.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.355 -0.384 . . . . 1.09 110.47 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.56 18.68 1.58 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.886 -0.673 . . . . 0.78 112.941 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.53 -112.25 4.6 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.269 -0.491 . . . . 0.81 113.024 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.52 -31.03 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.608 0.242 . . . . 2.47 111.167 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.21 -17.37 63.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.831 0.348 . . . . 1.94 110.639 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.81 -33.48 78.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.988 -0.625 . . . . 0.7 111.664 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -66.65 -33.07 74.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.906 0.384 . . . . 2.69 110.506 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -74.09 -41.18 62.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 1.65 110.533 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.553 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -64.24 -27.98 69.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.32 -0.4 . . . . 1.17 111.045 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.3 m -65.18 -36.03 82.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.065 0.46 . . . . 0.62 110.263 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 78' ' ' VAL . 15.1 tt0 -75.81 -37.93 58.65 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.132 -0.692 . . . . 1.21 109.132 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.42 -44.85 95.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.55 -0.75 . . . . 0.71 110.444 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.544 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 69.6 t-105 -61.11 -36.03 78.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.333 -0.849 . . . . 0.59 110.764 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.508 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -64.59 -37.76 88.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.931 0.396 . . . . 0.71 110.268 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 74' ' ' GLN . 57.0 t -65.68 -42.94 93.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.998 -0.546 . . . . 0.84 109.849 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.71 92.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.578 -0.737 . . . . 0.66 110.742 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 28.5 mtm -63.73 -39.14 93.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 1.08 111.196 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.07 -39.37 79.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.161 -0.472 . . . . 0.99 111.29 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.39 -29.35 47.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.242 -0.436 . . . . 0.97 111.36 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.74 10.41 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.692 -0.766 . . . . 0.78 111.964 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.98 26.08 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 110.548 -0.167 . . . . 0.81 110.548 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.544 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 3.5 mp0 -55.56 -61.99 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.439 . . . . 1.71 111.249 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -37.87 67.93 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.002 -0.545 . . . . 1.91 111.98 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm -64.0 -33.4 75.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.488 . . . . 2.28 112.084 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.2 m -101.17 -8.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.848 0.314 . . . . 0.65 111.848 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.9 m -58.19 -49.04 78.43 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.919 0.34 . . . . 0.98 111.919 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.46 -58.35 15.91 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 112.336 0.495 . . . . 0.62 112.336 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.46 -36.45 98.74 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.866 1.71 . . . . 0.61 113.221 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.84 -42.99 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.702 0.286 . . . . 0.79 110.279 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -62.69 -46.83 86.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.129 0.49 . . . . 0.58 110.722 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.06 -42.54 96.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.699 -0.682 . . . . 1.7 111.321 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.36 -14.13 68.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.955 -0.64 . . . . 0.82 113.527 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.1 -32.23 2.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 117.076 0.438 . . . . 0.75 112.025 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 31' ' ' PRO . 53.2 mt-30 -113.89 -42.77 3.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.783 1.031 . . . . 0.84 113.783 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -69.25 -61.96 1.58 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.773 0.32 . . . . 1.41 111.246 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.8 p -92.84 -30.17 15.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.315 -0.402 . . . . 1.31 110.743 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 61.28 33.31 19.09 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.627 -0.715 . . . . 1.44 110.121 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.7 -31.75 41.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.295 -0.866 . . . . 1.57 111.239 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.9 mt -70.75 106.09 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.91 110.421 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -129.15 -11.72 4.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.391 -0.822 . . . . 3.22 110.494 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.3 m -134.4 165.91 24.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.949 -0.569 . . . . 1.51 110.293 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.17 64.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.1 0.476 . . . . 1.08 110.738 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -36.73 84.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.784 -0.644 . . . . 1.43 110.602 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 111' ' ' VAL . 15.9 m-20 -63.8 -46.28 85.89 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.307 -0.627 . . . . 1.89 109.307 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 35.0 mt -59.47 -39.73 79.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.541 -0.754 . . . . 0.9 110.482 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -62.19 -43.36 99.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.81 -0.632 . . . . 2.19 110.689 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -65.28 -33.86 76.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.286 -0.416 . . . . 1.95 110.639 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 107' ' ' ASP . 92.6 t -62.2 -43.99 98.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.963 -0.562 . . . . 0.88 110.279 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -63.92 -39.03 93.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.92 110.56 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 80.0 mt -64.65 -30.81 51.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.433 0.635 . . . . 1.33 109.897 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -77.1 -14.91 59.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.547 -0.752 . . . . 1.93 110.821 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.82 1.07 57.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.029 -0.532 . . . . 1.1 111.054 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 103.82 4.12 45.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 1.15 112.881 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 49.1 mm -91.05 148.09 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 110.096 -0.335 . . . . 1.61 110.096 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -88.76 150.65 22.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.385 -0.37 . . . . 2.73 110.859 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.58 -56.31 22.23 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.998 -0.546 . . . . 1.19 113.183 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.82 -32.66 70.85 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.967 0.413 . . . . 2.98 110.93 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.2 -42.6 96.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.827 -0.624 . . . . 2.52 109.779 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -69.38 -44.25 71.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.465 -0.788 . . . . 1.51 110.234 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -60.27 -39.94 88.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.146 -0.479 . . . . 2.3 110.877 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.62 -48.44 79.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.915 -0.584 . . . . 1.23 111.578 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.43 -33.43 72.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 1.11 111.673 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.5 t-105 -56.7 -31.42 64.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.98 0.419 . . . . 1.31 111.065 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -105.83 29.01 7.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.015 -0.538 . . . . 1.63 111.223 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.8 t -93.22 145.79 24.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.722 0.296 . . . . 2.04 110.626 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -61.65 -37.67 84.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 3.82 110.835 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.29 -42.05 86.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.217 0.532 . . . . 1.53 110.314 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 77' ' ' ALA . 44.8 t -67.3 -45.8 85.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.404 -0.816 . . . . 1.11 110.483 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -58.86 -38.23 78.3 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.264 -0.425 . . . . 2.43 110.875 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.04 -43.24 71.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.073 -0.512 . . . . 1.47 110.425 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.432 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 34.6 mt -62.82 -38.16 89.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.438 . . . . 0.93 110.9 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 131' ' ' VAL . 61.7 t -60.12 -52.33 62.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.275 -0.421 . . . . 0.8 110.317 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.3 -37.25 74.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 0.85 111.367 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -65.07 -39.76 93.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.147 -0.479 . . . . 1.39 111.293 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.481 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 53.0 mt-30 -60.53 -45.91 92.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.61 111.372 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -33.73 58.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.627 0.251 . . . . 2.82 111.149 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -65.69 -51.43 59.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.652 -0.249 . . . . 1.95 111.326 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.92 90.38 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.311 0.382 . . . . 0.65 111.468 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.26 86.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.399 -0.364 . . . . 0.61 111.404 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.08 -26.61 26.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.352 -0.385 . . . . 0.72 111.59 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -36.59 76.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.165 0.507 . . . . 1.39 110.637 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.68 -4.4 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.12 -0.491 . . . . 1.34 110.062 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.576 ' O ' ' HD3' ' A' ' 148' ' ' ARG . 88.8 mt-30 57.72 74.28 0.43 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.54 -0.755 . . . . 1.95 110.137 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tp -59.76 124.19 19.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.557 -0.747 . . . . 0.71 111.437 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.576 ' HD3' ' O ' ' A' ' 146' ' ' GLN . 1.6 mpp_? -103.45 18.65 21.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.182 0.515 . . . . 4.16 110.603 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -179.63 172.46 44.24 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.896 -0.882 . . . . 0.68 110.896 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.526 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 1.9 t -84.86 -56.79 0.39 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 117.324 0.562 . . . . 0.49 111.307 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.8 Cg_endo -82.2 88.92 1.24 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.149 1.9 . . . . 0.56 111.352 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.98 146.01 50.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.052 -0.522 . . . . 0.63 111.069 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 53.0 ttm -133.26 131.64 40.49 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.986 -0.375 . . . . 0.42 109.986 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -122.37 137.56 54.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.093 -0.503 . . . . 0.52 110.365 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.1 t -107.68 122.56 62.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.277 -0.42 . . . . 0.55 110.905 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 61.98 10.87 3.85 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.231 -0.895 . . . . 1.16 112.188 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 68.95 19.56 73.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.251 -0.499 . . . . 0.56 112.301 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -129.1 -41.11 1.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.924 0.392 . . . . 1.75 111.195 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.424 ' HB3' HD13 ' A' ' 185' ' ' LEU . 48.0 m-85 -96.71 123.79 40.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.143 -0.48 . . . . 1.16 111.568 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -108.07 123.99 49.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.712 -0.676 . . . . 0.98 109.251 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 mp -76.78 143.61 39.73 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.682 0.277 . . . . 1.2 111.118 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -119.43 96.75 50.01 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.173 0.511 . . . . 0.72 110.205 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.8 -19.29 41.15 Favored 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.443 2.095 . . . . 0.54 112.713 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -72.38 -22.23 61.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.956 -0.565 . . . . 2.22 111.284 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.27 21.04 34.06 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.646 -0.787 . . . . 0.59 112.056 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.0 mtt -106.29 -164.46 1.01 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.415 -0.217 . . . . 0.57 110.415 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.02 132.63 46.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 1.54 111.111 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.9 20.76 6.45 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.832 -0.622 . . . . 1.16 109.691 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.99 -41.84 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 1.53 110.914 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -126.8 126.42 43.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.119 -0.491 . . . . 1.21 110.169 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.477 ' O ' HG23 ' A' ' 175' ' ' VAL . 14.3 mmt -61.01 -44.32 97.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.948 -0.569 . . . . 1.96 110.573 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' A' ' 176' ' ' GLN . 31.6 t70 -58.72 -45.36 89.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.75 -0.659 . . . . 2.05 111.199 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.85 -43.82 99.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.312 -0.403 . . . . 0.65 110.718 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -57.32 -45.97 83.7 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.242 -0.435 . . . . 0.47 110.68 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 171' ' ' MET . 90.6 t -58.9 -47.42 89.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.48 110.93 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 172' ' ' ASP . 54.7 mm-40 -65.08 -48.71 72.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 1.7 110.776 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -58.6 -45.74 88.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 1.32 111.646 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 182' ' ' VAL . 31.7 t80 -60.44 -50.41 73.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.724 0.297 . . . . 0.46 111.002 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.98 87.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.43 111.111 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.63 -37.85 88.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 1.55 110.006 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 58.3 m -59.98 -40.49 89.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.028 -0.533 . . . . 0.48 110.224 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 178' ' ' TYR . 41.9 t -60.67 -51.43 73.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 CA-C-N 115.828 -0.623 . . . . 0.48 110.165 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -60.31 -44.59 95.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.954 -0.566 . . . . 1.59 110.536 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -57.77 -44.63 86.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.5 -0.773 . . . . 1.17 111.041 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 159' ' ' TYR . 96.0 mt -72.14 -29.37 63.98 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.321 -0.4 . . . . 0.68 111.438 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 40.4 m -71.49 -34.55 70.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.409 -0.36 . . . . 1.07 110.819 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -96.17 6.08 49.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.229 -0.442 . . . . 2.26 110.798 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -79.61 111.25 15.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.02 0.438 . . . . 1.72 110.633 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp . . . . . 0 C--O 1.251 1.146 0 CA-C-N 115.742 -0.663 . . . . 4.33 110.113 179.685 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SFQ . . . . . 0.552 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.983 0.421 . . . . 4.08 110.353 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.35 -43.41 2.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.1 -0.5 . . . . 3.58 110.975 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -130.55 102.72 6.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.24 -0.436 . . . . 1.32 110.711 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -119.43 148.36 43.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.345 -0.389 . . . . 2.29 110.94 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.97 130.2 41.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.935 -0.575 . . . . 1.83 109.693 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.15 -20.59 40.09 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.748 -0.941 . . . . 0.78 110.748 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.549 ' O ' ' HA3' ' A' ' 165' ' ' GLY . 36.4 tptt -105.78 -77.3 0.59 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.755 -0.222 . . . . 1.87 110.809 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -80.04 -35.24 37.49 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.832 0.349 . . . . 1.46 111.477 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -140.76 156.08 46.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.28 -0.418 . . . . 0.79 110.733 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -128.82 129.73 46.01 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.119 -0.492 . . . . 0.9 110.048 178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.7 m -77.84 121.04 23.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.017 0.437 . . . . 1.11 110.963 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 46.1 mt -68.57 127.31 32.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.751 -0.659 . . . . 0.74 110.829 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.13 -27.68 68.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.154 0.502 . . . . 2.33 110.746 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -120.86 96.7 48.62 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.983 -0.747 . . . . 3.64 108.983 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HB3' ' HG2' ' A' ' 158' ' ' LYS . 65.1 Cg_endo -76.1 153.25 36.52 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 122.555 2.17 . . . . 0.85 112.584 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -90.93 122.5 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.674 -0.694 . . . . 0.72 109.739 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.7 127.2 31.77 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.786 -0.643 . . . . 0.89 111.084 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.33 31.92 49.66 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.686 -0.768 . . . . 0.73 112.142 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.61 145.54 32.47 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.396 -0.224 . . . . 0.64 110.396 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.3 164.77 26.93 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.446 2.097 . . . . 0.56 112.432 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -58.34 -56.54 20.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.281 -0.872 . . . . 1.79 111.243 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.4 t -120.33 105.56 17.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.989 0.423 . . . . 0.45 110.185 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.5 tp -105.95 129.73 54.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.08 -0.509 . . . . 0.53 110.15 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 25' ' ' PHE . 4.0 tt0 -127.58 149.44 50.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.455 -0.339 . . . . 1.61 110.456 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.495 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 61.3 m-85 -127.4 146.08 50.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.987 -0.551 . . . . 0.53 110.195 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -163.11 175.87 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.105 0.478 . . . . 0.55 110.906 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.46 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 8.6 t -156.13 141.59 17.66 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.923 -0.58 . . . . 0.96 109.967 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.411 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 88.0 m-85 -74.57 -8.58 56.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.959 -0.564 . . . . 0.62 110.751 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -101.37 8.12 42.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.224 -0.444 . . . . 1.78 111.002 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 20.8 t -111.65 119.63 44.36 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.62 -0.264 . . . . 0.48 111.202 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 22.0 Cg_endo -65.67 -21.99 58.2 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.402 2.068 . . . . 0.7 111.439 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.649 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 0.3 OUTLIER -64.14 -48.25 76.76 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.895 -0.593 . . . . 1.74 110.019 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 38.7 m -66.88 -31.82 72.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.984 -0.553 . . . . 0.37 110.394 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -60.07 -44.47 94.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.479 -0.563 . . . . 1.44 109.479 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 31' ' ' PRO . 34.8 mm-40 -73.38 -41.29 63.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.731 -0.668 . . . . 2.27 110.65 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.487 ' CD2' HG13 ' A' ' 42' ' ' ILE . 3.4 m-85 -63.76 -35.44 80.61 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.026 -0.534 . . . . 0.87 112.428 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -93.3 -50.16 5.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.065 0.765 . . . . 1.89 113.065 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -77.36 -35.81 54.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.127 0.788 . . . . 2.0 113.127 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 35' ' ' GLN . 53.9 t -94.61 -57.77 4.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.586 -0.446 . . . . 0.58 112.148 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.513 HD11 ' O2 ' ' A' ' 201' ' ' SFQ . 70.7 mt -82.27 -26.57 33.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.061 0.763 . . . . 0.41 113.061 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 60.95 44.91 10.01 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.982 -0.377 . . . . 0.84 109.982 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.487 HG13 ' CD2' ' A' ' 36' ' ' PHE . 33.9 mm -57.11 -66.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.505 0.557 . . . . 0.41 112.505 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.0 m -62.01 -34.18 75.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 1.03 110.78 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.92 -45.6 93.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.814 -0.63 . . . . 1.73 110.143 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -69.45 -37.5 77.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 1.19 110.214 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 54.4 t -60.96 -42.31 92.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 0.49 110.433 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -63.22 -12.72 30.66 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.189 -0.459 . . . . 1.53 110.948 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -113.78 6.21 16.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.127 0.489 . . . . 2.02 111.192 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -116.29 -27.83 6.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.103 -0.499 . . . . 1.44 110.535 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 81.6 mt -66.24 145.1 98.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.224 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -78.0 170.85 18.16 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.36 2.04 . . . . 0.74 111.643 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.81 137.67 54.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.865 0.364 . . . . 2.63 111.145 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.92 -21.79 43.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.093 -0.575 . . . . 0.82 112.038 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 t -92.83 108.09 19.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.865 0.364 . . . . 1.03 110.098 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -89.93 156.52 18.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 2.51 110.933 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 17.1 ttt -109.06 143.86 37.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.781 -0.645 . . . . 1.28 109.707 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.52 108.08 9.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 0.61 110.826 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 14.6 ttmm -94.17 116.85 29.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.725 -0.67 . . . . 0.86 110.154 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 10.0 m-30 -114.46 161.4 18.04 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.157 0.503 . . . . 0.71 111.688 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.46 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 43.2 t-80 -105.79 142.19 35.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.61 . . . . 0.57 111.002 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -97.62 149.58 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.794 0.33 . . . . 0.68 110.89 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -93.52 -16.47 24.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.837 0.68 . . . . 0.93 112.837 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -83.21 10.24 8.83 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.696 0.628 . . . . 0.74 112.696 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.1 96.17 3.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.973 0.416 . . . . 1.09 111.044 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.87 0.17 6.09 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.936 -0.649 . . . . 0.78 112.467 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.06 -129.34 43.52 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.283 -0.484 . . . . 0.81 112.647 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.62 -38.15 65.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.7 -0.482 . . . . 2.47 109.7 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.55 -26.94 68.93 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.573 -0.739 . . . . 1.94 109.897 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.84 -43.51 96.03 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.515 -0.766 . . . . 0.7 111.823 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -63.84 -35.55 81.01 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.207 -0.294 . . . . 2.69 110.207 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -43.22 99.3 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.394 0.616 . . . . 1.65 109.857 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.34 -34.38 78.0 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 115.549 -0.75 . . . . 1.17 110.689 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.6 m -62.11 -36.48 81.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.385 -0.37 . . . . 0.62 111.101 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.549 ' HA ' HG22 ' A' ' 135' ' ' VAL . 42.7 tt0 -76.43 -45.02 33.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.623 -0.262 . . . . 1.21 110.39 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.19 88.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.046 0.45 . . . . 0.71 110.677 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.508 ' CH2' ' HB3' ' A' ' 85' ' ' GLU . 66.5 t-105 -61.26 -37.69 84.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.543 -0.753 . . . . 0.59 110.961 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.644 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.5 -34.01 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.101 0.477 . . . . 0.71 110.3 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.443 HG22 HG21 ' A' ' 131' ' ' VAL . 58.2 t -66.14 -41.66 89.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.945 -0.57 . . . . 0.84 109.62 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.52 81.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.479 -0.782 . . . . 0.66 111.08 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 29.4 mtm -68.41 -38.68 81.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.979 -0.555 . . . . 1.08 111.095 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.68 -31.41 70.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.191 -0.458 . . . . 0.99 111.877 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.2 mt -92.72 -13.7 28.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.543 -0.299 . . . . 0.97 111.531 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.44 39.7 49.92 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.488 -0.863 . . . . 0.78 111.791 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.87 22.58 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.012 -0.366 . . . . 0.81 110.012 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.508 ' HB3' ' CH2' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -56.23 -59.92 4.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.662 -0.699 . . . . 1.71 111.406 -178.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.52 -19.15 64.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.531 . . . . 1.91 111.514 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -78.05 -39.78 40.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.334 -0.393 . . . . 2.28 111.442 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.5 m -94.72 -10.4 9.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.381 0.511 . . . . 0.65 112.381 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.1 m -59.26 -49.39 78.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.738 0.304 . . . . 0.98 111.558 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.425 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 47.1 t -62.46 -58.8 15.17 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 112.099 0.407 . . . . 0.62 112.099 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 15.6 Cg_endo -57.24 -33.39 95.94 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.059 1.839 . . . . 0.61 113.018 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.478 HD23 HD13 ' A' ' 102' ' ' ILE . 17.3 mt -73.02 -46.97 48.98 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.974 -0.29 . . . . 0.79 110.701 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -58.59 -52.38 65.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.156 0.503 . . . . 0.58 110.779 179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.52 -42.42 95.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.644 -0.707 . . . . 1.7 111.182 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -70.37 -14.22 71.54 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.217 -0.516 . . . . 0.82 114.232 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.21 -42.51 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.539 0.669 . . . . 0.75 112.276 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -99.6 -38.45 8.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.861 0.689 . . . . 0.84 112.861 -178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -78.7 -64.64 1.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.511 -0.476 . . . . 1.41 110.542 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -34.21 40.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.124 -0.489 . . . . 1.31 111.615 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 60.97 31.85 19.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.144 0.497 . . . . 1.44 110.819 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.35 -35.37 19.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.794 -0.639 . . . . 1.57 111.211 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.478 HD13 HD23 ' A' ' 92' ' ' LEU . 30.2 mt -79.33 96.97 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.838 -0.619 . . . . 0.91 110.971 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -135.25 22.16 3.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.026 0.441 . . . . 3.22 111.082 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.416 ' O ' HG13 ' A' ' 108' ' ' ILE . 83.6 p -159.49 160.38 34.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.035 -0.53 . . . . 1.51 109.717 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.39 -28.99 70.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.126 0.489 . . . . 1.08 110.392 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 m -61.21 -34.28 74.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.428 -0.806 . . . . 1.43 110.435 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.498 ' O ' HG23 ' A' ' 111' ' ' VAL . 56.9 m-20 -76.2 -47.59 23.51 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.898 -0.592 . . . . 1.89 109.589 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 104' ' ' SER . 27.5 mt -55.3 -46.41 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.67 -0.695 . . . . 0.9 111.156 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 113' ' ' ILE . 62.7 ttt-85 -59.13 -45.43 90.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.2 -0.455 . . . . 2.19 110.679 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.75 -42.04 99.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.304 -0.407 . . . . 1.95 110.904 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 107' ' ' ASP . 90.6 t -60.55 -44.79 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.222 -0.444 . . . . 0.88 110.595 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 7.6 m-85 -62.5 -44.9 95.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.093 -0.503 . . . . 0.92 110.727 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 73.3 mt -63.68 -38.82 83.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 1.33 110.525 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -67.8 -31.67 71.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.47 . . . . 1.93 110.759 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.38 -8.1 53.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.313 -0.403 . . . . 1.1 111.591 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.37 0.74 26.46 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.475 -0.869 . . . . 1.15 112.98 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 3.3 mp -85.93 121.7 37.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.867 -0.42 . . . . 1.61 109.867 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -60.91 136.69 58.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.824 -0.625 . . . . 2.73 111.107 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.57 -41.92 98.97 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.609 -0.597 . . . . 1.19 111.609 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -65.74 -23.17 66.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 2.98 110.685 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -82.75 -45.33 14.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.97 -0.559 . . . . 2.52 109.515 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -63.55 -44.25 94.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.506 -0.77 . . . . 1.51 110.483 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.34 -43.16 96.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.978 0.418 . . . . 2.3 110.827 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.29 -47.6 83.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 1.23 110.624 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.05 -41.21 95.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.842 -0.617 . . . . 1.11 111.109 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -59.94 -30.02 68.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.31 111.504 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -96.15 -26.12 15.59 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.148 0.425 . . . . 1.63 112.148 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.4 m -65.22 149.42 49.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.321 0.581 . . . . 2.04 112.507 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -73.01 -21.14 60.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.513 -0.767 . . . . 3.82 111.723 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.87 -50.1 70.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.26 0.552 . . . . 1.53 110.101 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.644 HG13 ' HB3' ' A' ' 77' ' ' ALA . 36.0 t -66.5 -41.69 88.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.419 -0.81 . . . . 1.11 110.414 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -56.87 -41.31 77.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.088 -0.505 . . . . 2.43 111.075 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.5 m -63.37 -39.41 94.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.983 -0.553 . . . . 1.47 110.202 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.44 -37.71 83.39 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.331 -0.395 . . . . 0.93 110.479 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 131' ' ' VAL . 41.5 t -61.46 -51.68 70.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 110.023 -0.362 . . . . 0.8 110.023 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.56 69.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.772 -0.649 . . . . 0.85 111.048 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -66.31 -42.45 88.24 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.009 -0.541 . . . . 1.39 110.271 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.53 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 51.8 mt-30 -62.59 -48.15 80.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.833 -0.621 . . . . 0.61 109.919 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 135' ' ' VAL . 29.0 mt-10 -62.37 -44.47 96.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.341 -0.845 . . . . 2.82 111.194 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -60.91 -46.99 88.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.849 -0.614 . . . . 1.95 111.514 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.55 -44.12 84.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.912 0.338 . . . . 0.65 111.912 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.38 -30.52 64.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.224 0.453 . . . . 0.61 112.224 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.4 -27.18 25.96 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.565 0.579 . . . . 0.72 112.565 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.17 -47.71 23.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.629 0.252 . . . . 1.39 110.565 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.5 p -80.76 -8.31 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.814 0.34 . . . . 1.34 110.764 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 58.21 58.53 3.45 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.735 -0.666 . . . . 1.95 110.435 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 149' ' ' GLY . 40.9 tp -67.13 111.74 4.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.461 -0.79 . . . . 0.71 110.803 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -87.31 -33.71 19.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.611 -0.722 . . . . 4.16 110.556 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.591 ' O ' ' HG ' ' A' ' 147' ' ' LEU . . . -93.9 173.61 33.56 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.989 -0.845 . . . . 0.68 110.989 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.557 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 4.6 t -102.89 -57.56 0.1 OUTLIER Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 117.865 0.832 . . . . 0.49 112.761 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 4.1 Cg_endo -85.27 70.16 5.27 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.231 1.954 . . . . 0.56 111.928 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.22 139.31 50.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.905 -0.589 . . . . 0.63 110.766 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 21.6 ttm -113.38 139.02 49.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.042 -0.526 . . . . 0.42 109.912 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -122.96 133.98 54.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.549 -0.296 . . . . 0.52 110.728 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.8 t -101.3 114.76 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.343 -0.389 . . . . 0.55 110.752 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.69 25.84 10.57 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.524 -0.762 . . . . 1.16 111.418 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.48 26.88 60.18 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.743 -0.662 . . . . 0.56 113.167 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 15' ' ' PRO . 30.1 mtmm -126.9 -39.23 1.97 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.099 0.407 . . . . 1.75 112.099 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -106.66 135.9 47.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.003 -0.279 . . . . 1.16 111.432 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -108.23 136.18 48.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.794 -0.639 . . . . 0.98 110.056 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.61 129.63 34.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.472 -0.331 . . . . 1.2 110.54 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -112.73 100.6 51.07 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.415 -0.357 . . . . 0.72 110.723 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.47 -15.32 34.4 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.685 2.257 . . . . 0.54 112.321 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -86.04 2.63 45.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.107 0.48 . . . . 2.22 111.02 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 7' ' ' LYS . . . -105.15 16.38 45.98 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.006 -0.616 . . . . 0.59 111.592 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 40.1 mtt -127.67 166.21 18.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.0 -0.37 . . . . 0.57 110.0 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -80.81 133.4 35.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.381 -0.372 . . . . 1.54 111.132 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.475 ' O ' ' I1 ' ' A' ' 201' ' ' SFQ . 0.2 OUTLIER -98.78 -3.16 36.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.15 -0.477 . . . . 1.16 111.744 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.1 m -67.22 -36.21 81.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.874 0.368 . . . . 1.53 110.814 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -118.33 111.12 18.32 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.235 -0.654 . . . . 1.21 109.235 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 42.9 mtt -66.08 -40.83 91.14 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.488 0.551 . . . . 1.96 112.488 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -60.46 -50.28 74.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.808 0.337 . . . . 2.05 111.15 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.99 -38.91 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.967 -0.56 . . . . 0.65 110.472 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -62.81 -53.38 55.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.47 110.908 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 70.2 t -58.3 -48.32 85.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.98 -0.555 . . . . 0.48 111.312 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 61.6 mm-40 -64.67 -40.13 94.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.602 -0.272 . . . . 1.7 111.548 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -64.22 -43.89 93.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.069 -0.345 . . . . 1.32 110.069 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.427 ' O ' HG23 ' A' ' 182' ' ' VAL . 20.4 t80 -57.37 -54.23 49.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.46 110.289 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.83 85.09 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.97 -0.559 . . . . 0.43 111.787 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -67.21 -37.64 83.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.594 -0.276 . . . . 1.55 110.584 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 37.8 m -61.73 -42.6 99.17 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.047 0.451 . . . . 0.48 109.911 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 178' ' ' TYR . 49.0 t -61.49 -47.64 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.672 -0.695 . . . . 0.48 110.274 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 187' ' ' GLU . 34.4 tttp -56.84 -53.38 58.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.818 -0.628 . . . . 1.59 110.948 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -54.68 -41.66 70.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.423 -0.353 . . . . 1.17 111.33 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.55 -38.65 67.92 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.938 0.348 . . . . 0.68 111.938 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 35.2 p -65.86 -35.34 80.37 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.103 -0.239 . . . . 1.07 111.608 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 183' ' ' LYS . 12.3 pt-20 -93.84 15.94 15.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.105 0.478 . . . . 2.26 111.334 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -115.55 105.77 13.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.224 -0.444 . . . . 1.72 110.26 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 40.8 tttp . . . . . 0 C--O 1.254 1.301 0 CA-C-O 118.267 -0.873 . . . . 4.33 110.604 -179.745 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SFQ . . . . . 0.649 ' C13' ' HE2' ' A' ' 32' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 110.334 -0.247 . . . . 4.08 110.334 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.62 131.51 40.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.671 -0.492 . . . . 3.58 109.671 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -134.09 112.03 10.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.826 0.346 . . . . 1.32 110.322 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -110.22 140.96 43.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.051 -0.522 . . . . 2.29 109.812 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -69.88 122.01 18.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.531 -0.544 . . . . 1.83 109.531 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.579 ' HA2' HG23 ' A' ' 10' ' ' THR . . . 97.94 -11.36 64.21 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.939 -0.648 . . . . 0.78 111.607 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -95.68 -83.16 0.37 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.493 0.187 . . . . 1.87 110.736 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.495 ' HG2' HE21 ' A' ' 177' ' ' GLN . 23.9 mp0 -84.57 -25.31 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.08 0.467 . . . . 1.46 110.52 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -142.98 153.9 43.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.819 -0.628 . . . . 0.79 109.627 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.579 HG23 ' HA2' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -127.38 133.52 50.01 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.398 -0.364 . . . . 0.9 110.563 -179.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.5 m -87.83 126.7 35.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.9 0.381 . . . . 1.11 111.051 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.1 mt -85.51 140.84 30.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.448 -0.342 . . . . 0.74 110.39 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -20.28 46.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.981 0.419 . . . . 2.33 110.116 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -118.98 93.93 47.46 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.88 -0.6 . . . . 3.64 109.955 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.69 145.23 12.84 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.681 2.254 . . . . 0.85 112.847 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.1 t -80.56 113.84 20.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.828 -0.623 . . . . 0.72 110.22 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.0 128.77 37.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.424 . . . . 0.89 111.36 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.47 16.17 74.32 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.86 -0.609 . . . . 0.73 112.91 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.9 144.58 79.94 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 116.697 0.248 . . . . 0.64 110.616 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 14.8 Cg_endo -60.15 160.98 20.78 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.606 2.204 . . . . 0.56 112.051 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.485 ' NE2' ' HA ' ' A' ' 54' ' ' VAL . 46.4 mt-30 -57.1 -51.34 69.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.843 -0.617 . . . . 1.79 111.245 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.6 t -128.18 104.5 11.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.837 -0.431 . . . . 0.45 109.837 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.544 HD21 ' HB1' ' A' ' 141' ' ' ALA . 46.3 tp -102.97 132.89 48.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.632 -0.713 . . . . 0.53 110.746 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.89 150.82 49.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.366 -0.379 . . . . 1.61 110.065 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -122.71 148.29 45.48 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.465 -0.334 . . . . 0.53 110.72 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.01 173.55 15.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.136 -0.484 . . . . 0.55 110.591 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.54 ' OG ' HG22 ' A' ' 61' ' ' VAL . 52.5 m -154.47 132.42 11.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.134 -0.484 . . . . 0.96 110.651 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.585 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 67.5 m-85 -66.81 -20.68 65.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.62 111.012 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.77 2.89 54.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 1.78 111.04 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 32' ' ' HIS . 40.5 t -108.41 119.82 48.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.328 -0.396 . . . . 0.48 110.658 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.33 -27.73 63.42 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.615 2.21 . . . . 0.7 112.105 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.494 ' HE2' ' C13' ' A' ' 201' ' ' SFQ . 0.1 OUTLIER -64.85 -47.26 78.58 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.583 -0.735 . . . . 1.74 109.984 179.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.7 m -63.82 -37.31 86.9 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.801 0.334 . . . . 0.37 110.528 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -60.89 -51.98 66.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 1.44 109.942 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -65.0 -35.03 79.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.394 -0.821 . . . . 2.27 111.549 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -62.61 -29.69 70.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.928 0.714 . . . . 0.87 112.928 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -105.92 -35.32 7.34 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.705 -0.398 . . . . 1.89 111.397 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -43.35 60.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.825 0.345 . . . . 2.0 111.847 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.81 -58.01 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.166 0.432 . . . . 0.58 112.166 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.3 mt -69.85 -37.24 76.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.37 0.507 . . . . 0.41 112.37 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 63.42 42.4 6.78 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.04 -0.356 . . . . 0.84 110.04 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.3 mm -61.38 -58.39 7.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.096 -0.502 . . . . 0.41 111.21 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.563 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 1.5 m -61.95 -44.31 97.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.745 -0.465 . . . . 1.03 109.745 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.52 ' O ' ' HE3' ' A' ' 48' ' ' LYS . 24.1 t70 -54.99 -44.42 74.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.235 -0.893 . . . . 1.73 111.186 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -69.37 -43.53 73.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.631 -0.258 . . . . 1.19 111.051 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 54.9 t -58.87 -36.9 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.49 110.427 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 43' ' ' SER . 56.9 mttt -56.18 -31.76 63.72 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.361 -0.382 . . . . 1.53 111.202 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' A' ' 44' ' ' ASP . 16.6 mttt -109.73 8.9 24.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 2.02 111.705 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -121.58 21.03 11.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.69 0.281 . . . . 1.44 111.164 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 34.7 mt -104.83 153.03 39.62 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.738 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 50' ' ' LEU . 3.1 Cg_exo -75.17 161.17 38.68 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.722 2.281 . . . . 0.74 111.654 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -65.24 134.45 53.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.965 0.412 . . . . 2.63 110.916 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.53 -17.29 58.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.57 -0.824 . . . . 0.82 111.945 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.485 ' HA ' ' NE2' ' A' ' 21' ' ' GLN . 90.7 t -95.85 125.91 48.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 1.03 110.936 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -110.54 155.9 21.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.305 -0.407 . . . . 2.51 109.997 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.6 ttt -108.16 132.03 54.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.181 -0.463 . . . . 1.28 110.512 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.18 112.34 18.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.134 -0.485 . . . . 0.61 110.576 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -96.58 129.43 43.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.91 -0.586 . . . . 0.86 109.843 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.46 ' CG ' ' HG2' ' A' ' 138' ' ' GLN . 6.8 m-30 -118.16 160.95 20.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.158 0.504 . . . . 0.71 111.634 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -111.54 133.12 54.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.644 -0.707 . . . . 0.57 110.224 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.54 HG22 ' OG ' ' A' ' 27' ' ' SER . 2.7 m -85.83 162.36 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.575 0.226 . . . . 0.68 110.591 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -113.34 21.4 15.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.388 0.514 . . . . 0.93 112.388 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -120.06 16.53 12.46 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.6 -0.44 . . . . 0.74 111.643 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 75.3 mmm -135.09 106.95 7.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.236 -0.438 . . . . 1.09 110.936 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.55 13.72 9.39 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.946 -0.645 . . . . 0.78 112.59 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.67 -147.89 31.5 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.455 -0.878 . . . . 0.81 111.854 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -81.99 -19.28 40.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 2.47 110.863 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.25 -16.32 63.42 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.397 0.617 . . . . 1.94 109.9 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.56 -30.36 77.38 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.502 -0.772 . . . . 0.7 111.422 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -64.0 -44.32 92.99 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.968 0.413 . . . . 2.69 110.106 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.25 -41.72 97.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.824 -0.626 . . . . 1.65 109.961 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.04 -32.52 74.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.706 -0.679 . . . . 1.17 110.827 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.4 m -68.67 -40.77 80.01 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.042 0.449 . . . . 0.62 110.365 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -42.81 71.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 1.21 109.762 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.21 92.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.925 -0.579 . . . . 0.71 110.942 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -62.53 -38.9 91.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.242 -0.435 . . . . 0.59 110.253 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.439 ' HB3' HG13 ' A' ' 131' ' ' VAL . . . -63.41 -34.62 78.14 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.833 -0.432 . . . . 0.71 109.833 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -64.96 -44.11 96.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.729 -0.669 . . . . 0.84 109.575 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.83 -38.29 87.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.66 -0.7 . . . . 0.66 111.043 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.2 mtm -65.31 -25.97 67.85 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.825 0.345 . . . . 1.08 111.345 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.18 -29.52 24.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.99 110.718 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 68.6 mt -82.7 -36.0 26.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.898 -0.592 . . . . 0.97 111.368 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.49 23.51 21.28 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.886 -0.673 . . . . 0.78 112.635 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 88' ' ' VAL . 13.6 m -121.25 18.73 5.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 122.705 -0.291 . . . . 0.81 110.989 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -53.42 -60.59 3.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.559 -0.746 . . . . 1.71 111.749 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.25 -35.13 67.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.72 -0.673 . . . . 1.91 112.116 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -74.45 -43.29 56.85 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.011 0.374 . . . . 2.28 112.011 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 84' ' ' VAL . 28.6 m -80.68 -2.87 5.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.414 -0.514 . . . . 0.65 111.807 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 m -59.31 -48.25 82.34 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.823 0.305 . . . . 0.98 111.823 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.449 ' HB ' ' CD ' ' A' ' 91' ' ' PRO . 22.0 t -61.33 -59.09 14.69 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.191 0.441 . . . . 0.62 112.191 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.449 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 9.5 Cg_endo -54.39 -33.93 78.86 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.276 1.984 . . . . 0.61 112.446 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 28' ' ' PHE . 10.6 mt -66.88 -52.79 39.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.439 -0.346 . . . . 0.79 110.435 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 1.9 m-85 -58.21 -45.84 86.92 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.936 0.398 . . . . 0.58 110.401 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.13 -48.53 78.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.716 -0.675 . . . . 1.7 110.426 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.31 -7.04 43.48 Favored Glycine 0 C--O 1.223 -0.579 0 CA-C-N 116.153 -0.476 . . . . 0.82 113.644 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 50.2 t -105.14 -49.2 9.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 117.412 0.606 . . . . 0.75 112.014 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -99.42 -50.12 4.21 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.629 0.603 . . . . 0.84 112.629 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -69.14 -70.91 0.25 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.46 0.541 . . . . 1.41 112.46 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.46 ' HB ' ' OG1' ' A' ' 101' ' ' THR . 0.2 OUTLIER -79.84 -31.89 40.55 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.259 0.466 . . . . 1.31 112.259 -178.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 64.58 29.36 13.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.096 0.474 . . . . 1.44 110.992 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.46 ' OG1' ' HB ' ' A' ' 99' ' ' THR . 0.2 OUTLIER -69.51 -31.25 69.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.572 -0.74 . . . . 1.57 111.328 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.409 ' HA ' ' CB ' ' A' ' 107' ' ' ASP . 48.6 mt -88.68 105.71 16.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.894 -0.594 . . . . 0.91 111.661 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -122.72 -12.02 8.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.458 -0.792 . . . . 3.22 109.095 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.0 164.41 30.68 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.868 -1.06 . . . . 1.51 109.704 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.06 -25.5 68.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 1.08 111.177 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -33.01 72.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.54 -0.755 . . . . 1.43 110.489 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.409 ' CB ' ' HA ' ' A' ' 102' ' ' ILE . 32.7 m-20 -72.55 -38.8 67.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.84 -0.618 . . . . 1.89 110.253 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 108' ' ' ILE . 9.3 mt -62.04 -37.97 79.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.221 -0.659 . . . . 0.9 109.221 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.657 ' O ' HG12 ' A' ' 113' ' ' ILE . 72.8 ttt-85 -57.88 -47.2 83.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.845 -1.07 . . . . 2.19 110.357 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.93 -35.41 80.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.163 -0.471 . . . . 1.95 110.764 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.18 -43.34 97.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.053 0.454 . . . . 0.88 110.384 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.74 -41.0 96.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.077 -0.51 . . . . 0.92 110.309 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.657 HG12 ' O ' ' A' ' 109' ' ' ARG . 20.3 mm -64.49 -31.36 53.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.268 0.556 . . . . 1.33 109.733 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -69.25 -16.6 63.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.887 -0.597 . . . . 1.93 111.403 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.02 -5.63 47.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.406 -0.361 . . . . 1.1 111.389 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 109.8 4.11 29.98 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.462 -0.875 . . . . 1.15 112.616 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.5 mm -80.41 138.07 20.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.698 -0.482 . . . . 1.61 109.698 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 121' ' ' GLU . 39.1 mttt -75.12 150.82 38.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.657 -0.247 . . . . 2.73 110.452 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -58.3 -52.7 51.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.017 -0.611 . . . . 1.19 112.692 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -66.83 -20.76 65.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.62 0.23 . . . . 2.98 111.62 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 118' ' ' LYS . 10.8 tp10 -68.41 -49.19 61.79 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.216 0.532 . . . . 2.52 109.747 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 109' ' ' ARG . 82.8 t80 -67.3 -42.43 83.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.382 -0.826 . . . . 1.51 109.807 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.33 -42.04 90.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 2.3 111.048 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.79 -46.39 72.1 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.026 -0.533 . . . . 1.23 110.846 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.21 89.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.03 -0.532 . . . . 1.11 111.526 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -56.63 -30.54 63.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.349 -0.387 . . . . 1.31 111.321 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -111.22 23.07 14.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.35 -0.386 . . . . 1.63 110.834 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.8 m -91.63 149.54 21.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.963 0.411 . . . . 2.04 111.655 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -65.21 -40.87 94.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.58 . . . . 3.82 110.484 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 81.1 t -55.66 -50.0 70.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 1.53 110.559 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 77' ' ' ALA . 54.3 t -64.34 -46.88 91.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.666 -0.697 . . . . 1.11 111.091 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -55.57 -41.59 73.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.232 0.539 . . . . 2.43 110.919 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.9 m -68.05 -36.07 79.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.906 -0.588 . . . . 1.47 111.018 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.426 ' O ' ' HG3' ' A' ' 138' ' ' GLN . 94.6 mt -67.39 -39.38 85.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.779 0.323 . . . . 0.93 110.657 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 81.2 t -60.29 -45.94 95.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.366 -0.379 . . . . 0.8 110.517 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.59 83.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.85 111.082 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -70.22 -34.32 72.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 1.39 110.627 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.46 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 47.6 mt-30 -63.99 -49.67 71.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.61 109.936 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.37 -33.7 76.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.496 -0.775 . . . . 2.82 110.207 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -67.01 -54.54 20.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.734 -0.666 . . . . 1.95 110.68 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.544 ' HB1' HD21 ' A' ' 23' ' ' LEU . . . -53.33 -48.23 68.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 0.65 112.22 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.29 94.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.934 0.397 . . . . 0.61 111.769 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.98 -31.98 39.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.007 0.373 . . . . 0.72 112.007 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -42.67 98.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.332 -0.394 . . . . 1.39 111.892 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 141' ' ' ALA . 35.3 m -85.6 -0.87 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.405 -0.361 . . . . 1.34 111.606 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 59.03 53.67 5.43 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.557 0.694 . . . . 1.95 109.989 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.5 tp -65.33 120.66 13.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.996 -1.002 . . . . 0.71 111.481 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -103.21 -34.32 8.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.063 -0.517 . . . . 4.16 110.085 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -95.93 -169.11 35.07 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 110.921 -0.872 . . . . 0.68 110.921 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.522 ' HB ' ' HD3' ' A' ' 151' ' ' PRO . 3.0 t -111.75 -56.85 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.304 -0.558 . . . . 0.49 111.435 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.522 ' HD3' ' HB ' ' A' ' 150' ' ' VAL . 1.1 Cg_endo -84.35 72.75 4.93 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.457 2.105 . . . . 0.56 111.701 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.5 144.78 46.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.051 -0.522 . . . . 0.63 110.922 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.2 ttm -121.47 133.02 55.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.165 -0.47 . . . . 0.42 110.102 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.95 124.65 43.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.213 -0.449 . . . . 0.52 109.92 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.33 117.1 32.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.889 0.376 . . . . 0.55 110.839 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 58.12 16.68 4.01 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.376 -0.829 . . . . 1.16 111.531 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 64.8 22.47 68.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.85 -0.691 . . . . 0.56 112.019 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -120.46 -42.06 2.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.08 0.467 . . . . 1.75 110.73 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -104.29 129.39 52.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 1.16 111.612 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -109.33 126.87 53.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.431 -0.804 . . . . 0.98 109.45 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.13 139.83 32.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.09 0.471 . . . . 1.2 111.09 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -114.33 100.91 53.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.872 -0.604 . . . . 0.72 109.91 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.58 -19.28 37.17 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.477 2.118 . . . . 0.54 112.568 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.512 HE21 ' C10' ' A' ' 201' ' ' SFQ . 5.6 mm-40 -80.9 -4.61 55.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.95 0.405 . . . . 2.22 110.674 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -115.3 26.99 8.77 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.808 -0.71 . . . . 0.59 112.004 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 46.3 mtt -115.12 166.93 11.28 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.656 -0.272 . . . . 0.57 110.349 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -71.48 100.34 2.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.147 0.499 . . . . 1.54 109.997 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.72 26.86 2.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.782 -0.644 . . . . 1.16 112.118 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.3 p -74.95 -35.47 62.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.452 0.644 . . . . 1.53 110.585 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.437 ' HB3' HG23 ' A' ' 173' ' ' VAL . 21.0 t30 -143.36 129.12 19.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.611 -0.722 . . . . 1.21 109.614 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 175' ' ' VAL . 1.9 mmm -56.74 -34.51 67.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.414 -0.357 . . . . 1.96 111.378 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -39.97 89.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.331 0.586 . . . . 2.05 110.48 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 170' ' ' ASN . 38.2 t -69.08 -43.65 81.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.65 -0.705 . . . . 0.65 110.551 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -53.5 -46.17 69.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.207 -0.906 . . . . 0.47 111.463 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 171' ' ' MET . 61.1 t -57.76 -51.48 69.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.975 0.416 . . . . 0.48 111.417 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 82.6 mm-40 -66.01 -44.8 83.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 1.7 111.458 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.495 HE21 ' HG2' ' A' ' 8' ' ' GLN . 52.8 tt0 -60.98 -45.68 93.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.653 -0.249 . . . . 1.32 111.17 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 182' ' ' VAL . 15.6 t80 -59.48 -53.04 62.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.877 0.37 . . . . 0.46 110.497 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.39 -36.86 85.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.43 112.016 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 2.8 t0 -65.33 -36.56 84.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.046 0.45 . . . . 1.55 110.379 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 51.7 m -63.16 -42.46 99.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.868 -0.605 . . . . 0.48 109.925 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 178' ' ' TYR . 44.2 t -62.8 -42.49 96.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.158 -0.474 . . . . 0.48 110.33 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -62.37 -32.31 73.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.393 -0.821 . . . . 1.59 111.0 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.3 -46.3 20.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.278 -0.419 . . . . 1.17 110.817 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.58 -34.51 75.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.462 0.541 . . . . 0.68 112.462 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.5 p -71.61 -21.41 61.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.95 0.352 . . . . 1.07 111.95 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -103.7 -7.83 20.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.104 0.478 . . . . 2.26 110.703 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -79.49 -29.13 41.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.432 -0.803 . . . . 1.72 110.536 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.501 -0.761 . . . . 4.33 109.957 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SFQ . . . . . 0.558 ' N1 ' ' O4 ' ' A' ' 201' ' ' SFQ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_